data_2l76_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2l76 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 4.1 mp . . . . . 0 N--CA 1.477 0.884 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' PHE . . . . . 0.457 ' CE1' ' HG2' ' A' ' 282' ' ' MET . 31.4 p90 -147.85 152.5 40.8 Favored Pre-proline 0 CA--C 1.544 0.73 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 174.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -69.27 93.64 0.48 Allowed 'Trans proline' 0 C--N 1.371 1.747 0 C-N-CA 122.383 2.055 . . . . 0.0 111.634 173.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 267' ' ' LEU . . . . . 0.506 HD13 HG13 ' A' ' 269' ' ' ILE . 1.3 tm? -60.28 127.55 32.34 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 173.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . 0.426 ' HG2' HG12 ' A' ' 329' ' ' ILE . 4.1 tppp? -91.7 103.96 16.48 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 123.763 0.665 . . . . 0.0 110.438 -179.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . 0.506 HG13 HD13 ' A' ' 267' ' ' LEU . 1.4 mp -101.82 146.14 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 174.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 27.8 ttp180 -106.7 118.89 37.86 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 172.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 271' ' ' CYS . . . . . 0.56 ' SG ' HD23 ' A' ' 297' ' ' LEU . 13.7 t -73.92 -158.33 0.06 Allowed 'General case' 0 CA--C 1.562 1.407 0 C-N-CA 124.473 1.109 . . . . 0.0 109.638 172.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 -64.94 -31.04 72.09 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 122.828 0.451 . . . . 0.0 111.791 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -160.27 22.91 0.16 Allowed 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -175.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -152.93 162.11 41.72 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 122.752 0.421 . . . . 0.0 110.596 -172.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.411 HD13 ' HD2' ' A' ' 268' ' ' LYS . 76.3 mt -107.19 129.06 54.91 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.627 0.771 . . . . 0.0 110.948 176.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 46.5 t -115.79 138.61 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.467 1.107 . . . . 0.0 108.668 174.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . 0.423 ' HA ' ' O ' ' A' ' 267' ' ' LEU . 74.5 mtm180 -116.65 130.42 56.72 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.654 0.781 . . . . 0.0 109.598 173.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . 0.442 HD23 ' HA ' ' A' ' 289' ' ' VAL . 4.6 pp -128.63 144.99 54.33 Favored Pre-proline 0 N--CA 1.488 1.436 0 CA-C-O 119.245 -0.407 . . . . 0.0 110.229 172.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -71.95 117.87 5.35 Favored 'Trans proline' 0 C--N 1.379 2.142 0 C-N-CA 122.467 2.111 . . . . 0.0 110.677 178.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.658 HD21 ' HG3' ' A' ' 319' ' ' PRO . 0.2 OUTLIER -144.87 148.41 33.92 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.877 0.871 . . . . 0.0 110.103 -174.45 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 87.7 mtm180 -86.4 152.28 22.84 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.99 0.916 . . . . 0.0 109.781 176.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 282' ' ' MET . . . . . 0.457 ' HG2' ' CE1' ' A' ' 265' ' ' PHE . 11.2 mtp -66.72 -31.77 72.64 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.127 0.489 . . . . 0.0 109.926 176.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 39.0 p -77.04 -18.96 57.75 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.855 1.262 . . . . 0.0 111.93 177.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -70.45 128.39 91.24 Favored Pre-proline 0 N--CA 1.475 0.813 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 176.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -65.65 161.55 38.23 Favored 'Trans proline' 0 C--N 1.377 2.033 0 C-N-CA 122.116 1.877 . . . . 0.0 111.554 174.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 58.5 mt -64.63 -10.76 28.83 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 118.83 -0.605 . . . . 0.0 112.272 -178.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 -52.45 -27.49 16.31 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.614 0.765 . . . . 0.0 111.864 176.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 288' ' ' SER . . . . . 0.409 ' HB3' HD12 ' A' ' 280' ' ' LEU . 46.8 t -60.69 -57.06 14.3 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.831 0.852 . . . . 0.0 111.084 172.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.442 ' HA ' HD23 ' A' ' 278' ' ' LEU . 15.8 m -69.18 -30.21 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 122.494 0.317 . . . . 0.0 110.749 -178.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . 0.558 HG12 ' HB ' ' A' ' 304' ' ' ILE . 45.1 t -64.1 -52.37 57.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 124.323 1.049 . . . . 0.0 110.705 179.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -61.74 -43.72 98.3 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.293 1.037 . . . . 0.0 110.694 -179.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 54.5 t60 -68.09 -45.26 74.23 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.045 -176.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 293' ' ' MET . . . . . 0.466 ' HB3' ' SG ' ' A' ' 332' ' ' CYS . 92.9 mmm -68.77 -32.21 71.8 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 123.543 0.527 . . . . 0.0 110.908 178.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -64.42 -43.94 92.78 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.335 0.654 . . . . 0.0 110.557 177.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 52.5 m -68.45 -31.72 71.22 Favored 'General case' 0 CA--C 1.554 1.106 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.562 177.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -73.33 -39.01 65.57 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.304 1.041 . . . . 0.0 111.723 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 297' ' ' LEU . . . . . 0.56 HD23 ' SG ' ' A' ' 271' ' ' CYS . 71.4 mt -94.16 -8.6 38.95 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.852 0.861 . . . . 0.0 111.467 -176.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 76.15 20.89 76.9 Favored Glycine 0 C--N 1.349 1.258 0 O-C-N 123.505 0.503 . . . . 0.0 113.496 178.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 30.1 m -111.75 176.97 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 124.229 1.012 . . . . 0.0 110.865 -177.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 48.9 m -80.08 143.65 57.42 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 123.361 0.664 . . . . 0.0 110.005 175.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -54.16 -28.72 52.74 Favored 'Trans proline' 0 C--N 1.39 2.726 0 C-N-CA 123.228 2.619 . . . . 0.0 112.691 173.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 39.5 t -64.46 -27.55 69.07 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 122.925 0.49 . . . . 0.0 111.62 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 61.3 mtt180 -82.59 -20.08 37.16 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.562 0.745 . . . . 0.0 111.684 -176.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 304' ' ' ILE . . . . . 0.633 HD11 ' SG ' ' A' ' 332' ' ' CYS . 42.6 mm -76.68 125.56 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 123.152 0.581 . . . . 0.0 110.763 -176.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 37.9 tp -126.52 120.76 30.47 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.934 0.894 . . . . 0.0 108.664 174.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -85.64 134.67 33.98 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 177.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . 0.45 HD22 ' HA ' ' A' ' 312' ' ' GLU . 94.2 mt -136.94 106.7 6.21 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.636 0.774 . . . . 0.0 109.975 -175.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -87.51 95.44 10.03 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 175.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 74.72 -80.74 0.9 Allowed Glycine 0 C--N 1.339 0.73 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.438 178.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -135.6 -5.65 2.24 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.966 0.906 . . . . 0.0 111.856 -177.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 11.6 t -89.37 148.91 23.25 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 117.987 0.358 . . . . 0.0 110.48 -177.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . 0.45 ' HA ' HD22 ' A' ' 307' ' ' LEU . 38.8 tt0 -98.64 110.74 23.29 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.363 0.665 . . . . 0.0 109.628 -178.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 44.7 mt -95.42 167.75 11.13 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.742 0.417 . . . . 0.0 110.012 177.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 53.2 m -134.4 154.94 80.11 Favored Pre-proline 0 N--CA 1.48 1.06 0 C-N-CA 123.187 0.595 . . . . 0.0 109.963 -177.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . 0.519 ' HB3' HG23 ' A' ' 290' ' ' VAL . 26.9 Cg_endo -58.43 -26.94 80.0 Favored 'Trans proline' 0 C--N 1.385 2.465 0 C-N-CA 123.31 2.674 . . . . 0.0 113.309 177.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 20.8 m -78.5 -29.03 46.41 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 123.668 0.787 . . . . 0.0 111.406 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -66.48 143.42 57.1 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.75 0.82 . . . . 0.0 111.126 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 318' ' ' THR . . . . . . . . . . . . . 36.1 p -108.26 135.82 19.9 Favored Pre-proline 0 N--CA 1.475 0.788 0 C-N-CA 123.318 0.647 . . . . 0.0 111.072 -177.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 319' ' ' PRO . . . . . 0.658 ' HG3' HD21 ' A' ' 280' ' ' LEU . 6.4 Cg_endo -47.35 -23.04 2.91 Favored 'Trans proline' 0 C--N 1.375 1.96 0 C-N-CA 124.824 3.683 . . . . 0.0 115.088 172.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 30.3 ttt180 -60.54 -62.25 2.0 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.156 0.582 . . . . 0.0 110.834 175.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 8.9 t -68.49 -30.35 69.17 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 122.66 0.384 . . . . 0.0 111.151 -178.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 322' ' ' LEU . . . . . 0.446 ' HB2' ' HG ' ' A' ' 324' ' ' LEU . 86.4 mt -78.55 -17.91 55.44 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.288 0.635 . . . . 0.0 111.868 -178.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 83.7 tttt 64.01 38.81 8.36 Favored 'General case' 0 CA--C 1.562 1.432 0 C-N-CA 124.158 0.983 . . . . 0.0 110.882 -177.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . 0.446 ' HG ' ' HB2' ' A' ' 322' ' ' LEU . 31.7 mt -78.52 162.6 26.21 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 122.921 0.488 . . . . 0.0 110.141 175.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . -166.49 -160.79 14.24 Favored Glycine 0 C--N 1.341 0.808 0 CA-C-N 116.325 -0.398 . . . . 0.0 112.887 -173.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 24.7 m -77.97 -31.68 16.98 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 C-N-CA 124.046 0.938 . . . . 0.0 111.062 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -98.65 -19.01 17.77 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.959 0.903 . . . . 0.0 110.701 178.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -87.2 108.25 18.84 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 -177.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . 0.426 HG12 ' HG2' ' A' ' 268' ' ' LYS . 7.7 mt -104.53 134.5 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 123.463 0.705 . . . . 0.0 111.254 -165.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 34.6 pt -120.05 127.08 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 123.225 0.61 . . . . 0.0 111.225 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -76.66 116.43 17.34 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.849 0.859 . . . . 0.0 111.251 -177.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 332' ' ' CYS . . . . . 0.633 ' SG ' HD11 ' A' ' 304' ' ' ILE . 36.2 t -82.77 98.42 9.1 Favored 'General case' 0 C--O 1.243 0.752 0 C-N-CA 123.587 0.755 . . . . 0.0 109.851 172.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 59.2 t -108.84 125.57 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 123.449 0.699 . . . . 0.0 109.792 -176.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 61.3 t -86.23 111.09 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.23 0.612 . . . . 0.0 109.401 177.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 60.7 mt . . . . . 0 N--CA 1.474 0.737 0 C-N-CA 123.57 0.748 . . . . 0.0 111.263 177.614 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 1.5 mp . . . . . 0 CA--C 1.541 0.612 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -113.46 149.04 40.94 Favored Pre-proline 0 N--CA 1.475 0.791 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 172.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' PRO . . . . . 0.506 ' HB2' ' HB3' ' A' ' 277' ' ' ARG . 56.8 Cg_endo -69.06 97.41 0.57 Allowed 'Trans proline' 0 C--N 1.372 1.765 0 C-N-CA 122.275 1.984 . . . . 0.0 111.892 175.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.01 119.25 13.01 Favored 'General case' 0 C--N 1.35 0.603 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 171.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 24.6 ttpt -95.73 109.09 21.44 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 121.652 0.739 . . . . 0.0 111.133 -178.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 2.8 mp -100.51 143.86 13.42 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 C-N-CA 125.083 1.353 . . . . 0.0 108.118 176.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 37.2 ttp180 -106.15 95.88 6.08 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 123.315 0.646 . . . . 0.0 109.94 178.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 271' ' ' CYS . . . . . 0.54 ' SG ' HD22 ' A' ' 297' ' ' LEU . 44.6 t -71.92 178.82 3.5 Favored 'General case' 0 C--O 1.245 0.827 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.827 170.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -59.5 -31.35 69.28 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.523 0.729 . . . . 0.0 111.995 177.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -147.38 14.71 1.12 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 122.843 0.457 . . . . 0.0 112.187 -177.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -137.31 129.58 29.52 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 122.806 0.443 . . . . 0.0 110.556 -174.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 24.1 mt -95.5 90.86 5.91 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 164.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 58.6 t -82.48 122.7 37.49 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.861 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.163 -175.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . 0.506 ' HB3' ' HB2' ' A' ' 266' ' ' PRO . 77.0 mtm180 -116.13 75.54 0.96 Allowed 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . 0.513 HD12 HG12 ' A' ' 289' ' ' VAL . 4.6 pp -85.58 147.66 47.11 Favored Pre-proline 0 N--CA 1.483 1.204 0 CA-C-O 119.527 -0.273 . . . . 0.0 110.826 -172.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -69.17 118.48 5.7 Favored 'Trans proline' 0 C--N 1.374 1.92 0 C-N-CA 122.112 1.875 . . . . 0.0 110.719 175.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.592 HD23 ' HG3' ' A' ' 319' ' ' PRO . 0.8 OUTLIER -143.24 147.89 35.55 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.861 0.864 . . . . 0.0 110.242 -178.537 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 25.5 mmm180 -96.97 143.57 27.71 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.236 1.015 . . . . 0.0 109.045 174.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 282' ' ' MET . . . . . 0.554 ' HE3' ' HD2' ' A' ' 323' ' ' LYS . 44.1 mtp -61.06 -39.57 90.37 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 122.839 0.456 . . . . 0.0 111.813 -177.078 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 53.7 m -67.44 -25.37 65.88 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.6 0.76 . . . . 0.0 111.584 178.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 284' ' ' GLU . . . . . 0.401 ' HG3' ' HG ' ' A' ' 288' ' ' SER . 10.7 tp10 -77.67 126.08 84.91 Favored Pre-proline 0 CA--C 1.546 0.797 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 173.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 285' ' ' PRO . . . . . 0.566 ' HA ' ' HA ' ' A' ' 318' ' ' THR . 60.2 Cg_endo -66.51 174.81 5.83 Favored 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 122.421 2.081 . . . . 0.0 113.682 -176.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.407 ' O ' HG22 ' A' ' 289' ' ' VAL . 90.8 mt -65.74 -13.2 58.87 Favored 'General case' 0 C--O 1.21 -1.007 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.643 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 26.5 tp60 -55.24 -24.08 25.88 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.198 0.599 . . . . 0.0 111.589 177.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 288' ' ' SER . . . . . 0.512 ' HB2' HD12 ' A' ' 280' ' ' LEU . 22.3 m -68.67 -47.68 65.89 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.941 0.897 . . . . 0.0 111.221 174.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.513 HG12 HD12 ' A' ' 278' ' ' LEU . 13.8 m -69.92 -34.91 62.15 Favored 'Isoleucine or valine' 0 C--N 1.365 1.253 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 177.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . 0.549 HG12 ' HB ' ' A' ' 304' ' ' ILE . 54.0 t -63.77 -43.62 98.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 124.594 1.157 . . . . 0.0 110.733 179.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -63.27 -45.7 90.29 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 124.088 0.868 . . . . 0.0 110.065 -179.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 24.6 t60 -63.43 -49.53 73.35 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.211 178.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 293' ' ' MET . . . . . 0.465 ' HE2' ' HB2' ' A' ' 271' ' ' CYS . 85.5 mmm -68.19 -33.03 73.68 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 123.669 0.606 . . . . 0.0 111.057 -175.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -65.58 -47.16 76.71 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.373 0.669 . . . . 0.0 110.327 176.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 29.3 m -64.44 -38.23 90.29 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 123.403 0.681 . . . . 0.0 111.104 177.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 78.9 t60 -67.0 -39.24 87.05 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.341 1.056 . . . . 0.0 111.047 -178.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 297' ' ' LEU . . . . . 0.54 HD22 ' SG ' ' A' ' 271' ' ' CYS . 40.8 mt -95.93 -3.63 44.88 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.845 0.858 . . . . 0.0 111.416 -178.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 71.65 14.33 75.14 Favored Glycine 0 N--CA 1.476 1.333 0 C-N-CA 123.075 0.369 . . . . 0.0 113.769 177.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 299' ' ' VAL . . . . . 0.47 HG11 HG13 ' A' ' 334' ' ' VAL . 33.0 m -101.91 173.41 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.042 0.937 . . . . 0.0 110.624 -178.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 300' ' ' SER . . . . . 0.435 ' HB2' ' HG3' ' A' ' 303' ' ' ARG . 16.5 m -79.97 151.59 73.46 Favored Pre-proline 0 CA--C 1.555 1.162 0 C-N-CA 123.141 0.576 . . . . 0.0 110.042 178.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -56.08 -29.11 73.07 Favored 'Trans proline' 0 C--N 1.385 2.459 0 C-N-CA 123.193 2.595 . . . . 0.0 113.216 177.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 33.5 t -69.31 -18.71 63.85 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.633 0.373 . . . . 0.0 111.212 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 303' ' ' ARG . . . . . 0.435 ' HG3' ' HB2' ' A' ' 300' ' ' SER . 52.1 mtt-85 -90.17 -12.91 36.79 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.246 0.618 . . . . 0.0 111.811 -174.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 304' ' ' ILE . . . . . 0.549 ' HB ' HG12 ' A' ' 290' ' ' VAL . 49.7 mm -86.77 117.59 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 122.944 0.498 . . . . 0.0 110.233 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 40.3 tp -114.02 120.08 39.37 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.665 0.786 . . . . 0.0 109.205 174.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . 0.433 ' HA ' ' O ' ' A' ' 331' ' ' ASP . 2.8 mm? -91.36 136.74 32.89 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 177.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . 0.495 HD21 ' HA ' ' A' ' 312' ' ' GLU . 75.5 mt -134.28 106.96 7.38 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.602 0.761 . . . . 0.0 109.471 -177.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . 0.527 ' HB2' HD11 ' A' ' 313' ' ' LEU . 44.8 t80 -85.84 90.28 8.01 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -178.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 64.94 -88.89 0.09 OUTLIER Glycine 0 C--N 1.349 1.289 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.818 -178.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -129.9 70.26 1.43 Allowed 'General case' 0 C--O 1.242 0.705 0 C-N-CA 124.191 0.996 . . . . 0.0 109.667 176.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 10.0 t -169.23 150.87 4.45 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.691 0.796 . . . . 0.0 109.533 170.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . 0.495 ' HA ' HD21 ' A' ' 307' ' ' LEU . 36.3 tt0 -92.97 134.48 35.07 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 177.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . 0.527 HD11 ' HB2' ' A' ' 308' ' ' PHE . 49.7 mt -117.52 149.7 40.18 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.014 0.526 . . . . 0.0 110.551 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 50.9 m -108.24 149.88 39.8 Favored Pre-proline 0 CA--C 1.551 1.016 0 C-N-CA 123.688 0.795 . . . . 0.0 110.472 179.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . 0.529 ' HB3' HG21 ' A' ' 290' ' ' VAL . 12.1 Cg_endo -56.14 -39.94 88.03 Favored 'Trans proline' 0 C--N 1.383 2.349 0 C-N-CA 123.325 2.684 . . . . 0.0 112.639 173.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 41.7 p -75.5 -18.23 59.88 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.22 0.608 . . . . 0.0 112.182 -177.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -74.27 142.61 45.26 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.102 0.561 . . . . 0.0 109.493 174.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 318' ' ' THR . . . . . 0.566 ' HA ' ' HA ' ' A' ' 285' ' ' PRO . 75.5 p -98.28 146.27 31.25 Favored Pre-proline 0 N--CA 1.473 0.71 0 C-N-CA 122.977 0.511 . . . . 0.0 110.533 -176.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 319' ' ' PRO . . . . . 0.592 ' HG3' HD23 ' A' ' 280' ' ' LEU . 31.6 Cg_endo -62.07 -14.33 36.96 Favored 'Trans proline' 0 C--N 1.365 1.418 0 C-N-CA 122.903 2.402 . . . . 0.0 111.962 168.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . 0.501 ' HA ' ' HE2' ' A' ' 282' ' ' MET . 43.6 ttt85 -61.55 -58.21 9.03 Favored 'General case' 0 C--N 1.352 0.711 0 C-N-CA 123.505 0.722 . . . . 0.0 110.761 172.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 10.1 t -66.83 -32.36 73.59 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 122.544 0.338 . . . . 0.0 111.461 -178.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 322' ' ' LEU . . . . . . . . . . . . . 47.7 mt -77.95 -20.66 52.31 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.311 0.644 . . . . 0.0 111.21 177.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 323' ' ' LYS . . . . . 0.554 ' HD2' ' HE3' ' A' ' 282' ' ' MET . 20.7 tptm 55.14 63.19 2.19 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.397 1.479 . . . . 0.0 110.914 -174.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 76.4 mt -90.25 170.05 10.6 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.04 178.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 325' ' ' GLY . . . . . 0.425 ' H ' ' HB2' ' A' ' 328' ' ' ASP . . . -162.54 -161.14 11.78 Favored Glycine 0 C--N 1.339 0.729 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.047 -171.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 31.5 m -76.89 -19.75 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 123.633 0.773 . . . . 0.0 111.872 -176.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -111.52 -17.34 13.09 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.833 0.853 . . . . 0.0 111.424 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 328' ' ' ASP . . . . . 0.425 ' HB2' ' H ' ' A' ' 325' ' ' GLY . 49.0 m-20 -75.71 101.05 4.88 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 177.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 46.1 mt -95.29 134.54 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 123.567 0.747 . . . . 0.0 110.404 -175.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 37.4 pt -121.97 127.23 75.3 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.929 0 C-N-CA 123.568 0.747 . . . . 0.0 110.114 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 331' ' ' ASP . . . . . 0.433 ' O ' ' HA ' ' A' ' 306' ' ' LEU . 5.1 m-20 -74.46 126.99 31.93 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.042 0.937 . . . . 0.0 111.778 -175.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 332' ' ' CYS . . . . . 0.473 ' SG ' HD12 ' A' ' 304' ' ' ILE . 52.5 t -93.76 93.41 7.97 Favored 'General case' 0 C--O 1.244 0.794 0 C-N-CA 123.983 0.913 . . . . 0.0 109.74 175.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 71.8 t -100.42 122.47 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 123.53 0.732 . . . . 0.0 109.573 177.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 334' ' ' VAL . . . . . 0.47 HG13 HG11 ' A' ' 299' ' ' VAL . 94.0 t -87.78 112.92 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 122.906 0.482 . . . . 0.0 110.265 177.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 84.0 mt . . . . . 0 N--CA 1.47 0.559 0 C-N-CA 124.069 0.948 . . . . 0.0 109.093 171.532 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 3.4 mp . . . . . 0 C--O 1.24 0.583 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -106.56 147.6 35.27 Favored Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 123.839 0.856 . . . . 0.0 109.111 176.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -63.84 95.58 0.2 Allowed 'Trans proline' 0 C--N 1.376 1.988 0 C-N-CA 122.478 2.118 . . . . 0.0 111.812 172.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' LEU . . . . . 0.474 HD11 HG13 ' A' ' 269' ' ' ILE . 1.5 tm? -62.89 130.59 45.5 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 173.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . 0.53 ' HG2' HG12 ' A' ' 329' ' ' ILE . 3.8 tppp? -94.51 107.39 19.37 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 123.539 0.736 . . . . 0.0 110.244 -177.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . 0.474 HG13 HD11 ' A' ' 267' ' ' LEU . 2.1 mp -106.56 131.96 55.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 175.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 270' ' ' ARG . . . . . 0.414 ' HB2' ' CG2' ' A' ' 329' ' ' ILE . 26.4 ttm180 -91.63 111.38 22.88 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 171.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 271' ' ' CYS . . . . . 0.59 ' SG ' HD22 ' A' ' 297' ' ' LEU . 16.5 t -75.53 -166.69 0.57 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 122.634 0.373 . . . . 0.0 110.222 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 272' ' ' ARG . . . . . 0.433 ' HG2' ' SG ' ' A' ' 271' ' ' CYS . 23.4 ptt180 -53.55 -27.76 27.88 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.354 1.062 . . . . 0.0 112.992 172.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -139.3 -63.49 0.52 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.019 0.528 . . . . 0.0 111.502 -177.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -107.48 163.44 13.05 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 123.692 0.797 . . . . 0.0 111.191 -170.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.515 HD13 ' HD2' ' A' ' 268' ' ' LYS . 96.0 mt -78.7 127.18 31.74 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 123.828 0.851 . . . . 0.0 111.898 -179.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 85.7 t -99.66 139.31 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 170.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . 0.42 ' HD3' ' HE2' ' A' ' 268' ' ' LYS . 62.9 mtm180 -128.19 122.49 31.97 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.794 0.838 . . . . 0.0 108.915 177.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 4.2 pp -131.08 139.65 36.19 Favored Pre-proline 0 N--CA 1.485 1.293 0 CA-C-O 119.379 -0.343 . . . . 0.0 110.52 177.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -70.77 107.62 2.09 Favored 'Trans proline' 0 C--N 1.382 2.313 0 C-N-CA 122.622 2.215 . . . . 0.0 110.618 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.609 HD22 ' HG3' ' A' ' 319' ' ' PRO . 0.1 OUTLIER -124.92 151.94 44.73 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.214 1.006 . . . . 0.0 110.274 -175.933 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . 0.558 ' HB2' ' HB2' ' A' ' 284' ' ' GLU . 58.5 mtm180 -89.97 153.82 20.31 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.973 0.909 . . . . 0.0 109.688 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 282' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -66.54 -44.55 82.08 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 122.572 0.349 . . . . 0.0 110.591 178.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 49.9 m -70.39 -20.3 62.95 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.39 0.676 . . . . 0.0 112.061 178.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 284' ' ' GLU . . . . . 0.558 ' HB2' ' HB2' ' A' ' 281' ' ' ARG . 6.7 tp10 -65.57 126.34 91.39 Favored Pre-proline 0 CA--C 1.542 0.639 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 176.191 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -65.06 168.25 14.32 Favored 'Trans proline' 0 C--N 1.368 1.595 0 C-N-CA 121.98 1.786 . . . . 0.0 111.707 172.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 62.6 mt -64.95 -15.43 62.15 Favored 'General case' 0 C--O 1.214 -0.809 0 CA-C-O 118.837 -0.601 . . . . 0.0 111.263 -178.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 287' ' ' GLN . . . . . 0.462 ' HA ' ' HB ' ' A' ' 290' ' ' VAL . 24.0 tp60 -52.25 -23.54 5.86 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 123.71 0.804 . . . . 0.0 112.402 178.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 288' ' ' SER . . . . . 0.491 ' HB3' HD13 ' A' ' 280' ' ' LEU . 37.9 t -58.61 -60.95 3.0 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.337 0.655 . . . . 0.0 110.69 168.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 15.2 m -68.98 -29.82 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 122.821 0.448 . . . . 0.0 111.065 -178.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . 0.466 HG13 ' HB ' ' A' ' 304' ' ' ILE . 76.4 t -66.46 -51.85 53.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 123.782 0.833 . . . . 0.0 109.974 -178.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -70.18 -37.95 75.28 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.815 0.846 . . . . 0.0 111.017 -178.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 13.1 t60 -66.04 -50.65 63.43 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.033 0.533 . . . . 0.0 110.142 -178.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 293' ' ' MET . . . . . 0.41 ' HG3' HG23 ' A' ' 269' ' ' ILE . 94.6 mmm -63.68 -37.3 86.82 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 123.8 0.687 . . . . 0.0 110.784 178.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -61.48 -51.27 69.36 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 123.847 0.717 . . . . 0.0 111.591 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 9.8 m -68.22 -30.84 70.0 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 123.186 0.595 . . . . 0.0 110.838 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -71.45 -35.39 70.88 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.577 0.751 . . . . 0.0 111.26 178.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 297' ' ' LEU . . . . . 0.59 HD22 ' SG ' ' A' ' 271' ' ' CYS . 95.9 mt -96.14 -10.62 27.79 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.745 0.818 . . . . 0.0 112.007 -177.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 80.29 16.84 75.37 Favored Glycine 0 CA--C 1.534 1.227 0 O-C-N 123.379 0.424 . . . . 0.0 113.485 178.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 299' ' ' VAL . . . . . 0.476 HG13 HG13 ' A' ' 334' ' ' VAL . 28.7 m -109.17 173.92 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 124.08 0.952 . . . . 0.0 111.003 178.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 22.8 m -80.07 147.32 65.2 Favored Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 123.306 0.643 . . . . 0.0 110.724 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.09 -23.49 73.56 Favored 'Trans proline' 0 C--N 1.383 2.394 0 C-N-CA 122.72 2.28 . . . . 0.0 112.334 170.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 48.6 p -69.95 -15.41 63.04 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-O 121.041 0.448 . . . . 0.0 111.574 176.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -102.98 -15.56 16.08 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.106 0.962 . . . . 0.0 111.824 -175.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 304' ' ' ILE . . . . . 0.572 HD12 ' SG ' ' A' ' 332' ' ' CYS . 36.2 mm -83.84 110.06 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 176.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 37.5 tp -114.08 114.93 26.77 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.614 0.766 . . . . 0.0 109.362 178.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . 0.424 ' HG ' HD12 ' A' ' 330' ' ' ILE . 3.2 mm? -86.99 124.14 32.85 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . 0.43 HD13 HG21 ' A' ' 333' ' ' VAL . 41.3 mt -133.88 108.86 8.68 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . 0.487 ' HB2' HG23 ' A' ' 330' ' ' ILE . 71.0 t80 -75.67 86.82 2.72 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 174.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 68.17 -84.99 0.17 Allowed Glycine 0 C--N 1.349 1.257 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.963 -179.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -133.66 75.24 1.59 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.319 1.048 . . . . 0.0 109.11 177.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 15.2 t -159.1 151.75 21.72 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.318 1.047 . . . . 0.0 108.309 171.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -104.13 114.41 28.63 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 122.856 0.462 . . . . 0.0 109.868 -176.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 30.1 mt -117.88 142.78 46.94 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.199 0.6 . . . . 0.0 109.92 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 60.7 m -109.31 159.49 31.13 Favored Pre-proline 0 CA--C 1.556 1.203 0 C-N-CA 123.808 0.843 . . . . 0.0 110.952 -178.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_exo -56.86 -32.07 90.93 Favored 'Trans proline' 0 C--N 1.39 2.739 0 C-N-CA 123.202 2.601 . . . . 0.0 112.573 172.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 45.7 p -70.65 -29.6 65.99 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 114.922 -1.035 . . . . 0.0 111.715 -179.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -68.02 138.24 55.7 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.628 0.771 . . . . 0.0 110.706 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 318' ' ' THR . . . . . . . . . . . . . 71.2 p -98.49 140.23 21.68 Favored Pre-proline 0 CA--C 1.543 0.702 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 178.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 319' ' ' PRO . . . . . 0.609 ' HG3' HD22 ' A' ' 280' ' ' LEU . 19.8 Cg_endo -55.2 -17.12 14.41 Favored 'Trans proline' 0 C--N 1.367 1.512 0 C-N-CA 123.529 2.819 . . . . 0.0 112.878 171.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 50.5 ttt-85 -67.43 -55.85 12.02 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.441 0.696 . . . . 0.0 110.395 172.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 13.7 t -71.32 -22.01 61.99 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.633 0.373 . . . . 0.0 111.427 -177.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 322' ' ' LEU . . . . . 0.466 ' HB2' ' HG ' ' A' ' 324' ' ' LEU . 58.2 mt -90.9 -16.63 27.83 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.412 0.685 . . . . 0.0 110.996 177.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 19.7 tptm 65.45 32.31 9.65 Favored 'General case' 0 CA--C 1.562 1.416 0 C-N-CA 124.962 1.305 . . . . 0.0 111.408 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . 0.466 ' HG ' ' HB2' ' A' ' 322' ' ' LEU . 33.8 mt -69.8 172.5 7.54 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 123.605 0.762 . . . . 0.0 111.175 178.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . -167.9 -164.64 23.93 Favored Glycine 0 C--N 1.347 1.152 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.942 -177.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 33.1 m -73.6 -28.81 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 124.168 0.987 . . . . 0.0 111.578 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -88.35 -25.86 22.52 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.533 0.733 . . . . 0.0 111.053 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 328' ' ' ASP . . . . . 0.434 ' O ' ' HB3' ' A' ' 268' ' ' LYS . 12.9 t70 -76.87 130.46 37.62 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.077 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . 0.53 HG12 ' HG2' ' A' ' 268' ' ' LYS . 5.9 mt -121.87 99.63 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 122.984 0.513 . . . . 0.0 110.605 -171.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 330' ' ' ILE . . . . . 0.487 HG23 ' HB2' ' A' ' 308' ' ' PHE . 25.0 pt -87.54 126.78 41.17 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 C-N-CA 122.679 0.392 . . . . 0.0 111.086 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -79.05 118.33 20.93 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.552 0.741 . . . . 0.0 110.588 -175.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 332' ' ' CYS . . . . . 0.572 ' SG ' HD12 ' A' ' 304' ' ' ILE . 43.2 t -78.04 90.1 4.2 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.439 1.096 . . . . 0.0 110.191 176.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . 0.43 HG21 HD13 ' A' ' 307' ' ' LEU . 74.0 t -94.75 110.68 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 123.322 0.649 . . . . 0.0 109.355 -177.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 334' ' ' VAL . . . . . 0.476 HG13 HG13 ' A' ' 299' ' ' VAL . 62.0 t -81.42 94.53 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 CA-C-O 121.319 0.58 . . . . 0.0 110.014 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 60.3 mt . . . . . 0 CA--C 1.546 0.799 0 C-N-CA 124.536 1.134 . . . . 0.0 108.971 170.745 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 2.9 mp . . . . . 0 N--CA 1.483 1.175 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' PHE . . . . . 0.464 ' CE1' ' HG2' ' A' ' 282' ' ' MET . 28.0 p90 -109.32 146.15 33.33 Favored Pre-proline 0 CA--C 1.55 0.948 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 176.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -64.19 98.65 0.27 Allowed 'Trans proline' 0 C--N 1.378 2.091 0 C-N-CA 122.573 2.182 . . . . 0.0 111.904 171.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' LEU . . . . . 0.532 HD13 HG13 ' A' ' 269' ' ' ILE . 1.2 tm? -61.8 130.43 45.7 Favored 'General case' 0 C--O 1.244 0.8 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 172.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . 0.403 ' O ' ' HA ' ' A' ' 329' ' ' ILE . 3.3 tppp? -94.55 104.43 16.38 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . 0.532 HG13 HD13 ' A' ' 267' ' ' LEU . 2.9 mp -97.86 133.81 38.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 123.334 0.653 . . . . 0.0 109.257 176.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 270' ' ' ARG . . . . . 0.593 ' HB3' ' HA ' ' A' ' 331' ' ' ASP . 5.4 tpm_? -85.16 106.47 16.63 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 170.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 271' ' ' CYS . . . . . 0.471 ' SG ' HD23 ' A' ' 297' ' ' LEU . 41.8 t -74.28 176.8 6.33 Favored 'General case' 0 C--O 1.247 0.935 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 170.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -51.1 -36.11 38.63 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.235 1.014 . . . . 0.0 112.756 -178.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -156.62 22.9 0.34 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.179 0.592 . . . . 0.0 111.608 178.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -146.97 179.99 7.21 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 178.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.527 HD23 ' HA ' ' A' ' 270' ' ' ARG . 91.5 mt -121.11 126.3 49.41 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.018 0.927 . . . . 0.0 109.729 174.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 97.7 t -100.01 141.7 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 124.121 0.969 . . . . 0.0 108.522 174.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 39.4 mtt180 -128.5 122.74 31.86 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 178.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . 0.456 HD12 HG13 ' A' ' 289' ' ' VAL . 4.2 pp -134.86 143.32 45.78 Favored Pre-proline 0 N--CA 1.491 1.587 0 CA-C-N 118.139 0.427 . . . . 0.0 110.925 176.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.33 120.28 6.86 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 122.498 2.132 . . . . 0.0 110.865 175.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.625 HD21 ' HG3' ' A' ' 319' ' ' PRO . 0.0 OUTLIER -141.96 145.87 34.99 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.828 0.851 . . . . 0.0 109.932 -177.15 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . 0.406 ' HB2' ' HB2' ' A' ' 284' ' ' GLU . 48.5 mtt85 -79.35 147.71 32.31 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.835 0.854 . . . . 0.0 108.729 176.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 282' ' ' MET . . . . . 0.544 ' HE3' ' HA ' ' A' ' 320' ' ' ARG . 26.8 mtp -66.62 -32.03 73.1 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 118.292 0.497 . . . . 0.0 109.878 174.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 38.8 p -72.06 -29.19 63.89 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.716 1.207 . . . . 0.0 112.007 178.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 284' ' ' GLU . . . . . 0.45 ' O ' ' HD2' ' A' ' 319' ' ' PRO . 18.5 tp10 -66.46 129.85 94.15 Favored Pre-proline 0 N--CA 1.474 0.772 0 C-N-CA 124.282 1.033 . . . . 0.0 109.269 177.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -65.07 166.5 18.54 Favored 'Trans proline' 0 C--N 1.377 2.037 0 C-N-CA 122.012 1.808 . . . . 0.0 111.567 174.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 71.7 mt -65.59 -11.63 45.91 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 118.65 -0.691 . . . . 0.0 112.292 -177.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 287' ' ' GLN . . . . . 0.436 ' HA ' ' HB ' ' A' ' 290' ' ' VAL . 22.9 tp60 -55.62 -22.06 20.66 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.167 0.587 . . . . 0.0 112.013 178.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 288' ' ' SER . . . . . 0.463 ' HB3' HD12 ' A' ' 280' ' ' LEU . 33.5 t -60.34 -57.11 14.16 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 123.292 0.637 . . . . 0.0 110.566 170.021 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.456 HG13 HD12 ' A' ' 278' ' ' LEU . 18.1 m -71.83 -28.73 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 122.725 0.41 . . . . 0.0 111.531 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . 0.519 HG12 ' HB ' ' A' ' 304' ' ' ILE . 73.3 t -67.03 -51.12 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.809 0.844 . . . . 0.0 110.333 -179.151 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -69.8 -36.58 75.8 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.428 0.691 . . . . 0.0 111.44 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -66.21 -48.65 69.92 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.325 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 293' ' ' MET . . . . . 0.433 ' HG3' HG23 ' A' ' 269' ' ' ILE . 94.0 mmm -67.7 -29.17 68.36 Favored 'General case' 0 N--CA 1.479 0.976 0 O-C-N 123.918 0.761 . . . . 0.0 110.958 178.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -61.44 -49.5 76.59 Favored 'General case' 0 C--O 1.219 -0.516 0 O-C-N 123.65 0.594 . . . . 0.0 110.657 174.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 33.0 m -70.68 -31.81 68.83 Favored 'General case' 0 CA--C 1.549 0.909 0 O-C-N 123.512 0.508 . . . . 0.0 111.045 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 80.8 t60 -69.22 -35.49 76.23 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 123.733 0.813 . . . . 0.0 111.034 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 297' ' ' LEU . . . . . 0.471 HD23 ' SG ' ' A' ' 271' ' ' CYS . 67.7 mt -101.38 -4.07 27.61 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 124.052 0.941 . . . . 0.0 111.339 -179.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 78.63 12.08 84.6 Favored Glycine 0 C--N 1.351 1.398 0 C-N-CA 123.481 0.563 . . . . 0.0 114.073 173.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 299' ' ' VAL . . . . . 0.46 HG11 HG11 ' A' ' 334' ' ' VAL . 33.9 m -106.1 -176.53 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 124.266 1.026 . . . . 0.0 111.293 -178.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 42.7 m -84.29 148.29 52.46 Favored Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 123.749 0.82 . . . . 0.0 110.327 177.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -57.27 -30.58 88.06 Favored 'Trans proline' 0 C--N 1.379 2.166 0 C-N-CA 123.357 2.705 . . . . 0.0 112.144 172.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 20.4 m -70.5 -12.02 61.3 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 123.26 0.624 . . . . 0.0 112.006 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 75.8 mtt180 -95.94 -24.17 16.53 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.142 0.977 . . . . 0.0 110.923 176.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 304' ' ' ILE . . . . . 0.537 HD12 ' SG ' ' A' ' 332' ' ' CYS . 34.5 mm -78.45 122.9 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 123.016 0.526 . . . . 0.0 110.499 -178.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 36.8 tp -126.2 116.36 21.19 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.822 0.849 . . . . 0.0 109.033 177.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -85.06 135.06 34.16 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 177.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 74.3 mt -134.17 115.21 13.94 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.299 1.04 . . . . 0.0 109.208 -176.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -83.77 88.08 7.08 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 174.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 74.88 -81.87 0.87 Allowed Glycine 0 C--N 1.35 1.336 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.856 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -118.32 -32.13 4.75 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.07 0.948 . . . . 0.0 110.403 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 6.0 t -74.6 141.68 44.69 Favored 'General case' 0 C--O 1.245 0.859 0 CA-C-O 121.016 0.436 . . . . 0.0 110.249 -170.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -93.45 116.9 29.44 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.73 -175.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . 0.449 HD12 HD11 ' A' ' 322' ' ' LEU . 47.2 mt -95.67 164.87 12.59 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.784 0.434 . . . . 0.0 110.17 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 49.8 m -123.1 147.47 51.82 Favored Pre-proline 0 N--CA 1.479 1.015 0 C-N-CA 123.436 0.694 . . . . 0.0 109.734 -178.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -55.83 -29.02 70.36 Favored 'Trans proline' 0 C--N 1.383 2.36 0 C-N-CA 122.976 2.451 . . . . 0.0 113.036 173.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 29.4 p -76.01 -29.53 58.17 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.621 0.768 . . . . 0.0 111.837 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -65.6 143.5 57.57 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.141 0.576 . . . . 0.0 110.747 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 318' ' ' THR . . . . . . . . . . . . . 78.0 p -100.32 141.21 22.29 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 122.903 0.481 . . . . 0.0 110.408 -178.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 319' ' ' PRO . . . . . 0.625 ' HG3' HD21 ' A' ' 280' ' ' LEU . 19.2 Cg_endo -55.92 -16.89 17.21 Favored 'Trans proline' 0 C--N 1.37 1.708 0 C-N-CA 123.789 2.993 . . . . 0.0 113.48 171.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . 0.544 ' HA ' ' HE3' ' A' ' 282' ' ' MET . 53.0 ttt180 -67.66 -54.9 15.78 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 122.836 0.454 . . . . 0.0 110.346 175.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 13.7 t -71.09 -21.93 62.16 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 122.844 0.458 . . . . 0.0 111.97 -177.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 322' ' ' LEU . . . . . 0.449 HD11 HD12 ' A' ' 313' ' ' LEU . 53.8 mt -88.87 -18.92 26.59 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.648 0.779 . . . . 0.0 111.161 176.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 20.9 tptm 56.63 53.02 8.89 Favored 'General case' 0 CA--C 1.56 1.351 0 C-N-CA 125.044 1.337 . . . . 0.0 110.842 -175.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . 0.44 HD11 ' HB3' ' A' ' 319' ' ' PRO . 61.5 mt -79.71 164.84 23.41 Favored 'General case' 0 C--O 1.246 0.9 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.375 173.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . -160.08 -175.84 31.5 Favored Glycine 0 C--N 1.34 0.801 0 CA-C-N 116.372 -0.376 . . . . 0.0 113.087 -173.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 35.2 m -70.21 -28.93 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.119 0.968 . . . . 0.0 111.046 176.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -105.74 15.26 27.07 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.595 1.158 . . . . 0.0 110.658 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -123.8 124.81 43.52 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 177.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . 0.403 ' HA ' ' O ' ' A' ' 268' ' ' LYS . 3.1 mt -113.37 146.38 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 O-C-N 123.708 0.63 . . . . 0.0 110.622 -169.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 330' ' ' ILE . . . . . 0.405 HD12 HD13 ' A' ' 324' ' ' LEU . 24.1 pt -133.72 129.71 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 123.646 0.779 . . . . 0.0 110.944 179.025 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 331' ' ' ASP . . . . . 0.593 ' HA ' ' HB3' ' A' ' 270' ' ' ARG . 5.4 m-20 -74.56 114.43 12.96 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.75 1.22 . . . . 0.0 112.351 -173.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 332' ' ' CYS . . . . . 0.537 ' SG ' HD12 ' A' ' 304' ' ' ILE . 42.6 t -83.46 97.48 9.01 Favored 'General case' 0 C--O 1.243 0.729 0 C-N-CA 124.246 1.018 . . . . 0.0 110.136 173.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 89.0 t -102.1 122.5 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 123.747 0.819 . . . . 0.0 109.936 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 334' ' ' VAL . . . . . 0.46 HG11 HG11 ' A' ' 299' ' ' VAL . 90.2 t -85.62 102.93 11.99 Favored 'Isoleucine or valine' 0 C--O 1.242 0.683 0 C-N-CA 123.176 0.591 . . . . 0.0 109.514 175.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 81.1 mt . . . . . 0 C--O 1.242 0.693 0 C-N-CA 123.349 0.659 . . . . 0.0 109.753 171.708 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . 0.404 HD12 ' HB2' ' A' ' 279' ' ' PRO . 0.4 OUTLIER . . . . . 0 N--CA 1.474 0.772 0 CA-C-O 121.357 0.599 . . . . 0.0 110.361 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' PHE . . . . . 0.527 ' CE1' ' SD ' ' A' ' 282' ' ' MET . 11.0 p90 -130.9 149.15 72.89 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 124.409 1.083 . . . . 0.0 108.942 -172.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 266' ' ' PRO . . . . . 0.521 ' HB2' ' HB3' ' A' ' 277' ' ' ARG . 45.7 Cg_endo -66.03 92.28 0.26 Allowed 'Trans proline' 0 C--N 1.369 1.656 0 C-N-CA 122.42 2.08 . . . . 0.0 112.086 173.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 267' ' ' LEU . . . . . 0.463 HD13 HG13 ' A' ' 269' ' ' ILE . 1.6 tm? -61.52 127.51 31.81 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 170.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . 0.488 ' HG2' HG12 ' A' ' 329' ' ' ILE . 3.9 ttpt -91.08 111.65 23.21 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-O 121.5 0.666 . . . . 0.0 110.699 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . 0.49 HG23 ' HG3' ' A' ' 293' ' ' MET . 1.9 mp -106.81 133.59 50.94 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 C-N-CA 124.198 0.999 . . . . 0.0 108.306 176.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 270' ' ' ARG . . . . . 0.575 ' HB2' HG21 ' A' ' 329' ' ' ILE . 28.2 ttp180 -99.97 101.08 12.08 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 123.924 0.889 . . . . 0.0 109.997 178.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 271' ' ' CYS . . . . . 0.743 ' SG ' HD23 ' A' ' 297' ' ' LEU . 49.0 t -70.05 177.43 3.21 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.918 172.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 272' ' ' ARG . . . . . 0.531 ' HG2' ' SG ' ' A' ' 271' ' ' CYS . 38.8 ptt180 -43.14 -40.84 3.43 Favored 'General case' 0 CA--C 1.559 1.299 0 C-N-CA 125.372 1.469 . . . . 0.0 113.147 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -152.03 6.09 0.43 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.588 0.755 . . . . 0.0 111.31 174.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -115.57 158.09 23.15 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.449 1.1 . . . . 0.0 109.848 -174.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -119.76 117.87 29.36 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.533 0.733 . . . . 0.0 109.45 175.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 276' ' ' VAL . . . . . 0.421 HG23 ' SD ' ' A' ' 293' ' ' MET . 67.8 t -102.04 137.89 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.168 0.987 . . . . 0.0 108.452 171.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . 0.521 ' HB3' ' HB2' ' A' ' 266' ' ' PRO . 83.7 mtm180 -128.37 95.66 4.21 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 173.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . 0.489 HD22 ' HA ' ' A' ' 289' ' ' VAL . 4.2 pp -109.74 142.45 25.82 Favored Pre-proline 0 N--CA 1.487 1.403 0 CA-C-O 119.39 -0.338 . . . . 0.0 110.868 -173.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 279' ' ' PRO . . . . . 0.404 ' HB2' HD12 ' A' ' 264' ' ' LEU . 73.4 Cg_endo -70.69 86.74 0.7 Allowed 'Trans proline' 0 C--N 1.383 2.361 0 C-N-CA 122.945 2.43 . . . . 0.0 112.279 -176.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.625 HD21 ' HG3' ' A' ' 319' ' ' PRO . 3.0 tt -95.94 144.43 26.26 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 114.768 -1.105 . . . . 0.0 109.502 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . 0.568 ' HB2' ' HB2' ' A' ' 284' ' ' GLU . 32.3 mtm180 -90.0 143.73 26.53 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.943 0.897 . . . . 0.0 110.415 178.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 282' ' ' MET . . . . . 0.527 ' SD ' ' CE1' ' A' ' 265' ' ' PHE . 87.2 mmm -64.18 -33.38 75.67 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 122.803 0.441 . . . . 0.0 111.621 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 35.6 t -86.94 -0.82 57.2 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.469 0.708 . . . . 0.0 111.524 178.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 284' ' ' GLU . . . . . 0.568 ' HB2' ' HB2' ' A' ' 281' ' ' ARG . 6.8 tp10 -91.33 134.82 29.01 Favored Pre-proline 0 CA--C 1.538 0.488 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 174.086 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.07 170.71 8.62 Favored 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 121.897 1.732 . . . . 0.0 111.683 170.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 84.1 mt -67.53 -11.42 57.95 Favored 'General case' 0 C--O 1.219 -0.548 0 C-N-CA 123.153 0.581 . . . . 0.0 111.714 -178.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 287' ' ' GLN . . . . . 0.56 ' HA ' ' HB ' ' A' ' 290' ' ' VAL . 26.4 tp60 -55.05 -20.66 10.07 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 123.136 0.574 . . . . 0.0 111.95 175.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 288' ' ' SER . . . . . 0.555 ' HB3' HD13 ' A' ' 280' ' ' LEU . 47.4 t -60.7 -54.62 43.04 Favored 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 123.011 0.524 . . . . 0.0 111.19 169.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.489 ' HA ' HD22 ' A' ' 278' ' ' LEU . 34.9 m -69.83 -35.56 65.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 CA-C-N 117.716 0.235 . . . . 0.0 110.974 177.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . 0.56 ' HB ' ' HA ' ' A' ' 287' ' ' GLN . 76.9 t -61.2 -41.9 91.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 123.995 0.918 . . . . 0.0 111.078 -179.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -69.88 -47.48 62.44 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.694 0.798 . . . . 0.0 110.837 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 292' ' ' HIS . . . . . 0.459 ' HB3' HD21 ' A' ' 278' ' ' LEU . 9.8 t60 -71.68 -36.64 70.67 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.135 -174.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 293' ' ' MET . . . . . 0.49 ' HG3' HG23 ' A' ' 269' ' ' ILE . 95.6 mmm -72.36 -29.88 64.2 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.367 0.667 . . . . 0.0 110.514 177.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -63.35 -44.7 94.09 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 123.776 0.673 . . . . 0.0 110.847 175.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 24.2 m -70.85 -31.38 68.06 Favored 'General case' 0 CA--C 1.552 1.026 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.052 176.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -71.66 -30.14 65.4 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.959 0.904 . . . . 0.0 111.709 179.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 297' ' ' LEU . . . . . 0.743 HD23 ' SG ' ' A' ' 271' ' ' CYS . 50.1 mt -107.73 -5.68 17.24 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 124.009 0.924 . . . . 0.0 111.892 -176.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 72.86 22.4 79.1 Favored Glycine 0 CA--C 1.531 1.072 0 O-C-N 123.573 0.546 . . . . 0.0 113.198 177.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 299' ' ' VAL . . . . . 0.465 HG12 HG11 ' A' ' 334' ' ' VAL . 22.7 m -114.45 179.92 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 124.513 1.125 . . . . 0.0 110.341 -176.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 48.3 t -81.42 145.54 55.58 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 123.554 0.742 . . . . 0.0 110.29 177.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -57.6 -29.91 86.8 Favored 'Trans proline' 0 C--N 1.376 2.004 0 C-N-CA 122.72 2.28 . . . . 0.0 111.815 167.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 38.7 t -67.65 -13.87 62.45 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 123.491 0.716 . . . . 0.0 111.1 179.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -106.15 -17.11 14.42 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.216 1.006 . . . . 0.0 112.264 -178.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 304' ' ' ILE . . . . . 0.543 HD13 ' SG ' ' A' ' 332' ' ' CYS . 30.1 mm -77.49 112.58 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 CA-C-O 120.775 0.322 . . . . 0.0 110.145 176.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 41.6 tp -114.43 127.65 55.94 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.696 0.798 . . . . 0.0 108.992 175.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -95.9 133.65 39.82 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 176.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . 0.457 HD21 ' HA ' ' A' ' 312' ' ' GLU . 46.0 mt -140.38 111.54 7.12 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.437 1.095 . . . . 0.0 108.294 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . 0.508 ' HB2' HG22 ' A' ' 330' ' ' ILE . 68.9 t80 -81.33 82.55 7.15 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 173.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 69.87 -94.36 0.43 Allowed Glycine 0 C--N 1.35 1.317 0 CA-C-N 114.827 -1.079 . . . . 0.0 112.586 -175.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -95.76 -31.36 13.24 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.604 0.762 . . . . 0.0 112.407 -174.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 14.6 t -77.77 151.87 33.83 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.68 0.392 . . . . 0.0 111.151 -172.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . 0.457 ' HA ' HD21 ' A' ' 307' ' ' LEU . 33.3 tt0 -98.12 122.21 40.99 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 176.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 29.7 mt -110.08 114.78 28.56 Favored 'General case' 0 C--O 1.243 0.752 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 49.5 m -77.98 139.79 61.76 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 123.755 0.822 . . . . 0.0 110.699 -178.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . 0.465 ' HB3' HG22 ' A' ' 290' ' ' VAL . 43.4 Cg_exo -57.52 -28.38 80.6 Favored 'Trans proline' 0 C--N 1.386 2.536 0 C-N-CA 123.317 2.678 . . . . 0.0 112.886 174.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 56.3 p -74.71 -25.97 59.5 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.052 0.941 . . . . 0.0 111.828 -178.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -81.38 156.02 25.64 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.431 0.692 . . . . 0.0 111.084 -178.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 318' ' ' THR . . . . . . . . . . . . . 71.6 p -98.54 159.29 30.84 Favored Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 123.691 0.796 . . . . 0.0 110.334 -177.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 319' ' ' PRO . . . . . 0.625 ' HG3' HD21 ' A' ' 280' ' ' LEU . 92.0 Cg_endo -70.28 -18.03 34.83 Favored 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 122.778 2.319 . . . . 0.0 112.042 174.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -65.82 -51.98 54.4 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.685 1.194 . . . . 0.0 109.944 -175.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 9.8 t -69.72 -23.83 63.47 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.559 179.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 322' ' ' LEU . . . . . 0.443 ' HB2' ' HG ' ' A' ' 324' ' ' LEU . 68.5 mt -91.12 -11.73 37.66 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.757 0.823 . . . . 0.0 111.974 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 48.9 tptt 55.31 46.98 22.42 Favored 'General case' 0 CA--C 1.565 1.541 0 C-N-CA 124.429 1.092 . . . . 0.0 111.339 -176.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . 0.443 ' HG ' ' HB2' ' A' ' 322' ' ' LEU . 46.6 mt -81.48 165.42 21.23 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.696 0.799 . . . . 0.0 109.478 175.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . -164.7 -171.7 31.26 Favored Glycine 0 C--N 1.34 0.769 0 CA-C-N 116.423 -0.353 . . . . 0.0 112.417 -176.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 28.3 m -69.6 -25.3 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 C-N-CA 123.617 0.767 . . . . 0.0 111.178 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -104.27 13.4 32.25 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.866 0.866 . . . . 0.0 111.344 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -109.25 127.66 54.44 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 177.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . 0.575 HG21 ' HB2' ' A' ' 270' ' ' ARG . 13.2 mt -120.72 99.14 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 O-C-N 123.798 0.686 . . . . 0.0 110.463 -164.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 330' ' ' ILE . . . . . 0.508 HG22 ' HB2' ' A' ' 308' ' ' PHE . 39.4 pt -100.31 127.18 53.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 123.371 0.668 . . . . 0.0 111.913 -173.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -71.94 116.92 12.91 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.116 0.967 . . . . 0.0 111.875 -173.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 332' ' ' CYS . . . . . 0.543 ' SG ' HD13 ' A' ' 304' ' ' ILE . 48.8 t -86.06 99.41 11.46 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.017 0.927 . . . . 0.0 109.901 174.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 47.0 t -103.9 115.86 46.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 C-N-CA 123.6 0.76 . . . . 0.0 109.004 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 334' ' ' VAL . . . . . 0.465 HG11 HG12 ' A' ' 299' ' ' VAL . 82.5 t -80.28 104.33 8.45 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 CA-C-O 120.942 0.401 . . . . 0.0 109.962 176.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 93.9 mt . . . . . 0 N--CA 1.468 0.464 0 C-N-CA 124.031 0.932 . . . . 0.0 109.092 173.529 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 3.7 mp . . . . . 0 C--O 1.238 0.473 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -101.94 150.24 37.24 Favored Pre-proline 0 CA--C 1.547 0.847 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 174.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.9 93.82 0.54 Allowed 'Trans proline' 0 C--N 1.375 1.964 0 C-N-CA 121.881 1.72 . . . . 0.0 111.292 176.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 267' ' ' LEU . . . . . 0.5 HD11 HG13 ' A' ' 269' ' ' ILE . 1.6 tm? -59.97 130.54 47.26 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 114.942 -1.026 . . . . 0.0 108.255 175.087 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . 0.461 ' HG2' HG12 ' A' ' 329' ' ' ILE . 4.0 tppp? -93.0 107.92 19.6 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.172 0.51 . . . . 0.0 110.421 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . 0.505 HG21 ' HG3' ' A' ' 293' ' ' MET . 2.4 mp -106.19 132.92 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 175.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 270' ' ' ARG . . . . . 0.52 ' HA ' HD23 ' A' ' 275' ' ' LEU . 18.3 ttm-85 -86.76 104.41 16.11 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 173.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 271' ' ' CYS . . . . . 0.609 ' SG ' HD22 ' A' ' 297' ' ' LEU . 49.6 t -68.77 176.22 3.16 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.581 0.752 . . . . 0.0 109.992 175.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -58.22 -23.19 54.98 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -174.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -163.62 36.04 0.09 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.467 0.707 . . . . 0.0 111.012 175.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -164.44 178.2 7.62 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.26 0.624 . . . . 0.0 110.116 -177.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.52 HD23 ' HA ' ' A' ' 270' ' ' ARG . 92.9 mt -119.89 119.92 34.92 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.115 0.966 . . . . 0.0 110.337 173.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 89.9 t -97.4 137.38 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.518 0.727 . . . . 0.0 109.088 173.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 73.3 mtt180 -118.96 108.68 15.06 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 173.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . 0.483 HD11 HG11 ' A' ' 289' ' ' VAL . 4.6 pp -114.91 144.12 31.39 Favored Pre-proline 0 N--CA 1.488 1.46 0 CA-C-N 118.42 0.555 . . . . 0.0 110.34 177.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -67.13 123.55 11.06 Favored 'Trans proline' 0 C--N 1.369 1.655 0 C-N-CA 122.641 2.227 . . . . 0.0 110.784 174.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.644 HD23 ' HG3' ' A' ' 319' ' ' PRO . 0.1 OUTLIER -150.33 141.31 22.93 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.561 0.744 . . . . 0.0 109.824 -179.225 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 40.0 mtm180 -82.46 156.87 23.86 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.43 0.692 . . . . 0.0 109.671 174.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 282' ' ' MET . . . . . 0.54 ' HE2' ' HA ' ' A' ' 320' ' ' ARG . 25.4 mtp -68.94 -31.66 70.71 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 175.014 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 23.6 p -68.6 -30.3 69.01 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.359 1.063 . . . . 0.0 111.833 176.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -68.85 128.35 92.86 Favored Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 123.601 0.76 . . . . 0.0 109.11 177.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -66.99 170.69 12.46 Favored 'Trans proline' 0 C--N 1.374 1.883 0 C-N-CA 122.33 2.02 . . . . 0.0 112.21 176.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 67.9 mt -66.56 -15.09 63.16 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-O 118.776 -0.63 . . . . 0.0 111.52 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 27.4 tp60 -53.19 -23.33 8.2 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 123.169 0.588 . . . . 0.0 112.023 176.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 288' ' ' SER . . . . . 0.491 ' HB3' HD11 ' A' ' 280' ' ' LEU . 23.2 t -65.49 -53.64 39.6 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.225 0.61 . . . . 0.0 111.129 173.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.483 HG11 HD11 ' A' ' 278' ' ' LEU . 17.7 m -68.81 -32.62 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-O 120.578 0.227 . . . . 0.0 110.408 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . 0.522 HG13 ' HB ' ' A' ' 304' ' ' ILE . 55.0 t -62.7 -51.49 71.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 124.015 0.926 . . . . 0.0 110.675 177.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -62.44 -49.2 76.4 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.226 1.01 . . . . 0.0 110.975 -178.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 21.9 t60 -64.4 -45.12 88.98 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.814 -176.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 293' ' ' MET . . . . . 0.505 ' HG3' HG21 ' A' ' 269' ' ' ILE . 97.1 mmm -71.72 -28.41 63.66 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.312 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -67.27 -42.66 83.49 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 122.621 0.368 . . . . 0.0 110.7 175.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 29.2 m -69.8 -36.18 75.45 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.443 178.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -69.98 -48.62 57.49 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.609 0.764 . . . . 0.0 110.963 -179.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 297' ' ' LEU . . . . . 0.609 HD22 ' SG ' ' A' ' 271' ' ' CYS . 96.2 mt -82.98 -16.83 45.68 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.795 0.838 . . . . 0.0 112.086 -175.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 76.11 33.55 49.44 Favored Glycine 0 C--N 1.345 1.041 0 O-C-N 123.435 0.459 . . . . 0.0 112.446 -179.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 14.9 m -120.34 176.39 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 124.411 1.085 . . . . 0.0 109.47 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 15.4 m -81.51 145.78 55.79 Favored Pre-proline 0 CA--C 1.547 0.848 0 CA-C-O 118.902 -0.571 . . . . 0.0 109.929 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -55.26 -34.01 86.82 Favored 'Trans proline' 0 C--N 1.389 2.688 0 C-N-CA 122.663 2.242 . . . . 0.0 111.767 173.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 70.2 m -63.63 -32.44 73.92 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 120.779 0.323 . . . . 0.0 110.738 -178.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -75.23 -23.75 57.6 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.877 0.871 . . . . 0.0 112.284 -178.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 304' ' ' ILE . . . . . 0.564 HD12 ' SG ' ' A' ' 332' ' ' CYS . 31.3 mm -73.64 101.72 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . 0.571 HD12 ' HG3' ' A' ' 312' ' ' GLU . 38.8 tp -103.99 116.94 33.16 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 173.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -87.89 135.55 33.35 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 177.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 69.3 mt -133.67 107.28 7.85 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -178.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . 0.44 ' HB2' HD11 ' A' ' 313' ' ' LEU . 61.1 t80 -79.0 88.41 4.77 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 177.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 67.71 -90.69 0.21 Allowed Glycine 0 C--N 1.346 1.11 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.431 -174.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -132.59 78.71 1.81 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.598 0.759 . . . . 0.0 109.627 -179.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 12.7 t -171.19 149.49 2.84 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.98 0.912 . . . . 0.0 109.287 175.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . 0.571 ' HG3' HD12 ' A' ' 305' ' ' LEU . 35.0 tt0 -91.86 119.2 31.43 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . 0.444 HD12 HD12 ' A' ' 322' ' ' LEU . 57.1 mt -107.42 123.68 48.74 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.23 179.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 29.5 m -82.6 150.44 62.97 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 123.789 0.836 . . . . 0.0 110.604 179.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . 0.517 ' HB3' HG21 ' A' ' 290' ' ' VAL . 22.1 Cg_endo -59.92 -25.46 79.54 Favored 'Trans proline' 0 C--N 1.381 2.255 0 C-N-CA 122.73 2.287 . . . . 0.0 112.875 172.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 42.4 p -84.69 -3.69 58.66 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.808 0.843 . . . . 0.0 112.274 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -85.8 148.18 25.96 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 122.901 0.48 . . . . 0.0 109.957 175.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 318' ' ' THR . . . . . . . . . . . . . 28.9 p -103.4 139.74 20.39 Favored Pre-proline 0 N--CA 1.476 0.845 0 C-N-CA 122.754 0.422 . . . . 0.0 110.865 178.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 319' ' ' PRO . . . . . 0.644 ' HG3' HD23 ' A' ' 280' ' ' LEU . 27.0 Cg_endo -57.88 -15.99 24.13 Favored 'Trans proline' 0 C--N 1.374 1.906 0 C-N-CA 123.856 3.038 . . . . 0.0 113.094 171.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . 0.54 ' HA ' ' HE2' ' A' ' 282' ' ' MET . 37.0 ttt180 -56.99 -62.8 1.49 Allowed 'General case' 0 C--N 1.352 0.702 0 C-N-CA 123.921 0.888 . . . . 0.0 110.446 173.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 15.1 t -71.59 -23.32 61.71 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 122.895 0.478 . . . . 0.0 111.479 -176.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 322' ' ' LEU . . . . . 0.444 HD12 HD12 ' A' ' 313' ' ' LEU . 59.3 mt -82.71 -16.03 49.62 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.328 0.651 . . . . 0.0 111.575 178.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp 59.91 44.02 14.13 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.784 1.234 . . . . 0.0 111.749 178.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . 0.441 HD11 ' HB3' ' A' ' 319' ' ' PRO . 63.9 mt -79.28 168.56 19.37 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.194 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 325' ' ' GLY . . . . . 0.412 ' H ' ' HB2' ' A' ' 328' ' ' ASP . . . -167.32 -162.85 20.05 Favored Glycine 0 C--N 1.35 1.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 113.061 -172.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 25.0 m -74.89 -30.32 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 123.414 0.686 . . . . 0.0 111.204 -178.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -94.97 -25.93 16.32 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.713 0.805 . . . . 0.0 110.907 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 328' ' ' ASP . . . . . 0.412 ' HB2' ' H ' ' A' ' 325' ' ' GLY . 7.1 m-20 -77.77 106.77 9.82 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 122.932 0.493 . . . . 0.0 109.823 -178.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . 0.461 HG12 ' HG2' ' A' ' 268' ' ' LYS . 3.1 mt -97.04 139.13 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 122.83 0.452 . . . . 0.0 110.681 -174.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 32.3 pt -119.93 125.01 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 123.061 0.545 . . . . 0.0 109.99 174.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -71.15 114.4 9.17 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.198 0.999 . . . . 0.0 111.274 -175.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 332' ' ' CYS . . . . . 0.564 ' SG ' HD12 ' A' ' 304' ' ' ILE . 45.0 t -81.28 88.89 6.04 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.305 0.642 . . . . 0.0 109.704 174.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 85.5 t -98.85 111.98 29.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 123.619 0.767 . . . . 0.0 109.413 -177.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 90.8 t -82.41 106.19 13.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.808 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 97.0 mt . . . . . 0 N--CA 1.475 0.812 0 C-N-CA 123.605 0.762 . . . . 0.0 109.687 176.386 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.469 0.487 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 265' ' ' PHE . . . . . 0.531 ' CE1' ' SD ' ' A' ' 282' ' ' MET . 28.9 p90 -98.08 150.5 36.81 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 124.776 1.23 . . . . 0.0 108.526 -178.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 266' ' ' PRO . . . . . 0.467 ' HB2' ' HB3' ' A' ' 277' ' ' ARG . 56.0 Cg_endo -67.66 92.61 0.36 Allowed 'Trans proline' 0 C--N 1.368 1.554 0 C-N-CA 122.405 2.07 . . . . 0.0 112.443 175.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.1 111.99 3.67 Favored 'General case' 0 C--O 1.247 0.933 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 173.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . 0.43 ' HE3' HG12 ' A' ' 329' ' ' ILE . 22.3 ttpt -83.81 126.65 33.15 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.65 0.738 . . . . 0.0 111.009 -178.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 5.0 mt -125.91 124.3 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.92 1.288 . . . . 0.0 108.52 -175.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 23.0 ttp180 -89.07 102.36 15.01 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-O 121.287 0.565 . . . . 0.0 109.575 176.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 271' ' ' CYS . . . . . 0.741 ' SG ' HD23 ' A' ' 297' ' ' LEU . 36.5 t -73.11 -174.99 1.68 Allowed 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.064 170.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 35.4 ptt180 -56.41 -28.44 59.39 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 124.477 1.111 . . . . 0.0 113.543 -178.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -166.47 32.07 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.629 0.772 . . . . 0.0 110.322 177.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -151.16 150.88 31.16 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.102 0.561 . . . . 0.0 110.103 -172.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -117.18 101.13 8.2 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.932 0.893 . . . . 0.0 109.858 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 72.8 t -92.7 117.71 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.618 0.767 . . . . 0.0 109.707 176.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . 0.467 ' HB3' ' HB2' ' A' ' 266' ' ' PRO . 44.0 mtm-85 -112.48 91.4 3.64 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 175.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . 0.521 HD22 ' HA ' ' A' ' 289' ' ' VAL . 4.6 pp -98.3 147.69 33.47 Favored Pre-proline 0 N--CA 1.483 1.195 0 C-N-CA 122.485 0.314 . . . . 0.0 110.319 -174.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -71.5 107.21 2.11 Favored 'Trans proline' 0 C--N 1.373 1.843 0 C-N-CA 122.416 2.077 . . . . 0.0 111.689 177.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.745 HD23 ' HG3' ' A' ' 319' ' ' PRO . 0.5 OUTLIER -129.11 150.34 50.55 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.145 1.378 . . . . 0.0 108.473 178.137 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.4 155.64 17.43 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.02 0.528 . . . . 0.0 109.905 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 282' ' ' MET . . . . . 0.531 ' SD ' ' CE1' ' A' ' 265' ' ' PHE . 76.7 mmm -60.32 -33.86 72.98 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.262 0.625 . . . . 0.0 112.059 -175.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 35.0 t -83.77 -19.18 35.55 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.271 0.628 . . . . 0.0 111.896 -178.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -67.74 127.66 93.39 Favored Pre-proline 0 N--CA 1.484 1.233 0 CA-C-O 118.272 -0.87 . . . . 0.0 109.153 175.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -64.95 166.61 17.97 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 122.019 1.813 . . . . 0.0 111.394 173.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.413 ' O ' HG21 ' A' ' 290' ' ' VAL . 82.6 mt -66.74 -10.01 42.62 Favored 'General case' 0 C--O 1.213 -0.834 0 CA-C-O 118.594 -0.717 . . . . 0.0 111.939 -176.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 287' ' ' GLN . . . . . 0.436 ' HA ' ' HB ' ' A' ' 290' ' ' VAL . 27.3 tp60 -53.85 -26.2 23.38 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 123.345 0.658 . . . . 0.0 112.541 178.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 288' ' ' SER . . . . . 0.609 ' HB3' HD11 ' A' ' 280' ' ' LEU . 34.6 t -60.66 -52.63 64.32 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.936 0.494 . . . . 0.0 110.642 171.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.521 ' HA ' HD22 ' A' ' 278' ' ' LEU . 10.2 m -71.75 -30.72 38.96 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 122.364 0.266 . . . . 0.0 110.85 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . 0.533 HG12 ' HB ' ' A' ' 304' ' ' ILE . 66.8 t -65.44 -51.23 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.084 0.954 . . . . 0.0 110.657 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -67.54 -39.61 85.03 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.868 0.867 . . . . 0.0 110.984 -176.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 21.5 t60 -66.27 -52.48 47.11 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.751 179.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 94.7 mmm -65.22 -27.89 68.98 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 123.44 0.462 . . . . 0.0 111.214 -177.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -61.84 -49.97 74.14 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.644 0.777 . . . . 0.0 110.476 172.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 36.8 m -70.9 -28.66 64.7 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.639 0.775 . . . . 0.0 111.195 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -70.3 -36.77 74.54 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.292 1.037 . . . . 0.0 110.87 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 297' ' ' LEU . . . . . 0.741 HD23 ' SG ' ' A' ' 271' ' ' CYS . 78.7 mt -101.87 -5.6 24.57 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.996 0.919 . . . . 0.0 112.095 -178.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 79.4 3.38 88.64 Favored Glycine 0 N--CA 1.475 1.243 0 O-C-N 123.417 0.448 . . . . 0.0 113.239 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 299' ' ' VAL . . . . . 0.466 HG13 HG12 ' A' ' 334' ' ' VAL . 30.9 m -91.48 -177.78 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 124.244 1.017 . . . . 0.0 111.083 -178.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 39.7 m -89.15 150.19 44.56 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 123.482 0.713 . . . . 0.0 110.922 -178.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.13 -30.37 90.22 Favored 'Trans proline' 0 C--N 1.391 2.775 0 C-N-CA 123.094 2.529 . . . . 0.0 111.594 172.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 16.7 m -64.95 -15.77 62.55 Favored 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 123.18 0.592 . . . . 0.0 111.907 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 55.1 mtt180 -100.51 -15.78 17.75 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.933 0.893 . . . . 0.0 112.782 -175.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 304' ' ' ILE . . . . . 0.533 ' HB ' HG12 ' A' ' 290' ' ' VAL . 42.7 mm -82.58 102.48 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 CA-C-N 118.148 0.431 . . . . 0.0 110.682 -176.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 53.6 tp -101.37 114.78 29.08 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.969 0.908 . . . . 0.0 109.363 175.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . 0.413 ' HG ' HD13 ' A' ' 330' ' ' ILE . 2.5 mm? -86.5 133.04 33.78 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 178.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . 0.434 HD21 ' HA ' ' A' ' 312' ' ' GLU . 92.7 mt -132.58 103.29 6.07 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.927 0.891 . . . . 0.0 109.009 -176.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . 0.471 ' HB2' HD13 ' A' ' 313' ' ' LEU . 33.1 t80 -82.89 89.67 6.87 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -174.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 67.35 -84.58 0.13 Allowed Glycine 0 C--N 1.348 1.231 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.238 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -134.27 52.04 2.08 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.953 0.901 . . . . 0.0 110.036 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 11.7 t -153.49 149.29 27.56 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 122.805 0.442 . . . . 0.0 110.689 172.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . 0.434 ' HA ' HD21 ' A' ' 307' ' ' LEU . 42.4 tt0 -96.79 121.36 38.57 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.179 0.592 . . . . 0.0 110.058 -178.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . 0.471 HD13 ' HB2' ' A' ' 308' ' ' PHE . 58.5 mt -102.05 175.71 5.44 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 122.961 0.504 . . . . 0.0 111.406 -176.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 50.1 m -130.39 146.63 62.53 Favored Pre-proline 0 CA--C 1.547 0.842 0 C-N-CA 123.545 0.738 . . . . 0.0 110.056 -177.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . 0.51 ' HB3' HG23 ' A' ' 290' ' ' VAL . 31.1 Cg_endo -61.45 -26.88 81.72 Favored 'Trans proline' 0 C--N 1.385 2.477 0 C-N-CA 123.036 2.491 . . . . 0.0 112.373 174.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 73.1 p -80.19 -22.99 41.33 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.474 1.11 . . . . 0.0 111.889 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -76.82 147.44 37.18 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.553 0.741 . . . . 0.0 111.519 -176.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 318' ' ' THR . . . . . . . . . . . . . 41.3 p -100.98 141.44 22.63 Favored Pre-proline 0 N--CA 1.475 0.782 0 C-N-CA 124.155 0.982 . . . . 0.0 110.05 -178.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 319' ' ' PRO . . . . . 0.745 ' HG3' HD23 ' A' ' 280' ' ' LEU . 59.0 Cg_endo -62.39 -19.71 68.13 Favored 'Trans proline' 0 C--N 1.37 1.665 0 C-N-CA 123.668 2.912 . . . . 0.0 113.294 -178.118 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 53.3 ttp180 -59.28 -56.51 21.23 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 123.893 0.877 . . . . 0.0 110.697 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 15.3 t -69.63 -25.67 64.05 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.066 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 322' ' ' LEU . . . . . 0.5 ' HB2' ' HG ' ' A' ' 324' ' ' LEU . 46.4 mt -85.71 -4.8 59.26 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.63 0.772 . . . . 0.0 111.842 -178.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp 64.49 29.57 13.25 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.499 1.12 . . . . 0.0 112.063 176.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . 0.5 ' HG ' ' HB2' ' A' ' 322' ' ' LEU . 46.8 mt -78.19 168.74 19.38 Favored 'General case' 0 C--O 1.243 0.755 0 C-N-CA 123.603 0.761 . . . . 0.0 110.774 178.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 325' ' ' GLY . . . . . 0.417 ' H ' ' HB2' ' A' ' 328' ' ' ASP . . . -168.5 -162.48 20.66 Favored Glycine 0 C--O 1.243 0.665 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.89 -173.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 35.1 m -73.41 -36.99 50.06 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 C-N-CA 123.737 0.815 . . . . 0.0 111.478 -177.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -100.15 -12.84 19.27 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.428 1.091 . . . . 0.0 111.292 -177.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 328' ' ' ASP . . . . . 0.417 ' HB2' ' H ' ' A' ' 325' ' ' GLY . 31.8 m-20 -76.22 116.57 17.03 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 174.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . 0.43 HG12 ' HE3' ' A' ' 268' ' ' LYS . 18.0 mt -105.04 124.86 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 123.242 0.617 . . . . 0.0 110.55 -170.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 330' ' ' ILE . . . . . 0.43 HG21 ' HB2' ' A' ' 308' ' ' PHE . 40.2 pt -106.5 126.88 62.24 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 123.103 0.561 . . . . 0.0 110.51 176.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -72.98 106.06 4.71 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.727 0.811 . . . . 0.0 111.328 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 332' ' ' CYS . . . . . 0.45 ' SG ' HD13 ' A' ' 304' ' ' ILE . 34.7 t -71.71 102.27 2.76 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 169.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . 0.432 HG21 HD11 ' A' ' 307' ' ' LEU . 87.1 t -113.78 112.53 40.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 334' ' ' VAL . . . . . 0.466 HG12 HG13 ' A' ' 299' ' ' VAL . 76.7 t -77.86 104.18 5.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.746 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 75.0 mt . . . . . 0 N--CA 1.468 0.426 0 C-N-CA 124.022 0.929 . . . . 0.0 109.193 172.243 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 4.2 mp . . . . . 0 C--O 1.238 0.474 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 265' ' ' PHE . . . . . 0.485 ' CE1' ' HG2' ' A' ' 282' ' ' MET . 31.3 p90 -112.0 141.16 24.37 Favored Pre-proline 0 CA--C 1.55 0.95 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 175.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 266' ' ' PRO . . . . . 0.532 ' HB2' ' HB3' ' A' ' 277' ' ' ARG . 38.0 Cg_endo -65.11 92.64 0.21 Allowed 'Trans proline' 0 C--N 1.375 1.922 0 C-N-CA 122.696 2.264 . . . . 0.0 112.974 176.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 267' ' ' LEU . . . . . 0.465 HD11 HG13 ' A' ' 269' ' ' ILE . 0.4 OUTLIER -61.69 122.55 15.61 Favored 'General case' 0 C--N 1.356 0.88 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 173.271 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . 0.43 ' HD2' HD13 ' A' ' 275' ' ' LEU . 20.8 ttpt -88.27 108.38 19.29 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 121.216 0.531 . . . . 0.0 110.614 178.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . 0.465 HG13 HD11 ' A' ' 267' ' ' LEU . 3.8 mp -105.79 129.22 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 176.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 270' ' ' ARG . . . . . 0.42 ' HA ' HD22 ' A' ' 275' ' ' LEU . 41.1 ttm180 -87.0 119.34 27.11 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 122.847 0.459 . . . . 0.0 110.016 174.021 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 271' ' ' CYS . . . . . 0.701 ' SG ' HD22 ' A' ' 297' ' ' LEU . 10.1 t -88.75 -165.06 1.24 Allowed 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.722 0.809 . . . . 0.0 109.687 173.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -52.96 -39.73 63.18 Favored 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 124.584 1.154 . . . . 0.0 112.85 176.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -162.19 42.82 0.13 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.511 0.725 . . . . 0.0 109.87 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -155.58 162.01 40.73 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.704 -171.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.43 HD13 ' HD2' ' A' ' 268' ' ' LYS . 72.3 mt -127.85 106.58 9.21 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.176 0.99 . . . . 0.0 110.032 174.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 84.6 t -92.88 108.99 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 123.696 0.798 . . . . 0.0 108.937 174.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . 0.532 ' HB3' ' HB2' ' A' ' 266' ' ' PRO . 67.4 mtm180 -98.76 83.46 2.96 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 174.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . 0.4 HD12 HG12 ' A' ' 289' ' ' VAL . 4.3 pp -93.38 137.14 23.6 Favored Pre-proline 0 N--CA 1.488 1.447 0 CA-C-O 119.141 -0.457 . . . . 0.0 110.413 -175.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -63.91 123.67 12.32 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 122.54 2.16 . . . . 0.0 111.477 175.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.588 HD22 ' HG3' ' A' ' 319' ' ' PRO . 0.0 OUTLIER -143.72 151.94 40.66 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.226 1.01 . . . . 0.0 110.066 -176.549 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -87.85 149.71 23.96 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 177.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 282' ' ' MET . . . . . 0.485 ' HG2' ' CE1' ' A' ' 265' ' ' PHE . 14.9 mtp -68.06 -37.08 80.87 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 117.928 0.331 . . . . 0.0 110.672 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 22.8 t -75.08 -15.34 60.62 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.748 0.819 . . . . 0.0 111.314 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 284' ' ' GLU . . . . . 0.431 ' O ' ' HD2' ' A' ' 319' ' ' PRO . 4.5 tp10 -73.52 134.31 79.45 Favored Pre-proline 0 CA--C 1.543 0.691 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 174.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.89 166.57 26.01 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 122.062 1.842 . . . . 0.0 111.686 175.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 82.6 mt -66.7 -12.62 59.17 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.985 0.514 . . . . 0.0 111.721 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 287' ' ' GLN . . . . . 0.487 ' HA ' ' HB ' ' A' ' 290' ' ' VAL . 25.6 tp60 -56.2 -22.36 28.75 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.342 0.657 . . . . 0.0 111.687 173.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 288' ' ' SER . . . . . 0.458 ' HB3' HD13 ' A' ' 280' ' ' LEU . 22.8 t -61.22 -57.64 11.58 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.462 0.705 . . . . 0.0 110.455 172.095 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.409 HG11 HD12 ' A' ' 280' ' ' LEU . 17.9 m -68.99 -30.36 46.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 122.484 0.313 . . . . 0.0 110.553 -179.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . 0.554 HG12 ' HB ' ' A' ' 304' ' ' ILE . 43.0 t -63.72 -44.51 98.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.507 1.123 . . . . 0.0 111.15 176.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -59.58 -47.61 84.89 Favored 'General case' 0 N--CA 1.479 0.998 0 O-C-N 124.044 0.84 . . . . 0.0 110.204 178.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 42.7 t60 -64.62 -50.63 66.37 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.406 -178.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 293' ' ' MET . . . . . 0.429 ' HG3' HG23 ' A' ' 269' ' ' ILE . 94.3 mmm -69.37 -30.55 68.58 Favored 'General case' 0 N--CA 1.483 1.177 0 O-C-N 123.666 0.604 . . . . 0.0 111.356 -174.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -64.68 -46.44 82.37 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 123.656 0.598 . . . . 0.0 110.277 175.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 26.1 m -73.26 -29.24 62.61 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.309 0.644 . . . . 0.0 111.119 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 67.6 t60 -65.05 -38.74 91.82 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.404 1.082 . . . . 0.0 110.279 176.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 297' ' ' LEU . . . . . 0.701 HD22 ' SG ' ' A' ' 271' ' ' CYS . 58.2 mt -101.05 -5.84 25.21 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.369 1.068 . . . . 0.0 111.876 -177.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 74.21 10.37 81.51 Favored Glycine 0 N--CA 1.476 1.303 0 O-C-N 123.267 0.355 . . . . 0.0 113.61 178.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 299' ' ' VAL . . . . . 0.417 HG12 HG13 ' A' ' 334' ' ' VAL . 33.5 m -95.99 176.03 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.208 1.003 . . . . 0.0 110.855 -178.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 20.2 m -78.95 148.56 72.24 Favored Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 123.298 0.639 . . . . 0.0 110.428 178.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -57.86 -28.33 82.06 Favored 'Trans proline' 0 C--N 1.385 2.486 0 C-N-CA 122.97 2.446 . . . . 0.0 112.247 172.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 19.5 m -72.58 -7.54 50.69 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.429 0.691 . . . . 0.0 111.958 -178.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -99.25 -21.28 16.16 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.845 0.858 . . . . 0.0 110.943 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 304' ' ' ILE . . . . . 0.554 ' HB ' HG12 ' A' ' 290' ' ' VAL . 39.4 mm -80.73 115.34 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 122.852 0.461 . . . . 0.0 110.506 -176.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 33.5 tp -113.46 137.65 51.24 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 171.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . 0.404 ' HG ' HD13 ' A' ' 330' ' ' ILE . 2.0 mm? -104.15 133.8 48.48 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 177.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 80.8 mt -131.42 111.43 11.81 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.47 0.708 . . . . 0.0 109.101 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . 0.508 ' HB2' HD11 ' A' ' 313' ' ' LEU . 87.1 t80 -82.49 81.79 8.17 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 77.16 -67.8 2.71 Favored Glycine 0 C--N 1.354 1.53 0 CA-C-N 114.885 -1.052 . . . . 0.0 112.842 -178.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -134.96 -26.8 1.3 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.087 0.955 . . . . 0.0 111.596 -174.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 14.3 t -82.1 147.66 28.97 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 122.658 0.383 . . . . 0.0 110.641 -176.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -93.44 117.39 30.02 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 120.923 0.392 . . . . 0.0 110.01 -178.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . 0.508 HD11 ' HB2' ' A' ' 308' ' ' PHE . 48.1 mt -105.9 114.71 29.03 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.841 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 49.5 m -75.15 147.44 83.19 Favored Pre-proline 0 CA--C 1.553 1.059 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.388 177.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . 0.551 ' HB3' HG21 ' A' ' 290' ' ' VAL . 33.9 Cg_endo -60.23 -23.6 74.56 Favored 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 123.265 2.643 . . . . 0.0 112.937 177.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 4.6 m -72.48 -33.95 67.33 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.785 0.834 . . . . 0.0 111.08 178.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -66.43 146.24 54.78 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.826 0.85 . . . . 0.0 111.425 -177.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 318' ' ' THR . . . . . . . . . . . . . 81.2 p -100.83 138.35 20.03 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 123.027 0.531 . . . . 0.0 109.921 -178.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 319' ' ' PRO . . . . . 0.588 ' HG3' HD22 ' A' ' 280' ' ' LEU . 10.0 Cg_endo -51.03 -20.08 6.73 Favored 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 124.153 3.235 . . . . 0.0 113.531 170.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 40.9 ttt180 -60.92 -58.79 6.94 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.649 0.78 . . . . 0.0 110.912 173.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 13.2 t -71.34 -20.72 62.14 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 122.932 0.493 . . . . 0.0 111.531 -175.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 322' ' ' LEU . . . . . 0.445 HD11 HD12 ' A' ' 313' ' ' LEU . 39.0 mt -88.9 -22.03 23.32 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.646 0.778 . . . . 0.0 111.01 178.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 2.3 tmtp? 56.41 80.83 0.14 Allowed 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.869 1.267 . . . . 0.0 109.204 -167.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 69.5 mt -110.31 143.83 39.94 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 172.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 325' ' ' GLY . . . . . 0.403 ' H ' ' HB2' ' A' ' 328' ' ' ASP . . . -128.22 -167.72 12.29 Favored Glycine 0 C--N 1.337 0.613 0 C-N-CA 123.939 0.78 . . . . 0.0 111.511 -178.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 14.5 m -73.88 -21.98 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 123.314 0.645 . . . . 0.0 111.469 -177.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -99.96 -22.84 15.11 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.193 0.997 . . . . 0.0 111.253 -178.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 328' ' ' ASP . . . . . 0.403 ' HB2' ' H ' ' A' ' 325' ' ' GLY . 3.9 m-20 -70.37 124.96 25.46 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.992 0.517 . . . . 0.0 109.813 178.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . 0.421 HG12 ' HG2' ' A' ' 268' ' ' LYS . 12.9 mt -104.11 139.57 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.028 0.531 . . . . 0.0 109.933 -178.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 330' ' ' ILE . . . . . 0.404 HD13 ' HG ' ' A' ' 306' ' ' LEU . 35.7 pt -123.84 126.58 72.87 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 123.162 0.585 . . . . 0.0 109.837 174.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -75.39 106.1 6.75 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.027 0.931 . . . . 0.0 110.963 -176.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 332' ' ' CYS . . . . . 0.546 ' SG ' HD12 ' A' ' 304' ' ' ILE . 38.1 t -74.54 92.06 2.35 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.701 0.801 . . . . 0.0 110.168 172.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 97.4 t -95.87 117.08 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 123.431 0.693 . . . . 0.0 109.679 177.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 334' ' ' VAL . . . . . 0.417 HG13 HG12 ' A' ' 299' ' ' VAL . 62.1 t -83.38 99.76 6.32 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 123.582 0.753 . . . . 0.0 109.713 177.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 84.9 mt . . . . . 0 CA--C 1.542 0.64 0 C-N-CA 123.883 0.873 . . . . 0.0 110.535 172.663 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 4.2 mp . . . . . 0 N--CA 1.477 0.879 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -125.88 141.57 39.77 Favored Pre-proline 0 CA--C 1.549 0.931 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 175.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -64.26 94.13 0.2 Allowed 'Trans proline' 0 C--N 1.379 2.137 0 C-N-CA 122.531 2.154 . . . . 0.0 112.091 176.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 267' ' ' LEU . . . . . 0.446 HD13 HG13 ' A' ' 269' ' ' ILE . 1.1 tm? -59.6 131.71 51.75 Favored 'General case' 0 C--N 1.354 0.782 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 173.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . 0.414 ' HG2' HG12 ' A' ' 329' ' ' ILE . 3.0 tppp? -94.96 103.53 15.39 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.465 0.65 . . . . 0.0 109.973 -178.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . 0.446 HG13 HD13 ' A' ' 267' ' ' LEU . 2.4 mp -100.59 154.03 4.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 175.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 270' ' ' ARG . . . . . 0.455 ' HB2' HG22 ' A' ' 329' ' ' ILE . 22.5 ttp180 -118.35 103.61 9.96 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.792 0.837 . . . . 0.0 109.017 176.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 271' ' ' CYS . . . . . 0.703 ' SG ' HD22 ' A' ' 297' ' ' LEU . 21.0 t -69.09 -178.14 1.21 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.007 0.923 . . . . 0.0 110.598 176.103 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -50.98 -32.84 22.37 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.712 1.205 . . . . 0.0 113.175 -177.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -161.04 42.08 0.16 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.645 0.778 . . . . 0.0 110.03 178.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -161.35 164.84 29.77 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.257 -174.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 69.6 mt -112.53 113.46 25.62 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.252 1.021 . . . . 0.0 110.155 172.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 276' ' ' VAL . . . . . 0.431 HG21 ' SD ' ' A' ' 293' ' ' MET . 65.7 t -95.43 138.89 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 123.684 0.794 . . . . 0.0 109.264 178.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 42.7 mtt180 -125.08 115.64 20.82 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 177.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . 0.464 HD22 ' HA ' ' A' ' 289' ' ' VAL . 4.0 pp -126.49 135.58 27.43 Favored Pre-proline 0 N--CA 1.482 1.13 0 CA-C-O 119.258 -0.401 . . . . 0.0 109.942 175.174 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -64.7 127.91 19.85 Favored 'Trans proline' 0 C--N 1.375 1.97 0 C-N-CA 122.657 2.238 . . . . 0.0 110.149 174.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.689 HD21 ' HG3' ' A' ' 319' ' ' PRO . 0.2 OUTLIER -150.22 150.92 32.24 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.002 0.921 . . . . 0.0 109.943 -173.815 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . 0.483 ' HB2' ' HB2' ' A' ' 284' ' ' GLU . 83.5 mtm180 -93.17 155.43 17.46 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.588 0.755 . . . . 0.0 110.815 -178.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 282' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -65.72 -38.24 88.62 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.885 0.474 . . . . 0.0 110.213 176.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 24.3 t -73.99 -17.93 60.93 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.552 0.741 . . . . 0.0 111.802 178.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 284' ' ' GLU . . . . . 0.483 ' HB2' ' HB2' ' A' ' 281' ' ' ARG . 5.9 tp10 -72.93 131.77 83.56 Favored Pre-proline 0 N--CA 1.473 0.72 0 C-N-CA 123.712 0.805 . . . . 0.0 109.121 179.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -67.76 168.38 18.67 Favored 'Trans proline' 0 C--N 1.374 1.918 0 C-N-CA 121.903 1.735 . . . . 0.0 111.79 171.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 54.3 mt -70.41 -10.22 58.5 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 118.982 -0.532 . . . . 0.0 110.874 179.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 26.0 tp60 -54.68 -23.08 15.85 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.217 0.607 . . . . 0.0 111.644 175.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 288' ' ' SER . . . . . 0.536 ' HB3' HD12 ' A' ' 280' ' ' LEU . 34.3 t -64.42 -56.48 14.01 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.619 0.768 . . . . 0.0 110.935 171.108 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.464 ' HA ' HD22 ' A' ' 278' ' ' LEU . 18.0 m -66.73 -30.43 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 C-N-CA 122.254 0.222 . . . . 0.0 110.701 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . 0.56 HG11 ' HB ' ' A' ' 304' ' ' ILE . 43.9 t -66.88 -50.24 66.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 124.397 1.079 . . . . 0.0 110.565 179.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -64.1 -43.54 95.03 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.105 0.962 . . . . 0.0 110.887 -178.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 26.0 t60 -67.2 -49.09 65.87 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.378 -177.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 293' ' ' MET . . . . . 0.431 ' SD ' HG21 ' A' ' 276' ' ' VAL . 90.0 mmm -66.36 -32.52 73.96 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.447 0.699 . . . . 0.0 111.369 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -61.57 -53.63 53.79 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 123.863 0.727 . . . . 0.0 110.352 177.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 28.3 m -66.2 -34.09 77.24 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.658 0.783 . . . . 0.0 111.304 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -67.46 -35.44 79.19 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.682 0.793 . . . . 0.0 111.499 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 297' ' ' LEU . . . . . 0.703 HD22 ' SG ' ' A' ' 271' ' ' CYS . 86.6 mt -97.83 -3.46 38.75 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.874 0.87 . . . . 0.0 111.319 178.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 75.15 10.15 84.18 Favored Glycine 0 C--N 1.345 1.049 0 O-C-N 123.625 0.578 . . . . 0.0 113.44 177.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 33.1 m -98.6 -179.04 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.126 0.97 . . . . 0.0 111.252 -178.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 21.7 m -85.2 147.78 48.44 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 123.347 0.659 . . . . 0.0 110.686 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -56.79 -29.65 81.7 Favored 'Trans proline' 0 C--N 1.384 2.428 0 C-N-CA 123.044 2.496 . . . . 0.0 112.297 171.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 44.8 m -68.24 -19.56 64.74 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.037 0.535 . . . . 0.0 111.739 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 61.3 mtt85 -89.19 -19.48 25.4 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.924 0.89 . . . . 0.0 111.737 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 304' ' ' ILE . . . . . 0.56 ' HB ' HG11 ' A' ' 290' ' ' VAL . 41.9 mm -80.62 125.39 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 CA-C-N 117.997 0.362 . . . . 0.0 110.748 -178.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . 0.578 HD22 HD11 ' A' ' 335' ' ' LEU . 46.3 tp -129.76 121.52 27.01 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.809 0.844 . . . . 0.0 108.963 176.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . 0.419 ' HA ' ' O ' ' A' ' 331' ' ' ASP . 2.6 mm? -88.43 127.86 35.51 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -179.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . 0.511 HD11 HG23 ' A' ' 333' ' ' VAL . 79.1 mt -136.32 104.76 5.73 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.794 0.837 . . . . 0.0 109.615 -176.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . 0.516 ' HB2' HG21 ' A' ' 330' ' ' ILE . 85.3 t80 -81.84 93.65 6.91 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 177.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 66.77 -87.72 0.13 Allowed Glycine 0 C--N 1.349 1.274 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.595 -177.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -137.17 77.46 1.64 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.277 1.031 . . . . 0.0 109.339 177.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 14.3 t -166.92 146.26 5.39 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.234 1.014 . . . . 0.0 108.899 173.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . 0.424 ' HA ' HD21 ' A' ' 307' ' ' LEU . 44.3 tt0 -97.36 123.38 41.16 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 122.532 0.333 . . . . 0.0 110.345 -176.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . 0.455 HD23 HD23 ' A' ' 322' ' ' LEU . 27.7 mt -121.11 131.63 54.38 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.59 0.756 . . . . 0.0 109.099 -179.3 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 52.6 m -98.75 152.69 37.96 Favored Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 123.59 0.756 . . . . 0.0 111.573 -174.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -49.23 -37.82 40.29 Favored 'Trans proline' 0 C--N 1.388 2.617 0 C-N-CA 123.695 2.93 . . . . 0.0 113.294 167.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 43.1 p -70.44 -27.61 64.39 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.321 -178.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -73.51 145.71 45.42 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.608 0.763 . . . . 0.0 110.857 -179.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 318' ' ' THR . . . . . . . . . . . . . 76.1 p -99.2 146.79 32.32 Favored Pre-proline 0 N--CA 1.476 0.857 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 177.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 319' ' ' PRO . . . . . 0.689 ' HG3' HD21 ' A' ' 280' ' ' LEU . 34.8 Cg_endo -62.19 -12.18 25.59 Favored 'Trans proline' 0 C--N 1.367 1.518 0 C-N-CA 123.081 2.521 . . . . 0.0 112.56 171.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 44.2 ttt-85 -68.25 -56.13 9.74 Favored 'General case' 0 C--N 1.35 0.613 0 C-N-CA 122.999 0.519 . . . . 0.0 110.15 173.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 13.6 t -68.81 -25.42 64.67 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 120.639 0.257 . . . . 0.0 111.265 -178.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 322' ' ' LEU . . . . . 0.455 HD23 HD23 ' A' ' 313' ' ' LEU . 52.2 mt -90.04 -13.75 35.3 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.288 0.635 . . . . 0.0 111.721 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt 61.87 35.15 16.6 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.657 1.183 . . . . 0.0 112.384 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . 0.447 ' HG ' ' HB2' ' A' ' 322' ' ' LEU . 30.8 mt -73.74 166.13 23.85 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.545 0.738 . . . . 0.0 109.836 175.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . -164.03 -171.91 30.86 Favored Glycine 0 C--N 1.337 0.635 0 CA-C-N 116.475 -0.33 . . . . 0.0 112.326 -176.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 35.0 m -68.4 -27.87 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 123.973 0.909 . . . . 0.0 111.402 178.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -99.57 11.63 38.65 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.118 0.967 . . . . 0.0 111.625 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -122.8 124.09 42.52 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -175.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . 0.455 HG22 ' HB2' ' A' ' 270' ' ' ARG . 3.5 mt -116.72 109.83 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 O-C-N 123.411 0.445 . . . . 0.0 111.824 -163.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 330' ' ' ILE . . . . . 0.516 HG21 ' HB2' ' A' ' 308' ' ' PHE . 34.4 pt -102.06 131.94 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 123.679 0.792 . . . . 0.0 111.117 -177.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 331' ' ' ASP . . . . . 0.419 ' O ' ' HA ' ' A' ' 306' ' ' LEU . 7.5 m-20 -73.95 126.91 31.52 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 123.293 0.637 . . . . 0.0 111.759 -178.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 332' ' ' CYS . . . . . 0.556 ' SG ' HD13 ' A' ' 304' ' ' ILE . 43.2 t -90.55 91.17 8.31 Favored 'General case' 0 C--O 1.244 0.785 0 C-N-CA 123.89 0.876 . . . . 0.0 109.043 172.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . 0.511 HG23 HD11 ' A' ' 307' ' ' LEU . 90.8 t -95.02 115.55 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 123.253 0.621 . . . . 0.0 109.506 -178.108 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 93.1 t -83.69 98.77 5.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 177.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 335' ' ' LEU . . . . . 0.578 HD11 HD22 ' A' ' 305' ' ' LEU . 86.3 mt . . . . . 0 N--CA 1.47 0.529 0 CA-C-N 114.662 -1.153 . . . . 0.0 111.401 172.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 3.0 mp . . . . . 0 N--CA 1.472 0.668 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -141.75 145.67 37.92 Favored Pre-proline 0 CA--C 1.546 0.792 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 175.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 266' ' ' PRO . . . . . 0.431 ' HB2' ' HB3' ' A' ' 277' ' ' ARG . 58.5 Cg_endo -67.93 89.11 0.37 Allowed 'Trans proline' 0 C--N 1.374 1.909 0 C-N-CA 122.875 2.383 . . . . 0.0 112.626 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 267' ' ' LEU . . . . . 0.497 ' O ' ' HA ' ' A' ' 277' ' ' ARG . 1.4 tm? -58.93 127.83 34.18 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.478 1.111 . . . . 0.0 108.96 176.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . 0.641 ' HG2' HG12 ' A' ' 329' ' ' ILE . 5.6 tppp? -83.6 109.35 17.35 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-O 121.336 0.589 . . . . 0.0 111.19 176.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . 0.477 HG12 ' HB ' ' A' ' 289' ' ' VAL . 2.4 mp -106.39 145.22 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 171.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 30.8 ttp180 -107.47 106.88 17.49 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 173.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 271' ' ' CYS . . . . . 0.575 ' SG ' HD21 ' A' ' 297' ' ' LEU . 17.4 t -69.82 172.65 7.32 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.746 171.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 16.3 ptt180 -62.13 -14.1 33.6 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 123.871 0.868 . . . . 0.0 113.187 -174.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -162.52 34.03 0.11 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.694 0.798 . . . . 0.0 111.029 176.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -164.23 162.82 22.8 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 122.826 0.451 . . . . 0.0 111.647 -175.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 51.9 mt -114.2 116.36 28.93 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.244 1.018 . . . . 0.0 109.653 170.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 60.3 t -100.46 142.72 15.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 124.193 0.997 . . . . 0.0 109.114 176.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . 0.497 ' HA ' ' O ' ' A' ' 267' ' ' LEU . 57.8 mtm180 -127.72 120.8 28.77 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 167.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . 0.494 HD21 ' HA ' ' A' ' 289' ' ' VAL . 4.1 pp -123.9 146.33 50.54 Favored Pre-proline 0 N--CA 1.48 1.04 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 178.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -64.67 110.91 1.54 Allowed 'Trans proline' 0 C--N 1.372 1.788 0 C-N-CA 122.805 2.337 . . . . 0.0 110.94 174.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.617 HD23 ' HG3' ' A' ' 319' ' ' PRO . 0.1 OUTLIER -130.05 143.67 50.92 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.15 0.98 . . . . 0.0 109.835 178.9 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 70.4 mtp180 -89.44 159.79 17.11 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.001 0.92 . . . . 0.0 110.728 178.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 282' ' ' MET . . . . . . . . . . . . . 1.3 mmt -70.53 -34.02 71.82 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.199 176.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 35.2 m -77.81 -26.64 49.74 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.734 0.814 . . . . 0.0 111.222 177.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -72.56 123.37 89.45 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-O 118.135 -0.936 . . . . 0.0 108.642 176.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -68.25 179.52 2.87 Favored 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 122.759 2.306 . . . . 0.0 112.481 179.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.418 HD11 ' O ' ' A' ' 314' ' ' SER . 66.6 mt -64.43 -18.37 64.67 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 118.954 -0.545 . . . . 0.0 111.557 177.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 26.6 tp60 -53.47 -22.61 8.25 Favored 'General case' 0 CA--C 1.559 1.294 0 C-N-CA 123.543 0.737 . . . . 0.0 112.307 178.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 288' ' ' SER . . . . . 0.489 ' HB3' HD13 ' A' ' 280' ' ' LEU . 32.1 t -63.18 -56.65 14.92 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.847 0.859 . . . . 0.0 111.069 171.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.494 ' HA ' HD21 ' A' ' 278' ' ' LEU . 15.4 m -67.33 -33.72 64.41 Favored 'Isoleucine or valine' 0 C--N 1.361 1.085 0 C-N-CA 122.64 0.376 . . . . 0.0 110.498 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . 0.561 HG12 ' HB ' ' A' ' 304' ' ' ILE . 73.8 t -61.12 -49.24 85.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 124.426 1.09 . . . . 0.0 111.026 177.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -61.27 -50.05 74.59 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 124.31 1.006 . . . . 0.0 110.467 -178.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 22.8 t60 -59.32 -49.03 79.41 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 124.526 1.141 . . . . 0.0 111.203 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 91.7 mmm -68.33 -31.08 70.24 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 122.779 0.431 . . . . 0.0 111.103 -178.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -70.0 -38.16 75.91 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.272 0.629 . . . . 0.0 111.034 176.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 27.7 m -68.96 -43.35 75.16 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.611 0.764 . . . . 0.0 110.275 178.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 83.4 t60 -67.66 -47.98 67.98 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.546 -177.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 297' ' ' LEU . . . . . 0.575 HD21 ' SG ' ' A' ' 271' ' ' CYS . 76.6 mt -83.52 -9.0 59.24 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.512 0.725 . . . . 0.0 111.654 -178.099 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 69.66 26.4 74.49 Favored Glycine 0 C--N 1.349 1.28 0 O-C-N 123.697 0.623 . . . . 0.0 112.682 177.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 299' ' ' VAL . . . . . 0.475 HG13 HG11 ' A' ' 334' ' ' VAL . 28.0 m -110.36 178.14 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.435 1.094 . . . . 0.0 110.434 -177.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 27.4 m -80.4 143.16 55.23 Favored Pre-proline 0 CA--C 1.55 0.971 0 CA-C-O 119.114 -0.469 . . . . 0.0 110.207 178.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -56.91 -28.19 76.42 Favored 'Trans proline' 0 C--N 1.384 2.398 0 C-N-CA 123.052 2.502 . . . . 0.0 112.45 171.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 41.2 t -68.56 -27.31 65.96 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 120.83 0.347 . . . . 0.0 110.978 179.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 66.7 mtt180 -85.55 -11.86 53.05 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.34 1.056 . . . . 0.0 112.047 -176.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 304' ' ' ILE . . . . . 0.561 ' HB ' HG12 ' A' ' 290' ' ' VAL . 35.5 mm -82.67 101.97 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 177.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 36.9 tp -102.37 112.05 24.6 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.271 0.628 . . . . 0.0 109.471 176.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -81.56 131.22 35.27 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 177.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . 0.468 HD11 HG23 ' A' ' 333' ' ' VAL . 72.5 mt -131.99 109.94 10.4 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.04 0.936 . . . . 0.0 108.735 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . 0.495 ' HB2' HD12 ' A' ' 313' ' ' LEU . 28.7 t80 -77.74 89.64 4.01 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -179.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 66.44 -83.43 0.1 Allowed Glycine 0 C--N 1.346 1.112 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.728 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -122.56 3.09 9.62 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.134 0.973 . . . . 0.0 112.207 -176.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 5.0 t -115.26 147.01 40.91 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 118.256 0.48 . . . . 0.0 110.225 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -85.05 132.71 34.29 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 123.184 0.594 . . . . 0.0 110.007 177.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . 0.52 HD13 HD11 ' A' ' 322' ' ' LEU . 53.2 mt -112.3 156.74 21.93 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.114 0.566 . . . . 0.0 110.366 177.152 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 314' ' ' SER . . . . . 0.418 ' O ' HD11 ' A' ' 286' ' ' LEU . 22.3 m -99.22 130.4 27.28 Favored Pre-proline 0 CA--C 1.544 0.749 0 CA-C-O 118.644 -0.693 . . . . 0.0 109.44 175.133 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -59.51 -21.92 64.11 Favored 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 123.228 2.618 . . . . 0.0 113.475 175.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 27.3 p -78.26 -29.44 48.06 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.969 0.908 . . . . 0.0 111.858 176.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -67.28 157.74 33.17 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.366 0.666 . . . . 0.0 111.475 -177.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 318' ' ' THR . . . . . . . . . . . . . 61.6 p -99.36 144.17 27.77 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 123.158 0.583 . . . . 0.0 109.916 -173.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 319' ' ' PRO . . . . . 0.617 ' HG3' HD23 ' A' ' 280' ' ' LEU . 55.7 Cg_endo -63.22 -16.65 55.81 Favored 'Trans proline' 0 C--N 1.363 1.342 0 C-N-CA 123.43 2.753 . . . . 0.0 112.508 175.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 -73.21 -48.65 33.33 Favored 'General case' 0 C--N 1.355 0.843 0 C-N-CA 122.72 0.408 . . . . 0.0 110.488 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 13.7 t -70.54 -26.37 63.53 Favored 'General case' 0 CA--C 1.549 0.926 0 O-C-N 123.324 0.39 . . . . 0.0 110.637 178.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 322' ' ' LEU . . . . . 0.52 HD11 HD13 ' A' ' 313' ' ' LEU . 68.6 mt -85.7 -12.17 51.87 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.362 0.665 . . . . 0.0 111.41 175.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp 60.02 35.74 21.45 Favored 'General case' 0 CA--C 1.561 1.394 0 C-N-CA 124.712 1.205 . . . . 0.0 111.52 175.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 60.5 mt -69.31 169.75 11.65 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.198 0.999 . . . . 0.0 111.26 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . -154.89 -170.18 20.3 Favored Glycine 0 C--N 1.348 1.212 0 CA-C-N 116.411 -0.358 . . . . 0.0 113.084 -172.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 14.9 m -81.56 -28.45 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 123.683 0.793 . . . . 0.0 111.542 -176.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -99.33 -23.78 15.04 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.17 0.988 . . . . 0.0 110.041 176.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -72.19 120.09 17.31 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.889 0.876 . . . . 0.0 110.245 -175.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . 0.641 HG12 ' HG2' ' A' ' 268' ' ' LYS . 5.2 mt -100.6 134.36 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 123.819 0.848 . . . . 0.0 111.812 -166.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 42.8 pt -126.3 126.34 69.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 123.471 0.708 . . . . 0.0 110.345 172.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -73.89 110.44 8.19 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.485 1.114 . . . . 0.0 112.132 -175.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 332' ' ' CYS . . . . . 0.477 ' SG ' HD13 ' A' ' 304' ' ' ILE . 41.6 t -74.57 89.89 2.22 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.563 0.745 . . . . 0.0 109.878 167.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . 0.468 HG23 HD11 ' A' ' 307' ' ' LEU . 93.1 t -100.61 111.1 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 123.226 0.61 . . . . 0.0 109.483 -178.03 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 334' ' ' VAL . . . . . 0.475 HG11 HG13 ' A' ' 299' ' ' VAL . 57.9 t -83.41 108.91 16.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 123.033 0.533 . . . . 0.0 109.947 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 88.9 mt . . . . . 0 N--CA 1.48 1.053 0 C-N-CA 123.881 0.872 . . . . 0.0 110.58 178.898 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 1.6 mp . . . . . 0 N--CA 1.475 0.803 0 CA-C-O 121.107 0.48 . . . . 0.0 109.949 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 265' ' ' PHE . . . . . 0.488 ' CE1' ' HG2' ' A' ' 282' ' ' MET . 10.1 p90 -150.45 138.94 12.64 Favored Pre-proline 0 CA--C 1.545 0.78 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 170.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -62.54 94.38 0.14 Allowed 'Trans proline' 0 C--N 1.377 2.03 0 C-N-CA 122.616 2.211 . . . . 0.0 111.555 173.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 267' ' ' LEU . . . . . 0.534 HD11 HG13 ' A' ' 269' ' ' ILE . 0.9 OUTLIER -59.69 125.82 25.15 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 174.266 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . 0.553 ' HG2' HG12 ' A' ' 329' ' ' ILE . 4.8 tppp? -88.41 102.64 15.08 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.348 0.659 . . . . 0.0 110.396 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . 0.534 HG13 HD11 ' A' ' 267' ' ' LEU . 2.1 mp -103.63 129.8 55.07 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 173.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 30.8 ttp180 -90.45 109.37 20.5 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-O 121.303 0.573 . . . . 0.0 110.192 174.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 271' ' ' CYS . . . . . 0.696 ' SG ' HD22 ' A' ' 297' ' ' LEU . 49.2 t -77.87 -179.59 6.11 Favored 'General case' 0 CA--C 1.55 0.95 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.315 172.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 272' ' ' ARG . . . . . 0.401 ' N ' ' SG ' ' A' ' 271' ' ' CYS . 15.9 ptt-85 -53.24 -31.67 44.53 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.978 1.311 . . . . 0.0 113.805 -178.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -161.68 27.98 0.12 Allowed 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.694 0.798 . . . . 0.0 110.279 177.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 274' ' ' ASP . . . . . 0.463 ' HB3' ' HB3' ' A' ' 271' ' ' CYS . 34.8 t70 -144.76 158.68 43.69 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.447 0.699 . . . . 0.0 109.795 -172.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 66.2 mt -119.92 101.47 7.89 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.652 0.781 . . . . 0.0 109.81 176.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 276' ' ' VAL . . . . . 0.502 HG23 ' SD ' ' A' ' 293' ' ' MET . 65.0 t -83.75 125.57 40.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.924 179.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 86.1 mtm180 -118.86 104.83 10.9 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 175.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . 0.464 HD12 HG13 ' A' ' 289' ' ' VAL . 4.3 pp -116.21 131.99 23.51 Favored Pre-proline 0 N--CA 1.487 1.398 0 CA-C-N 118.182 0.446 . . . . 0.0 110.744 178.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -65.9 115.95 3.71 Favored 'Trans proline' 0 C--N 1.381 2.24 0 C-N-CA 122.627 2.218 . . . . 0.0 110.736 177.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.608 HD21 ' HG3' ' A' ' 319' ' ' PRO . 0.4 OUTLIER -136.66 148.29 47.32 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.521 1.128 . . . . 0.0 109.463 -174.688 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -88.18 144.37 26.5 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 178.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 282' ' ' MET . . . . . 0.492 ' HB3' ' HB2' ' A' ' 320' ' ' ARG . 16.2 mtp -66.3 -27.41 67.9 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 118.154 0.434 . . . . 0.0 111.68 -177.105 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 35.1 m -79.16 -12.17 59.98 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.52 0.728 . . . . 0.0 112.01 176.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 25.6 tp10 -85.67 130.17 52.0 Favored Pre-proline 0 N--CA 1.472 0.632 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 178.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -65.01 167.32 16.24 Favored 'Trans proline' 0 C--N 1.381 2.267 0 C-N-CA 122.498 2.132 . . . . 0.0 113.119 178.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 91.5 mt -68.48 -9.29 47.92 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.502 -178.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 26.3 tp60 -53.85 -27.98 33.13 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.563 0.745 . . . . 0.0 111.444 174.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 288' ' ' SER . . . . . 0.428 ' HB2' HD12 ' A' ' 280' ' ' LEU . 67.0 m -65.92 -47.08 75.93 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.709 0.804 . . . . 0.0 112.075 175.184 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.464 HG13 HD12 ' A' ' 278' ' ' LEU . 17.1 m -71.55 -34.31 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 177.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . 0.553 HG11 ' HB ' ' A' ' 304' ' ' ILE . 37.5 t -61.61 -45.07 99.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.667 1.187 . . . . 0.0 110.95 177.483 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -63.74 -48.95 74.94 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.04 0.936 . . . . 0.0 110.79 -178.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 74.7 t60 -64.36 -44.9 89.98 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.18 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 293' ' ' MET . . . . . 0.502 ' SD ' HG23 ' A' ' 276' ' ' VAL . 90.9 mmm -68.34 -32.08 71.94 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 123.724 0.64 . . . . 0.0 111.42 -177.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -63.76 -43.36 96.63 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 123.698 0.624 . . . . 0.0 110.404 176.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 29.2 m -73.5 -33.08 64.62 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 123.272 0.629 . . . . 0.0 111.254 176.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 58.4 t60 -66.2 -34.43 78.0 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.183 0.993 . . . . 0.0 110.719 -178.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 297' ' ' LEU . . . . . 0.696 HD22 ' SG ' ' A' ' 271' ' ' CYS . 62.2 mt -102.31 -21.35 14.33 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.921 0.888 . . . . 0.0 111.83 -177.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 85.36 24.42 43.62 Favored Glycine 0 N--CA 1.475 1.258 0 O-C-N 123.007 0.192 . . . . 0.0 112.999 -178.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 299' ' ' VAL . . . . . 0.484 HG11 HG11 ' A' ' 334' ' ' VAL . 31.4 m -109.87 -179.42 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 124.013 0.925 . . . . 0.0 110.808 177.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 19.2 m -82.82 146.29 52.17 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 123.542 0.737 . . . . 0.0 110.277 178.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -58.92 -27.35 84.29 Favored 'Trans proline' 0 C--N 1.386 2.545 0 C-N-CA 123.001 2.468 . . . . 0.0 112.295 173.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 40.2 p -67.06 -17.39 64.87 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.847 0.859 . . . . 0.0 112.021 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 89.5 mtt180 -95.68 -25.79 15.98 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.041 0.937 . . . . 0.0 111.926 -176.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 304' ' ' ILE . . . . . 0.553 ' HB ' HG11 ' A' ' 290' ' ' VAL . 32.9 mm -72.51 115.66 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 122.601 0.36 . . . . 0.0 110.363 -177.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 27.0 tp -124.17 122.32 37.49 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.241 0.616 . . . . 0.0 109.367 177.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -89.16 123.31 33.3 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -177.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . 0.509 HD11 HG23 ' A' ' 333' ' ' VAL . 72.7 mt -129.74 112.89 14.08 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.469 0.708 . . . . 0.0 109.622 -177.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -84.7 92.55 8.22 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 173.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 70.43 -94.59 0.49 Allowed Glycine 0 C--N 1.346 1.088 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 -174.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -133.69 82.67 2.0 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.577 0.751 . . . . 0.0 109.411 174.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 12.1 t -166.0 138.84 4.09 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 174.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -90.74 114.03 26.28 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-O 120.697 0.284 . . . . 0.0 110.698 -174.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 46.0 mt -103.74 114.49 28.8 Favored 'General case' 0 C--O 1.245 0.842 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 177.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 12.8 m -72.6 143.9 85.51 Favored Pre-proline 0 CA--C 1.553 1.079 0 C-N-CA 124.215 1.006 . . . . 0.0 111.219 -173.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . 0.526 ' HB3' HG22 ' A' ' 290' ' ' VAL . 36.5 Cg_endo -62.63 -28.65 77.1 Favored 'Trans proline' 0 C--N 1.381 2.263 0 C-N-CA 123.015 2.477 . . . . 0.0 112.357 175.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 4.7 m -73.67 -28.72 61.9 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.09 0.956 . . . . 0.0 111.329 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -78.29 154.78 30.62 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.532 0.733 . . . . 0.0 110.756 -178.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 318' ' ' THR . . . . . . . . . . . . . 82.8 p -99.46 152.9 37.96 Favored Pre-proline 0 CA--C 1.545 0.764 0 C-N-CA 123.495 0.718 . . . . 0.0 109.901 -178.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 319' ' ' PRO . . . . . 0.608 ' HG3' HD21 ' A' ' 280' ' ' LEU . 60.9 Cg_endo -67.92 -9.69 26.44 Favored 'Trans proline' 0 C--N 1.363 1.339 0 C-N-CA 122.975 2.45 . . . . 0.0 113.324 174.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . 0.492 ' HB2' ' HB3' ' A' ' 282' ' ' MET . 44.5 ttm180 -75.11 -48.2 24.95 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 117.786 0.266 . . . . 0.0 110.474 178.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 14.6 t -68.74 -22.88 64.29 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 122.659 0.383 . . . . 0.0 110.946 179.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 322' ' ' LEU . . . . . 0.442 ' HB2' ' HG ' ' A' ' 324' ' ' LEU . 53.2 mt -92.05 -16.13 26.86 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.73 0.812 . . . . 0.0 111.511 176.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp 65.06 31.94 10.71 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.753 1.221 . . . . 0.0 112.57 -179.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . 0.442 ' HG ' ' HB2' ' A' ' 322' ' ' LEU . 42.0 mt -67.54 165.12 17.51 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.682 0.793 . . . . 0.0 110.839 175.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 325' ' ' GLY . . . . . 0.42 ' H ' ' HB3' ' A' ' 328' ' ' ASP . . . -158.63 -169.48 22.13 Favored Glycine 0 C--N 1.342 0.884 0 CA-C-N 116.046 -0.524 . . . . 0.0 112.699 -173.137 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 21.5 m -77.25 -25.72 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.542 0.737 . . . . 0.0 110.46 178.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -94.28 -19.44 20.69 Favored 'General case' 0 C--N 1.353 0.734 0 C-N-CA 124.164 0.985 . . . . 0.0 110.957 179.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 328' ' ' ASP . . . . . 0.42 ' HB3' ' H ' ' A' ' 325' ' ' GLY . 13.1 t70 -82.77 128.4 34.36 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 178.086 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . 0.553 HG12 ' HG2' ' A' ' 268' ' ' LYS . 9.4 mt -115.21 113.87 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 123.107 0.563 . . . . 0.0 109.852 -170.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 38.6 pt -108.43 125.47 65.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-O 121.083 0.468 . . . . 0.0 110.79 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -72.34 116.96 13.4 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.839 0.856 . . . . 0.0 111.387 -175.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 332' ' ' CYS . . . . . 0.535 ' SG ' HD13 ' A' ' 304' ' ' ILE . 37.6 t -74.27 92.1 2.22 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 123.307 0.643 . . . . 0.0 109.415 169.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . 0.509 HG23 HD11 ' A' ' 307' ' ' LEU . 60.5 t -101.36 109.84 26.74 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -178.25 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 334' ' ' VAL . . . . . 0.484 HG11 HG11 ' A' ' 299' ' ' VAL . 57.6 t -79.31 93.91 1.77 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.451 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.694 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 87.4 mt . . . . . 0 C--O 1.239 0.506 0 CA-C-O 121.565 0.698 . . . . 0.0 109.508 172.72 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . 0.454 HD21 ' HG2' ' A' ' 281' ' ' ARG . 45.9 mt . . . . . 0 C--O 1.24 0.569 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -109.18 142.23 25.15 Favored Pre-proline 0 C--O 1.247 0.924 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 173.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -67.09 96.01 0.38 Allowed 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 122.275 1.983 . . . . 0.0 111.363 175.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 267' ' ' LEU . . . . . 0.516 HD11 HG13 ' A' ' 269' ' ' ILE . 1.0 OUTLIER -62.06 129.07 39.12 Favored 'General case' 0 C--O 1.246 0.899 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 174.656 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . 0.485 ' HG2' HG12 ' A' ' 329' ' ' ILE . 2.6 tppp? -94.37 102.32 14.29 Favored 'General case' 0 C--O 1.241 0.653 0 O-C-N 123.751 0.657 . . . . 0.0 109.872 -176.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . 0.516 HG13 HD11 ' A' ' 267' ' ' LEU . 1.5 mp -104.48 114.19 43.42 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 176.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 270' ' ' ARG . . . . . 0.408 ' HA ' HD11 ' A' ' 275' ' ' LEU . 33.1 ttp180 -75.54 104.28 6.03 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 175.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 271' ' ' CYS . . . . . 0.582 ' SG ' HD23 ' A' ' 297' ' ' LEU . 38.1 t -72.59 175.98 5.87 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.27 1.028 . . . . 0.0 110.069 174.445 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 25.7 ptt180 -57.13 -28.05 62.37 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.017 0.927 . . . . 0.0 113.142 -178.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -155.45 30.14 0.38 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.376 0.67 . . . . 0.0 111.175 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -160.56 164.0 32.33 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 122.696 0.398 . . . . 0.0 110.907 -173.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.408 HD11 ' HA ' ' A' ' 270' ' ' ARG . 4.4 mm? -113.54 103.08 10.9 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.258 1.023 . . . . 0.0 108.948 171.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 72.8 t -83.68 130.61 35.54 Favored 'Isoleucine or valine' 0 C--N 1.343 0.301 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 177.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 76.4 mtt85 -124.32 99.49 6.23 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -179.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . 0.439 HD23 ' HA ' ' A' ' 289' ' ' VAL . 4.3 pp -111.8 142.36 26.53 Favored Pre-proline 0 N--CA 1.489 1.476 0 CA-C-N 117.917 0.326 . . . . 0.0 110.324 -178.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -69.26 115.57 4.09 Favored 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 122.282 1.988 . . . . 0.0 110.502 177.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.626 HD22 ' HG3' ' A' ' 319' ' ' PRO . 0.9 OUTLIER -138.34 149.94 46.11 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.835 0.854 . . . . 0.0 109.992 -176.481 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . 0.454 ' HG2' HD21 ' A' ' 264' ' ' LEU . 16.2 mmm180 -94.36 151.1 19.66 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.104 0.962 . . . . 0.0 111.092 178.001 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 282' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -57.1 -41.31 78.67 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.122 0.569 . . . . 0.0 111.118 175.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 19.6 m -76.25 -17.83 59.3 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.378 1.071 . . . . 0.0 112.554 -177.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 284' ' ' GLU . . . . . 0.436 ' O ' ' HD2' ' A' ' 319' ' ' PRO . 8.5 tp10 -72.49 130.29 86.03 Favored Pre-proline 0 N--CA 1.476 0.838 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 176.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -66.23 166.7 20.37 Favored 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 121.937 1.758 . . . . 0.0 111.807 172.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.433 ' O ' HG23 ' A' ' 290' ' ' VAL . 65.3 mt -66.27 -15.12 62.95 Favored 'General case' 0 C--O 1.215 -0.751 0 CA-C-O 118.932 -0.556 . . . . 0.0 111.779 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 -50.54 -26.2 4.95 Favored 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 123.967 0.907 . . . . 0.0 112.204 178.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 288' ' ' SER . . . . . 0.464 ' HB3' HD13 ' A' ' 280' ' ' LEU . 29.5 t -61.61 -57.2 12.96 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.087 0.955 . . . . 0.0 110.939 171.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.458 ' HB ' HG12 ' A' ' 269' ' ' ILE . 13.2 m -68.03 -29.68 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 122.494 0.317 . . . . 0.0 110.908 -179.376 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . 0.564 HG11 ' HB ' ' A' ' 304' ' ' ILE . 78.1 t -66.2 -55.37 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 123.951 0.9 . . . . 0.0 110.35 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -64.0 -37.66 88.25 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.276 -179.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 62.5 t60 -68.72 -47.63 65.87 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 122.982 0.513 . . . . 0.0 110.978 -177.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 293' ' ' MET . . . . . 0.465 ' HG3' HG23 ' A' ' 269' ' ' ILE . 91.0 mmm -65.9 -32.68 74.32 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.276 0.63 . . . . 0.0 110.966 178.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -63.6 -53.08 57.26 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 123.876 0.735 . . . . 0.0 110.964 176.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 55.4 m -64.46 -29.49 70.53 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.814 0.846 . . . . 0.0 111.176 179.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 71.1 t60 -71.42 -46.25 60.62 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.614 0.766 . . . . 0.0 110.997 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 297' ' ' LEU . . . . . 0.582 HD23 ' SG ' ' A' ' 271' ' ' CYS . 72.7 mt -91.74 -3.56 56.07 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.733 0.813 . . . . 0.0 111.797 -176.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 77.27 22.68 70.14 Favored Glycine 0 C--N 1.349 1.292 0 C-N-CA 123.206 0.432 . . . . 0.0 113.196 175.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 299' ' ' VAL . . . . . 0.505 HG13 HG13 ' A' ' 334' ' ' VAL . 25.0 m -112.07 -179.23 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 124.777 1.231 . . . . 0.0 110.832 178.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 51.7 m -87.81 147.61 41.6 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 123.831 0.852 . . . . 0.0 110.769 178.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.36 -25.9 75.06 Favored 'Trans proline' 0 C--N 1.391 2.773 0 C-N-CA 123.215 2.61 . . . . 0.0 111.909 173.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 9.2 m -61.1 -22.47 64.66 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 123.817 0.847 . . . . 0.0 111.995 178.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 46.6 mtt180 -97.83 -19.88 17.87 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.485 0.714 . . . . 0.0 112.385 -174.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 304' ' ' ILE . . . . . 0.564 ' HB ' HG11 ' A' ' 290' ' ' VAL . 37.0 mm -77.39 99.31 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 CA-C-O 121.101 0.477 . . . . 0.0 110.28 -177.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . 0.409 HD21 HD13 ' A' ' 335' ' ' LEU . 29.2 tp -101.55 112.32 24.84 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.843 0.857 . . . . 0.0 109.209 178.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -85.05 120.94 27.13 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . 0.477 HD13 HG23 ' A' ' 333' ' ' VAL . 70.8 mt -129.41 116.2 18.66 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.035 0.934 . . . . 0.0 108.868 -177.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -87.56 85.71 7.13 Favored 'General case' 0 C--O 1.244 0.764 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 174.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 67.62 -96.98 0.38 Allowed Glycine 0 C--N 1.342 0.898 0 CA-C-N 115.154 -0.93 . . . . 0.0 112.991 -179.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -110.21 11.68 23.54 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.528 0.731 . . . . 0.0 112.06 -174.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 11.4 t -116.98 152.85 33.71 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 117.863 0.301 . . . . 0.0 110.244 176.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -105.36 129.42 53.69 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.2 0.6 . . . . 0.0 109.818 178.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . 0.429 HD21 HD23 ' A' ' 322' ' ' LEU . 49.8 mt -113.33 135.17 54.14 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.353 0.661 . . . . 0.0 109.921 -179.049 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 20.1 m -80.65 143.36 54.54 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 123.457 0.703 . . . . 0.0 110.717 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -63.26 -29.88 73.47 Favored 'Trans proline' 0 C--N 1.384 2.408 0 C-N-CA 122.866 2.377 . . . . 0.0 112.127 174.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 34.1 p -88.13 -1.36 57.96 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.273 1.029 . . . . 0.0 111.944 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -88.58 153.17 21.35 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.274 0.63 . . . . 0.0 109.981 175.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 318' ' ' THR . . . . . . . . . . . . . 82.6 p -99.37 142.79 25.24 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 123.372 0.669 . . . . 0.0 109.979 -178.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 319' ' ' PRO . . . . . 0.626 ' HG3' HD22 ' A' ' 280' ' ' LEU . 29.8 Cg_endo -60.76 -13.69 27.81 Favored 'Trans proline' 0 C--N 1.369 1.65 0 C-N-CA 123.441 2.761 . . . . 0.0 113.143 172.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 53.1 ttt180 -67.07 -55.2 15.32 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.167 0.587 . . . . 0.0 110.105 174.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 10.8 t -71.09 -21.06 62.27 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.06 -177.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 322' ' ' LEU . . . . . 0.443 ' HB2' ' HG ' ' A' ' 324' ' ' LEU . 53.5 mt -93.76 -10.19 35.07 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.657 0.783 . . . . 0.0 111.518 176.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 11.3 mptt 62.15 25.65 15.37 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 125.129 1.371 . . . . 0.0 112.592 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . 0.443 ' HG ' ' HB2' ' A' ' 322' ' ' LEU . 33.3 mt -66.79 159.09 28.79 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.363 0.665 . . . . 0.0 110.276 177.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . -157.06 -157.17 8.23 Favored Glycine 0 C--O 1.242 0.598 0 CA-C-N 116.233 -0.439 . . . . 0.0 112.466 -173.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 17.6 m -83.31 -36.67 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 123.258 0.623 . . . . 0.0 110.625 -179.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -88.85 -17.64 29.27 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.053 0.941 . . . . 0.0 110.727 178.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -90.39 115.96 27.97 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . 0.485 HG12 ' HG2' ' A' ' 268' ' ' LYS . 16.0 mt -114.52 120.95 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 123.144 0.578 . . . . 0.0 111.353 -163.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 330' ' ' ILE . . . . . 0.439 HD12 HD11 ' A' ' 324' ' ' LEU . 35.8 pt -108.95 137.08 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 123.344 0.657 . . . . 0.0 111.311 -176.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -79.9 119.46 22.79 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.724 0.81 . . . . 0.0 111.713 -176.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 332' ' ' CYS . . . . . 0.514 ' SG ' HD11 ' A' ' 304' ' ' ILE . 26.9 t -77.79 90.27 4.05 Favored 'General case' 0 C--O 1.243 0.741 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 167.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . 0.477 HG23 HD13 ' A' ' 307' ' ' LEU . 28.3 t -97.27 109.45 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -178.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 334' ' ' VAL . . . . . 0.505 HG13 HG13 ' A' ' 299' ' ' VAL . 40.0 t -85.08 100.96 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.03 -175.379 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 335' ' ' LEU . . . . . 0.409 HD13 HD21 ' A' ' 305' ' ' LEU . 3.4 pp . . . . . 0 N--CA 1.472 0.638 0 C-N-CA 122.764 0.426 . . . . 0.0 111.087 -179.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . 0.434 HD22 HH11 ' A' ' 281' ' ' ARG . 0.9 OUTLIER . . . . . 0 N--CA 1.476 0.838 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -113.41 142.56 27.75 Favored Pre-proline 0 N--CA 1.481 1.092 0 C-N-CA 123.053 0.541 . . . . 0.0 109.841 176.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 266' ' ' PRO . . . . . 0.416 ' O ' ' HA ' ' A' ' 326' ' ' VAL . 23.5 Cg_exo -63.3 100.43 0.26 Allowed 'Trans proline' 0 C--N 1.379 2.162 0 C-N-CA 122.914 2.409 . . . . 0.0 112.362 175.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 267' ' ' LEU . . . . . 0.47 HD22 HD23 ' A' ' 280' ' ' LEU . 0.4 OUTLIER -71.23 122.41 20.17 Favored 'General case' 0 CA--C 1.551 0.99 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 173.583 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . 0.591 ' HG2' HG12 ' A' ' 329' ' ' ILE . 13.8 tppt? -85.52 119.97 26.46 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.528 0.731 . . . . 0.0 110.081 179.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 16.4 mt -121.18 138.56 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 124.539 1.136 . . . . 0.0 109.032 179.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 270' ' ' ARG . . . . . 0.412 ' HB2' HG21 ' A' ' 329' ' ' ILE . 29.7 ttp180 -107.82 103.88 13.24 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 123.715 0.806 . . . . 0.0 109.443 177.229 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 271' ' ' CYS . . . . . 0.739 ' SG ' HD23 ' A' ' 297' ' ' LEU . 49.8 t -77.93 179.53 6.68 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 124.482 1.113 . . . . 0.0 110.616 176.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 272' ' ' ARG . . . . . 0.42 ' N ' ' SG ' ' A' ' 271' ' ' CYS . 26.8 ptt180 -54.22 -31.87 54.31 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 125.414 1.486 . . . . 0.0 113.192 -179.149 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -162.82 33.83 0.1 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.981 0.913 . . . . 0.0 110.362 -178.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -157.97 158.05 34.2 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.353 0.661 . . . . 0.0 110.097 -170.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -117.78 123.21 45.43 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.055 0.942 . . . . 0.0 108.881 173.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 276' ' ' VAL . . . . . 0.529 HG23 ' SD ' ' A' ' 293' ' ' MET . 91.8 t -109.73 121.87 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 124.096 0.958 . . . . 0.0 109.818 178.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . 0.539 ' HD3' ' HZ2' ' A' ' 268' ' ' LYS . 20.7 mtm180 -111.51 122.17 47.13 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 169.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . 0.473 HD12 HG12 ' A' ' 289' ' ' VAL . 4.6 pp -131.43 138.78 33.51 Favored Pre-proline 0 N--CA 1.476 0.85 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 175.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.89 94.22 0.87 Allowed 'Trans proline' 0 C--N 1.367 1.511 0 C-N-CA 122.326 2.017 . . . . 0.0 111.312 -177.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.64 HD21 ' HG3' ' A' ' 319' ' ' PRO . 2.8 tt -103.11 156.95 17.33 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.629 1.172 . . . . 0.0 110.287 -178.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . 0.434 HH11 HD22 ' A' ' 264' ' ' LEU . 0.1 OUTLIER -99.43 144.79 28.13 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.177 0.991 . . . . 0.0 110.087 -179.55 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 282' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -58.07 -34.18 69.85 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 123.918 0.887 . . . . 0.0 112.372 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 16.1 m -78.57 -22.45 47.12 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.77 0.828 . . . . 0.0 111.78 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 284' ' ' GLU . . . . . 0.411 ' HB2' ' HB2' ' A' ' 281' ' ' ARG . 8.2 tp10 -75.22 130.77 79.54 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 124.084 0.953 . . . . 0.0 109.647 -176.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -68.48 169.83 16.3 Favored 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 122.229 1.953 . . . . 0.0 112.209 174.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 87.4 mt -71.01 -6.63 40.43 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.073 0.549 . . . . 0.0 111.688 -179.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 26.5 tp60 -57.06 -26.1 59.8 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.617 0.767 . . . . 0.0 110.526 173.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 40.6 t -61.46 -55.9 26.16 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.591 1.156 . . . . 0.0 111.423 172.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.473 HG12 HD12 ' A' ' 278' ' ' LEU . 21.0 m -67.62 -32.5 57.16 Favored 'Isoleucine or valine' 0 C--N 1.359 1.021 0 CA-C-N 116.695 -0.229 . . . . 0.0 110.429 -179.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . 0.526 HG12 ' HB ' ' A' ' 304' ' ' ILE . 40.0 t -59.53 -48.02 88.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 124.576 1.15 . . . . 0.0 110.842 176.32 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -59.81 -48.08 83.11 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 124.243 0.964 . . . . 0.0 110.973 -179.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 13.9 t60 -65.64 -46.29 79.76 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.99 -178.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 293' ' ' MET . . . . . 0.529 ' SD ' HG23 ' A' ' 276' ' ' VAL . 89.5 mmm -67.56 -34.53 77.25 Favored 'General case' 0 N--CA 1.484 1.242 0 O-C-N 123.652 0.595 . . . . 0.0 111.418 -176.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -64.3 -42.25 96.45 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 123.733 0.646 . . . . 0.0 110.178 175.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 37.0 m -74.16 -23.86 59.31 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 123.754 0.822 . . . . 0.0 111.169 178.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 77.3 t60 -82.69 -27.39 31.27 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.267 0.627 . . . . 0.0 111.151 -178.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 297' ' ' LEU . . . . . 0.739 HD23 ' SG ' ' A' ' 271' ' ' CYS . 87.8 mt -110.44 -7.33 14.78 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.59 0.756 . . . . 0.0 111.966 -176.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 71.66 30.74 65.94 Favored Glycine 0 C--N 1.342 0.894 0 O-C-N 123.315 0.384 . . . . 0.0 112.763 178.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 299' ' ' VAL . . . . . 0.451 HG11 HG13 ' A' ' 334' ' ' VAL . 33.0 m -115.29 -177.95 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.234 1.014 . . . . 0.0 110.232 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 300' ' ' SER . . . . . 0.512 ' HB2' ' HG3' ' A' ' 303' ' ' ARG . 45.1 m -85.3 146.53 45.09 Favored Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 123.37 0.668 . . . . 0.0 110.969 178.047 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -56.65 -30.59 84.21 Favored 'Trans proline' 0 C--N 1.386 2.506 0 C-N-CA 123.036 2.491 . . . . 0.0 112.227 169.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 32.1 t -74.95 -2.42 27.02 Favored 'General case' 0 CA--C 1.556 1.195 0 C-N-CA 123.323 0.649 . . . . 0.0 111.629 -178.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 303' ' ' ARG . . . . . 0.512 ' HG3' ' HB2' ' A' ' 300' ' ' SER . 60.4 mtt-85 -101.47 -27.01 13.37 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.849 0.859 . . . . 0.0 111.645 177.371 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 304' ' ' ILE . . . . . 0.526 ' HB ' HG12 ' A' ' 290' ' ' VAL . 33.5 mm -74.26 112.52 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 C-N-CA 122.938 0.495 . . . . 0.0 110.868 -174.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 48.3 tp -114.61 117.04 29.75 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.891 0.876 . . . . 0.0 109.331 176.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -86.86 127.81 35.04 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 177.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 72.8 mt -132.31 108.15 9.02 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 177.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . 0.5 ' HB2' HG23 ' A' ' 330' ' ' ILE . 39.6 t80 -75.55 92.19 2.89 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -176.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 71.56 -78.39 0.59 Allowed Glycine 0 C--N 1.348 1.239 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.065 -177.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -130.52 -12.08 3.93 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.825 0.85 . . . . 0.0 111.79 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 5.1 t -90.91 147.31 23.22 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 118.353 0.524 . . . . 0.0 110.95 -172.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -87.02 121.07 28.98 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.391 0.676 . . . . 0.0 110.534 -174.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . 0.53 HD22 HD21 ' A' ' 322' ' ' LEU . 24.7 mt -114.5 168.75 9.59 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.073 0.549 . . . . 0.0 109.535 175.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 45.6 m -126.89 152.87 75.95 Favored Pre-proline 0 N--CA 1.48 1.066 0 C-N-CA 123.317 0.647 . . . . 0.0 109.879 177.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . 0.468 ' HB3' HG23 ' A' ' 290' ' ' VAL . 34.9 Cg_exo -58.24 -33.28 97.43 Favored 'Trans proline' 0 C--N 1.382 2.31 0 C-N-CA 122.916 2.411 . . . . 0.0 111.502 170.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 53.9 p -81.63 -0.79 44.1 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 114.643 -1.162 . . . . 0.0 112.369 -177.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -96.99 149.08 22.32 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.655 0.782 . . . . 0.0 110.755 179.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 318' ' ' THR . . . . . . . . . . . . . 28.2 p -102.39 139.94 20.68 Favored Pre-proline 0 N--CA 1.48 1.068 0 C-N-CA 123.87 0.868 . . . . 0.0 110.257 -177.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 319' ' ' PRO . . . . . 0.64 ' HG3' HD21 ' A' ' 280' ' ' LEU . 72.3 Cg_endo -66.12 -14.68 45.47 Favored 'Trans proline' 0 C--N 1.371 1.731 0 C-N-CA 123.753 2.969 . . . . 0.0 113.363 -173.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 22.5 ttt180 -63.37 -56.29 17.54 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.537 0.735 . . . . 0.0 110.592 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 10.0 t -70.83 -27.93 64.23 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.337 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 322' ' ' LEU . . . . . 0.53 HD21 HD22 ' A' ' 313' ' ' LEU . 43.9 mt -80.44 -10.01 59.75 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.531 0.732 . . . . 0.0 111.093 178.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp 68.49 24.3 7.13 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 125.31 1.444 . . . . 0.0 112.148 175.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . 0.444 ' HG ' ' HB2' ' A' ' 322' ' ' LEU . 23.7 mt -75.29 156.91 35.13 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.752 0.821 . . . . 0.0 110.681 178.046 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 325' ' ' GLY . . . . . 0.429 ' H ' ' HB2' ' A' ' 328' ' ' ASP . . . -163.04 -151.97 6.62 Favored Glycine 0 C--O 1.243 0.705 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.348 -175.146 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 266' ' ' PRO . 34.0 m -76.73 -33.05 21.19 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 C-N-CA 123.08 0.552 . . . . 0.0 111.325 -178.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -94.77 -20.06 19.82 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.595 0.758 . . . . 0.0 111.629 -176.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 328' ' ' ASP . . . . . 0.429 ' HB2' ' H ' ' A' ' 325' ' ' GLY . 7.7 m-20 -78.02 120.68 23.21 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 122.922 0.489 . . . . 0.0 109.927 -177.177 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . 0.591 HG12 ' HG2' ' A' ' 268' ' ' LYS . 8.7 mt -105.19 111.23 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 123.84 0.856 . . . . 0.0 110.623 -169.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 330' ' ' ILE . . . . . 0.5 HG23 ' HB2' ' A' ' 308' ' ' PHE . 45.5 pt -102.56 124.21 56.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 CA-C-O 121.22 0.533 . . . . 0.0 111.135 -179.02 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -73.34 115.89 13.25 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.673 0.789 . . . . 0.0 111.035 -178.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 332' ' ' CYS . . . . . 0.462 ' SG ' HD13 ' A' ' 304' ' ' ILE . 39.5 t -78.11 95.03 4.8 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 170.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 59.4 t -102.02 109.91 27.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 123.452 0.701 . . . . 0.0 109.111 -177.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 334' ' ' VAL . . . . . 0.472 HG22 HD12 ' A' ' 304' ' ' ILE . 47.5 t -83.8 99.32 6.2 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 C-N-CA 123.26 0.624 . . . . 0.0 110.052 -178.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 85.8 mt . . . . . 0 N--CA 1.479 1.007 0 C-N-CA 123.967 0.907 . . . . 0.0 110.225 175.65 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . 0.498 ' HG ' ' HG3' ' A' ' 281' ' ' ARG . 3.3 mp . . . . . 0 C--O 1.239 0.522 0 CA-C-O 120.828 0.347 . . . . 0.0 110.707 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 265' ' ' PHE . . . . . 0.454 ' CE1' ' HG2' ' A' ' 282' ' ' MET . 15.2 p90 -125.34 143.83 45.76 Favored Pre-proline 0 CA--C 1.549 0.92 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 172.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -62.93 96.61 0.17 Allowed 'Trans proline' 0 C--N 1.373 1.852 0 C-N-CA 122.564 2.176 . . . . 0.0 112.01 174.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.37 120.14 12.8 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 170.099 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . 0.507 ' HE3' HG12 ' A' ' 329' ' ' ILE . 25.5 ttpt -93.95 111.61 23.34 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 121.464 0.65 . . . . 0.0 110.008 -177.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 4.3 mp -106.75 130.33 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.31 1.044 . . . . 0.0 108.872 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 23.1 ttm180 -84.5 101.01 11.74 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.196 0.522 . . . . 0.0 109.916 173.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 271' ' ' CYS . . . . . 0.571 ' SG ' HD21 ' A' ' 297' ' ' LEU . 52.5 t -69.5 175.56 4.0 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.971 169.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 272' ' ' ARG . . . . . 0.452 ' HG2' ' SG ' ' A' ' 271' ' ' CYS . 7.5 ptm180 -53.29 -25.95 16.65 Favored 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 124.862 1.265 . . . . 0.0 113.344 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -163.45 37.24 0.09 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.268 0.627 . . . . 0.0 111.205 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -165.27 162.65 19.94 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 122.838 0.455 . . . . 0.0 111.4 -175.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.432 HD11 ' HD2' ' A' ' 268' ' ' LYS . 86.5 mt -114.55 104.15 11.72 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.437 1.095 . . . . 0.0 109.662 172.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 79.5 t -86.47 110.29 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 174.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 20.6 mtm180 -103.95 84.13 2.21 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . 0.471 HD22 ' HA ' ' A' ' 289' ' ' VAL . 4.4 pp -94.68 147.58 33.42 Favored Pre-proline 0 N--CA 1.486 1.367 0 CA-C-O 119.296 -0.383 . . . . 0.0 110.797 -174.386 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.01 120.75 6.5 Favored 'Trans proline' 0 C--N 1.378 2.105 0 C-N-CA 122.35 2.033 . . . . 0.0 111.008 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.69 HD23 ' HG3' ' A' ' 319' ' ' PRO . 1.0 OUTLIER -139.72 151.19 45.66 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.488 1.115 . . . . 0.0 109.265 -175.98 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . 0.498 ' HG3' ' HG ' ' A' ' 264' ' ' LEU . 0.0 OUTLIER -97.15 149.36 22.08 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.534 -0.914 . . . . 0.0 108.534 -177.386 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 282' ' ' MET . . . . . 0.515 ' HA ' ' HG2' ' A' ' 319' ' ' PRO . 14.4 mtp -70.88 -20.15 62.55 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 118.448 0.567 . . . . 0.0 111.378 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 20.6 t -92.6 5.03 52.43 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 123.696 0.799 . . . . 0.0 111.081 176.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -99.25 133.47 22.03 Favored Pre-proline 0 N--CA 1.478 0.96 0 C-N-CA 124.178 0.991 . . . . 0.0 109.027 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.32 164.38 23.2 Favored 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 122.154 1.903 . . . . 0.0 111.941 171.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 67.9 mt -65.64 -12.03 49.85 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 118.861 -0.59 . . . . 0.0 112.204 -178.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 287' ' ' GLN . . . . . 0.418 ' HA ' ' HB ' ' A' ' 290' ' ' VAL . 25.5 tp60 -55.0 -23.42 19.27 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 122.94 0.496 . . . . 0.0 111.945 177.126 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 288' ' ' SER . . . . . 0.57 ' HB3' HD11 ' A' ' 280' ' ' LEU . 43.7 t -59.4 -54.19 49.52 Favored 'General case' 0 CA--C 1.557 1.249 0 C-N-CA 123.464 0.706 . . . . 0.0 111.47 169.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.471 ' HA ' HD22 ' A' ' 278' ' ' LEU . 20.6 m -70.42 -36.15 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 C-N-CA 122.026 0.131 . . . . 0.0 110.862 179.246 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . 0.551 HG13 ' HB ' ' A' ' 304' ' ' ILE . 74.3 t -61.82 -45.29 99.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.184 0.994 . . . . 0.0 110.853 -178.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -64.08 -51.26 64.91 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 124.046 0.842 . . . . 0.0 110.975 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 47.8 t60 -63.99 -42.55 97.17 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 123.784 0.678 . . . . 0.0 111.097 -176.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 95.4 mmm -67.32 -35.62 79.8 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.218 0.607 . . . . 0.0 110.766 178.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -65.78 -43.78 87.78 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.148 0.579 . . . . 0.0 110.923 176.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 31.9 m -68.36 -34.51 76.2 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.581 0.753 . . . . 0.0 111.068 178.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 23.3 t60 -69.97 -49.87 47.45 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.677 0.791 . . . . 0.0 110.2 -179.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 297' ' ' LEU . . . . . 0.571 HD21 ' SG ' ' A' ' 271' ' ' CYS . 55.9 mt -84.49 -11.66 55.71 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.017 0.927 . . . . 0.0 111.737 -175.159 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 72.04 37.91 59.99 Favored Glycine 0 C--N 1.351 1.362 0 O-C-N 123.273 0.358 . . . . 0.0 112.757 178.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 299' ' ' VAL . . . . . 0.49 HG11 HG11 ' A' ' 334' ' ' VAL . 34.8 m -123.42 177.9 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.326 1.051 . . . . 0.0 110.145 178.292 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 300' ' ' SER . . . . . 0.485 ' HB2' ' HG3' ' A' ' 303' ' ' ARG . 46.9 m -79.03 147.88 70.69 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 123.431 0.692 . . . . 0.0 110.556 175.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -57.68 -27.29 76.87 Favored 'Trans proline' 0 C--N 1.385 2.46 0 C-N-CA 123.068 2.512 . . . . 0.0 112.336 172.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 57.3 p -68.42 -18.52 64.46 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.768 0.827 . . . . 0.0 111.922 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 303' ' ' ARG . . . . . 0.485 ' HG3' ' HB2' ' A' ' 300' ' ' SER . 97.1 mtt180 -89.21 -28.05 20.23 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.69 0.796 . . . . 0.0 111.707 -178.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 304' ' ' ILE . . . . . 0.551 ' HB ' HG13 ' A' ' 290' ' ' VAL . 40.3 mm -72.95 117.72 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 123.06 0.544 . . . . 0.0 109.737 -179.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 31.4 tp -125.16 114.73 19.4 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 177.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -83.91 121.67 27.67 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -178.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . 0.467 HD13 HG23 ' A' ' 333' ' ' VAL . 76.7 mt -129.54 116.46 18.96 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.298 1.039 . . . . 0.0 109.082 -176.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -91.82 96.66 10.53 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 174.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 74.36 -82.98 0.77 Allowed Glycine 0 C--N 1.345 1.045 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.872 177.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -132.05 -6.19 3.49 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.296 0.638 . . . . 0.0 111.458 -179.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 6.2 t -91.98 147.2 23.14 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 122.538 0.335 . . . . 0.0 110.344 -179.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -98.84 131.05 45.25 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.066 0.546 . . . . 0.0 109.757 178.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . 0.509 HD21 HD23 ' A' ' 322' ' ' LEU . 44.9 mt -113.53 130.76 56.28 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.3 0.64 . . . . 0.0 109.63 -179.115 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 37.4 m -76.24 142.33 71.61 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 123.153 0.581 . . . . 0.0 111.314 178.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . 0.48 ' HB3' HG21 ' A' ' 290' ' ' VAL . 35.3 Cg_endo -62.5 -23.26 74.83 Favored 'Trans proline' 0 C--N 1.38 2.217 0 C-N-CA 123.041 2.494 . . . . 0.0 112.436 173.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 52.3 p -80.78 -22.83 39.76 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.035 0.934 . . . . 0.0 111.573 178.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -71.6 154.74 41.21 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.289 0.636 . . . . 0.0 111.477 -178.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 318' ' ' THR . . . . . . . . . . . . . 74.2 p -105.74 149.41 37.91 Favored Pre-proline 0 N--CA 1.477 0.89 0 C-N-CA 123.998 0.919 . . . . 0.0 109.884 -176.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 319' ' ' PRO . . . . . 0.69 ' HG3' HD23 ' A' ' 280' ' ' LEU . 85.6 Cg_endo -68.66 -11.38 31.74 Favored 'Trans proline' 0 C--N 1.372 1.789 0 C-N-CA 123.263 2.642 . . . . 0.0 112.871 -178.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 38.5 ttt180 -69.01 -56.37 7.99 Favored 'General case' 0 C--N 1.347 0.488 0 C-N-CA 123.138 0.575 . . . . 0.0 109.6 177.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 15.1 t -71.01 -24.31 62.35 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.259 -178.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 322' ' ' LEU . . . . . 0.509 HD23 HD21 ' A' ' 313' ' ' LEU . 69.8 mt -86.01 -15.75 40.44 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.24 0.616 . . . . 0.0 111.31 175.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 44.4 tptt 68.05 27.89 6.87 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 125.251 1.42 . . . . 0.0 111.804 177.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . 0.434 ' HG ' ' HB2' ' A' ' 322' ' ' LEU . 29.0 mt -68.29 159.18 31.83 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.483 0.713 . . . . 0.0 110.59 178.264 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 325' ' ' GLY . . . . . 0.403 ' H ' ' HB3' ' A' ' 328' ' ' ASP . . . -160.8 -178.15 34.53 Favored Glycine 0 C--N 1.341 0.846 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.429 -172.104 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 34.2 m -70.81 -20.06 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 123.943 0.897 . . . . 0.0 111.909 179.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -97.51 -15.76 20.41 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.001 0.92 . . . . 0.0 111.274 176.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 328' ' ' ASP . . . . . 0.403 ' HB3' ' H ' ' A' ' 325' ' ' GLY . 15.4 t70 -83.35 143.38 30.38 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.113 0.565 . . . . 0.0 109.671 -177.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . 0.507 HG12 ' HE3' ' A' ' 268' ' ' LYS . 6.2 mt -130.0 120.6 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 122.72 0.408 . . . . 0.0 110.402 -178.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 30.1 pt -113.55 131.87 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 123.42 0.688 . . . . 0.0 110.595 178.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -77.35 118.68 20.05 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.729 0.812 . . . . 0.0 111.792 -172.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 332' ' ' CYS . . . . . 0.544 ' SG ' HD11 ' A' ' 304' ' ' ILE . 40.5 t -80.03 94.58 5.96 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.947 0.899 . . . . 0.0 109.999 171.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . 0.467 HG23 HD13 ' A' ' 307' ' ' LEU . 90.9 t -97.36 112.54 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 123.213 0.605 . . . . 0.0 109.594 178.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 334' ' ' VAL . . . . . 0.49 HG11 HG11 ' A' ' 299' ' ' VAL . 83.9 t -82.85 125.24 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 175.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 1.2 pp . . . . . 0 N--CA 1.48 1.038 0 C-N-CA 124.261 1.025 . . . . 0.0 110.564 -177.907 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 3.6 mp . . . . . 0 CA--C 1.547 0.865 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 265' ' ' PHE . . . . . 0.406 ' CE1' ' HG2' ' A' ' 282' ' ' MET . 34.8 p90 -138.39 144.58 43.36 Favored Pre-proline 0 N--CA 1.478 0.934 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 177.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.09 88.34 0.08 OUTLIER 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 123.25 2.633 . . . . 0.0 113.325 175.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -67.48 121.76 16.51 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 171.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . 0.449 ' HE3' HG12 ' A' ' 329' ' ' ILE . 23.4 ttpt -97.32 122.76 40.72 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 121.37 0.605 . . . . 0.0 110.769 -178.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . 0.451 HG21 ' HG3' ' A' ' 293' ' ' MET . 2.1 mp -119.36 130.99 73.26 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 C-N-CA 124.943 1.297 . . . . 0.0 108.163 -178.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 25.5 ttp180 -94.92 107.41 19.45 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 122.989 0.516 . . . . 0.0 110.447 177.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 271' ' ' CYS . . . . . 0.777 ' SG ' HD21 ' A' ' 297' ' ' LEU . 37.7 t -70.42 -176.54 1.25 Allowed 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.147 0.979 . . . . 0.0 110.065 168.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 21.3 ptt180 -59.78 -30.6 68.99 Favored 'General case' 0 CA--C 1.557 1.23 0 C-N-CA 123.455 0.702 . . . . 0.0 112.077 179.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -159.42 35.03 0.2 Allowed 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.409 0.684 . . . . 0.0 111.37 -178.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -156.02 151.73 27.23 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 122.766 0.426 . . . . 0.0 110.519 -176.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -116.37 114.76 24.73 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.137 0.975 . . . . 0.0 109.109 174.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 95.6 t -99.85 129.48 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.086 0.955 . . . . 0.0 108.883 173.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 90.7 mtm180 -119.47 86.17 2.51 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 176.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 4.3 pp -96.72 141.03 22.49 Favored Pre-proline 0 N--CA 1.478 0.941 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -176.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.62 120.49 7.42 Favored 'Trans proline' 0 C--N 1.371 1.718 0 C-N-CA 122.407 2.071 . . . . 0.0 110.841 173.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.641 HD23 ' HG3' ' A' ' 319' ' ' PRO . 0.0 OUTLIER -135.39 155.42 50.6 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.31 1.044 . . . . 0.0 110.001 -178.329 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -93.23 143.16 26.53 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.514 1.126 . . . . 0.0 109.641 177.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 282' ' ' MET . . . . . 0.525 ' HE3' ' HA ' ' A' ' 320' ' ' ARG . 35.0 mtp -67.99 -25.2 65.29 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 118.354 0.524 . . . . 0.0 110.095 176.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 10.3 p -74.64 -34.72 62.81 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.004 1.321 . . . . 0.0 111.592 176.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -70.02 125.49 92.01 Favored Pre-proline 0 N--CA 1.473 0.715 0 C-N-CA 124.121 0.969 . . . . 0.0 108.764 173.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 285' ' ' PRO . . . . . 0.466 ' HA ' ' HA ' ' A' ' 318' ' ' THR . 44.8 Cg_endo -63.58 176.81 2.0 Favored 'Trans proline' 0 C--N 1.381 2.263 0 C-N-CA 122.598 2.199 . . . . 0.0 112.439 174.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.409 ' O ' HG21 ' A' ' 290' ' ' VAL . 86.5 mt -65.26 -17.01 64.16 Favored 'General case' 0 C--O 1.22 -0.483 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.773 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 24.7 tp60 -48.89 -27.63 3.21 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.905 0.882 . . . . 0.0 112.657 178.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 288' ' ' SER . . . . . 0.464 ' HB3' HD13 ' A' ' 280' ' ' LEU . 43.2 t -57.4 -62.13 1.99 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.553 1.141 . . . . 0.0 111.205 170.221 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.427 ' HB ' HG12 ' A' ' 269' ' ' ILE . 15.9 m -69.19 -26.84 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 123.149 0.58 . . . . 0.0 110.784 -176.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . 0.531 HG13 ' HB ' ' A' ' 304' ' ' ILE . 77.1 t -62.62 -52.16 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 123.802 0.841 . . . . 0.0 110.223 176.394 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -67.24 -39.6 86.21 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.378 0.671 . . . . 0.0 110.882 -178.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 23.3 t60 -67.5 -45.58 75.41 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 123.443 0.465 . . . . 0.0 110.833 -176.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 293' ' ' MET . . . . . 0.451 ' HG3' HG21 ' A' ' 269' ' ' ILE . 93.3 mmm -70.06 -30.09 67.26 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.064 0.546 . . . . 0.0 110.818 178.529 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -64.91 -42.72 94.5 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.201 0.6 . . . . 0.0 110.64 173.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 41.3 m -68.71 -34.26 75.34 Favored 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 123.781 0.832 . . . . 0.0 110.62 176.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -70.54 -34.39 72.2 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.185 0.994 . . . . 0.0 111.3 -178.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 297' ' ' LEU . . . . . 0.777 HD21 ' SG ' ' A' ' 271' ' ' CYS . 36.8 mt -100.73 -7.19 24.01 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.116 0.966 . . . . 0.0 111.501 -179.124 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 77.2 6.06 85.88 Favored Glycine 0 N--CA 1.474 1.194 0 C-N-CA 123.412 0.53 . . . . 0.0 113.784 178.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 32.3 m -94.88 -176.82 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 124.139 0.975 . . . . 0.0 111.053 -177.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 19.8 m -87.28 147.34 42.07 Favored Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 123.238 0.615 . . . . 0.0 110.159 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -55.08 -29.67 66.59 Favored 'Trans proline' 0 C--N 1.387 2.559 0 C-N-CA 122.946 2.431 . . . . 0.0 112.459 170.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 20.3 m -62.57 -26.92 68.84 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 122.941 0.496 . . . . 0.0 111.478 178.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 58.3 mtt180 -88.0 -20.13 26.25 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.301 1.04 . . . . 0.0 112.416 -175.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 304' ' ' ILE . . . . . 0.575 HD12 ' SG ' ' A' ' 332' ' ' CYS . 41.7 mm -82.64 125.65 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 122.811 0.444 . . . . 0.0 110.996 -177.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 48.6 tp -127.98 121.69 30.45 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.101 0.96 . . . . 0.0 108.94 176.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -88.48 134.54 33.82 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . 0.404 HD12 HG23 ' A' ' 333' ' ' VAL . 76.1 mt -136.48 103.97 5.43 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.86 0.864 . . . . 0.0 109.257 -177.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . 0.449 ' HB2' HD13 ' A' ' 313' ' ' LEU . 82.5 t80 -77.37 92.44 3.94 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -178.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 70.5 -78.52 0.46 Allowed Glycine 0 C--N 1.349 1.275 0 CA-C-N 116.24 -0.436 . . . . 0.0 112.326 -179.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -146.49 54.47 1.13 Allowed 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 123.929 0.892 . . . . 0.0 110.643 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 11.2 t -147.27 150.82 35.56 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 122.815 0.446 . . . . 0.0 110.238 175.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -87.98 119.73 28.63 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.807 0.843 . . . . 0.0 110.119 -179.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . 0.513 HD21 HD21 ' A' ' 322' ' ' LEU . 45.7 mt -117.55 122.3 43.29 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 178.055 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 18.3 m -79.73 150.81 73.24 Favored Pre-proline 0 CA--C 1.55 0.979 0 C-N-CA 123.413 0.685 . . . . 0.0 110.853 178.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . 0.429 ' HB3' HG23 ' A' ' 290' ' ' VAL . 51.2 Cg_exo -56.21 -32.48 87.61 Favored 'Trans proline' 0 C--N 1.382 2.298 0 C-N-CA 122.827 2.351 . . . . 0.0 112.22 170.371 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 77.2 p -75.77 -16.93 60.05 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-N 114.353 -1.294 . . . . 0.0 112.128 -178.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -77.18 144.45 38.33 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.236 0.614 . . . . 0.0 110.334 178.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 318' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 285' ' ' PRO . 25.2 p -99.21 138.38 20.55 Favored Pre-proline 0 N--CA 1.474 0.76 0 C-N-CA 123.568 0.747 . . . . 0.0 109.981 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 319' ' ' PRO . . . . . 0.641 ' HG3' HD23 ' A' ' 280' ' ' LEU . 18.5 Cg_endo -55.94 -19.82 27.31 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 123.926 3.084 . . . . 0.0 113.974 179.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . 0.525 ' HA ' ' HE3' ' A' ' 282' ' ' MET . 79.4 ttt180 -66.63 -51.01 61.03 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.146 0.578 . . . . 0.0 111.5 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 15.2 t -72.94 -20.16 61.11 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.502 0.321 . . . . 0.0 110.93 -179.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 322' ' ' LEU . . . . . 0.513 HD21 HD21 ' A' ' 313' ' ' LEU . 36.9 mt -85.1 -17.55 37.0 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.362 0.665 . . . . 0.0 110.404 176.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 323' ' ' LYS . . . . . 0.488 ' HA ' ' HE2' ' A' ' 323' ' ' LYS . 0.5 OUTLIER 61.56 58.1 2.14 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.233 1.413 . . . . 0.0 110.466 -178.749 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . 0.454 ' HG ' ' HB2' ' A' ' 322' ' ' LEU . 76.3 mt -95.56 171.27 8.79 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.051 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . -167.87 -171.99 34.42 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.108 -175.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 34.1 m -67.82 -28.93 43.28 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 C-N-CA 123.977 0.911 . . . . 0.0 111.452 177.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -93.54 -15.87 25.02 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.144 0.978 . . . . 0.0 111.387 -178.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -89.78 123.94 34.21 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.176 0.591 . . . . 0.0 109.708 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . 0.449 HG12 ' HE3' ' A' ' 268' ' ' LYS . 19.6 mt -109.41 127.36 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 123.378 0.671 . . . . 0.0 110.183 -175.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 330' ' ' ILE . . . . . 0.414 HG21 ' HB2' ' A' ' 308' ' ' PHE . 30.9 pt -111.56 128.53 68.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 C-N-CA 123.251 0.62 . . . . 0.0 110.346 177.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -76.81 110.43 11.41 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.844 0.858 . . . . 0.0 111.587 -174.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 332' ' ' CYS . . . . . 0.575 ' SG ' HD12 ' A' ' 304' ' ' ILE . 31.8 t -75.69 105.2 6.6 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.788 0.835 . . . . 0.0 110.447 172.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . 0.404 HG23 HD12 ' A' ' 307' ' ' LEU . 88.4 t -111.47 122.03 65.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 123.668 0.787 . . . . 0.0 110.041 -178.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 59.7 t -86.05 98.62 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 123.305 0.642 . . . . 0.0 109.741 178.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 92.8 mt . . . . . 0 N--CA 1.471 0.603 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 172.107 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 3.7 mp . . . . . 0 N--CA 1.469 0.513 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -136.9 150.52 69.99 Favored Pre-proline 0 CA--C 1.549 0.905 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -68.07 90.73 0.38 Allowed 'Trans proline' 0 C--N 1.376 1.983 0 C-N-CA 122.459 2.106 . . . . 0.0 112.029 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.37 113.49 4.68 Favored 'General case' 0 C--N 1.349 0.55 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 169.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . 0.457 ' O ' ' HA ' ' A' ' 329' ' ' ILE . 22.6 ttpt -92.37 111.58 23.21 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.259 0.623 . . . . 0.0 109.883 -176.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 4.7 mp -106.72 129.3 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 123.703 0.801 . . . . 0.0 109.271 179.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 270' ' ' ARG . . . . . 0.421 ' HA ' HD13 ' A' ' 275' ' ' LEU . 39.5 ttp180 -84.57 98.78 10.34 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 122.879 0.471 . . . . 0.0 110.002 175.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 271' ' ' CYS . . . . . 0.727 ' SG ' HD23 ' A' ' 297' ' ' LEU . 41.9 t -69.56 175.6 4.02 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.1 171.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 272' ' ' ARG . . . . . 0.416 ' N ' ' SG ' ' A' ' 271' ' ' CYS . 16.2 ptt180 -54.33 -30.1 50.24 Favored 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 124.299 1.04 . . . . 0.0 112.314 178.433 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -159.76 37.82 0.19 Allowed 'General case' 0 C--N 1.354 0.801 0 C-N-CA 123.794 0.838 . . . . 0.0 110.948 -176.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -166.23 158.79 14.47 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 122.673 0.389 . . . . 0.0 111.128 -175.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.421 HD13 ' HA ' ' A' ' 270' ' ' ARG . 4.2 mm? -115.69 97.39 6.1 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.118 0.967 . . . . 0.0 109.07 173.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 46.3 t -84.99 98.53 6.29 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.595 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 39.6 mtt85 -96.89 79.86 2.96 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -178.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.6 pp -92.15 142.53 26.34 Favored Pre-proline 0 N--CA 1.487 1.386 0 CA-C-O 119.404 -0.331 . . . . 0.0 110.392 -172.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -74.23 109.75 2.95 Favored 'Trans proline' 0 C--N 1.373 1.835 0 C-N-CA 122.223 1.949 . . . . 0.0 110.698 177.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.597 HD21 ' HG3' ' A' ' 319' ' ' PRO . 0.0 OUTLIER -123.46 153.06 41.0 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.342 1.057 . . . . 0.0 109.617 179.018 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . 0.564 ' HB2' ' HB2' ' A' ' 284' ' ' GLU . 31.9 mtp180 -88.38 147.34 24.78 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.932 0.893 . . . . 0.0 110.318 177.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 282' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -62.51 -34.19 76.39 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 122.928 0.491 . . . . 0.0 110.361 173.514 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 23.7 m -67.79 -31.32 71.11 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.203 1.001 . . . . 0.0 111.718 176.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 284' ' ' GLU . . . . . 0.564 ' HB2' ' HB2' ' A' ' 281' ' ' ARG . 6.2 tp10 -73.31 132.21 82.15 Favored Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 124.009 0.923 . . . . 0.0 109.108 -178.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -70.39 178.32 5.08 Favored 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 122.163 1.908 . . . . 0.0 112.28 174.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.403 ' O ' HG23 ' A' ' 290' ' ' VAL . 70.7 mt -67.1 -19.04 65.57 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 118.744 -0.646 . . . . 0.0 111.66 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 27.7 tp60 -53.68 -22.39 8.87 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.282 0.633 . . . . 0.0 112.193 178.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 288' ' ' SER . . . . . 0.515 ' HB3' HD11 ' A' ' 280' ' ' LEU . 24.8 t -64.74 -54.32 33.26 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.413 0.685 . . . . 0.0 110.984 172.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.422 HG11 HD13 ' A' ' 280' ' ' LEU . 17.2 m -70.9 -29.21 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 122.532 0.333 . . . . 0.0 110.753 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . 0.513 HG13 ' HB ' ' A' ' 304' ' ' ILE . 78.1 t -63.83 -49.22 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 123.702 0.801 . . . . 0.0 110.099 176.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -63.89 -46.93 82.64 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.743 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 43.2 t60 -67.15 -41.83 85.4 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.15 -174.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 90.9 mmm -68.09 -30.33 69.48 Favored 'General case' 0 N--CA 1.483 1.201 0 O-C-N 123.401 0.438 . . . . 0.0 111.227 177.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -67.47 -43.45 80.99 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.13 0.572 . . . . 0.0 110.615 175.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 27.7 m -69.43 -29.59 67.34 Favored 'General case' 0 CA--C 1.557 1.216 0 C-N-CA 124.063 0.945 . . . . 0.0 110.837 176.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 77.8 t60 -74.59 -34.63 62.91 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.839 0.856 . . . . 0.0 111.442 -178.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 297' ' ' LEU . . . . . 0.727 HD23 ' SG ' ' A' ' 271' ' ' CYS . 75.5 mt -105.74 -8.26 17.93 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.655 0.782 . . . . 0.0 112.283 -175.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 72.93 31.67 61.8 Favored Glycine 0 C--N 1.347 1.188 0 O-C-N 123.598 0.561 . . . . 0.0 112.55 178.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 299' ' ' VAL . . . . . 0.514 HG13 HG13 ' A' ' 334' ' ' VAL . 33.2 m -117.75 -177.33 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.357 1.063 . . . . 0.0 110.057 179.313 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 300' ' ' SER . . . . . 0.542 ' HB3' ' HG3' ' A' ' 303' ' ' ARG . 32.2 t -82.36 147.02 55.54 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 123.194 0.598 . . . . 0.0 110.18 178.119 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -59.49 -27.97 86.31 Favored 'Trans proline' 0 C--N 1.385 2.453 0 C-N-CA 122.774 2.316 . . . . 0.0 111.124 169.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 22.8 t -67.11 -15.73 63.9 Favored 'General case' 0 CA--C 1.559 1.29 0 C-N-CA 123.454 0.702 . . . . 0.0 111.207 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 303' ' ' ARG . . . . . 0.542 ' HG3' ' HB3' ' A' ' 300' ' ' SER . 59.3 mtt180 -94.59 -26.51 16.35 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.006 0.922 . . . . 0.0 111.63 -178.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 304' ' ' ILE . . . . . 0.54 HD13 ' SG ' ' A' ' 332' ' ' CYS . 37.9 mm -77.02 103.58 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 122.861 0.464 . . . . 0.0 110.865 -175.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 34.8 tp -105.68 123.79 48.51 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 174.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . 0.442 ' HA ' ' O ' ' A' ' 331' ' ' ASP . 3.4 mm? -89.26 128.35 35.84 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 177.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . 0.409 HD22 ' HA ' ' A' ' 312' ' ' GLU . 68.4 mt -134.05 114.8 13.58 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.477 1.111 . . . . 0.0 108.608 -177.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -79.42 81.26 5.7 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 176.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 66.63 -85.97 0.11 Allowed Glycine 0 C--N 1.357 1.731 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.862 -176.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -127.1 75.68 1.6 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.142 0.977 . . . . 0.0 109.684 177.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 14.5 t -173.51 147.37 1.44 Allowed 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.489 1.116 . . . . 0.0 108.831 169.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . 0.409 ' HA ' HD22 ' A' ' 307' ' ' LEU . 42.2 tt0 -93.52 128.87 39.83 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 -178.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . 0.476 HD13 HD12 ' A' ' 322' ' ' LEU . 45.2 mt -113.33 127.42 56.13 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 123.667 0.604 . . . . 0.0 109.762 177.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 314' ' ' SER . . . . . 0.401 ' O ' HD12 ' A' ' 286' ' ' LEU . 39.0 m -77.81 140.61 63.16 Favored Pre-proline 0 CA--C 1.554 1.105 0 C-N-CA 123.529 0.731 . . . . 0.0 110.633 179.248 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -63.94 -24.34 67.52 Favored 'Trans proline' 0 C--N 1.384 2.402 0 C-N-CA 122.871 2.381 . . . . 0.0 113.042 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 6.5 m -81.75 -18.47 44.13 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 123.788 0.835 . . . . 0.0 111.344 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -70.25 150.72 46.11 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 122.852 0.461 . . . . 0.0 109.967 176.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 318' ' ' THR . . . . . . . . . . . . . 69.5 p -98.57 144.4 28.07 Favored Pre-proline 0 CA--C 1.541 0.598 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 319' ' ' PRO . . . . . 0.597 ' HG3' HD21 ' A' ' 280' ' ' LEU . 20.8 Cg_endo -57.83 -17.31 29.35 Favored 'Trans proline' 0 C--N 1.366 1.486 0 C-N-CA 123.171 2.581 . . . . 0.0 112.578 170.578 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 44.9 ttt180 -71.02 -48.5 52.72 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.525 0.73 . . . . 0.0 110.454 -179.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 15.0 t -70.27 -29.08 65.77 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-O 120.809 0.338 . . . . 0.0 110.626 178.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 322' ' ' LEU . . . . . 0.476 HD12 HD13 ' A' ' 313' ' ' LEU . 64.7 mt -81.58 -14.83 56.32 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.82 177.266 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp 59.62 36.32 22.59 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.566 1.146 . . . . 0.0 112.413 -177.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . 0.424 ' HG ' ' HB2' ' A' ' 322' ' ' LEU . 44.7 mt -68.96 145.46 53.6 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.701 0.8 . . . . 0.0 109.809 174.177 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . -140.31 -169.29 11.64 Favored Glycine 0 C--O 1.24 0.472 0 C-N-CA 123.435 0.541 . . . . 0.0 112.08 -174.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 26.0 m -74.09 -26.86 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.771 0.828 . . . . 0.0 111.915 -175.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -101.03 -3.24 29.72 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.713 0.805 . . . . 0.0 111.141 179.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -83.28 144.78 29.49 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 175.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . 0.457 ' HA ' ' O ' ' A' ' 268' ' ' LYS . 24.2 mt -131.29 125.33 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 123.232 0.613 . . . . 0.0 109.673 -178.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 28.4 pt -116.82 131.93 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 123.367 0.667 . . . . 0.0 110.365 176.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 331' ' ' ASP . . . . . 0.442 ' O ' ' HA ' ' A' ' 306' ' ' LEU . 7.1 m-20 -68.13 135.67 52.5 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.951 0.9 . . . . 0.0 111.712 -179.193 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 332' ' ' CYS . . . . . 0.54 ' SG ' HD13 ' A' ' 304' ' ' ILE . 26.2 t -103.79 99.51 9.3 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.08 0.952 . . . . 0.0 109.011 171.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 47.9 t -104.48 113.46 41.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -178.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 334' ' ' VAL . . . . . 0.514 HG13 HG13 ' A' ' 299' ' ' VAL . 58.3 t -81.71 99.01 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.723 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 80.6 mt . . . . . 0 N--CA 1.47 0.551 0 C-N-CA 123.655 0.782 . . . . 0.0 110.389 175.941 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 3.8 mp . . . . . 0 C--O 1.24 0.591 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 265' ' ' PHE . . . . . 0.455 ' CE1' ' SD ' ' A' ' 282' ' ' MET . 46.4 p90 -145.63 147.33 32.64 Favored Pre-proline 0 C--O 1.243 0.725 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 173.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -68.12 94.02 0.41 Allowed 'Trans proline' 0 C--N 1.37 1.691 0 C-N-CA 122.061 1.84 . . . . 0.0 110.759 174.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 267' ' ' LEU . . . . . 0.494 HD11 HG13 ' A' ' 269' ' ' ILE . 1.9 tm? -58.55 130.14 45.41 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 173.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . 0.572 ' HD2' HD21 ' A' ' 275' ' ' LEU . 4.7 tppp? -90.04 109.63 20.66 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 123.846 0.716 . . . . 0.0 110.497 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . 0.494 HG13 HD11 ' A' ' 267' ' ' LEU . 2.8 mp -110.93 154.95 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 174.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 270' ' ' ARG . . . . . 0.466 ' HG2' HD23 ' A' ' 275' ' ' LEU . 30.0 mtp-105 -113.75 131.11 56.32 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 162.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 271' ' ' CYS . . . . . 0.618 ' SG ' HD22 ' A' ' 297' ' ' LEU . 30.7 t -74.1 -160.14 0.09 Allowed 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 123.961 0.905 . . . . 0.0 109.399 168.335 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -58.67 -19.07 36.2 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.324 0.65 . . . . 0.0 112.051 173.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -153.86 -56.21 0.11 Allowed 'General case' 0 C--N 1.352 0.706 0 C-N-CA 123.532 0.733 . . . . 0.0 110.631 176.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -68.19 162.38 25.0 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.473 1.109 . . . . 0.0 112.652 -170.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.572 HD21 ' HD2' ' A' ' 268' ' ' LYS . 66.3 mt -88.86 128.09 35.65 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.714 0.806 . . . . 0.0 110.063 170.232 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 94.2 t -115.53 131.74 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 174.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 88.8 mtm180 -124.79 127.72 47.63 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.606 0.762 . . . . 0.0 109.189 176.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . 0.473 HD22 ' HA ' ' A' ' 289' ' ' VAL . 3.7 pp -135.43 144.33 49.02 Favored Pre-proline 0 N--CA 1.483 1.187 0 CA-C-O 119.436 -0.316 . . . . 0.0 110.242 177.369 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -71.57 116.33 4.65 Favored 'Trans proline' 0 C--N 1.372 1.799 0 C-N-CA 122.179 1.919 . . . . 0.0 111.033 177.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.684 HD23 ' HG3' ' A' ' 319' ' ' PRO . 0.5 OUTLIER -135.23 151.6 50.76 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.82 1.248 . . . . 0.0 109.544 -178.051 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -96.48 154.31 17.34 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.248 0.619 . . . . 0.0 109.585 178.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 282' ' ' MET . . . . . 0.455 ' SD ' ' CE1' ' A' ' 265' ' ' PHE . 94.2 mmm -63.44 -29.01 70.37 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 122.851 0.46 . . . . 0.0 111.577 176.415 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 39.7 t -79.91 -28.5 39.81 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.76 0.824 . . . . 0.0 111.363 176.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -67.96 123.22 86.62 Favored Pre-proline 0 N--CA 1.481 1.084 0 C-N-CA 123.915 0.886 . . . . 0.0 109.843 -177.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -64.51 167.47 15.01 Favored 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 122.573 2.182 . . . . 0.0 112.118 178.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 56.2 mt -63.9 -16.47 61.49 Favored 'General case' 0 C--O 1.216 -0.705 0 CA-C-O 118.596 -0.716 . . . . 0.0 112.028 -177.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 287' ' ' GLN . . . . . 0.409 ' HA ' ' HB ' ' A' ' 290' ' ' VAL . 24.9 tp60 -49.82 -27.33 4.9 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.58 0.752 . . . . 0.0 112.379 177.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 288' ' ' SER . . . . . 0.552 ' HB3' HD13 ' A' ' 280' ' ' LEU . 36.2 t -60.83 -55.87 27.91 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 123.925 0.89 . . . . 0.0 111.201 172.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.473 ' HA ' HD22 ' A' ' 278' ' ' LEU . 15.6 m -69.56 -31.5 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 122.413 0.285 . . . . 0.0 110.934 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . 0.546 HG12 ' HB ' ' A' ' 304' ' ' ILE . 46.1 t -63.21 -55.69 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 124.794 1.237 . . . . 0.0 111.018 -178.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -67.99 -36.21 79.63 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.844 -176.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 9.7 t60 -61.07 -49.96 75.22 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.475 0.71 . . . . 0.0 110.374 176.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 93.9 mmm -69.65 -29.16 66.55 Favored 'General case' 0 C--O 1.217 -0.624 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.97 -179.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -69.59 -37.61 76.99 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.327 0.651 . . . . 0.0 110.777 178.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 56.1 m -73.26 -37.37 66.34 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.229 0.611 . . . . 0.0 110.161 176.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -63.61 -47.25 82.2 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.954 0.901 . . . . 0.0 110.522 179.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 297' ' ' LEU . . . . . 0.618 HD22 ' SG ' ' A' ' 271' ' ' CYS . 38.2 mt -89.26 -11.13 44.43 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.258 1.023 . . . . 0.0 112.125 -174.587 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 72.9 19.2 79.37 Favored Glycine 0 C--N 1.352 1.433 0 O-C-N 123.515 0.51 . . . . 0.0 112.932 -178.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 20.5 m -105.33 178.85 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 124.405 1.082 . . . . 0.0 110.305 -177.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 21.2 m -82.62 148.01 57.14 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 123.262 0.625 . . . . 0.0 109.898 178.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -60.83 -29.15 87.62 Favored 'Trans proline' 0 C--N 1.386 2.511 0 C-N-CA 122.494 2.129 . . . . 0.0 112.334 175.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 36.1 t -72.47 -17.93 61.72 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 122.261 -0.274 . . . . 0.0 110.739 -179.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -90.21 -7.37 53.72 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.779 0.832 . . . . 0.0 111.372 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 304' ' ' ILE . . . . . 0.556 HD12 ' SG ' ' A' ' 332' ' ' CYS . 41.6 mm -84.83 109.2 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 CA-C-N 118.373 0.533 . . . . 0.0 110.187 177.422 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 39.5 tp -109.8 112.09 23.93 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.47 0.708 . . . . 0.0 109.095 177.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . 0.442 HD22 HG21 ' A' ' 290' ' ' VAL . 2.5 mm? -85.05 133.46 34.24 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . 0.479 HD23 ' HA ' ' A' ' 312' ' ' GLU . 76.7 mt -132.8 103.09 5.92 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.312 0.645 . . . . 0.0 109.987 -177.1 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . 0.462 ' HB2' HD11 ' A' ' 313' ' ' LEU . 69.8 t80 -77.56 92.3 4.05 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -178.428 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 72.27 -81.29 0.59 Allowed Glycine 0 C--N 1.343 0.953 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.703 -174.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -131.75 -11.76 3.42 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.584 0.754 . . . . 0.0 112.384 -179.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 6.9 t -86.79 148.55 25.35 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 118.115 0.416 . . . . 0.0 111.004 -177.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . 0.479 ' HA ' HD23 ' A' ' 307' ' ' LEU . 37.2 tt0 -93.79 123.97 37.48 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 122.847 0.459 . . . . 0.0 110.226 -176.397 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . 0.474 HD12 HD13 ' A' ' 322' ' ' LEU . 47.5 mt -111.4 126.98 55.51 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.995 -178.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 42.0 m -71.37 144.46 89.32 Favored Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 123.693 0.797 . . . . 0.0 110.12 173.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -63.11 -18.11 63.48 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 123.027 2.485 . . . . 0.0 112.751 176.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 37.7 p -90.36 -8.42 50.78 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.573 1.149 . . . . 0.0 112.427 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -72.88 152.71 41.35 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.099 0.559 . . . . 0.0 111.036 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 318' ' ' THR . . . . . . . . . . . . . 32.4 p -103.93 142.82 25.4 Favored Pre-proline 0 N--CA 1.478 0.928 0 C-N-CA 122.999 0.52 . . . . 0.0 109.672 177.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 319' ' ' PRO . . . . . 0.684 ' HG3' HD23 ' A' ' 280' ' ' LEU . 70.3 Cg_endo -66.0 -14.17 43.24 Favored 'Trans proline' 0 C--N 1.369 1.64 0 C-N-CA 123.649 2.899 . . . . 0.0 113.192 -176.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 70.3 ttt180 -69.21 -53.47 19.78 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.234 0.614 . . . . 0.0 110.557 -177.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 9.8 t -66.8 -29.92 69.99 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.347 0.659 . . . . 0.0 111.364 177.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 322' ' ' LEU . . . . . 0.474 HD13 HD12 ' A' ' 313' ' ' LEU . 43.4 mt -81.89 -19.41 40.91 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.395 0.678 . . . . 0.0 111.0 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 53.69 75.67 0.25 Allowed 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 125.108 1.363 . . . . 0.0 109.623 -170.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 70.6 mt -106.98 164.57 12.03 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.627 176.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 325' ' ' GLY . . . . . 0.423 ' N ' ' HB2' ' A' ' 328' ' ' ASP . . . -169.53 -160.63 18.22 Favored Glycine 0 C--N 1.343 0.95 0 CA-C-N 115.928 -0.578 . . . . 0.0 113.374 -170.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 30.6 m -80.5 -24.55 11.26 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 124.481 1.112 . . . . 0.0 111.296 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -101.73 -25.85 13.69 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.054 0.942 . . . . 0.0 110.457 177.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 328' ' ' ASP . . . . . 0.423 ' HB2' ' N ' ' A' ' 325' ' ' GLY . 34.1 m-20 -76.02 111.5 11.47 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . 0.506 HG12 ' HG2' ' A' ' 268' ' ' LYS . 4.4 mt -99.13 133.21 42.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.088 0.555 . . . . 0.0 110.942 -173.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 41.2 pt -119.23 128.91 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 123.211 0.605 . . . . 0.0 109.739 174.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -85.22 109.65 18.47 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.374 0.67 . . . . 0.0 110.514 -176.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 332' ' ' CYS . . . . . 0.556 ' SG ' HD12 ' A' ' 304' ' ' ILE . 35.9 t -73.12 95.08 2.01 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.385 0.674 . . . . 0.0 109.583 170.1 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 58.2 t -106.86 122.39 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 178.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 91.4 t -78.53 102.01 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-O 121.18 0.514 . . . . 0.0 110.517 -176.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.554 1.114 0 C-N-CA 125.077 1.351 . . . . 0.0 109.061 170.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 3.0 mp . . . . . 0 C--O 1.243 0.757 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -144.85 146.51 31.71 Favored Pre-proline 0 CA--C 1.543 0.697 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 175.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 266' ' ' PRO . . . . . 0.494 ' HB2' ' HB3' ' A' ' 277' ' ' ARG . 46.2 Cg_endo -66.85 91.36 0.3 Allowed 'Trans proline' 0 C--N 1.374 1.903 0 C-N-CA 122.182 1.921 . . . . 0.0 112.197 176.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 267' ' ' LEU . . . . . 0.56 HD21 HD21 ' A' ' 280' ' ' LEU . 0.4 OUTLIER -63.28 115.53 4.64 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 170.747 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . 0.516 ' HD3' HD12 ' A' ' 275' ' ' LEU . 30.7 ttmt -90.96 118.38 30.3 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 123.414 0.446 . . . . 0.0 109.892 -179.378 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . 0.552 HG21 ' HG3' ' A' ' 293' ' ' MET . 2.4 mp -113.93 136.37 50.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 C-N-CA 123.6 0.76 . . . . 0.0 108.958 177.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 270' ' ' ARG . . . . . 0.47 ' HA ' HD23 ' A' ' 275' ' ' LEU . 0.7 OUTLIER -85.95 106.67 17.3 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 123.626 0.579 . . . . 0.0 110.469 -177.561 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 271' ' ' CYS . . . . . 0.528 ' SG ' HD22 ' A' ' 297' ' ' LEU . 38.6 t -75.2 179.49 5.06 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.742 0.817 . . . . 0.0 109.789 167.208 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 272' ' ' ARG . . . . . 0.46 ' N ' ' SG ' ' A' ' 271' ' ' CYS . 17.2 ptm180 -54.18 -36.08 63.03 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.012 0.925 . . . . 0.0 112.789 178.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -159.44 49.39 0.32 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.63 0.772 . . . . 0.0 109.621 178.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 274' ' ' ASP . . . . . 0.456 ' HB3' ' HB3' ' A' ' 271' ' ' CYS . 19.9 t70 -166.43 162.52 17.01 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.714 0.805 . . . . 0.0 110.123 -173.4 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.516 HD12 ' HD3' ' A' ' 268' ' ' LYS . 81.0 mt -131.36 104.72 7.18 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.392 1.077 . . . . 0.0 109.615 176.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 276' ' ' VAL . . . . . 0.405 ' O ' HD13 ' A' ' 269' ' ' ILE . 78.3 t -83.44 115.5 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 177.302 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . 0.494 ' HB3' ' HB2' ' A' ' 266' ' ' PRO . 61.2 mtm-85 -107.31 80.68 1.44 Allowed 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -179.046 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 4.3 pp -93.13 142.89 25.92 Favored Pre-proline 0 N--CA 1.484 1.226 0 CA-C-O 119.579 -0.248 . . . . 0.0 111.054 -173.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -68.23 109.14 1.92 Allowed 'Trans proline' 0 C--N 1.375 1.932 0 C-N-CA 122.833 2.355 . . . . 0.0 110.696 177.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.57 HD22 ' HG3' ' A' ' 319' ' ' PRO . 2.9 tt -127.39 139.17 53.02 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.448 1.099 . . . . 0.0 109.466 -178.073 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 68.3 mtm180 -80.45 152.71 28.64 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.898 0.879 . . . . 0.0 110.649 179.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 282' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -65.66 -23.85 66.89 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 122.543 0.337 . . . . 0.0 111.581 177.531 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 20.7 t -91.17 -1.36 57.74 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.117 0.967 . . . . 0.0 111.985 179.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -85.01 132.89 44.32 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 123.606 0.763 . . . . 0.0 109.537 -178.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -66.58 164.46 28.81 Favored 'Trans proline' 0 C--N 1.372 1.797 0 C-N-CA 121.864 1.71 . . . . 0.0 111.203 169.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 49.3 mt -67.85 -13.7 62.36 Favored 'General case' 0 C--O 1.211 -0.936 0 CA-C-O 119.027 -0.511 . . . . 0.0 111.261 178.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 26.6 tp60 -51.1 -27.61 8.73 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.282 1.033 . . . . 0.0 112.013 178.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 39.9 t -58.14 -59.84 4.66 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.206 1.002 . . . . 0.0 111.114 170.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.448 ' HB ' HG12 ' A' ' 269' ' ' ILE . 13.0 m -70.15 -25.76 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 122.774 0.43 . . . . 0.0 110.833 -178.391 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . 0.469 HG13 ' HB ' ' A' ' 304' ' ' ILE . 55.8 t -65.19 -51.34 66.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 123.92 0.888 . . . . 0.0 109.97 178.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -71.29 -38.18 71.82 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.881 -178.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 8.5 t60 -66.8 -48.45 68.95 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.234 0.614 . . . . 0.0 110.36 -178.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 293' ' ' MET . . . . . 0.552 ' HG3' HG21 ' A' ' 269' ' ' ILE . 97.5 mmm -67.69 -31.08 70.79 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.783 0.433 . . . . 0.0 110.87 179.254 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -59.71 -45.85 90.88 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 122.844 0.458 . . . . 0.0 110.403 173.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 24.9 m -69.98 -30.3 67.6 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 123.191 0.597 . . . . 0.0 110.958 178.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 71.7 t60 -73.81 -29.1 61.97 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.781 0.832 . . . . 0.0 111.211 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 297' ' ' LEU . . . . . 0.528 HD22 ' SG ' ' A' ' 271' ' ' CYS . 52.4 mt -109.0 -2.44 18.22 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.946 0.898 . . . . 0.0 111.507 -175.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 77.47 19.09 76.92 Favored Glycine 0 N--CA 1.478 1.471 0 C-N-CA 123.343 0.497 . . . . 0.0 113.869 172.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 299' ' ' VAL . . . . . 0.631 ' HB ' ' HD2' ' A' ' 303' ' ' ARG . 27.3 m -116.29 -176.38 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 124.551 1.14 . . . . 0.0 111.369 -176.205 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 20.3 m -86.3 146.61 42.75 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 123.612 0.765 . . . . 0.0 110.457 178.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -53.46 -35.59 76.49 Favored 'Trans proline' 0 C--N 1.387 2.578 0 C-N-CA 123.14 2.56 . . . . 0.0 112.294 176.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 29.7 p -61.14 -24.48 66.31 Favored 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 123.354 0.661 . . . . 0.0 112.29 -174.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 303' ' ' ARG . . . . . 0.631 ' HD2' ' HB ' ' A' ' 299' ' ' VAL . 90.1 mtt180 -82.16 -25.58 34.19 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.268 1.027 . . . . 0.0 112.096 -176.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 304' ' ' ILE . . . . . 0.557 HD13 ' SG ' ' A' ' 332' ' ' CYS . 38.0 mm -73.77 103.55 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 C-N-CA 123.42 0.688 . . . . 0.0 111.308 -173.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 50.9 tp -101.17 114.68 28.86 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.661 0.784 . . . . 0.0 108.913 173.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -86.32 131.34 34.24 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 177.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 312' ' ' GLU . 75.2 mt -130.86 111.06 11.76 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 178.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . 0.433 ' HB2' HD11 ' A' ' 313' ' ' LEU . 56.4 t80 -78.7 88.57 4.58 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 72.99 -82.35 0.63 Allowed Glycine 0 C--N 1.345 1.076 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.808 -175.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -121.48 -27.56 4.76 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.903 0.881 . . . . 0.0 111.103 -176.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 6.1 t -78.74 145.45 34.44 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 122.649 0.38 . . . . 0.0 110.789 -173.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . 0.427 ' HA ' HD23 ' A' ' 307' ' ' LEU . 44.1 tt0 -89.28 124.45 34.41 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 122.901 0.481 . . . . 0.0 110.343 -177.611 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . 0.468 HD12 HD11 ' A' ' 322' ' ' LEU . 28.0 mt -106.79 154.56 20.82 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 122.899 0.479 . . . . 0.0 110.067 177.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 49.0 m -107.92 151.29 41.17 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 123.412 0.685 . . . . 0.0 110.111 -179.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -62.45 -27.03 76.83 Favored 'Trans proline' 0 C--N 1.381 2.266 0 C-N-CA 122.585 2.19 . . . . 0.0 112.352 174.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 38.5 p -78.77 -21.68 47.51 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.626 0.77 . . . . 0.0 112.114 177.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -66.22 144.56 56.55 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.427 0.691 . . . . 0.0 111.798 -175.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 318' ' ' THR . . . . . . . . . . . . . 68.3 p -100.11 153.47 37.74 Favored Pre-proline 0 CA--C 1.553 1.074 0 C-N-CA 123.839 0.856 . . . . 0.0 109.754 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 319' ' ' PRO . . . . . 0.57 ' HG3' HD22 ' A' ' 280' ' ' LEU . 60.3 Cg_endo -73.49 -10.6 23.93 Favored 'Trans proline' 0 C--N 1.371 1.725 0 C-N-CA 123.165 2.577 . . . . 0.0 112.179 -177.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -69.23 -54.71 13.36 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.91 0.884 . . . . 0.0 110.183 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 10.2 t -67.18 -23.03 65.72 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.384 0.674 . . . . 0.0 111.44 178.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 322' ' ' LEU . . . . . 0.522 ' HB2' ' HG ' ' A' ' 324' ' ' LEU . 54.9 mt -96.67 -8.38 31.69 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.438 0.695 . . . . 0.0 111.993 -178.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt 59.16 29.24 18.76 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 124.238 1.015 . . . . 0.0 113.008 -178.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . 0.522 ' HG ' ' HB2' ' A' ' 322' ' ' LEU . 55.3 mt -72.81 132.54 43.7 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 122.877 0.471 . . . . 0.0 110.476 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 325' ' ' GLY . . . . . 0.412 ' H ' ' HB2' ' A' ' 328' ' ' ASP . . . -138.15 -146.62 5.06 Favored Glycine 0 C--N 1.337 0.629 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 179.05 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . 0.415 ' O ' ' HE3' ' A' ' 268' ' ' LYS . 11.3 m -81.19 -26.33 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 123.033 0.533 . . . . 0.0 110.937 -176.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -97.53 -12.91 22.03 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.469 0.708 . . . . 0.0 111.665 -177.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 328' ' ' ASP . . . . . 0.412 ' HB2' ' H ' ' A' ' 325' ' ' GLY . 24.6 m-20 -87.3 108.37 18.93 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.002 0.43 . . . . 0.0 109.856 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . 0.447 HG12 ' HD2' ' A' ' 268' ' ' LYS . 38.0 mt -92.95 128.64 44.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.665 177.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 330' ' ' ILE . . . . . 0.447 HG13 HG22 ' A' ' 269' ' ' ILE . 41.0 pt -112.73 122.34 66.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 121.14 0.495 . . . . 0.0 109.711 175.176 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -71.78 113.82 9.21 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.045 0.938 . . . . 0.0 111.181 -173.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 332' ' ' CYS . . . . . 0.557 ' SG ' HD13 ' A' ' 304' ' ' ILE . 42.1 t -81.9 97.59 8.12 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.552 0.741 . . . . 0.0 110.198 177.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . 0.423 HG21 HD13 ' A' ' 307' ' ' LEU . 47.0 t -99.85 111.99 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 123.437 0.695 . . . . 0.0 109.435 -177.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 334' ' ' VAL . . . . . 0.517 HG12 HG11 ' A' ' 299' ' ' VAL . 60.5 t -80.84 103.93 8.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 80.3 mt . . . . . 0 C--O 1.24 0.574 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.229 173.859 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 4.8 mp . . . . . 0 CA--C 1.54 0.566 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -93.08 148.04 34.97 Favored Pre-proline 0 CA--C 1.55 0.955 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 266' ' ' PRO . . . . . 0.483 ' HB2' ' HB3' ' A' ' 277' ' ' ARG . 74.3 Cg_endo -70.41 92.12 0.58 Allowed 'Trans proline' 0 C--N 1.376 2.007 0 C-N-CA 122.393 2.062 . . . . 0.0 112.239 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 267' ' ' LEU . . . . . 0.483 HD22 HD22 ' A' ' 280' ' ' LEU . 0.3 OUTLIER -64.32 126.21 27.05 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 172.304 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 22.9 ttpt -95.17 114.64 26.45 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-O 121.486 0.66 . . . . 0.0 111.083 -178.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 2.3 mp -113.08 124.99 70.27 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 C-N-CA 124.811 1.245 . . . . 0.0 109.231 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 35.5 ttp180 -93.09 107.21 19.05 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.165 0.507 . . . . 0.0 109.995 175.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 271' ' ' CYS . . . . . 0.641 ' SG ' HD22 ' A' ' 297' ' ' LEU . 48.9 t -82.33 -172.76 4.17 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.782 0.833 . . . . 0.0 111.322 179.042 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 272' ' ' ARG . . . . . 0.471 ' N ' ' SG ' ' A' ' 271' ' ' CYS . 35.8 ptt180 -57.37 -34.88 69.3 Favored 'General case' 0 CA--C 1.552 1.058 0 C-N-CA 124.622 1.169 . . . . 0.0 112.772 176.168 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -153.62 27.54 0.49 Allowed 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.165 0.586 . . . . 0.0 110.687 -177.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 274' ' ' ASP . . . . . 0.52 ' HB2' ' HB3' ' A' ' 271' ' ' CYS . 4.7 m-20 -141.29 158.85 43.34 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.589 0.756 . . . . 0.0 109.681 -175.316 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 26.9 tp -132.79 86.46 2.32 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 169.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 67.7 t -86.23 144.43 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.6 0.76 . . . . 0.0 109.927 -174.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . 0.483 ' HB3' ' HB2' ' A' ' 266' ' ' PRO . 52.9 mtp180 -128.5 87.02 2.52 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 172.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . 0.444 HD12 HG12 ' A' ' 289' ' ' VAL . 3.9 pp -95.66 142.93 25.27 Favored Pre-proline 0 N--CA 1.48 1.056 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 -175.546 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -65.55 125.33 14.21 Favored 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 122.919 2.413 . . . . 0.0 111.343 175.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.597 HD23 ' HG3' ' A' ' 319' ' ' PRO . 0.1 OUTLIER -140.72 148.31 40.55 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.954 0.902 . . . . 0.0 110.639 -178.151 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 70.3 mtp180 -87.9 142.94 27.4 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.347 1.059 . . . . 0.0 110.671 179.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 282' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -62.04 -35.03 77.36 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.658 0.783 . . . . 0.0 111.829 175.024 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 44.4 p -75.36 -20.38 59.04 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.892 0.877 . . . . 0.0 111.595 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -86.57 130.23 49.96 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 124.207 1.003 . . . . 0.0 108.99 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 285' ' ' PRO . . . . . 0.517 ' HA ' ' HA ' ' A' ' 318' ' ' THR . 40.9 Cg_endo -65.76 178.25 2.38 Favored 'Trans proline' 0 C--N 1.38 2.209 0 C-N-CA 122.608 2.205 . . . . 0.0 112.753 173.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.41 ' O ' HG21 ' A' ' 290' ' ' VAL . 90.7 mt -64.43 -18.22 64.53 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.563 0.745 . . . . 0.0 111.965 -179.122 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 27.7 tp60 -52.48 -23.36 6.07 Favored 'General case' 0 CA--C 1.558 1.264 0 C-N-CA 123.678 0.791 . . . . 0.0 112.271 178.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 288' ' ' SER . . . . . 0.536 ' HB3' HD12 ' A' ' 280' ' ' LEU . 37.3 t -63.24 -57.31 10.87 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.841 0.856 . . . . 0.0 110.856 171.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.455 ' O ' ' HG2' ' A' ' 293' ' ' MET . 27.7 m -65.4 -35.36 75.13 Favored 'Isoleucine or valine' 0 C--N 1.368 1.381 0 O-C-N 123.167 0.292 . . . . 0.0 110.342 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . 0.553 HG13 ' HB ' ' A' ' 304' ' ' ILE . 71.6 t -55.73 -53.21 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 124.42 1.088 . . . . 0.0 111.336 178.259 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -63.87 -42.97 97.4 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.066 -177.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 13.5 t60 -71.85 -38.09 70.15 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.231 -176.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 293' ' ' MET . . . . . 0.455 ' HG2' ' O ' ' A' ' 289' ' ' VAL . 91.0 mmm -68.9 -34.38 75.31 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 123.156 0.582 . . . . 0.0 110.125 177.327 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -66.29 -43.4 86.46 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.571 0.748 . . . . 0.0 111.376 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 26.2 m -70.14 -32.65 70.74 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.381 0.672 . . . . 0.0 110.644 176.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 79.2 t60 -63.36 -35.11 79.32 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.905 0.882 . . . . 0.0 111.812 177.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 297' ' ' LEU . . . . . 0.641 HD22 ' SG ' ' A' ' 271' ' ' CYS . 75.7 mt -99.53 -23.27 15.14 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.244 0.618 . . . . 0.0 111.893 -177.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 82.63 25.12 51.57 Favored Glycine 0 CA--C 1.531 1.071 0 O-C-N 123.262 0.351 . . . . 0.0 112.787 -173.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 33.4 m -107.33 177.99 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 124.521 1.128 . . . . 0.0 109.878 176.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 47.6 m -83.17 144.36 46.93 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 123.042 0.537 . . . . 0.0 110.6 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -55.75 -31.99 82.48 Favored 'Trans proline' 0 C--N 1.388 2.606 0 C-N-CA 123.263 2.642 . . . . 0.0 112.096 170.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 34.2 t -70.85 -6.02 34.9 Favored 'General case' 0 CA--C 1.56 1.328 0 C-N-CA 122.558 0.343 . . . . 0.0 111.787 -178.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 58.1 mtt180 -106.44 -16.25 14.59 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.243 1.017 . . . . 0.0 112.173 178.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 304' ' ' ILE . . . . . 0.592 HD12 ' SG ' ' A' ' 332' ' ' CYS . 38.9 mm -81.16 108.17 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 177.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 24.1 tp -110.36 130.25 55.59 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 174.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -95.89 131.41 42.26 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . 0.449 HD12 HG23 ' A' ' 333' ' ' VAL . 72.9 mt -133.48 105.69 7.05 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.587 0.755 . . . . 0.0 109.602 -175.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . 0.55 ' HB2' HD13 ' A' ' 313' ' ' LEU . 85.4 t80 -78.23 95.1 4.89 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -176.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 73.17 -85.11 0.59 Allowed Glycine 0 C--N 1.344 1.017 0 N-CA-C 111.436 -0.666 . . . . 0.0 111.436 -177.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -139.2 13.59 2.61 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.706 0.802 . . . . 0.0 111.566 -179.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 6.2 t -104.77 147.49 27.65 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 175.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -92.92 122.97 35.84 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.956 0.502 . . . . 0.0 110.32 -176.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . 0.55 HD13 ' HB2' ' A' ' 308' ' ' PHE . 40.2 mt -110.83 130.72 55.5 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.096 0.559 . . . . 0.0 109.802 -179.49 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 16.5 m -73.65 142.18 80.32 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 123.054 0.542 . . . . 0.0 110.198 174.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -62.62 -25.81 75.49 Favored 'Trans proline' 0 C--N 1.381 2.255 0 C-N-CA 122.821 2.347 . . . . 0.0 111.934 173.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 28.6 p -78.63 -18.32 54.67 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.558 1.143 . . . . 0.0 111.853 177.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -73.94 149.77 41.21 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.052 0.541 . . . . 0.0 110.257 176.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 318' ' ' THR . . . . . 0.517 ' HA ' ' HA ' ' A' ' 285' ' ' PRO . 60.7 p -99.2 142.6 24.9 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 123.26 0.624 . . . . 0.0 110.361 -176.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 319' ' ' PRO . . . . . 0.597 ' HG3' HD23 ' A' ' 280' ' ' LEU . 37.9 Cg_endo -62.49 -15.96 48.96 Favored 'Trans proline' 0 C--N 1.377 2.046 0 C-N-CA 123.378 2.719 . . . . 0.0 112.521 174.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 73.4 ttt-85 -60.78 -57.8 11.14 Favored 'General case' 0 C--N 1.358 0.951 0 C-N-CA 123.826 0.851 . . . . 0.0 111.044 176.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 14.7 t -70.73 -25.14 62.79 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.309 -177.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 322' ' ' LEU . . . . . 0.502 HD12 HD11 ' A' ' 313' ' ' LEU . 65.5 mt -79.0 -19.7 50.91 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.277 0.631 . . . . 0.0 110.689 177.457 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt 59.06 57.44 3.52 Favored 'General case' 0 CA--C 1.55 0.942 0 C-N-CA 124.787 1.235 . . . . 0.0 109.9 -176.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . 0.42 ' HG ' ' HB2' ' A' ' 322' ' ' LEU . 69.8 mt -93.9 140.24 29.93 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 114.416 -1.266 . . . . 0.0 108.85 177.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . -128.82 -157.73 9.38 Favored Glycine 0 C--O 1.239 0.436 0 O-C-N 123.977 0.798 . . . . 0.0 111.156 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . 0.421 ' HB ' ' NH2' ' A' ' 277' ' ' ARG . 29.6 m -75.07 -25.58 18.46 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 C-N-CA 123.382 0.673 . . . . 0.0 111.868 -175.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -98.31 -16.79 19.23 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.006 0.922 . . . . 0.0 111.915 -177.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -73.13 123.67 24.06 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.04 0.536 . . . . 0.0 110.605 -176.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 29.0 mt -106.26 120.32 57.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 C-N-CA 123.975 0.91 . . . . 0.0 110.357 -175.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 32.1 pt -113.71 130.4 67.85 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 174.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -77.76 111.08 13.19 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.74 0.816 . . . . 0.0 111.823 -174.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 332' ' ' CYS . . . . . 0.592 ' SG ' HD12 ' A' ' 304' ' ' ILE . 29.5 t -72.57 96.62 1.99 Allowed 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.545 0.738 . . . . 0.0 109.783 166.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . 0.449 HG23 HD12 ' A' ' 307' ' ' LEU . 75.3 t -105.28 114.34 44.57 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 177.576 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 52.5 t -78.66 90.13 1.27 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.775 0 CA-C-O 121.565 0.698 . . . . 0.0 109.606 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 86.0 mt . . . . . 0 C--O 1.235 0.296 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.067 174.402 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 5.0 mp . . . . . 0 C--O 1.234 0.262 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -79.39 141.48 57.16 Favored Pre-proline 0 C--O 1.245 0.854 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -178.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -66.15 101.33 0.5 Allowed 'Trans proline' 0 C--N 1.373 1.829 0 C-N-CA 122.228 1.952 . . . . 0.0 111.153 175.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 267' ' ' LEU . . . . . 0.401 ' O ' ' HA ' ' A' ' 277' ' ' ARG . 0.8 OUTLIER -68.03 127.77 34.07 Favored 'General case' 0 CA--C 1.549 0.937 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 172.498 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . 0.498 ' HG2' HG12 ' A' ' 329' ' ' ILE . 5.2 tppp? -90.62 108.43 19.8 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.313 0.645 . . . . 0.0 110.238 177.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 3.6 mp -102.67 126.2 56.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 123.917 0.887 . . . . 0.0 109.177 178.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 30.8 ttp180 -96.93 95.13 7.62 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.276 0.631 . . . . 0.0 109.413 173.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 271' ' ' CYS . . . . . 0.501 ' HA ' ' HB3' ' A' ' 332' ' ' CYS . 42.8 t -71.85 -173.65 1.04 Allowed 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 123.819 0.848 . . . . 0.0 110.651 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 272' ' ' ARG . . . . . 0.403 ' N ' ' SG ' ' A' ' 271' ' ' CYS . 7.5 ptm180 -55.48 -30.97 61.58 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.406 1.082 . . . . 0.0 112.311 174.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -144.89 -38.35 0.27 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.118 0.967 . . . . 0.0 110.366 -178.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -79.3 154.09 29.37 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.206 1.002 . . . . 0.0 111.433 -173.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 25.4 tp -119.69 85.33 2.36 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 173.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 95.0 t -89.94 147.56 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 114.856 -1.065 . . . . 0.0 109.875 -167.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . 0.401 ' HA ' ' O ' ' A' ' 267' ' ' LEU . 88.5 mtt180 -127.9 127.68 43.79 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 171.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . 0.48 HD12 HG12 ' A' ' 289' ' ' VAL . 4.2 pp -129.41 144.35 52.48 Favored Pre-proline 0 N--CA 1.482 1.161 0 CA-C-N 118.023 0.374 . . . . 0.0 110.411 174.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -68.33 122.45 9.48 Favored 'Trans proline' 0 C--N 1.374 1.906 0 C-N-CA 122.68 2.254 . . . . 0.0 110.714 174.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.639 HD22 ' HG3' ' A' ' 319' ' ' PRO . 0.3 OUTLIER -149.02 150.75 33.34 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.007 0.923 . . . . 0.0 109.993 -177.441 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 58.1 mtm-85 -97.72 155.88 16.81 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.306 0.643 . . . . 0.0 110.486 179.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 282' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -61.31 -39.51 90.73 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.335 0.654 . . . . 0.0 111.228 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 12.1 t -78.67 -23.93 45.42 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.348 -178.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -70.61 122.36 86.4 Favored Pre-proline 0 C--N 1.352 0.707 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 175.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 285' ' ' PRO . . . . . 0.481 ' HA ' ' HA ' ' A' ' 318' ' ' THR . 55.5 Cg_endo -65.59 175.45 4.32 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 122.363 2.042 . . . . 0.0 112.639 -179.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 78.4 mt -64.87 -16.97 63.87 Favored 'General case' 0 C--O 1.211 -0.967 0 CA-C-O 118.449 -0.786 . . . . 0.0 111.64 178.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 23.8 tp60 -52.52 -27.48 16.65 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.218 0.607 . . . . 0.0 112.274 179.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 288' ' ' SER . . . . . 0.576 ' HB3' HD13 ' A' ' 280' ' ' LEU . 41.8 t -61.12 -55.7 29.38 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.7 0.8 . . . . 0.0 110.524 171.165 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.48 HG12 HD12 ' A' ' 278' ' ' LEU . 11.4 m -69.33 -28.27 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 122.503 0.321 . . . . 0.0 111.441 179.375 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . 0.502 HG11 ' HB ' ' A' ' 304' ' ' ILE . 54.9 t -69.53 -52.39 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 123.731 0.812 . . . . 0.0 109.991 -177.192 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -71.84 -32.99 68.09 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 122.955 0.502 . . . . 0.0 110.869 -178.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -64.3 -51.89 61.23 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.341 0.656 . . . . 0.0 110.008 178.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 94.2 mmm -68.99 -29.3 67.48 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.365 0.666 . . . . 0.0 111.065 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -61.7 -53.33 57.53 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.341 0.656 . . . . 0.0 110.682 176.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 21.9 m -65.25 -35.61 81.55 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 123.689 0.796 . . . . 0.0 110.846 178.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -67.04 -33.22 75.05 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.324 1.049 . . . . 0.0 111.663 -179.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 297' ' ' LEU . . . . . 0.468 HD21 ' SG ' ' A' ' 271' ' ' CYS . 47.6 mt -102.17 -3.68 27.04 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.06 0.944 . . . . 0.0 111.248 178.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 76.74 9.37 86.41 Favored Glycine 0 C--N 1.352 1.46 0 C-N-CA 123.548 0.594 . . . . 0.0 113.909 176.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 299' ' ' VAL . . . . . 0.466 HG12 HG13 ' A' ' 334' ' ' VAL . 35.4 m -102.48 179.82 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.056 0.942 . . . . 0.0 111.462 -177.173 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 49.4 m -77.65 147.62 75.09 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 123.54 0.736 . . . . 0.0 111.14 178.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.68 -27.47 83.28 Favored 'Trans proline' 0 C--N 1.384 2.407 0 C-N-CA 122.634 2.222 . . . . 0.0 111.333 168.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 20.2 m -64.12 -26.16 68.42 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 124.107 0.963 . . . . 0.0 111.549 178.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 78.2 mtt85 -84.35 -33.58 23.83 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.899 0.88 . . . . 0.0 111.64 179.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 304' ' ' ILE . . . . . 0.502 ' HB ' HG11 ' A' ' 290' ' ' VAL . 36.5 mm -72.55 105.12 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 122.703 0.401 . . . . 0.0 110.942 -175.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . 0.506 HD23 HD12 ' A' ' 335' ' ' LEU . 29.7 tp -107.62 129.24 55.02 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 123.618 0.767 . . . . 0.0 109.231 172.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -92.11 138.26 31.68 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 174.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . 0.449 HD22 ' HA ' ' A' ' 312' ' ' GLU . 92.6 mt -133.3 115.02 14.42 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.99 0.916 . . . . 0.0 109.47 -177.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . 0.543 ' HB2' HD13 ' A' ' 313' ' ' LEU . 66.0 t80 -87.25 88.16 7.62 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.06 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 73.74 -78.36 0.89 Allowed Glycine 0 C--N 1.349 1.269 0 CA-C-N 115.209 -0.905 . . . . 0.0 112.331 -177.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -120.62 -33.47 3.81 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.449 0.699 . . . . 0.0 110.644 179.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 8.5 t -76.65 148.38 36.91 Favored 'General case' 0 C--N 1.35 0.622 0 C-N-CA 122.757 0.423 . . . . 0.0 111.393 -169.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . 0.449 ' HA ' HD22 ' A' ' 307' ' ' LEU . 42.7 tt0 -85.24 130.56 34.58 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.687 178.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . 0.586 HD22 HD22 ' A' ' 322' ' ' LEU . 46.9 mt -111.85 126.93 55.62 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 176.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 31.9 m -78.89 144.72 64.54 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 123.237 0.615 . . . . 0.0 110.727 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -59.75 -32.51 95.74 Favored 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 123.103 2.535 . . . . 0.0 112.747 178.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 7.1 m -79.36 -20.48 47.68 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 123.415 0.686 . . . . 0.0 111.361 -179.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -68.72 144.66 54.32 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.17 0.588 . . . . 0.0 110.543 178.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 318' ' ' THR . . . . . 0.481 ' HA ' ' HA ' ' A' ' 285' ' ' PRO . 81.8 p -98.8 142.72 25.08 Favored Pre-proline 0 N--CA 1.475 0.808 0 C-N-CA 123.399 0.679 . . . . 0.0 109.98 -175.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 319' ' ' PRO . . . . . 0.639 ' HG3' HD22 ' A' ' 280' ' ' LEU . 18.8 Cg_endo -56.88 -19.97 34.03 Favored 'Trans proline' 0 C--N 1.368 1.586 0 C-N-CA 123.143 2.562 . . . . 0.0 112.477 173.015 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 31.2 ttt180 -60.55 -55.33 34.71 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.504 0.722 . . . . 0.0 110.62 170.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 321' ' ' THR . . . . . 0.421 HG21 ' O ' ' A' ' 318' ' ' THR . 12.4 t -72.17 -18.9 61.83 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -176.017 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 322' ' ' LEU . . . . . 0.586 HD22 HD22 ' A' ' 313' ' ' LEU . 47.0 mt -91.68 -18.74 23.52 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.657 0.783 . . . . 0.0 111.332 179.256 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 58.02 78.59 0.24 Allowed 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 124.606 1.162 . . . . 0.0 108.821 -169.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 66.5 mt -116.15 165.17 13.45 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.76 0.824 . . . . 0.0 109.022 174.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . -158.69 -171.62 24.76 Favored Glycine 0 C--N 1.345 1.072 0 O-C-N 122.946 0.154 . . . . 0.0 112.76 -171.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 35.1 m -64.58 -32.73 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.325 1.05 . . . . 0.0 112.102 -175.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -112.17 4.84 18.14 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.606 0.762 . . . . 0.0 111.499 -178.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -95.89 127.47 41.94 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -178.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . 0.498 HG12 ' HG2' ' A' ' 268' ' ' LYS . 6.0 mt -111.47 143.15 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 C-N-CA 123.414 0.686 . . . . 0.0 111.798 -165.028 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 27.7 pt -137.54 133.9 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 123.612 0.765 . . . . 0.0 111.168 177.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 331' ' ' ASP . . . . . 0.402 ' HB2' ' HB2' ' A' ' 307' ' ' LEU . 6.2 m-20 -72.89 111.49 8.06 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.709 1.204 . . . . 0.0 112.523 -175.588 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 332' ' ' CYS . . . . . 0.501 ' HB3' ' HA ' ' A' ' 271' ' ' CYS . 42.0 t -75.61 115.97 15.84 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 165.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . 0.416 HG22 HD11 ' A' ' 307' ' ' LEU . 99.3 t -126.12 117.84 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 123.812 0.845 . . . . 0.0 109.402 -177.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 334' ' ' VAL . . . . . 0.466 HG13 HG12 ' A' ' 299' ' ' VAL . 62.0 t -84.57 99.69 7.12 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 123.187 0.595 . . . . 0.0 109.664 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 335' ' ' LEU . . . . . 0.506 HD12 HD23 ' A' ' 305' ' ' LEU . 89.1 mt . . . . . 0 N--CA 1.472 0.657 0 C-N-CA 123.863 0.865 . . . . 0.0 111.165 177.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 . . . . . 0 N--CA 1.476 0.871 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 156.98 67.93 0.01 OUTLIER Glycine 0 C--N 1.349 1.269 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.612 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 12.3 mp0 -82.63 81.67 8.32 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.835 0.854 . . . . 0.0 108.763 177.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -99.27 96.21 7.59 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.921 -175.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -172.09 163.1 5.94 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.859 0.863 . . . . 0.0 109.617 175.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -137.51 118.02 13.85 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.989 0.916 . . . . 0.0 108.598 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 15.9 m -76.65 81.18 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 CA-C-O 121.981 0.896 . . . . 0.0 111.068 -177.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 17.7 t -88.46 64.2 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-O 122.192 0.996 . . . . 0.0 108.785 177.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 35.4 tp -172.29 146.75 1.89 Allowed 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 113.864 -1.516 . . . . 0.0 107.966 -178.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 62.0 t 60.98 87.99 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 124.299 1.04 . . . . 0.0 109.401 -176.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 72.68 140.08 0.06 Allowed 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 125.442 1.497 . . . . 0.0 110.628 -171.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -118.34 85.28 0.39 Allowed Glycine 0 N--CA 1.471 0.997 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 174.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -76.86 173.39 14.55 Favored 'Trans proline' 0 C--N 1.375 1.939 0 C-N-CA 123.104 2.536 . . . . 0.0 112.796 -176.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 20.3 p -74.03 106.3 5.66 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 173.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 74.9 mt -102.66 97.01 8.31 Favored Pre-proline 0 CA--C 1.546 0.826 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 176.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -66.52 -27.41 46.31 Favored 'Trans proline' 0 C--N 1.38 2.23 0 C-N-CA 122.668 2.246 . . . . 0.0 111.737 177.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -69.65 105.5 2.72 Favored 'General case' 0 C--O 1.245 0.825 0 O-C-N 123.788 0.68 . . . . 0.0 109.279 172.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 25.0 p -72.14 158.04 88.3 Favored Pre-proline 0 CA--C 1.549 0.907 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.306 172.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . 0.452 ' O ' HD12 ' A' ' 264' ' ' LEU . 34.9 Cg_endo -60.51 168.03 7.25 Favored 'Trans proline' 0 C--N 1.375 1.932 0 C-N-CA 122.768 2.312 . . . . 0.0 111.731 171.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 87.9 mtt180 -84.33 90.7 7.61 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 121.37 0.605 . . . . 0.0 109.425 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . 0.452 HD12 ' O ' ' A' ' 262' ' ' PRO . 4.1 mp -81.46 172.36 13.61 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 114.741 -1.118 . . . . 0.0 109.397 173.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' PHE . . . . . 0.457 ' CE1' ' HG2' ' A' ' 282' ' ' MET . 31.4 p90 -147.85 152.5 40.8 Favored Pre-proline 0 CA--C 1.544 0.73 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 174.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -69.27 93.64 0.48 Allowed 'Trans proline' 0 C--N 1.371 1.747 0 C-N-CA 122.383 2.055 . . . . 0.0 111.634 173.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' LEU . . . . . 0.506 HD13 HG13 ' A' ' 269' ' ' ILE . 1.3 tm? -60.28 127.55 32.34 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 173.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.426 ' HG2' HG12 ' A' ' 329' ' ' ILE . 4.1 tppp? -91.7 103.96 16.48 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 123.763 0.665 . . . . 0.0 110.438 -179.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . 0.506 HG13 HD13 ' A' ' 267' ' ' LEU . 1.4 mp -101.82 146.14 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 174.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 27.8 ttp180 -106.7 118.89 37.86 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 172.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' CYS . . . . . 0.56 ' SG ' HD23 ' A' ' 297' ' ' LEU . 13.7 t -73.92 -158.33 0.06 Allowed 'General case' 0 CA--C 1.562 1.407 0 C-N-CA 124.473 1.109 . . . . 0.0 109.638 172.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 -64.94 -31.04 72.09 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 122.828 0.451 . . . . 0.0 111.791 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -160.27 22.91 0.16 Allowed 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -175.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -152.93 162.11 41.72 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 122.752 0.421 . . . . 0.0 110.596 -172.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.411 HD13 ' HD2' ' A' ' 268' ' ' LYS . 76.3 mt -107.19 129.06 54.91 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.627 0.771 . . . . 0.0 110.948 176.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 46.5 t -115.79 138.61 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.467 1.107 . . . . 0.0 108.668 174.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . 0.423 ' HA ' ' O ' ' A' ' 267' ' ' LEU . 74.5 mtm180 -116.65 130.42 56.72 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.654 0.781 . . . . 0.0 109.598 173.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . 0.442 HD23 ' HA ' ' A' ' 289' ' ' VAL . 4.6 pp -128.63 144.99 54.33 Favored Pre-proline 0 N--CA 1.488 1.436 0 CA-C-O 119.245 -0.407 . . . . 0.0 110.229 172.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -71.95 117.87 5.35 Favored 'Trans proline' 0 C--N 1.379 2.142 0 C-N-CA 122.467 2.111 . . . . 0.0 110.677 178.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.658 HD21 ' HG3' ' A' ' 319' ' ' PRO . 0.2 OUTLIER -144.87 148.41 33.92 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.877 0.871 . . . . 0.0 110.103 -174.45 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 87.7 mtm180 -86.4 152.28 22.84 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.99 0.916 . . . . 0.0 109.781 176.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' MET . . . . . 0.457 ' HG2' ' CE1' ' A' ' 265' ' ' PHE . 11.2 mtp -66.72 -31.77 72.64 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.127 0.489 . . . . 0.0 109.926 176.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 39.0 p -77.04 -18.96 57.75 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.855 1.262 . . . . 0.0 111.93 177.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -70.45 128.39 91.24 Favored Pre-proline 0 N--CA 1.475 0.813 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 176.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -65.65 161.55 38.23 Favored 'Trans proline' 0 C--N 1.377 2.033 0 C-N-CA 122.116 1.877 . . . . 0.0 111.554 174.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 58.5 mt -64.63 -10.76 28.83 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 118.83 -0.605 . . . . 0.0 112.272 -178.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 -52.45 -27.49 16.31 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.614 0.765 . . . . 0.0 111.864 176.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' SER . . . . . 0.409 ' HB3' HD12 ' A' ' 280' ' ' LEU . 46.8 t -60.69 -57.06 14.3 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.831 0.852 . . . . 0.0 111.084 172.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.442 ' HA ' HD23 ' A' ' 278' ' ' LEU . 15.8 m -69.18 -30.21 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 122.494 0.317 . . . . 0.0 110.749 -178.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . 0.558 HG12 ' HB ' ' A' ' 304' ' ' ILE . 45.1 t -64.1 -52.37 57.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 124.323 1.049 . . . . 0.0 110.705 179.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -61.74 -43.72 98.3 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.293 1.037 . . . . 0.0 110.694 -179.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 54.5 t60 -68.09 -45.26 74.23 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.045 -176.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' MET . . . . . 0.466 ' HB3' ' SG ' ' A' ' 332' ' ' CYS . 92.9 mmm -68.77 -32.21 71.8 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 123.543 0.527 . . . . 0.0 110.908 178.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -64.42 -43.94 92.78 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.335 0.654 . . . . 0.0 110.557 177.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 52.5 m -68.45 -31.72 71.22 Favored 'General case' 0 CA--C 1.554 1.106 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.562 177.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -73.33 -39.01 65.57 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.304 1.041 . . . . 0.0 111.723 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' LEU . . . . . 0.56 HD23 ' SG ' ' A' ' 271' ' ' CYS . 71.4 mt -94.16 -8.6 38.95 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.852 0.861 . . . . 0.0 111.467 -176.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 76.15 20.89 76.9 Favored Glycine 0 C--N 1.349 1.258 0 O-C-N 123.505 0.503 . . . . 0.0 113.496 178.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 30.1 m -111.75 176.97 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 124.229 1.012 . . . . 0.0 110.865 -177.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 48.9 m -80.08 143.65 57.42 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 123.361 0.664 . . . . 0.0 110.005 175.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -54.16 -28.72 52.74 Favored 'Trans proline' 0 C--N 1.39 2.726 0 C-N-CA 123.228 2.619 . . . . 0.0 112.691 173.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 39.5 t -64.46 -27.55 69.07 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 122.925 0.49 . . . . 0.0 111.62 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 61.3 mtt180 -82.59 -20.08 37.16 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.562 0.745 . . . . 0.0 111.684 -176.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' ILE . . . . . 0.633 HD11 ' SG ' ' A' ' 332' ' ' CYS . 42.6 mm -76.68 125.56 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 123.152 0.581 . . . . 0.0 110.763 -176.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 37.9 tp -126.52 120.76 30.47 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.934 0.894 . . . . 0.0 108.664 174.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -85.64 134.67 33.98 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 177.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . 0.45 HD22 ' HA ' ' A' ' 312' ' ' GLU . 94.2 mt -136.94 106.7 6.21 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.636 0.774 . . . . 0.0 109.975 -175.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -87.51 95.44 10.03 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 175.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 74.72 -80.74 0.9 Allowed Glycine 0 C--N 1.339 0.73 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.438 178.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -135.6 -5.65 2.24 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.966 0.906 . . . . 0.0 111.856 -177.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 11.6 t -89.37 148.91 23.25 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 117.987 0.358 . . . . 0.0 110.48 -177.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . 0.45 ' HA ' HD22 ' A' ' 307' ' ' LEU . 38.8 tt0 -98.64 110.74 23.29 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.363 0.665 . . . . 0.0 109.628 -178.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 44.7 mt -95.42 167.75 11.13 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.742 0.417 . . . . 0.0 110.012 177.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 53.2 m -134.4 154.94 80.11 Favored Pre-proline 0 N--CA 1.48 1.06 0 C-N-CA 123.187 0.595 . . . . 0.0 109.963 -177.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . 0.519 ' HB3' HG23 ' A' ' 290' ' ' VAL . 26.9 Cg_endo -58.43 -26.94 80.0 Favored 'Trans proline' 0 C--N 1.385 2.465 0 C-N-CA 123.31 2.674 . . . . 0.0 113.309 177.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 20.8 m -78.5 -29.03 46.41 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 123.668 0.787 . . . . 0.0 111.406 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -66.48 143.42 57.1 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.75 0.82 . . . . 0.0 111.126 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' THR . . . . . . . . . . . . . 36.1 p -108.26 135.82 19.9 Favored Pre-proline 0 N--CA 1.475 0.788 0 C-N-CA 123.318 0.647 . . . . 0.0 111.072 -177.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . 0.658 ' HG3' HD21 ' A' ' 280' ' ' LEU . 6.4 Cg_endo -47.35 -23.04 2.91 Favored 'Trans proline' 0 C--N 1.375 1.96 0 C-N-CA 124.824 3.683 . . . . 0.0 115.088 172.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 30.3 ttt180 -60.54 -62.25 2.0 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.156 0.582 . . . . 0.0 110.834 175.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 8.9 t -68.49 -30.35 69.17 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 122.66 0.384 . . . . 0.0 111.151 -178.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 322' ' ' LEU . . . . . 0.446 ' HB2' ' HG ' ' A' ' 324' ' ' LEU . 86.4 mt -78.55 -17.91 55.44 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.288 0.635 . . . . 0.0 111.868 -178.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 83.7 tttt 64.01 38.81 8.36 Favored 'General case' 0 CA--C 1.562 1.432 0 C-N-CA 124.158 0.983 . . . . 0.0 110.882 -177.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . 0.446 ' HG ' ' HB2' ' A' ' 322' ' ' LEU . 31.7 mt -78.52 162.6 26.21 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 122.921 0.488 . . . . 0.0 110.141 175.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . -166.49 -160.79 14.24 Favored Glycine 0 C--N 1.341 0.808 0 CA-C-N 116.325 -0.398 . . . . 0.0 112.887 -173.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 24.7 m -77.97 -31.68 16.98 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 C-N-CA 124.046 0.938 . . . . 0.0 111.062 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -98.65 -19.01 17.77 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.959 0.903 . . . . 0.0 110.701 178.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -87.2 108.25 18.84 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 -177.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . 0.426 HG12 ' HG2' ' A' ' 268' ' ' LYS . 7.7 mt -104.53 134.5 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 123.463 0.705 . . . . 0.0 111.254 -165.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 34.6 pt -120.05 127.08 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 123.225 0.61 . . . . 0.0 111.225 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -76.66 116.43 17.34 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.849 0.859 . . . . 0.0 111.251 -177.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 332' ' ' CYS . . . . . 0.633 ' SG ' HD11 ' A' ' 304' ' ' ILE . 36.2 t -82.77 98.42 9.1 Favored 'General case' 0 C--O 1.243 0.752 0 C-N-CA 123.587 0.755 . . . . 0.0 109.851 172.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 59.2 t -108.84 125.57 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 123.449 0.699 . . . . 0.0 109.792 -176.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 61.3 t -86.23 111.09 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.23 0.612 . . . . 0.0 109.401 177.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 60.7 mt -102.88 168.95 8.89 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.57 0.748 . . . . 0.0 111.263 177.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 336' ' ' THR . . . . . . . . . . . . . 37.9 p -83.76 73.28 10.3 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.799 172.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 50.7 p -73.92 93.72 2.23 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.418 -177.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 56.5 m . . . . . 0 C--O 1.252 1.204 0 C-N-CA 124.382 1.073 . . . . 0.0 109.636 -177.312 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 . . . . . 0 N--CA 1.475 0.791 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 75.21 69.5 1.38 Allowed Glycine 0 C--N 1.348 1.206 0 O-C-N 123.656 0.597 . . . . 0.0 111.641 -175.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -61.48 -30.86 70.87 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.697 0.799 . . . . 0.0 111.508 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -112.26 78.97 1.17 Allowed 'General case' 0 C--O 1.244 0.779 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 174.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -107.49 95.62 5.83 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.156 177.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -85.06 136.09 33.72 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.349 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 23.8 m -73.02 103.53 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.994 0 CA-C-O 122.123 0.963 . . . . 0.0 111.41 -174.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 5.7 p -131.18 124.81 56.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 124.154 0.981 . . . . 0.0 108.904 177.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -162.43 77.61 0.48 Allowed 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 177.18 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 61.6 t -112.84 114.97 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 67.8 129.03 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 125.066 1.347 . . . . 0.0 112.832 176.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 135.7 98.03 0.54 Allowed Glycine 0 C--N 1.343 0.921 0 CA-C-O 118.875 -0.958 . . . . 0.0 112.007 177.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -66.5 145.67 77.48 Favored 'Trans proline' 0 C--N 1.38 2.231 0 C-N-CA 122.661 2.24 . . . . 0.0 110.838 175.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 17.4 m 73.98 145.38 0.08 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 125.256 1.422 . . . . 0.0 111.025 -173.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 70.2 mt -98.01 97.94 4.94 Favored Pre-proline 0 CA--C 1.55 0.972 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 172.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -64.08 -10.87 24.85 Favored 'Trans proline' 0 C--N 1.386 2.505 0 C-N-CA 123.474 2.783 . . . . 0.0 113.156 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -65.8 128.03 34.38 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.979 0.911 . . . . 0.0 110.225 174.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 90.9 m -66.73 121.55 78.04 Favored Pre-proline 0 CA--C 1.551 0.997 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 170.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -59.64 110.35 0.72 Allowed 'Trans proline' 0 C--N 1.383 2.348 0 C-N-CA 122.36 2.04 . . . . 0.0 109.336 175.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 59.7 ttt180 -71.19 92.51 1.01 Allowed 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.173 0.589 . . . . 0.0 110.382 -168.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 1.5 mp -77.02 154.5 33.39 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.569 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -113.46 149.04 40.94 Favored Pre-proline 0 N--CA 1.475 0.791 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 172.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' PRO . . . . . 0.506 ' HB2' ' HB3' ' A' ' 277' ' ' ARG . 56.8 Cg_endo -69.06 97.41 0.57 Allowed 'Trans proline' 0 C--N 1.372 1.765 0 C-N-CA 122.275 1.984 . . . . 0.0 111.892 175.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.01 119.25 13.01 Favored 'General case' 0 C--N 1.35 0.603 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 171.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 24.6 ttpt -95.73 109.09 21.44 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 121.652 0.739 . . . . 0.0 111.133 -178.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 2.8 mp -100.51 143.86 13.42 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 C-N-CA 125.083 1.353 . . . . 0.0 108.118 176.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 37.2 ttp180 -106.15 95.88 6.08 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 123.315 0.646 . . . . 0.0 109.94 178.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' CYS . . . . . 0.54 ' SG ' HD22 ' A' ' 297' ' ' LEU . 44.6 t -71.92 178.82 3.5 Favored 'General case' 0 C--O 1.245 0.827 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.827 170.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -59.5 -31.35 69.28 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.523 0.729 . . . . 0.0 111.995 177.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -147.38 14.71 1.12 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 122.843 0.457 . . . . 0.0 112.187 -177.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -137.31 129.58 29.52 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 122.806 0.443 . . . . 0.0 110.556 -174.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 24.1 mt -95.5 90.86 5.91 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 164.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 58.6 t -82.48 122.7 37.49 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.861 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.163 -175.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . 0.506 ' HB3' ' HB2' ' A' ' 266' ' ' PRO . 77.0 mtm180 -116.13 75.54 0.96 Allowed 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . 0.513 HD12 HG12 ' A' ' 289' ' ' VAL . 4.6 pp -85.58 147.66 47.11 Favored Pre-proline 0 N--CA 1.483 1.204 0 CA-C-O 119.527 -0.273 . . . . 0.0 110.826 -172.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -69.17 118.48 5.7 Favored 'Trans proline' 0 C--N 1.374 1.92 0 C-N-CA 122.112 1.875 . . . . 0.0 110.719 175.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.592 HD23 ' HG3' ' A' ' 319' ' ' PRO . 0.8 OUTLIER -143.24 147.89 35.55 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.861 0.864 . . . . 0.0 110.242 -178.537 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 25.5 mmm180 -96.97 143.57 27.71 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.236 1.015 . . . . 0.0 109.045 174.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' MET . . . . . 0.554 ' HE3' ' HD2' ' A' ' 323' ' ' LYS . 44.1 mtp -61.06 -39.57 90.37 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 122.839 0.456 . . . . 0.0 111.813 -177.078 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 53.7 m -67.44 -25.37 65.88 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.6 0.76 . . . . 0.0 111.584 178.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' GLU . . . . . 0.401 ' HG3' ' HG ' ' A' ' 288' ' ' SER . 10.7 tp10 -77.67 126.08 84.91 Favored Pre-proline 0 CA--C 1.546 0.797 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 173.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . 0.566 ' HA ' ' HA ' ' A' ' 318' ' ' THR . 60.2 Cg_endo -66.51 174.81 5.83 Favored 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 122.421 2.081 . . . . 0.0 113.682 -176.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.407 ' O ' HG22 ' A' ' 289' ' ' VAL . 90.8 mt -65.74 -13.2 58.87 Favored 'General case' 0 C--O 1.21 -1.007 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.643 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 26.5 tp60 -55.24 -24.08 25.88 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.198 0.599 . . . . 0.0 111.589 177.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' SER . . . . . 0.512 ' HB2' HD12 ' A' ' 280' ' ' LEU . 22.3 m -68.67 -47.68 65.89 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.941 0.897 . . . . 0.0 111.221 174.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.513 HG12 HD12 ' A' ' 278' ' ' LEU . 13.8 m -69.92 -34.91 62.15 Favored 'Isoleucine or valine' 0 C--N 1.365 1.253 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 177.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . 0.549 HG12 ' HB ' ' A' ' 304' ' ' ILE . 54.0 t -63.77 -43.62 98.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 124.594 1.157 . . . . 0.0 110.733 179.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -63.27 -45.7 90.29 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 124.088 0.868 . . . . 0.0 110.065 -179.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 24.6 t60 -63.43 -49.53 73.35 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.211 178.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' MET . . . . . 0.465 ' HE2' ' HB2' ' A' ' 271' ' ' CYS . 85.5 mmm -68.19 -33.03 73.68 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 123.669 0.606 . . . . 0.0 111.057 -175.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -65.58 -47.16 76.71 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.373 0.669 . . . . 0.0 110.327 176.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 29.3 m -64.44 -38.23 90.29 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 123.403 0.681 . . . . 0.0 111.104 177.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 78.9 t60 -67.0 -39.24 87.05 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.341 1.056 . . . . 0.0 111.047 -178.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' LEU . . . . . 0.54 HD22 ' SG ' ' A' ' 271' ' ' CYS . 40.8 mt -95.93 -3.63 44.88 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.845 0.858 . . . . 0.0 111.416 -178.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 71.65 14.33 75.14 Favored Glycine 0 N--CA 1.476 1.333 0 C-N-CA 123.075 0.369 . . . . 0.0 113.769 177.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 299' ' ' VAL . . . . . 0.47 HG11 HG13 ' A' ' 334' ' ' VAL . 33.0 m -101.91 173.41 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.042 0.937 . . . . 0.0 110.624 -178.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' SER . . . . . 0.435 ' HB2' ' HG3' ' A' ' 303' ' ' ARG . 16.5 m -79.97 151.59 73.46 Favored Pre-proline 0 CA--C 1.555 1.162 0 C-N-CA 123.141 0.576 . . . . 0.0 110.042 178.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -56.08 -29.11 73.07 Favored 'Trans proline' 0 C--N 1.385 2.459 0 C-N-CA 123.193 2.595 . . . . 0.0 113.216 177.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' SER . . . . . 0.42 ' O ' ' HB2' ' A' ' 338' ' ' SER . 33.5 t -69.31 -18.71 63.85 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.633 0.373 . . . . 0.0 111.212 -179.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 303' ' ' ARG . . . . . 0.435 ' HG3' ' HB2' ' A' ' 300' ' ' SER . 52.1 mtt-85 -90.17 -12.91 36.79 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.246 0.618 . . . . 0.0 111.811 -174.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 304' ' ' ILE . . . . . 0.549 ' HB ' HG12 ' A' ' 290' ' ' VAL . 49.7 mm -86.77 117.59 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 122.944 0.498 . . . . 0.0 110.233 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 40.3 tp -114.02 120.08 39.37 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.665 0.786 . . . . 0.0 109.205 174.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . 0.433 ' HA ' ' O ' ' A' ' 331' ' ' ASP . 2.8 mm? -91.36 136.74 32.89 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 177.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . 0.495 HD21 ' HA ' ' A' ' 312' ' ' GLU . 75.5 mt -134.28 106.96 7.38 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.602 0.761 . . . . 0.0 109.471 -177.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . 0.527 ' HB2' HD11 ' A' ' 313' ' ' LEU . 44.8 t80 -85.84 90.28 8.01 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -178.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 64.94 -88.89 0.09 OUTLIER Glycine 0 C--N 1.349 1.289 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.818 -178.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -129.9 70.26 1.43 Allowed 'General case' 0 C--O 1.242 0.705 0 C-N-CA 124.191 0.996 . . . . 0.0 109.667 176.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 10.0 t -169.23 150.87 4.45 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.691 0.796 . . . . 0.0 109.533 170.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . 0.495 ' HA ' HD21 ' A' ' 307' ' ' LEU . 36.3 tt0 -92.97 134.48 35.07 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 177.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . 0.527 HD11 ' HB2' ' A' ' 308' ' ' PHE . 49.7 mt -117.52 149.7 40.18 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.014 0.526 . . . . 0.0 110.551 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 50.9 m -108.24 149.88 39.8 Favored Pre-proline 0 CA--C 1.551 1.016 0 C-N-CA 123.688 0.795 . . . . 0.0 110.472 179.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . 0.529 ' HB3' HG21 ' A' ' 290' ' ' VAL . 12.1 Cg_endo -56.14 -39.94 88.03 Favored 'Trans proline' 0 C--N 1.383 2.349 0 C-N-CA 123.325 2.684 . . . . 0.0 112.639 173.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 41.7 p -75.5 -18.23 59.88 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.22 0.608 . . . . 0.0 112.182 -177.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -74.27 142.61 45.26 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.102 0.561 . . . . 0.0 109.493 174.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 318' ' ' THR . . . . . 0.566 ' HA ' ' HA ' ' A' ' 285' ' ' PRO . 75.5 p -98.28 146.27 31.25 Favored Pre-proline 0 N--CA 1.473 0.71 0 C-N-CA 122.977 0.511 . . . . 0.0 110.533 -176.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . 0.592 ' HG3' HD23 ' A' ' 280' ' ' LEU . 31.6 Cg_endo -62.07 -14.33 36.96 Favored 'Trans proline' 0 C--N 1.365 1.418 0 C-N-CA 122.903 2.402 . . . . 0.0 111.962 168.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . 0.501 ' HA ' ' HE2' ' A' ' 282' ' ' MET . 43.6 ttt85 -61.55 -58.21 9.03 Favored 'General case' 0 C--N 1.352 0.711 0 C-N-CA 123.505 0.722 . . . . 0.0 110.761 172.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 10.1 t -66.83 -32.36 73.59 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 122.544 0.338 . . . . 0.0 111.461 -178.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 322' ' ' LEU . . . . . . . . . . . . . 47.7 mt -77.95 -20.66 52.31 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.311 0.644 . . . . 0.0 111.21 177.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 323' ' ' LYS . . . . . 0.554 ' HD2' ' HE3' ' A' ' 282' ' ' MET . 20.7 tptm 55.14 63.19 2.19 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.397 1.479 . . . . 0.0 110.914 -174.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 76.4 mt -90.25 170.05 10.6 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.04 178.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 325' ' ' GLY . . . . . 0.425 ' H ' ' HB2' ' A' ' 328' ' ' ASP . . . -162.54 -161.14 11.78 Favored Glycine 0 C--N 1.339 0.729 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.047 -171.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 31.5 m -76.89 -19.75 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 123.633 0.773 . . . . 0.0 111.872 -176.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -111.52 -17.34 13.09 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.833 0.853 . . . . 0.0 111.424 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 328' ' ' ASP . . . . . 0.425 ' HB2' ' H ' ' A' ' 325' ' ' GLY . 49.0 m-20 -75.71 101.05 4.88 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 177.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 46.1 mt -95.29 134.54 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 123.567 0.747 . . . . 0.0 110.404 -175.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 37.4 pt -121.97 127.23 75.3 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.929 0 C-N-CA 123.568 0.747 . . . . 0.0 110.114 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 331' ' ' ASP . . . . . 0.433 ' O ' ' HA ' ' A' ' 306' ' ' LEU . 5.1 m-20 -74.46 126.99 31.93 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.042 0.937 . . . . 0.0 111.778 -175.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 332' ' ' CYS . . . . . 0.473 ' SG ' HD12 ' A' ' 304' ' ' ILE . 52.5 t -93.76 93.41 7.97 Favored 'General case' 0 C--O 1.244 0.794 0 C-N-CA 123.983 0.913 . . . . 0.0 109.74 175.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 71.8 t -100.42 122.47 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 123.53 0.732 . . . . 0.0 109.573 177.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 334' ' ' VAL . . . . . 0.47 HG13 HG11 ' A' ' 299' ' ' VAL . 94.0 t -87.78 112.92 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 122.906 0.482 . . . . 0.0 110.265 177.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 84.0 mt -103.8 159.81 15.32 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.069 0.948 . . . . 0.0 109.093 171.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 336' ' ' THR . . . . . . . . . . . . . 32.4 p -78.2 88.01 4.28 Favored 'General case' 0 CA--C 1.55 0.964 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 176.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 22.9 m 74.12 157.78 0.2 Allowed 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 125.65 1.58 . . . . 0.0 111.794 -177.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 338' ' ' SER . . . . . 0.42 ' HB2' ' O ' ' A' ' 302' ' ' SER . 24.7 t . . . . . 0 CA--C 1.549 0.916 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 173.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 . . . . . 0 N--CA 1.472 0.637 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -85.16 57.55 4.97 Favored Glycine 0 C--N 1.353 1.517 0 O-C-N 123.638 0.586 . . . . 0.0 112.446 178.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -85.33 6.29 27.01 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.04 0.936 . . . . 0.0 112.487 -175.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -72.61 81.9 1.11 Allowed 'General case' 0 CA--C 1.55 0.949 0 CA-C-O 121.623 0.725 . . . . 0.0 110.29 -177.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -132.77 70.28 1.47 Allowed 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 179.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -167.67 156.46 9.59 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 114.383 -1.28 . . . . 0.0 108.191 -171.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 28.4 m -81.79 42.3 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.563 1.443 0 C-N-CA 123.797 0.839 . . . . 0.0 111.563 178.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 6.4 p -79.4 91.05 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.074 0 C-N-CA 124.768 1.227 . . . . 0.0 110.237 -176.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 6.5 tt -84.58 83.73 7.91 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.292 -178.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 10.0 p -167.99 129.7 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.162 0 C-N-CA 124.329 1.052 . . . . 0.0 109.203 173.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -146.2 128.92 16.21 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.969 0.907 . . . . 0.0 109.058 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 55.49 63.59 5.15 Favored Glycine 0 CA--C 1.535 1.335 0 O-C-N 124.116 0.885 . . . . 0.0 112.496 -176.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -76.15 72.49 5.32 Favored 'Trans proline' 0 C--N 1.378 2.117 0 C-N-CA 123.082 2.522 . . . . 0.0 110.692 -177.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 17.4 m 68.99 156.21 0.13 Allowed 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 125.122 1.369 . . . . 0.0 109.991 -165.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 89.6 mt -107.94 92.56 9.31 Favored Pre-proline 0 N--CA 1.477 0.891 0 O-C-N 121.657 -0.652 . . . . 0.0 109.515 173.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.5 -17.49 34.19 Favored 'Trans proline' 0 C--N 1.379 2.179 0 C-N-CA 122.547 2.165 . . . . 0.0 111.25 169.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -112.48 104.12 12.23 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 125.282 1.433 . . . . 0.0 108.153 177.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 12.3 p -81.42 145.65 55.82 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 122.867 0.467 . . . . 0.0 110.591 176.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -63.67 117.56 4.53 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 122.439 2.093 . . . . 0.0 110.257 173.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 74.7 mtt180 -56.44 125.75 23.39 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.591 1.156 . . . . 0.0 112.167 -165.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 3.4 mp -103.17 130.71 50.45 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.12 -174.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -106.56 147.6 35.27 Favored Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 123.839 0.856 . . . . 0.0 109.111 176.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -63.84 95.58 0.2 Allowed 'Trans proline' 0 C--N 1.376 1.988 0 C-N-CA 122.478 2.118 . . . . 0.0 111.812 172.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' LEU . . . . . 0.474 HD11 HG13 ' A' ' 269' ' ' ILE . 1.5 tm? -62.89 130.59 45.5 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 173.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.53 ' HG2' HG12 ' A' ' 329' ' ' ILE . 3.8 tppp? -94.51 107.39 19.37 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 123.539 0.736 . . . . 0.0 110.244 -177.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . 0.474 HG13 HD11 ' A' ' 267' ' ' LEU . 2.1 mp -106.56 131.96 55.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 175.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' ARG . . . . . 0.414 ' HB2' ' CG2' ' A' ' 329' ' ' ILE . 26.4 ttm180 -91.63 111.38 22.88 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 171.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' CYS . . . . . 0.59 ' SG ' HD22 ' A' ' 297' ' ' LEU . 16.5 t -75.53 -166.69 0.57 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 122.634 0.373 . . . . 0.0 110.222 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' ARG . . . . . 0.433 ' HG2' ' SG ' ' A' ' 271' ' ' CYS . 23.4 ptt180 -53.55 -27.76 27.88 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.354 1.062 . . . . 0.0 112.992 172.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -139.3 -63.49 0.52 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.019 0.528 . . . . 0.0 111.502 -177.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -107.48 163.44 13.05 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 123.692 0.797 . . . . 0.0 111.191 -170.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.515 HD13 ' HD2' ' A' ' 268' ' ' LYS . 96.0 mt -78.7 127.18 31.74 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 123.828 0.851 . . . . 0.0 111.898 -179.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 85.7 t -99.66 139.31 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 170.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . 0.42 ' HD3' ' HE2' ' A' ' 268' ' ' LYS . 62.9 mtm180 -128.19 122.49 31.97 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.794 0.838 . . . . 0.0 108.915 177.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 4.2 pp -131.08 139.65 36.19 Favored Pre-proline 0 N--CA 1.485 1.293 0 CA-C-O 119.379 -0.343 . . . . 0.0 110.52 177.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -70.77 107.62 2.09 Favored 'Trans proline' 0 C--N 1.382 2.313 0 C-N-CA 122.622 2.215 . . . . 0.0 110.618 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.609 HD22 ' HG3' ' A' ' 319' ' ' PRO . 0.1 OUTLIER -124.92 151.94 44.73 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.214 1.006 . . . . 0.0 110.274 -175.933 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . 0.558 ' HB2' ' HB2' ' A' ' 284' ' ' GLU . 58.5 mtm180 -89.97 153.82 20.31 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.973 0.909 . . . . 0.0 109.688 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -66.54 -44.55 82.08 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 122.572 0.349 . . . . 0.0 110.591 178.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 49.9 m -70.39 -20.3 62.95 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.39 0.676 . . . . 0.0 112.061 178.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' GLU . . . . . 0.558 ' HB2' ' HB2' ' A' ' 281' ' ' ARG . 6.7 tp10 -65.57 126.34 91.39 Favored Pre-proline 0 CA--C 1.542 0.639 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 176.191 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -65.06 168.25 14.32 Favored 'Trans proline' 0 C--N 1.368 1.595 0 C-N-CA 121.98 1.786 . . . . 0.0 111.707 172.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 62.6 mt -64.95 -15.43 62.15 Favored 'General case' 0 C--O 1.214 -0.809 0 CA-C-O 118.837 -0.601 . . . . 0.0 111.263 -178.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' GLN . . . . . 0.462 ' HA ' ' HB ' ' A' ' 290' ' ' VAL . 24.0 tp60 -52.25 -23.54 5.86 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 123.71 0.804 . . . . 0.0 112.402 178.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' SER . . . . . 0.491 ' HB3' HD13 ' A' ' 280' ' ' LEU . 37.9 t -58.61 -60.95 3.0 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.337 0.655 . . . . 0.0 110.69 168.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 15.2 m -68.98 -29.82 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 122.821 0.448 . . . . 0.0 111.065 -178.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . 0.466 HG13 ' HB ' ' A' ' 304' ' ' ILE . 76.4 t -66.46 -51.85 53.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 123.782 0.833 . . . . 0.0 109.974 -178.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -70.18 -37.95 75.28 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.815 0.846 . . . . 0.0 111.017 -178.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 13.1 t60 -66.04 -50.65 63.43 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.033 0.533 . . . . 0.0 110.142 -178.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' MET . . . . . 0.41 ' HG3' HG23 ' A' ' 269' ' ' ILE . 94.6 mmm -63.68 -37.3 86.82 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 123.8 0.687 . . . . 0.0 110.784 178.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -61.48 -51.27 69.36 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 123.847 0.717 . . . . 0.0 111.591 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 9.8 m -68.22 -30.84 70.0 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 123.186 0.595 . . . . 0.0 110.838 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -71.45 -35.39 70.88 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.577 0.751 . . . . 0.0 111.26 178.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' LEU . . . . . 0.59 HD22 ' SG ' ' A' ' 271' ' ' CYS . 95.9 mt -96.14 -10.62 27.79 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.745 0.818 . . . . 0.0 112.007 -177.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 80.29 16.84 75.37 Favored Glycine 0 CA--C 1.534 1.227 0 O-C-N 123.379 0.424 . . . . 0.0 113.485 178.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 299' ' ' VAL . . . . . 0.476 HG13 HG13 ' A' ' 334' ' ' VAL . 28.7 m -109.17 173.92 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 124.08 0.952 . . . . 0.0 111.003 178.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 22.8 m -80.07 147.32 65.2 Favored Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 123.306 0.643 . . . . 0.0 110.724 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.09 -23.49 73.56 Favored 'Trans proline' 0 C--N 1.383 2.394 0 C-N-CA 122.72 2.28 . . . . 0.0 112.334 170.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 48.6 p -69.95 -15.41 63.04 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-O 121.041 0.448 . . . . 0.0 111.574 176.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 303' ' ' ARG . . . . . 0.676 ' HG2' ' HA ' ' A' ' 336' ' ' THR . 94.3 mtt180 -102.98 -15.56 16.08 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.106 0.962 . . . . 0.0 111.824 -175.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 304' ' ' ILE . . . . . 0.572 HD12 ' SG ' ' A' ' 332' ' ' CYS . 36.2 mm -83.84 110.06 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 176.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 37.5 tp -114.08 114.93 26.77 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.614 0.766 . . . . 0.0 109.362 178.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . 0.424 ' HG ' HD12 ' A' ' 330' ' ' ILE . 3.2 mm? -86.99 124.14 32.85 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . 0.43 HD13 HG21 ' A' ' 333' ' ' VAL . 41.3 mt -133.88 108.86 8.68 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . 0.487 ' HB2' HG23 ' A' ' 330' ' ' ILE . 71.0 t80 -75.67 86.82 2.72 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 174.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 68.17 -84.99 0.17 Allowed Glycine 0 C--N 1.349 1.257 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.963 -179.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -133.66 75.24 1.59 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.319 1.048 . . . . 0.0 109.11 177.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 15.2 t -159.1 151.75 21.72 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.318 1.047 . . . . 0.0 108.309 171.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -104.13 114.41 28.63 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 122.856 0.462 . . . . 0.0 109.868 -176.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 30.1 mt -117.88 142.78 46.94 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.199 0.6 . . . . 0.0 109.92 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 60.7 m -109.31 159.49 31.13 Favored Pre-proline 0 CA--C 1.556 1.203 0 C-N-CA 123.808 0.843 . . . . 0.0 110.952 -178.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_exo -56.86 -32.07 90.93 Favored 'Trans proline' 0 C--N 1.39 2.739 0 C-N-CA 123.202 2.601 . . . . 0.0 112.573 172.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 45.7 p -70.65 -29.6 65.99 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 114.922 -1.035 . . . . 0.0 111.715 -179.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -68.02 138.24 55.7 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.628 0.771 . . . . 0.0 110.706 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 318' ' ' THR . . . . . . . . . . . . . 71.2 p -98.49 140.23 21.68 Favored Pre-proline 0 CA--C 1.543 0.702 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 178.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . 0.609 ' HG3' HD22 ' A' ' 280' ' ' LEU . 19.8 Cg_endo -55.2 -17.12 14.41 Favored 'Trans proline' 0 C--N 1.367 1.512 0 C-N-CA 123.529 2.819 . . . . 0.0 112.878 171.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 50.5 ttt-85 -67.43 -55.85 12.02 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.441 0.696 . . . . 0.0 110.395 172.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 13.7 t -71.32 -22.01 61.99 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.633 0.373 . . . . 0.0 111.427 -177.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 322' ' ' LEU . . . . . 0.466 ' HB2' ' HG ' ' A' ' 324' ' ' LEU . 58.2 mt -90.9 -16.63 27.83 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.412 0.685 . . . . 0.0 110.996 177.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 19.7 tptm 65.45 32.31 9.65 Favored 'General case' 0 CA--C 1.562 1.416 0 C-N-CA 124.962 1.305 . . . . 0.0 111.408 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . 0.466 ' HG ' ' HB2' ' A' ' 322' ' ' LEU . 33.8 mt -69.8 172.5 7.54 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 123.605 0.762 . . . . 0.0 111.175 178.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . -167.9 -164.64 23.93 Favored Glycine 0 C--N 1.347 1.152 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.942 -177.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 33.1 m -73.6 -28.81 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 124.168 0.987 . . . . 0.0 111.578 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -88.35 -25.86 22.52 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.533 0.733 . . . . 0.0 111.053 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 328' ' ' ASP . . . . . 0.434 ' O ' ' HB3' ' A' ' 268' ' ' LYS . 12.9 t70 -76.87 130.46 37.62 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.077 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . 0.53 HG12 ' HG2' ' A' ' 268' ' ' LYS . 5.9 mt -121.87 99.63 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 122.984 0.513 . . . . 0.0 110.605 -171.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 330' ' ' ILE . . . . . 0.487 HG23 ' HB2' ' A' ' 308' ' ' PHE . 25.0 pt -87.54 126.78 41.17 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 C-N-CA 122.679 0.392 . . . . 0.0 111.086 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -79.05 118.33 20.93 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.552 0.741 . . . . 0.0 110.588 -175.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 332' ' ' CYS . . . . . 0.572 ' SG ' HD12 ' A' ' 304' ' ' ILE . 43.2 t -78.04 90.1 4.2 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.439 1.096 . . . . 0.0 110.191 176.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . 0.43 HG21 HD13 ' A' ' 307' ' ' LEU . 74.0 t -94.75 110.68 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 123.322 0.649 . . . . 0.0 109.355 -177.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 334' ' ' VAL . . . . . 0.476 HG13 HG13 ' A' ' 299' ' ' VAL . 62.0 t -81.42 94.53 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 CA-C-O 121.319 0.58 . . . . 0.0 110.014 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 60.3 mt -98.57 -146.58 0.32 Allowed 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.536 1.134 . . . . 0.0 108.971 170.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 336' ' ' THR . . . . . 0.676 ' HA ' ' HG2' ' A' ' 303' ' ' ARG . 13.3 t -151.42 154.39 36.52 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.377 0.671 . . . . 0.0 109.621 171.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 27.4 t -135.4 144.2 46.41 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.038 0.535 . . . . 0.0 110.494 -174.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 48.3 t . . . . . 0 C--O 1.251 1.174 0 C-N-CA 123.88 0.872 . . . . 0.0 108.743 -179.997 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 . . . . . 0 N--CA 1.479 0.978 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -80.12 89.42 1.28 Allowed Glycine 0 C--N 1.346 1.094 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.101 -178.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -65.62 -22.77 66.7 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.174 0.59 . . . . 0.0 110.518 174.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -66.7 113.94 5.22 Favored 'General case' 0 CA--C 1.552 1.044 0 O-C-N 123.683 0.614 . . . . 0.0 109.727 171.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -83.65 -27.27 29.22 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.798 0.839 . . . . 0.0 110.255 177.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -52.34 125.29 15.6 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.463 1.105 . . . . 0.0 112.752 -175.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 51.1 t -70.82 118.46 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 123.068 0.547 . . . . 0.0 109.956 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' VAL . . . . . 0.413 HG11 HG21 ' A' ' 253' ' ' VAL . 15.2 t -101.67 65.63 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 123.956 0.903 . . . . 0.0 108.661 179.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 55.3 tp -77.33 87.46 3.73 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.514 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.413 HG21 HG11 ' A' ' 251' ' ' VAL . 4.5 m -140.3 103.29 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 124.454 1.102 . . . . 0.0 108.575 177.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -72.52 91.92 1.44 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.602 0.761 . . . . 0.0 109.871 -177.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -174.29 -69.43 0.05 OUTLIER Glycine 0 CA--C 1.529 0.929 0 CA-C-N 115.109 -0.951 . . . . 0.0 111.09 -176.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -77.39 -156.32 0.06 OUTLIER 'Trans proline' 0 C--N 1.376 2.022 0 C-N-CA 123.161 2.574 . . . . 0.0 111.315 173.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 21.1 m -63.05 135.29 57.17 Favored 'General case' 0 C--N 1.358 0.951 0 C-N-CA 122.666 0.387 . . . . 0.0 110.163 176.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 86.0 mt -109.53 89.5 7.48 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 123.662 0.785 . . . . 0.0 109.98 178.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -74.2 -26.94 12.12 Favored 'Trans proline' 0 C--N 1.379 2.15 0 C-N-CA 123.115 2.543 . . . . 0.0 113.476 -175.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.56 96.17 2.91 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-O 122.044 0.926 . . . . 0.0 109.47 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 41.2 m -76.09 133.71 71.91 Favored Pre-proline 0 CA--C 1.552 1.05 0 CA-C-N 115.133 -0.939 . . . . 0.0 110.013 -178.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -54.32 147.06 47.8 Favored 'Trans proline' 0 C--N 1.388 2.608 0 C-N-CA 123.003 2.469 . . . . 0.0 112.263 172.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -62.83 108.47 1.19 Allowed 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.287 1.035 . . . . 0.0 112.017 -170.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 2.9 mp -86.22 140.06 30.48 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 174.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' PHE . . . . . 0.464 ' CE1' ' HG2' ' A' ' 282' ' ' MET . 28.0 p90 -109.32 146.15 33.33 Favored Pre-proline 0 CA--C 1.55 0.948 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 176.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -64.19 98.65 0.27 Allowed 'Trans proline' 0 C--N 1.378 2.091 0 C-N-CA 122.573 2.182 . . . . 0.0 111.904 171.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' LEU . . . . . 0.532 HD13 HG13 ' A' ' 269' ' ' ILE . 1.2 tm? -61.8 130.43 45.7 Favored 'General case' 0 C--O 1.244 0.8 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 172.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.403 ' O ' ' HA ' ' A' ' 329' ' ' ILE . 3.3 tppp? -94.55 104.43 16.38 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . 0.532 HG13 HD13 ' A' ' 267' ' ' LEU . 2.9 mp -97.86 133.81 38.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 123.334 0.653 . . . . 0.0 109.257 176.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' ARG . . . . . 0.593 ' HB3' ' HA ' ' A' ' 331' ' ' ASP . 5.4 tpm_? -85.16 106.47 16.63 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 170.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' CYS . . . . . 0.471 ' SG ' HD23 ' A' ' 297' ' ' LEU . 41.8 t -74.28 176.8 6.33 Favored 'General case' 0 C--O 1.247 0.935 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 170.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -51.1 -36.11 38.63 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.235 1.014 . . . . 0.0 112.756 -178.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -156.62 22.9 0.34 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.179 0.592 . . . . 0.0 111.608 178.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -146.97 179.99 7.21 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 178.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.527 HD23 ' HA ' ' A' ' 270' ' ' ARG . 91.5 mt -121.11 126.3 49.41 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.018 0.927 . . . . 0.0 109.729 174.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 97.7 t -100.01 141.7 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 124.121 0.969 . . . . 0.0 108.522 174.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 39.4 mtt180 -128.5 122.74 31.86 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 178.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . 0.456 HD12 HG13 ' A' ' 289' ' ' VAL . 4.2 pp -134.86 143.32 45.78 Favored Pre-proline 0 N--CA 1.491 1.587 0 CA-C-N 118.139 0.427 . . . . 0.0 110.925 176.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.33 120.28 6.86 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 122.498 2.132 . . . . 0.0 110.865 175.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.625 HD21 ' HG3' ' A' ' 319' ' ' PRO . 0.0 OUTLIER -141.96 145.87 34.99 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.828 0.851 . . . . 0.0 109.932 -177.15 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . 0.406 ' HB2' ' HB2' ' A' ' 284' ' ' GLU . 48.5 mtt85 -79.35 147.71 32.31 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.835 0.854 . . . . 0.0 108.729 176.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' MET . . . . . 0.544 ' HE3' ' HA ' ' A' ' 320' ' ' ARG . 26.8 mtp -66.62 -32.03 73.1 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 118.292 0.497 . . . . 0.0 109.878 174.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 38.8 p -72.06 -29.19 63.89 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.716 1.207 . . . . 0.0 112.007 178.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' GLU . . . . . 0.45 ' O ' ' HD2' ' A' ' 319' ' ' PRO . 18.5 tp10 -66.46 129.85 94.15 Favored Pre-proline 0 N--CA 1.474 0.772 0 C-N-CA 124.282 1.033 . . . . 0.0 109.269 177.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -65.07 166.5 18.54 Favored 'Trans proline' 0 C--N 1.377 2.037 0 C-N-CA 122.012 1.808 . . . . 0.0 111.567 174.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 71.7 mt -65.59 -11.63 45.91 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 118.65 -0.691 . . . . 0.0 112.292 -177.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' GLN . . . . . 0.436 ' HA ' ' HB ' ' A' ' 290' ' ' VAL . 22.9 tp60 -55.62 -22.06 20.66 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.167 0.587 . . . . 0.0 112.013 178.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' SER . . . . . 0.463 ' HB3' HD12 ' A' ' 280' ' ' LEU . 33.5 t -60.34 -57.11 14.16 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 123.292 0.637 . . . . 0.0 110.566 170.021 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.456 HG13 HD12 ' A' ' 278' ' ' LEU . 18.1 m -71.83 -28.73 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 122.725 0.41 . . . . 0.0 111.531 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . 0.519 HG12 ' HB ' ' A' ' 304' ' ' ILE . 73.3 t -67.03 -51.12 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.809 0.844 . . . . 0.0 110.333 -179.151 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -69.8 -36.58 75.8 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.428 0.691 . . . . 0.0 111.44 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -66.21 -48.65 69.92 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.325 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' MET . . . . . 0.433 ' HG3' HG23 ' A' ' 269' ' ' ILE . 94.0 mmm -67.7 -29.17 68.36 Favored 'General case' 0 N--CA 1.479 0.976 0 O-C-N 123.918 0.761 . . . . 0.0 110.958 178.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -61.44 -49.5 76.59 Favored 'General case' 0 C--O 1.219 -0.516 0 O-C-N 123.65 0.594 . . . . 0.0 110.657 174.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 33.0 m -70.68 -31.81 68.83 Favored 'General case' 0 CA--C 1.549 0.909 0 O-C-N 123.512 0.508 . . . . 0.0 111.045 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 80.8 t60 -69.22 -35.49 76.23 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 123.733 0.813 . . . . 0.0 111.034 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' LEU . . . . . 0.471 HD23 ' SG ' ' A' ' 271' ' ' CYS . 67.7 mt -101.38 -4.07 27.61 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 124.052 0.941 . . . . 0.0 111.339 -179.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 78.63 12.08 84.6 Favored Glycine 0 C--N 1.351 1.398 0 C-N-CA 123.481 0.563 . . . . 0.0 114.073 173.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 299' ' ' VAL . . . . . 0.46 HG11 HG11 ' A' ' 334' ' ' VAL . 33.9 m -106.1 -176.53 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 124.266 1.026 . . . . 0.0 111.293 -178.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 42.7 m -84.29 148.29 52.46 Favored Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 123.749 0.82 . . . . 0.0 110.327 177.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -57.27 -30.58 88.06 Favored 'Trans proline' 0 C--N 1.379 2.166 0 C-N-CA 123.357 2.705 . . . . 0.0 112.144 172.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 20.4 m -70.5 -12.02 61.3 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 123.26 0.624 . . . . 0.0 112.006 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 75.8 mtt180 -95.94 -24.17 16.53 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.142 0.977 . . . . 0.0 110.923 176.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 304' ' ' ILE . . . . . 0.537 HD12 ' SG ' ' A' ' 332' ' ' CYS . 34.5 mm -78.45 122.9 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 123.016 0.526 . . . . 0.0 110.499 -178.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 36.8 tp -126.2 116.36 21.19 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.822 0.849 . . . . 0.0 109.033 177.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -85.06 135.06 34.16 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 177.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 74.3 mt -134.17 115.21 13.94 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.299 1.04 . . . . 0.0 109.208 -176.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -83.77 88.08 7.08 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 174.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 74.88 -81.87 0.87 Allowed Glycine 0 C--N 1.35 1.336 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.856 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -118.32 -32.13 4.75 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.07 0.948 . . . . 0.0 110.403 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 6.0 t -74.6 141.68 44.69 Favored 'General case' 0 C--O 1.245 0.859 0 CA-C-O 121.016 0.436 . . . . 0.0 110.249 -170.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -93.45 116.9 29.44 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.73 -175.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . 0.449 HD12 HD11 ' A' ' 322' ' ' LEU . 47.2 mt -95.67 164.87 12.59 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.784 0.434 . . . . 0.0 110.17 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 49.8 m -123.1 147.47 51.82 Favored Pre-proline 0 N--CA 1.479 1.015 0 C-N-CA 123.436 0.694 . . . . 0.0 109.734 -178.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -55.83 -29.02 70.36 Favored 'Trans proline' 0 C--N 1.383 2.36 0 C-N-CA 122.976 2.451 . . . . 0.0 113.036 173.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 29.4 p -76.01 -29.53 58.17 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.621 0.768 . . . . 0.0 111.837 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -65.6 143.5 57.57 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.141 0.576 . . . . 0.0 110.747 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 318' ' ' THR . . . . . . . . . . . . . 78.0 p -100.32 141.21 22.29 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 122.903 0.481 . . . . 0.0 110.408 -178.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . 0.625 ' HG3' HD21 ' A' ' 280' ' ' LEU . 19.2 Cg_endo -55.92 -16.89 17.21 Favored 'Trans proline' 0 C--N 1.37 1.708 0 C-N-CA 123.789 2.993 . . . . 0.0 113.48 171.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . 0.544 ' HA ' ' HE3' ' A' ' 282' ' ' MET . 53.0 ttt180 -67.66 -54.9 15.78 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 122.836 0.454 . . . . 0.0 110.346 175.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 13.7 t -71.09 -21.93 62.16 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 122.844 0.458 . . . . 0.0 111.97 -177.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 322' ' ' LEU . . . . . 0.449 HD11 HD12 ' A' ' 313' ' ' LEU . 53.8 mt -88.87 -18.92 26.59 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.648 0.779 . . . . 0.0 111.161 176.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 20.9 tptm 56.63 53.02 8.89 Favored 'General case' 0 CA--C 1.56 1.351 0 C-N-CA 125.044 1.337 . . . . 0.0 110.842 -175.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . 0.44 HD11 ' HB3' ' A' ' 319' ' ' PRO . 61.5 mt -79.71 164.84 23.41 Favored 'General case' 0 C--O 1.246 0.9 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.375 173.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . -160.08 -175.84 31.5 Favored Glycine 0 C--N 1.34 0.801 0 CA-C-N 116.372 -0.376 . . . . 0.0 113.087 -173.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 35.2 m -70.21 -28.93 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.119 0.968 . . . . 0.0 111.046 176.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -105.74 15.26 27.07 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.595 1.158 . . . . 0.0 110.658 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -123.8 124.81 43.52 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 177.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . 0.403 ' HA ' ' O ' ' A' ' 268' ' ' LYS . 3.1 mt -113.37 146.38 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 O-C-N 123.708 0.63 . . . . 0.0 110.622 -169.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 330' ' ' ILE . . . . . 0.405 HD12 HD13 ' A' ' 324' ' ' LEU . 24.1 pt -133.72 129.71 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 123.646 0.779 . . . . 0.0 110.944 179.025 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 331' ' ' ASP . . . . . 0.593 ' HA ' ' HB3' ' A' ' 270' ' ' ARG . 5.4 m-20 -74.56 114.43 12.96 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.75 1.22 . . . . 0.0 112.351 -173.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 332' ' ' CYS . . . . . 0.537 ' SG ' HD12 ' A' ' 304' ' ' ILE . 42.6 t -83.46 97.48 9.01 Favored 'General case' 0 C--O 1.243 0.729 0 C-N-CA 124.246 1.018 . . . . 0.0 110.136 173.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 89.0 t -102.1 122.5 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 123.747 0.819 . . . . 0.0 109.936 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 334' ' ' VAL . . . . . 0.46 HG11 HG11 ' A' ' 299' ' ' VAL . 90.2 t -85.62 102.93 11.99 Favored 'Isoleucine or valine' 0 C--O 1.242 0.683 0 C-N-CA 123.176 0.591 . . . . 0.0 109.514 175.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 81.1 mt -77.79 106.32 9.53 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 123.349 0.659 . . . . 0.0 109.753 171.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 336' ' ' THR . . . . . . . . . . . . . 33.2 p -82.39 81.42 8.24 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.684 178.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 43.5 m 60.01 82.16 0.16 Allowed 'General case' 0 CA--C 1.55 0.942 0 C-N-CA 124.754 1.221 . . . . 0.0 111.208 -177.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 47.0 t . . . . . 0 CA--C 1.554 1.124 0 C-N-CA 123.508 0.723 . . . . 0.0 109.517 179.224 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . 0.513 ' H3 ' ' NE2' ' A' ' 244' ' ' GLN . 0.6 OUTLIER . . . . . 0 N--CA 1.488 1.44 0 N-CA-C 110.352 -0.24 . . . . 0.0 110.352 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 83.57 161.86 32.37 Favored Glycine 0 C--N 1.349 1.268 0 O-C-N 123.802 0.689 . . . . 0.0 112.058 -176.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -130.21 108.02 9.73 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.192 0.597 . . . . 0.0 109.883 179.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -124.31 31.71 5.7 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.243 1.017 . . . . 0.0 110.224 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -64.33 -18.58 64.76 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 123.748 0.819 . . . . 0.0 111.95 -173.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -54.78 104.63 0.12 Allowed 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.033 1.333 . . . . 0.0 109.878 177.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 16.0 m -122.63 117.29 51.5 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.999 0 C-N-CA 124.003 0.921 . . . . 0.0 109.791 178.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 35.8 m -77.16 -26.36 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 123.0 0.52 . . . . 0.0 110.147 176.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 89.7 mt -74.76 94.05 2.68 Favored 'General case' 0 C--N 1.347 0.461 0 C-N-CA 123.534 0.734 . . . . 0.0 109.423 173.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 7.3 p -146.65 133.85 14.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 176.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -118.38 175.08 5.88 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.35 0.66 . . . . 0.0 110.735 -176.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 157.39 79.94 0.03 OUTLIER Glycine 0 CA--C 1.524 0.622 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -173.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -69.69 159.98 51.44 Favored 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 122.863 2.376 . . . . 0.0 112.571 -176.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 39.1 m -58.96 139.7 56.42 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 123.582 0.753 . . . . 0.0 110.506 177.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 47.8 mt -109.1 85.39 3.28 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 123.902 0.881 . . . . 0.0 109.022 177.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -74.95 -19.24 18.16 Favored 'Trans proline' 0 C--N 1.383 2.374 0 C-N-CA 122.113 1.875 . . . . 0.0 111.565 176.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -91.34 135.69 33.64 Favored 'General case' 0 C--O 1.244 0.778 0 C-N-CA 124.13 0.972 . . . . 0.0 109.128 173.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 18.4 p -65.81 147.91 98.51 Favored Pre-proline 0 CA--C 1.549 0.925 0 O-C-N 123.728 0.643 . . . . 0.0 110.597 173.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -64.79 171.5 8.43 Favored 'Trans proline' 0 C--N 1.372 1.814 0 C-N-CA 123.041 2.494 . . . . 0.0 113.4 -178.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -76.78 80.99 3.38 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.696 176.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . 0.404 HD12 ' HB2' ' A' ' 279' ' ' PRO . 0.4 OUTLIER -113.27 150.68 32.1 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.361 177.57 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' PHE . . . . . 0.527 ' CE1' ' SD ' ' A' ' 282' ' ' MET . 11.0 p90 -130.9 149.15 72.89 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 124.409 1.083 . . . . 0.0 108.942 -172.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' PRO . . . . . 0.521 ' HB2' ' HB3' ' A' ' 277' ' ' ARG . 45.7 Cg_endo -66.03 92.28 0.26 Allowed 'Trans proline' 0 C--N 1.369 1.656 0 C-N-CA 122.42 2.08 . . . . 0.0 112.086 173.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' LEU . . . . . 0.463 HD13 HG13 ' A' ' 269' ' ' ILE . 1.6 tm? -61.52 127.51 31.81 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 170.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.488 ' HG2' HG12 ' A' ' 329' ' ' ILE . 3.9 ttpt -91.08 111.65 23.21 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-O 121.5 0.666 . . . . 0.0 110.699 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . 0.49 HG23 ' HG3' ' A' ' 293' ' ' MET . 1.9 mp -106.81 133.59 50.94 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 C-N-CA 124.198 0.999 . . . . 0.0 108.306 176.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' ARG . . . . . 0.575 ' HB2' HG21 ' A' ' 329' ' ' ILE . 28.2 ttp180 -99.97 101.08 12.08 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 123.924 0.889 . . . . 0.0 109.997 178.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' CYS . . . . . 0.743 ' SG ' HD23 ' A' ' 297' ' ' LEU . 49.0 t -70.05 177.43 3.21 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.918 172.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' ARG . . . . . 0.531 ' HG2' ' SG ' ' A' ' 271' ' ' CYS . 38.8 ptt180 -43.14 -40.84 3.43 Favored 'General case' 0 CA--C 1.559 1.299 0 C-N-CA 125.372 1.469 . . . . 0.0 113.147 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -152.03 6.09 0.43 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.588 0.755 . . . . 0.0 111.31 174.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -115.57 158.09 23.15 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.449 1.1 . . . . 0.0 109.848 -174.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -119.76 117.87 29.36 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.533 0.733 . . . . 0.0 109.45 175.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' VAL . . . . . 0.421 HG23 ' SD ' ' A' ' 293' ' ' MET . 67.8 t -102.04 137.89 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.168 0.987 . . . . 0.0 108.452 171.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . 0.521 ' HB3' ' HB2' ' A' ' 266' ' ' PRO . 83.7 mtm180 -128.37 95.66 4.21 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 173.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . 0.489 HD22 ' HA ' ' A' ' 289' ' ' VAL . 4.2 pp -109.74 142.45 25.82 Favored Pre-proline 0 N--CA 1.487 1.403 0 CA-C-O 119.39 -0.338 . . . . 0.0 110.868 -173.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' PRO . . . . . 0.404 ' HB2' HD12 ' A' ' 264' ' ' LEU . 73.4 Cg_endo -70.69 86.74 0.7 Allowed 'Trans proline' 0 C--N 1.383 2.361 0 C-N-CA 122.945 2.43 . . . . 0.0 112.279 -176.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.625 HD21 ' HG3' ' A' ' 319' ' ' PRO . 3.0 tt -95.94 144.43 26.26 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 114.768 -1.105 . . . . 0.0 109.502 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . 0.568 ' HB2' ' HB2' ' A' ' 284' ' ' GLU . 32.3 mtm180 -90.0 143.73 26.53 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.943 0.897 . . . . 0.0 110.415 178.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' MET . . . . . 0.527 ' SD ' ' CE1' ' A' ' 265' ' ' PHE . 87.2 mmm -64.18 -33.38 75.67 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 122.803 0.441 . . . . 0.0 111.621 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 35.6 t -86.94 -0.82 57.2 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.469 0.708 . . . . 0.0 111.524 178.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' GLU . . . . . 0.568 ' HB2' ' HB2' ' A' ' 281' ' ' ARG . 6.8 tp10 -91.33 134.82 29.01 Favored Pre-proline 0 CA--C 1.538 0.488 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 174.086 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.07 170.71 8.62 Favored 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 121.897 1.732 . . . . 0.0 111.683 170.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 84.1 mt -67.53 -11.42 57.95 Favored 'General case' 0 C--O 1.219 -0.548 0 C-N-CA 123.153 0.581 . . . . 0.0 111.714 -178.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' GLN . . . . . 0.56 ' HA ' ' HB ' ' A' ' 290' ' ' VAL . 26.4 tp60 -55.05 -20.66 10.07 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 123.136 0.574 . . . . 0.0 111.95 175.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' SER . . . . . 0.555 ' HB3' HD13 ' A' ' 280' ' ' LEU . 47.4 t -60.7 -54.62 43.04 Favored 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 123.011 0.524 . . . . 0.0 111.19 169.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.489 ' HA ' HD22 ' A' ' 278' ' ' LEU . 34.9 m -69.83 -35.56 65.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 CA-C-N 117.716 0.235 . . . . 0.0 110.974 177.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . 0.56 ' HB ' ' HA ' ' A' ' 287' ' ' GLN . 76.9 t -61.2 -41.9 91.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 123.995 0.918 . . . . 0.0 111.078 -179.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -69.88 -47.48 62.44 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.694 0.798 . . . . 0.0 110.837 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' HIS . . . . . 0.459 ' HB3' HD21 ' A' ' 278' ' ' LEU . 9.8 t60 -71.68 -36.64 70.67 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.135 -174.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' MET . . . . . 0.49 ' HG3' HG23 ' A' ' 269' ' ' ILE . 95.6 mmm -72.36 -29.88 64.2 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.367 0.667 . . . . 0.0 110.514 177.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -63.35 -44.7 94.09 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 123.776 0.673 . . . . 0.0 110.847 175.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 24.2 m -70.85 -31.38 68.06 Favored 'General case' 0 CA--C 1.552 1.026 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.052 176.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -71.66 -30.14 65.4 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.959 0.904 . . . . 0.0 111.709 179.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' LEU . . . . . 0.743 HD23 ' SG ' ' A' ' 271' ' ' CYS . 50.1 mt -107.73 -5.68 17.24 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 124.009 0.924 . . . . 0.0 111.892 -176.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 72.86 22.4 79.1 Favored Glycine 0 CA--C 1.531 1.072 0 O-C-N 123.573 0.546 . . . . 0.0 113.198 177.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 299' ' ' VAL . . . . . 0.465 HG12 HG11 ' A' ' 334' ' ' VAL . 22.7 m -114.45 179.92 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 124.513 1.125 . . . . 0.0 110.341 -176.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 48.3 t -81.42 145.54 55.58 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 123.554 0.742 . . . . 0.0 110.29 177.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -57.6 -29.91 86.8 Favored 'Trans proline' 0 C--N 1.376 2.004 0 C-N-CA 122.72 2.28 . . . . 0.0 111.815 167.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 38.7 t -67.65 -13.87 62.45 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 123.491 0.716 . . . . 0.0 111.1 179.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -106.15 -17.11 14.42 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.216 1.006 . . . . 0.0 112.264 -178.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 304' ' ' ILE . . . . . 0.543 HD13 ' SG ' ' A' ' 332' ' ' CYS . 30.1 mm -77.49 112.58 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 CA-C-O 120.775 0.322 . . . . 0.0 110.145 176.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 41.6 tp -114.43 127.65 55.94 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.696 0.798 . . . . 0.0 108.992 175.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -95.9 133.65 39.82 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 176.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . 0.457 HD21 ' HA ' ' A' ' 312' ' ' GLU . 46.0 mt -140.38 111.54 7.12 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.437 1.095 . . . . 0.0 108.294 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . 0.508 ' HB2' HG22 ' A' ' 330' ' ' ILE . 68.9 t80 -81.33 82.55 7.15 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 173.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 69.87 -94.36 0.43 Allowed Glycine 0 C--N 1.35 1.317 0 CA-C-N 114.827 -1.079 . . . . 0.0 112.586 -175.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -95.76 -31.36 13.24 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.604 0.762 . . . . 0.0 112.407 -174.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 14.6 t -77.77 151.87 33.83 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.68 0.392 . . . . 0.0 111.151 -172.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . 0.457 ' HA ' HD21 ' A' ' 307' ' ' LEU . 33.3 tt0 -98.12 122.21 40.99 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 176.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 29.7 mt -110.08 114.78 28.56 Favored 'General case' 0 C--O 1.243 0.752 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 49.5 m -77.98 139.79 61.76 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 123.755 0.822 . . . . 0.0 110.699 -178.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . 0.465 ' HB3' HG22 ' A' ' 290' ' ' VAL . 43.4 Cg_exo -57.52 -28.38 80.6 Favored 'Trans proline' 0 C--N 1.386 2.536 0 C-N-CA 123.317 2.678 . . . . 0.0 112.886 174.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 56.3 p -74.71 -25.97 59.5 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.052 0.941 . . . . 0.0 111.828 -178.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -81.38 156.02 25.64 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.431 0.692 . . . . 0.0 111.084 -178.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 318' ' ' THR . . . . . . . . . . . . . 71.6 p -98.54 159.29 30.84 Favored Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 123.691 0.796 . . . . 0.0 110.334 -177.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . 0.625 ' HG3' HD21 ' A' ' 280' ' ' LEU . 92.0 Cg_endo -70.28 -18.03 34.83 Favored 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 122.778 2.319 . . . . 0.0 112.042 174.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -65.82 -51.98 54.4 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.685 1.194 . . . . 0.0 109.944 -175.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 9.8 t -69.72 -23.83 63.47 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.559 179.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 322' ' ' LEU . . . . . 0.443 ' HB2' ' HG ' ' A' ' 324' ' ' LEU . 68.5 mt -91.12 -11.73 37.66 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.757 0.823 . . . . 0.0 111.974 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 48.9 tptt 55.31 46.98 22.42 Favored 'General case' 0 CA--C 1.565 1.541 0 C-N-CA 124.429 1.092 . . . . 0.0 111.339 -176.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . 0.443 ' HG ' ' HB2' ' A' ' 322' ' ' LEU . 46.6 mt -81.48 165.42 21.23 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.696 0.799 . . . . 0.0 109.478 175.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . -164.7 -171.7 31.26 Favored Glycine 0 C--N 1.34 0.769 0 CA-C-N 116.423 -0.353 . . . . 0.0 112.417 -176.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 28.3 m -69.6 -25.3 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 C-N-CA 123.617 0.767 . . . . 0.0 111.178 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -104.27 13.4 32.25 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.866 0.866 . . . . 0.0 111.344 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -109.25 127.66 54.44 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 177.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . 0.575 HG21 ' HB2' ' A' ' 270' ' ' ARG . 13.2 mt -120.72 99.14 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 O-C-N 123.798 0.686 . . . . 0.0 110.463 -164.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 330' ' ' ILE . . . . . 0.508 HG22 ' HB2' ' A' ' 308' ' ' PHE . 39.4 pt -100.31 127.18 53.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 123.371 0.668 . . . . 0.0 111.913 -173.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -71.94 116.92 12.91 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.116 0.967 . . . . 0.0 111.875 -173.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 332' ' ' CYS . . . . . 0.543 ' SG ' HD13 ' A' ' 304' ' ' ILE . 48.8 t -86.06 99.41 11.46 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.017 0.927 . . . . 0.0 109.901 174.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 47.0 t -103.9 115.86 46.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 C-N-CA 123.6 0.76 . . . . 0.0 109.004 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 334' ' ' VAL . . . . . 0.465 HG11 HG12 ' A' ' 299' ' ' VAL . 82.5 t -80.28 104.33 8.45 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 CA-C-O 120.942 0.401 . . . . 0.0 109.962 176.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 93.9 mt -111.68 116.81 31.38 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.031 0.932 . . . . 0.0 109.092 173.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 336' ' ' THR . . . . . . . . . . . . . 21.1 p -65.14 106.26 1.26 Allowed 'General case' 0 C--O 1.241 0.64 0 C-N-CA 123.541 0.736 . . . . 0.0 110.308 -178.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 14.6 p -74.73 72.71 2.02 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.681 1.192 . . . . 0.0 110.708 -178.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 25.5 m . . . . . 0 CA--C 1.556 1.2 0 C-N-CA 123.77 0.828 . . . . 0.0 109.271 -175.083 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 . . . . . 0 N--CA 1.484 1.259 0 CA-C-O 120.716 0.293 . . . . 0.0 110.753 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -141.21 75.46 0.33 Allowed Glycine 0 C--N 1.341 0.812 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 178.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -86.47 71.72 10.39 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.514 0.725 . . . . 0.0 110.447 -178.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 61.66 40.1 13.63 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.976 0.911 . . . . 0.0 111.158 -178.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -90.89 -0.01 57.61 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 115.387 -0.824 . . . . 0.0 112.176 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . 0.595 ' HA ' ' HB2' ' A' ' 259' ' ' PRO . 46.8 mt-10 -55.8 90.1 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.959 0.904 . . . . 0.0 112.821 -173.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 26.3 m -111.54 171.98 3.01 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 C-N-CA 124.31 1.044 . . . . 0.0 109.798 175.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 19.2 m -87.43 27.92 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 C-N-CA 122.985 0.514 . . . . 0.0 111.581 177.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 56.4 tp -127.93 96.6 4.54 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 124.412 1.085 . . . . 0.0 108.298 172.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.502 HG12 ' HG2' ' A' ' 259' ' ' PRO . 15.8 m -119.28 178.52 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.559 0.744 . . . . 0.0 110.111 -177.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 59.16 78.51 0.26 Allowed 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.343 1.057 . . . . 0.0 111.626 170.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 154.17 -109.39 0.4 Allowed Glycine 0 N--CA 1.471 1.005 0 CA-C-O 118.776 -1.013 . . . . 0.0 112.558 178.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.26 -20.07 28.51 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 122.918 2.412 . . . . 0.0 112.588 -175.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 17.1 m -143.4 144.9 32.23 Favored 'General case' 0 C--O 1.244 0.773 0 C-N-CA 124.447 1.099 . . . . 0.0 108.148 -179.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 77.7 mt -119.09 77.4 16.25 Favored Pre-proline 0 N--CA 1.478 0.959 0 C-N-CA 123.511 0.724 . . . . 0.0 109.12 171.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' PRO . . . . . 0.595 ' HB2' ' HA ' ' A' ' 249' ' ' GLU . 49.2 Cg_endo -86.49 -7.31 7.73 Favored 'Trans proline' 0 C--N 1.371 1.756 0 C-N-CA 122.746 2.298 . . . . 0.0 112.27 176.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.39 118.05 12.71 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 17.2 m -70.6 124.92 91.76 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 123.138 0.575 . . . . 0.0 109.8 -173.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . 0.447 ' O ' HD13 ' A' ' 264' ' ' LEU . 15.4 Cg_endo -55.96 154.8 25.68 Favored 'Trans proline' 0 C--N 1.383 2.344 0 C-N-CA 122.582 2.188 . . . . 0.0 111.779 176.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 87.2 mtt180 -90.06 86.13 6.49 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-O 121.668 0.747 . . . . 0.0 110.367 -175.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . 0.447 HD13 ' O ' ' A' ' 262' ' ' PRO . 3.7 mp -92.76 128.61 38.68 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 114.245 -1.343 . . . . 0.0 108.614 173.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -101.94 150.24 37.24 Favored Pre-proline 0 CA--C 1.547 0.847 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 174.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.9 93.82 0.54 Allowed 'Trans proline' 0 C--N 1.375 1.964 0 C-N-CA 121.881 1.72 . . . . 0.0 111.292 176.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' LEU . . . . . 0.5 HD11 HG13 ' A' ' 269' ' ' ILE . 1.6 tm? -59.97 130.54 47.26 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 114.942 -1.026 . . . . 0.0 108.255 175.087 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.461 ' HG2' HG12 ' A' ' 329' ' ' ILE . 4.0 tppp? -93.0 107.92 19.6 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.172 0.51 . . . . 0.0 110.421 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . 0.505 HG21 ' HG3' ' A' ' 293' ' ' MET . 2.4 mp -106.19 132.92 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 175.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' ARG . . . . . 0.52 ' HA ' HD23 ' A' ' 275' ' ' LEU . 18.3 ttm-85 -86.76 104.41 16.11 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 173.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' CYS . . . . . 0.609 ' SG ' HD22 ' A' ' 297' ' ' LEU . 49.6 t -68.77 176.22 3.16 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.581 0.752 . . . . 0.0 109.992 175.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -58.22 -23.19 54.98 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -174.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -163.62 36.04 0.09 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.467 0.707 . . . . 0.0 111.012 175.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -164.44 178.2 7.62 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.26 0.624 . . . . 0.0 110.116 -177.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.52 HD23 ' HA ' ' A' ' 270' ' ' ARG . 92.9 mt -119.89 119.92 34.92 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.115 0.966 . . . . 0.0 110.337 173.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 89.9 t -97.4 137.38 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.518 0.727 . . . . 0.0 109.088 173.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 73.3 mtt180 -118.96 108.68 15.06 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 173.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . 0.483 HD11 HG11 ' A' ' 289' ' ' VAL . 4.6 pp -114.91 144.12 31.39 Favored Pre-proline 0 N--CA 1.488 1.46 0 CA-C-N 118.42 0.555 . . . . 0.0 110.34 177.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -67.13 123.55 11.06 Favored 'Trans proline' 0 C--N 1.369 1.655 0 C-N-CA 122.641 2.227 . . . . 0.0 110.784 174.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.644 HD23 ' HG3' ' A' ' 319' ' ' PRO . 0.1 OUTLIER -150.33 141.31 22.93 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.561 0.744 . . . . 0.0 109.824 -179.225 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 40.0 mtm180 -82.46 156.87 23.86 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.43 0.692 . . . . 0.0 109.671 174.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' MET . . . . . 0.54 ' HE2' ' HA ' ' A' ' 320' ' ' ARG . 25.4 mtp -68.94 -31.66 70.71 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 175.014 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 23.6 p -68.6 -30.3 69.01 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.359 1.063 . . . . 0.0 111.833 176.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -68.85 128.35 92.86 Favored Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 123.601 0.76 . . . . 0.0 109.11 177.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -66.99 170.69 12.46 Favored 'Trans proline' 0 C--N 1.374 1.883 0 C-N-CA 122.33 2.02 . . . . 0.0 112.21 176.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 67.9 mt -66.56 -15.09 63.16 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-O 118.776 -0.63 . . . . 0.0 111.52 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 27.4 tp60 -53.19 -23.33 8.2 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 123.169 0.588 . . . . 0.0 112.023 176.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 288' ' ' SER . . . . . 0.491 ' HB3' HD11 ' A' ' 280' ' ' LEU . 23.2 t -65.49 -53.64 39.6 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.225 0.61 . . . . 0.0 111.129 173.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.483 HG11 HD11 ' A' ' 278' ' ' LEU . 17.7 m -68.81 -32.62 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-O 120.578 0.227 . . . . 0.0 110.408 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . 0.522 HG13 ' HB ' ' A' ' 304' ' ' ILE . 55.0 t -62.7 -51.49 71.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 124.015 0.926 . . . . 0.0 110.675 177.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -62.44 -49.2 76.4 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.226 1.01 . . . . 0.0 110.975 -178.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 21.9 t60 -64.4 -45.12 88.98 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.814 -176.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 293' ' ' MET . . . . . 0.505 ' HG3' HG21 ' A' ' 269' ' ' ILE . 97.1 mmm -71.72 -28.41 63.66 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.312 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -67.27 -42.66 83.49 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 122.621 0.368 . . . . 0.0 110.7 175.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 29.2 m -69.8 -36.18 75.45 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.443 178.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -69.98 -48.62 57.49 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.609 0.764 . . . . 0.0 110.963 -179.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 297' ' ' LEU . . . . . 0.609 HD22 ' SG ' ' A' ' 271' ' ' CYS . 96.2 mt -82.98 -16.83 45.68 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.795 0.838 . . . . 0.0 112.086 -175.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 76.11 33.55 49.44 Favored Glycine 0 C--N 1.345 1.041 0 O-C-N 123.435 0.459 . . . . 0.0 112.446 -179.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 14.9 m -120.34 176.39 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 124.411 1.085 . . . . 0.0 109.47 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 15.4 m -81.51 145.78 55.79 Favored Pre-proline 0 CA--C 1.547 0.848 0 CA-C-O 118.902 -0.571 . . . . 0.0 109.929 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -55.26 -34.01 86.82 Favored 'Trans proline' 0 C--N 1.389 2.688 0 C-N-CA 122.663 2.242 . . . . 0.0 111.767 173.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 70.2 m -63.63 -32.44 73.92 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 120.779 0.323 . . . . 0.0 110.738 -178.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -75.23 -23.75 57.6 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.877 0.871 . . . . 0.0 112.284 -178.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 304' ' ' ILE . . . . . 0.564 HD12 ' SG ' ' A' ' 332' ' ' CYS . 31.3 mm -73.64 101.72 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . 0.571 HD12 ' HG3' ' A' ' 312' ' ' GLU . 38.8 tp -103.99 116.94 33.16 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 173.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -87.89 135.55 33.35 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 177.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 69.3 mt -133.67 107.28 7.85 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -178.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . 0.44 ' HB2' HD11 ' A' ' 313' ' ' LEU . 61.1 t80 -79.0 88.41 4.77 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 177.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 67.71 -90.69 0.21 Allowed Glycine 0 C--N 1.346 1.11 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.431 -174.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -132.59 78.71 1.81 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.598 0.759 . . . . 0.0 109.627 -179.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 12.7 t -171.19 149.49 2.84 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.98 0.912 . . . . 0.0 109.287 175.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . 0.571 ' HG3' HD12 ' A' ' 305' ' ' LEU . 35.0 tt0 -91.86 119.2 31.43 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . 0.444 HD12 HD12 ' A' ' 322' ' ' LEU . 57.1 mt -107.42 123.68 48.74 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.23 179.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 29.5 m -82.6 150.44 62.97 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 123.789 0.836 . . . . 0.0 110.604 179.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . 0.517 ' HB3' HG21 ' A' ' 290' ' ' VAL . 22.1 Cg_endo -59.92 -25.46 79.54 Favored 'Trans proline' 0 C--N 1.381 2.255 0 C-N-CA 122.73 2.287 . . . . 0.0 112.875 172.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 42.4 p -84.69 -3.69 58.66 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.808 0.843 . . . . 0.0 112.274 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -85.8 148.18 25.96 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 122.901 0.48 . . . . 0.0 109.957 175.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 318' ' ' THR . . . . . . . . . . . . . 28.9 p -103.4 139.74 20.39 Favored Pre-proline 0 N--CA 1.476 0.845 0 C-N-CA 122.754 0.422 . . . . 0.0 110.865 178.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . 0.644 ' HG3' HD23 ' A' ' 280' ' ' LEU . 27.0 Cg_endo -57.88 -15.99 24.13 Favored 'Trans proline' 0 C--N 1.374 1.906 0 C-N-CA 123.856 3.038 . . . . 0.0 113.094 171.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . 0.54 ' HA ' ' HE2' ' A' ' 282' ' ' MET . 37.0 ttt180 -56.99 -62.8 1.49 Allowed 'General case' 0 C--N 1.352 0.702 0 C-N-CA 123.921 0.888 . . . . 0.0 110.446 173.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 15.1 t -71.59 -23.32 61.71 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 122.895 0.478 . . . . 0.0 111.479 -176.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 322' ' ' LEU . . . . . 0.444 HD12 HD12 ' A' ' 313' ' ' LEU . 59.3 mt -82.71 -16.03 49.62 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.328 0.651 . . . . 0.0 111.575 178.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp 59.91 44.02 14.13 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.784 1.234 . . . . 0.0 111.749 178.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . 0.441 HD11 ' HB3' ' A' ' 319' ' ' PRO . 63.9 mt -79.28 168.56 19.37 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.194 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 325' ' ' GLY . . . . . 0.412 ' H ' ' HB2' ' A' ' 328' ' ' ASP . . . -167.32 -162.85 20.05 Favored Glycine 0 C--N 1.35 1.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 113.061 -172.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 25.0 m -74.89 -30.32 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 123.414 0.686 . . . . 0.0 111.204 -178.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -94.97 -25.93 16.32 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.713 0.805 . . . . 0.0 110.907 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 328' ' ' ASP . . . . . 0.412 ' HB2' ' H ' ' A' ' 325' ' ' GLY . 7.1 m-20 -77.77 106.77 9.82 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 122.932 0.493 . . . . 0.0 109.823 -178.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . 0.461 HG12 ' HG2' ' A' ' 268' ' ' LYS . 3.1 mt -97.04 139.13 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 122.83 0.452 . . . . 0.0 110.681 -174.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 32.3 pt -119.93 125.01 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 123.061 0.545 . . . . 0.0 109.99 174.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -71.15 114.4 9.17 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.198 0.999 . . . . 0.0 111.274 -175.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 332' ' ' CYS . . . . . 0.564 ' SG ' HD12 ' A' ' 304' ' ' ILE . 45.0 t -81.28 88.89 6.04 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.305 0.642 . . . . 0.0 109.704 174.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 85.5 t -98.85 111.98 29.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 123.619 0.767 . . . . 0.0 109.413 -177.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 90.8 t -82.41 106.19 13.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.808 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 97.0 mt -110.82 132.79 53.9 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.605 0.762 . . . . 0.0 109.687 176.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 336' ' ' THR . . . . . . . . . . . . . 70.8 p -71.23 -31.77 67.97 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.101 0.56 . . . . 0.0 110.791 177.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 54.1 m -82.52 59.32 4.59 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.149 0.98 . . . . 0.0 110.363 176.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 68.0 m . . . . . 0 C--O 1.252 1.22 0 C-N-CA 124.139 0.975 . . . . 0.0 109.336 -174.24 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 . . . . . 0 N--CA 1.482 1.159 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 79.77 137.81 1.68 Allowed Glycine 0 C--N 1.354 1.55 0 CA-C-N 116.13 -0.487 . . . . 0.0 112.8 -178.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 26.2 pt20 -94.99 44.27 1.1 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.209 0.604 . . . . 0.0 109.896 175.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -62.72 -51.46 67.1 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.51 1.124 . . . . 0.0 111.535 -172.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -70.29 92.75 0.8 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.57 1.148 . . . . 0.0 110.827 -174.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -120.13 155.8 32.32 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.661 0.784 . . . . 0.0 108.902 175.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 35.7 m -73.62 160.04 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 CA-C-O 120.532 0.206 . . . . 0.0 110.736 176.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' VAL . . . . . 0.413 HG12 HG11 ' A' ' 253' ' ' VAL . 59.7 t -68.0 92.95 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 173.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 21.2 tp -96.71 14.36 25.27 Favored 'General case' 0 CA--C 1.551 0.997 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.32 -171.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.514 HG21 ' H ' ' A' ' 255' ' ' GLY . 11.9 p -65.29 128.27 27.76 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.188 0 CA-C-O 121.152 0.501 . . . . 0.0 110.353 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -106.48 12.97 29.01 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.322 1.049 . . . . 0.0 110.372 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' GLY . . . . . 0.514 ' H ' HG21 ' A' ' 253' ' ' VAL . . . -113.82 87.23 0.44 Allowed Glycine 0 CA--C 1.53 1.013 0 CA-C-O 119.355 -0.691 . . . . 0.0 112.211 -178.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -86.93 176.53 4.46 Favored 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 123.137 2.558 . . . . 0.0 111.155 174.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 40.6 p -73.12 141.97 47.5 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 122.512 0.325 . . . . 0.0 110.137 176.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 96.5 mt -102.78 97.92 10.22 Favored Pre-proline 0 C--O 1.242 0.689 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 175.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.53 -17.63 57.64 Favored 'Trans proline' 0 C--N 1.375 1.924 0 C-N-CA 122.763 2.308 . . . . 0.0 112.821 174.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 21.1 mp0 -68.4 89.98 0.36 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.818 0.847 . . . . 0.0 109.726 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 21.9 p -76.99 138.5 65.41 Favored Pre-proline 0 C--O 1.242 0.663 0 C-N-CA 123.05 0.54 . . . . 0.0 109.695 174.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . 0.499 ' HB2' ' HG2' ' A' ' 281' ' ' ARG . 74.4 Cg_endo -68.2 143.51 59.31 Favored 'Trans proline' 0 C--N 1.369 1.613 0 C-N-CA 122.502 2.135 . . . . 0.0 111.251 -179.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 40.8 mtt180 -68.96 87.25 0.37 Allowed 'General case' 0 N--CA 1.477 0.91 0 CA-C-O 121.648 0.737 . . . . 0.0 110.533 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -86.73 124.94 33.54 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 114.616 -1.174 . . . . 0.0 109.336 174.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' PHE . . . . . 0.531 ' CE1' ' SD ' ' A' ' 282' ' ' MET . 28.9 p90 -98.08 150.5 36.81 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 124.776 1.23 . . . . 0.0 108.526 -178.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' PRO . . . . . 0.467 ' HB2' ' HB3' ' A' ' 277' ' ' ARG . 56.0 Cg_endo -67.66 92.61 0.36 Allowed 'Trans proline' 0 C--N 1.368 1.554 0 C-N-CA 122.405 2.07 . . . . 0.0 112.443 175.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.1 111.99 3.67 Favored 'General case' 0 C--O 1.247 0.933 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 173.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.43 ' HE3' HG12 ' A' ' 329' ' ' ILE . 22.3 ttpt -83.81 126.65 33.15 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.65 0.738 . . . . 0.0 111.009 -178.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 5.0 mt -125.91 124.3 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.92 1.288 . . . . 0.0 108.52 -175.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 23.0 ttp180 -89.07 102.36 15.01 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-O 121.287 0.565 . . . . 0.0 109.575 176.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' CYS . . . . . 0.741 ' SG ' HD23 ' A' ' 297' ' ' LEU . 36.5 t -73.11 -174.99 1.68 Allowed 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.064 170.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 35.4 ptt180 -56.41 -28.44 59.39 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 124.477 1.111 . . . . 0.0 113.543 -178.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -166.47 32.07 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.629 0.772 . . . . 0.0 110.322 177.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -151.16 150.88 31.16 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.102 0.561 . . . . 0.0 110.103 -172.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -117.18 101.13 8.2 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.932 0.893 . . . . 0.0 109.858 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 72.8 t -92.7 117.71 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.618 0.767 . . . . 0.0 109.707 176.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . 0.467 ' HB3' ' HB2' ' A' ' 266' ' ' PRO . 44.0 mtm-85 -112.48 91.4 3.64 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 175.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . 0.521 HD22 ' HA ' ' A' ' 289' ' ' VAL . 4.6 pp -98.3 147.69 33.47 Favored Pre-proline 0 N--CA 1.483 1.195 0 C-N-CA 122.485 0.314 . . . . 0.0 110.319 -174.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -71.5 107.21 2.11 Favored 'Trans proline' 0 C--N 1.373 1.843 0 C-N-CA 122.416 2.077 . . . . 0.0 111.689 177.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.745 HD23 ' HG3' ' A' ' 319' ' ' PRO . 0.5 OUTLIER -129.11 150.34 50.55 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.145 1.378 . . . . 0.0 108.473 178.137 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . 0.499 ' HG2' ' HB2' ' A' ' 262' ' ' PRO . 0.1 OUTLIER -99.4 155.64 17.43 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.02 0.528 . . . . 0.0 109.905 179.683 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' MET . . . . . 0.531 ' SD ' ' CE1' ' A' ' 265' ' ' PHE . 76.7 mmm -60.32 -33.86 72.98 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.262 0.625 . . . . 0.0 112.059 -175.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 35.0 t -83.77 -19.18 35.55 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.271 0.628 . . . . 0.0 111.896 -178.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -67.74 127.66 93.39 Favored Pre-proline 0 N--CA 1.484 1.233 0 CA-C-O 118.272 -0.87 . . . . 0.0 109.153 175.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -64.95 166.61 17.97 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 122.019 1.813 . . . . 0.0 111.394 173.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.413 ' O ' HG21 ' A' ' 290' ' ' VAL . 82.6 mt -66.74 -10.01 42.62 Favored 'General case' 0 C--O 1.213 -0.834 0 CA-C-O 118.594 -0.717 . . . . 0.0 111.939 -176.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' GLN . . . . . 0.436 ' HA ' ' HB ' ' A' ' 290' ' ' VAL . 27.3 tp60 -53.85 -26.2 23.38 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 123.345 0.658 . . . . 0.0 112.541 178.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 288' ' ' SER . . . . . 0.609 ' HB3' HD11 ' A' ' 280' ' ' LEU . 34.6 t -60.66 -52.63 64.32 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.936 0.494 . . . . 0.0 110.642 171.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.521 ' HA ' HD22 ' A' ' 278' ' ' LEU . 10.2 m -71.75 -30.72 38.96 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 122.364 0.266 . . . . 0.0 110.85 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . 0.533 HG12 ' HB ' ' A' ' 304' ' ' ILE . 66.8 t -65.44 -51.23 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.084 0.954 . . . . 0.0 110.657 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -67.54 -39.61 85.03 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.868 0.867 . . . . 0.0 110.984 -176.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 21.5 t60 -66.27 -52.48 47.11 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.751 179.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 94.7 mmm -65.22 -27.89 68.98 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 123.44 0.462 . . . . 0.0 111.214 -177.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -61.84 -49.97 74.14 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.644 0.777 . . . . 0.0 110.476 172.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 36.8 m -70.9 -28.66 64.7 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.639 0.775 . . . . 0.0 111.195 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -70.3 -36.77 74.54 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.292 1.037 . . . . 0.0 110.87 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 297' ' ' LEU . . . . . 0.741 HD23 ' SG ' ' A' ' 271' ' ' CYS . 78.7 mt -101.87 -5.6 24.57 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.996 0.919 . . . . 0.0 112.095 -178.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 79.4 3.38 88.64 Favored Glycine 0 N--CA 1.475 1.243 0 O-C-N 123.417 0.448 . . . . 0.0 113.239 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 299' ' ' VAL . . . . . 0.466 HG13 HG12 ' A' ' 334' ' ' VAL . 30.9 m -91.48 -177.78 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 124.244 1.017 . . . . 0.0 111.083 -178.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 39.7 m -89.15 150.19 44.56 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 123.482 0.713 . . . . 0.0 110.922 -178.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.13 -30.37 90.22 Favored 'Trans proline' 0 C--N 1.391 2.775 0 C-N-CA 123.094 2.529 . . . . 0.0 111.594 172.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 16.7 m -64.95 -15.77 62.55 Favored 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 123.18 0.592 . . . . 0.0 111.907 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 303' ' ' ARG . . . . . 0.463 ' HG2' ' HA ' ' A' ' 336' ' ' THR . 55.1 mtt180 -100.51 -15.78 17.75 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.933 0.893 . . . . 0.0 112.782 -175.142 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 304' ' ' ILE . . . . . 0.533 ' HB ' HG12 ' A' ' 290' ' ' VAL . 42.7 mm -82.58 102.48 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 CA-C-N 118.148 0.431 . . . . 0.0 110.682 -176.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 53.6 tp -101.37 114.78 29.08 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.969 0.908 . . . . 0.0 109.363 175.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . 0.413 ' HG ' HD13 ' A' ' 330' ' ' ILE . 2.5 mm? -86.5 133.04 33.78 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 178.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . 0.434 HD21 ' HA ' ' A' ' 312' ' ' GLU . 92.7 mt -132.58 103.29 6.07 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.927 0.891 . . . . 0.0 109.009 -176.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . 0.471 ' HB2' HD13 ' A' ' 313' ' ' LEU . 33.1 t80 -82.89 89.67 6.87 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -174.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 67.35 -84.58 0.13 Allowed Glycine 0 C--N 1.348 1.231 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.238 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -134.27 52.04 2.08 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.953 0.901 . . . . 0.0 110.036 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 11.7 t -153.49 149.29 27.56 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 122.805 0.442 . . . . 0.0 110.689 172.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . 0.434 ' HA ' HD21 ' A' ' 307' ' ' LEU . 42.4 tt0 -96.79 121.36 38.57 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.179 0.592 . . . . 0.0 110.058 -178.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . 0.471 HD13 ' HB2' ' A' ' 308' ' ' PHE . 58.5 mt -102.05 175.71 5.44 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 122.961 0.504 . . . . 0.0 111.406 -176.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 50.1 m -130.39 146.63 62.53 Favored Pre-proline 0 CA--C 1.547 0.842 0 C-N-CA 123.545 0.738 . . . . 0.0 110.056 -177.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . 0.51 ' HB3' HG23 ' A' ' 290' ' ' VAL . 31.1 Cg_endo -61.45 -26.88 81.72 Favored 'Trans proline' 0 C--N 1.385 2.477 0 C-N-CA 123.036 2.491 . . . . 0.0 112.373 174.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 73.1 p -80.19 -22.99 41.33 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.474 1.11 . . . . 0.0 111.889 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -76.82 147.44 37.18 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.553 0.741 . . . . 0.0 111.519 -176.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 318' ' ' THR . . . . . . . . . . . . . 41.3 p -100.98 141.44 22.63 Favored Pre-proline 0 N--CA 1.475 0.782 0 C-N-CA 124.155 0.982 . . . . 0.0 110.05 -178.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . 0.745 ' HG3' HD23 ' A' ' 280' ' ' LEU . 59.0 Cg_endo -62.39 -19.71 68.13 Favored 'Trans proline' 0 C--N 1.37 1.665 0 C-N-CA 123.668 2.912 . . . . 0.0 113.294 -178.118 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 53.3 ttp180 -59.28 -56.51 21.23 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 123.893 0.877 . . . . 0.0 110.697 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 15.3 t -69.63 -25.67 64.05 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.066 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 322' ' ' LEU . . . . . 0.5 ' HB2' ' HG ' ' A' ' 324' ' ' LEU . 46.4 mt -85.71 -4.8 59.26 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.63 0.772 . . . . 0.0 111.842 -178.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp 64.49 29.57 13.25 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.499 1.12 . . . . 0.0 112.063 176.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . 0.5 ' HG ' ' HB2' ' A' ' 322' ' ' LEU . 46.8 mt -78.19 168.74 19.38 Favored 'General case' 0 C--O 1.243 0.755 0 C-N-CA 123.603 0.761 . . . . 0.0 110.774 178.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 325' ' ' GLY . . . . . 0.417 ' H ' ' HB2' ' A' ' 328' ' ' ASP . . . -168.5 -162.48 20.66 Favored Glycine 0 C--O 1.243 0.665 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.89 -173.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 35.1 m -73.41 -36.99 50.06 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 C-N-CA 123.737 0.815 . . . . 0.0 111.478 -177.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -100.15 -12.84 19.27 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.428 1.091 . . . . 0.0 111.292 -177.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 328' ' ' ASP . . . . . 0.417 ' HB2' ' H ' ' A' ' 325' ' ' GLY . 31.8 m-20 -76.22 116.57 17.03 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 174.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . 0.43 HG12 ' HE3' ' A' ' 268' ' ' LYS . 18.0 mt -105.04 124.86 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 123.242 0.617 . . . . 0.0 110.55 -170.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 330' ' ' ILE . . . . . 0.43 HG21 ' HB2' ' A' ' 308' ' ' PHE . 40.2 pt -106.5 126.88 62.24 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 123.103 0.561 . . . . 0.0 110.51 176.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -72.98 106.06 4.71 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.727 0.811 . . . . 0.0 111.328 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 332' ' ' CYS . . . . . 0.45 ' SG ' HD13 ' A' ' 304' ' ' ILE . 34.7 t -71.71 102.27 2.76 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 169.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . 0.432 HG21 HD11 ' A' ' 307' ' ' LEU . 87.1 t -113.78 112.53 40.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 334' ' ' VAL . . . . . 0.466 HG12 HG13 ' A' ' 299' ' ' VAL . 76.7 t -77.86 104.18 5.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.746 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 75.0 mt -116.57 123.53 47.61 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.022 0.929 . . . . 0.0 109.193 172.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 336' ' ' THR . . . . . 0.463 ' HA ' ' HG2' ' A' ' 303' ' ' ARG . 13.4 t -89.03 8.26 30.63 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.272 0.629 . . . . 0.0 111.082 -179.104 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 15.8 m 71.11 157.38 0.17 Allowed 'General case' 0 C--N 1.362 1.12 0 C-N-CA 125.969 1.708 . . . . 0.0 111.274 -175.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 22.3 p . . . . . 0 C--O 1.252 1.189 0 C-N-CA 123.16 0.584 . . . . 0.0 109.454 -176.578 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 . . . . . 0 N--CA 1.48 1.03 0 N-CA-C 110.463 -0.199 . . . . 0.0 110.463 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -93.64 -75.18 1.29 Allowed Glycine 0 C--N 1.346 1.124 0 CA-C-N 116.255 -0.43 . . . . 0.0 112.319 -178.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 58.76 26.06 14.23 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 124.646 1.178 . . . . 0.0 111.726 -179.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.19 72.29 9.25 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.523 1.129 . . . . 0.0 108.362 -178.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -169.67 92.45 0.24 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 114.496 -1.229 . . . . 0.0 108.424 -171.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.51 166.84 26.5 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.81 0.844 . . . . 0.0 109.473 176.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 27.3 m -67.14 164.26 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 123.379 0.672 . . . . 0.0 111.848 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 28.7 m -82.12 41.71 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.244 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.42 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 45.5 tp -156.39 95.18 1.56 Allowed 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.26 1.024 . . . . 0.0 108.277 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 30.2 m -109.15 145.39 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 123.898 0.879 . . . . 0.0 109.623 176.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . 0.505 ' HG3' ' HD3' ' A' ' 256' ' ' PRO . 11.7 tp10 -95.79 140.41 30.61 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.52 0.728 . . . . 0.0 109.798 178.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -159.86 78.38 0.17 Allowed Glycine 0 C--N 1.341 0.813 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 178.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . 0.505 ' HD3' ' HG3' ' A' ' 254' ' ' GLU . 48.1 Cg_endo -81.47 -152.76 0.04 OUTLIER 'Trans proline' 0 C--N 1.372 1.816 0 C-N-CA 123.518 2.812 . . . . 0.0 112.03 -177.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 41.3 m -64.01 99.8 0.28 Allowed 'General case' 0 C--N 1.352 0.704 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 169.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 94.6 mt -110.81 98.07 36.36 Favored Pre-proline 0 N--CA 1.471 0.613 0 C-N-CA 123.104 0.561 . . . . 0.0 109.671 178.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -69.0 -14.15 37.94 Favored 'Trans proline' 0 C--N 1.377 2.074 0 C-N-CA 122.494 2.13 . . . . 0.0 111.353 168.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -65.28 89.68 0.09 Allowed 'General case' 0 C--O 1.244 0.776 0 C-N-CA 124.66 1.184 . . . . 0.0 109.699 173.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 16.3 p -81.78 135.68 48.71 Favored Pre-proline 0 C--O 1.241 0.62 0 C-N-CA 123.052 0.541 . . . . 0.0 110.63 177.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -61.67 118.23 5.1 Favored 'Trans proline' 0 C--N 1.379 2.137 0 C-N-CA 122.566 2.177 . . . . 0.0 109.964 171.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -54.67 105.73 0.17 Allowed 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.484 1.114 . . . . 0.0 112.617 -164.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 4.2 mp -80.79 133.77 35.68 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.714 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' PHE . . . . . 0.485 ' CE1' ' HG2' ' A' ' 282' ' ' MET . 31.3 p90 -112.0 141.16 24.37 Favored Pre-proline 0 CA--C 1.55 0.95 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 175.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' PRO . . . . . 0.532 ' HB2' ' HB3' ' A' ' 277' ' ' ARG . 38.0 Cg_endo -65.11 92.64 0.21 Allowed 'Trans proline' 0 C--N 1.375 1.922 0 C-N-CA 122.696 2.264 . . . . 0.0 112.974 176.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' LEU . . . . . 0.465 HD11 HG13 ' A' ' 269' ' ' ILE . 0.4 OUTLIER -61.69 122.55 15.61 Favored 'General case' 0 C--N 1.356 0.88 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 173.271 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.43 ' HD2' HD13 ' A' ' 275' ' ' LEU . 20.8 ttpt -88.27 108.38 19.29 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 121.216 0.531 . . . . 0.0 110.614 178.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . 0.465 HG13 HD11 ' A' ' 267' ' ' LEU . 3.8 mp -105.79 129.22 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 176.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' ARG . . . . . 0.42 ' HA ' HD22 ' A' ' 275' ' ' LEU . 41.1 ttm180 -87.0 119.34 27.11 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 122.847 0.459 . . . . 0.0 110.016 174.021 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' CYS . . . . . 0.701 ' SG ' HD22 ' A' ' 297' ' ' LEU . 10.1 t -88.75 -165.06 1.24 Allowed 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.722 0.809 . . . . 0.0 109.687 173.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -52.96 -39.73 63.18 Favored 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 124.584 1.154 . . . . 0.0 112.85 176.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -162.19 42.82 0.13 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.511 0.725 . . . . 0.0 109.87 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -155.58 162.01 40.73 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.704 -171.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.43 HD13 ' HD2' ' A' ' 268' ' ' LYS . 72.3 mt -127.85 106.58 9.21 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.176 0.99 . . . . 0.0 110.032 174.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 84.6 t -92.88 108.99 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 123.696 0.798 . . . . 0.0 108.937 174.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . 0.532 ' HB3' ' HB2' ' A' ' 266' ' ' PRO . 67.4 mtm180 -98.76 83.46 2.96 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 174.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . 0.4 HD12 HG12 ' A' ' 289' ' ' VAL . 4.3 pp -93.38 137.14 23.6 Favored Pre-proline 0 N--CA 1.488 1.447 0 CA-C-O 119.141 -0.457 . . . . 0.0 110.413 -175.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -63.91 123.67 12.32 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 122.54 2.16 . . . . 0.0 111.477 175.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.588 HD22 ' HG3' ' A' ' 319' ' ' PRO . 0.0 OUTLIER -143.72 151.94 40.66 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.226 1.01 . . . . 0.0 110.066 -176.549 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -87.85 149.71 23.96 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 177.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' MET . . . . . 0.485 ' HG2' ' CE1' ' A' ' 265' ' ' PHE . 14.9 mtp -68.06 -37.08 80.87 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 117.928 0.331 . . . . 0.0 110.672 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 22.8 t -75.08 -15.34 60.62 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.748 0.819 . . . . 0.0 111.314 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' GLU . . . . . 0.431 ' O ' ' HD2' ' A' ' 319' ' ' PRO . 4.5 tp10 -73.52 134.31 79.45 Favored Pre-proline 0 CA--C 1.543 0.691 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 174.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.89 166.57 26.01 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 122.062 1.842 . . . . 0.0 111.686 175.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 82.6 mt -66.7 -12.62 59.17 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.985 0.514 . . . . 0.0 111.721 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' GLN . . . . . 0.487 ' HA ' ' HB ' ' A' ' 290' ' ' VAL . 25.6 tp60 -56.2 -22.36 28.75 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.342 0.657 . . . . 0.0 111.687 173.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 288' ' ' SER . . . . . 0.458 ' HB3' HD13 ' A' ' 280' ' ' LEU . 22.8 t -61.22 -57.64 11.58 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.462 0.705 . . . . 0.0 110.455 172.095 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.409 HG11 HD12 ' A' ' 280' ' ' LEU . 17.9 m -68.99 -30.36 46.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 122.484 0.313 . . . . 0.0 110.553 -179.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . 0.554 HG12 ' HB ' ' A' ' 304' ' ' ILE . 43.0 t -63.72 -44.51 98.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.507 1.123 . . . . 0.0 111.15 176.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -59.58 -47.61 84.89 Favored 'General case' 0 N--CA 1.479 0.998 0 O-C-N 124.044 0.84 . . . . 0.0 110.204 178.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 42.7 t60 -64.62 -50.63 66.37 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.406 -178.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 293' ' ' MET . . . . . 0.429 ' HG3' HG23 ' A' ' 269' ' ' ILE . 94.3 mmm -69.37 -30.55 68.58 Favored 'General case' 0 N--CA 1.483 1.177 0 O-C-N 123.666 0.604 . . . . 0.0 111.356 -174.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -64.68 -46.44 82.37 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 123.656 0.598 . . . . 0.0 110.277 175.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 26.1 m -73.26 -29.24 62.61 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.309 0.644 . . . . 0.0 111.119 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 67.6 t60 -65.05 -38.74 91.82 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.404 1.082 . . . . 0.0 110.279 176.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 297' ' ' LEU . . . . . 0.701 HD22 ' SG ' ' A' ' 271' ' ' CYS . 58.2 mt -101.05 -5.84 25.21 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.369 1.068 . . . . 0.0 111.876 -177.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 74.21 10.37 81.51 Favored Glycine 0 N--CA 1.476 1.303 0 O-C-N 123.267 0.355 . . . . 0.0 113.61 178.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 299' ' ' VAL . . . . . 0.417 HG12 HG13 ' A' ' 334' ' ' VAL . 33.5 m -95.99 176.03 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.208 1.003 . . . . 0.0 110.855 -178.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 20.2 m -78.95 148.56 72.24 Favored Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 123.298 0.639 . . . . 0.0 110.428 178.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -57.86 -28.33 82.06 Favored 'Trans proline' 0 C--N 1.385 2.486 0 C-N-CA 122.97 2.446 . . . . 0.0 112.247 172.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 19.5 m -72.58 -7.54 50.69 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.429 0.691 . . . . 0.0 111.958 -178.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -99.25 -21.28 16.16 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.845 0.858 . . . . 0.0 110.943 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 304' ' ' ILE . . . . . 0.554 ' HB ' HG12 ' A' ' 290' ' ' VAL . 39.4 mm -80.73 115.34 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 122.852 0.461 . . . . 0.0 110.506 -176.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 33.5 tp -113.46 137.65 51.24 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 171.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . 0.404 ' HG ' HD13 ' A' ' 330' ' ' ILE . 2.0 mm? -104.15 133.8 48.48 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 177.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 80.8 mt -131.42 111.43 11.81 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.47 0.708 . . . . 0.0 109.101 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . 0.508 ' HB2' HD11 ' A' ' 313' ' ' LEU . 87.1 t80 -82.49 81.79 8.17 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 77.16 -67.8 2.71 Favored Glycine 0 C--N 1.354 1.53 0 CA-C-N 114.885 -1.052 . . . . 0.0 112.842 -178.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -134.96 -26.8 1.3 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.087 0.955 . . . . 0.0 111.596 -174.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 14.3 t -82.1 147.66 28.97 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 122.658 0.383 . . . . 0.0 110.641 -176.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -93.44 117.39 30.02 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 120.923 0.392 . . . . 0.0 110.01 -178.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . 0.508 HD11 ' HB2' ' A' ' 308' ' ' PHE . 48.1 mt -105.9 114.71 29.03 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.841 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 49.5 m -75.15 147.44 83.19 Favored Pre-proline 0 CA--C 1.553 1.059 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.388 177.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . 0.551 ' HB3' HG21 ' A' ' 290' ' ' VAL . 33.9 Cg_endo -60.23 -23.6 74.56 Favored 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 123.265 2.643 . . . . 0.0 112.937 177.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 4.6 m -72.48 -33.95 67.33 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.785 0.834 . . . . 0.0 111.08 178.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -66.43 146.24 54.78 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.826 0.85 . . . . 0.0 111.425 -177.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 318' ' ' THR . . . . . . . . . . . . . 81.2 p -100.83 138.35 20.03 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 123.027 0.531 . . . . 0.0 109.921 -178.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . 0.588 ' HG3' HD22 ' A' ' 280' ' ' LEU . 10.0 Cg_endo -51.03 -20.08 6.73 Favored 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 124.153 3.235 . . . . 0.0 113.531 170.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 40.9 ttt180 -60.92 -58.79 6.94 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.649 0.78 . . . . 0.0 110.912 173.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 13.2 t -71.34 -20.72 62.14 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 122.932 0.493 . . . . 0.0 111.531 -175.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 322' ' ' LEU . . . . . 0.445 HD11 HD12 ' A' ' 313' ' ' LEU . 39.0 mt -88.9 -22.03 23.32 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.646 0.778 . . . . 0.0 111.01 178.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 2.3 tmtp? 56.41 80.83 0.14 Allowed 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.869 1.267 . . . . 0.0 109.204 -167.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 69.5 mt -110.31 143.83 39.94 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 172.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 325' ' ' GLY . . . . . 0.403 ' H ' ' HB2' ' A' ' 328' ' ' ASP . . . -128.22 -167.72 12.29 Favored Glycine 0 C--N 1.337 0.613 0 C-N-CA 123.939 0.78 . . . . 0.0 111.511 -178.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 14.5 m -73.88 -21.98 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 123.314 0.645 . . . . 0.0 111.469 -177.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -99.96 -22.84 15.11 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.193 0.997 . . . . 0.0 111.253 -178.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 328' ' ' ASP . . . . . 0.403 ' HB2' ' H ' ' A' ' 325' ' ' GLY . 3.9 m-20 -70.37 124.96 25.46 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.992 0.517 . . . . 0.0 109.813 178.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . 0.421 HG12 ' HG2' ' A' ' 268' ' ' LYS . 12.9 mt -104.11 139.57 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.028 0.531 . . . . 0.0 109.933 -178.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 330' ' ' ILE . . . . . 0.404 HD13 ' HG ' ' A' ' 306' ' ' LEU . 35.7 pt -123.84 126.58 72.87 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 123.162 0.585 . . . . 0.0 109.837 174.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -75.39 106.1 6.75 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.027 0.931 . . . . 0.0 110.963 -176.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 332' ' ' CYS . . . . . 0.546 ' SG ' HD12 ' A' ' 304' ' ' ILE . 38.1 t -74.54 92.06 2.35 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.701 0.801 . . . . 0.0 110.168 172.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 97.4 t -95.87 117.08 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 123.431 0.693 . . . . 0.0 109.679 177.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 334' ' ' VAL . . . . . 0.417 HG13 HG12 ' A' ' 299' ' ' VAL . 62.1 t -83.38 99.76 6.32 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 123.582 0.753 . . . . 0.0 109.713 177.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 84.9 mt -78.48 178.84 7.43 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.883 0.873 . . . . 0.0 110.535 172.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 336' ' ' THR . . . . . . . . . . . . . 94.8 m -68.01 -54.02 21.58 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 170.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 66.4 m -157.56 136.12 11.3 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.79 1.236 . . . . 0.0 108.437 176.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 15.0 m . . . . . 0 C--O 1.253 1.286 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -178.579 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 . . . . . 0 N--CA 1.481 1.119 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -160.63 63.48 0.28 Allowed Glycine 0 C--N 1.348 1.196 0 N-CA-C 111.106 -0.797 . . . . 0.0 111.106 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 65.48 41.54 4.15 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.566 1.147 . . . . 0.0 110.465 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -73.22 97.67 2.48 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.186 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -93.59 22.82 5.08 Favored 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 124.444 1.098 . . . . 0.0 109.997 177.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -68.37 157.22 36.18 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.944 0.898 . . . . 0.0 112.405 -175.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 6.4 m -74.89 113.6 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.173 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.235 175.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 58.2 t -89.53 141.91 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.488 0.715 . . . . 0.0 111.369 -169.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 33.1 tp 65.37 35.96 7.16 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 125.375 1.47 . . . . 0.0 110.895 175.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 8.0 m -73.64 87.78 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 CA-C-O 122.342 1.068 . . . . 0.0 110.232 174.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -164.47 146.92 8.76 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 114.204 -1.362 . . . . 0.0 108.657 -176.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -76.17 105.57 2.0 Favored Glycine 0 C--N 1.346 1.085 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 170.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -80.56 172.92 12.86 Favored 'Trans proline' 0 C--N 1.37 1.67 0 C-N-CA 122.503 2.135 . . . . 0.0 113.046 -170.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 65.3 m -72.61 142.39 48.36 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 169.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 76.3 mt -104.05 94.08 6.19 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 123.699 0.8 . . . . 0.0 109.416 178.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -74.97 -15.41 20.84 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 122.346 2.031 . . . . 0.0 111.682 172.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -96.42 103.93 15.86 Favored 'General case' 0 C--O 1.242 0.7 0 C-N-CA 124.244 1.018 . . . . 0.0 108.85 174.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 55.5 m -85.03 135.03 40.05 Favored Pre-proline 0 C--O 1.243 0.761 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 171.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -63.19 149.4 91.51 Favored 'Trans proline' 0 C--N 1.385 2.453 0 C-N-CA 121.834 1.689 . . . . 0.0 110.327 170.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 21.7 ptt-85 -91.98 110.68 22.05 Favored 'General case' 0 N--CA 1.482 1.175 0 CA-C-O 121.644 0.735 . . . . 0.0 110.006 -177.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 4.2 mp -107.81 151.66 25.43 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.005 0.922 . . . . 0.0 109.383 177.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -125.88 141.57 39.77 Favored Pre-proline 0 CA--C 1.549 0.931 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 175.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -64.26 94.13 0.2 Allowed 'Trans proline' 0 C--N 1.379 2.137 0 C-N-CA 122.531 2.154 . . . . 0.0 112.091 176.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' LEU . . . . . 0.446 HD13 HG13 ' A' ' 269' ' ' ILE . 1.1 tm? -59.6 131.71 51.75 Favored 'General case' 0 C--N 1.354 0.782 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 173.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.414 ' HG2' HG12 ' A' ' 329' ' ' ILE . 3.0 tppp? -94.96 103.53 15.39 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.465 0.65 . . . . 0.0 109.973 -178.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . 0.446 HG13 HD13 ' A' ' 267' ' ' LEU . 2.4 mp -100.59 154.03 4.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 175.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' ARG . . . . . 0.455 ' HB2' HG22 ' A' ' 329' ' ' ILE . 22.5 ttp180 -118.35 103.61 9.96 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.792 0.837 . . . . 0.0 109.017 176.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' CYS . . . . . 0.703 ' SG ' HD22 ' A' ' 297' ' ' LEU . 21.0 t -69.09 -178.14 1.21 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.007 0.923 . . . . 0.0 110.598 176.103 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -50.98 -32.84 22.37 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.712 1.205 . . . . 0.0 113.175 -177.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -161.04 42.08 0.16 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.645 0.778 . . . . 0.0 110.03 178.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -161.35 164.84 29.77 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.257 -174.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 69.6 mt -112.53 113.46 25.62 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.252 1.021 . . . . 0.0 110.155 172.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' VAL . . . . . 0.431 HG21 ' SD ' ' A' ' 293' ' ' MET . 65.7 t -95.43 138.89 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 123.684 0.794 . . . . 0.0 109.264 178.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 42.7 mtt180 -125.08 115.64 20.82 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 177.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . 0.464 HD22 ' HA ' ' A' ' 289' ' ' VAL . 4.0 pp -126.49 135.58 27.43 Favored Pre-proline 0 N--CA 1.482 1.13 0 CA-C-O 119.258 -0.401 . . . . 0.0 109.942 175.174 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -64.7 127.91 19.85 Favored 'Trans proline' 0 C--N 1.375 1.97 0 C-N-CA 122.657 2.238 . . . . 0.0 110.149 174.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.689 HD21 ' HG3' ' A' ' 319' ' ' PRO . 0.2 OUTLIER -150.22 150.92 32.24 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.002 0.921 . . . . 0.0 109.943 -173.815 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . 0.483 ' HB2' ' HB2' ' A' ' 284' ' ' GLU . 83.5 mtm180 -93.17 155.43 17.46 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.588 0.755 . . . . 0.0 110.815 -178.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -65.72 -38.24 88.62 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.885 0.474 . . . . 0.0 110.213 176.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 24.3 t -73.99 -17.93 60.93 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.552 0.741 . . . . 0.0 111.802 178.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' GLU . . . . . 0.483 ' HB2' ' HB2' ' A' ' 281' ' ' ARG . 5.9 tp10 -72.93 131.77 83.56 Favored Pre-proline 0 N--CA 1.473 0.72 0 C-N-CA 123.712 0.805 . . . . 0.0 109.121 179.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -67.76 168.38 18.67 Favored 'Trans proline' 0 C--N 1.374 1.918 0 C-N-CA 121.903 1.735 . . . . 0.0 111.79 171.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 54.3 mt -70.41 -10.22 58.5 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 118.982 -0.532 . . . . 0.0 110.874 179.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 26.0 tp60 -54.68 -23.08 15.85 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.217 0.607 . . . . 0.0 111.644 175.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 288' ' ' SER . . . . . 0.536 ' HB3' HD12 ' A' ' 280' ' ' LEU . 34.3 t -64.42 -56.48 14.01 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.619 0.768 . . . . 0.0 110.935 171.108 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.464 ' HA ' HD22 ' A' ' 278' ' ' LEU . 18.0 m -66.73 -30.43 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 C-N-CA 122.254 0.222 . . . . 0.0 110.701 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . 0.56 HG11 ' HB ' ' A' ' 304' ' ' ILE . 43.9 t -66.88 -50.24 66.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 124.397 1.079 . . . . 0.0 110.565 179.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -64.1 -43.54 95.03 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.105 0.962 . . . . 0.0 110.887 -178.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 26.0 t60 -67.2 -49.09 65.87 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.378 -177.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 293' ' ' MET . . . . . 0.431 ' SD ' HG21 ' A' ' 276' ' ' VAL . 90.0 mmm -66.36 -32.52 73.96 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.447 0.699 . . . . 0.0 111.369 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -61.57 -53.63 53.79 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 123.863 0.727 . . . . 0.0 110.352 177.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 28.3 m -66.2 -34.09 77.24 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.658 0.783 . . . . 0.0 111.304 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -67.46 -35.44 79.19 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.682 0.793 . . . . 0.0 111.499 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 297' ' ' LEU . . . . . 0.703 HD22 ' SG ' ' A' ' 271' ' ' CYS . 86.6 mt -97.83 -3.46 38.75 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.874 0.87 . . . . 0.0 111.319 178.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 75.15 10.15 84.18 Favored Glycine 0 C--N 1.345 1.049 0 O-C-N 123.625 0.578 . . . . 0.0 113.44 177.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 33.1 m -98.6 -179.04 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.126 0.97 . . . . 0.0 111.252 -178.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 21.7 m -85.2 147.78 48.44 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 123.347 0.659 . . . . 0.0 110.686 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -56.79 -29.65 81.7 Favored 'Trans proline' 0 C--N 1.384 2.428 0 C-N-CA 123.044 2.496 . . . . 0.0 112.297 171.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 44.8 m -68.24 -19.56 64.74 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.037 0.535 . . . . 0.0 111.739 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 61.3 mtt85 -89.19 -19.48 25.4 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.924 0.89 . . . . 0.0 111.737 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 304' ' ' ILE . . . . . 0.56 ' HB ' HG11 ' A' ' 290' ' ' VAL . 41.9 mm -80.62 125.39 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 CA-C-N 117.997 0.362 . . . . 0.0 110.748 -178.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . 0.578 HD22 HD11 ' A' ' 335' ' ' LEU . 46.3 tp -129.76 121.52 27.01 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.809 0.844 . . . . 0.0 108.963 176.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . 0.419 ' HA ' ' O ' ' A' ' 331' ' ' ASP . 2.6 mm? -88.43 127.86 35.51 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -179.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . 0.511 HD11 HG23 ' A' ' 333' ' ' VAL . 79.1 mt -136.32 104.76 5.73 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.794 0.837 . . . . 0.0 109.615 -176.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . 0.516 ' HB2' HG21 ' A' ' 330' ' ' ILE . 85.3 t80 -81.84 93.65 6.91 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 177.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 66.77 -87.72 0.13 Allowed Glycine 0 C--N 1.349 1.274 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.595 -177.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -137.17 77.46 1.64 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.277 1.031 . . . . 0.0 109.339 177.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 14.3 t -166.92 146.26 5.39 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.234 1.014 . . . . 0.0 108.899 173.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . 0.424 ' HA ' HD21 ' A' ' 307' ' ' LEU . 44.3 tt0 -97.36 123.38 41.16 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 122.532 0.333 . . . . 0.0 110.345 -176.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . 0.455 HD23 HD23 ' A' ' 322' ' ' LEU . 27.7 mt -121.11 131.63 54.38 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.59 0.756 . . . . 0.0 109.099 -179.3 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 52.6 m -98.75 152.69 37.96 Favored Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 123.59 0.756 . . . . 0.0 111.573 -174.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -49.23 -37.82 40.29 Favored 'Trans proline' 0 C--N 1.388 2.617 0 C-N-CA 123.695 2.93 . . . . 0.0 113.294 167.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 43.1 p -70.44 -27.61 64.39 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.321 -178.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -73.51 145.71 45.42 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.608 0.763 . . . . 0.0 110.857 -179.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 318' ' ' THR . . . . . . . . . . . . . 76.1 p -99.2 146.79 32.32 Favored Pre-proline 0 N--CA 1.476 0.857 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 177.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . 0.689 ' HG3' HD21 ' A' ' 280' ' ' LEU . 34.8 Cg_endo -62.19 -12.18 25.59 Favored 'Trans proline' 0 C--N 1.367 1.518 0 C-N-CA 123.081 2.521 . . . . 0.0 112.56 171.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 44.2 ttt-85 -68.25 -56.13 9.74 Favored 'General case' 0 C--N 1.35 0.613 0 C-N-CA 122.999 0.519 . . . . 0.0 110.15 173.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 13.6 t -68.81 -25.42 64.67 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 120.639 0.257 . . . . 0.0 111.265 -178.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 322' ' ' LEU . . . . . 0.455 HD23 HD23 ' A' ' 313' ' ' LEU . 52.2 mt -90.04 -13.75 35.3 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.288 0.635 . . . . 0.0 111.721 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt 61.87 35.15 16.6 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.657 1.183 . . . . 0.0 112.384 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . 0.447 ' HG ' ' HB2' ' A' ' 322' ' ' LEU . 30.8 mt -73.74 166.13 23.85 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.545 0.738 . . . . 0.0 109.836 175.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . -164.03 -171.91 30.86 Favored Glycine 0 C--N 1.337 0.635 0 CA-C-N 116.475 -0.33 . . . . 0.0 112.326 -176.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 35.0 m -68.4 -27.87 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 123.973 0.909 . . . . 0.0 111.402 178.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -99.57 11.63 38.65 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.118 0.967 . . . . 0.0 111.625 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -122.8 124.09 42.52 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -175.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . 0.455 HG22 ' HB2' ' A' ' 270' ' ' ARG . 3.5 mt -116.72 109.83 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 O-C-N 123.411 0.445 . . . . 0.0 111.824 -163.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 330' ' ' ILE . . . . . 0.516 HG21 ' HB2' ' A' ' 308' ' ' PHE . 34.4 pt -102.06 131.94 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 123.679 0.792 . . . . 0.0 111.117 -177.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 331' ' ' ASP . . . . . 0.419 ' O ' ' HA ' ' A' ' 306' ' ' LEU . 7.5 m-20 -73.95 126.91 31.52 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 123.293 0.637 . . . . 0.0 111.759 -178.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 332' ' ' CYS . . . . . 0.556 ' SG ' HD13 ' A' ' 304' ' ' ILE . 43.2 t -90.55 91.17 8.31 Favored 'General case' 0 C--O 1.244 0.785 0 C-N-CA 123.89 0.876 . . . . 0.0 109.043 172.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . 0.511 HG23 HD11 ' A' ' 307' ' ' LEU . 90.8 t -95.02 115.55 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 123.253 0.621 . . . . 0.0 109.506 -178.108 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 93.1 t -83.69 98.77 5.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 177.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 335' ' ' LEU . . . . . 0.578 HD11 HD22 ' A' ' 305' ' ' LEU . 86.3 mt -67.25 168.9 9.61 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 114.662 -1.153 . . . . 0.0 111.401 172.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 336' ' ' THR . . . . . . . . . . . . . 37.4 p -90.89 26.7 2.01 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.876 0.87 . . . . 0.0 111.374 174.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 18.4 m -57.37 114.45 2.2 Favored 'General case' 0 C--N 1.359 0.99 0 C-N-CA 123.948 0.899 . . . . 0.0 110.609 176.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 29.9 m . . . . . 0 C--O 1.254 1.311 0 C-N-CA 123.11 0.564 . . . . 0.0 110.007 -177.999 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 . . . . . 0 N--CA 1.478 0.967 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -85.81 45.29 3.46 Favored Glycine 0 C--N 1.349 1.289 0 N-CA-C 114.165 0.426 . . . . 0.0 114.165 -171.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -90.06 174.75 7.47 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.757 0.823 . . . . 0.0 110.392 175.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -86.28 79.54 9.02 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.498 0.666 . . . . 0.0 109.231 178.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -147.38 12.74 1.06 Allowed 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.122 178.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.33 119.7 8.44 Favored 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 124.385 1.074 . . . . 0.0 111.568 -172.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 17.7 m -137.74 175.23 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 125.069 1.347 . . . . 0.0 109.783 -178.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 5.4 p -71.89 105.71 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 CA-C-O 121.87 0.843 . . . . 0.0 109.123 172.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 43.0 tp -152.08 129.38 11.27 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 -178.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 16.2 m -73.29 79.33 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 CA-C-O 122.81 1.291 . . . . 0.0 111.086 -178.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -135.64 141.72 45.09 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 114.076 -1.42 . . . . 0.0 109.019 179.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -108.84 79.3 0.25 Allowed Glycine 0 CA--C 1.524 0.641 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 165.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -81.25 154.16 18.85 Favored 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 122.771 2.314 . . . . 0.0 111.54 -171.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 31.6 m -65.12 124.09 21.21 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 174.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 87.1 mt -112.48 88.94 11.75 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 123.371 0.668 . . . . 0.0 109.261 178.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -76.75 -22.02 12.21 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 121.909 1.74 . . . . 0.0 110.872 169.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -80.01 106.73 12.25 Favored 'General case' 0 C--O 1.242 0.687 0 C-N-CA 124.018 0.927 . . . . 0.0 108.937 176.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 27.2 m -75.33 137.2 71.67 Favored Pre-proline 0 CA--C 1.548 0.893 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 172.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . 0.434 ' O ' HD11 ' A' ' 264' ' ' LEU . 99.7 Cg_exo -48.28 173.93 0.03 OUTLIER 'Trans proline' 0 C--N 1.383 2.383 0 C-N-CA 123.318 2.679 . . . . 0.0 114.567 175.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 75.6 mtt180 -92.73 89.27 6.58 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-O 121.703 0.763 . . . . 0.0 109.664 -177.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . 0.434 HD11 ' O ' ' A' ' 262' ' ' PRO . 3.0 mp -89.82 162.89 15.27 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 114.187 -1.369 . . . . 0.0 109.017 174.141 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -141.75 145.67 37.92 Favored Pre-proline 0 CA--C 1.546 0.792 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 175.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' PRO . . . . . 0.431 ' HB2' ' HB3' ' A' ' 277' ' ' ARG . 58.5 Cg_endo -67.93 89.11 0.37 Allowed 'Trans proline' 0 C--N 1.374 1.909 0 C-N-CA 122.875 2.383 . . . . 0.0 112.626 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' LEU . . . . . 0.497 ' O ' ' HA ' ' A' ' 277' ' ' ARG . 1.4 tm? -58.93 127.83 34.18 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.478 1.111 . . . . 0.0 108.96 176.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.641 ' HG2' HG12 ' A' ' 329' ' ' ILE . 5.6 tppp? -83.6 109.35 17.35 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-O 121.336 0.589 . . . . 0.0 111.19 176.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . 0.477 HG12 ' HB ' ' A' ' 289' ' ' VAL . 2.4 mp -106.39 145.22 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 171.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 30.8 ttp180 -107.47 106.88 17.49 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 173.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' CYS . . . . . 0.575 ' SG ' HD21 ' A' ' 297' ' ' LEU . 17.4 t -69.82 172.65 7.32 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.746 171.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 16.3 ptt180 -62.13 -14.1 33.6 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 123.871 0.868 . . . . 0.0 113.187 -174.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -162.52 34.03 0.11 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.694 0.798 . . . . 0.0 111.029 176.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -164.23 162.82 22.8 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 122.826 0.451 . . . . 0.0 111.647 -175.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 51.9 mt -114.2 116.36 28.93 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.244 1.018 . . . . 0.0 109.653 170.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 60.3 t -100.46 142.72 15.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 124.193 0.997 . . . . 0.0 109.114 176.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . 0.497 ' HA ' ' O ' ' A' ' 267' ' ' LEU . 57.8 mtm180 -127.72 120.8 28.77 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 167.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . 0.494 HD21 ' HA ' ' A' ' 289' ' ' VAL . 4.1 pp -123.9 146.33 50.54 Favored Pre-proline 0 N--CA 1.48 1.04 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 178.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -64.67 110.91 1.54 Allowed 'Trans proline' 0 C--N 1.372 1.788 0 C-N-CA 122.805 2.337 . . . . 0.0 110.94 174.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.617 HD23 ' HG3' ' A' ' 319' ' ' PRO . 0.1 OUTLIER -130.05 143.67 50.92 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.15 0.98 . . . . 0.0 109.835 178.9 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 70.4 mtp180 -89.44 159.79 17.11 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.001 0.92 . . . . 0.0 110.728 178.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' MET . . . . . . . . . . . . . 1.3 mmt -70.53 -34.02 71.82 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.199 176.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 35.2 m -77.81 -26.64 49.74 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.734 0.814 . . . . 0.0 111.222 177.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -72.56 123.37 89.45 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-O 118.135 -0.936 . . . . 0.0 108.642 176.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -68.25 179.52 2.87 Favored 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 122.759 2.306 . . . . 0.0 112.481 179.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.418 HD11 ' O ' ' A' ' 314' ' ' SER . 66.6 mt -64.43 -18.37 64.67 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 118.954 -0.545 . . . . 0.0 111.557 177.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 26.6 tp60 -53.47 -22.61 8.25 Favored 'General case' 0 CA--C 1.559 1.294 0 C-N-CA 123.543 0.737 . . . . 0.0 112.307 178.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 288' ' ' SER . . . . . 0.489 ' HB3' HD13 ' A' ' 280' ' ' LEU . 32.1 t -63.18 -56.65 14.92 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.847 0.859 . . . . 0.0 111.069 171.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.494 ' HA ' HD21 ' A' ' 278' ' ' LEU . 15.4 m -67.33 -33.72 64.41 Favored 'Isoleucine or valine' 0 C--N 1.361 1.085 0 C-N-CA 122.64 0.376 . . . . 0.0 110.498 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . 0.561 HG12 ' HB ' ' A' ' 304' ' ' ILE . 73.8 t -61.12 -49.24 85.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 124.426 1.09 . . . . 0.0 111.026 177.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -61.27 -50.05 74.59 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 124.31 1.006 . . . . 0.0 110.467 -178.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 22.8 t60 -59.32 -49.03 79.41 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 124.526 1.141 . . . . 0.0 111.203 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 91.7 mmm -68.33 -31.08 70.24 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 122.779 0.431 . . . . 0.0 111.103 -178.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -70.0 -38.16 75.91 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.272 0.629 . . . . 0.0 111.034 176.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 27.7 m -68.96 -43.35 75.16 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.611 0.764 . . . . 0.0 110.275 178.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 83.4 t60 -67.66 -47.98 67.98 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.546 -177.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 297' ' ' LEU . . . . . 0.575 HD21 ' SG ' ' A' ' 271' ' ' CYS . 76.6 mt -83.52 -9.0 59.24 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.512 0.725 . . . . 0.0 111.654 -178.099 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 69.66 26.4 74.49 Favored Glycine 0 C--N 1.349 1.28 0 O-C-N 123.697 0.623 . . . . 0.0 112.682 177.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 299' ' ' VAL . . . . . 0.475 HG13 HG11 ' A' ' 334' ' ' VAL . 28.0 m -110.36 178.14 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.435 1.094 . . . . 0.0 110.434 -177.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 27.4 m -80.4 143.16 55.23 Favored Pre-proline 0 CA--C 1.55 0.971 0 CA-C-O 119.114 -0.469 . . . . 0.0 110.207 178.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -56.91 -28.19 76.42 Favored 'Trans proline' 0 C--N 1.384 2.398 0 C-N-CA 123.052 2.502 . . . . 0.0 112.45 171.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 41.2 t -68.56 -27.31 65.96 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 120.83 0.347 . . . . 0.0 110.978 179.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 66.7 mtt180 -85.55 -11.86 53.05 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.34 1.056 . . . . 0.0 112.047 -176.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 304' ' ' ILE . . . . . 0.561 ' HB ' HG12 ' A' ' 290' ' ' VAL . 35.5 mm -82.67 101.97 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 177.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 36.9 tp -102.37 112.05 24.6 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.271 0.628 . . . . 0.0 109.471 176.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -81.56 131.22 35.27 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 177.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . 0.468 HD11 HG23 ' A' ' 333' ' ' VAL . 72.5 mt -131.99 109.94 10.4 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.04 0.936 . . . . 0.0 108.735 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . 0.495 ' HB2' HD12 ' A' ' 313' ' ' LEU . 28.7 t80 -77.74 89.64 4.01 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -179.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 66.44 -83.43 0.1 Allowed Glycine 0 C--N 1.346 1.112 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.728 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -122.56 3.09 9.62 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.134 0.973 . . . . 0.0 112.207 -176.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 5.0 t -115.26 147.01 40.91 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 118.256 0.48 . . . . 0.0 110.225 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -85.05 132.71 34.29 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 123.184 0.594 . . . . 0.0 110.007 177.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . 0.52 HD13 HD11 ' A' ' 322' ' ' LEU . 53.2 mt -112.3 156.74 21.93 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.114 0.566 . . . . 0.0 110.366 177.152 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 314' ' ' SER . . . . . 0.418 ' O ' HD11 ' A' ' 286' ' ' LEU . 22.3 m -99.22 130.4 27.28 Favored Pre-proline 0 CA--C 1.544 0.749 0 CA-C-O 118.644 -0.693 . . . . 0.0 109.44 175.133 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -59.51 -21.92 64.11 Favored 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 123.228 2.618 . . . . 0.0 113.475 175.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 27.3 p -78.26 -29.44 48.06 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.969 0.908 . . . . 0.0 111.858 176.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -67.28 157.74 33.17 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.366 0.666 . . . . 0.0 111.475 -177.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 318' ' ' THR . . . . . . . . . . . . . 61.6 p -99.36 144.17 27.77 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 123.158 0.583 . . . . 0.0 109.916 -173.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . 0.617 ' HG3' HD23 ' A' ' 280' ' ' LEU . 55.7 Cg_endo -63.22 -16.65 55.81 Favored 'Trans proline' 0 C--N 1.363 1.342 0 C-N-CA 123.43 2.753 . . . . 0.0 112.508 175.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 -73.21 -48.65 33.33 Favored 'General case' 0 C--N 1.355 0.843 0 C-N-CA 122.72 0.408 . . . . 0.0 110.488 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 13.7 t -70.54 -26.37 63.53 Favored 'General case' 0 CA--C 1.549 0.926 0 O-C-N 123.324 0.39 . . . . 0.0 110.637 178.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 322' ' ' LEU . . . . . 0.52 HD11 HD13 ' A' ' 313' ' ' LEU . 68.6 mt -85.7 -12.17 51.87 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.362 0.665 . . . . 0.0 111.41 175.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp 60.02 35.74 21.45 Favored 'General case' 0 CA--C 1.561 1.394 0 C-N-CA 124.712 1.205 . . . . 0.0 111.52 175.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 60.5 mt -69.31 169.75 11.65 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.198 0.999 . . . . 0.0 111.26 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . -154.89 -170.18 20.3 Favored Glycine 0 C--N 1.348 1.212 0 CA-C-N 116.411 -0.358 . . . . 0.0 113.084 -172.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 14.9 m -81.56 -28.45 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 123.683 0.793 . . . . 0.0 111.542 -176.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -99.33 -23.78 15.04 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.17 0.988 . . . . 0.0 110.041 176.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -72.19 120.09 17.31 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.889 0.876 . . . . 0.0 110.245 -175.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . 0.641 HG12 ' HG2' ' A' ' 268' ' ' LYS . 5.2 mt -100.6 134.36 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 123.819 0.848 . . . . 0.0 111.812 -166.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 42.8 pt -126.3 126.34 69.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 123.471 0.708 . . . . 0.0 110.345 172.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -73.89 110.44 8.19 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.485 1.114 . . . . 0.0 112.132 -175.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 332' ' ' CYS . . . . . 0.477 ' SG ' HD13 ' A' ' 304' ' ' ILE . 41.6 t -74.57 89.89 2.22 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.563 0.745 . . . . 0.0 109.878 167.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . 0.468 HG23 HD11 ' A' ' 307' ' ' LEU . 93.1 t -100.61 111.1 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 123.226 0.61 . . . . 0.0 109.483 -178.03 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 334' ' ' VAL . . . . . 0.475 HG11 HG13 ' A' ' 299' ' ' VAL . 57.9 t -83.41 108.91 16.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 123.033 0.533 . . . . 0.0 109.947 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 88.9 mt -115.17 156.38 25.41 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.881 0.872 . . . . 0.0 110.58 178.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 336' ' ' THR . . . . . . . . . . . . . 7.1 t -80.67 71.13 7.55 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-O 122.524 1.154 . . . . 0.0 110.032 176.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 21.9 p -79.53 112.25 16.6 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 114.685 -1.143 . . . . 0.0 111.434 -173.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 58.0 m . . . . . 0 C--O 1.257 1.467 0 C-N-CA 124.247 1.019 . . . . 0.0 108.499 175.76 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . 0.404 ' H3 ' ' HB3' ' A' ' 247' ' ' GLU . 47.7 mt-30 . . . . . 0 N--CA 1.483 1.209 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 80.78 -72.26 2.73 Favored Glycine 0 C--N 1.348 1.212 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 -169.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' GLN . . . . . 0.652 ' HG2' ' H ' ' A' ' 247' ' ' GLU . 53.8 tt0 -90.85 -168.34 2.05 Favored 'General case' 0 CA--C 1.562 1.417 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 161.268 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . 0.652 ' H ' ' HG2' ' A' ' 246' ' ' GLN . 38.2 tt0 78.2 -4.84 2.15 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 124.645 1.178 . . . . 0.0 111.256 175.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -83.39 103.68 12.95 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 177.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -124.98 112.66 16.84 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 178.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 27.7 m -57.83 110.78 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.051 0 O-C-N 124.167 0.917 . . . . 0.0 111.192 -171.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' VAL . . . . . 0.593 HG13 HG22 ' A' ' 253' ' ' VAL . 24.5 t -76.09 86.96 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.561 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 175.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 35.7 tp -78.64 75.66 5.15 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.369 -172.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.593 HG22 HG13 ' A' ' 251' ' ' VAL . 16.0 m -146.86 148.59 16.61 Favored 'Isoleucine or valine' 0 C--O 1.247 0.965 0 C-N-CA 125.229 1.411 . . . . 0.0 108.678 175.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -170.13 172.96 6.11 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.762 0.825 . . . . 0.0 109.768 175.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 133.96 -69.5 0.53 Allowed Glycine 0 CA--C 1.533 1.174 0 N-CA-C 110.901 -0.879 . . . . 0.0 110.901 -178.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.08 169.17 21.22 Favored 'Trans proline' 0 C--N 1.38 2.217 0 C-N-CA 122.95 2.434 . . . . 0.0 112.585 177.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 16.5 p -66.78 99.48 0.62 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.221 0.608 . . . . 0.0 109.696 175.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 94.1 mt -100.23 99.27 9.16 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 123.588 0.755 . . . . 0.0 109.291 177.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -67.51 -19.36 48.85 Favored 'Trans proline' 0 C--N 1.383 2.356 0 C-N-CA 122.767 2.312 . . . . 0.0 112.771 176.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -68.69 96.35 0.72 Allowed 'General case' 0 C--N 1.354 0.787 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 174.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 23.1 m -89.87 134.37 32.13 Favored Pre-proline 0 CA--C 1.546 0.809 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.756 -177.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -60.63 152.81 66.2 Favored 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 122.345 2.03 . . . . 0.0 111.59 172.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -71.65 109.14 5.37 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.687 0.795 . . . . 0.0 111.063 -173.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 1.6 mp -91.21 169.24 11.0 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.949 177.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 265' ' ' PHE . . . . . 0.488 ' CE1' ' HG2' ' A' ' 282' ' ' MET . 10.1 p90 -150.45 138.94 12.64 Favored Pre-proline 0 CA--C 1.545 0.78 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 170.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -62.54 94.38 0.14 Allowed 'Trans proline' 0 C--N 1.377 2.03 0 C-N-CA 122.616 2.211 . . . . 0.0 111.555 173.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 267' ' ' LEU . . . . . 0.534 HD11 HG13 ' A' ' 269' ' ' ILE . 0.9 OUTLIER -59.69 125.82 25.15 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 174.266 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.553 ' HG2' HG12 ' A' ' 329' ' ' ILE . 4.8 tppp? -88.41 102.64 15.08 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.348 0.659 . . . . 0.0 110.396 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . 0.534 HG13 HD11 ' A' ' 267' ' ' LEU . 2.1 mp -103.63 129.8 55.07 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 173.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 30.8 ttp180 -90.45 109.37 20.5 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-O 121.303 0.573 . . . . 0.0 110.192 174.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 271' ' ' CYS . . . . . 0.696 ' SG ' HD22 ' A' ' 297' ' ' LEU . 49.2 t -77.87 -179.59 6.11 Favored 'General case' 0 CA--C 1.55 0.95 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.315 172.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 272' ' ' ARG . . . . . 0.401 ' N ' ' SG ' ' A' ' 271' ' ' CYS . 15.9 ptt-85 -53.24 -31.67 44.53 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.978 1.311 . . . . 0.0 113.805 -178.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -161.68 27.98 0.12 Allowed 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.694 0.798 . . . . 0.0 110.279 177.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 274' ' ' ASP . . . . . 0.463 ' HB3' ' HB3' ' A' ' 271' ' ' CYS . 34.8 t70 -144.76 158.68 43.69 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.447 0.699 . . . . 0.0 109.795 -172.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 66.2 mt -119.92 101.47 7.89 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.652 0.781 . . . . 0.0 109.81 176.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 276' ' ' VAL . . . . . 0.502 HG23 ' SD ' ' A' ' 293' ' ' MET . 65.0 t -83.75 125.57 40.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.924 179.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 86.1 mtm180 -118.86 104.83 10.9 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 175.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . 0.464 HD12 HG13 ' A' ' 289' ' ' VAL . 4.3 pp -116.21 131.99 23.51 Favored Pre-proline 0 N--CA 1.487 1.398 0 CA-C-N 118.182 0.446 . . . . 0.0 110.744 178.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -65.9 115.95 3.71 Favored 'Trans proline' 0 C--N 1.381 2.24 0 C-N-CA 122.627 2.218 . . . . 0.0 110.736 177.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.608 HD21 ' HG3' ' A' ' 319' ' ' PRO . 0.4 OUTLIER -136.66 148.29 47.32 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.521 1.128 . . . . 0.0 109.463 -174.688 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -88.18 144.37 26.5 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 178.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 282' ' ' MET . . . . . 0.492 ' HB3' ' HB2' ' A' ' 320' ' ' ARG . 16.2 mtp -66.3 -27.41 67.9 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 118.154 0.434 . . . . 0.0 111.68 -177.105 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 35.1 m -79.16 -12.17 59.98 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.52 0.728 . . . . 0.0 112.01 176.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 25.6 tp10 -85.67 130.17 52.0 Favored Pre-proline 0 N--CA 1.472 0.632 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 178.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -65.01 167.32 16.24 Favored 'Trans proline' 0 C--N 1.381 2.267 0 C-N-CA 122.498 2.132 . . . . 0.0 113.119 178.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 91.5 mt -68.48 -9.29 47.92 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.502 -178.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 26.3 tp60 -53.85 -27.98 33.13 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.563 0.745 . . . . 0.0 111.444 174.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 288' ' ' SER . . . . . 0.428 ' HB2' HD12 ' A' ' 280' ' ' LEU . 67.0 m -65.92 -47.08 75.93 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.709 0.804 . . . . 0.0 112.075 175.184 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.464 HG13 HD12 ' A' ' 278' ' ' LEU . 17.1 m -71.55 -34.31 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 177.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . 0.553 HG11 ' HB ' ' A' ' 304' ' ' ILE . 37.5 t -61.61 -45.07 99.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.667 1.187 . . . . 0.0 110.95 177.483 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -63.74 -48.95 74.94 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.04 0.936 . . . . 0.0 110.79 -178.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 74.7 t60 -64.36 -44.9 89.98 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.18 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 293' ' ' MET . . . . . 0.502 ' SD ' HG23 ' A' ' 276' ' ' VAL . 90.9 mmm -68.34 -32.08 71.94 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 123.724 0.64 . . . . 0.0 111.42 -177.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -63.76 -43.36 96.63 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 123.698 0.624 . . . . 0.0 110.404 176.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 29.2 m -73.5 -33.08 64.62 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 123.272 0.629 . . . . 0.0 111.254 176.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 58.4 t60 -66.2 -34.43 78.0 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.183 0.993 . . . . 0.0 110.719 -178.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 297' ' ' LEU . . . . . 0.696 HD22 ' SG ' ' A' ' 271' ' ' CYS . 62.2 mt -102.31 -21.35 14.33 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.921 0.888 . . . . 0.0 111.83 -177.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 85.36 24.42 43.62 Favored Glycine 0 N--CA 1.475 1.258 0 O-C-N 123.007 0.192 . . . . 0.0 112.999 -178.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 299' ' ' VAL . . . . . 0.484 HG11 HG11 ' A' ' 334' ' ' VAL . 31.4 m -109.87 -179.42 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 124.013 0.925 . . . . 0.0 110.808 177.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 19.2 m -82.82 146.29 52.17 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 123.542 0.737 . . . . 0.0 110.277 178.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -58.92 -27.35 84.29 Favored 'Trans proline' 0 C--N 1.386 2.545 0 C-N-CA 123.001 2.468 . . . . 0.0 112.295 173.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 40.2 p -67.06 -17.39 64.87 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.847 0.859 . . . . 0.0 112.021 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 89.5 mtt180 -95.68 -25.79 15.98 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.041 0.937 . . . . 0.0 111.926 -176.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 304' ' ' ILE . . . . . 0.553 ' HB ' HG11 ' A' ' 290' ' ' VAL . 32.9 mm -72.51 115.66 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 122.601 0.36 . . . . 0.0 110.363 -177.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 27.0 tp -124.17 122.32 37.49 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.241 0.616 . . . . 0.0 109.367 177.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -89.16 123.31 33.3 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -177.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . 0.509 HD11 HG23 ' A' ' 333' ' ' VAL . 72.7 mt -129.74 112.89 14.08 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.469 0.708 . . . . 0.0 109.622 -177.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -84.7 92.55 8.22 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 173.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 70.43 -94.59 0.49 Allowed Glycine 0 C--N 1.346 1.088 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 -174.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -133.69 82.67 2.0 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.577 0.751 . . . . 0.0 109.411 174.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 12.1 t -166.0 138.84 4.09 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 174.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -90.74 114.03 26.28 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-O 120.697 0.284 . . . . 0.0 110.698 -174.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 46.0 mt -103.74 114.49 28.8 Favored 'General case' 0 C--O 1.245 0.842 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 177.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 12.8 m -72.6 143.9 85.51 Favored Pre-proline 0 CA--C 1.553 1.079 0 C-N-CA 124.215 1.006 . . . . 0.0 111.219 -173.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . 0.526 ' HB3' HG22 ' A' ' 290' ' ' VAL . 36.5 Cg_endo -62.63 -28.65 77.1 Favored 'Trans proline' 0 C--N 1.381 2.263 0 C-N-CA 123.015 2.477 . . . . 0.0 112.357 175.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 4.7 m -73.67 -28.72 61.9 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.09 0.956 . . . . 0.0 111.329 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -78.29 154.78 30.62 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.532 0.733 . . . . 0.0 110.756 -178.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 318' ' ' THR . . . . . . . . . . . . . 82.8 p -99.46 152.9 37.96 Favored Pre-proline 0 CA--C 1.545 0.764 0 C-N-CA 123.495 0.718 . . . . 0.0 109.901 -178.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . 0.608 ' HG3' HD21 ' A' ' 280' ' ' LEU . 60.9 Cg_endo -67.92 -9.69 26.44 Favored 'Trans proline' 0 C--N 1.363 1.339 0 C-N-CA 122.975 2.45 . . . . 0.0 113.324 174.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . 0.492 ' HB2' ' HB3' ' A' ' 282' ' ' MET . 44.5 ttm180 -75.11 -48.2 24.95 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 117.786 0.266 . . . . 0.0 110.474 178.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 14.6 t -68.74 -22.88 64.29 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 122.659 0.383 . . . . 0.0 110.946 179.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 322' ' ' LEU . . . . . 0.442 ' HB2' ' HG ' ' A' ' 324' ' ' LEU . 53.2 mt -92.05 -16.13 26.86 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.73 0.812 . . . . 0.0 111.511 176.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp 65.06 31.94 10.71 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.753 1.221 . . . . 0.0 112.57 -179.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . 0.442 ' HG ' ' HB2' ' A' ' 322' ' ' LEU . 42.0 mt -67.54 165.12 17.51 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.682 0.793 . . . . 0.0 110.839 175.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 325' ' ' GLY . . . . . 0.42 ' H ' ' HB3' ' A' ' 328' ' ' ASP . . . -158.63 -169.48 22.13 Favored Glycine 0 C--N 1.342 0.884 0 CA-C-N 116.046 -0.524 . . . . 0.0 112.699 -173.137 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 21.5 m -77.25 -25.72 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.542 0.737 . . . . 0.0 110.46 178.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -94.28 -19.44 20.69 Favored 'General case' 0 C--N 1.353 0.734 0 C-N-CA 124.164 0.985 . . . . 0.0 110.957 179.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 328' ' ' ASP . . . . . 0.42 ' HB3' ' H ' ' A' ' 325' ' ' GLY . 13.1 t70 -82.77 128.4 34.36 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 178.086 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . 0.553 HG12 ' HG2' ' A' ' 268' ' ' LYS . 9.4 mt -115.21 113.87 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 123.107 0.563 . . . . 0.0 109.852 -170.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 38.6 pt -108.43 125.47 65.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-O 121.083 0.468 . . . . 0.0 110.79 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -72.34 116.96 13.4 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.839 0.856 . . . . 0.0 111.387 -175.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 332' ' ' CYS . . . . . 0.535 ' SG ' HD13 ' A' ' 304' ' ' ILE . 37.6 t -74.27 92.1 2.22 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 123.307 0.643 . . . . 0.0 109.415 169.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . 0.509 HG23 HD11 ' A' ' 307' ' ' LEU . 60.5 t -101.36 109.84 26.74 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -178.25 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 334' ' ' VAL . . . . . 0.484 HG11 HG11 ' A' ' 299' ' ' VAL . 57.6 t -79.31 93.91 1.77 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.451 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.694 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 87.4 mt -91.74 97.36 10.96 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.565 0.698 . . . . 0.0 109.508 172.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 336' ' ' THR . . . . . . . . . . . . . 10.4 t -79.61 -22.81 43.18 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 114.502 -1.226 . . . . 0.0 109.65 176.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 42.8 p -71.23 103.09 2.7 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.556 0.742 . . . . 0.0 109.548 173.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 C--O 1.251 1.149 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -179.659 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 23.0 mp0 . . . . . 0 N--CA 1.479 1.019 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -107.15 130.29 10.09 Favored Glycine 0 C--N 1.343 0.938 0 CA-C-O 119.449 -0.639 . . . . 0.0 111.557 178.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -78.78 79.42 5.19 Favored 'General case' 0 C--N 1.354 0.797 0 CA-C-O 122.029 0.918 . . . . 0.0 110.168 -178.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -104.0 25.45 9.93 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 114.662 -1.154 . . . . 0.0 109.62 174.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -72.55 84.21 1.13 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.354 1.062 . . . . 0.0 110.241 -178.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -127.52 144.9 51.01 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 114.842 -1.072 . . . . 0.0 108.8 174.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 19.6 m -94.05 59.19 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 CA-C-O 121.791 0.805 . . . . 0.0 110.186 178.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 38.1 t -69.14 95.82 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.578 -177.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 52.7 tp -152.34 95.88 2.1 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 -175.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 7.1 m -111.94 94.4 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 CA-C-O 122.034 0.921 . . . . 0.0 109.728 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.69 -169.03 1.51 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.196 0.998 . . . . 0.0 109.959 -178.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 105.76 101.19 2.69 Favored Glycine 0 C--N 1.339 0.734 0 CA-C-O 119.029 -0.873 . . . . 0.0 110.974 -176.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -73.83 171.57 17.6 Favored 'Trans proline' 0 C--N 1.376 1.986 0 C-N-CA 122.647 2.231 . . . . 0.0 112.08 -177.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 13.1 m -69.19 98.05 0.98 Allowed 'General case' 0 C--N 1.347 0.487 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 176.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 86.1 mt -91.37 107.74 23.81 Favored Pre-proline 0 CA--C 1.544 0.713 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 174.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -62.49 -23.12 74.78 Favored 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 122.728 2.285 . . . . 0.0 111.719 169.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -81.6 127.61 33.05 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 124.674 1.19 . . . . 0.0 110.15 176.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 67.6 m -68.59 126.12 92.42 Favored Pre-proline 0 CA--C 1.548 0.881 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 168.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.78 143.05 82.3 Favored 'Trans proline' 0 C--N 1.379 2.163 0 C-N-CA 122.584 2.19 . . . . 0.0 111.01 174.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 84.7 mtt180 -66.69 81.43 0.1 Allowed 'General case' 0 N--CA 1.483 1.205 0 CA-C-O 122.024 0.916 . . . . 0.0 112.299 -169.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . 0.454 HD21 ' HG2' ' A' ' 281' ' ' ARG . 45.9 mt -72.22 125.37 27.15 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 114.736 -1.12 . . . . 0.0 108.536 174.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -109.18 142.23 25.15 Favored Pre-proline 0 C--O 1.247 0.924 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 173.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -67.09 96.01 0.38 Allowed 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 122.275 1.983 . . . . 0.0 111.363 175.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 267' ' ' LEU . . . . . 0.516 HD11 HG13 ' A' ' 269' ' ' ILE . 1.0 OUTLIER -62.06 129.07 39.12 Favored 'General case' 0 C--O 1.246 0.899 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 174.656 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.485 ' HG2' HG12 ' A' ' 329' ' ' ILE . 2.6 tppp? -94.37 102.32 14.29 Favored 'General case' 0 C--O 1.241 0.653 0 O-C-N 123.751 0.657 . . . . 0.0 109.872 -176.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . 0.516 HG13 HD11 ' A' ' 267' ' ' LEU . 1.5 mp -104.48 114.19 43.42 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 176.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 270' ' ' ARG . . . . . 0.408 ' HA ' HD11 ' A' ' 275' ' ' LEU . 33.1 ttp180 -75.54 104.28 6.03 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 175.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 271' ' ' CYS . . . . . 0.582 ' SG ' HD23 ' A' ' 297' ' ' LEU . 38.1 t -72.59 175.98 5.87 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.27 1.028 . . . . 0.0 110.069 174.445 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 25.7 ptt180 -57.13 -28.05 62.37 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.017 0.927 . . . . 0.0 113.142 -178.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -155.45 30.14 0.38 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.376 0.67 . . . . 0.0 111.175 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -160.56 164.0 32.33 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 122.696 0.398 . . . . 0.0 110.907 -173.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.408 HD11 ' HA ' ' A' ' 270' ' ' ARG . 4.4 mm? -113.54 103.08 10.9 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.258 1.023 . . . . 0.0 108.948 171.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 72.8 t -83.68 130.61 35.54 Favored 'Isoleucine or valine' 0 C--N 1.343 0.301 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 177.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 76.4 mtt85 -124.32 99.49 6.23 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -179.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . 0.439 HD23 ' HA ' ' A' ' 289' ' ' VAL . 4.3 pp -111.8 142.36 26.53 Favored Pre-proline 0 N--CA 1.489 1.476 0 CA-C-N 117.917 0.326 . . . . 0.0 110.324 -178.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -69.26 115.57 4.09 Favored 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 122.282 1.988 . . . . 0.0 110.502 177.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.626 HD22 ' HG3' ' A' ' 319' ' ' PRO . 0.9 OUTLIER -138.34 149.94 46.11 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.835 0.854 . . . . 0.0 109.992 -176.481 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . 0.454 ' HG2' HD21 ' A' ' 264' ' ' LEU . 16.2 mmm180 -94.36 151.1 19.66 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.104 0.962 . . . . 0.0 111.092 178.001 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 282' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -57.1 -41.31 78.67 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.122 0.569 . . . . 0.0 111.118 175.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 19.6 m -76.25 -17.83 59.3 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.378 1.071 . . . . 0.0 112.554 -177.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 284' ' ' GLU . . . . . 0.436 ' O ' ' HD2' ' A' ' 319' ' ' PRO . 8.5 tp10 -72.49 130.29 86.03 Favored Pre-proline 0 N--CA 1.476 0.838 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 176.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -66.23 166.7 20.37 Favored 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 121.937 1.758 . . . . 0.0 111.807 172.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.433 ' O ' HG23 ' A' ' 290' ' ' VAL . 65.3 mt -66.27 -15.12 62.95 Favored 'General case' 0 C--O 1.215 -0.751 0 CA-C-O 118.932 -0.556 . . . . 0.0 111.779 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 -50.54 -26.2 4.95 Favored 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 123.967 0.907 . . . . 0.0 112.204 178.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 288' ' ' SER . . . . . 0.464 ' HB3' HD13 ' A' ' 280' ' ' LEU . 29.5 t -61.61 -57.2 12.96 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.087 0.955 . . . . 0.0 110.939 171.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.458 ' HB ' HG12 ' A' ' 269' ' ' ILE . 13.2 m -68.03 -29.68 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 122.494 0.317 . . . . 0.0 110.908 -179.376 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . 0.564 HG11 ' HB ' ' A' ' 304' ' ' ILE . 78.1 t -66.2 -55.37 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 123.951 0.9 . . . . 0.0 110.35 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -64.0 -37.66 88.25 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.276 -179.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 62.5 t60 -68.72 -47.63 65.87 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 122.982 0.513 . . . . 0.0 110.978 -177.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 293' ' ' MET . . . . . 0.465 ' HG3' HG23 ' A' ' 269' ' ' ILE . 91.0 mmm -65.9 -32.68 74.32 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.276 0.63 . . . . 0.0 110.966 178.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -63.6 -53.08 57.26 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 123.876 0.735 . . . . 0.0 110.964 176.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 55.4 m -64.46 -29.49 70.53 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.814 0.846 . . . . 0.0 111.176 179.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 71.1 t60 -71.42 -46.25 60.62 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.614 0.766 . . . . 0.0 110.997 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 297' ' ' LEU . . . . . 0.582 HD23 ' SG ' ' A' ' 271' ' ' CYS . 72.7 mt -91.74 -3.56 56.07 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.733 0.813 . . . . 0.0 111.797 -176.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 77.27 22.68 70.14 Favored Glycine 0 C--N 1.349 1.292 0 C-N-CA 123.206 0.432 . . . . 0.0 113.196 175.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 299' ' ' VAL . . . . . 0.505 HG13 HG13 ' A' ' 334' ' ' VAL . 25.0 m -112.07 -179.23 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 124.777 1.231 . . . . 0.0 110.832 178.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 51.7 m -87.81 147.61 41.6 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 123.831 0.852 . . . . 0.0 110.769 178.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.36 -25.9 75.06 Favored 'Trans proline' 0 C--N 1.391 2.773 0 C-N-CA 123.215 2.61 . . . . 0.0 111.909 173.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 9.2 m -61.1 -22.47 64.66 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 123.817 0.847 . . . . 0.0 111.995 178.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 46.6 mtt180 -97.83 -19.88 17.87 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.485 0.714 . . . . 0.0 112.385 -174.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 304' ' ' ILE . . . . . 0.564 ' HB ' HG11 ' A' ' 290' ' ' VAL . 37.0 mm -77.39 99.31 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 CA-C-O 121.101 0.477 . . . . 0.0 110.28 -177.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . 0.409 HD21 HD13 ' A' ' 335' ' ' LEU . 29.2 tp -101.55 112.32 24.84 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.843 0.857 . . . . 0.0 109.209 178.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -85.05 120.94 27.13 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . 0.477 HD13 HG23 ' A' ' 333' ' ' VAL . 70.8 mt -129.41 116.2 18.66 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.035 0.934 . . . . 0.0 108.868 -177.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -87.56 85.71 7.13 Favored 'General case' 0 C--O 1.244 0.764 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 174.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 67.62 -96.98 0.38 Allowed Glycine 0 C--N 1.342 0.898 0 CA-C-N 115.154 -0.93 . . . . 0.0 112.991 -179.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -110.21 11.68 23.54 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.528 0.731 . . . . 0.0 112.06 -174.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 11.4 t -116.98 152.85 33.71 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 117.863 0.301 . . . . 0.0 110.244 176.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -105.36 129.42 53.69 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.2 0.6 . . . . 0.0 109.818 178.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . 0.429 HD21 HD23 ' A' ' 322' ' ' LEU . 49.8 mt -113.33 135.17 54.14 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.353 0.661 . . . . 0.0 109.921 -179.049 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 20.1 m -80.65 143.36 54.54 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 123.457 0.703 . . . . 0.0 110.717 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -63.26 -29.88 73.47 Favored 'Trans proline' 0 C--N 1.384 2.408 0 C-N-CA 122.866 2.377 . . . . 0.0 112.127 174.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 34.1 p -88.13 -1.36 57.96 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.273 1.029 . . . . 0.0 111.944 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -88.58 153.17 21.35 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.274 0.63 . . . . 0.0 109.981 175.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 318' ' ' THR . . . . . . . . . . . . . 82.6 p -99.37 142.79 25.24 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 123.372 0.669 . . . . 0.0 109.979 -178.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . 0.626 ' HG3' HD22 ' A' ' 280' ' ' LEU . 29.8 Cg_endo -60.76 -13.69 27.81 Favored 'Trans proline' 0 C--N 1.369 1.65 0 C-N-CA 123.441 2.761 . . . . 0.0 113.143 172.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 53.1 ttt180 -67.07 -55.2 15.32 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.167 0.587 . . . . 0.0 110.105 174.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 10.8 t -71.09 -21.06 62.27 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.06 -177.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 322' ' ' LEU . . . . . 0.443 ' HB2' ' HG ' ' A' ' 324' ' ' LEU . 53.5 mt -93.76 -10.19 35.07 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.657 0.783 . . . . 0.0 111.518 176.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 11.3 mptt 62.15 25.65 15.37 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 125.129 1.371 . . . . 0.0 112.592 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . 0.443 ' HG ' ' HB2' ' A' ' 322' ' ' LEU . 33.3 mt -66.79 159.09 28.79 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.363 0.665 . . . . 0.0 110.276 177.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . -157.06 -157.17 8.23 Favored Glycine 0 C--O 1.242 0.598 0 CA-C-N 116.233 -0.439 . . . . 0.0 112.466 -173.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 17.6 m -83.31 -36.67 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 123.258 0.623 . . . . 0.0 110.625 -179.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -88.85 -17.64 29.27 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.053 0.941 . . . . 0.0 110.727 178.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -90.39 115.96 27.97 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . 0.485 HG12 ' HG2' ' A' ' 268' ' ' LYS . 16.0 mt -114.52 120.95 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 123.144 0.578 . . . . 0.0 111.353 -163.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 330' ' ' ILE . . . . . 0.439 HD12 HD11 ' A' ' 324' ' ' LEU . 35.8 pt -108.95 137.08 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 123.344 0.657 . . . . 0.0 111.311 -176.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -79.9 119.46 22.79 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.724 0.81 . . . . 0.0 111.713 -176.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 332' ' ' CYS . . . . . 0.514 ' SG ' HD11 ' A' ' 304' ' ' ILE . 26.9 t -77.79 90.27 4.05 Favored 'General case' 0 C--O 1.243 0.741 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 167.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . 0.477 HG23 HD13 ' A' ' 307' ' ' LEU . 28.3 t -97.27 109.45 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -178.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 334' ' ' VAL . . . . . 0.505 HG13 HG13 ' A' ' 299' ' ' VAL . 40.0 t -85.08 100.96 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.03 -175.379 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 335' ' ' LEU . . . . . 0.409 HD13 HD21 ' A' ' 305' ' ' LEU . 3.4 pp -142.31 155.35 45.19 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.764 0.426 . . . . 0.0 111.087 -179.103 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 336' ' ' THR . . . . . . . . . . . . . 3.5 t -131.19 94.69 3.62 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 174.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 19.4 m -71.06 80.34 0.67 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.774 0.83 . . . . 0.0 109.697 178.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 42.7 m . . . . . 0 C--O 1.249 1.05 0 C-N-CA 124.518 1.127 . . . . 0.0 108.356 -175.12 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 . . . . . 0 N--CA 1.481 1.102 0 CA-C-O 120.718 0.294 . . . . 0.0 110.412 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -166.55 63.62 0.21 Allowed Glycine 0 C--N 1.343 0.967 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 -178.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -114.43 97.61 6.41 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.417 1.087 . . . . 0.0 110.397 -175.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -87.31 66.21 9.07 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 175.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -73.42 -32.05 64.19 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.314 175.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -99.3 114.5 27.39 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 166.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 31.8 m -75.63 148.73 7.21 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 122.906 0.482 . . . . 0.0 110.938 -178.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 5.7 p -154.55 126.38 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 123.257 0.623 . . . . 0.0 110.214 -175.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 14.6 tp -128.97 29.86 5.14 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 121.768 0.794 . . . . 0.0 109.352 178.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 3.5 p -142.83 123.27 10.43 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 124.425 1.09 . . . . 0.0 108.837 178.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 61.28 26.0 15.9 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 124.199 0.999 . . . . 0.0 112.573 178.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -133.12 109.1 0.8 Allowed Glycine 0 C--N 1.349 1.257 0 CA-C-O 119.059 -0.856 . . . . 0.0 111.697 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -87.41 11.07 3.31 Favored 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 123.138 2.559 . . . . 0.0 112.229 177.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 31.4 p -69.95 141.43 53.05 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 123.925 0.89 . . . . 0.0 110.691 178.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 85.2 mt -114.67 99.56 51.87 Favored Pre-proline 0 C--O 1.244 0.79 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 175.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -48.71 -35.27 29.71 Favored 'Trans proline' 0 C--N 1.381 2.276 0 C-N-CA 123.304 2.669 . . . . 0.0 111.823 170.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -73.3 92.04 1.76 Allowed 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 114.534 -1.212 . . . . 0.0 108.591 172.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 54.5 m -100.63 127.13 33.4 Favored Pre-proline 0 CA--C 1.547 0.859 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -70.4 111.74 3.02 Favored 'Trans proline' 0 C--N 1.377 2.069 0 C-N-CA 122.207 1.938 . . . . 0.0 110.712 175.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 24.8 ptt-85 -58.69 142.14 50.63 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.258 1.023 . . . . 0.0 112.147 -175.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . 0.434 HD22 HH11 ' A' ' 281' ' ' ARG . 0.9 OUTLIER -126.6 136.12 52.11 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.948 0.899 . . . . 0.0 109.165 -175.298 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -113.41 142.56 27.75 Favored Pre-proline 0 N--CA 1.481 1.092 0 C-N-CA 123.053 0.541 . . . . 0.0 109.841 176.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 266' ' ' PRO . . . . . 0.416 ' O ' ' HA ' ' A' ' 326' ' ' VAL . 23.5 Cg_exo -63.3 100.43 0.26 Allowed 'Trans proline' 0 C--N 1.379 2.162 0 C-N-CA 122.914 2.409 . . . . 0.0 112.362 175.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 267' ' ' LEU . . . . . 0.47 HD22 HD23 ' A' ' 280' ' ' LEU . 0.4 OUTLIER -71.23 122.41 20.17 Favored 'General case' 0 CA--C 1.551 0.99 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 173.583 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.591 ' HG2' HG12 ' A' ' 329' ' ' ILE . 13.8 tppt? -85.52 119.97 26.46 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.528 0.731 . . . . 0.0 110.081 179.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 16.4 mt -121.18 138.56 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 124.539 1.136 . . . . 0.0 109.032 179.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 270' ' ' ARG . . . . . 0.412 ' HB2' HG21 ' A' ' 329' ' ' ILE . 29.7 ttp180 -107.82 103.88 13.24 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 123.715 0.806 . . . . 0.0 109.443 177.229 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 271' ' ' CYS . . . . . 0.739 ' SG ' HD23 ' A' ' 297' ' ' LEU . 49.8 t -77.93 179.53 6.68 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 124.482 1.113 . . . . 0.0 110.616 176.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 272' ' ' ARG . . . . . 0.42 ' N ' ' SG ' ' A' ' 271' ' ' CYS . 26.8 ptt180 -54.22 -31.87 54.31 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 125.414 1.486 . . . . 0.0 113.192 -179.149 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -162.82 33.83 0.1 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.981 0.913 . . . . 0.0 110.362 -178.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -157.97 158.05 34.2 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.353 0.661 . . . . 0.0 110.097 -170.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -117.78 123.21 45.43 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.055 0.942 . . . . 0.0 108.881 173.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 276' ' ' VAL . . . . . 0.529 HG23 ' SD ' ' A' ' 293' ' ' MET . 91.8 t -109.73 121.87 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 124.096 0.958 . . . . 0.0 109.818 178.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . 0.539 ' HD3' ' HZ2' ' A' ' 268' ' ' LYS . 20.7 mtm180 -111.51 122.17 47.13 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 169.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . 0.473 HD12 HG12 ' A' ' 289' ' ' VAL . 4.6 pp -131.43 138.78 33.51 Favored Pre-proline 0 N--CA 1.476 0.85 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 175.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.89 94.22 0.87 Allowed 'Trans proline' 0 C--N 1.367 1.511 0 C-N-CA 122.326 2.017 . . . . 0.0 111.312 -177.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.64 HD21 ' HG3' ' A' ' 319' ' ' PRO . 2.8 tt -103.11 156.95 17.33 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.629 1.172 . . . . 0.0 110.287 -178.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . 0.434 HH11 HD22 ' A' ' 264' ' ' LEU . 0.1 OUTLIER -99.43 144.79 28.13 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.177 0.991 . . . . 0.0 110.087 -179.55 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 282' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -58.07 -34.18 69.85 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 123.918 0.887 . . . . 0.0 112.372 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 16.1 m -78.57 -22.45 47.12 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.77 0.828 . . . . 0.0 111.78 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 284' ' ' GLU . . . . . 0.411 ' HB2' ' HB2' ' A' ' 281' ' ' ARG . 8.2 tp10 -75.22 130.77 79.54 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 124.084 0.953 . . . . 0.0 109.647 -176.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -68.48 169.83 16.3 Favored 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 122.229 1.953 . . . . 0.0 112.209 174.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 87.4 mt -71.01 -6.63 40.43 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.073 0.549 . . . . 0.0 111.688 -179.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 26.5 tp60 -57.06 -26.1 59.8 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.617 0.767 . . . . 0.0 110.526 173.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 40.6 t -61.46 -55.9 26.16 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.591 1.156 . . . . 0.0 111.423 172.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.473 HG12 HD12 ' A' ' 278' ' ' LEU . 21.0 m -67.62 -32.5 57.16 Favored 'Isoleucine or valine' 0 C--N 1.359 1.021 0 CA-C-N 116.695 -0.229 . . . . 0.0 110.429 -179.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . 0.526 HG12 ' HB ' ' A' ' 304' ' ' ILE . 40.0 t -59.53 -48.02 88.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 124.576 1.15 . . . . 0.0 110.842 176.32 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -59.81 -48.08 83.11 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 124.243 0.964 . . . . 0.0 110.973 -179.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 13.9 t60 -65.64 -46.29 79.76 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.99 -178.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 293' ' ' MET . . . . . 0.529 ' SD ' HG23 ' A' ' 276' ' ' VAL . 89.5 mmm -67.56 -34.53 77.25 Favored 'General case' 0 N--CA 1.484 1.242 0 O-C-N 123.652 0.595 . . . . 0.0 111.418 -176.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -64.3 -42.25 96.45 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 123.733 0.646 . . . . 0.0 110.178 175.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 37.0 m -74.16 -23.86 59.31 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 123.754 0.822 . . . . 0.0 111.169 178.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 77.3 t60 -82.69 -27.39 31.27 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.267 0.627 . . . . 0.0 111.151 -178.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 297' ' ' LEU . . . . . 0.739 HD23 ' SG ' ' A' ' 271' ' ' CYS . 87.8 mt -110.44 -7.33 14.78 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.59 0.756 . . . . 0.0 111.966 -176.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 71.66 30.74 65.94 Favored Glycine 0 C--N 1.342 0.894 0 O-C-N 123.315 0.384 . . . . 0.0 112.763 178.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 299' ' ' VAL . . . . . 0.451 HG11 HG13 ' A' ' 334' ' ' VAL . 33.0 m -115.29 -177.95 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.234 1.014 . . . . 0.0 110.232 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 300' ' ' SER . . . . . 0.512 ' HB2' ' HG3' ' A' ' 303' ' ' ARG . 45.1 m -85.3 146.53 45.09 Favored Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 123.37 0.668 . . . . 0.0 110.969 178.047 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -56.65 -30.59 84.21 Favored 'Trans proline' 0 C--N 1.386 2.506 0 C-N-CA 123.036 2.491 . . . . 0.0 112.227 169.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 32.1 t -74.95 -2.42 27.02 Favored 'General case' 0 CA--C 1.556 1.195 0 C-N-CA 123.323 0.649 . . . . 0.0 111.629 -178.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 303' ' ' ARG . . . . . 0.512 ' HG3' ' HB2' ' A' ' 300' ' ' SER . 60.4 mtt-85 -101.47 -27.01 13.37 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.849 0.859 . . . . 0.0 111.645 177.371 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 304' ' ' ILE . . . . . 0.526 ' HB ' HG12 ' A' ' 290' ' ' VAL . 33.5 mm -74.26 112.52 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 C-N-CA 122.938 0.495 . . . . 0.0 110.868 -174.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 48.3 tp -114.61 117.04 29.75 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.891 0.876 . . . . 0.0 109.331 176.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -86.86 127.81 35.04 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 177.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 72.8 mt -132.31 108.15 9.02 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 177.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . 0.5 ' HB2' HG23 ' A' ' 330' ' ' ILE . 39.6 t80 -75.55 92.19 2.89 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -176.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 71.56 -78.39 0.59 Allowed Glycine 0 C--N 1.348 1.239 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.065 -177.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -130.52 -12.08 3.93 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.825 0.85 . . . . 0.0 111.79 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 5.1 t -90.91 147.31 23.22 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 118.353 0.524 . . . . 0.0 110.95 -172.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -87.02 121.07 28.98 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.391 0.676 . . . . 0.0 110.534 -174.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . 0.53 HD22 HD21 ' A' ' 322' ' ' LEU . 24.7 mt -114.5 168.75 9.59 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.073 0.549 . . . . 0.0 109.535 175.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 45.6 m -126.89 152.87 75.95 Favored Pre-proline 0 N--CA 1.48 1.066 0 C-N-CA 123.317 0.647 . . . . 0.0 109.879 177.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . 0.468 ' HB3' HG23 ' A' ' 290' ' ' VAL . 34.9 Cg_exo -58.24 -33.28 97.43 Favored 'Trans proline' 0 C--N 1.382 2.31 0 C-N-CA 122.916 2.411 . . . . 0.0 111.502 170.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 53.9 p -81.63 -0.79 44.1 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 114.643 -1.162 . . . . 0.0 112.369 -177.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -96.99 149.08 22.32 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.655 0.782 . . . . 0.0 110.755 179.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 318' ' ' THR . . . . . . . . . . . . . 28.2 p -102.39 139.94 20.68 Favored Pre-proline 0 N--CA 1.48 1.068 0 C-N-CA 123.87 0.868 . . . . 0.0 110.257 -177.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . 0.64 ' HG3' HD21 ' A' ' 280' ' ' LEU . 72.3 Cg_endo -66.12 -14.68 45.47 Favored 'Trans proline' 0 C--N 1.371 1.731 0 C-N-CA 123.753 2.969 . . . . 0.0 113.363 -173.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 22.5 ttt180 -63.37 -56.29 17.54 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.537 0.735 . . . . 0.0 110.592 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 10.0 t -70.83 -27.93 64.23 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.337 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 322' ' ' LEU . . . . . 0.53 HD21 HD22 ' A' ' 313' ' ' LEU . 43.9 mt -80.44 -10.01 59.75 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.531 0.732 . . . . 0.0 111.093 178.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp 68.49 24.3 7.13 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 125.31 1.444 . . . . 0.0 112.148 175.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . 0.444 ' HG ' ' HB2' ' A' ' 322' ' ' LEU . 23.7 mt -75.29 156.91 35.13 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.752 0.821 . . . . 0.0 110.681 178.046 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 325' ' ' GLY . . . . . 0.429 ' H ' ' HB2' ' A' ' 328' ' ' ASP . . . -163.04 -151.97 6.62 Favored Glycine 0 C--O 1.243 0.705 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.348 -175.146 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 266' ' ' PRO . 34.0 m -76.73 -33.05 21.19 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 C-N-CA 123.08 0.552 . . . . 0.0 111.325 -178.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -94.77 -20.06 19.82 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.595 0.758 . . . . 0.0 111.629 -176.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 328' ' ' ASP . . . . . 0.429 ' HB2' ' H ' ' A' ' 325' ' ' GLY . 7.7 m-20 -78.02 120.68 23.21 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 122.922 0.489 . . . . 0.0 109.927 -177.177 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . 0.591 HG12 ' HG2' ' A' ' 268' ' ' LYS . 8.7 mt -105.19 111.23 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 123.84 0.856 . . . . 0.0 110.623 -169.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 330' ' ' ILE . . . . . 0.5 HG23 ' HB2' ' A' ' 308' ' ' PHE . 45.5 pt -102.56 124.21 56.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 CA-C-O 121.22 0.533 . . . . 0.0 111.135 -179.02 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -73.34 115.89 13.25 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.673 0.789 . . . . 0.0 111.035 -178.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 332' ' ' CYS . . . . . 0.462 ' SG ' HD13 ' A' ' 304' ' ' ILE . 39.5 t -78.11 95.03 4.8 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 170.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 59.4 t -102.02 109.91 27.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 123.452 0.701 . . . . 0.0 109.111 -177.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 334' ' ' VAL . . . . . 0.472 HG22 HD12 ' A' ' 304' ' ' ILE . 47.5 t -83.8 99.32 6.2 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 C-N-CA 123.26 0.624 . . . . 0.0 110.052 -178.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 85.8 mt -101.38 -172.38 2.15 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.967 0.907 . . . . 0.0 110.225 175.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 336' ' ' THR . . . . . . . . . . . . . 25.9 m -124.66 59.38 1.2 Allowed 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 174.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 11.9 p -67.83 108.56 3.03 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 114.316 -1.311 . . . . 0.0 110.193 -178.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 15.6 m . . . . . 0 C--O 1.254 1.316 0 C-N-CA 124.221 1.009 . . . . 0.0 109.3 -175.883 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 . . . . . 0 N--CA 1.474 0.726 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -88.81 -26.08 27.94 Favored Glycine 0 C--N 1.349 1.267 0 CA-C-O 119.551 -0.583 . . . . 0.0 113.245 179.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 63.95 -79.79 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 125.225 1.41 . . . . 0.0 110.98 -175.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 56.12 35.02 24.92 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.555 1.142 . . . . 0.0 111.093 -176.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -133.22 70.63 1.46 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 -179.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.82 36.84 4.39 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 114.389 -1.278 . . . . 0.0 110.392 -176.194 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 59.4 t -64.89 140.61 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 CA-C-N 114.717 -1.128 . . . . 0.0 109.638 175.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 45.7 t -72.71 81.15 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 CA-C-O 121.9 0.857 . . . . 0.0 109.996 -179.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 27.8 tp -159.95 16.25 0.14 Allowed 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 125.833 1.653 . . . . 0.0 107.313 170.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 7.3 p -72.55 133.12 32.39 Favored 'Isoleucine or valine' 0 C--N 1.354 0.773 0 C-N-CA 123.846 0.858 . . . . 0.0 110.618 -171.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -162.32 103.02 1.09 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.936 0.894 . . . . 0.0 108.738 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 135.94 -73.06 0.45 Allowed Glycine 0 CA--C 1.535 1.305 0 CA-C-O 118.987 -0.896 . . . . 0.0 112.998 -178.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -59.74 -67.46 0.05 OUTLIER 'Trans proline' 0 C--N 1.382 2.301 0 C-N-CA 123.28 2.653 . . . . 0.0 113.4 -175.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 23.8 p -145.37 132.89 20.82 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.233 1.013 . . . . 0.0 109.126 -177.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 87.9 mt -114.97 79.58 6.17 Favored Pre-proline 0 N--CA 1.481 1.103 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 171.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.66 -32.19 24.55 Favored 'Trans proline' 0 C--N 1.383 2.365 0 C-N-CA 122.666 2.244 . . . . 0.0 112.202 -173.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -138.14 107.44 6.1 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.409 1.083 . . . . 0.0 109.648 177.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 19.4 p -94.22 167.44 13.47 Favored Pre-proline 0 CA--C 1.556 1.176 0 C-N-CA 124.483 1.113 . . . . 0.0 109.943 172.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -45.1 117.42 1.59 Allowed 'Trans proline' 0 C--N 1.392 2.868 0 C-N-CA 123.155 2.57 . . . . 0.0 111.11 170.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 19.2 mtp180 -56.54 124.78 19.41 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 124.587 1.179 . . . . 0.0 111.871 -165.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . 0.498 ' HG ' ' HG3' ' A' ' 281' ' ' ARG . 3.3 mp -96.4 149.26 21.92 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.707 -170.256 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 265' ' ' PHE . . . . . 0.454 ' CE1' ' HG2' ' A' ' 282' ' ' MET . 15.2 p90 -125.34 143.83 45.76 Favored Pre-proline 0 CA--C 1.549 0.92 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 172.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -62.93 96.61 0.17 Allowed 'Trans proline' 0 C--N 1.373 1.852 0 C-N-CA 122.564 2.176 . . . . 0.0 112.01 174.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.37 120.14 12.8 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 170.099 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.507 ' HE3' HG12 ' A' ' 329' ' ' ILE . 25.5 ttpt -93.95 111.61 23.34 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 121.464 0.65 . . . . 0.0 110.008 -177.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 4.3 mp -106.75 130.33 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.31 1.044 . . . . 0.0 108.872 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 23.1 ttm180 -84.5 101.01 11.74 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.196 0.522 . . . . 0.0 109.916 173.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 271' ' ' CYS . . . . . 0.571 ' SG ' HD21 ' A' ' 297' ' ' LEU . 52.5 t -69.5 175.56 4.0 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.971 169.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 272' ' ' ARG . . . . . 0.452 ' HG2' ' SG ' ' A' ' 271' ' ' CYS . 7.5 ptm180 -53.29 -25.95 16.65 Favored 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 124.862 1.265 . . . . 0.0 113.344 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -163.45 37.24 0.09 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.268 0.627 . . . . 0.0 111.205 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -165.27 162.65 19.94 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 122.838 0.455 . . . . 0.0 111.4 -175.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.432 HD11 ' HD2' ' A' ' 268' ' ' LYS . 86.5 mt -114.55 104.15 11.72 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.437 1.095 . . . . 0.0 109.662 172.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 79.5 t -86.47 110.29 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 174.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 20.6 mtm180 -103.95 84.13 2.21 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . 0.471 HD22 ' HA ' ' A' ' 289' ' ' VAL . 4.4 pp -94.68 147.58 33.42 Favored Pre-proline 0 N--CA 1.486 1.367 0 CA-C-O 119.296 -0.383 . . . . 0.0 110.797 -174.386 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.01 120.75 6.5 Favored 'Trans proline' 0 C--N 1.378 2.105 0 C-N-CA 122.35 2.033 . . . . 0.0 111.008 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.69 HD23 ' HG3' ' A' ' 319' ' ' PRO . 1.0 OUTLIER -139.72 151.19 45.66 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.488 1.115 . . . . 0.0 109.265 -175.98 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . 0.498 ' HG3' ' HG ' ' A' ' 264' ' ' LEU . 0.0 OUTLIER -97.15 149.36 22.08 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.534 -0.914 . . . . 0.0 108.534 -177.386 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 282' ' ' MET . . . . . 0.515 ' HA ' ' HG2' ' A' ' 319' ' ' PRO . 14.4 mtp -70.88 -20.15 62.55 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 118.448 0.567 . . . . 0.0 111.378 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 20.6 t -92.6 5.03 52.43 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 123.696 0.799 . . . . 0.0 111.081 176.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -99.25 133.47 22.03 Favored Pre-proline 0 N--CA 1.478 0.96 0 C-N-CA 124.178 0.991 . . . . 0.0 109.027 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.32 164.38 23.2 Favored 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 122.154 1.903 . . . . 0.0 111.941 171.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 67.9 mt -65.64 -12.03 49.85 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 118.861 -0.59 . . . . 0.0 112.204 -178.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 287' ' ' GLN . . . . . 0.418 ' HA ' ' HB ' ' A' ' 290' ' ' VAL . 25.5 tp60 -55.0 -23.42 19.27 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 122.94 0.496 . . . . 0.0 111.945 177.126 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 288' ' ' SER . . . . . 0.57 ' HB3' HD11 ' A' ' 280' ' ' LEU . 43.7 t -59.4 -54.19 49.52 Favored 'General case' 0 CA--C 1.557 1.249 0 C-N-CA 123.464 0.706 . . . . 0.0 111.47 169.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.471 ' HA ' HD22 ' A' ' 278' ' ' LEU . 20.6 m -70.42 -36.15 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 C-N-CA 122.026 0.131 . . . . 0.0 110.862 179.246 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . 0.551 HG13 ' HB ' ' A' ' 304' ' ' ILE . 74.3 t -61.82 -45.29 99.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.184 0.994 . . . . 0.0 110.853 -178.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -64.08 -51.26 64.91 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 124.046 0.842 . . . . 0.0 110.975 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 47.8 t60 -63.99 -42.55 97.17 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 123.784 0.678 . . . . 0.0 111.097 -176.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 95.4 mmm -67.32 -35.62 79.8 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.218 0.607 . . . . 0.0 110.766 178.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -65.78 -43.78 87.78 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.148 0.579 . . . . 0.0 110.923 176.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 31.9 m -68.36 -34.51 76.2 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.581 0.753 . . . . 0.0 111.068 178.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 23.3 t60 -69.97 -49.87 47.45 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.677 0.791 . . . . 0.0 110.2 -179.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 297' ' ' LEU . . . . . 0.571 HD21 ' SG ' ' A' ' 271' ' ' CYS . 55.9 mt -84.49 -11.66 55.71 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.017 0.927 . . . . 0.0 111.737 -175.159 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 72.04 37.91 59.99 Favored Glycine 0 C--N 1.351 1.362 0 O-C-N 123.273 0.358 . . . . 0.0 112.757 178.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 299' ' ' VAL . . . . . 0.49 HG11 HG11 ' A' ' 334' ' ' VAL . 34.8 m -123.42 177.9 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.326 1.051 . . . . 0.0 110.145 178.292 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 300' ' ' SER . . . . . 0.485 ' HB2' ' HG3' ' A' ' 303' ' ' ARG . 46.9 m -79.03 147.88 70.69 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 123.431 0.692 . . . . 0.0 110.556 175.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -57.68 -27.29 76.87 Favored 'Trans proline' 0 C--N 1.385 2.46 0 C-N-CA 123.068 2.512 . . . . 0.0 112.336 172.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 57.3 p -68.42 -18.52 64.46 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.768 0.827 . . . . 0.0 111.922 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 303' ' ' ARG . . . . . 0.485 ' HG3' ' HB2' ' A' ' 300' ' ' SER . 97.1 mtt180 -89.21 -28.05 20.23 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.69 0.796 . . . . 0.0 111.707 -178.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 304' ' ' ILE . . . . . 0.551 ' HB ' HG13 ' A' ' 290' ' ' VAL . 40.3 mm -72.95 117.72 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 123.06 0.544 . . . . 0.0 109.737 -179.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 31.4 tp -125.16 114.73 19.4 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 177.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -83.91 121.67 27.67 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -178.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . 0.467 HD13 HG23 ' A' ' 333' ' ' VAL . 76.7 mt -129.54 116.46 18.96 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.298 1.039 . . . . 0.0 109.082 -176.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -91.82 96.66 10.53 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 174.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 74.36 -82.98 0.77 Allowed Glycine 0 C--N 1.345 1.045 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.872 177.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -132.05 -6.19 3.49 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.296 0.638 . . . . 0.0 111.458 -179.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 6.2 t -91.98 147.2 23.14 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 122.538 0.335 . . . . 0.0 110.344 -179.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -98.84 131.05 45.25 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.066 0.546 . . . . 0.0 109.757 178.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . 0.509 HD21 HD23 ' A' ' 322' ' ' LEU . 44.9 mt -113.53 130.76 56.28 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.3 0.64 . . . . 0.0 109.63 -179.115 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 37.4 m -76.24 142.33 71.61 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 123.153 0.581 . . . . 0.0 111.314 178.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . 0.48 ' HB3' HG21 ' A' ' 290' ' ' VAL . 35.3 Cg_endo -62.5 -23.26 74.83 Favored 'Trans proline' 0 C--N 1.38 2.217 0 C-N-CA 123.041 2.494 . . . . 0.0 112.436 173.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 52.3 p -80.78 -22.83 39.76 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.035 0.934 . . . . 0.0 111.573 178.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -71.6 154.74 41.21 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.289 0.636 . . . . 0.0 111.477 -178.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 318' ' ' THR . . . . . . . . . . . . . 74.2 p -105.74 149.41 37.91 Favored Pre-proline 0 N--CA 1.477 0.89 0 C-N-CA 123.998 0.919 . . . . 0.0 109.884 -176.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . 0.69 ' HG3' HD23 ' A' ' 280' ' ' LEU . 85.6 Cg_endo -68.66 -11.38 31.74 Favored 'Trans proline' 0 C--N 1.372 1.789 0 C-N-CA 123.263 2.642 . . . . 0.0 112.871 -178.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 38.5 ttt180 -69.01 -56.37 7.99 Favored 'General case' 0 C--N 1.347 0.488 0 C-N-CA 123.138 0.575 . . . . 0.0 109.6 177.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 15.1 t -71.01 -24.31 62.35 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.259 -178.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 322' ' ' LEU . . . . . 0.509 HD23 HD21 ' A' ' 313' ' ' LEU . 69.8 mt -86.01 -15.75 40.44 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.24 0.616 . . . . 0.0 111.31 175.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 44.4 tptt 68.05 27.89 6.87 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 125.251 1.42 . . . . 0.0 111.804 177.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . 0.434 ' HG ' ' HB2' ' A' ' 322' ' ' LEU . 29.0 mt -68.29 159.18 31.83 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.483 0.713 . . . . 0.0 110.59 178.264 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 325' ' ' GLY . . . . . 0.403 ' H ' ' HB3' ' A' ' 328' ' ' ASP . . . -160.8 -178.15 34.53 Favored Glycine 0 C--N 1.341 0.846 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.429 -172.104 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 34.2 m -70.81 -20.06 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 123.943 0.897 . . . . 0.0 111.909 179.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -97.51 -15.76 20.41 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.001 0.92 . . . . 0.0 111.274 176.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 328' ' ' ASP . . . . . 0.403 ' HB3' ' H ' ' A' ' 325' ' ' GLY . 15.4 t70 -83.35 143.38 30.38 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.113 0.565 . . . . 0.0 109.671 -177.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . 0.507 HG12 ' HE3' ' A' ' 268' ' ' LYS . 6.2 mt -130.0 120.6 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 122.72 0.408 . . . . 0.0 110.402 -178.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 30.1 pt -113.55 131.87 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 123.42 0.688 . . . . 0.0 110.595 178.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -77.35 118.68 20.05 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.729 0.812 . . . . 0.0 111.792 -172.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 332' ' ' CYS . . . . . 0.544 ' SG ' HD11 ' A' ' 304' ' ' ILE . 40.5 t -80.03 94.58 5.96 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.947 0.899 . . . . 0.0 109.999 171.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . 0.467 HG23 HD13 ' A' ' 307' ' ' LEU . 90.9 t -97.36 112.54 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 123.213 0.605 . . . . 0.0 109.594 178.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 334' ' ' VAL . . . . . 0.49 HG11 HG11 ' A' ' 299' ' ' VAL . 83.9 t -82.85 125.24 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 175.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 1.2 pp -148.34 173.43 13.06 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.261 1.025 . . . . 0.0 110.564 -177.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 336' ' ' THR . . . . . . . . . . . . . 76.0 m -104.54 -60.62 1.57 Allowed 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.142 0.577 . . . . 0.0 110.204 177.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 36.7 m 65.33 -73.08 0.06 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 125.769 1.628 . . . . 0.0 112.213 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 19.9 m . . . . . 0 CA--C 1.558 1.283 0 C-N-CA 125.259 1.423 . . . . 0.0 110.934 179.289 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 24.2 mp0 . . . . . 0 N--CA 1.482 1.138 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 156.48 145.99 4.35 Favored Glycine 0 C--N 1.346 1.113 0 O-C-N 123.562 0.539 . . . . 0.0 112.686 173.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -141.28 89.67 2.25 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 172.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -99.21 18.15 18.24 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 123.654 0.782 . . . . 0.0 109.6 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -75.69 83.19 2.68 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 124.327 1.051 . . . . 0.0 110.082 -178.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -89.5 49.71 1.79 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.469 1.108 . . . . 0.0 110.011 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 31.3 m -87.77 153.28 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.02 0.928 . . . . 0.0 110.879 -176.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 17.8 m -70.54 -14.8 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 C-N-CA 122.431 0.292 . . . . 0.0 111.206 179.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 55.2 tp -78.96 90.98 4.78 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.749 0.82 . . . . 0.0 108.973 171.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 4.1 p -88.73 102.14 12.58 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 172.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -103.02 147.02 27.48 Favored 'General case' 0 C--O 1.242 0.658 0 C-N-CA 123.384 0.673 . . . . 0.0 110.236 -176.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 127.15 72.41 0.18 Allowed Glycine 0 CA--C 1.528 0.871 0 CA-C-O 119.17 -0.794 . . . . 0.0 111.818 178.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -68.64 141.32 49.7 Favored 'Trans proline' 0 C--N 1.383 2.357 0 C-N-CA 123.543 2.829 . . . . 0.0 110.835 178.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 47.8 m 69.75 162.0 0.22 Allowed 'General case' 0 CA--C 1.563 1.449 0 C-N-CA 124.7 1.2 . . . . 0.0 110.609 -175.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 61.2 mt -113.74 79.0 4.18 Favored Pre-proline 0 CA--C 1.553 1.074 0 O-C-N 121.481 -0.762 . . . . 0.0 109.293 171.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -72.69 -41.94 1.37 Allowed 'Trans proline' 0 C--N 1.383 2.353 0 C-N-CA 122.398 2.066 . . . . 0.0 110.88 177.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -103.11 96.58 6.88 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.901 1.28 . . . . 0.0 108.049 170.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 65.5 m -57.59 135.65 82.36 Favored Pre-proline 0 CA--C 1.554 1.111 0 CA-C-O 117.951 -1.023 . . . . 0.0 109.987 173.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -42.07 115.77 0.51 Allowed 'Trans proline' 0 C--N 1.399 3.192 0 C-N-CA 123.993 3.128 . . . . 0.0 111.402 178.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 64.8 ttt180 -57.65 104.96 0.21 Allowed 'General case' 0 C--N 1.354 0.785 0 O-C-N 124.171 0.919 . . . . 0.0 112.868 -162.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 3.6 mp -76.89 167.82 21.16 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.49 176.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 265' ' ' PHE . . . . . 0.406 ' CE1' ' HG2' ' A' ' 282' ' ' MET . 34.8 p90 -138.39 144.58 43.36 Favored Pre-proline 0 N--CA 1.478 0.934 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 177.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.09 88.34 0.08 OUTLIER 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 123.25 2.633 . . . . 0.0 113.325 175.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -67.48 121.76 16.51 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 171.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.449 ' HE3' HG12 ' A' ' 329' ' ' ILE . 23.4 ttpt -97.32 122.76 40.72 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 121.37 0.605 . . . . 0.0 110.769 -178.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . 0.451 HG21 ' HG3' ' A' ' 293' ' ' MET . 2.1 mp -119.36 130.99 73.26 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 C-N-CA 124.943 1.297 . . . . 0.0 108.163 -178.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 25.5 ttp180 -94.92 107.41 19.45 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 122.989 0.516 . . . . 0.0 110.447 177.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 271' ' ' CYS . . . . . 0.777 ' SG ' HD21 ' A' ' 297' ' ' LEU . 37.7 t -70.42 -176.54 1.25 Allowed 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.147 0.979 . . . . 0.0 110.065 168.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 21.3 ptt180 -59.78 -30.6 68.99 Favored 'General case' 0 CA--C 1.557 1.23 0 C-N-CA 123.455 0.702 . . . . 0.0 112.077 179.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -159.42 35.03 0.2 Allowed 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.409 0.684 . . . . 0.0 111.37 -178.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -156.02 151.73 27.23 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 122.766 0.426 . . . . 0.0 110.519 -176.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -116.37 114.76 24.73 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.137 0.975 . . . . 0.0 109.109 174.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 95.6 t -99.85 129.48 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.086 0.955 . . . . 0.0 108.883 173.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 90.7 mtm180 -119.47 86.17 2.51 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 176.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 4.3 pp -96.72 141.03 22.49 Favored Pre-proline 0 N--CA 1.478 0.941 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -176.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.62 120.49 7.42 Favored 'Trans proline' 0 C--N 1.371 1.718 0 C-N-CA 122.407 2.071 . . . . 0.0 110.841 173.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.641 HD23 ' HG3' ' A' ' 319' ' ' PRO . 0.0 OUTLIER -135.39 155.42 50.6 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.31 1.044 . . . . 0.0 110.001 -178.329 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -93.23 143.16 26.53 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.514 1.126 . . . . 0.0 109.641 177.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 282' ' ' MET . . . . . 0.525 ' HE3' ' HA ' ' A' ' 320' ' ' ARG . 35.0 mtp -67.99 -25.2 65.29 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 118.354 0.524 . . . . 0.0 110.095 176.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 10.3 p -74.64 -34.72 62.81 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.004 1.321 . . . . 0.0 111.592 176.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -70.02 125.49 92.01 Favored Pre-proline 0 N--CA 1.473 0.715 0 C-N-CA 124.121 0.969 . . . . 0.0 108.764 173.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . 0.466 ' HA ' ' HA ' ' A' ' 318' ' ' THR . 44.8 Cg_endo -63.58 176.81 2.0 Favored 'Trans proline' 0 C--N 1.381 2.263 0 C-N-CA 122.598 2.199 . . . . 0.0 112.439 174.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.409 ' O ' HG21 ' A' ' 290' ' ' VAL . 86.5 mt -65.26 -17.01 64.16 Favored 'General case' 0 C--O 1.22 -0.483 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.773 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 24.7 tp60 -48.89 -27.63 3.21 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.905 0.882 . . . . 0.0 112.657 178.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 288' ' ' SER . . . . . 0.464 ' HB3' HD13 ' A' ' 280' ' ' LEU . 43.2 t -57.4 -62.13 1.99 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.553 1.141 . . . . 0.0 111.205 170.221 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.427 ' HB ' HG12 ' A' ' 269' ' ' ILE . 15.9 m -69.19 -26.84 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 123.149 0.58 . . . . 0.0 110.784 -176.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . 0.531 HG13 ' HB ' ' A' ' 304' ' ' ILE . 77.1 t -62.62 -52.16 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 123.802 0.841 . . . . 0.0 110.223 176.394 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -67.24 -39.6 86.21 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.378 0.671 . . . . 0.0 110.882 -178.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 23.3 t60 -67.5 -45.58 75.41 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 123.443 0.465 . . . . 0.0 110.833 -176.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 293' ' ' MET . . . . . 0.451 ' HG3' HG21 ' A' ' 269' ' ' ILE . 93.3 mmm -70.06 -30.09 67.26 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.064 0.546 . . . . 0.0 110.818 178.529 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -64.91 -42.72 94.5 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.201 0.6 . . . . 0.0 110.64 173.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 41.3 m -68.71 -34.26 75.34 Favored 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 123.781 0.832 . . . . 0.0 110.62 176.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -70.54 -34.39 72.2 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.185 0.994 . . . . 0.0 111.3 -178.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 297' ' ' LEU . . . . . 0.777 HD21 ' SG ' ' A' ' 271' ' ' CYS . 36.8 mt -100.73 -7.19 24.01 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.116 0.966 . . . . 0.0 111.501 -179.124 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 77.2 6.06 85.88 Favored Glycine 0 N--CA 1.474 1.194 0 C-N-CA 123.412 0.53 . . . . 0.0 113.784 178.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 32.3 m -94.88 -176.82 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 124.139 0.975 . . . . 0.0 111.053 -177.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 19.8 m -87.28 147.34 42.07 Favored Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 123.238 0.615 . . . . 0.0 110.159 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -55.08 -29.67 66.59 Favored 'Trans proline' 0 C--N 1.387 2.559 0 C-N-CA 122.946 2.431 . . . . 0.0 112.459 170.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 20.3 m -62.57 -26.92 68.84 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 122.941 0.496 . . . . 0.0 111.478 178.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 58.3 mtt180 -88.0 -20.13 26.25 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.301 1.04 . . . . 0.0 112.416 -175.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 304' ' ' ILE . . . . . 0.575 HD12 ' SG ' ' A' ' 332' ' ' CYS . 41.7 mm -82.64 125.65 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 122.811 0.444 . . . . 0.0 110.996 -177.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 48.6 tp -127.98 121.69 30.45 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.101 0.96 . . . . 0.0 108.94 176.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -88.48 134.54 33.82 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . 0.404 HD12 HG23 ' A' ' 333' ' ' VAL . 76.1 mt -136.48 103.97 5.43 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.86 0.864 . . . . 0.0 109.257 -177.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . 0.449 ' HB2' HD13 ' A' ' 313' ' ' LEU . 82.5 t80 -77.37 92.44 3.94 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -178.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 70.5 -78.52 0.46 Allowed Glycine 0 C--N 1.349 1.275 0 CA-C-N 116.24 -0.436 . . . . 0.0 112.326 -179.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -146.49 54.47 1.13 Allowed 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 123.929 0.892 . . . . 0.0 110.643 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 11.2 t -147.27 150.82 35.56 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 122.815 0.446 . . . . 0.0 110.238 175.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -87.98 119.73 28.63 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.807 0.843 . . . . 0.0 110.119 -179.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . 0.513 HD21 HD21 ' A' ' 322' ' ' LEU . 45.7 mt -117.55 122.3 43.29 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 178.055 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 18.3 m -79.73 150.81 73.24 Favored Pre-proline 0 CA--C 1.55 0.979 0 C-N-CA 123.413 0.685 . . . . 0.0 110.853 178.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . 0.429 ' HB3' HG23 ' A' ' 290' ' ' VAL . 51.2 Cg_exo -56.21 -32.48 87.61 Favored 'Trans proline' 0 C--N 1.382 2.298 0 C-N-CA 122.827 2.351 . . . . 0.0 112.22 170.371 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 77.2 p -75.77 -16.93 60.05 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-N 114.353 -1.294 . . . . 0.0 112.128 -178.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -77.18 144.45 38.33 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.236 0.614 . . . . 0.0 110.334 178.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 318' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 285' ' ' PRO . 25.2 p -99.21 138.38 20.55 Favored Pre-proline 0 N--CA 1.474 0.76 0 C-N-CA 123.568 0.747 . . . . 0.0 109.981 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . 0.641 ' HG3' HD23 ' A' ' 280' ' ' LEU . 18.5 Cg_endo -55.94 -19.82 27.31 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 123.926 3.084 . . . . 0.0 113.974 179.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . 0.525 ' HA ' ' HE3' ' A' ' 282' ' ' MET . 79.4 ttt180 -66.63 -51.01 61.03 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.146 0.578 . . . . 0.0 111.5 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 15.2 t -72.94 -20.16 61.11 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.502 0.321 . . . . 0.0 110.93 -179.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 322' ' ' LEU . . . . . 0.513 HD21 HD21 ' A' ' 313' ' ' LEU . 36.9 mt -85.1 -17.55 37.0 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.362 0.665 . . . . 0.0 110.404 176.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 323' ' ' LYS . . . . . 0.488 ' HA ' ' HE2' ' A' ' 323' ' ' LYS . 0.5 OUTLIER 61.56 58.1 2.14 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.233 1.413 . . . . 0.0 110.466 -178.749 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . 0.454 ' HG ' ' HB2' ' A' ' 322' ' ' LEU . 76.3 mt -95.56 171.27 8.79 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.051 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . -167.87 -171.99 34.42 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.108 -175.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 34.1 m -67.82 -28.93 43.28 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 C-N-CA 123.977 0.911 . . . . 0.0 111.452 177.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -93.54 -15.87 25.02 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.144 0.978 . . . . 0.0 111.387 -178.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -89.78 123.94 34.21 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.176 0.591 . . . . 0.0 109.708 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . 0.449 HG12 ' HE3' ' A' ' 268' ' ' LYS . 19.6 mt -109.41 127.36 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 123.378 0.671 . . . . 0.0 110.183 -175.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 330' ' ' ILE . . . . . 0.414 HG21 ' HB2' ' A' ' 308' ' ' PHE . 30.9 pt -111.56 128.53 68.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 C-N-CA 123.251 0.62 . . . . 0.0 110.346 177.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -76.81 110.43 11.41 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.844 0.858 . . . . 0.0 111.587 -174.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 332' ' ' CYS . . . . . 0.575 ' SG ' HD12 ' A' ' 304' ' ' ILE . 31.8 t -75.69 105.2 6.6 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.788 0.835 . . . . 0.0 110.447 172.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . 0.404 HG23 HD12 ' A' ' 307' ' ' LEU . 88.4 t -111.47 122.03 65.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 123.668 0.787 . . . . 0.0 110.041 -178.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 59.7 t -86.05 98.62 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 123.305 0.642 . . . . 0.0 109.741 178.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 92.8 mt -100.35 137.28 38.98 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 172.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 336' ' ' THR . . . . . . . . . . . . . 40.3 p -72.46 81.43 1.06 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.644 0.777 . . . . 0.0 111.055 -176.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 19.3 m -86.1 142.95 28.32 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.997 0.919 . . . . 0.0 111.015 -177.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 29.0 p . . . . . 0 C--O 1.25 1.12 0 C-N-CA 123.517 0.727 . . . . 0.0 109.422 179.998 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 . . . . . 0 N--CA 1.482 1.136 0 CA-C-O 120.709 0.29 . . . . 0.0 111.224 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -174.47 -124.98 0.82 Allowed Glycine 0 C--N 1.35 1.349 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.528 179.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -76.99 -6.91 54.48 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.232 1.013 . . . . 0.0 111.499 -176.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -69.71 -12.23 61.47 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 123.34 0.656 . . . . 0.0 111.022 174.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -61.45 93.72 0.04 OUTLIER 'General case' 0 C--N 1.36 1.045 0 C-N-CA 123.852 0.861 . . . . 0.0 110.429 178.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -129.25 -170.93 2.37 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 114.272 -1.331 . . . . 0.0 109.396 178.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 35.9 m -59.77 135.04 24.78 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.222 0 C-N-CA 123.497 0.719 . . . . 0.0 111.878 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 44.1 t -80.67 93.97 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -178.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 3.3 pp -95.89 4.62 52.62 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.057 0.943 . . . . 0.0 111.925 -176.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 11.4 p -148.97 144.56 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 123.715 0.806 . . . . 0.0 109.027 -175.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . 0.444 ' HG2' ' HD3' ' A' ' 256' ' ' PRO . 0.5 OUTLIER -118.92 175.19 5.87 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.944 0.897 . . . . 0.0 110.036 175.762 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -129.39 80.45 0.35 Allowed Glycine 0 N--CA 1.468 0.824 0 N-CA-C 111.329 -0.708 . . . . 0.0 111.329 178.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . 0.444 ' HD3' ' HG2' ' A' ' 254' ' ' GLU . 58.4 Cg_endo -68.88 102.15 0.86 Allowed 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 122.68 2.253 . . . . 0.0 111.24 177.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 29.4 p -75.03 86.89 2.34 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.978 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 85.3 mt -121.51 92.51 48.68 Favored Pre-proline 0 N--CA 1.472 0.63 0 C-N-CA 124.755 1.222 . . . . 0.0 109.074 -178.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -72.33 -25.68 18.22 Favored 'Trans proline' 0 C--N 1.37 1.702 0 C-N-CA 122.254 1.969 . . . . 0.0 111.672 173.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -76.36 93.33 3.45 Favored 'General case' 0 C--N 1.352 0.687 0 C-N-CA 124.283 1.033 . . . . 0.0 109.049 177.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 20.9 m -73.48 141.15 79.62 Favored Pre-proline 0 CA--C 1.55 0.98 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.67 176.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . 0.4 ' O ' HD13 ' A' ' 264' ' ' LEU . 25.3 Cg_endo -58.71 168.77 3.86 Favored 'Trans proline' 0 C--N 1.389 2.708 0 C-N-CA 122.411 2.074 . . . . 0.0 112.256 172.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -88.43 92.2 9.09 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-O 121.363 0.601 . . . . 0.0 110.279 -178.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . 0.4 HD13 ' O ' ' A' ' 262' ' ' PRO . 3.7 mp -88.76 152.57 21.7 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 114.668 -1.151 . . . . 0.0 108.699 171.238 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -136.9 150.52 69.99 Favored Pre-proline 0 CA--C 1.549 0.905 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -68.07 90.73 0.38 Allowed 'Trans proline' 0 C--N 1.376 1.983 0 C-N-CA 122.459 2.106 . . . . 0.0 112.029 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.37 113.49 4.68 Favored 'General case' 0 C--N 1.349 0.55 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 169.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.457 ' O ' ' HA ' ' A' ' 329' ' ' ILE . 22.6 ttpt -92.37 111.58 23.21 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.259 0.623 . . . . 0.0 109.883 -176.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 4.7 mp -106.72 129.3 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 123.703 0.801 . . . . 0.0 109.271 179.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 270' ' ' ARG . . . . . 0.421 ' HA ' HD13 ' A' ' 275' ' ' LEU . 39.5 ttp180 -84.57 98.78 10.34 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 122.879 0.471 . . . . 0.0 110.002 175.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 271' ' ' CYS . . . . . 0.727 ' SG ' HD23 ' A' ' 297' ' ' LEU . 41.9 t -69.56 175.6 4.02 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.1 171.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 272' ' ' ARG . . . . . 0.416 ' N ' ' SG ' ' A' ' 271' ' ' CYS . 16.2 ptt180 -54.33 -30.1 50.24 Favored 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 124.299 1.04 . . . . 0.0 112.314 178.433 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -159.76 37.82 0.19 Allowed 'General case' 0 C--N 1.354 0.801 0 C-N-CA 123.794 0.838 . . . . 0.0 110.948 -176.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -166.23 158.79 14.47 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 122.673 0.389 . . . . 0.0 111.128 -175.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.421 HD13 ' HA ' ' A' ' 270' ' ' ARG . 4.2 mm? -115.69 97.39 6.1 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.118 0.967 . . . . 0.0 109.07 173.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 46.3 t -84.99 98.53 6.29 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.595 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 39.6 mtt85 -96.89 79.86 2.96 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -178.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.6 pp -92.15 142.53 26.34 Favored Pre-proline 0 N--CA 1.487 1.386 0 CA-C-O 119.404 -0.331 . . . . 0.0 110.392 -172.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -74.23 109.75 2.95 Favored 'Trans proline' 0 C--N 1.373 1.835 0 C-N-CA 122.223 1.949 . . . . 0.0 110.698 177.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.597 HD21 ' HG3' ' A' ' 319' ' ' PRO . 0.0 OUTLIER -123.46 153.06 41.0 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.342 1.057 . . . . 0.0 109.617 179.018 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . 0.564 ' HB2' ' HB2' ' A' ' 284' ' ' GLU . 31.9 mtp180 -88.38 147.34 24.78 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.932 0.893 . . . . 0.0 110.318 177.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 282' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -62.51 -34.19 76.39 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 122.928 0.491 . . . . 0.0 110.361 173.514 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 23.7 m -67.79 -31.32 71.11 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.203 1.001 . . . . 0.0 111.718 176.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 284' ' ' GLU . . . . . 0.564 ' HB2' ' HB2' ' A' ' 281' ' ' ARG . 6.2 tp10 -73.31 132.21 82.15 Favored Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 124.009 0.923 . . . . 0.0 109.108 -178.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -70.39 178.32 5.08 Favored 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 122.163 1.908 . . . . 0.0 112.28 174.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.403 ' O ' HG23 ' A' ' 290' ' ' VAL . 70.7 mt -67.1 -19.04 65.57 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 118.744 -0.646 . . . . 0.0 111.66 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 27.7 tp60 -53.68 -22.39 8.87 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.282 0.633 . . . . 0.0 112.193 178.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 288' ' ' SER . . . . . 0.515 ' HB3' HD11 ' A' ' 280' ' ' LEU . 24.8 t -64.74 -54.32 33.26 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.413 0.685 . . . . 0.0 110.984 172.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.422 HG11 HD13 ' A' ' 280' ' ' LEU . 17.2 m -70.9 -29.21 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 122.532 0.333 . . . . 0.0 110.753 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . 0.513 HG13 ' HB ' ' A' ' 304' ' ' ILE . 78.1 t -63.83 -49.22 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 123.702 0.801 . . . . 0.0 110.099 176.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -63.89 -46.93 82.64 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.743 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 43.2 t60 -67.15 -41.83 85.4 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.15 -174.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 90.9 mmm -68.09 -30.33 69.48 Favored 'General case' 0 N--CA 1.483 1.201 0 O-C-N 123.401 0.438 . . . . 0.0 111.227 177.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -67.47 -43.45 80.99 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.13 0.572 . . . . 0.0 110.615 175.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 27.7 m -69.43 -29.59 67.34 Favored 'General case' 0 CA--C 1.557 1.216 0 C-N-CA 124.063 0.945 . . . . 0.0 110.837 176.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 77.8 t60 -74.59 -34.63 62.91 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.839 0.856 . . . . 0.0 111.442 -178.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 297' ' ' LEU . . . . . 0.727 HD23 ' SG ' ' A' ' 271' ' ' CYS . 75.5 mt -105.74 -8.26 17.93 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.655 0.782 . . . . 0.0 112.283 -175.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 72.93 31.67 61.8 Favored Glycine 0 C--N 1.347 1.188 0 O-C-N 123.598 0.561 . . . . 0.0 112.55 178.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 299' ' ' VAL . . . . . 0.514 HG13 HG13 ' A' ' 334' ' ' VAL . 33.2 m -117.75 -177.33 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.357 1.063 . . . . 0.0 110.057 179.313 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 300' ' ' SER . . . . . 0.542 ' HB3' ' HG3' ' A' ' 303' ' ' ARG . 32.2 t -82.36 147.02 55.54 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 123.194 0.598 . . . . 0.0 110.18 178.119 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -59.49 -27.97 86.31 Favored 'Trans proline' 0 C--N 1.385 2.453 0 C-N-CA 122.774 2.316 . . . . 0.0 111.124 169.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 22.8 t -67.11 -15.73 63.9 Favored 'General case' 0 CA--C 1.559 1.29 0 C-N-CA 123.454 0.702 . . . . 0.0 111.207 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 303' ' ' ARG . . . . . 0.542 ' HG3' ' HB3' ' A' ' 300' ' ' SER . 59.3 mtt180 -94.59 -26.51 16.35 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.006 0.922 . . . . 0.0 111.63 -178.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 304' ' ' ILE . . . . . 0.54 HD13 ' SG ' ' A' ' 332' ' ' CYS . 37.9 mm -77.02 103.58 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 122.861 0.464 . . . . 0.0 110.865 -175.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 34.8 tp -105.68 123.79 48.51 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 174.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . 0.442 ' HA ' ' O ' ' A' ' 331' ' ' ASP . 3.4 mm? -89.26 128.35 35.84 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 177.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . 0.409 HD22 ' HA ' ' A' ' 312' ' ' GLU . 68.4 mt -134.05 114.8 13.58 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.477 1.111 . . . . 0.0 108.608 -177.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -79.42 81.26 5.7 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 176.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 66.63 -85.97 0.11 Allowed Glycine 0 C--N 1.357 1.731 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.862 -176.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -127.1 75.68 1.6 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.142 0.977 . . . . 0.0 109.684 177.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 14.5 t -173.51 147.37 1.44 Allowed 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.489 1.116 . . . . 0.0 108.831 169.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . 0.409 ' HA ' HD22 ' A' ' 307' ' ' LEU . 42.2 tt0 -93.52 128.87 39.83 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 -178.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . 0.476 HD13 HD12 ' A' ' 322' ' ' LEU . 45.2 mt -113.33 127.42 56.13 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 123.667 0.604 . . . . 0.0 109.762 177.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 314' ' ' SER . . . . . 0.401 ' O ' HD12 ' A' ' 286' ' ' LEU . 39.0 m -77.81 140.61 63.16 Favored Pre-proline 0 CA--C 1.554 1.105 0 C-N-CA 123.529 0.731 . . . . 0.0 110.633 179.248 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -63.94 -24.34 67.52 Favored 'Trans proline' 0 C--N 1.384 2.402 0 C-N-CA 122.871 2.381 . . . . 0.0 113.042 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 6.5 m -81.75 -18.47 44.13 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 123.788 0.835 . . . . 0.0 111.344 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -70.25 150.72 46.11 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 122.852 0.461 . . . . 0.0 109.967 176.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 318' ' ' THR . . . . . . . . . . . . . 69.5 p -98.57 144.4 28.07 Favored Pre-proline 0 CA--C 1.541 0.598 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . 0.597 ' HG3' HD21 ' A' ' 280' ' ' LEU . 20.8 Cg_endo -57.83 -17.31 29.35 Favored 'Trans proline' 0 C--N 1.366 1.486 0 C-N-CA 123.171 2.581 . . . . 0.0 112.578 170.578 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 44.9 ttt180 -71.02 -48.5 52.72 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.525 0.73 . . . . 0.0 110.454 -179.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 15.0 t -70.27 -29.08 65.77 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-O 120.809 0.338 . . . . 0.0 110.626 178.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 322' ' ' LEU . . . . . 0.476 HD12 HD13 ' A' ' 313' ' ' LEU . 64.7 mt -81.58 -14.83 56.32 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.82 177.266 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp 59.62 36.32 22.59 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.566 1.146 . . . . 0.0 112.413 -177.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . 0.424 ' HG ' ' HB2' ' A' ' 322' ' ' LEU . 44.7 mt -68.96 145.46 53.6 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.701 0.8 . . . . 0.0 109.809 174.177 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . -140.31 -169.29 11.64 Favored Glycine 0 C--O 1.24 0.472 0 C-N-CA 123.435 0.541 . . . . 0.0 112.08 -174.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 26.0 m -74.09 -26.86 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.771 0.828 . . . . 0.0 111.915 -175.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -101.03 -3.24 29.72 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.713 0.805 . . . . 0.0 111.141 179.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -83.28 144.78 29.49 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 175.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . 0.457 ' HA ' ' O ' ' A' ' 268' ' ' LYS . 24.2 mt -131.29 125.33 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 123.232 0.613 . . . . 0.0 109.673 -178.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 28.4 pt -116.82 131.93 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 123.367 0.667 . . . . 0.0 110.365 176.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 331' ' ' ASP . . . . . 0.442 ' O ' ' HA ' ' A' ' 306' ' ' LEU . 7.1 m-20 -68.13 135.67 52.5 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.951 0.9 . . . . 0.0 111.712 -179.193 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 332' ' ' CYS . . . . . 0.54 ' SG ' HD13 ' A' ' 304' ' ' ILE . 26.2 t -103.79 99.51 9.3 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.08 0.952 . . . . 0.0 109.011 171.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 47.9 t -104.48 113.46 41.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -178.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 334' ' ' VAL . . . . . 0.514 HG13 HG13 ' A' ' 299' ' ' VAL . 58.3 t -81.71 99.01 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.723 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 80.6 mt -83.57 160.14 21.5 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.655 0.782 . . . . 0.0 110.389 175.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 336' ' ' THR . . . . . . . . . . . . . 11.3 t -96.98 -22.4 16.86 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 171.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 44.4 t -113.11 132.41 55.45 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.115 0.966 . . . . 0.0 109.399 178.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 20.7 m . . . . . 0 C--O 1.257 1.472 0 C-N-CA 124.17 0.988 . . . . 0.0 109.444 176.866 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 . . . . . 0 N--CA 1.48 1.064 0 N-CA-C 111.366 0.136 . . . . 0.0 111.366 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -103.25 72.38 0.28 Allowed Glycine 0 C--N 1.355 1.634 0 N-CA-C 111.991 -0.444 . . . . 0.0 111.991 -177.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' GLN . . . . . 0.524 ' NE2' ' HB3' ' A' ' 248' ' ' ASP . 24.0 tm0? -75.54 107.85 7.96 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.57 0.748 . . . . 0.0 109.213 -178.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -101.71 -9.85 20.5 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.615 0.766 . . . . 0.0 112.524 -173.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . 0.524 ' HB3' ' NE2' ' A' ' 246' ' ' GLN . 16.2 t70 -69.34 93.18 0.63 Allowed 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -174.18 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -63.02 92.34 0.05 Allowed 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.653 173.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 33.4 m -64.3 124.78 19.76 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.943 -170.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 38.7 t 52.75 72.43 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.087 0 C-N-CA 124.861 1.264 . . . . 0.0 111.08 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 33.6 tp -151.39 85.21 1.32 Allowed 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.222 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.67 HG11 HD22 ' A' ' 258' ' ' LEU . 43.9 t -122.76 97.44 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 176.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -163.07 148.82 11.89 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.525 0.73 . . . . 0.0 109.42 -172.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 122.33 -77.99 0.34 Allowed Glycine 0 N--CA 1.472 1.056 0 N-CA-C 111.715 -0.554 . . . . 0.0 111.715 -178.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -75.88 -168.47 0.55 Allowed 'Trans proline' 0 C--N 1.373 1.823 0 C-N-CA 123.184 2.589 . . . . 0.0 112.32 175.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 70.4 m -63.28 128.12 34.39 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 123.544 0.738 . . . . 0.0 110.039 173.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . 0.67 HD22 HG11 ' A' ' 253' ' ' VAL . 31.2 mt -105.65 94.0 8.05 Favored Pre-proline 0 CA--C 1.543 0.705 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 176.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -69.64 -21.53 33.9 Favored 'Trans proline' 0 C--N 1.377 2.077 0 C-N-CA 122.366 2.044 . . . . 0.0 111.852 176.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -72.12 104.38 3.59 Favored 'General case' 0 C--N 1.349 0.56 0 C-N-CA 124.768 1.227 . . . . 0.0 109.704 -177.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 20.6 p -71.25 146.67 92.51 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 123.103 0.561 . . . . 0.0 110.224 176.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -65.73 -179.61 1.36 Allowed 'Trans proline' 0 C--N 1.376 2.017 0 C-N-CA 122.697 2.264 . . . . 0.0 112.732 -179.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 78.7 mtt180 -86.36 102.23 13.83 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.316 0.579 . . . . 0.0 110.022 174.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 3.8 mp -100.87 171.93 7.35 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.745 172.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 265' ' ' PHE . . . . . 0.455 ' CE1' ' SD ' ' A' ' 282' ' ' MET . 46.4 p90 -145.63 147.33 32.64 Favored Pre-proline 0 C--O 1.243 0.725 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 173.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -68.12 94.02 0.41 Allowed 'Trans proline' 0 C--N 1.37 1.691 0 C-N-CA 122.061 1.84 . . . . 0.0 110.759 174.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 267' ' ' LEU . . . . . 0.494 HD11 HG13 ' A' ' 269' ' ' ILE . 1.9 tm? -58.55 130.14 45.41 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 173.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.572 ' HD2' HD21 ' A' ' 275' ' ' LEU . 4.7 tppp? -90.04 109.63 20.66 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 123.846 0.716 . . . . 0.0 110.497 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . 0.494 HG13 HD11 ' A' ' 267' ' ' LEU . 2.8 mp -110.93 154.95 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 174.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 270' ' ' ARG . . . . . 0.466 ' HG2' HD23 ' A' ' 275' ' ' LEU . 30.0 mtp-105 -113.75 131.11 56.32 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 162.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 271' ' ' CYS . . . . . 0.618 ' SG ' HD22 ' A' ' 297' ' ' LEU . 30.7 t -74.1 -160.14 0.09 Allowed 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 123.961 0.905 . . . . 0.0 109.399 168.335 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -58.67 -19.07 36.2 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.324 0.65 . . . . 0.0 112.051 173.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -153.86 -56.21 0.11 Allowed 'General case' 0 C--N 1.352 0.706 0 C-N-CA 123.532 0.733 . . . . 0.0 110.631 176.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -68.19 162.38 25.0 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.473 1.109 . . . . 0.0 112.652 -170.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.572 HD21 ' HD2' ' A' ' 268' ' ' LYS . 66.3 mt -88.86 128.09 35.65 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.714 0.806 . . . . 0.0 110.063 170.232 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 94.2 t -115.53 131.74 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 174.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 88.8 mtm180 -124.79 127.72 47.63 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.606 0.762 . . . . 0.0 109.189 176.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . 0.473 HD22 ' HA ' ' A' ' 289' ' ' VAL . 3.7 pp -135.43 144.33 49.02 Favored Pre-proline 0 N--CA 1.483 1.187 0 CA-C-O 119.436 -0.316 . . . . 0.0 110.242 177.369 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -71.57 116.33 4.65 Favored 'Trans proline' 0 C--N 1.372 1.799 0 C-N-CA 122.179 1.919 . . . . 0.0 111.033 177.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.684 HD23 ' HG3' ' A' ' 319' ' ' PRO . 0.5 OUTLIER -135.23 151.6 50.76 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.82 1.248 . . . . 0.0 109.544 -178.051 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -96.48 154.31 17.34 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.248 0.619 . . . . 0.0 109.585 178.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 282' ' ' MET . . . . . 0.455 ' SD ' ' CE1' ' A' ' 265' ' ' PHE . 94.2 mmm -63.44 -29.01 70.37 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 122.851 0.46 . . . . 0.0 111.577 176.415 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 39.7 t -79.91 -28.5 39.81 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.76 0.824 . . . . 0.0 111.363 176.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -67.96 123.22 86.62 Favored Pre-proline 0 N--CA 1.481 1.084 0 C-N-CA 123.915 0.886 . . . . 0.0 109.843 -177.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -64.51 167.47 15.01 Favored 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 122.573 2.182 . . . . 0.0 112.118 178.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 56.2 mt -63.9 -16.47 61.49 Favored 'General case' 0 C--O 1.216 -0.705 0 CA-C-O 118.596 -0.716 . . . . 0.0 112.028 -177.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 287' ' ' GLN . . . . . 0.409 ' HA ' ' HB ' ' A' ' 290' ' ' VAL . 24.9 tp60 -49.82 -27.33 4.9 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.58 0.752 . . . . 0.0 112.379 177.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 288' ' ' SER . . . . . 0.552 ' HB3' HD13 ' A' ' 280' ' ' LEU . 36.2 t -60.83 -55.87 27.91 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 123.925 0.89 . . . . 0.0 111.201 172.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.473 ' HA ' HD22 ' A' ' 278' ' ' LEU . 15.6 m -69.56 -31.5 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 122.413 0.285 . . . . 0.0 110.934 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . 0.546 HG12 ' HB ' ' A' ' 304' ' ' ILE . 46.1 t -63.21 -55.69 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 124.794 1.237 . . . . 0.0 111.018 -178.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -67.99 -36.21 79.63 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.844 -176.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 9.7 t60 -61.07 -49.96 75.22 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.475 0.71 . . . . 0.0 110.374 176.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 93.9 mmm -69.65 -29.16 66.55 Favored 'General case' 0 C--O 1.217 -0.624 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.97 -179.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -69.59 -37.61 76.99 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.327 0.651 . . . . 0.0 110.777 178.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 56.1 m -73.26 -37.37 66.34 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.229 0.611 . . . . 0.0 110.161 176.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -63.61 -47.25 82.2 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.954 0.901 . . . . 0.0 110.522 179.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 297' ' ' LEU . . . . . 0.618 HD22 ' SG ' ' A' ' 271' ' ' CYS . 38.2 mt -89.26 -11.13 44.43 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.258 1.023 . . . . 0.0 112.125 -174.587 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 72.9 19.2 79.37 Favored Glycine 0 C--N 1.352 1.433 0 O-C-N 123.515 0.51 . . . . 0.0 112.932 -178.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 20.5 m -105.33 178.85 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 124.405 1.082 . . . . 0.0 110.305 -177.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 21.2 m -82.62 148.01 57.14 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 123.262 0.625 . . . . 0.0 109.898 178.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -60.83 -29.15 87.62 Favored 'Trans proline' 0 C--N 1.386 2.511 0 C-N-CA 122.494 2.129 . . . . 0.0 112.334 175.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 36.1 t -72.47 -17.93 61.72 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 122.261 -0.274 . . . . 0.0 110.739 -179.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -90.21 -7.37 53.72 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.779 0.832 . . . . 0.0 111.372 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 304' ' ' ILE . . . . . 0.556 HD12 ' SG ' ' A' ' 332' ' ' CYS . 41.6 mm -84.83 109.2 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 CA-C-N 118.373 0.533 . . . . 0.0 110.187 177.422 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 39.5 tp -109.8 112.09 23.93 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.47 0.708 . . . . 0.0 109.095 177.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . 0.442 HD22 HG21 ' A' ' 290' ' ' VAL . 2.5 mm? -85.05 133.46 34.24 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . 0.479 HD23 ' HA ' ' A' ' 312' ' ' GLU . 76.7 mt -132.8 103.09 5.92 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.312 0.645 . . . . 0.0 109.987 -177.1 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . 0.462 ' HB2' HD11 ' A' ' 313' ' ' LEU . 69.8 t80 -77.56 92.3 4.05 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -178.428 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 72.27 -81.29 0.59 Allowed Glycine 0 C--N 1.343 0.953 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.703 -174.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -131.75 -11.76 3.42 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.584 0.754 . . . . 0.0 112.384 -179.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 6.9 t -86.79 148.55 25.35 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 118.115 0.416 . . . . 0.0 111.004 -177.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . 0.479 ' HA ' HD23 ' A' ' 307' ' ' LEU . 37.2 tt0 -93.79 123.97 37.48 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 122.847 0.459 . . . . 0.0 110.226 -176.397 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . 0.474 HD12 HD13 ' A' ' 322' ' ' LEU . 47.5 mt -111.4 126.98 55.51 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.995 -178.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 42.0 m -71.37 144.46 89.32 Favored Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 123.693 0.797 . . . . 0.0 110.12 173.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -63.11 -18.11 63.48 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 123.027 2.485 . . . . 0.0 112.751 176.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 37.7 p -90.36 -8.42 50.78 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.573 1.149 . . . . 0.0 112.427 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -72.88 152.71 41.35 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.099 0.559 . . . . 0.0 111.036 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 318' ' ' THR . . . . . . . . . . . . . 32.4 p -103.93 142.82 25.4 Favored Pre-proline 0 N--CA 1.478 0.928 0 C-N-CA 122.999 0.52 . . . . 0.0 109.672 177.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . 0.684 ' HG3' HD23 ' A' ' 280' ' ' LEU . 70.3 Cg_endo -66.0 -14.17 43.24 Favored 'Trans proline' 0 C--N 1.369 1.64 0 C-N-CA 123.649 2.899 . . . . 0.0 113.192 -176.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 70.3 ttt180 -69.21 -53.47 19.78 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.234 0.614 . . . . 0.0 110.557 -177.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 9.8 t -66.8 -29.92 69.99 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.347 0.659 . . . . 0.0 111.364 177.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 322' ' ' LEU . . . . . 0.474 HD13 HD12 ' A' ' 313' ' ' LEU . 43.4 mt -81.89 -19.41 40.91 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.395 0.678 . . . . 0.0 111.0 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 53.69 75.67 0.25 Allowed 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 125.108 1.363 . . . . 0.0 109.623 -170.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 70.6 mt -106.98 164.57 12.03 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.627 176.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 325' ' ' GLY . . . . . 0.423 ' N ' ' HB2' ' A' ' 328' ' ' ASP . . . -169.53 -160.63 18.22 Favored Glycine 0 C--N 1.343 0.95 0 CA-C-N 115.928 -0.578 . . . . 0.0 113.374 -170.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 30.6 m -80.5 -24.55 11.26 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 124.481 1.112 . . . . 0.0 111.296 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -101.73 -25.85 13.69 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.054 0.942 . . . . 0.0 110.457 177.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 328' ' ' ASP . . . . . 0.423 ' HB2' ' N ' ' A' ' 325' ' ' GLY . 34.1 m-20 -76.02 111.5 11.47 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . 0.506 HG12 ' HG2' ' A' ' 268' ' ' LYS . 4.4 mt -99.13 133.21 42.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.088 0.555 . . . . 0.0 110.942 -173.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 41.2 pt -119.23 128.91 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 123.211 0.605 . . . . 0.0 109.739 174.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -85.22 109.65 18.47 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.374 0.67 . . . . 0.0 110.514 -176.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 332' ' ' CYS . . . . . 0.556 ' SG ' HD12 ' A' ' 304' ' ' ILE . 35.9 t -73.12 95.08 2.01 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.385 0.674 . . . . 0.0 109.583 170.1 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 58.2 t -106.86 122.39 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 178.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 91.4 t -78.53 102.01 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-O 121.18 0.514 . . . . 0.0 110.517 -176.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.54 138.12 58.07 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 125.077 1.351 . . . . 0.0 109.061 170.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 336' ' ' THR . . . . . . . . . . . . . 19.1 m -69.51 -72.79 0.18 Allowed 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 123.29 0.636 . . . . 0.0 110.75 -178.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 49.9 m -144.14 169.46 17.83 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.962 0.905 . . . . 0.0 109.463 -177.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 22.6 t . . . . . 0 CA--C 1.555 1.166 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -179.208 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 7.5 pm0 . . . . . 0 N--CA 1.476 0.87 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 53.89 42.84 70.56 Favored Glycine 0 C--N 1.346 1.12 0 O-C-N 123.837 0.71 . . . . 0.0 114.609 173.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -68.14 95.87 0.6 Allowed 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.195 0.522 . . . . 0.0 110.055 177.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -142.9 122.79 13.5 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 175.257 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -155.03 -43.3 0.08 Allowed 'General case' 0 C--O 1.24 0.59 0 C-N-CA 123.474 0.709 . . . . 0.0 110.4 -171.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -81.07 72.93 8.12 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.273 -173.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 46.2 t -83.59 131.02 34.82 Favored 'Isoleucine or valine' 0 C--O 1.244 0.795 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.338 176.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 59.2 t -71.47 83.38 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 176.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 6.2 tt -178.46 114.98 0.07 Allowed 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 -177.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 7.6 p -134.97 135.54 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 122.99 0.516 . . . . 0.0 109.794 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . 0.476 ' HG3' ' HD3' ' A' ' 256' ' ' PRO . 10.6 pt-20 -158.98 178.32 10.2 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.428 1.091 . . . . 0.0 109.304 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -125.78 79.72 0.37 Allowed Glycine 0 CA--C 1.528 0.852 0 CA-C-O 119.47 -0.628 . . . . 0.0 111.922 177.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . 0.476 ' HD3' ' HG3' ' A' ' 254' ' ' GLU . 83.1 Cg_endo -82.4 157.88 16.98 Favored 'Trans proline' 0 C--N 1.373 1.844 0 C-N-CA 122.658 2.239 . . . . 0.0 111.843 174.304 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 47.6 p -74.72 102.58 4.69 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 175.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 73.7 mt -100.67 96.82 5.82 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 123.601 0.761 . . . . 0.0 108.995 176.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -63.3 -35.24 63.67 Favored 'Trans proline' 0 C--N 1.379 2.151 0 C-N-CA 122.241 1.961 . . . . 0.0 111.264 176.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -77.53 97.0 4.89 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.504 0.722 . . . . 0.0 109.117 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 91.4 m -71.55 136.63 83.45 Favored Pre-proline 0 CA--C 1.553 1.071 0 C-N-CA 124.147 0.979 . . . . 0.0 110.889 -178.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -54.08 130.68 40.72 Favored 'Trans proline' 0 C--N 1.386 2.552 0 C-N-CA 122.738 2.292 . . . . 0.0 111.691 174.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 64.5 mtt180 -63.26 113.27 3.09 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 123.878 0.871 . . . . 0.0 111.737 -172.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 3.0 mp -84.59 167.99 15.77 Favored 'General case' 0 C--O 1.243 0.757 0 CA-C-N 114.653 -1.158 . . . . 0.0 108.632 173.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -144.85 146.51 31.71 Favored Pre-proline 0 CA--C 1.543 0.697 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 175.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 266' ' ' PRO . . . . . 0.494 ' HB2' ' HB3' ' A' ' 277' ' ' ARG . 46.2 Cg_endo -66.85 91.36 0.3 Allowed 'Trans proline' 0 C--N 1.374 1.903 0 C-N-CA 122.182 1.921 . . . . 0.0 112.197 176.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 267' ' ' LEU . . . . . 0.56 HD21 HD21 ' A' ' 280' ' ' LEU . 0.4 OUTLIER -63.28 115.53 4.64 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 170.747 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.516 ' HD3' HD12 ' A' ' 275' ' ' LEU . 30.7 ttmt -90.96 118.38 30.3 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 123.414 0.446 . . . . 0.0 109.892 -179.378 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . 0.552 HG21 ' HG3' ' A' ' 293' ' ' MET . 2.4 mp -113.93 136.37 50.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 C-N-CA 123.6 0.76 . . . . 0.0 108.958 177.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 270' ' ' ARG . . . . . 0.47 ' HA ' HD23 ' A' ' 275' ' ' LEU . 0.7 OUTLIER -85.95 106.67 17.3 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 123.626 0.579 . . . . 0.0 110.469 -177.561 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 271' ' ' CYS . . . . . 0.528 ' SG ' HD22 ' A' ' 297' ' ' LEU . 38.6 t -75.2 179.49 5.06 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.742 0.817 . . . . 0.0 109.789 167.208 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 272' ' ' ARG . . . . . 0.46 ' N ' ' SG ' ' A' ' 271' ' ' CYS . 17.2 ptm180 -54.18 -36.08 63.03 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.012 0.925 . . . . 0.0 112.789 178.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -159.44 49.39 0.32 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.63 0.772 . . . . 0.0 109.621 178.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 274' ' ' ASP . . . . . 0.456 ' HB3' ' HB3' ' A' ' 271' ' ' CYS . 19.9 t70 -166.43 162.52 17.01 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.714 0.805 . . . . 0.0 110.123 -173.4 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.516 HD12 ' HD3' ' A' ' 268' ' ' LYS . 81.0 mt -131.36 104.72 7.18 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.392 1.077 . . . . 0.0 109.615 176.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 276' ' ' VAL . . . . . 0.405 ' O ' HD13 ' A' ' 269' ' ' ILE . 78.3 t -83.44 115.5 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 177.302 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . 0.494 ' HB3' ' HB2' ' A' ' 266' ' ' PRO . 61.2 mtm-85 -107.31 80.68 1.44 Allowed 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -179.046 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 4.3 pp -93.13 142.89 25.92 Favored Pre-proline 0 N--CA 1.484 1.226 0 CA-C-O 119.579 -0.248 . . . . 0.0 111.054 -173.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -68.23 109.14 1.92 Allowed 'Trans proline' 0 C--N 1.375 1.932 0 C-N-CA 122.833 2.355 . . . . 0.0 110.696 177.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.57 HD22 ' HG3' ' A' ' 319' ' ' PRO . 2.9 tt -127.39 139.17 53.02 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.448 1.099 . . . . 0.0 109.466 -178.073 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 68.3 mtm180 -80.45 152.71 28.64 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.898 0.879 . . . . 0.0 110.649 179.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 282' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -65.66 -23.85 66.89 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 122.543 0.337 . . . . 0.0 111.581 177.531 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 20.7 t -91.17 -1.36 57.74 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.117 0.967 . . . . 0.0 111.985 179.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -85.01 132.89 44.32 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 123.606 0.763 . . . . 0.0 109.537 -178.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -66.58 164.46 28.81 Favored 'Trans proline' 0 C--N 1.372 1.797 0 C-N-CA 121.864 1.71 . . . . 0.0 111.203 169.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 49.3 mt -67.85 -13.7 62.36 Favored 'General case' 0 C--O 1.211 -0.936 0 CA-C-O 119.027 -0.511 . . . . 0.0 111.261 178.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 26.6 tp60 -51.1 -27.61 8.73 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.282 1.033 . . . . 0.0 112.013 178.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 39.9 t -58.14 -59.84 4.66 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.206 1.002 . . . . 0.0 111.114 170.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.448 ' HB ' HG12 ' A' ' 269' ' ' ILE . 13.0 m -70.15 -25.76 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 122.774 0.43 . . . . 0.0 110.833 -178.391 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . 0.469 HG13 ' HB ' ' A' ' 304' ' ' ILE . 55.8 t -65.19 -51.34 66.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 123.92 0.888 . . . . 0.0 109.97 178.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -71.29 -38.18 71.82 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.881 -178.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 8.5 t60 -66.8 -48.45 68.95 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.234 0.614 . . . . 0.0 110.36 -178.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 293' ' ' MET . . . . . 0.552 ' HG3' HG21 ' A' ' 269' ' ' ILE . 97.5 mmm -67.69 -31.08 70.79 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.783 0.433 . . . . 0.0 110.87 179.254 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -59.71 -45.85 90.88 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 122.844 0.458 . . . . 0.0 110.403 173.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 24.9 m -69.98 -30.3 67.6 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 123.191 0.597 . . . . 0.0 110.958 178.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 71.7 t60 -73.81 -29.1 61.97 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.781 0.832 . . . . 0.0 111.211 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 297' ' ' LEU . . . . . 0.528 HD22 ' SG ' ' A' ' 271' ' ' CYS . 52.4 mt -109.0 -2.44 18.22 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.946 0.898 . . . . 0.0 111.507 -175.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 77.47 19.09 76.92 Favored Glycine 0 N--CA 1.478 1.471 0 C-N-CA 123.343 0.497 . . . . 0.0 113.869 172.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 299' ' ' VAL . . . . . 0.631 ' HB ' ' HD2' ' A' ' 303' ' ' ARG . 27.3 m -116.29 -176.38 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 124.551 1.14 . . . . 0.0 111.369 -176.205 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 20.3 m -86.3 146.61 42.75 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 123.612 0.765 . . . . 0.0 110.457 178.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -53.46 -35.59 76.49 Favored 'Trans proline' 0 C--N 1.387 2.578 0 C-N-CA 123.14 2.56 . . . . 0.0 112.294 176.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 29.7 p -61.14 -24.48 66.31 Favored 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 123.354 0.661 . . . . 0.0 112.29 -174.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 303' ' ' ARG . . . . . 0.631 ' HD2' ' HB ' ' A' ' 299' ' ' VAL . 90.1 mtt180 -82.16 -25.58 34.19 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.268 1.027 . . . . 0.0 112.096 -176.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 304' ' ' ILE . . . . . 0.557 HD13 ' SG ' ' A' ' 332' ' ' CYS . 38.0 mm -73.77 103.55 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 C-N-CA 123.42 0.688 . . . . 0.0 111.308 -173.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 50.9 tp -101.17 114.68 28.86 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.661 0.784 . . . . 0.0 108.913 173.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -86.32 131.34 34.24 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 177.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 312' ' ' GLU . 75.2 mt -130.86 111.06 11.76 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 178.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . 0.433 ' HB2' HD11 ' A' ' 313' ' ' LEU . 56.4 t80 -78.7 88.57 4.58 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 72.99 -82.35 0.63 Allowed Glycine 0 C--N 1.345 1.076 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.808 -175.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -121.48 -27.56 4.76 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.903 0.881 . . . . 0.0 111.103 -176.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 6.1 t -78.74 145.45 34.44 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 122.649 0.38 . . . . 0.0 110.789 -173.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . 0.427 ' HA ' HD23 ' A' ' 307' ' ' LEU . 44.1 tt0 -89.28 124.45 34.41 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 122.901 0.481 . . . . 0.0 110.343 -177.611 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . 0.468 HD12 HD11 ' A' ' 322' ' ' LEU . 28.0 mt -106.79 154.56 20.82 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 122.899 0.479 . . . . 0.0 110.067 177.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 49.0 m -107.92 151.29 41.17 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 123.412 0.685 . . . . 0.0 110.111 -179.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -62.45 -27.03 76.83 Favored 'Trans proline' 0 C--N 1.381 2.266 0 C-N-CA 122.585 2.19 . . . . 0.0 112.352 174.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 38.5 p -78.77 -21.68 47.51 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.626 0.77 . . . . 0.0 112.114 177.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -66.22 144.56 56.55 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.427 0.691 . . . . 0.0 111.798 -175.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 318' ' ' THR . . . . . . . . . . . . . 68.3 p -100.11 153.47 37.74 Favored Pre-proline 0 CA--C 1.553 1.074 0 C-N-CA 123.839 0.856 . . . . 0.0 109.754 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . 0.57 ' HG3' HD22 ' A' ' 280' ' ' LEU . 60.3 Cg_endo -73.49 -10.6 23.93 Favored 'Trans proline' 0 C--N 1.371 1.725 0 C-N-CA 123.165 2.577 . . . . 0.0 112.179 -177.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -69.23 -54.71 13.36 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.91 0.884 . . . . 0.0 110.183 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 10.2 t -67.18 -23.03 65.72 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.384 0.674 . . . . 0.0 111.44 178.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 322' ' ' LEU . . . . . 0.522 ' HB2' ' HG ' ' A' ' 324' ' ' LEU . 54.9 mt -96.67 -8.38 31.69 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.438 0.695 . . . . 0.0 111.993 -178.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt 59.16 29.24 18.76 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 124.238 1.015 . . . . 0.0 113.008 -178.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . 0.522 ' HG ' ' HB2' ' A' ' 322' ' ' LEU . 55.3 mt -72.81 132.54 43.7 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 122.877 0.471 . . . . 0.0 110.476 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 325' ' ' GLY . . . . . 0.412 ' H ' ' HB2' ' A' ' 328' ' ' ASP . . . -138.15 -146.62 5.06 Favored Glycine 0 C--N 1.337 0.629 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 179.05 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . 0.415 ' O ' ' HE3' ' A' ' 268' ' ' LYS . 11.3 m -81.19 -26.33 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 123.033 0.533 . . . . 0.0 110.937 -176.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -97.53 -12.91 22.03 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.469 0.708 . . . . 0.0 111.665 -177.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 328' ' ' ASP . . . . . 0.412 ' HB2' ' H ' ' A' ' 325' ' ' GLY . 24.6 m-20 -87.3 108.37 18.93 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.002 0.43 . . . . 0.0 109.856 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . 0.447 HG12 ' HD2' ' A' ' 268' ' ' LYS . 38.0 mt -92.95 128.64 44.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.665 177.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 330' ' ' ILE . . . . . 0.447 HG13 HG22 ' A' ' 269' ' ' ILE . 41.0 pt -112.73 122.34 66.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 121.14 0.495 . . . . 0.0 109.711 175.176 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -71.78 113.82 9.21 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.045 0.938 . . . . 0.0 111.181 -173.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 332' ' ' CYS . . . . . 0.557 ' SG ' HD13 ' A' ' 304' ' ' ILE . 42.1 t -81.9 97.59 8.12 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.552 0.741 . . . . 0.0 110.198 177.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . 0.423 HG21 HD13 ' A' ' 307' ' ' LEU . 47.0 t -99.85 111.99 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 123.437 0.695 . . . . 0.0 109.435 -177.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 334' ' ' VAL . . . . . 0.517 HG12 HG11 ' A' ' 299' ' ' VAL . 60.5 t -80.84 103.93 8.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 80.3 mt -89.94 -175.07 4.47 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.229 173.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 336' ' ' THR . . . . . . . . . . . . . 68.4 p -86.55 -42.72 13.28 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 168.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 49.6 m 58.2 23.99 10.9 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 125.005 1.322 . . . . 0.0 111.856 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 14.7 m . . . . . 0 C--O 1.254 1.33 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.702 -177.196 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 . . . . . 0 N--CA 1.478 0.932 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -123.92 -140.62 5.62 Favored Glycine 0 C--N 1.346 1.135 0 CA-C-O 118.741 -1.033 . . . . 0.0 111.064 179.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 76.1 -37.03 0.29 Allowed 'General case' 0 N--CA 1.499 2.001 0 C-N-CA 125.905 1.682 . . . . 0.0 112.454 -178.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -88.99 46.13 1.36 Allowed 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.404 1.082 . . . . 0.0 110.298 176.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -68.03 -35.1 77.72 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.01 0.924 . . . . 0.0 110.004 175.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -63.89 115.76 5.16 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.668 173.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 21.8 m -83.79 61.7 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.03 0 CA-C-O 122.32 1.057 . . . . 0.0 111.149 -176.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 2.9 p -74.56 95.4 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 CA-C-N 114.465 -1.243 . . . . 0.0 110.457 -179.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 40.8 tp -95.8 87.9 4.79 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 115.454 -0.794 . . . . 0.0 108.95 -178.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 28.9 t 57.68 76.27 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.064 0 C-N-CA 125.177 1.391 . . . . 0.0 111.589 178.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -129.06 111.08 12.6 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 172.538 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 69.22 71.8 0.93 Allowed Glycine 0 CA--C 1.531 1.055 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 -170.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -60.16 88.38 0.08 OUTLIER 'Trans proline' 0 C--N 1.389 2.691 0 C-N-CA 123.781 2.987 . . . . 0.0 112.558 -178.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 68.0 m -153.21 146.91 25.14 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 125.758 1.623 . . . . 0.0 106.794 178.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 91.4 mt -101.43 97.19 7.12 Favored Pre-proline 0 N--CA 1.479 0.998 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 173.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -70.09 -34.03 14.24 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 122.293 1.995 . . . . 0.0 110.505 174.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -147.21 120.27 8.82 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 124.845 1.258 . . . . 0.0 107.991 171.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 89.6 m -73.3 132.84 81.47 Favored Pre-proline 0 CA--C 1.553 1.091 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 170.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -54.99 164.23 3.6 Favored 'Trans proline' 0 C--N 1.387 2.568 0 C-N-CA 123.236 2.624 . . . . 0.0 113.537 178.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -82.4 95.43 7.65 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.819 178.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 4.8 mp -95.27 104.36 16.25 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.162 173.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -93.08 148.04 34.97 Favored Pre-proline 0 CA--C 1.55 0.955 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 266' ' ' PRO . . . . . 0.483 ' HB2' ' HB3' ' A' ' 277' ' ' ARG . 74.3 Cg_endo -70.41 92.12 0.58 Allowed 'Trans proline' 0 C--N 1.376 2.007 0 C-N-CA 122.393 2.062 . . . . 0.0 112.239 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 267' ' ' LEU . . . . . 0.483 HD22 HD22 ' A' ' 280' ' ' LEU . 0.3 OUTLIER -64.32 126.21 27.05 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 172.304 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 22.9 ttpt -95.17 114.64 26.45 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-O 121.486 0.66 . . . . 0.0 111.083 -178.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 2.3 mp -113.08 124.99 70.27 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 C-N-CA 124.811 1.245 . . . . 0.0 109.231 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 35.5 ttp180 -93.09 107.21 19.05 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.165 0.507 . . . . 0.0 109.995 175.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 271' ' ' CYS . . . . . 0.641 ' SG ' HD22 ' A' ' 297' ' ' LEU . 48.9 t -82.33 -172.76 4.17 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.782 0.833 . . . . 0.0 111.322 179.042 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 272' ' ' ARG . . . . . 0.471 ' N ' ' SG ' ' A' ' 271' ' ' CYS . 35.8 ptt180 -57.37 -34.88 69.3 Favored 'General case' 0 CA--C 1.552 1.058 0 C-N-CA 124.622 1.169 . . . . 0.0 112.772 176.168 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -153.62 27.54 0.49 Allowed 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.165 0.586 . . . . 0.0 110.687 -177.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 274' ' ' ASP . . . . . 0.52 ' HB2' ' HB3' ' A' ' 271' ' ' CYS . 4.7 m-20 -141.29 158.85 43.34 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.589 0.756 . . . . 0.0 109.681 -175.316 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 26.9 tp -132.79 86.46 2.32 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 169.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 67.7 t -86.23 144.43 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.6 0.76 . . . . 0.0 109.927 -174.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . 0.483 ' HB3' ' HB2' ' A' ' 266' ' ' PRO . 52.9 mtp180 -128.5 87.02 2.52 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 172.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . 0.444 HD12 HG12 ' A' ' 289' ' ' VAL . 3.9 pp -95.66 142.93 25.27 Favored Pre-proline 0 N--CA 1.48 1.056 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 -175.546 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -65.55 125.33 14.21 Favored 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 122.919 2.413 . . . . 0.0 111.343 175.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.597 HD23 ' HG3' ' A' ' 319' ' ' PRO . 0.1 OUTLIER -140.72 148.31 40.55 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.954 0.902 . . . . 0.0 110.639 -178.151 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 70.3 mtp180 -87.9 142.94 27.4 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.347 1.059 . . . . 0.0 110.671 179.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 282' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -62.04 -35.03 77.36 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.658 0.783 . . . . 0.0 111.829 175.024 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 44.4 p -75.36 -20.38 59.04 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.892 0.877 . . . . 0.0 111.595 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -86.57 130.23 49.96 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 124.207 1.003 . . . . 0.0 108.99 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . 0.517 ' HA ' ' HA ' ' A' ' 318' ' ' THR . 40.9 Cg_endo -65.76 178.25 2.38 Favored 'Trans proline' 0 C--N 1.38 2.209 0 C-N-CA 122.608 2.205 . . . . 0.0 112.753 173.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.41 ' O ' HG21 ' A' ' 290' ' ' VAL . 90.7 mt -64.43 -18.22 64.53 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.563 0.745 . . . . 0.0 111.965 -179.122 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 27.7 tp60 -52.48 -23.36 6.07 Favored 'General case' 0 CA--C 1.558 1.264 0 C-N-CA 123.678 0.791 . . . . 0.0 112.271 178.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 288' ' ' SER . . . . . 0.536 ' HB3' HD12 ' A' ' 280' ' ' LEU . 37.3 t -63.24 -57.31 10.87 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.841 0.856 . . . . 0.0 110.856 171.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.455 ' O ' ' HG2' ' A' ' 293' ' ' MET . 27.7 m -65.4 -35.36 75.13 Favored 'Isoleucine or valine' 0 C--N 1.368 1.381 0 O-C-N 123.167 0.292 . . . . 0.0 110.342 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . 0.553 HG13 ' HB ' ' A' ' 304' ' ' ILE . 71.6 t -55.73 -53.21 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 124.42 1.088 . . . . 0.0 111.336 178.259 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -63.87 -42.97 97.4 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.066 -177.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 13.5 t60 -71.85 -38.09 70.15 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.231 -176.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 293' ' ' MET . . . . . 0.455 ' HG2' ' O ' ' A' ' 289' ' ' VAL . 91.0 mmm -68.9 -34.38 75.31 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 123.156 0.582 . . . . 0.0 110.125 177.327 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -66.29 -43.4 86.46 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.571 0.748 . . . . 0.0 111.376 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 26.2 m -70.14 -32.65 70.74 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.381 0.672 . . . . 0.0 110.644 176.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 79.2 t60 -63.36 -35.11 79.32 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.905 0.882 . . . . 0.0 111.812 177.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 297' ' ' LEU . . . . . 0.641 HD22 ' SG ' ' A' ' 271' ' ' CYS . 75.7 mt -99.53 -23.27 15.14 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.244 0.618 . . . . 0.0 111.893 -177.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 82.63 25.12 51.57 Favored Glycine 0 CA--C 1.531 1.071 0 O-C-N 123.262 0.351 . . . . 0.0 112.787 -173.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 33.4 m -107.33 177.99 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 124.521 1.128 . . . . 0.0 109.878 176.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 47.6 m -83.17 144.36 46.93 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 123.042 0.537 . . . . 0.0 110.6 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -55.75 -31.99 82.48 Favored 'Trans proline' 0 C--N 1.388 2.606 0 C-N-CA 123.263 2.642 . . . . 0.0 112.096 170.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 34.2 t -70.85 -6.02 34.9 Favored 'General case' 0 CA--C 1.56 1.328 0 C-N-CA 122.558 0.343 . . . . 0.0 111.787 -178.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 58.1 mtt180 -106.44 -16.25 14.59 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.243 1.017 . . . . 0.0 112.173 178.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 304' ' ' ILE . . . . . 0.592 HD12 ' SG ' ' A' ' 332' ' ' CYS . 38.9 mm -81.16 108.17 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 177.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 24.1 tp -110.36 130.25 55.59 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 174.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -95.89 131.41 42.26 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . 0.449 HD12 HG23 ' A' ' 333' ' ' VAL . 72.9 mt -133.48 105.69 7.05 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.587 0.755 . . . . 0.0 109.602 -175.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . 0.55 ' HB2' HD13 ' A' ' 313' ' ' LEU . 85.4 t80 -78.23 95.1 4.89 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -176.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 73.17 -85.11 0.59 Allowed Glycine 0 C--N 1.344 1.017 0 N-CA-C 111.436 -0.666 . . . . 0.0 111.436 -177.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -139.2 13.59 2.61 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.706 0.802 . . . . 0.0 111.566 -179.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 6.2 t -104.77 147.49 27.65 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 175.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -92.92 122.97 35.84 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.956 0.502 . . . . 0.0 110.32 -176.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . 0.55 HD13 ' HB2' ' A' ' 308' ' ' PHE . 40.2 mt -110.83 130.72 55.5 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.096 0.559 . . . . 0.0 109.802 -179.49 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 16.5 m -73.65 142.18 80.32 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 123.054 0.542 . . . . 0.0 110.198 174.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -62.62 -25.81 75.49 Favored 'Trans proline' 0 C--N 1.381 2.255 0 C-N-CA 122.821 2.347 . . . . 0.0 111.934 173.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 28.6 p -78.63 -18.32 54.67 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.558 1.143 . . . . 0.0 111.853 177.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -73.94 149.77 41.21 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.052 0.541 . . . . 0.0 110.257 176.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 318' ' ' THR . . . . . 0.517 ' HA ' ' HA ' ' A' ' 285' ' ' PRO . 60.7 p -99.2 142.6 24.9 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 123.26 0.624 . . . . 0.0 110.361 -176.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . 0.597 ' HG3' HD23 ' A' ' 280' ' ' LEU . 37.9 Cg_endo -62.49 -15.96 48.96 Favored 'Trans proline' 0 C--N 1.377 2.046 0 C-N-CA 123.378 2.719 . . . . 0.0 112.521 174.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 73.4 ttt-85 -60.78 -57.8 11.14 Favored 'General case' 0 C--N 1.358 0.951 0 C-N-CA 123.826 0.851 . . . . 0.0 111.044 176.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 14.7 t -70.73 -25.14 62.79 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.309 -177.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 322' ' ' LEU . . . . . 0.502 HD12 HD11 ' A' ' 313' ' ' LEU . 65.5 mt -79.0 -19.7 50.91 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.277 0.631 . . . . 0.0 110.689 177.457 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt 59.06 57.44 3.52 Favored 'General case' 0 CA--C 1.55 0.942 0 C-N-CA 124.787 1.235 . . . . 0.0 109.9 -176.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . 0.42 ' HG ' ' HB2' ' A' ' 322' ' ' LEU . 69.8 mt -93.9 140.24 29.93 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 114.416 -1.266 . . . . 0.0 108.85 177.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . -128.82 -157.73 9.38 Favored Glycine 0 C--O 1.239 0.436 0 O-C-N 123.977 0.798 . . . . 0.0 111.156 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . 0.421 ' HB ' ' NH2' ' A' ' 277' ' ' ARG . 29.6 m -75.07 -25.58 18.46 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 C-N-CA 123.382 0.673 . . . . 0.0 111.868 -175.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -98.31 -16.79 19.23 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.006 0.922 . . . . 0.0 111.915 -177.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -73.13 123.67 24.06 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.04 0.536 . . . . 0.0 110.605 -176.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 29.0 mt -106.26 120.32 57.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 C-N-CA 123.975 0.91 . . . . 0.0 110.357 -175.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 32.1 pt -113.71 130.4 67.85 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 174.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -77.76 111.08 13.19 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.74 0.816 . . . . 0.0 111.823 -174.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 332' ' ' CYS . . . . . 0.592 ' SG ' HD12 ' A' ' 304' ' ' ILE . 29.5 t -72.57 96.62 1.99 Allowed 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.545 0.738 . . . . 0.0 109.783 166.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . 0.449 HG23 HD12 ' A' ' 307' ' ' LEU . 75.3 t -105.28 114.34 44.57 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 177.576 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 52.5 t -78.66 90.13 1.27 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.775 0 CA-C-O 121.565 0.698 . . . . 0.0 109.606 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 86.0 mt -89.44 112.97 24.25 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.067 174.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 336' ' ' THR . . . . . . . . . . . . . 71.2 p -54.85 -32.97 61.24 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.754 1.222 . . . . 0.0 111.235 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 23.4 m 78.65 -51.73 0.47 Allowed 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 126.097 1.759 . . . . 0.0 111.812 175.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 49.5 m . . . . . 0 C--O 1.253 1.271 0 C-N-CA 124.48 1.112 . . . . 0.0 108.773 176.937 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 . . . . . 0 N--CA 1.48 1.056 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -177.3 168.69 40.56 Favored Glycine 0 C--N 1.34 0.761 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.178 179.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -70.39 138.06 51.01 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-O 121.077 0.465 . . . . 0.0 110.379 -179.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -90.62 24.94 2.47 Favored 'General case' 0 CA--C 1.562 1.41 0 C-N-CA 123.875 0.87 . . . . 0.0 110.67 -174.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 25.6 t70 56.19 70.28 0.66 Allowed 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.569 1.147 . . . . 0.0 110.487 -178.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -136.52 50.86 2.02 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.158 -173.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 23.0 m -67.89 141.18 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 177.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 12.1 m -70.26 87.78 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.088 0 CA-C-O 122.391 1.091 . . . . 0.0 110.491 177.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 5.5 tt -106.84 79.32 1.32 Allowed 'General case' 0 C--O 1.241 0.635 0 N-CA-C 106.714 -1.588 . . . . 0.0 106.714 175.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 51.4 t -81.82 104.38 10.3 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-N 114.74 -1.118 . . . . 0.0 109.324 -176.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -151.19 -73.51 0.15 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.835 0.854 . . . . 0.0 109.035 -178.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 173.69 66.59 0.05 OUTLIER Glycine 0 CA--C 1.528 0.856 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -177.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -62.83 135.14 50.36 Favored 'Trans proline' 0 C--N 1.38 2.211 0 C-N-CA 123.867 3.044 . . . . 0.0 112.737 -172.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 47.1 m -56.15 144.12 30.69 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.436 1.095 . . . . 0.0 110.783 176.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 90.8 mt -103.48 96.2 8.3 Favored Pre-proline 0 N--CA 1.479 1.009 0 C-N-CA 123.324 0.65 . . . . 0.0 110.943 -178.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -84.7 -14.39 6.5 Favored 'Trans proline' 0 C--N 1.373 1.86 0 C-N-CA 122.441 2.094 . . . . 0.0 111.094 163.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -74.89 92.99 2.6 Favored 'General case' 0 C--N 1.351 0.662 0 C-N-CA 124.971 1.308 . . . . 0.0 110.408 -174.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 18.7 p -71.73 149.06 92.9 Favored Pre-proline 0 CA--C 1.543 0.712 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.049 172.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -71.22 177.32 6.72 Favored 'Trans proline' 0 C--N 1.369 1.621 0 C-N-CA 122.458 2.105 . . . . 0.0 111.78 178.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -88.09 90.28 8.32 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 121.257 0.551 . . . . 0.0 109.711 178.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 5.0 mp -79.69 109.95 14.57 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.0 -1.0 . . . . 0.0 108.386 173.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -79.39 141.48 57.16 Favored Pre-proline 0 C--O 1.245 0.854 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -178.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -66.15 101.33 0.5 Allowed 'Trans proline' 0 C--N 1.373 1.829 0 C-N-CA 122.228 1.952 . . . . 0.0 111.153 175.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 267' ' ' LEU . . . . . 0.401 ' O ' ' HA ' ' A' ' 277' ' ' ARG . 0.8 OUTLIER -68.03 127.77 34.07 Favored 'General case' 0 CA--C 1.549 0.937 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 172.498 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.498 ' HG2' HG12 ' A' ' 329' ' ' ILE . 5.2 tppp? -90.62 108.43 19.8 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.313 0.645 . . . . 0.0 110.238 177.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 3.6 mp -102.67 126.2 56.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 123.917 0.887 . . . . 0.0 109.177 178.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 30.8 ttp180 -96.93 95.13 7.62 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.276 0.631 . . . . 0.0 109.413 173.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 271' ' ' CYS . . . . . 0.501 ' HA ' ' HB3' ' A' ' 332' ' ' CYS . 42.8 t -71.85 -173.65 1.04 Allowed 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 123.819 0.848 . . . . 0.0 110.651 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 272' ' ' ARG . . . . . 0.403 ' N ' ' SG ' ' A' ' 271' ' ' CYS . 7.5 ptm180 -55.48 -30.97 61.58 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.406 1.082 . . . . 0.0 112.311 174.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -144.89 -38.35 0.27 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.118 0.967 . . . . 0.0 110.366 -178.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -79.3 154.09 29.37 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.206 1.002 . . . . 0.0 111.433 -173.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 25.4 tp -119.69 85.33 2.36 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 173.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 95.0 t -89.94 147.56 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 114.856 -1.065 . . . . 0.0 109.875 -167.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . 0.401 ' HA ' ' O ' ' A' ' 267' ' ' LEU . 88.5 mtt180 -127.9 127.68 43.79 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 171.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . 0.48 HD12 HG12 ' A' ' 289' ' ' VAL . 4.2 pp -129.41 144.35 52.48 Favored Pre-proline 0 N--CA 1.482 1.161 0 CA-C-N 118.023 0.374 . . . . 0.0 110.411 174.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -68.33 122.45 9.48 Favored 'Trans proline' 0 C--N 1.374 1.906 0 C-N-CA 122.68 2.254 . . . . 0.0 110.714 174.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.639 HD22 ' HG3' ' A' ' 319' ' ' PRO . 0.3 OUTLIER -149.02 150.75 33.34 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.007 0.923 . . . . 0.0 109.993 -177.441 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 58.1 mtm-85 -97.72 155.88 16.81 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.306 0.643 . . . . 0.0 110.486 179.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 282' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -61.31 -39.51 90.73 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.335 0.654 . . . . 0.0 111.228 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 12.1 t -78.67 -23.93 45.42 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.348 -178.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -70.61 122.36 86.4 Favored Pre-proline 0 C--N 1.352 0.707 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 175.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . 0.481 ' HA ' ' HA ' ' A' ' 318' ' ' THR . 55.5 Cg_endo -65.59 175.45 4.32 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 122.363 2.042 . . . . 0.0 112.639 -179.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 78.4 mt -64.87 -16.97 63.87 Favored 'General case' 0 C--O 1.211 -0.967 0 CA-C-O 118.449 -0.786 . . . . 0.0 111.64 178.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 23.8 tp60 -52.52 -27.48 16.65 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.218 0.607 . . . . 0.0 112.274 179.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 288' ' ' SER . . . . . 0.576 ' HB3' HD13 ' A' ' 280' ' ' LEU . 41.8 t -61.12 -55.7 29.38 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.7 0.8 . . . . 0.0 110.524 171.165 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.48 HG12 HD12 ' A' ' 278' ' ' LEU . 11.4 m -69.33 -28.27 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 122.503 0.321 . . . . 0.0 111.441 179.375 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . 0.502 HG11 ' HB ' ' A' ' 304' ' ' ILE . 54.9 t -69.53 -52.39 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 123.731 0.812 . . . . 0.0 109.991 -177.192 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -71.84 -32.99 68.09 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 122.955 0.502 . . . . 0.0 110.869 -178.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -64.3 -51.89 61.23 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.341 0.656 . . . . 0.0 110.008 178.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 94.2 mmm -68.99 -29.3 67.48 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.365 0.666 . . . . 0.0 111.065 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -61.7 -53.33 57.53 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.341 0.656 . . . . 0.0 110.682 176.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 21.9 m -65.25 -35.61 81.55 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 123.689 0.796 . . . . 0.0 110.846 178.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -67.04 -33.22 75.05 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.324 1.049 . . . . 0.0 111.663 -179.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 297' ' ' LEU . . . . . 0.468 HD21 ' SG ' ' A' ' 271' ' ' CYS . 47.6 mt -102.17 -3.68 27.04 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.06 0.944 . . . . 0.0 111.248 178.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 76.74 9.37 86.41 Favored Glycine 0 C--N 1.352 1.46 0 C-N-CA 123.548 0.594 . . . . 0.0 113.909 176.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 299' ' ' VAL . . . . . 0.466 HG12 HG13 ' A' ' 334' ' ' VAL . 35.4 m -102.48 179.82 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.056 0.942 . . . . 0.0 111.462 -177.173 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 49.4 m -77.65 147.62 75.09 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 123.54 0.736 . . . . 0.0 111.14 178.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.68 -27.47 83.28 Favored 'Trans proline' 0 C--N 1.384 2.407 0 C-N-CA 122.634 2.222 . . . . 0.0 111.333 168.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 20.2 m -64.12 -26.16 68.42 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 124.107 0.963 . . . . 0.0 111.549 178.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 78.2 mtt85 -84.35 -33.58 23.83 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.899 0.88 . . . . 0.0 111.64 179.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 304' ' ' ILE . . . . . 0.502 ' HB ' HG11 ' A' ' 290' ' ' VAL . 36.5 mm -72.55 105.12 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 122.703 0.401 . . . . 0.0 110.942 -175.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . 0.506 HD23 HD12 ' A' ' 335' ' ' LEU . 29.7 tp -107.62 129.24 55.02 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 123.618 0.767 . . . . 0.0 109.231 172.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -92.11 138.26 31.68 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 174.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . 0.449 HD22 ' HA ' ' A' ' 312' ' ' GLU . 92.6 mt -133.3 115.02 14.42 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.99 0.916 . . . . 0.0 109.47 -177.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . 0.543 ' HB2' HD13 ' A' ' 313' ' ' LEU . 66.0 t80 -87.25 88.16 7.62 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.06 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 73.74 -78.36 0.89 Allowed Glycine 0 C--N 1.349 1.269 0 CA-C-N 115.209 -0.905 . . . . 0.0 112.331 -177.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -120.62 -33.47 3.81 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.449 0.699 . . . . 0.0 110.644 179.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 8.5 t -76.65 148.38 36.91 Favored 'General case' 0 C--N 1.35 0.622 0 C-N-CA 122.757 0.423 . . . . 0.0 111.393 -169.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . 0.449 ' HA ' HD22 ' A' ' 307' ' ' LEU . 42.7 tt0 -85.24 130.56 34.58 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.687 178.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . 0.586 HD22 HD22 ' A' ' 322' ' ' LEU . 46.9 mt -111.85 126.93 55.62 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 176.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 31.9 m -78.89 144.72 64.54 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 123.237 0.615 . . . . 0.0 110.727 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -59.75 -32.51 95.74 Favored 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 123.103 2.535 . . . . 0.0 112.747 178.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 7.1 m -79.36 -20.48 47.68 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 123.415 0.686 . . . . 0.0 111.361 -179.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -68.72 144.66 54.32 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.17 0.588 . . . . 0.0 110.543 178.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 318' ' ' THR . . . . . 0.481 ' HA ' ' HA ' ' A' ' 285' ' ' PRO . 81.8 p -98.8 142.72 25.08 Favored Pre-proline 0 N--CA 1.475 0.808 0 C-N-CA 123.399 0.679 . . . . 0.0 109.98 -175.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . 0.639 ' HG3' HD22 ' A' ' 280' ' ' LEU . 18.8 Cg_endo -56.88 -19.97 34.03 Favored 'Trans proline' 0 C--N 1.368 1.586 0 C-N-CA 123.143 2.562 . . . . 0.0 112.477 173.015 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 31.2 ttt180 -60.55 -55.33 34.71 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.504 0.722 . . . . 0.0 110.62 170.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 321' ' ' THR . . . . . 0.421 HG21 ' O ' ' A' ' 318' ' ' THR . 12.4 t -72.17 -18.9 61.83 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -176.017 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 322' ' ' LEU . . . . . 0.586 HD22 HD22 ' A' ' 313' ' ' LEU . 47.0 mt -91.68 -18.74 23.52 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.657 0.783 . . . . 0.0 111.332 179.256 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 58.02 78.59 0.24 Allowed 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 124.606 1.162 . . . . 0.0 108.821 -169.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 66.5 mt -116.15 165.17 13.45 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.76 0.824 . . . . 0.0 109.022 174.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . -158.69 -171.62 24.76 Favored Glycine 0 C--N 1.345 1.072 0 O-C-N 122.946 0.154 . . . . 0.0 112.76 -171.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 35.1 m -64.58 -32.73 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.325 1.05 . . . . 0.0 112.102 -175.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -112.17 4.84 18.14 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.606 0.762 . . . . 0.0 111.499 -178.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -95.89 127.47 41.94 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -178.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . 0.498 HG12 ' HG2' ' A' ' 268' ' ' LYS . 6.0 mt -111.47 143.15 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 C-N-CA 123.414 0.686 . . . . 0.0 111.798 -165.028 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 27.7 pt -137.54 133.9 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 123.612 0.765 . . . . 0.0 111.168 177.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 331' ' ' ASP . . . . . 0.402 ' HB2' ' HB2' ' A' ' 307' ' ' LEU . 6.2 m-20 -72.89 111.49 8.06 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.709 1.204 . . . . 0.0 112.523 -175.588 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 332' ' ' CYS . . . . . 0.501 ' HB3' ' HA ' ' A' ' 271' ' ' CYS . 42.0 t -75.61 115.97 15.84 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 165.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . 0.416 HG22 HD11 ' A' ' 307' ' ' LEU . 99.3 t -126.12 117.84 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 123.812 0.845 . . . . 0.0 109.402 -177.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 334' ' ' VAL . . . . . 0.466 HG13 HG12 ' A' ' 299' ' ' VAL . 62.0 t -84.57 99.69 7.12 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 123.187 0.595 . . . . 0.0 109.664 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 335' ' ' LEU . . . . . 0.506 HD12 HD23 ' A' ' 305' ' ' LEU . 89.1 mt -72.88 160.08 32.7 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.863 0.865 . . . . 0.0 111.165 177.392 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 336' ' ' THR . . . . . . . . . . . . . 9.4 t -86.74 57.58 4.58 Favored 'General case' 0 CA--C 1.555 1.169 0 CA-C-O 121.979 0.895 . . . . 0.0 110.153 178.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 11.0 m -73.19 82.91 1.33 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.106 0.963 . . . . 0.0 110.208 -176.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 13.4 p . . . . . 0 CA--C 1.553 1.081 0 C-N-CA 124.642 1.177 . . . . 0.0 108.502 -176.739 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 4.1 mp . . . . . 0 N--CA 1.477 0.884 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 265' ' ' PHE . . . . . 0.467 ' CE1' ' HG2' ' A' ' 282' ' ' MET . 31.4 p90 -147.85 152.5 40.8 Favored Pre-proline 0 CA--C 1.544 0.73 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 174.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -69.27 93.64 0.48 Allowed 'Trans proline' 0 C--N 1.371 1.747 0 C-N-CA 122.383 2.055 . . . . 0.0 111.634 173.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 267' ' ' LEU . . . . . 0.513 HD12 HG13 ' A' ' 269' ' ' ILE . 1.3 tm? -60.28 127.55 32.34 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 173.548 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 268' ' ' LYS . . . . . 0.44 ' HG2' HG12 ' A' ' 329' ' ' ILE . 4.1 tppp? -91.7 103.96 16.48 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 123.763 0.665 . . . . 0.0 110.438 -179.347 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 269' ' ' ILE . . . . . 0.513 HG13 HD12 ' A' ' 267' ' ' LEU . 1.4 mp -101.82 146.14 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 174.069 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 27.8 ttp180 -106.7 118.89 37.86 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 172.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 271' ' ' CYS . . . . . 0.559 ' SG ' HD21 ' A' ' 297' ' ' LEU . 13.7 t -73.92 -158.33 0.06 Allowed 'General case' 0 CA--C 1.562 1.407 0 C-N-CA 124.473 1.109 . . . . 0.0 109.638 172.643 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 -64.94 -31.04 72.09 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 122.828 0.451 . . . . 0.0 111.791 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -160.27 22.91 0.16 Allowed 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -175.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -152.93 162.11 41.72 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 122.752 0.421 . . . . 0.0 110.596 -172.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.419 HD13 ' HD2' ' A' ' 268' ' ' LYS . 76.3 mt -107.19 129.06 54.91 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.627 0.771 . . . . 0.0 110.948 176.718 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 46.5 t -115.79 138.61 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.467 1.107 . . . . 0.0 108.668 174.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 277' ' ' ARG . . . . . 0.409 ' HA ' ' O ' ' A' ' 267' ' ' LEU . 74.5 mtm180 -116.65 130.42 56.72 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.654 0.781 . . . . 0.0 109.598 173.374 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.488 HD21 ' HA ' ' A' ' 289' ' ' VAL . 4.6 pp -128.63 144.99 54.33 Favored Pre-proline 0 N--CA 1.488 1.436 0 CA-C-O 119.245 -0.407 . . . . 0.0 110.229 172.486 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -71.95 117.87 5.35 Favored 'Trans proline' 0 C--N 1.379 2.142 0 C-N-CA 122.467 2.111 . . . . 0.0 110.677 178.167 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.768 HD21 ' HG3' ' A' ' 319' ' ' PRO . 0.2 OUTLIER -144.87 148.41 33.92 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.877 0.871 . . . . 0.0 110.103 -174.45 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 281' ' ' ARG . . . . . 0.402 ' HB2' ' HB2' ' A' ' 284' ' ' GLU . 87.7 mtm180 -86.4 152.28 22.84 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.99 0.916 . . . . 0.0 109.781 176.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 282' ' ' MET . . . . . 0.467 ' HG2' ' CE1' ' A' ' 265' ' ' PHE . 11.2 mtp -66.72 -31.77 72.64 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.127 0.489 . . . . 0.0 109.926 176.424 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 39.0 p -77.04 -18.96 57.75 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.855 1.262 . . . . 0.0 111.93 177.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 284' ' ' GLU . . . . . 0.402 ' HB2' ' HB2' ' A' ' 281' ' ' ARG . 7.6 tp10 -70.45 128.39 91.24 Favored Pre-proline 0 N--CA 1.475 0.813 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 176.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -65.65 161.55 38.23 Favored 'Trans proline' 0 C--N 1.377 2.033 0 C-N-CA 122.116 1.877 . . . . 0.0 111.554 174.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.409 ' O ' HG23 ' A' ' 290' ' ' VAL . 58.5 mt -64.63 -10.76 28.83 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 118.83 -0.605 . . . . 0.0 112.272 -178.544 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 -52.45 -27.49 16.31 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.614 0.765 . . . . 0.0 111.864 176.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 288' ' ' SER . . . . . 0.418 ' HB3' HD12 ' A' ' 280' ' ' LEU . 46.8 t -60.69 -57.06 14.3 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.831 0.852 . . . . 0.0 111.084 172.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.488 ' HA ' HD21 ' A' ' 278' ' ' LEU . 15.8 m -69.18 -30.21 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 122.494 0.317 . . . . 0.0 110.749 -178.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 290' ' ' VAL . . . . . 0.57 HG13 ' HB ' ' A' ' 304' ' ' ILE . 45.1 t -64.1 -52.37 57.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 124.323 1.049 . . . . 0.0 110.705 179.084 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -61.74 -43.72 98.3 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.293 1.037 . . . . 0.0 110.694 -179.057 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 54.5 t60 -68.09 -45.26 74.23 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.045 -176.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 293' ' ' MET . . . . . 0.474 ' HB3' ' SG ' ' A' ' 332' ' ' CYS . 92.9 mmm -68.77 -32.21 71.8 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 123.543 0.527 . . . . 0.0 110.908 178.465 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -64.42 -43.94 92.78 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.335 0.654 . . . . 0.0 110.557 177.35 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 52.5 m -68.45 -31.72 71.22 Favored 'General case' 0 CA--C 1.554 1.106 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.562 177.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -73.33 -39.01 65.57 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.304 1.041 . . . . 0.0 111.723 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 297' ' ' LEU . . . . . 0.559 HD21 ' SG ' ' A' ' 271' ' ' CYS . 71.4 mt -94.16 -8.6 38.95 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.852 0.861 . . . . 0.0 111.467 -176.612 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 76.15 20.89 76.9 Favored Glycine 0 C--N 1.349 1.258 0 O-C-N 123.505 0.503 . . . . 0.0 113.496 178.096 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 30.1 m -111.75 176.97 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 124.229 1.012 . . . . 0.0 110.865 -177.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 48.9 m -80.08 143.65 57.42 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 123.361 0.664 . . . . 0.0 110.005 175.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -54.16 -28.72 52.74 Favored 'Trans proline' 0 C--N 1.39 2.726 0 C-N-CA 123.228 2.619 . . . . 0.0 112.691 173.013 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 39.5 t -64.46 -27.55 69.07 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 122.925 0.49 . . . . 0.0 111.62 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 61.3 mtt180 -82.59 -20.08 37.16 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.562 0.745 . . . . 0.0 111.684 -176.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 304' ' ' ILE . . . . . 0.639 HD12 ' SG ' ' A' ' 332' ' ' CYS . 42.6 mm -76.68 125.56 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 123.152 0.581 . . . . 0.0 110.763 -176.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 37.9 tp -126.52 120.76 30.47 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.934 0.894 . . . . 0.0 108.664 174.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 306' ' ' LEU . . . . . 0.411 ' HG ' HD12 ' A' ' 330' ' ' ILE . 2.6 mm? -85.64 134.67 33.98 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 177.387 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 307' ' ' LEU . . . . . 0.447 HD23 ' HA ' ' A' ' 312' ' ' GLU . 94.2 mt -136.94 106.7 6.21 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.636 0.774 . . . . 0.0 109.975 -175.662 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -87.51 95.44 10.03 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 175.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 74.72 -80.74 0.9 Allowed Glycine 0 C--N 1.339 0.73 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.438 178.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -135.6 -5.65 2.24 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.966 0.906 . . . . 0.0 111.856 -177.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 11.6 t -89.37 148.91 23.25 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 117.987 0.358 . . . . 0.0 110.48 -177.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 312' ' ' GLU . . . . . 0.447 ' HA ' HD23 ' A' ' 307' ' ' LEU . 38.8 tt0 -98.64 110.74 23.29 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.363 0.665 . . . . 0.0 109.628 -178.335 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 313' ' ' LEU . . . . . 0.411 HD22 HD22 ' A' ' 322' ' ' LEU . 44.7 mt -95.42 167.75 11.13 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.742 0.417 . . . . 0.0 110.012 177.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 53.2 m -134.4 154.94 80.11 Favored Pre-proline 0 N--CA 1.48 1.06 0 C-N-CA 123.187 0.595 . . . . 0.0 109.963 -177.283 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 315' ' ' PRO . . . . . 0.502 ' HB3' HG21 ' A' ' 290' ' ' VAL . 26.9 Cg_endo -58.43 -26.94 80.0 Favored 'Trans proline' 0 C--N 1.385 2.465 0 C-N-CA 123.31 2.674 . . . . 0.0 113.309 177.36 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 20.8 m -78.5 -29.03 46.41 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 123.668 0.787 . . . . 0.0 111.406 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -66.48 143.42 57.1 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.75 0.82 . . . . 0.0 111.126 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 318' ' ' THR . . . . . . . . . . . . . 36.1 p -108.26 135.82 19.9 Favored Pre-proline 0 N--CA 1.475 0.788 0 C-N-CA 123.318 0.647 . . . . 0.0 111.072 -177.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 319' ' ' PRO . . . . . 0.768 ' HG3' HD21 ' A' ' 280' ' ' LEU . 6.4 Cg_endo -47.35 -23.04 2.91 Favored 'Trans proline' 0 C--N 1.375 1.96 0 C-N-CA 124.824 3.683 . . . . 0.0 115.088 172.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 30.3 ttt180 -60.54 -62.25 2.0 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.156 0.582 . . . . 0.0 110.834 175.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 8.9 t -68.49 -30.35 69.17 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 122.66 0.384 . . . . 0.0 111.151 -178.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 322' ' ' LEU . . . . . 0.445 ' HB2' ' HG ' ' A' ' 324' ' ' LEU . 86.4 mt -78.55 -17.91 55.44 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.288 0.635 . . . . 0.0 111.868 -178.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 83.7 tttt 64.01 38.81 8.36 Favored 'General case' 0 CA--C 1.562 1.432 0 C-N-CA 124.158 0.983 . . . . 0.0 110.882 -177.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.445 ' HG ' ' HB2' ' A' ' 322' ' ' LEU . 31.7 mt -78.52 162.6 26.21 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 122.921 0.488 . . . . 0.0 110.141 175.034 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . -166.49 -160.79 14.24 Favored Glycine 0 C--N 1.341 0.808 0 CA-C-N 116.325 -0.398 . . . . 0.0 112.887 -173.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 24.7 m -77.97 -31.68 16.98 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 C-N-CA 124.046 0.938 . . . . 0.0 111.062 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -98.65 -19.01 17.77 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.959 0.903 . . . . 0.0 110.701 178.282 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -87.2 108.25 18.84 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 -177.111 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 329' ' ' ILE . . . . . 0.44 HG12 ' HG2' ' A' ' 268' ' ' LYS . 7.7 mt -104.53 134.5 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 123.463 0.705 . . . . 0.0 111.254 -165.423 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 330' ' ' ILE . . . . . 0.411 HD12 ' HG ' ' A' ' 306' ' ' LEU . 34.6 pt -120.05 127.08 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 123.225 0.61 . . . . 0.0 111.225 -179.546 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -76.66 116.43 17.34 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.849 0.859 . . . . 0.0 111.251 -177.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 332' ' ' CYS . . . . . 0.639 ' SG ' HD12 ' A' ' 304' ' ' ILE . 36.2 t -82.77 98.42 9.1 Favored 'General case' 0 C--O 1.243 0.752 0 C-N-CA 123.587 0.755 . . . . 0.0 109.851 172.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 59.2 t -108.84 125.57 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 123.449 0.699 . . . . 0.0 109.792 -176.569 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 61.3 t -86.23 111.09 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.23 0.612 . . . . 0.0 109.401 177.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 60.7 mt . . . . . 0 N--CA 1.474 0.737 0 C-N-CA 123.57 0.748 . . . . 0.0 111.263 177.614 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 1.5 mp . . . . . 0 CA--C 1.541 0.612 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 265' ' ' PHE . . . . . 0.407 ' CE1' ' HG2' ' A' ' 282' ' ' MET . 27.6 p90 -113.46 149.04 40.94 Favored Pre-proline 0 N--CA 1.475 0.791 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 172.338 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 266' ' ' PRO . . . . . 0.508 ' HB2' ' HB3' ' A' ' 277' ' ' ARG . 56.8 Cg_endo -69.06 97.41 0.57 Allowed 'Trans proline' 0 C--N 1.372 1.765 0 C-N-CA 122.275 1.984 . . . . 0.0 111.892 175.478 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.01 119.25 13.01 Favored 'General case' 0 C--N 1.35 0.603 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 171.501 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 24.6 ttpt -95.73 109.09 21.44 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 121.652 0.739 . . . . 0.0 111.133 -178.195 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 2.8 mp -100.51 143.86 13.42 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 C-N-CA 125.083 1.353 . . . . 0.0 108.118 176.09 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 37.2 ttp180 -106.15 95.88 6.08 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 123.315 0.646 . . . . 0.0 109.94 178.06 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 271' ' ' CYS . . . . . 0.546 ' SG ' HD21 ' A' ' 297' ' ' LEU . 44.6 t -71.92 178.82 3.5 Favored 'General case' 0 C--O 1.245 0.827 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.827 170.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -59.5 -31.35 69.28 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.523 0.729 . . . . 0.0 111.995 177.356 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -147.38 14.71 1.12 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 122.843 0.457 . . . . 0.0 112.187 -177.485 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -137.31 129.58 29.52 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 122.806 0.443 . . . . 0.0 110.556 -174.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 24.1 mt -95.5 90.86 5.91 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 164.031 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 58.6 t -82.48 122.7 37.49 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.861 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.163 -175.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 277' ' ' ARG . . . . . 0.508 ' HB3' ' HB2' ' A' ' 266' ' ' PRO . 77.0 mtm180 -116.13 75.54 0.96 Allowed 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.532 HD11 HG12 ' A' ' 289' ' ' VAL . 4.6 pp -85.58 147.66 47.11 Favored Pre-proline 0 N--CA 1.483 1.204 0 CA-C-O 119.527 -0.273 . . . . 0.0 110.826 -172.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -69.17 118.48 5.7 Favored 'Trans proline' 0 C--N 1.374 1.92 0 C-N-CA 122.112 1.875 . . . . 0.0 110.719 175.223 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.73 HD21 ' HG3' ' A' ' 319' ' ' PRO . 0.8 OUTLIER -143.24 147.89 35.55 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.861 0.864 . . . . 0.0 110.242 -178.537 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 25.5 mmm180 -96.97 143.57 27.71 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.236 1.015 . . . . 0.0 109.045 174.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 282' ' ' MET . . . . . 0.431 ' HA ' ' HG2' ' A' ' 319' ' ' PRO . 44.1 mtp -61.06 -39.57 90.37 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 122.839 0.456 . . . . 0.0 111.813 -177.078 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 53.7 m -67.44 -25.37 65.88 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.6 0.76 . . . . 0.0 111.584 178.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -77.67 126.08 84.91 Favored Pre-proline 0 CA--C 1.546 0.797 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 173.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 285' ' ' PRO . . . . . 0.558 ' HA ' ' HA ' ' A' ' 318' ' ' THR . 60.2 Cg_endo -66.51 174.81 5.83 Favored 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 122.421 2.081 . . . . 0.0 113.682 -176.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.461 ' O ' HG22 ' A' ' 289' ' ' VAL . 90.8 mt -65.74 -13.2 58.87 Favored 'General case' 0 C--O 1.21 -1.007 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.643 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 26.5 tp60 -55.24 -24.08 25.88 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.198 0.599 . . . . 0.0 111.589 177.003 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 288' ' ' SER . . . . . 0.543 ' HB2' HD12 ' A' ' 280' ' ' LEU . 22.3 m -68.67 -47.68 65.89 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.941 0.897 . . . . 0.0 111.221 174.308 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.532 HG12 HD11 ' A' ' 278' ' ' LEU . 13.8 m -69.92 -34.91 62.15 Favored 'Isoleucine or valine' 0 C--N 1.365 1.253 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 177.273 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 290' ' ' VAL . . . . . 0.559 HG13 ' HB ' ' A' ' 304' ' ' ILE . 54.0 t -63.77 -43.62 98.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 124.594 1.157 . . . . 0.0 110.733 179.501 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -63.27 -45.7 90.29 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 124.088 0.868 . . . . 0.0 110.065 -179.248 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 24.6 t60 -63.43 -49.53 73.35 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.211 178.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 293' ' ' MET . . . . . 0.455 ' HG2' ' O ' ' A' ' 289' ' ' VAL . 85.5 mmm -68.19 -33.03 73.68 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 123.669 0.606 . . . . 0.0 111.057 -175.022 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -65.58 -47.16 76.71 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.373 0.669 . . . . 0.0 110.327 176.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 29.3 m -64.44 -38.23 90.29 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 123.403 0.681 . . . . 0.0 111.104 177.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 78.9 t60 -67.0 -39.24 87.05 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.341 1.056 . . . . 0.0 111.047 -178.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 297' ' ' LEU . . . . . 0.546 HD21 ' SG ' ' A' ' 271' ' ' CYS . 40.8 mt -95.93 -3.63 44.88 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.845 0.858 . . . . 0.0 111.416 -178.671 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 71.65 14.33 75.14 Favored Glycine 0 N--CA 1.476 1.333 0 C-N-CA 123.075 0.369 . . . . 0.0 113.769 177.303 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 299' ' ' VAL . . . . . 0.481 HG11 HG11 ' A' ' 334' ' ' VAL . 33.0 m -101.91 173.41 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.042 0.937 . . . . 0.0 110.624 -178.558 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 300' ' ' SER . . . . . 0.443 ' HB2' ' HG3' ' A' ' 303' ' ' ARG . 16.5 m -79.97 151.59 73.46 Favored Pre-proline 0 CA--C 1.555 1.162 0 C-N-CA 123.141 0.576 . . . . 0.0 110.042 178.511 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -56.08 -29.11 73.07 Favored 'Trans proline' 0 C--N 1.385 2.459 0 C-N-CA 123.193 2.595 . . . . 0.0 113.216 177.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 33.5 t -69.31 -18.71 63.85 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.633 0.373 . . . . 0.0 111.212 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 303' ' ' ARG . . . . . 0.443 ' HG3' ' HB2' ' A' ' 300' ' ' SER . 52.1 mtt-85 -90.17 -12.91 36.79 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.246 0.618 . . . . 0.0 111.811 -174.103 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 304' ' ' ILE . . . . . 0.559 ' HB ' HG13 ' A' ' 290' ' ' VAL . 49.7 mm -86.77 117.59 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 122.944 0.498 . . . . 0.0 110.233 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 40.3 tp -114.02 120.08 39.37 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.665 0.786 . . . . 0.0 109.205 174.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 306' ' ' LEU . . . . . 0.421 HD21 HG22 ' A' ' 290' ' ' VAL . 2.8 mm? -91.36 136.74 32.89 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 177.182 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 307' ' ' LEU . . . . . 0.498 HD23 ' HA ' ' A' ' 312' ' ' GLU . 75.5 mt -134.28 106.96 7.38 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.602 0.761 . . . . 0.0 109.471 -177.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 308' ' ' PHE . . . . . 0.553 ' HB2' HD11 ' A' ' 313' ' ' LEU . 44.8 t80 -85.84 90.28 8.01 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -178.336 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 64.94 -88.89 0.09 OUTLIER Glycine 0 C--N 1.349 1.289 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.818 -178.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -129.9 70.26 1.43 Allowed 'General case' 0 C--O 1.242 0.705 0 C-N-CA 124.191 0.996 . . . . 0.0 109.667 176.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 10.0 t -169.23 150.87 4.45 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.691 0.796 . . . . 0.0 109.533 170.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 312' ' ' GLU . . . . . 0.498 ' HA ' HD23 ' A' ' 307' ' ' LEU . 36.3 tt0 -92.97 134.48 35.07 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 177.469 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 313' ' ' LEU . . . . . 0.553 HD11 ' HB2' ' A' ' 308' ' ' PHE . 49.7 mt -117.52 149.7 40.18 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.014 0.526 . . . . 0.0 110.551 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 50.9 m -108.24 149.88 39.8 Favored Pre-proline 0 CA--C 1.551 1.016 0 C-N-CA 123.688 0.795 . . . . 0.0 110.472 179.152 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 315' ' ' PRO . . . . . 0.515 ' HB3' HG21 ' A' ' 290' ' ' VAL . 12.1 Cg_endo -56.14 -39.94 88.03 Favored 'Trans proline' 0 C--N 1.383 2.349 0 C-N-CA 123.325 2.684 . . . . 0.0 112.639 173.013 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 41.7 p -75.5 -18.23 59.88 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.22 0.608 . . . . 0.0 112.182 -177.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -74.27 142.61 45.26 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.102 0.561 . . . . 0.0 109.493 174.156 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 318' ' ' THR . . . . . 0.558 ' HA ' ' HA ' ' A' ' 285' ' ' PRO . 75.5 p -98.28 146.27 31.25 Favored Pre-proline 0 N--CA 1.473 0.71 0 C-N-CA 122.977 0.511 . . . . 0.0 110.533 -176.523 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 319' ' ' PRO . . . . . 0.73 ' HG3' HD21 ' A' ' 280' ' ' LEU . 31.6 Cg_endo -62.07 -14.33 36.96 Favored 'Trans proline' 0 C--N 1.365 1.418 0 C-N-CA 122.903 2.402 . . . . 0.0 111.962 168.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 43.6 ttt85 -61.55 -58.21 9.03 Favored 'General case' 0 C--N 1.352 0.711 0 C-N-CA 123.505 0.722 . . . . 0.0 110.761 172.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 10.1 t -66.83 -32.36 73.59 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 122.544 0.338 . . . . 0.0 111.461 -178.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 322' ' ' LEU . . . . . . . . . . . . . 47.7 mt -77.95 -20.66 52.31 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.311 0.644 . . . . 0.0 111.21 177.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 20.7 tptm 55.14 63.19 2.19 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.397 1.479 . . . . 0.0 110.914 -174.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 76.4 mt -90.25 170.05 10.6 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.04 178.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 325' ' ' GLY . . . . . 0.468 ' H ' ' HB2' ' A' ' 328' ' ' ASP . . . -162.54 -161.14 11.78 Favored Glycine 0 C--N 1.339 0.729 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.047 -171.135 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 31.5 m -76.89 -19.75 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 123.633 0.773 . . . . 0.0 111.872 -176.348 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -111.52 -17.34 13.09 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.833 0.853 . . . . 0.0 111.424 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 328' ' ' ASP . . . . . 0.468 ' HB2' ' H ' ' A' ' 325' ' ' GLY . 49.0 m-20 -75.71 101.05 4.88 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 177.181 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 46.1 mt -95.29 134.54 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 123.567 0.747 . . . . 0.0 110.404 -175.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 37.4 pt -121.97 127.23 75.3 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.929 0 C-N-CA 123.568 0.747 . . . . 0.0 110.114 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 331' ' ' ASP . . . . . 0.418 ' O ' ' HA ' ' A' ' 306' ' ' LEU . 5.1 m-20 -74.46 126.99 31.93 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.042 0.937 . . . . 0.0 111.778 -175.067 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 332' ' ' CYS . . . . . 0.475 ' SG ' HD12 ' A' ' 304' ' ' ILE . 52.5 t -93.76 93.41 7.97 Favored 'General case' 0 C--O 1.244 0.794 0 C-N-CA 123.983 0.913 . . . . 0.0 109.74 175.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 71.8 t -100.42 122.47 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 123.53 0.732 . . . . 0.0 109.573 177.219 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 334' ' ' VAL . . . . . 0.481 HG11 HG11 ' A' ' 299' ' ' VAL . 94.0 t -87.78 112.92 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 122.906 0.482 . . . . 0.0 110.265 177.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 84.0 mt . . . . . 0 N--CA 1.47 0.559 0 C-N-CA 124.069 0.948 . . . . 0.0 109.093 171.532 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 3.4 mp . . . . . 0 C--O 1.24 0.583 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -106.56 147.6 35.27 Favored Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 123.839 0.856 . . . . 0.0 109.111 176.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -63.84 95.58 0.2 Allowed 'Trans proline' 0 C--N 1.376 1.988 0 C-N-CA 122.478 2.118 . . . . 0.0 111.812 172.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 267' ' ' LEU . . . . . 0.466 HD12 HG13 ' A' ' 269' ' ' ILE . 1.5 tm? -62.89 130.59 45.5 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 173.174 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 268' ' ' LYS . . . . . 0.549 ' HG2' HG12 ' A' ' 329' ' ' ILE . 3.8 tppp? -94.51 107.39 19.37 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 123.539 0.736 . . . . 0.0 110.244 -177.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 269' ' ' ILE . . . . . 0.466 HG13 HD12 ' A' ' 267' ' ' LEU . 2.1 mp -106.56 131.96 55.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 175.23 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 270' ' ' ARG . . . . . 0.429 ' HB2' ' CG2' ' A' ' 329' ' ' ILE . 26.4 ttm180 -91.63 111.38 22.88 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 171.21 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 271' ' ' CYS . . . . . 0.604 ' SG ' HD21 ' A' ' 297' ' ' LEU . 16.5 t -75.53 -166.69 0.57 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 122.634 0.373 . . . . 0.0 110.222 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 272' ' ' ARG . . . . . 0.437 ' HG2' ' SG ' ' A' ' 271' ' ' CYS . 23.4 ptt180 -53.55 -27.76 27.88 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.354 1.062 . . . . 0.0 112.992 172.304 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -139.3 -63.49 0.52 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.019 0.528 . . . . 0.0 111.502 -177.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -107.48 163.44 13.05 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 123.692 0.797 . . . . 0.0 111.191 -170.21 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.533 HD13 ' HD2' ' A' ' 268' ' ' LYS . 96.0 mt -78.7 127.18 31.74 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 123.828 0.851 . . . . 0.0 111.898 -179.344 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 85.7 t -99.66 139.31 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 170.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 277' ' ' ARG . . . . . 0.448 ' HD3' ' HE2' ' A' ' 268' ' ' LYS . 62.9 mtm180 -128.19 122.49 31.97 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.794 0.838 . . . . 0.0 108.915 177.512 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 4.2 pp -131.08 139.65 36.19 Favored Pre-proline 0 N--CA 1.485 1.293 0 CA-C-O 119.379 -0.343 . . . . 0.0 110.52 177.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -70.77 107.62 2.09 Favored 'Trans proline' 0 C--N 1.382 2.313 0 C-N-CA 122.622 2.215 . . . . 0.0 110.618 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.706 HD21 ' HG3' ' A' ' 319' ' ' PRO . 0.1 OUTLIER -124.92 151.94 44.73 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.214 1.006 . . . . 0.0 110.274 -175.933 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 281' ' ' ARG . . . . . 0.566 ' HB2' ' HB2' ' A' ' 284' ' ' GLU . 58.5 mtm180 -89.97 153.82 20.31 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.973 0.909 . . . . 0.0 109.688 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 282' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -66.54 -44.55 82.08 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 122.572 0.349 . . . . 0.0 110.591 178.472 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 49.9 m -70.39 -20.3 62.95 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.39 0.676 . . . . 0.0 112.061 178.105 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 284' ' ' GLU . . . . . 0.566 ' HB2' ' HB2' ' A' ' 281' ' ' ARG . 6.7 tp10 -65.57 126.34 91.39 Favored Pre-proline 0 CA--C 1.542 0.639 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 176.191 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -65.06 168.25 14.32 Favored 'Trans proline' 0 C--N 1.368 1.595 0 C-N-CA 121.98 1.786 . . . . 0.0 111.707 172.152 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.425 ' O ' HG23 ' A' ' 290' ' ' VAL . 62.6 mt -64.95 -15.43 62.15 Favored 'General case' 0 C--O 1.214 -0.809 0 CA-C-O 118.837 -0.601 . . . . 0.0 111.263 -178.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 287' ' ' GLN . . . . . 0.462 ' HA ' ' HB ' ' A' ' 290' ' ' VAL . 24.0 tp60 -52.25 -23.54 5.86 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 123.71 0.804 . . . . 0.0 112.402 178.454 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 288' ' ' SER . . . . . 0.504 ' HB3' HD12 ' A' ' 280' ' ' LEU . 37.9 t -58.61 -60.95 3.0 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.337 0.655 . . . . 0.0 110.69 168.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 15.2 m -68.98 -29.82 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 122.821 0.448 . . . . 0.0 111.065 -178.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 290' ' ' VAL . . . . . 0.477 HG13 ' HB ' ' A' ' 304' ' ' ILE . 76.4 t -66.46 -51.85 53.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 123.782 0.833 . . . . 0.0 109.974 -178.639 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -70.18 -37.95 75.28 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.815 0.846 . . . . 0.0 111.017 -178.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 13.1 t60 -66.04 -50.65 63.43 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.033 0.533 . . . . 0.0 110.142 -178.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 293' ' ' MET . . . . . 0.413 ' HG3' HG21 ' A' ' 269' ' ' ILE . 94.6 mmm -63.68 -37.3 86.82 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 123.8 0.687 . . . . 0.0 110.784 178.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -61.48 -51.27 69.36 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 123.847 0.717 . . . . 0.0 111.591 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 9.8 m -68.22 -30.84 70.0 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 123.186 0.595 . . . . 0.0 110.838 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -71.45 -35.39 70.88 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.577 0.751 . . . . 0.0 111.26 178.064 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 297' ' ' LEU . . . . . 0.604 HD21 ' SG ' ' A' ' 271' ' ' CYS . 95.9 mt -96.14 -10.62 27.79 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.745 0.818 . . . . 0.0 112.007 -177.407 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 80.29 16.84 75.37 Favored Glycine 0 CA--C 1.534 1.227 0 O-C-N 123.379 0.424 . . . . 0.0 113.485 178.226 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 299' ' ' VAL . . . . . 0.483 HG11 HG11 ' A' ' 334' ' ' VAL . 28.7 m -109.17 173.92 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 124.08 0.952 . . . . 0.0 111.003 178.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 22.8 m -80.07 147.32 65.2 Favored Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 123.306 0.643 . . . . 0.0 110.724 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.09 -23.49 73.56 Favored 'Trans proline' 0 C--N 1.383 2.394 0 C-N-CA 122.72 2.28 . . . . 0.0 112.334 170.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 48.6 p -69.95 -15.41 63.04 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-O 121.041 0.448 . . . . 0.0 111.574 176.168 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -102.98 -15.56 16.08 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.106 0.962 . . . . 0.0 111.824 -175.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 304' ' ' ILE . . . . . 0.58 HD12 ' SG ' ' A' ' 332' ' ' CYS . 36.2 mm -83.84 110.06 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 176.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 37.5 tp -114.08 114.93 26.77 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.614 0.766 . . . . 0.0 109.362 178.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 306' ' ' LEU . . . . . 0.476 ' HG ' HD12 ' A' ' 330' ' ' ILE . 3.2 mm? -86.99 124.14 32.85 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 307' ' ' LEU . . . . . 0.433 HD12 HG21 ' A' ' 333' ' ' VAL . 41.3 mt -133.88 108.86 8.68 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 308' ' ' PHE . . . . . 0.484 ' HB2' HG22 ' A' ' 330' ' ' ILE . 71.0 t80 -75.67 86.82 2.72 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 174.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 68.17 -84.99 0.17 Allowed Glycine 0 C--N 1.349 1.257 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.963 -179.348 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -133.66 75.24 1.59 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.319 1.048 . . . . 0.0 109.11 177.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 15.2 t -159.1 151.75 21.72 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.318 1.047 . . . . 0.0 108.309 171.179 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -104.13 114.41 28.63 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 122.856 0.462 . . . . 0.0 109.868 -176.345 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 30.1 mt -117.88 142.78 46.94 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.199 0.6 . . . . 0.0 109.92 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 60.7 m -109.31 159.49 31.13 Favored Pre-proline 0 CA--C 1.556 1.203 0 C-N-CA 123.808 0.843 . . . . 0.0 110.952 -178.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_exo -56.86 -32.07 90.93 Favored 'Trans proline' 0 C--N 1.39 2.739 0 C-N-CA 123.202 2.601 . . . . 0.0 112.573 172.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 45.7 p -70.65 -29.6 65.99 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 114.922 -1.035 . . . . 0.0 111.715 -179.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -68.02 138.24 55.7 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.628 0.771 . . . . 0.0 110.706 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 318' ' ' THR . . . . . . . . . . . . . 71.2 p -98.49 140.23 21.68 Favored Pre-proline 0 CA--C 1.543 0.702 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 178.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 319' ' ' PRO . . . . . 0.706 ' HG3' HD21 ' A' ' 280' ' ' LEU . 19.8 Cg_endo -55.2 -17.12 14.41 Favored 'Trans proline' 0 C--N 1.367 1.512 0 C-N-CA 123.529 2.819 . . . . 0.0 112.878 171.224 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 50.5 ttt-85 -67.43 -55.85 12.02 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.441 0.696 . . . . 0.0 110.395 172.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 13.7 t -71.32 -22.01 61.99 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.633 0.373 . . . . 0.0 111.427 -177.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 322' ' ' LEU . . . . . 0.469 ' HB2' ' HG ' ' A' ' 324' ' ' LEU . 58.2 mt -90.9 -16.63 27.83 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.412 0.685 . . . . 0.0 110.996 177.365 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 19.7 tptm 65.45 32.31 9.65 Favored 'General case' 0 CA--C 1.562 1.416 0 C-N-CA 124.962 1.305 . . . . 0.0 111.408 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.469 ' HG ' ' HB2' ' A' ' 322' ' ' LEU . 33.8 mt -69.8 172.5 7.54 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 123.605 0.762 . . . . 0.0 111.175 178.204 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 325' ' ' GLY . . . . . 0.445 ' H ' ' HB3' ' A' ' 328' ' ' ASP . . . -167.9 -164.64 23.93 Favored Glycine 0 C--N 1.347 1.152 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.942 -177.167 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 33.1 m -73.6 -28.81 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 124.168 0.987 . . . . 0.0 111.578 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -88.35 -25.86 22.52 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.533 0.733 . . . . 0.0 111.053 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 328' ' ' ASP . . . . . 0.445 ' HB3' ' H ' ' A' ' 325' ' ' GLY . 12.9 t70 -76.87 130.46 37.62 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.077 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 329' ' ' ILE . . . . . 0.549 HG12 ' HG2' ' A' ' 268' ' ' LYS . 5.9 mt -121.87 99.63 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 122.984 0.513 . . . . 0.0 110.605 -171.795 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 330' ' ' ILE . . . . . 0.484 HG22 ' HB2' ' A' ' 308' ' ' PHE . 25.0 pt -87.54 126.78 41.17 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 C-N-CA 122.679 0.392 . . . . 0.0 111.086 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -79.05 118.33 20.93 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.552 0.741 . . . . 0.0 110.588 -175.249 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 332' ' ' CYS . . . . . 0.58 ' SG ' HD12 ' A' ' 304' ' ' ILE . 43.2 t -78.04 90.1 4.2 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.439 1.096 . . . . 0.0 110.191 176.535 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 333' ' ' VAL . . . . . 0.433 HG21 HD12 ' A' ' 307' ' ' LEU . 74.0 t -94.75 110.68 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 123.322 0.649 . . . . 0.0 109.355 -177.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 334' ' ' VAL . . . . . 0.483 HG11 HG11 ' A' ' 299' ' ' VAL . 62.0 t -81.42 94.53 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 CA-C-O 121.319 0.58 . . . . 0.0 110.014 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 60.3 mt . . . . . 0 CA--C 1.546 0.799 0 C-N-CA 124.536 1.134 . . . . 0.0 108.971 170.745 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 2.9 mp . . . . . 0 N--CA 1.483 1.175 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 265' ' ' PHE . . . . . 0.476 ' CE1' ' HG2' ' A' ' 282' ' ' MET . 28.0 p90 -109.32 146.15 33.33 Favored Pre-proline 0 CA--C 1.55 0.948 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 176.572 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -64.19 98.65 0.27 Allowed 'Trans proline' 0 C--N 1.378 2.091 0 C-N-CA 122.573 2.182 . . . . 0.0 111.904 171.434 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 267' ' ' LEU . . . . . 0.528 HD12 HG13 ' A' ' 269' ' ' ILE . 1.2 tm? -61.8 130.43 45.7 Favored 'General case' 0 C--O 1.244 0.8 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 172.119 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -94.55 104.43 16.38 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 269' ' ' ILE . . . . . 0.528 HG13 HD12 ' A' ' 267' ' ' LEU . 2.9 mp -97.86 133.81 38.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 123.334 0.653 . . . . 0.0 109.257 176.384 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 270' ' ' ARG . . . . . 0.584 ' HB3' ' HA ' ' A' ' 331' ' ' ASP . 5.4 tpm_? -85.16 106.47 16.63 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 170.53 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 271' ' ' CYS . . . . . 0.479 ' SG ' HD21 ' A' ' 297' ' ' LEU . 41.8 t -74.28 176.8 6.33 Favored 'General case' 0 C--O 1.247 0.935 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 170.761 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -51.1 -36.11 38.63 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.235 1.014 . . . . 0.0 112.756 -178.047 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -156.62 22.9 0.34 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.179 0.592 . . . . 0.0 111.608 178.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -146.97 179.99 7.21 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 178.336 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.524 HD23 ' HA ' ' A' ' 270' ' ' ARG . 91.5 mt -121.11 126.3 49.41 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.018 0.927 . . . . 0.0 109.729 174.662 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 97.7 t -100.01 141.7 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 124.121 0.969 . . . . 0.0 108.522 174.556 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 39.4 mtt180 -128.5 122.74 31.86 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 178.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.468 HD11 HG12 ' A' ' 289' ' ' VAL . 4.2 pp -134.86 143.32 45.78 Favored Pre-proline 0 N--CA 1.491 1.587 0 CA-C-N 118.139 0.427 . . . . 0.0 110.925 176.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.33 120.28 6.86 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 122.498 2.132 . . . . 0.0 110.865 175.427 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.665 HD21 ' HG3' ' A' ' 319' ' ' PRO . 0.0 OUTLIER -141.96 145.87 34.99 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.828 0.851 . . . . 0.0 109.932 -177.15 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 281' ' ' ARG . . . . . 0.416 ' HB2' ' HB2' ' A' ' 284' ' ' GLU . 48.5 mtt85 -79.35 147.71 32.31 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.835 0.854 . . . . 0.0 108.729 176.455 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 282' ' ' MET . . . . . 0.476 ' HG2' ' CE1' ' A' ' 265' ' ' PHE . 26.8 mtp -66.62 -32.03 73.1 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 118.292 0.497 . . . . 0.0 109.878 174.434 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 38.8 p -72.06 -29.19 63.89 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.716 1.207 . . . . 0.0 112.007 178.125 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 284' ' ' GLU . . . . . 0.458 ' O ' ' HD2' ' A' ' 319' ' ' PRO . 18.5 tp10 -66.46 129.85 94.15 Favored Pre-proline 0 N--CA 1.474 0.772 0 C-N-CA 124.282 1.033 . . . . 0.0 109.269 177.369 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -65.07 166.5 18.54 Favored 'Trans proline' 0 C--N 1.377 2.037 0 C-N-CA 122.012 1.808 . . . . 0.0 111.567 174.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.431 ' O ' HG23 ' A' ' 290' ' ' VAL . 71.7 mt -65.59 -11.63 45.91 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 118.65 -0.691 . . . . 0.0 112.292 -177.143 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 287' ' ' GLN . . . . . 0.433 ' HA ' ' HB ' ' A' ' 290' ' ' VAL . 7.1 tp-100 -55.62 -22.06 20.66 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.167 0.587 . . . . 0.0 112.013 178.235 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 288' ' ' SER . . . . . 0.476 ' HB3' HD12 ' A' ' 280' ' ' LEU . 33.5 t -60.34 -57.11 14.16 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 123.292 0.637 . . . . 0.0 110.566 170.021 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.468 HG12 HD11 ' A' ' 278' ' ' LEU . 18.1 m -71.83 -28.73 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 122.725 0.41 . . . . 0.0 111.531 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 290' ' ' VAL . . . . . 0.532 HG13 ' HB ' ' A' ' 304' ' ' ILE . 73.3 t -67.03 -51.12 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.809 0.844 . . . . 0.0 110.333 -179.151 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -69.8 -36.58 75.8 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.428 0.691 . . . . 0.0 111.44 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -66.21 -48.65 69.92 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.325 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 293' ' ' MET . . . . . 0.445 ' HG3' HG21 ' A' ' 269' ' ' ILE . 94.0 mmm -67.7 -29.17 68.36 Favored 'General case' 0 N--CA 1.479 0.976 0 O-C-N 123.918 0.761 . . . . 0.0 110.958 178.647 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -61.44 -49.5 76.59 Favored 'General case' 0 C--O 1.219 -0.516 0 O-C-N 123.65 0.594 . . . . 0.0 110.657 174.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 33.0 m -70.68 -31.81 68.83 Favored 'General case' 0 CA--C 1.549 0.909 0 O-C-N 123.512 0.508 . . . . 0.0 111.045 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 80.8 t60 -69.22 -35.49 76.23 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 123.733 0.813 . . . . 0.0 111.034 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 297' ' ' LEU . . . . . 0.479 HD21 ' SG ' ' A' ' 271' ' ' CYS . 67.7 mt -101.38 -4.07 27.61 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 124.052 0.941 . . . . 0.0 111.339 -179.556 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 78.63 12.08 84.6 Favored Glycine 0 C--N 1.351 1.398 0 C-N-CA 123.481 0.563 . . . . 0.0 114.073 173.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 299' ' ' VAL . . . . . 0.473 HG11 HG11 ' A' ' 334' ' ' VAL . 33.9 m -106.1 -176.53 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 124.266 1.026 . . . . 0.0 111.293 -178.002 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 42.7 m -84.29 148.29 52.46 Favored Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 123.749 0.82 . . . . 0.0 110.327 177.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -57.27 -30.58 88.06 Favored 'Trans proline' 0 C--N 1.379 2.166 0 C-N-CA 123.357 2.705 . . . . 0.0 112.144 172.328 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 20.4 m -70.5 -12.02 61.3 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 123.26 0.624 . . . . 0.0 112.006 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 75.8 mtt180 -95.94 -24.17 16.53 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.142 0.977 . . . . 0.0 110.923 176.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 304' ' ' ILE . . . . . 0.549 HD12 ' SG ' ' A' ' 332' ' ' CYS . 34.5 mm -78.45 122.9 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 123.016 0.526 . . . . 0.0 110.499 -178.448 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 36.8 tp -126.2 116.36 21.19 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.822 0.849 . . . . 0.0 109.033 177.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -85.06 135.06 34.16 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 177.415 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 74.3 mt -134.17 115.21 13.94 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.299 1.04 . . . . 0.0 109.208 -176.263 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -83.77 88.08 7.08 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 174.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 74.88 -81.87 0.87 Allowed Glycine 0 C--N 1.35 1.336 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.856 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -118.32 -32.13 4.75 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.07 0.948 . . . . 0.0 110.403 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 6.0 t -74.6 141.68 44.69 Favored 'General case' 0 C--O 1.245 0.859 0 CA-C-O 121.016 0.436 . . . . 0.0 110.249 -170.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -93.45 116.9 29.44 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.73 -175.039 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 313' ' ' LEU . . . . . 0.442 HD13 HD13 ' A' ' 322' ' ' LEU . 47.2 mt -95.67 164.87 12.59 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.784 0.434 . . . . 0.0 110.17 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 49.8 m -123.1 147.47 51.82 Favored Pre-proline 0 N--CA 1.479 1.015 0 C-N-CA 123.436 0.694 . . . . 0.0 109.734 -178.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -55.83 -29.02 70.36 Favored 'Trans proline' 0 C--N 1.383 2.36 0 C-N-CA 122.976 2.451 . . . . 0.0 113.036 173.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 29.4 p -76.01 -29.53 58.17 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.621 0.768 . . . . 0.0 111.837 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -65.6 143.5 57.57 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.141 0.576 . . . . 0.0 110.747 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 318' ' ' THR . . . . . . . . . . . . . 78.0 p -100.32 141.21 22.29 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 122.903 0.481 . . . . 0.0 110.408 -178.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 319' ' ' PRO . . . . . 0.665 ' HG3' HD21 ' A' ' 280' ' ' LEU . 19.2 Cg_endo -55.92 -16.89 17.21 Favored 'Trans proline' 0 C--N 1.37 1.708 0 C-N-CA 123.789 2.993 . . . . 0.0 113.48 171.233 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 53.0 ttt180 -67.66 -54.9 15.78 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 122.836 0.454 . . . . 0.0 110.346 175.344 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 13.7 t -71.09 -21.93 62.16 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 122.844 0.458 . . . . 0.0 111.97 -177.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 322' ' ' LEU . . . . . 0.442 HD13 HD13 ' A' ' 313' ' ' LEU . 53.8 mt -88.87 -18.92 26.59 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.648 0.779 . . . . 0.0 111.161 176.528 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 20.9 tptm 56.63 53.02 8.89 Favored 'General case' 0 CA--C 1.56 1.351 0 C-N-CA 125.044 1.337 . . . . 0.0 110.842 -175.288 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.425 HD12 ' HB3' ' A' ' 319' ' ' PRO . 61.5 mt -79.71 164.84 23.41 Favored 'General case' 0 C--O 1.246 0.9 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.375 173.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 325' ' ' GLY . . . . . 0.433 ' H ' ' HB3' ' A' ' 328' ' ' ASP . . . -160.08 -175.84 31.5 Favored Glycine 0 C--N 1.34 0.801 0 CA-C-N 116.372 -0.376 . . . . 0.0 113.087 -173.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 35.2 m -70.21 -28.93 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.119 0.968 . . . . 0.0 111.046 176.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -105.74 15.26 27.07 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.595 1.158 . . . . 0.0 110.658 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 328' ' ' ASP . . . . . 0.433 ' HB3' ' H ' ' A' ' 325' ' ' GLY . 10.9 t70 -123.8 124.81 43.52 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 177.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 3.1 mt -113.37 146.38 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 O-C-N 123.708 0.63 . . . . 0.0 110.622 -169.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 24.1 pt -133.72 129.71 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 123.646 0.779 . . . . 0.0 110.944 179.025 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 331' ' ' ASP . . . . . 0.584 ' HA ' ' HB3' ' A' ' 270' ' ' ARG . 5.4 m-20 -74.56 114.43 12.96 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.75 1.22 . . . . 0.0 112.351 -173.631 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 332' ' ' CYS . . . . . 0.549 ' SG ' HD12 ' A' ' 304' ' ' ILE . 42.6 t -83.46 97.48 9.01 Favored 'General case' 0 C--O 1.243 0.729 0 C-N-CA 124.246 1.018 . . . . 0.0 110.136 173.7 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 89.0 t -102.1 122.5 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 123.747 0.819 . . . . 0.0 109.936 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 334' ' ' VAL . . . . . 0.473 HG11 HG11 ' A' ' 299' ' ' VAL . 90.2 t -85.62 102.93 11.99 Favored 'Isoleucine or valine' 0 C--O 1.242 0.683 0 C-N-CA 123.176 0.591 . . . . 0.0 109.514 175.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 81.1 mt . . . . . 0 C--O 1.242 0.693 0 C-N-CA 123.349 0.659 . . . . 0.0 109.753 171.708 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 0.408 HD13 ' HB2' ' A' ' 279' ' ' PRO . 0.4 OUTLIER . . . . . 0 N--CA 1.474 0.772 0 CA-C-O 121.357 0.599 . . . . 0.0 110.361 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 265' ' ' PHE . . . . . 0.527 ' CE1' ' SD ' ' A' ' 282' ' ' MET . 11.0 p90 -130.9 149.15 72.89 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 124.409 1.083 . . . . 0.0 108.942 -172.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 266' ' ' PRO . . . . . 0.524 ' HB2' ' HB3' ' A' ' 277' ' ' ARG . 45.7 Cg_endo -66.03 92.28 0.26 Allowed 'Trans proline' 0 C--N 1.369 1.656 0 C-N-CA 122.42 2.08 . . . . 0.0 112.086 173.133 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 267' ' ' LEU . . . . . 0.462 HD12 HG13 ' A' ' 269' ' ' ILE . 1.6 tm? -61.52 127.51 31.81 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 170.473 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 268' ' ' LYS . . . . . 0.488 ' HG2' HG12 ' A' ' 329' ' ' ILE . 3.9 ttpt -91.08 111.65 23.21 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-O 121.5 0.666 . . . . 0.0 110.699 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 269' ' ' ILE . . . . . 0.494 HG21 ' HG3' ' A' ' 293' ' ' MET . 1.9 mp -106.81 133.59 50.94 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 C-N-CA 124.198 0.999 . . . . 0.0 108.306 176.467 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 270' ' ' ARG . . . . . 0.6 ' HB2' HG22 ' A' ' 329' ' ' ILE . 28.2 ttp180 -99.97 101.08 12.08 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 123.924 0.889 . . . . 0.0 109.997 178.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 271' ' ' CYS . . . . . 0.753 ' SG ' HD21 ' A' ' 297' ' ' LEU . 49.0 t -70.05 177.43 3.21 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.918 172.514 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 272' ' ' ARG . . . . . 0.538 ' HG2' ' SG ' ' A' ' 271' ' ' CYS . 38.8 ptt180 -43.14 -40.84 3.43 Favored 'General case' 0 CA--C 1.559 1.299 0 C-N-CA 125.372 1.469 . . . . 0.0 113.147 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -152.03 6.09 0.43 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.588 0.755 . . . . 0.0 111.31 174.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -115.57 158.09 23.15 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.449 1.1 . . . . 0.0 109.848 -174.199 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -119.76 117.87 29.36 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.533 0.733 . . . . 0.0 109.45 175.279 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 276' ' ' VAL . . . . . 0.418 HG21 ' SD ' ' A' ' 293' ' ' MET . 67.8 t -102.04 137.89 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.168 0.987 . . . . 0.0 108.452 171.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 277' ' ' ARG . . . . . 0.524 ' HB3' ' HB2' ' A' ' 266' ' ' PRO . 83.7 mtm180 -128.37 95.66 4.21 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 173.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.512 HD21 ' HA ' ' A' ' 289' ' ' VAL . 4.2 pp -109.74 142.45 25.82 Favored Pre-proline 0 N--CA 1.487 1.403 0 CA-C-O 119.39 -0.338 . . . . 0.0 110.868 -173.231 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 279' ' ' PRO . . . . . 0.408 ' HB2' HD13 ' A' ' 264' ' ' LEU . 73.4 Cg_endo -70.69 86.74 0.7 Allowed 'Trans proline' 0 C--N 1.383 2.361 0 C-N-CA 122.945 2.43 . . . . 0.0 112.279 -176.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.64 HD21 ' HG3' ' A' ' 319' ' ' PRO . 3.0 tt -95.94 144.43 26.26 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 114.768 -1.105 . . . . 0.0 109.502 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 281' ' ' ARG . . . . . 0.588 ' HB2' ' HB2' ' A' ' 284' ' ' GLU . 32.3 mtm180 -90.0 143.73 26.53 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.943 0.897 . . . . 0.0 110.415 178.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 282' ' ' MET . . . . . 0.527 ' SD ' ' CE1' ' A' ' 265' ' ' PHE . 87.2 mmm -64.18 -33.38 75.67 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 122.803 0.441 . . . . 0.0 111.621 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 35.6 t -86.94 -0.82 57.2 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.469 0.708 . . . . 0.0 111.524 178.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 284' ' ' GLU . . . . . 0.588 ' HB2' ' HB2' ' A' ' 281' ' ' ARG . 6.8 tp10 -91.33 134.82 29.01 Favored Pre-proline 0 CA--C 1.538 0.488 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 174.086 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.07 170.71 8.62 Favored 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 121.897 1.732 . . . . 0.0 111.683 170.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.419 ' O ' HG23 ' A' ' 290' ' ' VAL . 84.1 mt -67.53 -11.42 57.95 Favored 'General case' 0 C--O 1.219 -0.548 0 C-N-CA 123.153 0.581 . . . . 0.0 111.714 -178.14 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 287' ' ' GLN . . . . . 0.564 ' HA ' ' HB ' ' A' ' 290' ' ' VAL . 8.0 tp-100 -55.05 -20.66 10.07 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 123.136 0.574 . . . . 0.0 111.95 175.573 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 288' ' ' SER . . . . . 0.63 ' HB3' HD12 ' A' ' 280' ' ' LEU . 47.4 t -60.7 -54.62 43.04 Favored 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 123.011 0.524 . . . . 0.0 111.19 169.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.512 ' HA ' HD21 ' A' ' 278' ' ' LEU . 34.9 m -69.83 -35.56 65.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 CA-C-N 117.716 0.235 . . . . 0.0 110.974 177.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 290' ' ' VAL . . . . . 0.587 HG13 ' HB ' ' A' ' 304' ' ' ILE . 76.9 t -61.2 -41.9 91.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 123.995 0.918 . . . . 0.0 111.078 -179.364 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -69.88 -47.48 62.44 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.694 0.798 . . . . 0.0 110.837 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 292' ' ' HIS . . . . . 0.459 ' HB3' HD22 ' A' ' 278' ' ' LEU . 9.8 t60 -71.68 -36.64 70.67 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.135 -174.213 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 293' ' ' MET . . . . . 0.494 ' HG3' HG21 ' A' ' 269' ' ' ILE . 95.6 mmm -72.36 -29.88 64.2 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.367 0.667 . . . . 0.0 110.514 177.69 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -63.35 -44.7 94.09 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 123.776 0.673 . . . . 0.0 110.847 175.008 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 24.2 m -70.85 -31.38 68.06 Favored 'General case' 0 CA--C 1.552 1.026 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.052 176.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -71.66 -30.14 65.4 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.959 0.904 . . . . 0.0 111.709 179.159 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 297' ' ' LEU . . . . . 0.753 HD21 ' SG ' ' A' ' 271' ' ' CYS . 50.1 mt -107.73 -5.68 17.24 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 124.009 0.924 . . . . 0.0 111.892 -176.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 72.86 22.4 79.1 Favored Glycine 0 CA--C 1.531 1.072 0 O-C-N 123.573 0.546 . . . . 0.0 113.198 177.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 299' ' ' VAL . . . . . 0.505 HG11 HG11 ' A' ' 334' ' ' VAL . 22.7 m -114.45 179.92 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 124.513 1.125 . . . . 0.0 110.341 -176.394 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 48.3 t -81.42 145.54 55.58 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 123.554 0.742 . . . . 0.0 110.29 177.174 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -57.6 -29.91 86.8 Favored 'Trans proline' 0 C--N 1.376 2.004 0 C-N-CA 122.72 2.28 . . . . 0.0 111.815 167.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 38.7 t -67.65 -13.87 62.45 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 123.491 0.716 . . . . 0.0 111.1 179.284 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -106.15 -17.11 14.42 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.216 1.006 . . . . 0.0 112.264 -178.081 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 304' ' ' ILE . . . . . 0.587 ' HB ' HG13 ' A' ' 290' ' ' VAL . 30.1 mm -77.49 112.58 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 CA-C-O 120.775 0.322 . . . . 0.0 110.145 176.459 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 41.6 tp -114.43 127.65 55.94 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.696 0.798 . . . . 0.0 108.992 175.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -95.9 133.65 39.82 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 176.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 307' ' ' LEU . . . . . 0.455 HD23 ' HA ' ' A' ' 312' ' ' GLU . 46.0 mt -140.38 111.54 7.12 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.437 1.095 . . . . 0.0 108.294 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 308' ' ' PHE . . . . . 0.496 ' HB2' HG22 ' A' ' 330' ' ' ILE . 68.9 t80 -81.33 82.55 7.15 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 173.363 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 69.87 -94.36 0.43 Allowed Glycine 0 C--N 1.35 1.317 0 CA-C-N 114.827 -1.079 . . . . 0.0 112.586 -175.312 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -95.76 -31.36 13.24 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.604 0.762 . . . . 0.0 112.407 -174.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 14.6 t -77.77 151.87 33.83 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.68 0.392 . . . . 0.0 111.151 -172.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 312' ' ' GLU . . . . . 0.455 ' HA ' HD23 ' A' ' 307' ' ' LEU . 33.3 tt0 -98.12 122.21 40.99 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 176.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 29.7 mt -110.08 114.78 28.56 Favored 'General case' 0 C--O 1.243 0.752 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 49.5 m -77.98 139.79 61.76 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 123.755 0.822 . . . . 0.0 110.699 -178.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 315' ' ' PRO . . . . . 0.452 ' HB3' HG21 ' A' ' 290' ' ' VAL . 43.4 Cg_exo -57.52 -28.38 80.6 Favored 'Trans proline' 0 C--N 1.386 2.536 0 C-N-CA 123.317 2.678 . . . . 0.0 112.886 174.406 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 56.3 p -74.71 -25.97 59.5 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.052 0.941 . . . . 0.0 111.828 -178.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -81.38 156.02 25.64 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.431 0.692 . . . . 0.0 111.084 -178.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 318' ' ' THR . . . . . . . . . . . . . 71.6 p -98.54 159.29 30.84 Favored Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 123.691 0.796 . . . . 0.0 110.334 -177.041 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 319' ' ' PRO . . . . . 0.64 ' HG3' HD21 ' A' ' 280' ' ' LEU . 92.0 Cg_endo -70.28 -18.03 34.83 Favored 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 122.778 2.319 . . . . 0.0 112.042 174.603 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -65.82 -51.98 54.4 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.685 1.194 . . . . 0.0 109.944 -175.46 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 9.8 t -69.72 -23.83 63.47 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.559 179.012 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 322' ' ' LEU . . . . . 0.447 ' HB2' ' HG ' ' A' ' 324' ' ' LEU . 68.5 mt -91.12 -11.73 37.66 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.757 0.823 . . . . 0.0 111.974 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 48.9 tptt 55.31 46.98 22.42 Favored 'General case' 0 CA--C 1.565 1.541 0 C-N-CA 124.429 1.092 . . . . 0.0 111.339 -176.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.447 ' HG ' ' HB2' ' A' ' 322' ' ' LEU . 46.6 mt -81.48 165.42 21.23 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.696 0.799 . . . . 0.0 109.478 175.36 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 325' ' ' GLY . . . . . 0.435 ' H ' ' HB3' ' A' ' 328' ' ' ASP . . . -164.7 -171.7 31.26 Favored Glycine 0 C--N 1.34 0.769 0 CA-C-N 116.423 -0.353 . . . . 0.0 112.417 -176.24 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 28.3 m -69.6 -25.3 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 C-N-CA 123.617 0.767 . . . . 0.0 111.178 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -104.27 13.4 32.25 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.866 0.866 . . . . 0.0 111.344 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 328' ' ' ASP . . . . . 0.435 ' HB3' ' H ' ' A' ' 325' ' ' GLY . 12.3 t70 -109.25 127.66 54.44 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 177.28 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 329' ' ' ILE . . . . . 0.6 HG22 ' HB2' ' A' ' 270' ' ' ARG . 13.2 mt -120.72 99.14 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 O-C-N 123.798 0.686 . . . . 0.0 110.463 -164.403 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 330' ' ' ILE . . . . . 0.496 HG22 ' HB2' ' A' ' 308' ' ' PHE . 39.4 pt -100.31 127.18 53.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 123.371 0.668 . . . . 0.0 111.913 -173.368 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -71.94 116.92 12.91 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.116 0.967 . . . . 0.0 111.875 -173.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 332' ' ' CYS . . . . . 0.547 ' SG ' HD12 ' A' ' 304' ' ' ILE . 48.8 t -86.06 99.41 11.46 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.017 0.927 . . . . 0.0 109.901 174.585 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 47.0 t -103.9 115.86 46.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 C-N-CA 123.6 0.76 . . . . 0.0 109.004 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 334' ' ' VAL . . . . . 0.505 HG11 HG11 ' A' ' 299' ' ' VAL . 82.5 t -80.28 104.33 8.45 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 CA-C-O 120.942 0.401 . . . . 0.0 109.962 176.676 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 93.9 mt . . . . . 0 N--CA 1.468 0.464 0 C-N-CA 124.031 0.932 . . . . 0.0 109.092 173.529 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 3.7 mp . . . . . 0 C--O 1.238 0.473 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -101.94 150.24 37.24 Favored Pre-proline 0 CA--C 1.547 0.847 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 174.108 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.9 93.82 0.54 Allowed 'Trans proline' 0 C--N 1.375 1.964 0 C-N-CA 121.881 1.72 . . . . 0.0 111.292 176.033 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 267' ' ' LEU . . . . . 0.49 HD12 HG13 ' A' ' 269' ' ' ILE . 1.6 tm? -59.97 130.54 47.26 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 114.942 -1.026 . . . . 0.0 108.255 175.087 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 268' ' ' LYS . . . . . 0.482 ' HG2' HG12 ' A' ' 329' ' ' ILE . 4.0 tppp? -93.0 107.92 19.6 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.172 0.51 . . . . 0.0 110.421 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 269' ' ' ILE . . . . . 0.511 HG21 ' HG3' ' A' ' 293' ' ' MET . 2.4 mp -106.19 132.92 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 175.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 270' ' ' ARG . . . . . 0.528 ' HA ' HD23 ' A' ' 275' ' ' LEU . 18.3 ttm-85 -86.76 104.41 16.11 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 173.273 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 271' ' ' CYS . . . . . 0.62 ' SG ' HD21 ' A' ' 297' ' ' LEU . 49.6 t -68.77 176.22 3.16 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.581 0.752 . . . . 0.0 109.992 175.43 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -58.22 -23.19 54.98 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -174.539 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -163.62 36.04 0.09 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.467 0.707 . . . . 0.0 111.012 175.308 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -164.44 178.2 7.62 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.26 0.624 . . . . 0.0 110.116 -177.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.528 HD23 ' HA ' ' A' ' 270' ' ' ARG . 92.9 mt -119.89 119.92 34.92 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.115 0.966 . . . . 0.0 110.337 173.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 89.9 t -97.4 137.38 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.518 0.727 . . . . 0.0 109.088 173.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 277' ' ' ARG . . . . . 0.426 ' HE ' ' HE2' ' A' ' 268' ' ' LYS . 73.3 mtt180 -118.96 108.68 15.06 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 173.103 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.504 HD11 HG12 ' A' ' 289' ' ' VAL . 4.6 pp -114.91 144.12 31.39 Favored Pre-proline 0 N--CA 1.488 1.46 0 CA-C-N 118.42 0.555 . . . . 0.0 110.34 177.618 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 279' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 278' ' ' LEU . 16.8 Cg_exo -67.13 123.55 11.06 Favored 'Trans proline' 0 C--N 1.369 1.655 0 C-N-CA 122.641 2.227 . . . . 0.0 110.784 174.428 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.72 HD21 ' HG3' ' A' ' 319' ' ' PRO . 0.1 OUTLIER -150.33 141.31 22.93 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.561 0.744 . . . . 0.0 109.824 -179.225 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 40.0 mtm180 -82.46 156.87 23.86 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.43 0.692 . . . . 0.0 109.671 174.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 282' ' ' MET . . . . . . . . . . . . . 25.4 mtp -68.94 -31.66 70.71 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 175.014 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 23.6 p -68.6 -30.3 69.01 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.359 1.063 . . . . 0.0 111.833 176.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -68.85 128.35 92.86 Favored Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 123.601 0.76 . . . . 0.0 109.11 177.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -66.99 170.69 12.46 Favored 'Trans proline' 0 C--N 1.374 1.883 0 C-N-CA 122.33 2.02 . . . . 0.0 112.21 176.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.42 ' O ' HG23 ' A' ' 290' ' ' VAL . 67.9 mt -66.56 -15.09 63.16 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-O 118.776 -0.63 . . . . 0.0 111.52 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 27.4 tp60 -53.19 -23.33 8.2 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 123.169 0.588 . . . . 0.0 112.023 176.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 288' ' ' SER . . . . . 0.508 ' HB3' HD12 ' A' ' 280' ' ' LEU . 23.2 t -65.49 -53.64 39.6 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.225 0.61 . . . . 0.0 111.129 173.321 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.504 HG12 HD11 ' A' ' 278' ' ' LEU . 17.7 m -68.81 -32.62 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-O 120.578 0.227 . . . . 0.0 110.408 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 290' ' ' VAL . . . . . 0.537 ' HA ' HG21 ' A' ' 304' ' ' ILE . 55.0 t -62.7 -51.49 71.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 124.015 0.926 . . . . 0.0 110.675 177.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -62.44 -49.2 76.4 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.226 1.01 . . . . 0.0 110.975 -178.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 21.9 t60 -64.4 -45.12 88.98 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.814 -176.22 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 293' ' ' MET . . . . . 0.511 ' HG3' HG21 ' A' ' 269' ' ' ILE . 97.1 mmm -71.72 -28.41 63.66 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.312 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -67.27 -42.66 83.49 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 122.621 0.368 . . . . 0.0 110.7 175.167 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 29.2 m -69.8 -36.18 75.45 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.443 178.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -69.98 -48.62 57.49 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.609 0.764 . . . . 0.0 110.963 -179.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 297' ' ' LEU . . . . . 0.62 HD21 ' SG ' ' A' ' 271' ' ' CYS . 96.2 mt -82.98 -16.83 45.68 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.795 0.838 . . . . 0.0 112.086 -175.221 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 76.11 33.55 49.44 Favored Glycine 0 C--N 1.345 1.041 0 O-C-N 123.435 0.459 . . . . 0.0 112.446 -179.22 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 14.9 m -120.34 176.39 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 124.411 1.085 . . . . 0.0 109.47 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 15.4 m -81.51 145.78 55.79 Favored Pre-proline 0 CA--C 1.547 0.848 0 CA-C-O 118.902 -0.571 . . . . 0.0 109.929 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -55.26 -34.01 86.82 Favored 'Trans proline' 0 C--N 1.389 2.688 0 C-N-CA 122.663 2.242 . . . . 0.0 111.767 173.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 70.2 m -63.63 -32.44 73.92 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 120.779 0.323 . . . . 0.0 110.738 -178.412 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -75.23 -23.75 57.6 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.877 0.871 . . . . 0.0 112.284 -178.167 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 304' ' ' ILE . . . . . 0.561 HD12 ' SG ' ' A' ' 332' ' ' CYS . 31.3 mm -73.64 101.72 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 305' ' ' LEU . . . . . 0.591 HD11 ' HG3' ' A' ' 312' ' ' GLU . 38.8 tp -103.99 116.94 33.16 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 173.777 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 306' ' ' LEU . . . . . 0.455 ' HG ' HD12 ' A' ' 330' ' ' ILE . 2.5 mm? -87.89 135.55 33.35 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 177.64 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 69.3 mt -133.67 107.28 7.85 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -178.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 308' ' ' PHE . . . . . 0.465 ' HB2' HD11 ' A' ' 313' ' ' LEU . 61.1 t80 -79.0 88.41 4.77 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 177.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 67.71 -90.69 0.21 Allowed Glycine 0 C--N 1.346 1.11 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.431 -174.049 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -132.59 78.71 1.81 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.598 0.759 . . . . 0.0 109.627 -179.343 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 12.7 t -171.19 149.49 2.84 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.98 0.912 . . . . 0.0 109.287 175.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 312' ' ' GLU . . . . . 0.591 ' HG3' HD11 ' A' ' 305' ' ' LEU . 35.0 tt0 -91.86 119.2 31.43 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.132 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 313' ' ' LEU . . . . . 0.465 HD11 ' HB2' ' A' ' 308' ' ' PHE . 57.1 mt -107.42 123.68 48.74 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.23 179.112 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 29.5 m -82.6 150.44 62.97 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 123.789 0.836 . . . . 0.0 110.604 179.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 315' ' ' PRO . . . . . 0.533 ' HB3' HG21 ' A' ' 290' ' ' VAL . 22.1 Cg_endo -59.92 -25.46 79.54 Favored 'Trans proline' 0 C--N 1.381 2.255 0 C-N-CA 122.73 2.287 . . . . 0.0 112.875 172.435 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 42.4 p -84.69 -3.69 58.66 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.808 0.843 . . . . 0.0 112.274 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -85.8 148.18 25.96 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 122.901 0.48 . . . . 0.0 109.957 175.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 318' ' ' THR . . . . . . . . . . . . . 28.9 p -103.4 139.74 20.39 Favored Pre-proline 0 N--CA 1.476 0.845 0 C-N-CA 122.754 0.422 . . . . 0.0 110.865 178.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 319' ' ' PRO . . . . . 0.72 ' HG3' HD21 ' A' ' 280' ' ' LEU . 27.0 Cg_endo -57.88 -15.99 24.13 Favored 'Trans proline' 0 C--N 1.374 1.906 0 C-N-CA 123.856 3.038 . . . . 0.0 113.094 171.108 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 37.0 ttt180 -56.99 -62.8 1.49 Allowed 'General case' 0 C--N 1.352 0.702 0 C-N-CA 123.921 0.888 . . . . 0.0 110.446 173.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 15.1 t -71.59 -23.32 61.71 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 122.895 0.478 . . . . 0.0 111.479 -176.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 322' ' ' LEU . . . . . 0.432 HD13 HD13 ' A' ' 313' ' ' LEU . 59.3 mt -82.71 -16.03 49.62 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.328 0.651 . . . . 0.0 111.575 178.012 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp 59.91 44.02 14.13 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.784 1.234 . . . . 0.0 111.749 178.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.427 HD12 ' HB3' ' A' ' 319' ' ' PRO . 63.9 mt -79.28 168.56 19.37 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.194 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 325' ' ' GLY . . . . . 0.465 ' H ' ' HB2' ' A' ' 328' ' ' ASP . . . -167.32 -162.85 20.05 Favored Glycine 0 C--N 1.35 1.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 113.061 -172.26 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 25.0 m -74.89 -30.32 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 123.414 0.686 . . . . 0.0 111.204 -178.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -94.97 -25.93 16.32 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.713 0.805 . . . . 0.0 110.907 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 328' ' ' ASP . . . . . 0.465 ' HB2' ' H ' ' A' ' 325' ' ' GLY . 7.1 m-20 -77.77 106.77 9.82 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 122.932 0.493 . . . . 0.0 109.823 -178.706 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 329' ' ' ILE . . . . . 0.482 HG12 ' HG2' ' A' ' 268' ' ' LYS . 3.1 mt -97.04 139.13 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 122.83 0.452 . . . . 0.0 110.681 -174.671 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 330' ' ' ILE . . . . . 0.455 HD12 ' HG ' ' A' ' 306' ' ' LEU . 32.3 pt -119.93 125.01 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 123.061 0.545 . . . . 0.0 109.99 174.69 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -71.15 114.4 9.17 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.198 0.999 . . . . 0.0 111.274 -175.181 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 332' ' ' CYS . . . . . 0.561 ' SG ' HD12 ' A' ' 304' ' ' ILE . 45.0 t -81.28 88.89 6.04 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.305 0.642 . . . . 0.0 109.704 174.505 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 85.5 t -98.85 111.98 29.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 123.619 0.767 . . . . 0.0 109.413 -177.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 90.8 t -82.41 106.19 13.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.808 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 97.0 mt . . . . . 0 N--CA 1.475 0.812 0 C-N-CA 123.605 0.762 . . . . 0.0 109.687 176.386 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.469 0.487 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 265' ' ' PHE . . . . . 0.531 ' CE1' ' SD ' ' A' ' 282' ' ' MET . 28.9 p90 -98.08 150.5 36.81 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 124.776 1.23 . . . . 0.0 108.526 -178.389 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 266' ' ' PRO . . . . . 0.467 ' HB2' ' HB3' ' A' ' 277' ' ' ARG . 56.0 Cg_endo -67.66 92.61 0.36 Allowed 'Trans proline' 0 C--N 1.368 1.554 0 C-N-CA 122.405 2.07 . . . . 0.0 112.443 175.513 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.1 111.99 3.67 Favored 'General case' 0 C--O 1.247 0.933 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 173.086 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 268' ' ' LYS . . . . . 0.428 ' HE3' HG12 ' A' ' 329' ' ' ILE . 22.3 ttpt -83.81 126.65 33.15 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.65 0.738 . . . . 0.0 111.009 -178.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 5.0 mt -125.91 124.3 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.92 1.288 . . . . 0.0 108.52 -175.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 23.0 ttp180 -89.07 102.36 15.01 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-O 121.287 0.565 . . . . 0.0 109.575 176.378 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 271' ' ' CYS . . . . . 0.765 ' SG ' HD21 ' A' ' 297' ' ' LEU . 36.5 t -73.11 -174.99 1.68 Allowed 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.064 170.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 35.4 ptt180 -56.41 -28.44 59.39 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 124.477 1.111 . . . . 0.0 113.543 -178.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -166.47 32.07 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.629 0.772 . . . . 0.0 110.322 177.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -151.16 150.88 31.16 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.102 0.561 . . . . 0.0 110.103 -172.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -117.18 101.13 8.2 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.932 0.893 . . . . 0.0 109.858 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 72.8 t -92.7 117.71 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.618 0.767 . . . . 0.0 109.707 176.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 277' ' ' ARG . . . . . 0.467 ' HB3' ' HB2' ' A' ' 266' ' ' PRO . 44.0 mtm-85 -112.48 91.4 3.64 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 175.136 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.576 HD21 ' HA ' ' A' ' 289' ' ' VAL . 4.6 pp -98.3 147.69 33.47 Favored Pre-proline 0 N--CA 1.483 1.195 0 C-N-CA 122.485 0.314 . . . . 0.0 110.319 -174.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -71.5 107.21 2.11 Favored 'Trans proline' 0 C--N 1.373 1.843 0 C-N-CA 122.416 2.077 . . . . 0.0 111.689 177.099 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.837 HD21 ' HG3' ' A' ' 319' ' ' PRO . 0.5 OUTLIER -129.11 150.34 50.55 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.145 1.378 . . . . 0.0 108.473 178.137 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.4 155.64 17.43 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.02 0.528 . . . . 0.0 109.905 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 282' ' ' MET . . . . . 0.531 ' SD ' ' CE1' ' A' ' 265' ' ' PHE . 76.7 mmm -60.32 -33.86 72.98 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.262 0.625 . . . . 0.0 112.059 -175.535 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 35.0 t -83.77 -19.18 35.55 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.271 0.628 . . . . 0.0 111.896 -178.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -67.74 127.66 93.39 Favored Pre-proline 0 N--CA 1.484 1.233 0 CA-C-O 118.272 -0.87 . . . . 0.0 109.153 175.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -64.95 166.61 17.97 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 122.019 1.813 . . . . 0.0 111.394 173.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.464 ' O ' HG22 ' A' ' 289' ' ' VAL . 82.6 mt -66.74 -10.01 42.62 Favored 'General case' 0 C--O 1.213 -0.834 0 CA-C-O 118.594 -0.717 . . . . 0.0 111.939 -176.215 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 287' ' ' GLN . . . . . 0.429 ' HA ' ' HB ' ' A' ' 290' ' ' VAL . 27.3 tp60 -53.85 -26.2 23.38 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 123.345 0.658 . . . . 0.0 112.541 178.25 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 288' ' ' SER . . . . . 0.642 ' HB3' HD12 ' A' ' 280' ' ' LEU . 34.6 t -60.66 -52.63 64.32 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.936 0.494 . . . . 0.0 110.642 171.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.576 ' HA ' HD21 ' A' ' 278' ' ' LEU . 10.2 m -71.75 -30.72 38.96 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 122.364 0.266 . . . . 0.0 110.85 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 290' ' ' VAL . . . . . 0.558 HG13 ' HB ' ' A' ' 304' ' ' ILE . 66.8 t -65.44 -51.23 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.084 0.954 . . . . 0.0 110.657 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -67.54 -39.61 85.03 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.868 0.867 . . . . 0.0 110.984 -176.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 21.5 t60 -66.27 -52.48 47.11 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.751 179.205 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 94.7 mmm -65.22 -27.89 68.98 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 123.44 0.462 . . . . 0.0 111.214 -177.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -61.84 -49.97 74.14 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.644 0.777 . . . . 0.0 110.476 172.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 36.8 m -70.9 -28.66 64.7 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.639 0.775 . . . . 0.0 111.195 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -70.3 -36.77 74.54 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.292 1.037 . . . . 0.0 110.87 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 297' ' ' LEU . . . . . 0.765 HD21 ' SG ' ' A' ' 271' ' ' CYS . 78.7 mt -101.87 -5.6 24.57 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.996 0.919 . . . . 0.0 112.095 -178.562 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 79.4 3.38 88.64 Favored Glycine 0 N--CA 1.475 1.243 0 O-C-N 123.417 0.448 . . . . 0.0 113.239 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 299' ' ' VAL . . . . . 0.479 HG11 HG11 ' A' ' 334' ' ' VAL . 30.9 m -91.48 -177.78 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 124.244 1.017 . . . . 0.0 111.083 -178.299 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 39.7 m -89.15 150.19 44.56 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 123.482 0.713 . . . . 0.0 110.922 -178.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.13 -30.37 90.22 Favored 'Trans proline' 0 C--N 1.391 2.775 0 C-N-CA 123.094 2.529 . . . . 0.0 111.594 172.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 16.7 m -64.95 -15.77 62.55 Favored 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 123.18 0.592 . . . . 0.0 111.907 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 55.1 mtt180 -100.51 -15.78 17.75 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.933 0.893 . . . . 0.0 112.782 -175.142 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 304' ' ' ILE . . . . . 0.558 ' HB ' HG13 ' A' ' 290' ' ' VAL . 42.7 mm -82.58 102.48 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 CA-C-N 118.148 0.431 . . . . 0.0 110.682 -176.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 53.6 tp -101.37 114.78 29.08 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.969 0.908 . . . . 0.0 109.363 175.11 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 306' ' ' LEU . . . . . 0.456 ' HG ' HD12 ' A' ' 330' ' ' ILE . 2.5 mm? -86.5 133.04 33.78 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 178.268 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 307' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' A' ' 312' ' ' GLU . 92.7 mt -132.58 103.29 6.07 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.927 0.891 . . . . 0.0 109.009 -176.27 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 308' ' ' PHE . . . . . 0.486 ' HB2' HD11 ' A' ' 313' ' ' LEU . 33.1 t80 -82.89 89.67 6.87 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -174.589 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 67.35 -84.58 0.13 Allowed Glycine 0 C--N 1.348 1.231 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.238 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -134.27 52.04 2.08 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.953 0.901 . . . . 0.0 110.036 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 11.7 t -153.49 149.29 27.56 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 122.805 0.442 . . . . 0.0 110.689 172.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 312' ' ' GLU . . . . . 0.436 ' HA ' HD23 ' A' ' 307' ' ' LEU . 42.4 tt0 -96.79 121.36 38.57 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.179 0.592 . . . . 0.0 110.058 -178.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 313' ' ' LEU . . . . . 0.486 HD11 ' HB2' ' A' ' 308' ' ' PHE . 58.5 mt -102.05 175.71 5.44 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 122.961 0.504 . . . . 0.0 111.406 -176.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 50.1 m -130.39 146.63 62.53 Favored Pre-proline 0 CA--C 1.547 0.842 0 C-N-CA 123.545 0.738 . . . . 0.0 110.056 -177.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 315' ' ' PRO . . . . . 0.537 ' HB3' HG21 ' A' ' 290' ' ' VAL . 31.1 Cg_endo -61.45 -26.88 81.72 Favored 'Trans proline' 0 C--N 1.385 2.477 0 C-N-CA 123.036 2.491 . . . . 0.0 112.373 174.776 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 73.1 p -80.19 -22.99 41.33 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.474 1.11 . . . . 0.0 111.889 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -76.82 147.44 37.18 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.553 0.741 . . . . 0.0 111.519 -176.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 318' ' ' THR . . . . . . . . . . . . . 41.3 p -100.98 141.44 22.63 Favored Pre-proline 0 N--CA 1.475 0.782 0 C-N-CA 124.155 0.982 . . . . 0.0 110.05 -178.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 319' ' ' PRO . . . . . 0.837 ' HG3' HD21 ' A' ' 280' ' ' LEU . 59.0 Cg_endo -62.39 -19.71 68.13 Favored 'Trans proline' 0 C--N 1.37 1.665 0 C-N-CA 123.668 2.912 . . . . 0.0 113.294 -178.118 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 53.3 ttp180 -59.28 -56.51 21.23 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 123.893 0.877 . . . . 0.0 110.697 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 15.3 t -69.63 -25.67 64.05 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.066 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 322' ' ' LEU . . . . . 0.507 ' HB2' ' HG ' ' A' ' 324' ' ' LEU . 46.4 mt -85.71 -4.8 59.26 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.63 0.772 . . . . 0.0 111.842 -178.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp 64.49 29.57 13.25 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.499 1.12 . . . . 0.0 112.063 176.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.507 ' HG ' ' HB2' ' A' ' 322' ' ' LEU . 46.8 mt -78.19 168.74 19.38 Favored 'General case' 0 C--O 1.243 0.755 0 C-N-CA 123.603 0.761 . . . . 0.0 110.774 178.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 325' ' ' GLY . . . . . 0.477 ' H ' ' HB2' ' A' ' 328' ' ' ASP . . . -168.5 -162.48 20.66 Favored Glycine 0 C--O 1.243 0.665 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.89 -173.275 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 35.1 m -73.41 -36.99 50.06 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 C-N-CA 123.737 0.815 . . . . 0.0 111.478 -177.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -100.15 -12.84 19.27 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.428 1.091 . . . . 0.0 111.292 -177.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 328' ' ' ASP . . . . . 0.477 ' HB2' ' H ' ' A' ' 325' ' ' GLY . 31.8 m-20 -76.22 116.57 17.03 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 174.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 329' ' ' ILE . . . . . 0.428 HG12 ' HE3' ' A' ' 268' ' ' LYS . 18.0 mt -105.04 124.86 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 123.242 0.617 . . . . 0.0 110.55 -170.448 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 330' ' ' ILE . . . . . 0.456 HD12 ' HG ' ' A' ' 306' ' ' LEU . 40.2 pt -106.5 126.88 62.24 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 123.103 0.561 . . . . 0.0 110.51 176.545 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 331' ' ' ASP . . . . . 0.404 ' HB2' ' HB2' ' A' ' 307' ' ' LEU . 7.1 m-20 -72.98 106.06 4.71 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.727 0.811 . . . . 0.0 111.328 -179.361 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 332' ' ' CYS . . . . . 0.457 ' SG ' HD12 ' A' ' 304' ' ' ILE . 34.7 t -71.71 102.27 2.76 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 169.345 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 333' ' ' VAL . . . . . 0.423 HG21 HD12 ' A' ' 307' ' ' LEU . 87.1 t -113.78 112.53 40.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 334' ' ' VAL . . . . . 0.479 HG11 HG11 ' A' ' 299' ' ' VAL . 76.7 t -77.86 104.18 5.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.746 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 75.0 mt . . . . . 0 N--CA 1.468 0.426 0 C-N-CA 124.022 0.929 . . . . 0.0 109.193 172.243 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 4.2 mp . . . . . 0 C--O 1.238 0.474 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 265' ' ' PHE . . . . . 0.499 ' CE1' ' HG2' ' A' ' 282' ' ' MET . 31.3 p90 -112.0 141.16 24.37 Favored Pre-proline 0 CA--C 1.55 0.95 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 175.537 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 266' ' ' PRO . . . . . 0.537 ' HB2' ' HB3' ' A' ' 277' ' ' ARG . 38.0 Cg_endo -65.11 92.64 0.21 Allowed 'Trans proline' 0 C--N 1.375 1.922 0 C-N-CA 122.696 2.264 . . . . 0.0 112.974 176.485 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 267' ' ' LEU . . . . . 0.464 HD12 HG13 ' A' ' 269' ' ' ILE . 0.4 OUTLIER -61.69 122.55 15.61 Favored 'General case' 0 C--N 1.356 0.88 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 173.271 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 268' ' ' LYS . . . . . 0.451 ' HD2' HD13 ' A' ' 275' ' ' LEU . 20.8 ttpt -88.27 108.38 19.29 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 121.216 0.531 . . . . 0.0 110.614 178.31 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 269' ' ' ILE . . . . . 0.464 HG13 HD12 ' A' ' 267' ' ' LEU . 3.8 mp -105.79 129.22 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 176.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 270' ' ' ARG . . . . . 0.425 ' HA ' HD23 ' A' ' 275' ' ' LEU . 41.1 ttm180 -87.0 119.34 27.11 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 122.847 0.459 . . . . 0.0 110.016 174.021 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 271' ' ' CYS . . . . . 0.712 ' SG ' HD21 ' A' ' 297' ' ' LEU . 10.1 t -88.75 -165.06 1.24 Allowed 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.722 0.809 . . . . 0.0 109.687 173.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -52.96 -39.73 63.18 Favored 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 124.584 1.154 . . . . 0.0 112.85 176.083 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -162.19 42.82 0.13 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.511 0.725 . . . . 0.0 109.87 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 274' ' ' ASP . . . . . 0.402 ' HB3' ' HB3' ' A' ' 271' ' ' CYS . 38.1 t70 -155.58 162.01 40.73 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.704 -171.162 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.451 HD13 ' HD2' ' A' ' 268' ' ' LYS . 72.3 mt -127.85 106.58 9.21 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.176 0.99 . . . . 0.0 110.032 174.001 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 84.6 t -92.88 108.99 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 123.696 0.798 . . . . 0.0 108.937 174.374 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 277' ' ' ARG . . . . . 0.537 ' HB3' ' HB2' ' A' ' 266' ' ' PRO . 67.4 mtm180 -98.76 83.46 2.96 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 174.573 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.404 HD11 HG12 ' A' ' 289' ' ' VAL . 4.3 pp -93.38 137.14 23.6 Favored Pre-proline 0 N--CA 1.488 1.447 0 CA-C-O 119.141 -0.457 . . . . 0.0 110.413 -175.418 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -63.91 123.67 12.32 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 122.54 2.16 . . . . 0.0 111.477 175.191 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.655 HD21 ' HG3' ' A' ' 319' ' ' PRO . 0.0 OUTLIER -143.72 151.94 40.66 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.226 1.01 . . . . 0.0 110.066 -176.549 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 281' ' ' ARG . . . . . 0.425 ' H ' ' HD2' ' A' ' 281' ' ' ARG . 1.6 mpt_? -87.85 149.71 23.96 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 177.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 282' ' ' MET . . . . . 0.499 ' HG2' ' CE1' ' A' ' 265' ' ' PHE . 14.9 mtp -68.06 -37.08 80.87 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 117.928 0.331 . . . . 0.0 110.672 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 22.8 t -75.08 -15.34 60.62 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.748 0.819 . . . . 0.0 111.314 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 284' ' ' GLU . . . . . 0.434 ' O ' ' HD2' ' A' ' 319' ' ' PRO . 4.5 tp10 -73.52 134.31 79.45 Favored Pre-proline 0 CA--C 1.543 0.691 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 174.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.89 166.57 26.01 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 122.062 1.842 . . . . 0.0 111.686 175.356 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 82.6 mt -66.7 -12.62 59.17 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.985 0.514 . . . . 0.0 111.721 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 287' ' ' GLN . . . . . 0.479 ' HA ' ' HB ' ' A' ' 290' ' ' VAL . 25.6 tp60 -56.2 -22.36 28.75 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.342 0.657 . . . . 0.0 111.687 173.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 288' ' ' SER . . . . . 0.465 ' HB3' HD12 ' A' ' 280' ' ' LEU . 22.8 t -61.22 -57.64 11.58 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.462 0.705 . . . . 0.0 110.455 172.095 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.416 HG13 HD13 ' A' ' 280' ' ' LEU . 17.9 m -68.99 -30.36 46.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 122.484 0.313 . . . . 0.0 110.553 -179.302 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 290' ' ' VAL . . . . . 0.6 HG13 ' HB ' ' A' ' 304' ' ' ILE . 43.0 t -63.72 -44.51 98.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.507 1.123 . . . . 0.0 111.15 176.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -59.58 -47.61 84.89 Favored 'General case' 0 N--CA 1.479 0.998 0 O-C-N 124.044 0.84 . . . . 0.0 110.204 178.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 42.7 t60 -64.62 -50.63 66.37 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.406 -178.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 293' ' ' MET . . . . . 0.432 ' HG3' HG21 ' A' ' 269' ' ' ILE . 94.3 mmm -69.37 -30.55 68.58 Favored 'General case' 0 N--CA 1.483 1.177 0 O-C-N 123.666 0.604 . . . . 0.0 111.356 -174.386 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -64.68 -46.44 82.37 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 123.656 0.598 . . . . 0.0 110.277 175.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 26.1 m -73.26 -29.24 62.61 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.309 0.644 . . . . 0.0 111.119 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 67.6 t60 -65.05 -38.74 91.82 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.404 1.082 . . . . 0.0 110.279 176.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 297' ' ' LEU . . . . . 0.712 HD21 ' SG ' ' A' ' 271' ' ' CYS . 58.2 mt -101.05 -5.84 25.21 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.369 1.068 . . . . 0.0 111.876 -177.439 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 74.21 10.37 81.51 Favored Glycine 0 N--CA 1.476 1.303 0 O-C-N 123.267 0.355 . . . . 0.0 113.61 178.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 299' ' ' VAL . . . . . 0.434 HG11 HG11 ' A' ' 334' ' ' VAL . 33.5 m -95.99 176.03 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.208 1.003 . . . . 0.0 110.855 -178.727 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 300' ' ' SER . . . . . 0.412 ' H ' ' HD2' ' A' ' 303' ' ' ARG . 20.2 m -78.95 148.56 72.24 Favored Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 123.298 0.639 . . . . 0.0 110.428 178.125 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -57.86 -28.33 82.06 Favored 'Trans proline' 0 C--N 1.385 2.486 0 C-N-CA 122.97 2.446 . . . . 0.0 112.247 172.123 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 19.5 m -72.58 -7.54 50.69 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.429 0.691 . . . . 0.0 111.958 -178.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 303' ' ' ARG . . . . . 0.412 ' HD2' ' H ' ' A' ' 300' ' ' SER . 95.7 mtt180 -99.25 -21.28 16.16 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.845 0.858 . . . . 0.0 110.943 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 304' ' ' ILE . . . . . 0.6 ' HB ' HG13 ' A' ' 290' ' ' VAL . 39.4 mm -80.73 115.34 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 122.852 0.461 . . . . 0.0 110.506 -176.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 33.5 tp -113.46 137.65 51.24 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 171.223 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 306' ' ' LEU . . . . . 0.448 ' HG ' HD12 ' A' ' 330' ' ' ILE . 2.0 mm? -104.15 133.8 48.48 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 177.286 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 80.8 mt -131.42 111.43 11.81 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.47 0.708 . . . . 0.0 109.101 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 308' ' ' PHE . . . . . 0.548 ' HB2' HD11 ' A' ' 313' ' ' LEU . 87.1 t80 -82.49 81.79 8.17 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.297 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 77.16 -67.8 2.71 Favored Glycine 0 C--N 1.354 1.53 0 CA-C-N 114.885 -1.052 . . . . 0.0 112.842 -178.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -134.96 -26.8 1.3 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.087 0.955 . . . . 0.0 111.596 -174.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 14.3 t -82.1 147.66 28.97 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 122.658 0.383 . . . . 0.0 110.641 -176.223 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -93.44 117.39 30.02 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 120.923 0.392 . . . . 0.0 110.01 -178.37 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 313' ' ' LEU . . . . . 0.548 HD11 ' HB2' ' A' ' 308' ' ' PHE . 48.1 mt -105.9 114.71 29.03 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.841 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 49.5 m -75.15 147.44 83.19 Favored Pre-proline 0 CA--C 1.553 1.059 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.388 177.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 315' ' ' PRO . . . . . 0.573 ' HB3' HG21 ' A' ' 290' ' ' VAL . 33.9 Cg_endo -60.23 -23.6 74.56 Favored 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 123.265 2.643 . . . . 0.0 112.937 177.358 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 4.6 m -72.48 -33.95 67.33 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.785 0.834 . . . . 0.0 111.08 178.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -66.43 146.24 54.78 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.826 0.85 . . . . 0.0 111.425 -177.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 318' ' ' THR . . . . . . . . . . . . . 81.2 p -100.83 138.35 20.03 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 123.027 0.531 . . . . 0.0 109.921 -178.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 319' ' ' PRO . . . . . 0.655 ' HG3' HD21 ' A' ' 280' ' ' LEU . 10.0 Cg_endo -51.03 -20.08 6.73 Favored 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 124.153 3.235 . . . . 0.0 113.531 170.641 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 40.9 ttt180 -60.92 -58.79 6.94 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.649 0.78 . . . . 0.0 110.912 173.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 13.2 t -71.34 -20.72 62.14 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 122.932 0.493 . . . . 0.0 111.531 -175.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 322' ' ' LEU . . . . . 0.466 HD13 HD13 ' A' ' 313' ' ' LEU . 39.0 mt -88.9 -22.03 23.32 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.646 0.778 . . . . 0.0 111.01 178.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 2.3 tmtp? 56.41 80.83 0.14 Allowed 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.869 1.267 . . . . 0.0 109.204 -167.613 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 69.5 mt -110.31 143.83 39.94 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 172.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 325' ' ' GLY . . . . . 0.437 ' H ' ' HB2' ' A' ' 328' ' ' ASP . . . -128.22 -167.72 12.29 Favored Glycine 0 C--N 1.337 0.613 0 C-N-CA 123.939 0.78 . . . . 0.0 111.511 -178.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 14.5 m -73.88 -21.98 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 123.314 0.645 . . . . 0.0 111.469 -177.13 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -99.96 -22.84 15.11 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.193 0.997 . . . . 0.0 111.253 -178.199 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 328' ' ' ASP . . . . . 0.437 ' HB2' ' H ' ' A' ' 325' ' ' GLY . 3.9 m-20 -70.37 124.96 25.46 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.992 0.517 . . . . 0.0 109.813 178.656 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 329' ' ' ILE . . . . . 0.412 HG12 ' HG2' ' A' ' 268' ' ' LYS . 12.9 mt -104.11 139.57 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.028 0.531 . . . . 0.0 109.933 -178.207 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 330' ' ' ILE . . . . . 0.448 HD12 ' HG ' ' A' ' 306' ' ' LEU . 35.7 pt -123.84 126.58 72.87 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 123.162 0.585 . . . . 0.0 109.837 174.029 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -75.39 106.1 6.75 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.027 0.931 . . . . 0.0 110.963 -176.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 332' ' ' CYS . . . . . 0.554 ' SG ' HD12 ' A' ' 304' ' ' ILE . 38.1 t -74.54 92.06 2.35 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.701 0.801 . . . . 0.0 110.168 172.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 97.4 t -95.87 117.08 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 123.431 0.693 . . . . 0.0 109.679 177.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 334' ' ' VAL . . . . . 0.434 HG11 HG11 ' A' ' 299' ' ' VAL . 62.1 t -83.38 99.76 6.32 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 123.582 0.753 . . . . 0.0 109.713 177.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 84.9 mt . . . . . 0 CA--C 1.542 0.64 0 C-N-CA 123.883 0.873 . . . . 0.0 110.535 172.663 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 4.2 mp . . . . . 0 N--CA 1.477 0.879 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -125.88 141.57 39.77 Favored Pre-proline 0 CA--C 1.549 0.931 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 175.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -64.26 94.13 0.2 Allowed 'Trans proline' 0 C--N 1.379 2.137 0 C-N-CA 122.531 2.154 . . . . 0.0 112.091 176.259 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 267' ' ' LEU . . . . . 0.437 HD12 HG13 ' A' ' 269' ' ' ILE . 1.1 tm? -59.6 131.71 51.75 Favored 'General case' 0 C--N 1.354 0.782 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 173.55 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 268' ' ' LYS . . . . . 0.43 ' HG2' HG12 ' A' ' 329' ' ' ILE . 3.0 tppp? -94.96 103.53 15.39 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.465 0.65 . . . . 0.0 109.973 -178.52 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 269' ' ' ILE . . . . . 0.437 HG13 HD12 ' A' ' 267' ' ' LEU . 2.4 mp -100.59 154.03 4.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 175.326 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 270' ' ' ARG . . . . . 0.486 ' HB2' HG22 ' A' ' 329' ' ' ILE . 22.5 ttp180 -118.35 103.61 9.96 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.792 0.837 . . . . 0.0 109.017 176.526 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 271' ' ' CYS . . . . . 0.722 ' SG ' HD21 ' A' ' 297' ' ' LEU . 21.0 t -69.09 -178.14 1.21 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.007 0.923 . . . . 0.0 110.598 176.103 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -50.98 -32.84 22.37 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.712 1.205 . . . . 0.0 113.175 -177.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -161.04 42.08 0.16 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.645 0.778 . . . . 0.0 110.03 178.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -161.35 164.84 29.77 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.257 -174.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 69.6 mt -112.53 113.46 25.62 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.252 1.021 . . . . 0.0 110.155 172.07 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 276' ' ' VAL . . . . . 0.438 HG21 ' SD ' ' A' ' 293' ' ' MET . 65.7 t -95.43 138.89 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 123.684 0.794 . . . . 0.0 109.264 178.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 42.7 mtt180 -125.08 115.64 20.82 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 177.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.523 HD21 ' HA ' ' A' ' 289' ' ' VAL . 4.0 pp -126.49 135.58 27.43 Favored Pre-proline 0 N--CA 1.482 1.13 0 CA-C-O 119.258 -0.401 . . . . 0.0 109.942 175.174 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -64.7 127.91 19.85 Favored 'Trans proline' 0 C--N 1.375 1.97 0 C-N-CA 122.657 2.238 . . . . 0.0 110.149 174.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.827 HD21 ' HG3' ' A' ' 319' ' ' PRO . 0.2 OUTLIER -150.22 150.92 32.24 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.002 0.921 . . . . 0.0 109.943 -173.815 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 281' ' ' ARG . . . . . 0.494 ' HB2' ' HB2' ' A' ' 284' ' ' GLU . 83.5 mtm180 -93.17 155.43 17.46 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.588 0.755 . . . . 0.0 110.815 -178.401 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 282' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -65.72 -38.24 88.62 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.885 0.474 . . . . 0.0 110.213 176.222 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 24.3 t -73.99 -17.93 60.93 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.552 0.741 . . . . 0.0 111.802 178.054 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 284' ' ' GLU . . . . . 0.494 ' HB2' ' HB2' ' A' ' 281' ' ' ARG . 5.9 tp10 -72.93 131.77 83.56 Favored Pre-proline 0 N--CA 1.473 0.72 0 C-N-CA 123.712 0.805 . . . . 0.0 109.121 179.277 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -67.76 168.38 18.67 Favored 'Trans proline' 0 C--N 1.374 1.918 0 C-N-CA 121.903 1.735 . . . . 0.0 111.79 171.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 54.3 mt -70.41 -10.22 58.5 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 118.982 -0.532 . . . . 0.0 110.874 179.025 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 26.0 tp60 -54.68 -23.08 15.85 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.217 0.607 . . . . 0.0 111.644 175.279 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 288' ' ' SER . . . . . 0.551 ' HB3' HD12 ' A' ' 280' ' ' LEU . 34.3 t -64.42 -56.48 14.01 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.619 0.768 . . . . 0.0 110.935 171.108 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.523 ' HA ' HD21 ' A' ' 278' ' ' LEU . 18.0 m -66.73 -30.43 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 C-N-CA 122.254 0.222 . . . . 0.0 110.701 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 290' ' ' VAL . . . . . 0.581 HG13 ' HB ' ' A' ' 304' ' ' ILE . 43.9 t -66.88 -50.24 66.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 124.397 1.079 . . . . 0.0 110.565 179.4 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -64.1 -43.54 95.03 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.105 0.962 . . . . 0.0 110.887 -178.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 26.0 t60 -67.2 -49.09 65.87 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.378 -177.174 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 293' ' ' MET . . . . . 0.438 ' SD ' HG21 ' A' ' 276' ' ' VAL . 90.0 mmm -66.36 -32.52 73.96 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.447 0.699 . . . . 0.0 111.369 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -61.57 -53.63 53.79 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 123.863 0.727 . . . . 0.0 110.352 177.285 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 28.3 m -66.2 -34.09 77.24 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.658 0.783 . . . . 0.0 111.304 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -67.46 -35.44 79.19 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.682 0.793 . . . . 0.0 111.499 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 297' ' ' LEU . . . . . 0.722 HD21 ' SG ' ' A' ' 271' ' ' CYS . 86.6 mt -97.83 -3.46 38.75 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.874 0.87 . . . . 0.0 111.319 178.399 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 75.15 10.15 84.18 Favored Glycine 0 C--N 1.345 1.049 0 O-C-N 123.625 0.578 . . . . 0.0 113.44 177.167 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 33.1 m -98.6 -179.04 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.126 0.97 . . . . 0.0 111.252 -178.214 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 21.7 m -85.2 147.78 48.44 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 123.347 0.659 . . . . 0.0 110.686 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -56.79 -29.65 81.7 Favored 'Trans proline' 0 C--N 1.384 2.428 0 C-N-CA 123.044 2.496 . . . . 0.0 112.297 171.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 44.8 m -68.24 -19.56 64.74 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.037 0.535 . . . . 0.0 111.739 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 61.3 mtt85 -89.19 -19.48 25.4 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.924 0.89 . . . . 0.0 111.737 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 304' ' ' ILE . . . . . 0.581 ' HB ' HG13 ' A' ' 290' ' ' VAL . 41.9 mm -80.62 125.39 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 CA-C-N 117.997 0.362 . . . . 0.0 110.748 -178.383 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 305' ' ' LEU . . . . . 0.604 HD22 HD11 ' A' ' 335' ' ' LEU . 46.3 tp -129.76 121.52 27.01 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.809 0.844 . . . . 0.0 108.963 176.564 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 306' ' ' LEU . . . . . 0.409 ' HA ' ' O ' ' A' ' 331' ' ' ASP . 2.6 mm? -88.43 127.86 35.51 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -179.328 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 307' ' ' LEU . . . . . 0.516 HD12 HG21 ' A' ' 333' ' ' VAL . 79.1 mt -136.32 104.76 5.73 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.794 0.837 . . . . 0.0 109.615 -176.666 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 308' ' ' PHE . . . . . 0.515 ' HB2' HG22 ' A' ' 330' ' ' ILE . 85.3 t80 -81.84 93.65 6.91 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 177.328 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 66.77 -87.72 0.13 Allowed Glycine 0 C--N 1.349 1.274 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.595 -177.294 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -137.17 77.46 1.64 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.277 1.031 . . . . 0.0 109.339 177.457 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 14.3 t -166.92 146.26 5.39 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.234 1.014 . . . . 0.0 108.899 173.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 312' ' ' GLU . . . . . 0.425 ' HA ' HD23 ' A' ' 307' ' ' LEU . 44.3 tt0 -97.36 123.38 41.16 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 122.532 0.333 . . . . 0.0 110.345 -176.326 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 313' ' ' LEU . . . . . 0.474 HD22 HD22 ' A' ' 322' ' ' LEU . 27.7 mt -121.11 131.63 54.38 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.59 0.756 . . . . 0.0 109.099 -179.3 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 52.6 m -98.75 152.69 37.96 Favored Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 123.59 0.756 . . . . 0.0 111.573 -174.075 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -49.23 -37.82 40.29 Favored 'Trans proline' 0 C--N 1.388 2.617 0 C-N-CA 123.695 2.93 . . . . 0.0 113.294 167.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 43.1 p -70.44 -27.61 64.39 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.321 -178.367 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -73.51 145.71 45.42 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.608 0.763 . . . . 0.0 110.857 -179.304 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 318' ' ' THR . . . . . . . . . . . . . 76.1 p -99.2 146.79 32.32 Favored Pre-proline 0 N--CA 1.476 0.857 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 177.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 319' ' ' PRO . . . . . 0.827 ' HG3' HD21 ' A' ' 280' ' ' LEU . 34.8 Cg_endo -62.19 -12.18 25.59 Favored 'Trans proline' 0 C--N 1.367 1.518 0 C-N-CA 123.081 2.521 . . . . 0.0 112.56 171.528 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 44.2 ttt-85 -68.25 -56.13 9.74 Favored 'General case' 0 C--N 1.35 0.613 0 C-N-CA 122.999 0.519 . . . . 0.0 110.15 173.051 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 13.6 t -68.81 -25.42 64.67 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 120.639 0.257 . . . . 0.0 111.265 -178.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 322' ' ' LEU . . . . . 0.474 HD22 HD22 ' A' ' 313' ' ' LEU . 52.2 mt -90.04 -13.75 35.3 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.288 0.635 . . . . 0.0 111.721 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt 61.87 35.15 16.6 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.657 1.183 . . . . 0.0 112.384 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.449 ' HG ' ' HB2' ' A' ' 322' ' ' LEU . 30.8 mt -73.74 166.13 23.85 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.545 0.738 . . . . 0.0 109.836 175.213 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 325' ' ' GLY . . . . . 0.447 ' H ' ' HB3' ' A' ' 328' ' ' ASP . . . -164.03 -171.91 30.86 Favored Glycine 0 C--N 1.337 0.635 0 CA-C-N 116.475 -0.33 . . . . 0.0 112.326 -176.629 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 35.0 m -68.4 -27.87 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 123.973 0.909 . . . . 0.0 111.402 178.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -99.57 11.63 38.65 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.118 0.967 . . . . 0.0 111.625 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 328' ' ' ASP . . . . . 0.447 ' HB3' ' H ' ' A' ' 325' ' ' GLY . 10.9 t70 -122.8 124.09 42.52 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -175.058 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 329' ' ' ILE . . . . . 0.486 HG22 ' HB2' ' A' ' 270' ' ' ARG . 3.5 mt -116.72 109.83 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 O-C-N 123.411 0.445 . . . . 0.0 111.824 -163.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 330' ' ' ILE . . . . . 0.515 HG22 ' HB2' ' A' ' 308' ' ' PHE . 34.4 pt -102.06 131.94 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 123.679 0.792 . . . . 0.0 111.117 -177.603 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 331' ' ' ASP . . . . . 0.409 ' O ' ' HA ' ' A' ' 306' ' ' LEU . 7.5 m-20 -73.95 126.91 31.52 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 123.293 0.637 . . . . 0.0 111.759 -178.739 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 332' ' ' CYS . . . . . 0.563 ' SG ' HD12 ' A' ' 304' ' ' ILE . 43.2 t -90.55 91.17 8.31 Favored 'General case' 0 C--O 1.244 0.785 0 C-N-CA 123.89 0.876 . . . . 0.0 109.043 172.692 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 333' ' ' VAL . . . . . 0.516 HG21 HD12 ' A' ' 307' ' ' LEU . 90.8 t -95.02 115.55 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 123.253 0.621 . . . . 0.0 109.506 -178.108 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 93.1 t -83.69 98.77 5.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 177.681 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 335' ' ' LEU . . . . . 0.604 HD11 HD22 ' A' ' 305' ' ' LEU . 86.3 mt . . . . . 0 N--CA 1.47 0.529 0 CA-C-N 114.662 -1.153 . . . . 0.0 111.401 172.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 3.0 mp . . . . . 0 N--CA 1.472 0.668 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -141.75 145.67 37.92 Favored Pre-proline 0 CA--C 1.546 0.792 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 175.023 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 266' ' ' PRO . . . . . 0.42 ' HB2' ' HB3' ' A' ' 277' ' ' ARG . 58.5 Cg_endo -67.93 89.11 0.37 Allowed 'Trans proline' 0 C--N 1.374 1.909 0 C-N-CA 122.875 2.383 . . . . 0.0 112.626 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 267' ' ' LEU . . . . . 0.497 ' O ' ' HA ' ' A' ' 277' ' ' ARG . 1.4 tm? -58.93 127.83 34.18 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.478 1.111 . . . . 0.0 108.96 176.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 268' ' ' LYS . . . . . 0.684 ' HG2' HG12 ' A' ' 329' ' ' ILE . 5.6 tppp? -83.6 109.35 17.35 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-O 121.336 0.589 . . . . 0.0 111.19 176.064 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 269' ' ' ILE . . . . . 0.46 HG12 ' HB ' ' A' ' 289' ' ' VAL . 2.4 mp -106.39 145.22 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 171.44 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 30.8 ttp180 -107.47 106.88 17.49 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 173.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 271' ' ' CYS . . . . . 0.583 ' SG ' HD21 ' A' ' 297' ' ' LEU . 17.4 t -69.82 172.65 7.32 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.746 171.334 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 16.3 ptt180 -62.13 -14.1 33.6 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 123.871 0.868 . . . . 0.0 113.187 -174.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -162.52 34.03 0.11 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.694 0.798 . . . . 0.0 111.029 176.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -164.23 162.82 22.8 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 122.826 0.451 . . . . 0.0 111.647 -175.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 51.9 mt -114.2 116.36 28.93 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.244 1.018 . . . . 0.0 109.653 170.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 60.3 t -100.46 142.72 15.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 124.193 0.997 . . . . 0.0 109.114 176.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 277' ' ' ARG . . . . . 0.497 ' HA ' ' O ' ' A' ' 267' ' ' LEU . 57.8 mtm180 -127.72 120.8 28.77 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 167.496 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.547 HD21 ' HA ' ' A' ' 289' ' ' VAL . 4.1 pp -123.9 146.33 50.54 Favored Pre-proline 0 N--CA 1.48 1.04 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 178.428 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -64.67 110.91 1.54 Allowed 'Trans proline' 0 C--N 1.372 1.788 0 C-N-CA 122.805 2.337 . . . . 0.0 110.94 174.266 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.659 HD21 ' HG3' ' A' ' 319' ' ' PRO . 0.1 OUTLIER -130.05 143.67 50.92 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.15 0.98 . . . . 0.0 109.835 178.9 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 70.4 mtp180 -89.44 159.79 17.11 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.001 0.92 . . . . 0.0 110.728 178.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 282' ' ' MET . . . . . . . . . . . . . 1.3 mmt -70.53 -34.02 71.82 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.199 176.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 35.2 m -77.81 -26.64 49.74 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.734 0.814 . . . . 0.0 111.222 177.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -72.56 123.37 89.45 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-O 118.135 -0.936 . . . . 0.0 108.642 176.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -68.25 179.52 2.87 Favored 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 122.759 2.306 . . . . 0.0 112.481 179.122 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.439 ' O ' HG23 ' A' ' 290' ' ' VAL . 66.6 mt -64.43 -18.37 64.67 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 118.954 -0.545 . . . . 0.0 111.557 177.449 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 26.6 tp60 -53.47 -22.61 8.25 Favored 'General case' 0 CA--C 1.559 1.294 0 C-N-CA 123.543 0.737 . . . . 0.0 112.307 178.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 288' ' ' SER . . . . . 0.494 ' HB3' HD12 ' A' ' 280' ' ' LEU . 32.1 t -63.18 -56.65 14.92 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.847 0.859 . . . . 0.0 111.069 171.46 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.547 ' HA ' HD21 ' A' ' 278' ' ' LEU . 15.4 m -67.33 -33.72 64.41 Favored 'Isoleucine or valine' 0 C--N 1.361 1.085 0 C-N-CA 122.64 0.376 . . . . 0.0 110.498 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 290' ' ' VAL . . . . . 0.576 HG13 ' HB ' ' A' ' 304' ' ' ILE . 73.8 t -61.12 -49.24 85.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 124.426 1.09 . . . . 0.0 111.026 177.287 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -61.27 -50.05 74.59 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 124.31 1.006 . . . . 0.0 110.467 -178.03 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 22.8 t60 -59.32 -49.03 79.41 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 124.526 1.141 . . . . 0.0 111.203 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 293' ' ' MET . . . . . 0.411 ' HG2' ' O ' ' A' ' 289' ' ' VAL . 91.7 mmm -68.33 -31.08 70.24 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 122.779 0.431 . . . . 0.0 111.103 -178.164 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -70.0 -38.16 75.91 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.272 0.629 . . . . 0.0 111.034 176.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 27.7 m -68.96 -43.35 75.16 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.611 0.764 . . . . 0.0 110.275 178.519 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 83.4 t60 -67.66 -47.98 67.98 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.546 -177.295 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 297' ' ' LEU . . . . . 0.583 HD21 ' SG ' ' A' ' 271' ' ' CYS . 76.6 mt -83.52 -9.0 59.24 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.512 0.725 . . . . 0.0 111.654 -178.099 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 69.66 26.4 74.49 Favored Glycine 0 C--N 1.349 1.28 0 O-C-N 123.697 0.623 . . . . 0.0 112.682 177.295 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 299' ' ' VAL . . . . . 0.488 HG11 HG11 ' A' ' 334' ' ' VAL . 28.0 m -110.36 178.14 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.435 1.094 . . . . 0.0 110.434 -177.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 27.4 m -80.4 143.16 55.23 Favored Pre-proline 0 CA--C 1.55 0.971 0 CA-C-O 119.114 -0.469 . . . . 0.0 110.207 178.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -56.91 -28.19 76.42 Favored 'Trans proline' 0 C--N 1.384 2.398 0 C-N-CA 123.052 2.502 . . . . 0.0 112.45 171.127 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 41.2 t -68.56 -27.31 65.96 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 120.83 0.347 . . . . 0.0 110.978 179.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 66.7 mtt180 -85.55 -11.86 53.05 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.34 1.056 . . . . 0.0 112.047 -176.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 304' ' ' ILE . . . . . 0.576 ' HB ' HG13 ' A' ' 290' ' ' VAL . 35.5 mm -82.67 101.97 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 177.078 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 36.9 tp -102.37 112.05 24.6 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.271 0.628 . . . . 0.0 109.471 176.275 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 306' ' ' LEU . . . . . 0.447 HD21 HG22 ' A' ' 290' ' ' VAL . 3.1 mm? -81.56 131.22 35.27 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 177.01 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 307' ' ' LEU . . . . . 0.505 HD12 HG21 ' A' ' 333' ' ' VAL . 72.5 mt -131.99 109.94 10.4 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.04 0.936 . . . . 0.0 108.735 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 308' ' ' PHE . . . . . 0.519 ' HB2' HD11 ' A' ' 313' ' ' LEU . 28.7 t80 -77.74 89.64 4.01 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -179.381 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 66.44 -83.43 0.1 Allowed Glycine 0 C--N 1.346 1.112 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.728 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -122.56 3.09 9.62 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.134 0.973 . . . . 0.0 112.207 -176.266 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 5.0 t -115.26 147.01 40.91 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 118.256 0.48 . . . . 0.0 110.225 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -85.05 132.71 34.29 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 123.184 0.594 . . . . 0.0 110.007 177.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 313' ' ' LEU . . . . . 0.522 HD13 HD13 ' A' ' 322' ' ' LEU . 53.2 mt -112.3 156.74 21.93 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.114 0.566 . . . . 0.0 110.366 177.152 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 314' ' ' SER . . . . . 0.424 ' O ' HD12 ' A' ' 286' ' ' LEU . 22.3 m -99.22 130.4 27.28 Favored Pre-proline 0 CA--C 1.544 0.749 0 CA-C-O 118.644 -0.693 . . . . 0.0 109.44 175.133 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -59.51 -21.92 64.11 Favored 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 123.228 2.618 . . . . 0.0 113.475 175.556 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 27.3 p -78.26 -29.44 48.06 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.969 0.908 . . . . 0.0 111.858 176.295 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -67.28 157.74 33.17 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.366 0.666 . . . . 0.0 111.475 -177.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 318' ' ' THR . . . . . . . . . . . . . 61.6 p -99.36 144.17 27.77 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 123.158 0.583 . . . . 0.0 109.916 -173.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 319' ' ' PRO . . . . . 0.659 ' HG3' HD21 ' A' ' 280' ' ' LEU . 55.7 Cg_endo -63.22 -16.65 55.81 Favored 'Trans proline' 0 C--N 1.363 1.342 0 C-N-CA 123.43 2.753 . . . . 0.0 112.508 175.657 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 -73.21 -48.65 33.33 Favored 'General case' 0 C--N 1.355 0.843 0 C-N-CA 122.72 0.408 . . . . 0.0 110.488 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 13.7 t -70.54 -26.37 63.53 Favored 'General case' 0 CA--C 1.549 0.926 0 O-C-N 123.324 0.39 . . . . 0.0 110.637 178.405 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 322' ' ' LEU . . . . . 0.522 HD13 HD13 ' A' ' 313' ' ' LEU . 68.6 mt -85.7 -12.17 51.87 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.362 0.665 . . . . 0.0 111.41 175.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp 60.02 35.74 21.45 Favored 'General case' 0 CA--C 1.561 1.394 0 C-N-CA 124.712 1.205 . . . . 0.0 111.52 175.224 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 60.5 mt -69.31 169.75 11.65 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.198 0.999 . . . . 0.0 111.26 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 325' ' ' GLY . . . . . 0.45 ' H ' ' HB3' ' A' ' 328' ' ' ASP . . . -154.89 -170.18 20.3 Favored Glycine 0 C--N 1.348 1.212 0 CA-C-N 116.411 -0.358 . . . . 0.0 113.084 -172.61 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 14.9 m -81.56 -28.45 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 123.683 0.793 . . . . 0.0 111.542 -176.378 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -99.33 -23.78 15.04 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.17 0.988 . . . . 0.0 110.041 176.203 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 328' ' ' ASP . . . . . 0.45 ' HB3' ' H ' ' A' ' 325' ' ' GLY . 17.3 t70 -72.19 120.09 17.31 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.889 0.876 . . . . 0.0 110.245 -175.371 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 329' ' ' ILE . . . . . 0.684 HG12 ' HG2' ' A' ' 268' ' ' LYS . 5.2 mt -100.6 134.36 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 123.819 0.848 . . . . 0.0 111.812 -166.559 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 42.8 pt -126.3 126.34 69.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 123.471 0.708 . . . . 0.0 110.345 172.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -73.89 110.44 8.19 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.485 1.114 . . . . 0.0 112.132 -175.2 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 332' ' ' CYS . . . . . 0.478 ' SG ' HD12 ' A' ' 304' ' ' ILE . 41.6 t -74.57 89.89 2.22 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.563 0.745 . . . . 0.0 109.878 167.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 333' ' ' VAL . . . . . 0.505 HG21 HD12 ' A' ' 307' ' ' LEU . 93.1 t -100.61 111.1 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 123.226 0.61 . . . . 0.0 109.483 -178.03 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 334' ' ' VAL . . . . . 0.488 HG11 HG11 ' A' ' 299' ' ' VAL . 57.9 t -83.41 108.91 16.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 123.033 0.533 . . . . 0.0 109.947 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 88.9 mt . . . . . 0 N--CA 1.48 1.053 0 C-N-CA 123.881 0.872 . . . . 0.0 110.58 178.898 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 1.6 mp . . . . . 0 N--CA 1.475 0.803 0 CA-C-O 121.107 0.48 . . . . 0.0 109.949 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 265' ' ' PHE . . . . . 0.495 ' CE1' ' HG2' ' A' ' 282' ' ' MET . 10.1 p90 -150.45 138.94 12.64 Favored Pre-proline 0 CA--C 1.545 0.78 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 170.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -62.54 94.38 0.14 Allowed 'Trans proline' 0 C--N 1.377 2.03 0 C-N-CA 122.616 2.211 . . . . 0.0 111.555 173.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 267' ' ' LEU . . . . . 0.538 HD12 HG13 ' A' ' 269' ' ' ILE . 0.9 OUTLIER -59.69 125.82 25.15 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 174.266 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 268' ' ' LYS . . . . . 0.579 ' HG2' HG12 ' A' ' 329' ' ' ILE . 4.8 tppp? -88.41 102.64 15.08 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.348 0.659 . . . . 0.0 110.396 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 269' ' ' ILE . . . . . 0.538 HG13 HD12 ' A' ' 267' ' ' LEU . 2.1 mp -103.63 129.8 55.07 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 173.439 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 30.8 ttp180 -90.45 109.37 20.5 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-O 121.303 0.573 . . . . 0.0 110.192 174.567 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 271' ' ' CYS . . . . . 0.709 ' SG ' HD21 ' A' ' 297' ' ' LEU . 49.2 t -77.87 -179.59 6.11 Favored 'General case' 0 CA--C 1.55 0.95 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.315 172.379 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 272' ' ' ARG . . . . . 0.401 ' N ' ' SG ' ' A' ' 271' ' ' CYS . 15.9 ptt-85 -53.24 -31.67 44.53 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.978 1.311 . . . . 0.0 113.805 -178.486 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -161.68 27.98 0.12 Allowed 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.694 0.798 . . . . 0.0 110.279 177.513 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 274' ' ' ASP . . . . . 0.462 ' HB3' ' HB3' ' A' ' 271' ' ' CYS . 34.8 t70 -144.76 158.68 43.69 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.447 0.699 . . . . 0.0 109.795 -172.752 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 66.2 mt -119.92 101.47 7.89 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.652 0.781 . . . . 0.0 109.81 176.429 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 276' ' ' VAL . . . . . 0.504 HG21 ' SD ' ' A' ' 293' ' ' MET . 65.0 t -83.75 125.57 40.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.924 179.577 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 86.1 mtm180 -118.86 104.83 10.9 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 175.41 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.494 HD21 ' HA ' ' A' ' 289' ' ' VAL . 4.3 pp -116.21 131.99 23.51 Favored Pre-proline 0 N--CA 1.487 1.398 0 CA-C-N 118.182 0.446 . . . . 0.0 110.744 178.829 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -65.9 115.95 3.71 Favored 'Trans proline' 0 C--N 1.381 2.24 0 C-N-CA 122.627 2.218 . . . . 0.0 110.736 177.225 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.714 HD21 ' HG3' ' A' ' 319' ' ' PRO . 0.4 OUTLIER -136.66 148.29 47.32 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.521 1.128 . . . . 0.0 109.463 -174.688 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -88.18 144.37 26.5 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 178.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 282' ' ' MET . . . . . 0.5 ' HB3' ' HB2' ' A' ' 320' ' ' ARG . 16.2 mtp -66.3 -27.41 67.9 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 118.154 0.434 . . . . 0.0 111.68 -177.105 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 35.1 m -79.16 -12.17 59.98 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.52 0.728 . . . . 0.0 112.01 176.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 25.6 tp10 -85.67 130.17 52.0 Favored Pre-proline 0 N--CA 1.472 0.632 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 178.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -65.01 167.32 16.24 Favored 'Trans proline' 0 C--N 1.381 2.267 0 C-N-CA 122.498 2.132 . . . . 0.0 113.119 178.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.402 ' O ' HG22 ' A' ' 289' ' ' VAL . 91.5 mt -68.48 -9.29 47.92 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.502 -178.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 26.3 tp60 -53.85 -27.98 33.13 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.563 0.745 . . . . 0.0 111.444 174.723 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 288' ' ' SER . . . . . 0.467 ' HB2' HD12 ' A' ' 280' ' ' LEU . 67.0 m -65.92 -47.08 75.93 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.709 0.804 . . . . 0.0 112.075 175.184 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.494 ' HA ' HD21 ' A' ' 278' ' ' LEU . 17.1 m -71.55 -34.31 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 177.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 290' ' ' VAL . . . . . 0.569 HG13 ' HB ' ' A' ' 304' ' ' ILE . 37.5 t -61.61 -45.07 99.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.667 1.187 . . . . 0.0 110.95 177.483 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -63.74 -48.95 74.94 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.04 0.936 . . . . 0.0 110.79 -178.092 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 49.4 t-80 -64.36 -44.9 89.98 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.18 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 293' ' ' MET . . . . . 0.504 ' SD ' HG21 ' A' ' 276' ' ' VAL . 90.9 mmm -68.34 -32.08 71.94 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 123.724 0.64 . . . . 0.0 111.42 -177.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -63.76 -43.36 96.63 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 123.698 0.624 . . . . 0.0 110.404 176.255 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 29.2 m -73.5 -33.08 64.62 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 123.272 0.629 . . . . 0.0 111.254 176.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 58.4 t60 -66.2 -34.43 78.0 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.183 0.993 . . . . 0.0 110.719 -178.435 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 297' ' ' LEU . . . . . 0.709 HD21 ' SG ' ' A' ' 271' ' ' CYS . 62.2 mt -102.31 -21.35 14.33 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.921 0.888 . . . . 0.0 111.83 -177.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 85.36 24.42 43.62 Favored Glycine 0 N--CA 1.475 1.258 0 O-C-N 123.007 0.192 . . . . 0.0 112.999 -178.123 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 299' ' ' VAL . . . . . 0.495 HG11 HG11 ' A' ' 334' ' ' VAL . 31.4 m -109.87 -179.42 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 124.013 0.925 . . . . 0.0 110.808 177.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 19.2 m -82.82 146.29 52.17 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 123.542 0.737 . . . . 0.0 110.277 178.224 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -58.92 -27.35 84.29 Favored 'Trans proline' 0 C--N 1.386 2.545 0 C-N-CA 123.001 2.468 . . . . 0.0 112.295 173.077 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 40.2 p -67.06 -17.39 64.87 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.847 0.859 . . . . 0.0 112.021 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 89.5 mtt180 -95.68 -25.79 15.98 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.041 0.937 . . . . 0.0 111.926 -176.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 304' ' ' ILE . . . . . 0.569 ' HB ' HG13 ' A' ' 290' ' ' VAL . 32.9 mm -72.51 115.66 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 122.601 0.36 . . . . 0.0 110.363 -177.755 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 27.0 tp -124.17 122.32 37.49 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.241 0.616 . . . . 0.0 109.367 177.606 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 306' ' ' LEU . . . . . 0.427 ' HG ' HD12 ' A' ' 330' ' ' ILE . 2.2 mm? -89.16 123.31 33.3 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -177.754 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 307' ' ' LEU . . . . . 0.516 HD12 HG21 ' A' ' 333' ' ' VAL . 72.7 mt -129.74 112.89 14.08 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.469 0.708 . . . . 0.0 109.622 -177.173 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -84.7 92.55 8.22 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 173.037 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 70.43 -94.59 0.49 Allowed Glycine 0 C--N 1.346 1.088 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 -174.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -133.69 82.67 2.0 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.577 0.751 . . . . 0.0 109.411 174.009 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 12.1 t -166.0 138.84 4.09 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 174.032 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -90.74 114.03 26.28 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-O 120.697 0.284 . . . . 0.0 110.698 -174.661 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 46.0 mt -103.74 114.49 28.8 Favored 'General case' 0 C--O 1.245 0.842 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 177.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 12.8 m -72.6 143.9 85.51 Favored Pre-proline 0 CA--C 1.553 1.079 0 C-N-CA 124.215 1.006 . . . . 0.0 111.219 -173.636 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 315' ' ' PRO . . . . . 0.542 ' HB3' HG21 ' A' ' 290' ' ' VAL . 36.5 Cg_endo -62.63 -28.65 77.1 Favored 'Trans proline' 0 C--N 1.381 2.263 0 C-N-CA 123.015 2.477 . . . . 0.0 112.357 175.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 4.7 m -73.67 -28.72 61.9 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.09 0.956 . . . . 0.0 111.329 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -78.29 154.78 30.62 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.532 0.733 . . . . 0.0 110.756 -178.044 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 318' ' ' THR . . . . . . . . . . . . . 82.8 p -99.46 152.9 37.96 Favored Pre-proline 0 CA--C 1.545 0.764 0 C-N-CA 123.495 0.718 . . . . 0.0 109.901 -178.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 319' ' ' PRO . . . . . 0.714 ' HG3' HD21 ' A' ' 280' ' ' LEU . 60.9 Cg_endo -67.92 -9.69 26.44 Favored 'Trans proline' 0 C--N 1.363 1.339 0 C-N-CA 122.975 2.45 . . . . 0.0 113.324 174.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 320' ' ' ARG . . . . . 0.5 ' HB2' ' HB3' ' A' ' 282' ' ' MET . 44.5 ttm180 -75.11 -48.2 24.95 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 117.786 0.266 . . . . 0.0 110.474 178.264 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 14.6 t -68.74 -22.88 64.29 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 122.659 0.383 . . . . 0.0 110.946 179.454 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 322' ' ' LEU . . . . . 0.449 ' HB2' ' HG ' ' A' ' 324' ' ' LEU . 53.2 mt -92.05 -16.13 26.86 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.73 0.812 . . . . 0.0 111.511 176.86 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp 65.06 31.94 10.71 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.753 1.221 . . . . 0.0 112.57 -179.223 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.449 ' HG ' ' HB2' ' A' ' 322' ' ' LEU . 42.0 mt -67.54 165.12 17.51 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.682 0.793 . . . . 0.0 110.839 175.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 325' ' ' GLY . . . . . 0.486 ' H ' ' HB3' ' A' ' 328' ' ' ASP . . . -158.63 -169.48 22.13 Favored Glycine 0 C--N 1.342 0.884 0 CA-C-N 116.046 -0.524 . . . . 0.0 112.699 -173.137 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 21.5 m -77.25 -25.72 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.542 0.737 . . . . 0.0 110.46 178.19 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -94.28 -19.44 20.69 Favored 'General case' 0 C--N 1.353 0.734 0 C-N-CA 124.164 0.985 . . . . 0.0 110.957 179.074 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 328' ' ' ASP . . . . . 0.486 ' HB3' ' H ' ' A' ' 325' ' ' GLY . 13.1 t70 -82.77 128.4 34.36 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 178.086 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 329' ' ' ILE . . . . . 0.579 HG12 ' HG2' ' A' ' 268' ' ' LYS . 9.4 mt -115.21 113.87 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 123.107 0.563 . . . . 0.0 109.852 -170.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 330' ' ' ILE . . . . . 0.427 HD12 ' HG ' ' A' ' 306' ' ' LEU . 38.6 pt -108.43 125.47 65.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-O 121.083 0.468 . . . . 0.0 110.79 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -72.34 116.96 13.4 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.839 0.856 . . . . 0.0 111.387 -175.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 332' ' ' CYS . . . . . 0.536 ' SG ' HD12 ' A' ' 304' ' ' ILE . 37.6 t -74.27 92.1 2.22 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 123.307 0.643 . . . . 0.0 109.415 169.599 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 333' ' ' VAL . . . . . 0.516 HG21 HD12 ' A' ' 307' ' ' LEU . 60.5 t -101.36 109.84 26.74 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -178.25 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 334' ' ' VAL . . . . . 0.495 HG11 HG11 ' A' ' 299' ' ' VAL . 57.6 t -79.31 93.91 1.77 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.451 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.694 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 87.4 mt . . . . . 0 C--O 1.239 0.506 0 CA-C-O 121.565 0.698 . . . . 0.0 109.508 172.72 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 0.485 HD23 ' HG2' ' A' ' 281' ' ' ARG . 45.9 mt . . . . . 0 C--O 1.24 0.569 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -109.18 142.23 25.15 Favored Pre-proline 0 C--O 1.247 0.924 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 173.031 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -67.09 96.01 0.38 Allowed 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 122.275 1.983 . . . . 0.0 111.363 175.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 267' ' ' LEU . . . . . 0.514 HD12 HG13 ' A' ' 269' ' ' ILE . 1.0 OUTLIER -62.06 129.07 39.12 Favored 'General case' 0 C--O 1.246 0.899 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 174.656 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 268' ' ' LYS . . . . . 0.495 ' HG2' HG12 ' A' ' 329' ' ' ILE . 2.6 tppp? -94.37 102.32 14.29 Favored 'General case' 0 C--O 1.241 0.653 0 O-C-N 123.751 0.657 . . . . 0.0 109.872 -176.769 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 269' ' ' ILE . . . . . 0.514 HG13 HD12 ' A' ' 267' ' ' LEU . 1.5 mp -104.48 114.19 43.42 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 176.664 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 33.1 ttp180 -75.54 104.28 6.03 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 175.38 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 271' ' ' CYS . . . . . 0.601 ' SG ' HD21 ' A' ' 297' ' ' LEU . 38.1 t -72.59 175.98 5.87 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.27 1.028 . . . . 0.0 110.069 174.445 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 25.7 ptt180 -57.13 -28.05 62.37 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.017 0.927 . . . . 0.0 113.142 -178.614 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -155.45 30.14 0.38 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.376 0.67 . . . . 0.0 111.175 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -160.56 164.0 32.33 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 122.696 0.398 . . . . 0.0 110.907 -173.634 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -113.54 103.08 10.9 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.258 1.023 . . . . 0.0 108.948 171.324 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 72.8 t -83.68 130.61 35.54 Favored 'Isoleucine or valine' 0 C--N 1.343 0.301 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 177.286 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 76.4 mtt85 -124.32 99.49 6.23 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -179.506 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.493 HD21 ' HA ' ' A' ' 289' ' ' VAL . 4.3 pp -111.8 142.36 26.53 Favored Pre-proline 0 N--CA 1.489 1.476 0 CA-C-N 117.917 0.326 . . . . 0.0 110.324 -178.495 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -69.26 115.57 4.09 Favored 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 122.282 1.988 . . . . 0.0 110.502 177.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.733 HD21 ' HG3' ' A' ' 319' ' ' PRO . 0.9 OUTLIER -138.34 149.94 46.11 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.835 0.854 . . . . 0.0 109.992 -176.481 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 281' ' ' ARG . . . . . 0.485 ' HG2' HD23 ' A' ' 264' ' ' LEU . 16.2 mmm180 -94.36 151.1 19.66 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.104 0.962 . . . . 0.0 111.092 178.001 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 282' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -57.1 -41.31 78.67 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.122 0.569 . . . . 0.0 111.118 175.223 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 19.6 m -76.25 -17.83 59.3 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.378 1.071 . . . . 0.0 112.554 -177.544 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 284' ' ' GLU . . . . . 0.451 ' O ' ' HD2' ' A' ' 319' ' ' PRO . 8.5 tp10 -72.49 130.29 86.03 Favored Pre-proline 0 N--CA 1.476 0.838 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 176.293 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -66.23 166.7 20.37 Favored 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 121.937 1.758 . . . . 0.0 111.807 172.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.482 ' O ' HG23 ' A' ' 290' ' ' VAL . 65.3 mt -66.27 -15.12 62.95 Favored 'General case' 0 C--O 1.215 -0.751 0 CA-C-O 118.932 -0.556 . . . . 0.0 111.779 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 -50.54 -26.2 4.95 Favored 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 123.967 0.907 . . . . 0.0 112.204 178.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 288' ' ' SER . . . . . 0.468 ' HB3' HD12 ' A' ' 280' ' ' LEU . 29.5 t -61.61 -57.2 12.96 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.087 0.955 . . . . 0.0 110.939 171.774 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.493 ' HA ' HD21 ' A' ' 278' ' ' LEU . 13.2 m -68.03 -29.68 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 122.494 0.317 . . . . 0.0 110.908 -179.376 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 290' ' ' VAL . . . . . 0.601 HG13 ' HB ' ' A' ' 304' ' ' ILE . 78.1 t -66.2 -55.37 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 123.951 0.9 . . . . 0.0 110.35 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -64.0 -37.66 88.25 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.276 -179.118 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 62.5 t60 -68.72 -47.63 65.87 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 122.982 0.513 . . . . 0.0 110.978 -177.079 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 293' ' ' MET . . . . . 0.472 ' HG3' HG21 ' A' ' 269' ' ' ILE . 91.0 mmm -65.9 -32.68 74.32 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.276 0.63 . . . . 0.0 110.966 178.83 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -63.6 -53.08 57.26 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 123.876 0.735 . . . . 0.0 110.964 176.122 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 55.4 m -64.46 -29.49 70.53 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.814 0.846 . . . . 0.0 111.176 179.305 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 71.1 t60 -71.42 -46.25 60.62 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.614 0.766 . . . . 0.0 110.997 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 297' ' ' LEU . . . . . 0.601 HD21 ' SG ' ' A' ' 271' ' ' CYS . 72.7 mt -91.74 -3.56 56.07 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.733 0.813 . . . . 0.0 111.797 -176.284 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 77.27 22.68 70.14 Favored Glycine 0 C--N 1.349 1.292 0 C-N-CA 123.206 0.432 . . . . 0.0 113.196 175.006 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 299' ' ' VAL . . . . . 0.518 HG11 HG11 ' A' ' 334' ' ' VAL . 25.0 m -112.07 -179.23 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 124.777 1.231 . . . . 0.0 110.832 178.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 51.7 m -87.81 147.61 41.6 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 123.831 0.852 . . . . 0.0 110.769 178.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.36 -25.9 75.06 Favored 'Trans proline' 0 C--N 1.391 2.773 0 C-N-CA 123.215 2.61 . . . . 0.0 111.909 173.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 9.2 m -61.1 -22.47 64.66 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 123.817 0.847 . . . . 0.0 111.995 178.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 46.6 mtt180 -97.83 -19.88 17.87 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.485 0.714 . . . . 0.0 112.385 -174.097 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 304' ' ' ILE . . . . . 0.601 ' HB ' HG13 ' A' ' 290' ' ' VAL . 37.0 mm -77.39 99.31 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 CA-C-O 121.101 0.477 . . . . 0.0 110.28 -177.619 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 305' ' ' LEU . . . . . 0.434 HD22 HD11 ' A' ' 335' ' ' LEU . 29.2 tp -101.55 112.32 24.84 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.843 0.857 . . . . 0.0 109.209 178.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -85.05 120.94 27.13 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 307' ' ' LEU . . . . . 0.487 HD12 HG21 ' A' ' 333' ' ' VAL . 70.8 mt -129.41 116.2 18.66 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.035 0.934 . . . . 0.0 108.868 -177.734 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -87.56 85.71 7.13 Favored 'General case' 0 C--O 1.244 0.764 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 174.602 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 67.62 -96.98 0.38 Allowed Glycine 0 C--N 1.342 0.898 0 CA-C-N 115.154 -0.93 . . . . 0.0 112.991 -179.489 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -110.21 11.68 23.54 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.528 0.731 . . . . 0.0 112.06 -174.678 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 11.4 t -116.98 152.85 33.71 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 117.863 0.301 . . . . 0.0 110.244 176.395 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -105.36 129.42 53.69 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.2 0.6 . . . . 0.0 109.818 178.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 313' ' ' LEU . . . . . 0.425 HD22 HD22 ' A' ' 322' ' ' LEU . 49.8 mt -113.33 135.17 54.14 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.353 0.661 . . . . 0.0 109.921 -179.049 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 20.1 m -80.65 143.36 54.54 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 123.457 0.703 . . . . 0.0 110.717 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -63.26 -29.88 73.47 Favored 'Trans proline' 0 C--N 1.384 2.408 0 C-N-CA 122.866 2.377 . . . . 0.0 112.127 174.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 34.1 p -88.13 -1.36 57.96 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.273 1.029 . . . . 0.0 111.944 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -88.58 153.17 21.35 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.274 0.63 . . . . 0.0 109.981 175.168 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 318' ' ' THR . . . . . . . . . . . . . 82.6 p -99.37 142.79 25.24 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 123.372 0.669 . . . . 0.0 109.979 -178.213 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 319' ' ' PRO . . . . . 0.733 ' HG3' HD21 ' A' ' 280' ' ' LEU . 29.8 Cg_endo -60.76 -13.69 27.81 Favored 'Trans proline' 0 C--N 1.369 1.65 0 C-N-CA 123.441 2.761 . . . . 0.0 113.143 172.868 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 53.1 ttt180 -67.07 -55.2 15.32 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.167 0.587 . . . . 0.0 110.105 174.536 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 10.8 t -71.09 -21.06 62.27 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.06 -177.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 322' ' ' LEU . . . . . 0.445 ' HB2' ' HG ' ' A' ' 324' ' ' LEU . 53.5 mt -93.76 -10.19 35.07 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.657 0.783 . . . . 0.0 111.518 176.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 11.3 mptt 62.15 25.65 15.37 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 125.129 1.371 . . . . 0.0 112.592 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.446 HD13 HD13 ' A' ' 330' ' ' ILE . 33.3 mt -66.79 159.09 28.79 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.363 0.665 . . . . 0.0 110.276 177.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 325' ' ' GLY . . . . . 0.43 ' H ' ' HB3' ' A' ' 328' ' ' ASP . . . -157.06 -157.17 8.23 Favored Glycine 0 C--O 1.242 0.598 0 CA-C-N 116.233 -0.439 . . . . 0.0 112.466 -173.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 17.6 m -83.31 -36.67 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 123.258 0.623 . . . . 0.0 110.625 -179.316 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -88.85 -17.64 29.27 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.053 0.941 . . . . 0.0 110.727 178.309 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 328' ' ' ASP . . . . . 0.43 ' HB3' ' H ' ' A' ' 325' ' ' GLY . 3.9 t70 -90.39 115.96 27.97 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.628 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 329' ' ' ILE . . . . . 0.495 HG12 ' HG2' ' A' ' 268' ' ' LYS . 16.0 mt -114.52 120.95 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 123.144 0.578 . . . . 0.0 111.353 -163.612 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 330' ' ' ILE . . . . . 0.446 HD13 HD13 ' A' ' 324' ' ' LEU . 35.8 pt -108.95 137.08 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 123.344 0.657 . . . . 0.0 111.311 -176.775 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -79.9 119.46 22.79 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.724 0.81 . . . . 0.0 111.713 -176.495 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 332' ' ' CYS . . . . . 0.524 ' SG ' HD12 ' A' ' 304' ' ' ILE . 26.9 t -77.79 90.27 4.05 Favored 'General case' 0 C--O 1.243 0.741 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 167.548 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 333' ' ' VAL . . . . . 0.487 HG21 HD12 ' A' ' 307' ' ' LEU . 28.3 t -97.27 109.45 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -178.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 334' ' ' VAL . . . . . 0.518 HG11 HG11 ' A' ' 299' ' ' VAL . 40.0 t -85.08 100.96 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.03 -175.379 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 335' ' ' LEU . . . . . 0.434 HD11 HD22 ' A' ' 305' ' ' LEU . 3.4 pp . . . . . 0 N--CA 1.472 0.638 0 C-N-CA 122.764 0.426 . . . . 0.0 111.087 -179.103 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 0.456 HD23 HH11 ' A' ' 281' ' ' ARG . 0.9 OUTLIER . . . . . 0 N--CA 1.476 0.838 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -113.41 142.56 27.75 Favored Pre-proline 0 N--CA 1.481 1.092 0 C-N-CA 123.053 0.541 . . . . 0.0 109.841 176.63 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 266' ' ' PRO . . . . . 0.412 ' O ' ' HA ' ' A' ' 326' ' ' VAL . 23.5 Cg_exo -63.3 100.43 0.26 Allowed 'Trans proline' 0 C--N 1.379 2.162 0 C-N-CA 122.914 2.409 . . . . 0.0 112.362 175.494 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 267' ' ' LEU . . . . . 0.518 HD23 HD22 ' A' ' 280' ' ' LEU . 0.4 OUTLIER -71.23 122.41 20.17 Favored 'General case' 0 CA--C 1.551 0.99 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 173.583 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 268' ' ' LYS . . . . . 0.611 ' HG2' HG12 ' A' ' 329' ' ' ILE . 13.8 tppt? -85.52 119.97 26.46 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.528 0.731 . . . . 0.0 110.081 179.299 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 16.4 mt -121.18 138.56 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 124.539 1.136 . . . . 0.0 109.032 179.051 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 270' ' ' ARG . . . . . 0.436 ' HB2' HG22 ' A' ' 329' ' ' ILE . 29.7 ttp180 -107.82 103.88 13.24 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 123.715 0.806 . . . . 0.0 109.443 177.229 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 271' ' ' CYS . . . . . 0.77 ' SG ' HD21 ' A' ' 297' ' ' LEU . 49.8 t -77.93 179.53 6.68 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 124.482 1.113 . . . . 0.0 110.616 176.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 272' ' ' ARG . . . . . 0.42 ' N ' ' SG ' ' A' ' 271' ' ' CYS . 26.8 ptt180 -54.22 -31.87 54.31 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 125.414 1.486 . . . . 0.0 113.192 -179.149 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -162.82 33.83 0.1 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.981 0.913 . . . . 0.0 110.362 -178.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -157.97 158.05 34.2 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.353 0.661 . . . . 0.0 110.097 -170.518 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -117.78 123.21 45.43 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.055 0.942 . . . . 0.0 108.881 173.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 276' ' ' VAL . . . . . 0.533 HG21 ' SD ' ' A' ' 293' ' ' MET . 91.8 t -109.73 121.87 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 124.096 0.958 . . . . 0.0 109.818 178.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 20.7 mtm180 -111.51 122.17 47.13 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 169.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.462 HD11 HG12 ' A' ' 289' ' ' VAL . 4.6 pp -131.43 138.78 33.51 Favored Pre-proline 0 N--CA 1.476 0.85 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 175.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.89 94.22 0.87 Allowed 'Trans proline' 0 C--N 1.367 1.511 0 C-N-CA 122.326 2.017 . . . . 0.0 111.312 -177.708 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.69 HD21 ' HG3' ' A' ' 319' ' ' PRO . 2.8 tt -103.11 156.95 17.33 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.629 1.172 . . . . 0.0 110.287 -178.25 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 281' ' ' ARG . . . . . 0.456 HH11 HD23 ' A' ' 264' ' ' LEU . 0.1 OUTLIER -99.43 144.79 28.13 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.177 0.991 . . . . 0.0 110.087 -179.55 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 282' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -58.07 -34.18 69.85 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 123.918 0.887 . . . . 0.0 112.372 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 16.1 m -78.57 -22.45 47.12 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.77 0.828 . . . . 0.0 111.78 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 284' ' ' GLU . . . . . 0.427 ' HB2' ' HB2' ' A' ' 281' ' ' ARG . 8.2 tp10 -75.22 130.77 79.54 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 124.084 0.953 . . . . 0.0 109.647 -176.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -68.48 169.83 16.3 Favored 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 122.229 1.953 . . . . 0.0 112.209 174.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.41 ' O ' HG23 ' A' ' 290' ' ' VAL . 87.4 mt -71.01 -6.63 40.43 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.073 0.549 . . . . 0.0 111.688 -179.25 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 26.5 tp60 -57.06 -26.1 59.8 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.617 0.767 . . . . 0.0 110.526 173.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 288' ' ' SER . . . . . 0.409 ' HB3' HD12 ' A' ' 280' ' ' LEU . 40.6 t -61.46 -55.9 26.16 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.591 1.156 . . . . 0.0 111.423 172.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.462 HG12 HD11 ' A' ' 278' ' ' LEU . 21.0 m -67.62 -32.5 57.16 Favored 'Isoleucine or valine' 0 C--N 1.359 1.021 0 CA-C-N 116.695 -0.229 . . . . 0.0 110.429 -179.354 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 290' ' ' VAL . . . . . 0.548 HG13 ' HB ' ' A' ' 304' ' ' ILE . 40.0 t -59.53 -48.02 88.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 124.576 1.15 . . . . 0.0 110.842 176.32 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -59.81 -48.08 83.11 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 124.243 0.964 . . . . 0.0 110.973 -179.071 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 13.9 t60 -65.64 -46.29 79.76 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.99 -178.757 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 293' ' ' MET . . . . . 0.533 ' SD ' HG21 ' A' ' 276' ' ' VAL . 89.5 mmm -67.56 -34.53 77.25 Favored 'General case' 0 N--CA 1.484 1.242 0 O-C-N 123.652 0.595 . . . . 0.0 111.418 -176.194 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -64.3 -42.25 96.45 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 123.733 0.646 . . . . 0.0 110.178 175.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 37.0 m -74.16 -23.86 59.31 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 123.754 0.822 . . . . 0.0 111.169 178.03 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 77.3 t60 -82.69 -27.39 31.27 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.267 0.627 . . . . 0.0 111.151 -178.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 297' ' ' LEU . . . . . 0.77 HD21 ' SG ' ' A' ' 271' ' ' CYS . 87.8 mt -110.44 -7.33 14.78 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.59 0.756 . . . . 0.0 111.966 -176.116 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 71.66 30.74 65.94 Favored Glycine 0 C--N 1.342 0.894 0 O-C-N 123.315 0.384 . . . . 0.0 112.763 178.779 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 299' ' ' VAL . . . . . 0.463 HG11 HG11 ' A' ' 334' ' ' VAL . 33.0 m -115.29 -177.95 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.234 1.014 . . . . 0.0 110.232 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 300' ' ' SER . . . . . 0.519 ' HB2' ' HG3' ' A' ' 303' ' ' ARG . 45.1 m -85.3 146.53 45.09 Favored Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 123.37 0.668 . . . . 0.0 110.969 178.047 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -56.65 -30.59 84.21 Favored 'Trans proline' 0 C--N 1.386 2.506 0 C-N-CA 123.036 2.491 . . . . 0.0 112.227 169.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 32.1 t -74.95 -2.42 27.02 Favored 'General case' 0 CA--C 1.556 1.195 0 C-N-CA 123.323 0.649 . . . . 0.0 111.629 -178.082 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 303' ' ' ARG . . . . . 0.519 ' HG3' ' HB2' ' A' ' 300' ' ' SER . 60.4 mtt-85 -101.47 -27.01 13.37 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.849 0.859 . . . . 0.0 111.645 177.371 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 304' ' ' ILE . . . . . 0.548 ' HB ' HG13 ' A' ' 290' ' ' VAL . 33.5 mm -74.26 112.52 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 C-N-CA 122.938 0.495 . . . . 0.0 110.868 -174.445 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 48.3 tp -114.61 117.04 29.75 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.891 0.876 . . . . 0.0 109.331 176.106 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -86.86 127.81 35.04 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 177.533 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 72.8 mt -132.31 108.15 9.02 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 177.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 308' ' ' PHE . . . . . 0.502 ' HB2' HG22 ' A' ' 330' ' ' ILE . 39.6 t80 -75.55 92.19 2.89 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -176.822 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 71.56 -78.39 0.59 Allowed Glycine 0 C--N 1.348 1.239 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.065 -177.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -130.52 -12.08 3.93 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.825 0.85 . . . . 0.0 111.79 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 5.1 t -90.91 147.31 23.22 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 118.353 0.524 . . . . 0.0 110.95 -172.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -87.02 121.07 28.98 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.391 0.676 . . . . 0.0 110.534 -174.611 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 313' ' ' LEU . . . . . 0.537 HD22 HD22 ' A' ' 322' ' ' LEU . 24.7 mt -114.5 168.75 9.59 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.073 0.549 . . . . 0.0 109.535 175.702 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 45.6 m -126.89 152.87 75.95 Favored Pre-proline 0 N--CA 1.48 1.066 0 C-N-CA 123.317 0.647 . . . . 0.0 109.879 177.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 315' ' ' PRO . . . . . 0.442 ' HB3' HG21 ' A' ' 290' ' ' VAL . 34.9 Cg_exo -58.24 -33.28 97.43 Favored 'Trans proline' 0 C--N 1.382 2.31 0 C-N-CA 122.916 2.411 . . . . 0.0 111.502 170.45 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 53.9 p -81.63 -0.79 44.1 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 114.643 -1.162 . . . . 0.0 112.369 -177.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -96.99 149.08 22.32 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.655 0.782 . . . . 0.0 110.755 179.331 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 318' ' ' THR . . . . . . . . . . . . . 28.2 p -102.39 139.94 20.68 Favored Pre-proline 0 N--CA 1.48 1.068 0 C-N-CA 123.87 0.868 . . . . 0.0 110.257 -177.427 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 319' ' ' PRO . . . . . 0.69 ' HG3' HD21 ' A' ' 280' ' ' LEU . 72.3 Cg_endo -66.12 -14.68 45.47 Favored 'Trans proline' 0 C--N 1.371 1.731 0 C-N-CA 123.753 2.969 . . . . 0.0 113.363 -173.607 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 22.5 ttt180 -63.37 -56.29 17.54 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.537 0.735 . . . . 0.0 110.592 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 10.0 t -70.83 -27.93 64.23 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.337 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 322' ' ' LEU . . . . . 0.537 HD22 HD22 ' A' ' 313' ' ' LEU . 43.9 mt -80.44 -10.01 59.75 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.531 0.732 . . . . 0.0 111.093 178.468 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp 68.49 24.3 7.13 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 125.31 1.444 . . . . 0.0 112.148 175.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.46 ' HG ' ' HB2' ' A' ' 322' ' ' LEU . 23.7 mt -75.29 156.91 35.13 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.752 0.821 . . . . 0.0 110.681 178.046 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 325' ' ' GLY . . . . . 0.449 ' H ' ' HB2' ' A' ' 328' ' ' ASP . . . -163.04 -151.97 6.62 Favored Glycine 0 C--O 1.243 0.705 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.348 -175.146 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 326' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 266' ' ' PRO . 34.0 m -76.73 -33.05 21.19 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 C-N-CA 123.08 0.552 . . . . 0.0 111.325 -178.481 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -94.77 -20.06 19.82 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.595 0.758 . . . . 0.0 111.629 -176.548 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 328' ' ' ASP . . . . . 0.449 ' HB2' ' H ' ' A' ' 325' ' ' GLY . 7.7 m-20 -78.02 120.68 23.21 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 122.922 0.489 . . . . 0.0 109.927 -177.177 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 329' ' ' ILE . . . . . 0.611 HG12 ' HG2' ' A' ' 268' ' ' LYS . 8.7 mt -105.19 111.23 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 123.84 0.856 . . . . 0.0 110.623 -169.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 330' ' ' ILE . . . . . 0.502 HG22 ' HB2' ' A' ' 308' ' ' PHE . 45.5 pt -102.56 124.21 56.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 CA-C-O 121.22 0.533 . . . . 0.0 111.135 -179.02 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -73.34 115.89 13.25 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.673 0.789 . . . . 0.0 111.035 -178.803 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 332' ' ' CYS . . . . . 0.471 ' SG ' HD12 ' A' ' 304' ' ' ILE . 39.5 t -78.11 95.03 4.8 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 170.598 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 59.4 t -102.02 109.91 27.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 123.452 0.701 . . . . 0.0 109.111 -177.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 334' ' ' VAL . . . . . 0.48 HG22 HD13 ' A' ' 304' ' ' ILE . 47.5 t -83.8 99.32 6.2 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 C-N-CA 123.26 0.624 . . . . 0.0 110.052 -178.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 85.8 mt . . . . . 0 N--CA 1.479 1.007 0 C-N-CA 123.967 0.907 . . . . 0.0 110.225 175.65 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 0.499 ' HG ' ' HG3' ' A' ' 281' ' ' ARG . 3.3 mp . . . . . 0 C--O 1.239 0.522 0 CA-C-O 120.828 0.347 . . . . 0.0 110.707 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 265' ' ' PHE . . . . . 0.468 ' CE1' ' HG2' ' A' ' 282' ' ' MET . 15.2 p90 -125.34 143.83 45.76 Favored Pre-proline 0 CA--C 1.549 0.92 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 172.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -62.93 96.61 0.17 Allowed 'Trans proline' 0 C--N 1.373 1.852 0 C-N-CA 122.564 2.176 . . . . 0.0 112.01 174.261 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.37 120.14 12.8 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 170.099 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 268' ' ' LYS . . . . . 0.513 ' HE3' HG12 ' A' ' 329' ' ' ILE . 25.5 ttpt -93.95 111.61 23.34 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 121.464 0.65 . . . . 0.0 110.008 -177.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 4.3 mp -106.75 130.33 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.31 1.044 . . . . 0.0 108.872 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 270' ' ' ARG . . . . . 0.409 ' HB2' ' CG2' ' A' ' 329' ' ' ILE . 23.1 ttm180 -84.5 101.01 11.74 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.196 0.522 . . . . 0.0 109.916 173.725 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 271' ' ' CYS . . . . . 0.586 ' SG ' HD21 ' A' ' 297' ' ' LEU . 52.5 t -69.5 175.56 4.0 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.971 169.687 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 272' ' ' ARG . . . . . 0.457 ' HG2' ' SG ' ' A' ' 271' ' ' CYS . 7.5 ptm180 -53.29 -25.95 16.65 Favored 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 124.862 1.265 . . . . 0.0 113.344 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -163.45 37.24 0.09 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.268 0.627 . . . . 0.0 111.205 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -165.27 162.65 19.94 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 122.838 0.455 . . . . 0.0 111.4 -175.536 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.447 HD13 ' HD2' ' A' ' 268' ' ' LYS . 86.5 mt -114.55 104.15 11.72 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.437 1.095 . . . . 0.0 109.662 172.197 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 79.5 t -86.47 110.29 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 174.533 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 20.6 mtm180 -103.95 84.13 2.21 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.519 HD21 ' HA ' ' A' ' 289' ' ' VAL . 4.4 pp -94.68 147.58 33.42 Favored Pre-proline 0 N--CA 1.486 1.367 0 CA-C-O 119.296 -0.383 . . . . 0.0 110.797 -174.386 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.01 120.75 6.5 Favored 'Trans proline' 0 C--N 1.378 2.105 0 C-N-CA 122.35 2.033 . . . . 0.0 111.008 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.718 HD21 ' HG3' ' A' ' 319' ' ' PRO . 1.0 OUTLIER -139.72 151.19 45.66 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.488 1.115 . . . . 0.0 109.265 -175.98 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 281' ' ' ARG . . . . . 0.501 ' H ' ' HD2' ' A' ' 281' ' ' ARG . 0.0 OUTLIER -97.15 149.36 22.08 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.534 -0.914 . . . . 0.0 108.534 -177.386 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 282' ' ' MET . . . . . 0.541 ' HA ' ' HG2' ' A' ' 319' ' ' PRO . 14.4 mtp -70.88 -20.15 62.55 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 118.448 0.567 . . . . 0.0 111.378 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 20.6 t -92.6 5.03 52.43 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 123.696 0.799 . . . . 0.0 111.081 176.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -99.25 133.47 22.03 Favored Pre-proline 0 N--CA 1.478 0.96 0 C-N-CA 124.178 0.991 . . . . 0.0 109.027 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.32 164.38 23.2 Favored 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 122.154 1.903 . . . . 0.0 111.941 171.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 67.9 mt -65.64 -12.03 49.85 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 118.861 -0.59 . . . . 0.0 112.204 -178.086 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 287' ' ' GLN . . . . . 0.414 ' HA ' ' HB ' ' A' ' 290' ' ' VAL . 25.5 tp60 -55.0 -23.42 19.27 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 122.94 0.496 . . . . 0.0 111.945 177.126 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 288' ' ' SER . . . . . 0.634 ' HB3' HD12 ' A' ' 280' ' ' LEU . 43.7 t -59.4 -54.19 49.52 Favored 'General case' 0 CA--C 1.557 1.249 0 C-N-CA 123.464 0.706 . . . . 0.0 111.47 169.795 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.519 ' HA ' HD21 ' A' ' 278' ' ' LEU . 20.6 m -70.42 -36.15 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 C-N-CA 122.026 0.131 . . . . 0.0 110.862 179.246 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 290' ' ' VAL . . . . . 0.565 HG13 ' HB ' ' A' ' 304' ' ' ILE . 74.3 t -61.82 -45.29 99.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.184 0.994 . . . . 0.0 110.853 -178.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -64.08 -51.26 64.91 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 124.046 0.842 . . . . 0.0 110.975 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 47.8 t60 -63.99 -42.55 97.17 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 123.784 0.678 . . . . 0.0 111.097 -176.348 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 95.4 mmm -67.32 -35.62 79.8 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.218 0.607 . . . . 0.0 110.766 178.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -65.78 -43.78 87.78 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.148 0.579 . . . . 0.0 110.923 176.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 31.9 m -68.36 -34.51 76.2 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.581 0.753 . . . . 0.0 111.068 178.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 23.3 t60 -69.97 -49.87 47.45 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.677 0.791 . . . . 0.0 110.2 -179.124 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 297' ' ' LEU . . . . . 0.586 HD21 ' SG ' ' A' ' 271' ' ' CYS . 55.9 mt -84.49 -11.66 55.71 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.017 0.927 . . . . 0.0 111.737 -175.159 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 72.04 37.91 59.99 Favored Glycine 0 C--N 1.351 1.362 0 O-C-N 123.273 0.358 . . . . 0.0 112.757 178.484 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 299' ' ' VAL . . . . . 0.496 HG11 HG11 ' A' ' 334' ' ' VAL . 34.8 m -123.42 177.9 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.326 1.051 . . . . 0.0 110.145 178.292 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 300' ' ' SER . . . . . 0.492 ' HB2' ' HG3' ' A' ' 303' ' ' ARG . 46.9 m -79.03 147.88 70.69 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 123.431 0.692 . . . . 0.0 110.556 175.619 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -57.68 -27.29 76.87 Favored 'Trans proline' 0 C--N 1.385 2.46 0 C-N-CA 123.068 2.512 . . . . 0.0 112.336 172.391 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 57.3 p -68.42 -18.52 64.46 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.768 0.827 . . . . 0.0 111.922 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 303' ' ' ARG . . . . . 0.492 ' HG3' ' HB2' ' A' ' 300' ' ' SER . 97.1 mtt180 -89.21 -28.05 20.23 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.69 0.796 . . . . 0.0 111.707 -178.487 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 304' ' ' ILE . . . . . 0.565 ' HB ' HG13 ' A' ' 290' ' ' VAL . 40.3 mm -72.95 117.72 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 123.06 0.544 . . . . 0.0 109.737 -179.434 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 31.4 tp -125.16 114.73 19.4 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 177.551 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -83.91 121.67 27.67 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -178.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 307' ' ' LEU . . . . . 0.451 HD12 HG21 ' A' ' 333' ' ' VAL . 76.7 mt -129.54 116.46 18.96 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.298 1.039 . . . . 0.0 109.082 -176.754 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -91.82 96.66 10.53 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 174.15 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 74.36 -82.98 0.77 Allowed Glycine 0 C--N 1.345 1.045 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.872 177.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -132.05 -6.19 3.49 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.296 0.638 . . . . 0.0 111.458 -179.406 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 6.2 t -91.98 147.2 23.14 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 122.538 0.335 . . . . 0.0 110.344 -179.15 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -98.84 131.05 45.25 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.066 0.546 . . . . 0.0 109.757 178.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 313' ' ' LEU . . . . . 0.525 HD22 HD22 ' A' ' 322' ' ' LEU . 44.9 mt -113.53 130.76 56.28 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.3 0.64 . . . . 0.0 109.63 -179.115 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 37.4 m -76.24 142.33 71.61 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 123.153 0.581 . . . . 0.0 111.314 178.359 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 315' ' ' PRO . . . . . 0.504 ' HB3' HG21 ' A' ' 290' ' ' VAL . 35.3 Cg_endo -62.5 -23.26 74.83 Favored 'Trans proline' 0 C--N 1.38 2.217 0 C-N-CA 123.041 2.494 . . . . 0.0 112.436 173.841 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 52.3 p -80.78 -22.83 39.76 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.035 0.934 . . . . 0.0 111.573 178.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -71.6 154.74 41.21 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.289 0.636 . . . . 0.0 111.477 -178.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 318' ' ' THR . . . . . . . . . . . . . 74.2 p -105.74 149.41 37.91 Favored Pre-proline 0 N--CA 1.477 0.89 0 C-N-CA 123.998 0.919 . . . . 0.0 109.884 -176.62 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 319' ' ' PRO . . . . . 0.718 ' HG3' HD21 ' A' ' 280' ' ' LEU . 85.6 Cg_endo -68.66 -11.38 31.74 Favored 'Trans proline' 0 C--N 1.372 1.789 0 C-N-CA 123.263 2.642 . . . . 0.0 112.871 -178.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 38.5 ttt180 -69.01 -56.37 7.99 Favored 'General case' 0 C--N 1.347 0.488 0 C-N-CA 123.138 0.575 . . . . 0.0 109.6 177.548 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 15.1 t -71.01 -24.31 62.35 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.259 -178.287 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 322' ' ' LEU . . . . . 0.525 HD22 HD22 ' A' ' 313' ' ' LEU . 69.8 mt -86.01 -15.75 40.44 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.24 0.616 . . . . 0.0 111.31 175.702 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 44.4 tptt 68.05 27.89 6.87 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 125.251 1.42 . . . . 0.0 111.804 177.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.439 ' HG ' ' HB2' ' A' ' 322' ' ' LEU . 29.0 mt -68.29 159.18 31.83 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.483 0.713 . . . . 0.0 110.59 178.264 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 325' ' ' GLY . . . . . 0.472 ' H ' ' HB3' ' A' ' 328' ' ' ASP . . . -160.8 -178.15 34.53 Favored Glycine 0 C--N 1.341 0.846 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.429 -172.104 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 34.2 m -70.81 -20.06 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 123.943 0.897 . . . . 0.0 111.909 179.473 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -97.51 -15.76 20.41 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.001 0.92 . . . . 0.0 111.274 176.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 328' ' ' ASP . . . . . 0.472 ' HB3' ' H ' ' A' ' 325' ' ' GLY . 15.4 t70 -83.35 143.38 30.38 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.113 0.565 . . . . 0.0 109.671 -177.796 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 329' ' ' ILE . . . . . 0.513 HG12 ' HE3' ' A' ' 268' ' ' LYS . 6.2 mt -130.0 120.6 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 122.72 0.408 . . . . 0.0 110.402 -178.483 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 30.1 pt -113.55 131.87 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 123.42 0.688 . . . . 0.0 110.595 178.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -77.35 118.68 20.05 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.729 0.812 . . . . 0.0 111.792 -172.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 332' ' ' CYS . . . . . 0.552 ' SG ' HD12 ' A' ' 304' ' ' ILE . 40.5 t -80.03 94.58 5.96 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.947 0.899 . . . . 0.0 109.999 171.535 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 333' ' ' VAL . . . . . 0.451 HG21 HD12 ' A' ' 307' ' ' LEU . 90.9 t -97.36 112.54 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 123.213 0.605 . . . . 0.0 109.594 178.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 334' ' ' VAL . . . . . 0.496 HG11 HG11 ' A' ' 299' ' ' VAL . 83.9 t -82.85 125.24 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 175.637 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 1.2 pp . . . . . 0 N--CA 1.48 1.038 0 C-N-CA 124.261 1.025 . . . . 0.0 110.564 -177.907 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 3.6 mp . . . . . 0 CA--C 1.547 0.865 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 265' ' ' PHE . . . . . 0.418 ' CE1' ' HG2' ' A' ' 282' ' ' MET . 34.8 p90 -138.39 144.58 43.36 Favored Pre-proline 0 N--CA 1.478 0.934 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 177.699 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.09 88.34 0.08 OUTLIER 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 123.25 2.633 . . . . 0.0 113.325 175.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -67.48 121.76 16.51 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 171.264 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 268' ' ' LYS . . . . . 0.45 ' HE3' HG12 ' A' ' 329' ' ' ILE . 23.4 ttpt -97.32 122.76 40.72 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 121.37 0.605 . . . . 0.0 110.769 -178.671 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 269' ' ' ILE . . . . . 0.451 HG21 ' HG3' ' A' ' 293' ' ' MET . 2.1 mp -119.36 130.99 73.26 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 C-N-CA 124.943 1.297 . . . . 0.0 108.163 -178.032 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 25.5 ttp180 -94.92 107.41 19.45 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 122.989 0.516 . . . . 0.0 110.447 177.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 271' ' ' CYS . . . . . 0.787 ' SG ' HD21 ' A' ' 297' ' ' LEU . 37.7 t -70.42 -176.54 1.25 Allowed 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.147 0.979 . . . . 0.0 110.065 168.676 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 21.3 ptt180 -59.78 -30.6 68.99 Favored 'General case' 0 CA--C 1.557 1.23 0 C-N-CA 123.455 0.702 . . . . 0.0 112.077 179.132 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -159.42 35.03 0.2 Allowed 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.409 0.684 . . . . 0.0 111.37 -178.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -156.02 151.73 27.23 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 122.766 0.426 . . . . 0.0 110.519 -176.065 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -116.37 114.76 24.73 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.137 0.975 . . . . 0.0 109.109 174.645 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 95.6 t -99.85 129.48 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.086 0.955 . . . . 0.0 108.883 173.196 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 90.7 mtm180 -119.47 86.17 2.51 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 176.315 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.401 HD21 HG12 ' A' ' 289' ' ' VAL . 4.3 pp -96.72 141.03 22.49 Favored Pre-proline 0 N--CA 1.478 0.941 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -176.253 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.62 120.49 7.42 Favored 'Trans proline' 0 C--N 1.371 1.718 0 C-N-CA 122.407 2.071 . . . . 0.0 110.841 173.021 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.712 HD21 ' HG3' ' A' ' 319' ' ' PRO . 0.0 OUTLIER -135.39 155.42 50.6 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.31 1.044 . . . . 0.0 110.001 -178.329 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -93.23 143.16 26.53 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.514 1.126 . . . . 0.0 109.641 177.131 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 282' ' ' MET . . . . . 0.477 ' HA ' ' HG2' ' A' ' 319' ' ' PRO . 35.0 mtp -67.99 -25.2 65.29 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 118.354 0.524 . . . . 0.0 110.095 176.736 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 10.3 p -74.64 -34.72 62.81 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.004 1.321 . . . . 0.0 111.592 176.23 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -70.02 125.49 92.01 Favored Pre-proline 0 N--CA 1.473 0.715 0 C-N-CA 124.121 0.969 . . . . 0.0 108.764 173.368 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 285' ' ' PRO . . . . . 0.481 ' HA ' ' HA ' ' A' ' 318' ' ' THR . 44.8 Cg_endo -63.58 176.81 2.0 Favored 'Trans proline' 0 C--N 1.381 2.263 0 C-N-CA 122.598 2.199 . . . . 0.0 112.439 174.66 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.458 ' O ' HG23 ' A' ' 290' ' ' VAL . 86.5 mt -65.26 -17.01 64.16 Favored 'General case' 0 C--O 1.22 -0.483 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.773 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 24.7 tp60 -48.89 -27.63 3.21 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.905 0.882 . . . . 0.0 112.657 178.597 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 288' ' ' SER . . . . . 0.467 ' HB3' HD12 ' A' ' 280' ' ' LEU . 43.2 t -57.4 -62.13 1.99 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.553 1.141 . . . . 0.0 111.205 170.221 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.403 ' HB ' HG12 ' A' ' 269' ' ' ILE . 15.9 m -69.19 -26.84 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 123.149 0.58 . . . . 0.0 110.784 -176.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 290' ' ' VAL . . . . . 0.556 HG13 ' HB ' ' A' ' 304' ' ' ILE . 77.1 t -62.62 -52.16 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 123.802 0.841 . . . . 0.0 110.223 176.394 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -67.24 -39.6 86.21 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.378 0.671 . . . . 0.0 110.882 -178.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 23.3 t60 -67.5 -45.58 75.41 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 123.443 0.465 . . . . 0.0 110.833 -176.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 293' ' ' MET . . . . . 0.451 ' HG3' HG21 ' A' ' 269' ' ' ILE . 93.3 mmm -70.06 -30.09 67.26 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.064 0.546 . . . . 0.0 110.818 178.529 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -64.91 -42.72 94.5 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.201 0.6 . . . . 0.0 110.64 173.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 41.3 m -68.71 -34.26 75.34 Favored 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 123.781 0.832 . . . . 0.0 110.62 176.643 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -70.54 -34.39 72.2 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.185 0.994 . . . . 0.0 111.3 -178.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 297' ' ' LEU . . . . . 0.787 HD21 ' SG ' ' A' ' 271' ' ' CYS . 36.8 mt -100.73 -7.19 24.01 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.116 0.966 . . . . 0.0 111.501 -179.124 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 77.2 6.06 85.88 Favored Glycine 0 N--CA 1.474 1.194 0 C-N-CA 123.412 0.53 . . . . 0.0 113.784 178.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 32.3 m -94.88 -176.82 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 124.139 0.975 . . . . 0.0 111.053 -177.128 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 19.8 m -87.28 147.34 42.07 Favored Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 123.238 0.615 . . . . 0.0 110.159 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -55.08 -29.67 66.59 Favored 'Trans proline' 0 C--N 1.387 2.559 0 C-N-CA 122.946 2.431 . . . . 0.0 112.459 170.173 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 20.3 m -62.57 -26.92 68.84 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 122.941 0.496 . . . . 0.0 111.478 178.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 58.3 mtt180 -88.0 -20.13 26.25 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.301 1.04 . . . . 0.0 112.416 -175.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 304' ' ' ILE . . . . . 0.58 HD12 ' SG ' ' A' ' 332' ' ' CYS . 41.7 mm -82.64 125.65 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 122.811 0.444 . . . . 0.0 110.996 -177.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 48.6 tp -127.98 121.69 30.45 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.101 0.96 . . . . 0.0 108.94 176.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 306' ' ' LEU . . . . . 0.445 ' HG ' HD12 ' A' ' 330' ' ' ILE . 3.0 mm? -88.48 134.54 33.82 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.538 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 307' ' ' LEU . . . . . 0.408 HD12 HG21 ' A' ' 333' ' ' VAL . 76.1 mt -136.48 103.97 5.43 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.86 0.864 . . . . 0.0 109.257 -177.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 308' ' ' PHE . . . . . 0.475 ' HB2' HD11 ' A' ' 313' ' ' LEU . 82.5 t80 -77.37 92.44 3.94 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -178.8 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 70.5 -78.52 0.46 Allowed Glycine 0 C--N 1.349 1.275 0 CA-C-N 116.24 -0.436 . . . . 0.0 112.326 -179.239 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -146.49 54.47 1.13 Allowed 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 123.929 0.892 . . . . 0.0 110.643 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 11.2 t -147.27 150.82 35.56 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 122.815 0.446 . . . . 0.0 110.238 175.223 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -87.98 119.73 28.63 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.807 0.843 . . . . 0.0 110.119 -179.184 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 313' ' ' LEU . . . . . 0.527 HD22 HD22 ' A' ' 322' ' ' LEU . 45.7 mt -117.55 122.3 43.29 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 178.055 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 18.3 m -79.73 150.81 73.24 Favored Pre-proline 0 CA--C 1.55 0.979 0 C-N-CA 123.413 0.685 . . . . 0.0 110.853 178.693 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 315' ' ' PRO . . . . . 0.414 ' HB3' HG21 ' A' ' 290' ' ' VAL . 51.2 Cg_exo -56.21 -32.48 87.61 Favored 'Trans proline' 0 C--N 1.382 2.298 0 C-N-CA 122.827 2.351 . . . . 0.0 112.22 170.371 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 77.2 p -75.77 -16.93 60.05 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-N 114.353 -1.294 . . . . 0.0 112.128 -178.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -77.18 144.45 38.33 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.236 0.614 . . . . 0.0 110.334 178.024 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 318' ' ' THR . . . . . 0.481 ' HA ' ' HA ' ' A' ' 285' ' ' PRO . 25.2 p -99.21 138.38 20.55 Favored Pre-proline 0 N--CA 1.474 0.76 0 C-N-CA 123.568 0.747 . . . . 0.0 109.981 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 319' ' ' PRO . . . . . 0.712 ' HG3' HD21 ' A' ' 280' ' ' LEU . 18.5 Cg_endo -55.94 -19.82 27.31 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 123.926 3.084 . . . . 0.0 113.974 179.695 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -66.63 -51.01 61.03 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.146 0.578 . . . . 0.0 111.5 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 15.2 t -72.94 -20.16 61.11 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.502 0.321 . . . . 0.0 110.93 -179.111 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 322' ' ' LEU . . . . . 0.527 HD22 HD22 ' A' ' 313' ' ' LEU . 36.9 mt -85.1 -17.55 37.0 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.362 0.665 . . . . 0.0 110.404 176.63 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 323' ' ' LYS . . . . . 0.526 ' HA ' ' HE2' ' A' ' 323' ' ' LYS . 0.5 OUTLIER 61.56 58.1 2.14 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.233 1.413 . . . . 0.0 110.466 -178.749 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.457 ' HG ' ' HB2' ' A' ' 322' ' ' LEU . 76.3 mt -95.56 171.27 8.79 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.051 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 325' ' ' GLY . . . . . 0.457 ' H ' ' HB2' ' A' ' 328' ' ' ASP . . . -167.87 -171.99 34.42 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.108 -175.189 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 34.1 m -67.82 -28.93 43.28 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 C-N-CA 123.977 0.911 . . . . 0.0 111.452 177.356 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -93.54 -15.87 25.02 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.144 0.978 . . . . 0.0 111.387 -178.58 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 328' ' ' ASP . . . . . 0.457 ' HB2' ' H ' ' A' ' 325' ' ' GLY . 5.3 m-20 -89.78 123.94 34.21 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.176 0.591 . . . . 0.0 109.708 -178.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 329' ' ' ILE . . . . . 0.45 HG12 ' HE3' ' A' ' 268' ' ' LYS . 19.6 mt -109.41 127.36 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 123.378 0.671 . . . . 0.0 110.183 -175.811 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 330' ' ' ILE . . . . . 0.445 HD12 ' HG ' ' A' ' 306' ' ' LEU . 30.9 pt -111.56 128.53 68.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 C-N-CA 123.251 0.62 . . . . 0.0 110.346 177.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -76.81 110.43 11.41 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.844 0.858 . . . . 0.0 111.587 -174.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 332' ' ' CYS . . . . . 0.58 ' SG ' HD12 ' A' ' 304' ' ' ILE . 31.8 t -75.69 105.2 6.6 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.788 0.835 . . . . 0.0 110.447 172.622 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 333' ' ' VAL . . . . . 0.408 HG21 HD12 ' A' ' 307' ' ' LEU . 88.4 t -111.47 122.03 65.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 123.668 0.787 . . . . 0.0 110.041 -178.561 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 59.7 t -86.05 98.62 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 123.305 0.642 . . . . 0.0 109.741 178.224 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 92.8 mt . . . . . 0 N--CA 1.471 0.603 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 172.107 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 3.7 mp . . . . . 0 N--CA 1.469 0.513 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -136.9 150.52 69.99 Favored Pre-proline 0 CA--C 1.549 0.905 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.677 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -68.07 90.73 0.38 Allowed 'Trans proline' 0 C--N 1.376 1.983 0 C-N-CA 122.459 2.106 . . . . 0.0 112.029 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.37 113.49 4.68 Favored 'General case' 0 C--N 1.349 0.55 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 169.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 268' ' ' LYS . . . . . 0.444 ' O ' ' HA ' ' A' ' 329' ' ' ILE . 22.6 ttpt -92.37 111.58 23.21 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.259 0.623 . . . . 0.0 109.883 -176.27 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 4.7 mp -106.72 129.3 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 123.703 0.801 . . . . 0.0 109.271 179.68 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 270' ' ' ARG . . . . . 0.414 ' HA ' HD13 ' A' ' 275' ' ' LEU . 39.5 ttp180 -84.57 98.78 10.34 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 122.879 0.471 . . . . 0.0 110.002 175.657 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 271' ' ' CYS . . . . . 0.745 ' SG ' HD21 ' A' ' 297' ' ' LEU . 41.9 t -69.56 175.6 4.02 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.1 171.51 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 272' ' ' ARG . . . . . 0.416 ' N ' ' SG ' ' A' ' 271' ' ' CYS . 16.2 ptt180 -54.33 -30.1 50.24 Favored 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 124.299 1.04 . . . . 0.0 112.314 178.433 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -159.76 37.82 0.19 Allowed 'General case' 0 C--N 1.354 0.801 0 C-N-CA 123.794 0.838 . . . . 0.0 110.948 -176.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -166.23 158.79 14.47 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 122.673 0.389 . . . . 0.0 111.128 -175.726 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.414 HD13 ' HA ' ' A' ' 270' ' ' ARG . 4.2 mm? -115.69 97.39 6.1 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.118 0.967 . . . . 0.0 109.07 173.575 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 46.3 t -84.99 98.53 6.29 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.595 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 39.6 mtt85 -96.89 79.86 2.96 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -178.209 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.6 pp -92.15 142.53 26.34 Favored Pre-proline 0 N--CA 1.487 1.386 0 CA-C-O 119.404 -0.331 . . . . 0.0 110.392 -172.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -74.23 109.75 2.95 Favored 'Trans proline' 0 C--N 1.373 1.835 0 C-N-CA 122.223 1.949 . . . . 0.0 110.698 177.277 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.725 HD21 ' HG3' ' A' ' 319' ' ' PRO . 0.0 OUTLIER -123.46 153.06 41.0 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.342 1.057 . . . . 0.0 109.617 179.018 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 281' ' ' ARG . . . . . 0.583 ' HB2' ' HB2' ' A' ' 284' ' ' GLU . 31.9 mtp180 -88.38 147.34 24.78 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.932 0.893 . . . . 0.0 110.318 177.711 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 282' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -62.51 -34.19 76.39 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 122.928 0.491 . . . . 0.0 110.361 173.514 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 23.7 m -67.79 -31.32 71.11 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.203 1.001 . . . . 0.0 111.718 176.2 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 284' ' ' GLU . . . . . 0.583 ' HB2' ' HB2' ' A' ' 281' ' ' ARG . 6.2 tp10 -73.31 132.21 82.15 Favored Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 124.009 0.923 . . . . 0.0 109.108 -178.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -70.39 178.32 5.08 Favored 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 122.163 1.908 . . . . 0.0 112.28 174.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.439 ' O ' HG23 ' A' ' 290' ' ' VAL . 70.7 mt -67.1 -19.04 65.57 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 118.744 -0.646 . . . . 0.0 111.66 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 27.7 tp60 -53.68 -22.39 8.87 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.282 0.633 . . . . 0.0 112.193 178.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 288' ' ' SER . . . . . 0.52 ' HB3' HD12 ' A' ' 280' ' ' LEU . 24.8 t -64.74 -54.32 33.26 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.413 0.685 . . . . 0.0 110.984 172.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.442 HG13 HD13 ' A' ' 280' ' ' LEU . 17.2 m -70.9 -29.21 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 122.532 0.333 . . . . 0.0 110.753 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 290' ' ' VAL . . . . . 0.538 HG13 ' HB ' ' A' ' 304' ' ' ILE . 78.1 t -63.83 -49.22 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 123.702 0.801 . . . . 0.0 110.099 176.418 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -63.89 -46.93 82.64 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.743 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 43.2 t60 -67.15 -41.83 85.4 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.15 -174.278 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 90.9 mmm -68.09 -30.33 69.48 Favored 'General case' 0 N--CA 1.483 1.201 0 O-C-N 123.401 0.438 . . . . 0.0 111.227 177.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -67.47 -43.45 80.99 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.13 0.572 . . . . 0.0 110.615 175.107 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 27.7 m -69.43 -29.59 67.34 Favored 'General case' 0 CA--C 1.557 1.216 0 C-N-CA 124.063 0.945 . . . . 0.0 110.837 176.174 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 77.8 t60 -74.59 -34.63 62.91 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.839 0.856 . . . . 0.0 111.442 -178.426 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 297' ' ' LEU . . . . . 0.745 HD21 ' SG ' ' A' ' 271' ' ' CYS . 75.5 mt -105.74 -8.26 17.93 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.655 0.782 . . . . 0.0 112.283 -175.58 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 72.93 31.67 61.8 Favored Glycine 0 C--N 1.347 1.188 0 O-C-N 123.598 0.561 . . . . 0.0 112.55 178.214 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 299' ' ' VAL . . . . . 0.531 HG11 HG11 ' A' ' 334' ' ' VAL . 33.2 m -117.75 -177.33 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.357 1.063 . . . . 0.0 110.057 179.313 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 300' ' ' SER . . . . . 0.551 ' HB3' ' HG3' ' A' ' 303' ' ' ARG . 32.2 t -82.36 147.02 55.54 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 123.194 0.598 . . . . 0.0 110.18 178.119 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -59.49 -27.97 86.31 Favored 'Trans proline' 0 C--N 1.385 2.453 0 C-N-CA 122.774 2.316 . . . . 0.0 111.124 169.198 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 22.8 t -67.11 -15.73 63.9 Favored 'General case' 0 CA--C 1.559 1.29 0 C-N-CA 123.454 0.702 . . . . 0.0 111.207 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 303' ' ' ARG . . . . . 0.551 ' HG3' ' HB3' ' A' ' 300' ' ' SER . 59.3 mtt180 -94.59 -26.51 16.35 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.006 0.922 . . . . 0.0 111.63 -178.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 304' ' ' ILE . . . . . 0.553 HD12 ' SG ' ' A' ' 332' ' ' CYS . 37.9 mm -77.02 103.58 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 122.861 0.464 . . . . 0.0 110.865 -175.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 34.8 tp -105.68 123.79 48.51 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 174.065 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 306' ' ' LEU . . . . . 0.433 ' HA ' ' O ' ' A' ' 331' ' ' ASP . 3.4 mm? -89.26 128.35 35.84 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 177.573 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 307' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 312' ' ' GLU . 68.4 mt -134.05 114.8 13.58 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.477 1.111 . . . . 0.0 108.608 -177.677 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -79.42 81.26 5.7 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 176.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 66.63 -85.97 0.11 Allowed Glycine 0 C--N 1.357 1.731 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.862 -176.705 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -127.1 75.68 1.6 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.142 0.977 . . . . 0.0 109.684 177.031 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 14.5 t -173.51 147.37 1.44 Allowed 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.489 1.116 . . . . 0.0 108.831 169.301 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 312' ' ' GLU . . . . . 0.414 ' HA ' HD23 ' A' ' 307' ' ' LEU . 42.2 tt0 -93.52 128.87 39.83 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 -178.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 313' ' ' LEU . . . . . 0.463 HD13 HD13 ' A' ' 322' ' ' LEU . 45.2 mt -113.33 127.42 56.13 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 123.667 0.604 . . . . 0.0 109.762 177.797 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 314' ' ' SER . . . . . 0.413 ' O ' HD12 ' A' ' 286' ' ' LEU . 39.0 m -77.81 140.61 63.16 Favored Pre-proline 0 CA--C 1.554 1.105 0 C-N-CA 123.529 0.731 . . . . 0.0 110.633 179.248 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 315' ' ' PRO . . . . . 0.424 ' HB3' HG21 ' A' ' 290' ' ' VAL . 40.8 Cg_endo -63.94 -24.34 67.52 Favored 'Trans proline' 0 C--N 1.384 2.402 0 C-N-CA 122.871 2.381 . . . . 0.0 113.042 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 6.5 m -81.75 -18.47 44.13 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 123.788 0.835 . . . . 0.0 111.344 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -70.25 150.72 46.11 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 122.852 0.461 . . . . 0.0 109.967 176.591 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 318' ' ' THR . . . . . . . . . . . . . 69.5 p -98.57 144.4 28.07 Favored Pre-proline 0 CA--C 1.541 0.598 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 319' ' ' PRO . . . . . 0.725 ' HG3' HD21 ' A' ' 280' ' ' LEU . 20.8 Cg_endo -57.83 -17.31 29.35 Favored 'Trans proline' 0 C--N 1.366 1.486 0 C-N-CA 123.171 2.581 . . . . 0.0 112.578 170.578 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 44.9 ttt180 -71.02 -48.5 52.72 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.525 0.73 . . . . 0.0 110.454 -179.533 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 15.0 t -70.27 -29.08 65.77 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-O 120.809 0.338 . . . . 0.0 110.626 178.376 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 322' ' ' LEU . . . . . 0.463 HD13 HD13 ' A' ' 313' ' ' LEU . 64.7 mt -81.58 -14.83 56.32 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.82 177.266 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp 59.62 36.32 22.59 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.566 1.146 . . . . 0.0 112.413 -177.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.426 ' HG ' ' HB2' ' A' ' 322' ' ' LEU . 44.7 mt -68.96 145.46 53.6 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.701 0.8 . . . . 0.0 109.809 174.177 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 325' ' ' GLY . . . . . 0.447 ' H ' ' HB3' ' A' ' 328' ' ' ASP . . . -140.31 -169.29 11.64 Favored Glycine 0 C--O 1.24 0.472 0 C-N-CA 123.435 0.541 . . . . 0.0 112.08 -174.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 26.0 m -74.09 -26.86 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.771 0.828 . . . . 0.0 111.915 -175.397 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -101.03 -3.24 29.72 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.713 0.805 . . . . 0.0 111.141 179.128 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 328' ' ' ASP . . . . . 0.447 ' HB3' ' H ' ' A' ' 325' ' ' GLY . 12.2 t70 -83.28 144.78 29.49 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 175.82 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 329' ' ' ILE . . . . . 0.444 ' HA ' ' O ' ' A' ' 268' ' ' LYS . 24.2 mt -131.29 125.33 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 123.232 0.613 . . . . 0.0 109.673 -178.77 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 28.4 pt -116.82 131.93 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 123.367 0.667 . . . . 0.0 110.365 176.708 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 331' ' ' ASP . . . . . 0.433 ' O ' ' HA ' ' A' ' 306' ' ' LEU . 7.1 m-20 -68.13 135.67 52.5 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.951 0.9 . . . . 0.0 111.712 -179.193 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 332' ' ' CYS . . . . . 0.553 ' SG ' HD12 ' A' ' 304' ' ' ILE . 26.2 t -103.79 99.51 9.3 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.08 0.952 . . . . 0.0 109.011 171.46 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 47.9 t -104.48 113.46 41.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -178.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 334' ' ' VAL . . . . . 0.531 HG11 HG11 ' A' ' 299' ' ' VAL . 58.3 t -81.71 99.01 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.723 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 80.6 mt . . . . . 0 N--CA 1.47 0.551 0 C-N-CA 123.655 0.782 . . . . 0.0 110.389 175.941 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 0.437 HD22 ' HB2' ' A' ' 279' ' ' PRO . 3.8 mp . . . . . 0 C--O 1.24 0.591 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 265' ' ' PHE . . . . . 0.455 ' CE1' ' SD ' ' A' ' 282' ' ' MET . 46.4 p90 -145.63 147.33 32.64 Favored Pre-proline 0 C--O 1.243 0.725 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 173.855 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -68.12 94.02 0.41 Allowed 'Trans proline' 0 C--N 1.37 1.691 0 C-N-CA 122.061 1.84 . . . . 0.0 110.759 174.763 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 267' ' ' LEU . . . . . 0.479 HD12 HG13 ' A' ' 269' ' ' ILE . 1.9 tm? -58.55 130.14 45.41 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 173.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 268' ' ' LYS . . . . . 0.58 ' HD2' HD22 ' A' ' 275' ' ' LEU . 4.7 tppp? -90.04 109.63 20.66 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 123.846 0.716 . . . . 0.0 110.497 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 269' ' ' ILE . . . . . 0.479 HG13 HD12 ' A' ' 267' ' ' LEU . 2.8 mp -110.93 154.95 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 174.401 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 270' ' ' ARG . . . . . 0.514 ' HG2' HD23 ' A' ' 275' ' ' LEU . 30.0 mtp-105 -113.75 131.11 56.32 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 162.812 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 271' ' ' CYS . . . . . 0.62 ' SG ' HD21 ' A' ' 297' ' ' LEU . 30.7 t -74.1 -160.14 0.09 Allowed 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 123.961 0.905 . . . . 0.0 109.399 168.335 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -58.67 -19.07 36.2 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.324 0.65 . . . . 0.0 112.051 173.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -153.86 -56.21 0.11 Allowed 'General case' 0 C--N 1.352 0.706 0 C-N-CA 123.532 0.733 . . . . 0.0 110.631 176.762 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -68.19 162.38 25.0 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.473 1.109 . . . . 0.0 112.652 -170.746 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.58 HD22 ' HD2' ' A' ' 268' ' ' LYS . 66.3 mt -88.86 128.09 35.65 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.714 0.806 . . . . 0.0 110.063 170.232 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 94.2 t -115.53 131.74 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 174.294 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 88.8 mtm180 -124.79 127.72 47.63 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.606 0.762 . . . . 0.0 109.189 176.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.545 HD21 ' HA ' ' A' ' 289' ' ' VAL . 3.7 pp -135.43 144.33 49.02 Favored Pre-proline 0 N--CA 1.483 1.187 0 CA-C-O 119.436 -0.316 . . . . 0.0 110.242 177.369 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 279' ' ' PRO . . . . . 0.437 ' HB2' HD22 ' A' ' 264' ' ' LEU . 69.1 Cg_endo -71.57 116.33 4.65 Favored 'Trans proline' 0 C--N 1.372 1.799 0 C-N-CA 122.179 1.919 . . . . 0.0 111.033 177.831 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.718 HD21 ' HG3' ' A' ' 319' ' ' PRO . 0.5 OUTLIER -135.23 151.6 50.76 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.82 1.248 . . . . 0.0 109.544 -178.051 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -96.48 154.31 17.34 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.248 0.619 . . . . 0.0 109.585 178.511 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 282' ' ' MET . . . . . 0.455 ' SD ' ' CE1' ' A' ' 265' ' ' PHE . 94.2 mmm -63.44 -29.01 70.37 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 122.851 0.46 . . . . 0.0 111.577 176.415 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 39.7 t -79.91 -28.5 39.81 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.76 0.824 . . . . 0.0 111.363 176.318 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -67.96 123.22 86.62 Favored Pre-proline 0 N--CA 1.481 1.084 0 C-N-CA 123.915 0.886 . . . . 0.0 109.843 -177.558 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -64.51 167.47 15.01 Favored 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 122.573 2.182 . . . . 0.0 112.118 178.646 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.426 ' O ' HG23 ' A' ' 290' ' ' VAL . 56.2 mt -63.9 -16.47 61.49 Favored 'General case' 0 C--O 1.216 -0.705 0 CA-C-O 118.596 -0.716 . . . . 0.0 112.028 -177.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 287' ' ' GLN . . . . . 0.406 ' HA ' ' HB ' ' A' ' 290' ' ' VAL . 24.9 tp60 -49.82 -27.33 4.9 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.58 0.752 . . . . 0.0 112.379 177.38 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 288' ' ' SER . . . . . 0.571 ' HB3' HD12 ' A' ' 280' ' ' LEU . 36.2 t -60.83 -55.87 27.91 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 123.925 0.89 . . . . 0.0 111.201 172.696 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.545 ' HA ' HD21 ' A' ' 278' ' ' LEU . 15.6 m -69.56 -31.5 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 122.413 0.285 . . . . 0.0 110.934 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 290' ' ' VAL . . . . . 0.56 HG13 ' HB ' ' A' ' 304' ' ' ILE . 46.1 t -63.21 -55.69 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 124.794 1.237 . . . . 0.0 111.018 -178.532 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -67.99 -36.21 79.63 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.844 -176.348 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 9.7 t60 -61.07 -49.96 75.22 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.475 0.71 . . . . 0.0 110.374 176.559 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 93.9 mmm -69.65 -29.16 66.55 Favored 'General case' 0 C--O 1.217 -0.624 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.97 -179.656 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -69.59 -37.61 76.99 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.327 0.651 . . . . 0.0 110.777 178.269 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 56.1 m -73.26 -37.37 66.34 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.229 0.611 . . . . 0.0 110.161 176.254 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -63.61 -47.25 82.2 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.954 0.901 . . . . 0.0 110.522 179.129 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 297' ' ' LEU . . . . . 0.62 HD21 ' SG ' ' A' ' 271' ' ' CYS . 38.2 mt -89.26 -11.13 44.43 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.258 1.023 . . . . 0.0 112.125 -174.587 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 72.9 19.2 79.37 Favored Glycine 0 C--N 1.352 1.433 0 O-C-N 123.515 0.51 . . . . 0.0 112.932 -178.537 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 20.5 m -105.33 178.85 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 124.405 1.082 . . . . 0.0 110.305 -177.14 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 21.2 m -82.62 148.01 57.14 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 123.262 0.625 . . . . 0.0 109.898 178.344 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -60.83 -29.15 87.62 Favored 'Trans proline' 0 C--N 1.386 2.511 0 C-N-CA 122.494 2.129 . . . . 0.0 112.334 175.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 36.1 t -72.47 -17.93 61.72 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 122.261 -0.274 . . . . 0.0 110.739 -179.27 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -90.21 -7.37 53.72 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.779 0.832 . . . . 0.0 111.372 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 304' ' ' ILE . . . . . 0.56 ' HB ' HG13 ' A' ' 290' ' ' VAL . 41.6 mm -84.83 109.2 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 CA-C-N 118.373 0.533 . . . . 0.0 110.187 177.422 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 39.5 tp -109.8 112.09 23.93 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.47 0.708 . . . . 0.0 109.095 177.77 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 306' ' ' LEU . . . . . 0.505 HD21 HG22 ' A' ' 290' ' ' VAL . 2.5 mm? -85.05 133.46 34.24 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.544 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 307' ' ' LEU . . . . . 0.48 HD23 ' HA ' ' A' ' 312' ' ' GLU . 76.7 mt -132.8 103.09 5.92 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.312 0.645 . . . . 0.0 109.987 -177.1 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 308' ' ' PHE . . . . . 0.479 ' HB2' HD11 ' A' ' 313' ' ' LEU . 69.8 t80 -77.56 92.3 4.05 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -178.428 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 72.27 -81.29 0.59 Allowed Glycine 0 C--N 1.343 0.953 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.703 -174.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -131.75 -11.76 3.42 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.584 0.754 . . . . 0.0 112.384 -179.314 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 6.9 t -86.79 148.55 25.35 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 118.115 0.416 . . . . 0.0 111.004 -177.493 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 312' ' ' GLU . . . . . 0.48 ' HA ' HD23 ' A' ' 307' ' ' LEU . 37.2 tt0 -93.79 123.97 37.48 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 122.847 0.459 . . . . 0.0 110.226 -176.397 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 313' ' ' LEU . . . . . 0.484 HD13 HD13 ' A' ' 322' ' ' LEU . 47.5 mt -111.4 126.98 55.51 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.995 -178.832 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 42.0 m -71.37 144.46 89.32 Favored Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 123.693 0.797 . . . . 0.0 110.12 173.687 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -63.11 -18.11 63.48 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 123.027 2.485 . . . . 0.0 112.751 176.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 37.7 p -90.36 -8.42 50.78 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.573 1.149 . . . . 0.0 112.427 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -72.88 152.71 41.35 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.099 0.559 . . . . 0.0 111.036 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 318' ' ' THR . . . . . . . . . . . . . 32.4 p -103.93 142.82 25.4 Favored Pre-proline 0 N--CA 1.478 0.928 0 C-N-CA 122.999 0.52 . . . . 0.0 109.672 177.525 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 319' ' ' PRO . . . . . 0.718 ' HG3' HD21 ' A' ' 280' ' ' LEU . 70.3 Cg_endo -66.0 -14.17 43.24 Favored 'Trans proline' 0 C--N 1.369 1.64 0 C-N-CA 123.649 2.899 . . . . 0.0 113.192 -176.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 70.3 ttt180 -69.21 -53.47 19.78 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.234 0.614 . . . . 0.0 110.557 -177.762 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 9.8 t -66.8 -29.92 69.99 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.347 0.659 . . . . 0.0 111.364 177.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 322' ' ' LEU . . . . . 0.484 HD13 HD13 ' A' ' 313' ' ' LEU . 43.4 mt -81.89 -19.41 40.91 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.395 0.678 . . . . 0.0 111.0 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 53.69 75.67 0.25 Allowed 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 125.108 1.363 . . . . 0.0 109.623 -170.868 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 70.6 mt -106.98 164.57 12.03 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.627 176.545 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 325' ' ' GLY . . . . . 0.467 ' H ' ' HB2' ' A' ' 328' ' ' ASP . . . -169.53 -160.63 18.22 Favored Glycine 0 C--N 1.343 0.95 0 CA-C-N 115.928 -0.578 . . . . 0.0 113.374 -170.683 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 30.6 m -80.5 -24.55 11.26 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 124.481 1.112 . . . . 0.0 111.296 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -101.73 -25.85 13.69 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.054 0.942 . . . . 0.0 110.457 177.635 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 328' ' ' ASP . . . . . 0.467 ' HB2' ' H ' ' A' ' 325' ' ' GLY . 34.1 m-20 -76.02 111.5 11.47 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.433 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 329' ' ' ILE . . . . . 0.516 HG12 ' HG2' ' A' ' 268' ' ' LYS . 4.4 mt -99.13 133.21 42.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.088 0.555 . . . . 0.0 110.942 -173.82 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 41.2 pt -119.23 128.91 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 123.211 0.605 . . . . 0.0 109.739 174.055 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -85.22 109.65 18.47 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.374 0.67 . . . . 0.0 110.514 -176.779 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 332' ' ' CYS . . . . . 0.559 ' SG ' HD12 ' A' ' 304' ' ' ILE . 35.9 t -73.12 95.08 2.01 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.385 0.674 . . . . 0.0 109.583 170.1 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 58.2 t -106.86 122.39 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 178.378 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 91.4 t -78.53 102.01 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-O 121.18 0.514 . . . . 0.0 110.517 -176.576 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.554 1.114 0 C-N-CA 125.077 1.351 . . . . 0.0 109.061 170.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 3.0 mp . . . . . 0 C--O 1.243 0.757 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -144.85 146.51 31.71 Favored Pre-proline 0 CA--C 1.543 0.697 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 175.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 266' ' ' PRO . . . . . 0.503 ' HB2' ' HB3' ' A' ' 277' ' ' ARG . 46.2 Cg_endo -66.85 91.36 0.3 Allowed 'Trans proline' 0 C--N 1.374 1.903 0 C-N-CA 122.182 1.921 . . . . 0.0 112.197 176.809 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 267' ' ' LEU . . . . . 0.581 HD23 HD22 ' A' ' 280' ' ' LEU . 0.4 OUTLIER -63.28 115.53 4.64 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 170.747 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 268' ' ' LYS . . . . . 0.582 ' HD3' HD13 ' A' ' 275' ' ' LEU . 30.7 ttmt -90.96 118.38 30.3 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 123.414 0.446 . . . . 0.0 109.892 -179.378 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 269' ' ' ILE . . . . . 0.571 HG21 ' HG3' ' A' ' 293' ' ' MET . 2.4 mp -113.93 136.37 50.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 C-N-CA 123.6 0.76 . . . . 0.0 108.958 177.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 270' ' ' ARG . . . . . 0.484 ' HA ' HD23 ' A' ' 275' ' ' LEU . 0.7 OUTLIER -85.95 106.67 17.3 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 123.626 0.579 . . . . 0.0 110.469 -177.561 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 271' ' ' CYS . . . . . 0.531 ' SG ' HD21 ' A' ' 297' ' ' LEU . 38.6 t -75.2 179.49 5.06 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.742 0.817 . . . . 0.0 109.789 167.208 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 272' ' ' ARG . . . . . 0.462 ' HG2' ' SG ' ' A' ' 271' ' ' CYS . 17.2 ptm180 -54.18 -36.08 63.03 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.012 0.925 . . . . 0.0 112.789 178.83 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -159.44 49.39 0.32 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.63 0.772 . . . . 0.0 109.621 178.594 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 274' ' ' ASP . . . . . 0.456 ' HB3' ' HB3' ' A' ' 271' ' ' CYS . 19.9 t70 -166.43 162.52 17.01 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.714 0.805 . . . . 0.0 110.123 -173.4 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.582 HD13 ' HD3' ' A' ' 268' ' ' LYS . 81.0 mt -131.36 104.72 7.18 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.392 1.077 . . . . 0.0 109.615 176.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 276' ' ' VAL . . . . . 0.43 ' O ' HD12 ' A' ' 269' ' ' ILE . 78.3 t -83.44 115.5 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 177.302 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 277' ' ' ARG . . . . . 0.503 ' HB3' ' HB2' ' A' ' 266' ' ' PRO . 61.2 mtm-85 -107.31 80.68 1.44 Allowed 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -179.046 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.406 ' HA ' ' HD3' ' A' ' 279' ' ' PRO . 4.3 pp -93.13 142.89 25.92 Favored Pre-proline 0 N--CA 1.484 1.226 0 CA-C-O 119.579 -0.248 . . . . 0.0 111.054 -173.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 279' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 278' ' ' LEU . 12.7 Cg_exo -68.23 109.14 1.92 Allowed 'Trans proline' 0 C--N 1.375 1.932 0 C-N-CA 122.833 2.355 . . . . 0.0 110.696 177.429 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.581 HD22 HD23 ' A' ' 267' ' ' LEU . 2.9 tt -127.39 139.17 53.02 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.448 1.099 . . . . 0.0 109.466 -178.073 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 68.3 mtm180 -80.45 152.71 28.64 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.898 0.879 . . . . 0.0 110.649 179.154 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 282' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -65.66 -23.85 66.89 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 122.543 0.337 . . . . 0.0 111.581 177.531 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 20.7 t -91.17 -1.36 57.74 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.117 0.967 . . . . 0.0 111.985 179.175 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -85.01 132.89 44.32 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 123.606 0.763 . . . . 0.0 109.537 -178.05 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -66.58 164.46 28.81 Favored 'Trans proline' 0 C--N 1.372 1.797 0 C-N-CA 121.864 1.71 . . . . 0.0 111.203 169.438 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.433 ' O ' HG23 ' A' ' 290' ' ' VAL . 49.3 mt -67.85 -13.7 62.36 Favored 'General case' 0 C--O 1.211 -0.936 0 CA-C-O 119.027 -0.511 . . . . 0.0 111.261 178.813 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 26.6 tp60 -51.1 -27.61 8.73 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.282 1.033 . . . . 0.0 112.013 178.077 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 39.9 t -58.14 -59.84 4.66 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.206 1.002 . . . . 0.0 111.114 170.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.418 ' HB ' HG12 ' A' ' 269' ' ' ILE . 13.0 m -70.15 -25.76 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 122.774 0.43 . . . . 0.0 110.833 -178.391 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 290' ' ' VAL . . . . . 0.476 HG13 ' HB ' ' A' ' 304' ' ' ILE . 55.8 t -65.19 -51.34 66.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 123.92 0.888 . . . . 0.0 109.97 178.597 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -71.29 -38.18 71.82 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.881 -178.332 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 8.5 t60 -66.8 -48.45 68.95 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.234 0.614 . . . . 0.0 110.36 -178.561 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 293' ' ' MET . . . . . 0.571 ' HG3' HG21 ' A' ' 269' ' ' ILE . 97.5 mmm -67.69 -31.08 70.79 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.783 0.433 . . . . 0.0 110.87 179.254 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -59.71 -45.85 90.88 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 122.844 0.458 . . . . 0.0 110.403 173.133 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 24.9 m -69.98 -30.3 67.6 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 123.191 0.597 . . . . 0.0 110.958 178.081 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 71.7 t60 -73.81 -29.1 61.97 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.781 0.832 . . . . 0.0 111.211 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 297' ' ' LEU . . . . . 0.531 HD21 ' SG ' ' A' ' 271' ' ' CYS . 52.4 mt -109.0 -2.44 18.22 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.946 0.898 . . . . 0.0 111.507 -175.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 77.47 19.09 76.92 Favored Glycine 0 N--CA 1.478 1.471 0 C-N-CA 123.343 0.497 . . . . 0.0 113.869 172.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 299' ' ' VAL . . . . . 0.641 ' HB ' ' HD2' ' A' ' 303' ' ' ARG . 27.3 m -116.29 -176.38 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 124.551 1.14 . . . . 0.0 111.369 -176.205 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 20.3 m -86.3 146.61 42.75 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 123.612 0.765 . . . . 0.0 110.457 178.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -53.46 -35.59 76.49 Favored 'Trans proline' 0 C--N 1.387 2.578 0 C-N-CA 123.14 2.56 . . . . 0.0 112.294 176.296 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 29.7 p -61.14 -24.48 66.31 Favored 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 123.354 0.661 . . . . 0.0 112.29 -174.37 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 303' ' ' ARG . . . . . 0.641 ' HD2' ' HB ' ' A' ' 299' ' ' VAL . 90.1 mtt180 -82.16 -25.58 34.19 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.268 1.027 . . . . 0.0 112.096 -176.653 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 304' ' ' ILE . . . . . 0.585 HD12 ' SG ' ' A' ' 332' ' ' CYS . 38.0 mm -73.77 103.55 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 C-N-CA 123.42 0.688 . . . . 0.0 111.308 -173.676 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 305' ' ' LEU . . . . . 0.416 HD22 HD11 ' A' ' 335' ' ' LEU . 50.9 tp -101.17 114.68 28.86 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.661 0.784 . . . . 0.0 108.913 173.64 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 306' ' ' LEU . . . . . 0.403 ' HG ' HD12 ' A' ' 330' ' ' ILE . 2.6 mm? -86.32 131.34 34.24 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 177.175 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 307' ' ' LEU . . . . . 0.455 HD12 HG21 ' A' ' 333' ' ' VAL . 75.2 mt -130.86 111.06 11.76 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 178.841 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 308' ' ' PHE . . . . . 0.453 ' HB2' HD11 ' A' ' 313' ' ' LEU . 56.4 t80 -78.7 88.57 4.58 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.79 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 72.99 -82.35 0.63 Allowed Glycine 0 C--N 1.345 1.076 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.808 -175.43 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -121.48 -27.56 4.76 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.903 0.881 . . . . 0.0 111.103 -176.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 6.1 t -78.74 145.45 34.44 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 122.649 0.38 . . . . 0.0 110.789 -173.292 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 312' ' ' GLU . . . . . 0.43 ' HA ' HD23 ' A' ' 307' ' ' LEU . 44.1 tt0 -89.28 124.45 34.41 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 122.901 0.481 . . . . 0.0 110.343 -177.611 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 313' ' ' LEU . . . . . 0.459 HD13 HD13 ' A' ' 322' ' ' LEU . 28.0 mt -106.79 154.56 20.82 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 122.899 0.479 . . . . 0.0 110.067 177.739 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 49.0 m -107.92 151.29 41.17 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 123.412 0.685 . . . . 0.0 110.111 -179.602 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -62.45 -27.03 76.83 Favored 'Trans proline' 0 C--N 1.381 2.266 0 C-N-CA 122.585 2.19 . . . . 0.0 112.352 174.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 38.5 p -78.77 -21.68 47.51 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.626 0.77 . . . . 0.0 112.114 177.744 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -66.22 144.56 56.55 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.427 0.691 . . . . 0.0 111.798 -175.354 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 318' ' ' THR . . . . . . . . . . . . . 68.3 p -100.11 153.47 37.74 Favored Pre-proline 0 CA--C 1.553 1.074 0 C-N-CA 123.839 0.856 . . . . 0.0 109.754 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 319' ' ' PRO . . . . . 0.565 ' HG3' HD21 ' A' ' 280' ' ' LEU . 60.3 Cg_endo -73.49 -10.6 23.93 Favored 'Trans proline' 0 C--N 1.371 1.725 0 C-N-CA 123.165 2.577 . . . . 0.0 112.179 -177.637 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -69.23 -54.71 13.36 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.91 0.884 . . . . 0.0 110.183 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 10.2 t -67.18 -23.03 65.72 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.384 0.674 . . . . 0.0 111.44 178.277 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 322' ' ' LEU . . . . . 0.531 ' HB2' ' HG ' ' A' ' 324' ' ' LEU . 54.9 mt -96.67 -8.38 31.69 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.438 0.695 . . . . 0.0 111.993 -178.448 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt 59.16 29.24 18.76 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 124.238 1.015 . . . . 0.0 113.008 -178.59 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.531 ' HG ' ' HB2' ' A' ' 322' ' ' LEU . 55.3 mt -72.81 132.54 43.7 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 122.877 0.471 . . . . 0.0 110.476 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 325' ' ' GLY . . . . . 0.422 ' H ' ' HB2' ' A' ' 328' ' ' ASP . . . -138.15 -146.62 5.06 Favored Glycine 0 C--N 1.337 0.629 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 179.05 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 326' ' ' VAL . . . . . 0.418 ' O ' ' HE3' ' A' ' 268' ' ' LYS . 11.3 m -81.19 -26.33 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 123.033 0.533 . . . . 0.0 110.937 -176.697 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -97.53 -12.91 22.03 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.469 0.708 . . . . 0.0 111.665 -177.3 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 328' ' ' ASP . . . . . 0.422 ' HB2' ' H ' ' A' ' 325' ' ' GLY . 24.6 m-20 -87.3 108.37 18.93 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.002 0.43 . . . . 0.0 109.856 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 329' ' ' ILE . . . . . 0.448 HG12 ' HD2' ' A' ' 268' ' ' LYS . 38.0 mt -92.95 128.64 44.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.665 177.482 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 330' ' ' ILE . . . . . 0.457 HG13 HG23 ' A' ' 269' ' ' ILE . 41.0 pt -112.73 122.34 66.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 121.14 0.495 . . . . 0.0 109.711 175.176 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -71.78 113.82 9.21 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.045 0.938 . . . . 0.0 111.181 -173.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 332' ' ' CYS . . . . . 0.585 ' SG ' HD12 ' A' ' 304' ' ' ILE . 42.1 t -81.9 97.59 8.12 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.552 0.741 . . . . 0.0 110.198 177.845 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 333' ' ' VAL . . . . . 0.455 HG21 HD12 ' A' ' 307' ' ' LEU . 47.0 t -99.85 111.99 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 123.437 0.695 . . . . 0.0 109.435 -177.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 334' ' ' VAL . . . . . 0.542 HG11 HG11 ' A' ' 299' ' ' VAL . 60.5 t -80.84 103.93 8.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.662 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 335' ' ' LEU . . . . . 0.416 HD11 HD22 ' A' ' 305' ' ' LEU . 80.3 mt . . . . . 0 C--O 1.24 0.574 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.229 173.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 4.8 mp . . . . . 0 CA--C 1.54 0.566 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -93.08 148.04 34.97 Favored Pre-proline 0 CA--C 1.55 0.955 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.227 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 266' ' ' PRO . . . . . 0.49 ' HB2' ' HB3' ' A' ' 277' ' ' ARG . 74.3 Cg_endo -70.41 92.12 0.58 Allowed 'Trans proline' 0 C--N 1.376 2.007 0 C-N-CA 122.393 2.062 . . . . 0.0 112.239 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 267' ' ' LEU . . . . . 0.474 HD23 HD22 ' A' ' 280' ' ' LEU . 0.3 OUTLIER -64.32 126.21 27.05 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 172.304 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 22.9 ttpt -95.17 114.64 26.45 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-O 121.486 0.66 . . . . 0.0 111.083 -178.546 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 2.3 mp -113.08 124.99 70.27 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 C-N-CA 124.811 1.245 . . . . 0.0 109.231 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 35.5 ttp180 -93.09 107.21 19.05 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.165 0.507 . . . . 0.0 109.995 175.506 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 271' ' ' CYS . . . . . 0.668 ' SG ' HD21 ' A' ' 297' ' ' LEU . 48.9 t -82.33 -172.76 4.17 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.782 0.833 . . . . 0.0 111.322 179.042 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 272' ' ' ARG . . . . . 0.478 ' N ' ' SG ' ' A' ' 271' ' ' CYS . 35.8 ptt180 -57.37 -34.88 69.3 Favored 'General case' 0 CA--C 1.552 1.058 0 C-N-CA 124.622 1.169 . . . . 0.0 112.772 176.168 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -153.62 27.54 0.49 Allowed 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.165 0.586 . . . . 0.0 110.687 -177.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 274' ' ' ASP . . . . . 0.531 ' HB2' ' HB3' ' A' ' 271' ' ' CYS . 4.7 m-20 -141.29 158.85 43.34 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.589 0.756 . . . . 0.0 109.681 -175.316 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 26.9 tp -132.79 86.46 2.32 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 169.479 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 67.7 t -86.23 144.43 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.6 0.76 . . . . 0.0 109.927 -174.525 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 277' ' ' ARG . . . . . 0.49 ' HB3' ' HB2' ' A' ' 266' ' ' PRO . 52.9 mtp180 -128.5 87.02 2.52 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 172.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.455 HD11 HG12 ' A' ' 289' ' ' VAL . 3.9 pp -95.66 142.93 25.27 Favored Pre-proline 0 N--CA 1.48 1.056 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 -175.546 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -65.55 125.33 14.21 Favored 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 122.919 2.413 . . . . 0.0 111.343 175.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.696 HD21 ' HG3' ' A' ' 319' ' ' PRO . 0.1 OUTLIER -140.72 148.31 40.55 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.954 0.902 . . . . 0.0 110.639 -178.151 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 70.3 mtp180 -87.9 142.94 27.4 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.347 1.059 . . . . 0.0 110.671 179.099 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 282' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -62.04 -35.03 77.36 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.658 0.783 . . . . 0.0 111.829 175.024 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 44.4 p -75.36 -20.38 59.04 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.892 0.877 . . . . 0.0 111.595 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -86.57 130.23 49.96 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 124.207 1.003 . . . . 0.0 108.99 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 285' ' ' PRO . . . . . 0.509 ' HA ' ' HA ' ' A' ' 318' ' ' THR . 40.9 Cg_endo -65.76 178.25 2.38 Favored 'Trans proline' 0 C--N 1.38 2.209 0 C-N-CA 122.608 2.205 . . . . 0.0 112.753 173.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.45 ' O ' HG23 ' A' ' 290' ' ' VAL . 90.7 mt -64.43 -18.22 64.53 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.563 0.745 . . . . 0.0 111.965 -179.122 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 27.7 tp60 -52.48 -23.36 6.07 Favored 'General case' 0 CA--C 1.558 1.264 0 C-N-CA 123.678 0.791 . . . . 0.0 112.271 178.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 288' ' ' SER . . . . . 0.56 ' HB3' HD12 ' A' ' 280' ' ' LEU . 37.3 t -63.24 -57.31 10.87 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.841 0.856 . . . . 0.0 110.856 171.785 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.47 ' O ' ' HG2' ' A' ' 293' ' ' MET . 27.7 m -65.4 -35.36 75.13 Favored 'Isoleucine or valine' 0 C--N 1.368 1.381 0 O-C-N 123.167 0.292 . . . . 0.0 110.342 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 290' ' ' VAL . . . . . 0.592 HG13 ' HB ' ' A' ' 304' ' ' ILE . 71.6 t -55.73 -53.21 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 124.42 1.088 . . . . 0.0 111.336 178.259 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -63.87 -42.97 97.4 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.066 -177.061 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 13.5 t60 -71.85 -38.09 70.15 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.231 -176.011 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 293' ' ' MET . . . . . 0.47 ' HG2' ' O ' ' A' ' 289' ' ' VAL . 91.0 mmm -68.9 -34.38 75.31 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 123.156 0.582 . . . . 0.0 110.125 177.327 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -66.29 -43.4 86.46 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.571 0.748 . . . . 0.0 111.376 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 26.2 m -70.14 -32.65 70.74 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.381 0.672 . . . . 0.0 110.644 176.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 79.2 t60 -63.36 -35.11 79.32 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.905 0.882 . . . . 0.0 111.812 177.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 297' ' ' LEU . . . . . 0.668 HD21 ' SG ' ' A' ' 271' ' ' CYS . 75.7 mt -99.53 -23.27 15.14 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.244 0.618 . . . . 0.0 111.893 -177.743 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 82.63 25.12 51.57 Favored Glycine 0 CA--C 1.531 1.071 0 O-C-N 123.262 0.351 . . . . 0.0 112.787 -173.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 33.4 m -107.33 177.99 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 124.521 1.128 . . . . 0.0 109.878 176.19 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 47.6 m -83.17 144.36 46.93 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 123.042 0.537 . . . . 0.0 110.6 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -55.75 -31.99 82.48 Favored 'Trans proline' 0 C--N 1.388 2.606 0 C-N-CA 123.263 2.642 . . . . 0.0 112.096 170.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 34.2 t -70.85 -6.02 34.9 Favored 'General case' 0 CA--C 1.56 1.328 0 C-N-CA 122.558 0.343 . . . . 0.0 111.787 -178.419 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 58.1 mtt180 -106.44 -16.25 14.59 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.243 1.017 . . . . 0.0 112.173 178.592 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 304' ' ' ILE . . . . . 0.592 ' HB ' HG13 ' A' ' 290' ' ' VAL . 38.9 mm -81.16 108.17 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 177.758 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 24.1 tp -110.36 130.25 55.59 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 174.429 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -95.89 131.41 42.26 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 307' ' ' LEU . . . . . 0.469 HD12 HG21 ' A' ' 333' ' ' VAL . 72.9 mt -133.48 105.69 7.05 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.587 0.755 . . . . 0.0 109.602 -175.623 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 308' ' ' PHE . . . . . 0.578 ' HB2' HD11 ' A' ' 313' ' ' LEU . 85.4 t80 -78.23 95.1 4.89 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -176.816 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 73.17 -85.11 0.59 Allowed Glycine 0 C--N 1.344 1.017 0 N-CA-C 111.436 -0.666 . . . . 0.0 111.436 -177.056 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -139.2 13.59 2.61 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.706 0.802 . . . . 0.0 111.566 -179.1 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 6.2 t -104.77 147.49 27.65 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 175.618 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -92.92 122.97 35.84 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.956 0.502 . . . . 0.0 110.32 -176.288 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 313' ' ' LEU . . . . . 0.578 HD11 ' HB2' ' A' ' 308' ' ' PHE . 40.2 mt -110.83 130.72 55.5 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.096 0.559 . . . . 0.0 109.802 -179.49 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 16.5 m -73.65 142.18 80.32 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 123.054 0.542 . . . . 0.0 110.198 174.434 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 315' ' ' PRO . . . . . 0.44 ' HB3' HG21 ' A' ' 290' ' ' VAL . 30.9 Cg_endo -62.62 -25.81 75.49 Favored 'Trans proline' 0 C--N 1.381 2.255 0 C-N-CA 122.821 2.347 . . . . 0.0 111.934 173.152 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 28.6 p -78.63 -18.32 54.67 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.558 1.143 . . . . 0.0 111.853 177.325 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -73.94 149.77 41.21 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.052 0.541 . . . . 0.0 110.257 176.651 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 318' ' ' THR . . . . . 0.509 ' HA ' ' HA ' ' A' ' 285' ' ' PRO . 60.7 p -99.2 142.6 24.9 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 123.26 0.624 . . . . 0.0 110.361 -176.827 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 319' ' ' PRO . . . . . 0.696 ' HG3' HD21 ' A' ' 280' ' ' LEU . 37.9 Cg_endo -62.49 -15.96 48.96 Favored 'Trans proline' 0 C--N 1.377 2.046 0 C-N-CA 123.378 2.719 . . . . 0.0 112.521 174.724 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 73.4 ttt-85 -60.78 -57.8 11.14 Favored 'General case' 0 C--N 1.358 0.951 0 C-N-CA 123.826 0.851 . . . . 0.0 111.044 176.298 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 14.7 t -70.73 -25.14 62.79 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.309 -177.086 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 322' ' ' LEU . . . . . 0.519 HD13 HD13 ' A' ' 313' ' ' LEU . 65.5 mt -79.0 -19.7 50.91 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.277 0.631 . . . . 0.0 110.689 177.457 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt 59.06 57.44 3.52 Favored 'General case' 0 CA--C 1.55 0.942 0 C-N-CA 124.787 1.235 . . . . 0.0 109.9 -176.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.426 ' HG ' ' HB2' ' A' ' 322' ' ' LEU . 69.8 mt -93.9 140.24 29.93 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 114.416 -1.266 . . . . 0.0 108.85 177.371 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . -128.82 -157.73 9.38 Favored Glycine 0 C--O 1.239 0.436 0 O-C-N 123.977 0.798 . . . . 0.0 111.156 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 326' ' ' VAL . . . . . 0.427 ' HB ' ' NH2' ' A' ' 277' ' ' ARG . 29.6 m -75.07 -25.58 18.46 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 C-N-CA 123.382 0.673 . . . . 0.0 111.868 -175.343 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -98.31 -16.79 19.23 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.006 0.922 . . . . 0.0 111.915 -177.138 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -73.13 123.67 24.06 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.04 0.536 . . . . 0.0 110.605 -176.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 29.0 mt -106.26 120.32 57.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 C-N-CA 123.975 0.91 . . . . 0.0 110.357 -175.206 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 32.1 pt -113.71 130.4 67.85 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 174.618 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -77.76 111.08 13.19 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.74 0.816 . . . . 0.0 111.823 -174.114 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 332' ' ' CYS . . . . . 0.591 ' SG ' HD12 ' A' ' 304' ' ' ILE . 29.5 t -72.57 96.62 1.99 Allowed 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.545 0.738 . . . . 0.0 109.783 166.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 333' ' ' VAL . . . . . 0.469 HG21 HD12 ' A' ' 307' ' ' LEU . 75.3 t -105.28 114.34 44.57 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 177.576 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 52.5 t -78.66 90.13 1.27 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.775 0 CA-C-O 121.565 0.698 . . . . 0.0 109.606 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 86.0 mt . . . . . 0 C--O 1.235 0.296 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.067 174.402 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 5.0 mp . . . . . 0 C--O 1.234 0.262 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -79.39 141.48 57.16 Favored Pre-proline 0 C--O 1.245 0.854 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -178.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -66.15 101.33 0.5 Allowed 'Trans proline' 0 C--N 1.373 1.829 0 C-N-CA 122.228 1.952 . . . . 0.0 111.153 175.21 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -68.03 127.77 34.07 Favored 'General case' 0 CA--C 1.549 0.937 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 172.498 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 268' ' ' LYS . . . . . 0.511 ' HG2' HG12 ' A' ' 329' ' ' ILE . 5.2 tppp? -90.62 108.43 19.8 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.313 0.645 . . . . 0.0 110.238 177.248 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 3.6 mp -102.67 126.2 56.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 123.917 0.887 . . . . 0.0 109.177 178.401 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 30.8 ttp180 -96.93 95.13 7.62 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.276 0.631 . . . . 0.0 109.413 173.342 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 271' ' ' CYS . . . . . 0.487 ' SG ' HD21 ' A' ' 297' ' ' LEU . 42.8 t -71.85 -173.65 1.04 Allowed 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 123.819 0.848 . . . . 0.0 110.651 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 272' ' ' ARG . . . . . 0.409 ' HG2' ' SG ' ' A' ' 271' ' ' CYS . 7.5 ptm180 -55.48 -30.97 61.58 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.406 1.082 . . . . 0.0 112.311 174.855 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -144.89 -38.35 0.27 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.118 0.967 . . . . 0.0 110.366 -178.298 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -79.3 154.09 29.37 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.206 1.002 . . . . 0.0 111.433 -173.022 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 25.4 tp -119.69 85.33 2.36 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 173.092 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 95.0 t -89.94 147.56 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 114.856 -1.065 . . . . 0.0 109.875 -167.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -127.9 127.68 43.79 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 171.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.497 HD11 HG12 ' A' ' 289' ' ' VAL . 4.2 pp -129.41 144.35 52.48 Favored Pre-proline 0 N--CA 1.482 1.161 0 CA-C-N 118.023 0.374 . . . . 0.0 110.411 174.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -68.33 122.45 9.48 Favored 'Trans proline' 0 C--N 1.374 1.906 0 C-N-CA 122.68 2.254 . . . . 0.0 110.714 174.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.807 HD21 ' HG3' ' A' ' 319' ' ' PRO . 0.3 OUTLIER -149.02 150.75 33.34 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.007 0.923 . . . . 0.0 109.993 -177.441 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 58.1 mtm-85 -97.72 155.88 16.81 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.306 0.643 . . . . 0.0 110.486 179.206 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 282' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -61.31 -39.51 90.73 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.335 0.654 . . . . 0.0 111.228 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 12.1 t -78.67 -23.93 45.42 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.348 -178.516 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -70.61 122.36 86.4 Favored Pre-proline 0 C--N 1.352 0.707 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 175.34 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 285' ' ' PRO . . . . . 0.507 ' HA ' ' HA ' ' A' ' 318' ' ' THR . 55.5 Cg_endo -65.59 175.45 4.32 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 122.363 2.042 . . . . 0.0 112.639 -179.279 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.42 ' O ' HG23 ' A' ' 290' ' ' VAL . 78.4 mt -64.87 -16.97 63.87 Favored 'General case' 0 C--O 1.211 -0.967 0 CA-C-O 118.449 -0.786 . . . . 0.0 111.64 178.816 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 23.8 tp60 -52.52 -27.48 16.65 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.218 0.607 . . . . 0.0 112.274 179.297 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 288' ' ' SER . . . . . 0.613 ' HB3' HD12 ' A' ' 280' ' ' LEU . 41.8 t -61.12 -55.7 29.38 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.7 0.8 . . . . 0.0 110.524 171.165 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.497 HG12 HD11 ' A' ' 278' ' ' LEU . 11.4 m -69.33 -28.27 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 122.503 0.321 . . . . 0.0 111.441 179.375 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 290' ' ' VAL . . . . . 0.529 HG13 ' HB ' ' A' ' 304' ' ' ILE . 54.9 t -69.53 -52.39 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 123.731 0.812 . . . . 0.0 109.991 -177.192 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -71.84 -32.99 68.09 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 122.955 0.502 . . . . 0.0 110.869 -178.423 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -64.3 -51.89 61.23 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.341 0.656 . . . . 0.0 110.008 178.298 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 94.2 mmm -68.99 -29.3 67.48 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.365 0.666 . . . . 0.0 111.065 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -61.7 -53.33 57.53 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.341 0.656 . . . . 0.0 110.682 176.241 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 21.9 m -65.25 -35.61 81.55 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 123.689 0.796 . . . . 0.0 110.846 178.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -67.04 -33.22 75.05 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.324 1.049 . . . . 0.0 111.663 -179.385 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 297' ' ' LEU . . . . . 0.487 HD21 ' SG ' ' A' ' 271' ' ' CYS . 47.6 mt -102.17 -3.68 27.04 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.06 0.944 . . . . 0.0 111.248 178.835 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 76.74 9.37 86.41 Favored Glycine 0 C--N 1.352 1.46 0 C-N-CA 123.548 0.594 . . . . 0.0 113.909 176.298 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 299' ' ' VAL . . . . . 0.484 HG11 HG11 ' A' ' 334' ' ' VAL . 35.4 m -102.48 179.82 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.056 0.942 . . . . 0.0 111.462 -177.173 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 49.4 m -77.65 147.62 75.09 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 123.54 0.736 . . . . 0.0 111.14 178.32 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.68 -27.47 83.28 Favored 'Trans proline' 0 C--N 1.384 2.407 0 C-N-CA 122.634 2.222 . . . . 0.0 111.333 168.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 20.2 m -64.12 -26.16 68.42 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 124.107 0.963 . . . . 0.0 111.549 178.698 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 78.2 mtt85 -84.35 -33.58 23.83 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.899 0.88 . . . . 0.0 111.64 179.41 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 304' ' ' ILE . . . . . 0.529 ' HB ' HG13 ' A' ' 290' ' ' VAL . 36.5 mm -72.55 105.12 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 122.703 0.401 . . . . 0.0 110.942 -175.84 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 305' ' ' LEU . . . . . 0.527 HD22 HD11 ' A' ' 335' ' ' LEU . 29.7 tp -107.62 129.24 55.02 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 123.618 0.767 . . . . 0.0 109.231 172.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -92.11 138.26 31.68 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 174.396 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 307' ' ' LEU . . . . . 0.463 HD23 ' HA ' ' A' ' 312' ' ' GLU . 92.6 mt -133.3 115.02 14.42 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.99 0.916 . . . . 0.0 109.47 -177.85 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 308' ' ' PHE . . . . . 0.572 ' HB2' HD11 ' A' ' 313' ' ' LEU . 66.0 t80 -87.25 88.16 7.62 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.06 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 73.74 -78.36 0.89 Allowed Glycine 0 C--N 1.349 1.269 0 CA-C-N 115.209 -0.905 . . . . 0.0 112.331 -177.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -120.62 -33.47 3.81 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.449 0.699 . . . . 0.0 110.644 179.193 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 8.5 t -76.65 148.38 36.91 Favored 'General case' 0 C--N 1.35 0.622 0 C-N-CA 122.757 0.423 . . . . 0.0 111.393 -169.019 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 312' ' ' GLU . . . . . 0.463 ' HA ' HD23 ' A' ' 307' ' ' LEU . 42.7 tt0 -85.24 130.56 34.58 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.687 178.772 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 313' ' ' LEU . . . . . 0.594 HD22 HD22 ' A' ' 322' ' ' LEU . 46.9 mt -111.85 126.93 55.62 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 176.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 31.9 m -78.89 144.72 64.54 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 123.237 0.615 . . . . 0.0 110.727 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -59.75 -32.51 95.74 Favored 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 123.103 2.535 . . . . 0.0 112.747 178.306 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 7.1 m -79.36 -20.48 47.68 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 123.415 0.686 . . . . 0.0 111.361 -179.323 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -68.72 144.66 54.32 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.17 0.588 . . . . 0.0 110.543 178.644 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 318' ' ' THR . . . . . 0.507 ' HA ' ' HA ' ' A' ' 285' ' ' PRO . 81.8 p -98.8 142.72 25.08 Favored Pre-proline 0 N--CA 1.475 0.808 0 C-N-CA 123.399 0.679 . . . . 0.0 109.98 -175.688 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 319' ' ' PRO . . . . . 0.807 ' HG3' HD21 ' A' ' 280' ' ' LEU . 18.8 Cg_endo -56.88 -19.97 34.03 Favored 'Trans proline' 0 C--N 1.368 1.586 0 C-N-CA 123.143 2.562 . . . . 0.0 112.477 173.015 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 31.2 ttt180 -60.55 -55.33 34.71 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.504 0.722 . . . . 0.0 110.62 170.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 321' ' ' THR . . . . . 0.453 HG22 ' O ' ' A' ' 318' ' ' THR . 12.4 t -72.17 -18.9 61.83 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -176.017 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 322' ' ' LEU . . . . . 0.594 HD22 HD22 ' A' ' 313' ' ' LEU . 47.0 mt -91.68 -18.74 23.52 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.657 0.783 . . . . 0.0 111.332 179.256 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 58.02 78.59 0.24 Allowed 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 124.606 1.162 . . . . 0.0 108.821 -169.833 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 66.5 mt -116.15 165.17 13.45 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.76 0.824 . . . . 0.0 109.022 174.359 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 325' ' ' GLY . . . . . 0.436 ' H ' ' HB3' ' A' ' 328' ' ' ASP . . . -158.69 -171.62 24.76 Favored Glycine 0 C--N 1.345 1.072 0 O-C-N 122.946 0.154 . . . . 0.0 112.76 -171.168 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 35.1 m -64.58 -32.73 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.325 1.05 . . . . 0.0 112.102 -175.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -112.17 4.84 18.14 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.606 0.762 . . . . 0.0 111.499 -178.522 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 328' ' ' ASP . . . . . 0.436 ' HB3' ' H ' ' A' ' 325' ' ' GLY . 23.7 t0 -95.89 127.47 41.94 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -178.203 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 329' ' ' ILE . . . . . 0.511 HG12 ' HG2' ' A' ' 268' ' ' LYS . 6.0 mt -111.47 143.15 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 C-N-CA 123.414 0.686 . . . . 0.0 111.798 -165.028 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 27.7 pt -137.54 133.9 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 123.612 0.765 . . . . 0.0 111.168 177.258 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 331' ' ' ASP . . . . . 0.404 ' HB2' ' HB2' ' A' ' 307' ' ' LEU . 6.2 m-20 -72.89 111.49 8.06 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.709 1.204 . . . . 0.0 112.523 -175.588 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 332' ' ' CYS . . . . . 0.487 ' HB3' ' HA ' ' A' ' 271' ' ' CYS . 42.0 t -75.61 115.97 15.84 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 165.819 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 333' ' ' VAL . . . . . 0.442 HG21 HD12 ' A' ' 307' ' ' LEU . 99.3 t -126.12 117.84 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 123.812 0.845 . . . . 0.0 109.402 -177.695 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 334' ' ' VAL . . . . . 0.484 HG11 HG11 ' A' ' 299' ' ' VAL . 62.0 t -84.57 99.69 7.12 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 123.187 0.595 . . . . 0.0 109.664 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 335' ' ' LEU . . . . . 0.527 HD11 HD22 ' A' ' 305' ' ' LEU . 89.1 mt . . . . . 0 N--CA 1.472 0.657 0 C-N-CA 123.863 0.865 . . . . 0.0 111.165 177.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 . . . . . 0 N--CA 1.476 0.871 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 156.98 67.93 0.01 OUTLIER Glycine 0 C--N 1.349 1.269 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.612 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 12.3 mp0 -82.63 81.67 8.32 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.835 0.854 . . . . 0.0 108.763 177.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -99.27 96.21 7.59 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.921 -175.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -172.09 163.1 5.94 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.859 0.863 . . . . 0.0 109.617 175.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -137.51 118.02 13.85 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.989 0.916 . . . . 0.0 108.598 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 15.9 m -76.65 81.18 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 CA-C-O 121.981 0.896 . . . . 0.0 111.068 -177.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 17.7 t -88.46 64.2 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-O 122.192 0.996 . . . . 0.0 108.785 177.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 35.4 tp -172.29 146.75 1.89 Allowed 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 113.864 -1.516 . . . . 0.0 107.966 -178.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 62.0 t 60.98 87.99 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 124.299 1.04 . . . . 0.0 109.401 -176.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 72.68 140.08 0.06 Allowed 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 125.442 1.497 . . . . 0.0 110.628 -171.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -118.34 85.28 0.39 Allowed Glycine 0 N--CA 1.471 0.997 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 174.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -76.86 173.39 14.55 Favored 'Trans proline' 0 C--N 1.375 1.939 0 C-N-CA 123.104 2.536 . . . . 0.0 112.796 -176.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 20.3 p -74.03 106.3 5.66 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 173.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 74.9 mt -102.66 97.01 8.31 Favored Pre-proline 0 CA--C 1.546 0.826 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 176.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -66.52 -27.41 46.31 Favored 'Trans proline' 0 C--N 1.38 2.23 0 C-N-CA 122.668 2.246 . . . . 0.0 111.737 177.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -69.65 105.5 2.72 Favored 'General case' 0 C--O 1.245 0.825 0 O-C-N 123.788 0.68 . . . . 0.0 109.279 172.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 25.0 p -72.14 158.04 88.3 Favored Pre-proline 0 CA--C 1.549 0.907 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.306 172.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 262' ' ' PRO . . . . . 0.499 ' O ' HD12 ' A' ' 264' ' ' LEU . 34.9 Cg_endo -60.51 168.03 7.25 Favored 'Trans proline' 0 C--N 1.375 1.932 0 C-N-CA 122.768 2.312 . . . . 0.0 111.731 171.06 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 87.9 mtt180 -84.33 90.7 7.61 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 121.37 0.605 . . . . 0.0 109.425 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.499 HD12 ' O ' ' A' ' 262' ' ' PRO . 4.1 mp -81.46 172.36 13.61 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 114.741 -1.118 . . . . 0.0 109.397 173.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 265' ' ' PHE . . . . . 0.467 ' CE1' ' HG2' ' A' ' 282' ' ' MET . 31.4 p90 -147.85 152.5 40.8 Favored Pre-proline 0 CA--C 1.544 0.73 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 174.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -69.27 93.64 0.48 Allowed 'Trans proline' 0 C--N 1.371 1.747 0 C-N-CA 122.383 2.055 . . . . 0.0 111.634 173.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 267' ' ' LEU . . . . . 0.513 HD12 HG13 ' A' ' 269' ' ' ILE . 1.3 tm? -60.28 127.55 32.34 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 173.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.44 ' HG2' HG12 ' A' ' 329' ' ' ILE . 4.1 tppp? -91.7 103.96 16.48 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 123.763 0.665 . . . . 0.0 110.438 -179.347 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 269' ' ' ILE . . . . . 0.513 HG13 HD12 ' A' ' 267' ' ' LEU . 1.4 mp -101.82 146.14 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 174.069 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 27.8 ttp180 -106.7 118.89 37.86 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 172.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 271' ' ' CYS . . . . . 0.559 ' SG ' HD21 ' A' ' 297' ' ' LEU . 13.7 t -73.92 -158.33 0.06 Allowed 'General case' 0 CA--C 1.562 1.407 0 C-N-CA 124.473 1.109 . . . . 0.0 109.638 172.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 -64.94 -31.04 72.09 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 122.828 0.451 . . . . 0.0 111.791 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -160.27 22.91 0.16 Allowed 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -175.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -152.93 162.11 41.72 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 122.752 0.421 . . . . 0.0 110.596 -172.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.419 HD13 ' HD2' ' A' ' 268' ' ' LYS . 76.3 mt -107.19 129.06 54.91 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.627 0.771 . . . . 0.0 110.948 176.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 46.5 t -115.79 138.61 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.467 1.107 . . . . 0.0 108.668 174.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 277' ' ' ARG . . . . . 0.409 ' HA ' ' O ' ' A' ' 267' ' ' LEU . 74.5 mtm180 -116.65 130.42 56.72 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.654 0.781 . . . . 0.0 109.598 173.374 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.488 HD21 ' HA ' ' A' ' 289' ' ' VAL . 4.6 pp -128.63 144.99 54.33 Favored Pre-proline 0 N--CA 1.488 1.436 0 CA-C-O 119.245 -0.407 . . . . 0.0 110.229 172.486 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -71.95 117.87 5.35 Favored 'Trans proline' 0 C--N 1.379 2.142 0 C-N-CA 122.467 2.111 . . . . 0.0 110.677 178.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.768 HD21 ' HG3' ' A' ' 319' ' ' PRO . 0.2 OUTLIER -144.87 148.41 33.92 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.877 0.871 . . . . 0.0 110.103 -174.45 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 281' ' ' ARG . . . . . 0.402 ' HB2' ' HB2' ' A' ' 284' ' ' GLU . 87.7 mtm180 -86.4 152.28 22.84 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.99 0.916 . . . . 0.0 109.781 176.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 282' ' ' MET . . . . . 0.467 ' HG2' ' CE1' ' A' ' 265' ' ' PHE . 11.2 mtp -66.72 -31.77 72.64 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.127 0.489 . . . . 0.0 109.926 176.424 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 39.0 p -77.04 -18.96 57.75 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.855 1.262 . . . . 0.0 111.93 177.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 284' ' ' GLU . . . . . 0.402 ' HB2' ' HB2' ' A' ' 281' ' ' ARG . 7.6 tp10 -70.45 128.39 91.24 Favored Pre-proline 0 N--CA 1.475 0.813 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 176.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -65.65 161.55 38.23 Favored 'Trans proline' 0 C--N 1.377 2.033 0 C-N-CA 122.116 1.877 . . . . 0.0 111.554 174.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.409 ' O ' HG23 ' A' ' 290' ' ' VAL . 58.5 mt -64.63 -10.76 28.83 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 118.83 -0.605 . . . . 0.0 112.272 -178.544 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 -52.45 -27.49 16.31 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.614 0.765 . . . . 0.0 111.864 176.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 288' ' ' SER . . . . . 0.418 ' HB3' HD12 ' A' ' 280' ' ' LEU . 46.8 t -60.69 -57.06 14.3 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.831 0.852 . . . . 0.0 111.084 172.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.488 ' HA ' HD21 ' A' ' 278' ' ' LEU . 15.8 m -69.18 -30.21 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 122.494 0.317 . . . . 0.0 110.749 -178.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 290' ' ' VAL . . . . . 0.57 HG13 ' HB ' ' A' ' 304' ' ' ILE . 45.1 t -64.1 -52.37 57.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 124.323 1.049 . . . . 0.0 110.705 179.084 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -61.74 -43.72 98.3 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.293 1.037 . . . . 0.0 110.694 -179.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 54.5 t60 -68.09 -45.26 74.23 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.045 -176.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 293' ' ' MET . . . . . 0.474 ' HB3' ' SG ' ' A' ' 332' ' ' CYS . 92.9 mmm -68.77 -32.21 71.8 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 123.543 0.527 . . . . 0.0 110.908 178.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -64.42 -43.94 92.78 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.335 0.654 . . . . 0.0 110.557 177.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 52.5 m -68.45 -31.72 71.22 Favored 'General case' 0 CA--C 1.554 1.106 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.562 177.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -73.33 -39.01 65.57 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.304 1.041 . . . . 0.0 111.723 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 297' ' ' LEU . . . . . 0.559 HD21 ' SG ' ' A' ' 271' ' ' CYS . 71.4 mt -94.16 -8.6 38.95 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.852 0.861 . . . . 0.0 111.467 -176.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 76.15 20.89 76.9 Favored Glycine 0 C--N 1.349 1.258 0 O-C-N 123.505 0.503 . . . . 0.0 113.496 178.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 30.1 m -111.75 176.97 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 124.229 1.012 . . . . 0.0 110.865 -177.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 48.9 m -80.08 143.65 57.42 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 123.361 0.664 . . . . 0.0 110.005 175.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -54.16 -28.72 52.74 Favored 'Trans proline' 0 C--N 1.39 2.726 0 C-N-CA 123.228 2.619 . . . . 0.0 112.691 173.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 39.5 t -64.46 -27.55 69.07 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 122.925 0.49 . . . . 0.0 111.62 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 61.3 mtt180 -82.59 -20.08 37.16 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.562 0.745 . . . . 0.0 111.684 -176.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 304' ' ' ILE . . . . . 0.639 HD12 ' SG ' ' A' ' 332' ' ' CYS . 42.6 mm -76.68 125.56 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 123.152 0.581 . . . . 0.0 110.763 -176.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 37.9 tp -126.52 120.76 30.47 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.934 0.894 . . . . 0.0 108.664 174.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 306' ' ' LEU . . . . . 0.411 ' HG ' HD12 ' A' ' 330' ' ' ILE . 2.6 mm? -85.64 134.67 33.98 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 177.387 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 307' ' ' LEU . . . . . 0.447 HD23 ' HA ' ' A' ' 312' ' ' GLU . 94.2 mt -136.94 106.7 6.21 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.636 0.774 . . . . 0.0 109.975 -175.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -87.51 95.44 10.03 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 175.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 74.72 -80.74 0.9 Allowed Glycine 0 C--N 1.339 0.73 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.438 178.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -135.6 -5.65 2.24 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.966 0.906 . . . . 0.0 111.856 -177.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 11.6 t -89.37 148.91 23.25 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 117.987 0.358 . . . . 0.0 110.48 -177.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 312' ' ' GLU . . . . . 0.447 ' HA ' HD23 ' A' ' 307' ' ' LEU . 38.8 tt0 -98.64 110.74 23.29 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.363 0.665 . . . . 0.0 109.628 -178.335 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.411 HD22 HD22 ' A' ' 322' ' ' LEU . 44.7 mt -95.42 167.75 11.13 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.742 0.417 . . . . 0.0 110.012 177.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 53.2 m -134.4 154.94 80.11 Favored Pre-proline 0 N--CA 1.48 1.06 0 C-N-CA 123.187 0.595 . . . . 0.0 109.963 -177.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 315' ' ' PRO . . . . . 0.502 ' HB3' HG21 ' A' ' 290' ' ' VAL . 26.9 Cg_endo -58.43 -26.94 80.0 Favored 'Trans proline' 0 C--N 1.385 2.465 0 C-N-CA 123.31 2.674 . . . . 0.0 113.309 177.36 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 20.8 m -78.5 -29.03 46.41 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 123.668 0.787 . . . . 0.0 111.406 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -66.48 143.42 57.1 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.75 0.82 . . . . 0.0 111.126 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 318' ' ' THR . . . . . . . . . . . . . 36.1 p -108.26 135.82 19.9 Favored Pre-proline 0 N--CA 1.475 0.788 0 C-N-CA 123.318 0.647 . . . . 0.0 111.072 -177.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 319' ' ' PRO . . . . . 0.768 ' HG3' HD21 ' A' ' 280' ' ' LEU . 6.4 Cg_endo -47.35 -23.04 2.91 Favored 'Trans proline' 0 C--N 1.375 1.96 0 C-N-CA 124.824 3.683 . . . . 0.0 115.088 172.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 30.3 ttt180 -60.54 -62.25 2.0 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.156 0.582 . . . . 0.0 110.834 175.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 8.9 t -68.49 -30.35 69.17 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 122.66 0.384 . . . . 0.0 111.151 -178.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 322' ' ' LEU . . . . . 0.445 ' HB2' ' HG ' ' A' ' 324' ' ' LEU . 86.4 mt -78.55 -17.91 55.44 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.288 0.635 . . . . 0.0 111.868 -178.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 83.7 tttt 64.01 38.81 8.36 Favored 'General case' 0 CA--C 1.562 1.432 0 C-N-CA 124.158 0.983 . . . . 0.0 110.882 -177.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.445 ' HG ' ' HB2' ' A' ' 322' ' ' LEU . 31.7 mt -78.52 162.6 26.21 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 122.921 0.488 . . . . 0.0 110.141 175.034 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . -166.49 -160.79 14.24 Favored Glycine 0 C--N 1.341 0.808 0 CA-C-N 116.325 -0.398 . . . . 0.0 112.887 -173.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 24.7 m -77.97 -31.68 16.98 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 C-N-CA 124.046 0.938 . . . . 0.0 111.062 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -98.65 -19.01 17.77 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.959 0.903 . . . . 0.0 110.701 178.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -87.2 108.25 18.84 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 -177.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 329' ' ' ILE . . . . . 0.44 HG12 ' HG2' ' A' ' 268' ' ' LYS . 7.7 mt -104.53 134.5 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 123.463 0.705 . . . . 0.0 111.254 -165.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 330' ' ' ILE . . . . . 0.411 HD12 ' HG ' ' A' ' 306' ' ' LEU . 34.6 pt -120.05 127.08 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 123.225 0.61 . . . . 0.0 111.225 -179.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -76.66 116.43 17.34 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.849 0.859 . . . . 0.0 111.251 -177.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 332' ' ' CYS . . . . . 0.639 ' SG ' HD12 ' A' ' 304' ' ' ILE . 36.2 t -82.77 98.42 9.1 Favored 'General case' 0 C--O 1.243 0.752 0 C-N-CA 123.587 0.755 . . . . 0.0 109.851 172.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 59.2 t -108.84 125.57 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 123.449 0.699 . . . . 0.0 109.792 -176.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 61.3 t -86.23 111.09 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.23 0.612 . . . . 0.0 109.401 177.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 60.7 mt -102.88 168.95 8.89 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.57 0.748 . . . . 0.0 111.263 177.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 336' ' ' THR . . . . . . . . . . . . . 37.9 p -83.76 73.28 10.3 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.799 172.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 50.7 p -73.92 93.72 2.23 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.418 -177.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 56.5 m . . . . . 0 C--O 1.252 1.204 0 C-N-CA 124.382 1.073 . . . . 0.0 109.636 -177.312 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 . . . . . 0 N--CA 1.475 0.791 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 75.21 69.5 1.38 Allowed Glycine 0 C--N 1.348 1.206 0 O-C-N 123.656 0.597 . . . . 0.0 111.641 -175.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -61.48 -30.86 70.87 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.697 0.799 . . . . 0.0 111.508 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -112.26 78.97 1.17 Allowed 'General case' 0 C--O 1.244 0.779 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 174.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -107.49 95.62 5.83 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.156 177.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -85.06 136.09 33.72 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.349 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 23.8 m -73.02 103.53 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.994 0 CA-C-O 122.123 0.963 . . . . 0.0 111.41 -174.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 5.7 p -131.18 124.81 56.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 124.154 0.981 . . . . 0.0 108.904 177.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -162.43 77.61 0.48 Allowed 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 177.18 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 61.6 t -112.84 114.97 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 67.8 129.03 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 125.066 1.347 . . . . 0.0 112.832 176.102 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 135.7 98.03 0.54 Allowed Glycine 0 C--N 1.343 0.921 0 CA-C-O 118.875 -0.958 . . . . 0.0 112.007 177.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -66.5 145.67 77.48 Favored 'Trans proline' 0 C--N 1.38 2.231 0 C-N-CA 122.661 2.24 . . . . 0.0 110.838 175.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 17.4 m 73.98 145.38 0.08 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 125.256 1.422 . . . . 0.0 111.025 -173.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 70.2 mt -98.01 97.94 4.94 Favored Pre-proline 0 CA--C 1.55 0.972 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 172.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -64.08 -10.87 24.85 Favored 'Trans proline' 0 C--N 1.386 2.505 0 C-N-CA 123.474 2.783 . . . . 0.0 113.156 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -65.8 128.03 34.38 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.979 0.911 . . . . 0.0 110.225 174.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 90.9 m -66.73 121.55 78.04 Favored Pre-proline 0 CA--C 1.551 0.997 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 170.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -59.64 110.35 0.72 Allowed 'Trans proline' 0 C--N 1.383 2.348 0 C-N-CA 122.36 2.04 . . . . 0.0 109.336 175.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 59.7 ttt180 -71.19 92.51 1.01 Allowed 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.173 0.589 . . . . 0.0 110.382 -168.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 1.5 mp -77.02 154.5 33.39 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.569 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 265' ' ' PHE . . . . . 0.407 ' CE1' ' HG2' ' A' ' 282' ' ' MET . 27.6 p90 -113.46 149.04 40.94 Favored Pre-proline 0 N--CA 1.475 0.791 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 172.338 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 266' ' ' PRO . . . . . 0.508 ' HB2' ' HB3' ' A' ' 277' ' ' ARG . 56.8 Cg_endo -69.06 97.41 0.57 Allowed 'Trans proline' 0 C--N 1.372 1.765 0 C-N-CA 122.275 1.984 . . . . 0.0 111.892 175.478 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.01 119.25 13.01 Favored 'General case' 0 C--N 1.35 0.603 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 171.501 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 24.6 ttpt -95.73 109.09 21.44 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 121.652 0.739 . . . . 0.0 111.133 -178.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 2.8 mp -100.51 143.86 13.42 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 C-N-CA 125.083 1.353 . . . . 0.0 108.118 176.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 37.2 ttp180 -106.15 95.88 6.08 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 123.315 0.646 . . . . 0.0 109.94 178.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 271' ' ' CYS . . . . . 0.546 ' SG ' HD21 ' A' ' 297' ' ' LEU . 44.6 t -71.92 178.82 3.5 Favored 'General case' 0 C--O 1.245 0.827 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.827 170.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -59.5 -31.35 69.28 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.523 0.729 . . . . 0.0 111.995 177.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -147.38 14.71 1.12 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 122.843 0.457 . . . . 0.0 112.187 -177.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -137.31 129.58 29.52 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 122.806 0.443 . . . . 0.0 110.556 -174.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 24.1 mt -95.5 90.86 5.91 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 164.031 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 58.6 t -82.48 122.7 37.49 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.861 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.163 -175.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 277' ' ' ARG . . . . . 0.508 ' HB3' ' HB2' ' A' ' 266' ' ' PRO . 77.0 mtm180 -116.13 75.54 0.96 Allowed 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.532 HD11 HG12 ' A' ' 289' ' ' VAL . 4.6 pp -85.58 147.66 47.11 Favored Pre-proline 0 N--CA 1.483 1.204 0 CA-C-O 119.527 -0.273 . . . . 0.0 110.826 -172.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -69.17 118.48 5.7 Favored 'Trans proline' 0 C--N 1.374 1.92 0 C-N-CA 122.112 1.875 . . . . 0.0 110.719 175.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.73 HD21 ' HG3' ' A' ' 319' ' ' PRO . 0.8 OUTLIER -143.24 147.89 35.55 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.861 0.864 . . . . 0.0 110.242 -178.537 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 25.5 mmm180 -96.97 143.57 27.71 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.236 1.015 . . . . 0.0 109.045 174.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 282' ' ' MET . . . . . 0.431 ' HA ' ' HG2' ' A' ' 319' ' ' PRO . 44.1 mtp -61.06 -39.57 90.37 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 122.839 0.456 . . . . 0.0 111.813 -177.078 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 53.7 m -67.44 -25.37 65.88 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.6 0.76 . . . . 0.0 111.584 178.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -77.67 126.08 84.91 Favored Pre-proline 0 CA--C 1.546 0.797 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 173.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 285' ' ' PRO . . . . . 0.558 ' HA ' ' HA ' ' A' ' 318' ' ' THR . 60.2 Cg_endo -66.51 174.81 5.83 Favored 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 122.421 2.081 . . . . 0.0 113.682 -176.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.461 ' O ' HG22 ' A' ' 289' ' ' VAL . 90.8 mt -65.74 -13.2 58.87 Favored 'General case' 0 C--O 1.21 -1.007 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.643 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 26.5 tp60 -55.24 -24.08 25.88 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.198 0.599 . . . . 0.0 111.589 177.003 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 288' ' ' SER . . . . . 0.543 ' HB2' HD12 ' A' ' 280' ' ' LEU . 22.3 m -68.67 -47.68 65.89 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.941 0.897 . . . . 0.0 111.221 174.308 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.532 HG12 HD11 ' A' ' 278' ' ' LEU . 13.8 m -69.92 -34.91 62.15 Favored 'Isoleucine or valine' 0 C--N 1.365 1.253 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 177.273 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 290' ' ' VAL . . . . . 0.559 HG13 ' HB ' ' A' ' 304' ' ' ILE . 54.0 t -63.77 -43.62 98.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 124.594 1.157 . . . . 0.0 110.733 179.501 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -63.27 -45.7 90.29 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 124.088 0.868 . . . . 0.0 110.065 -179.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 24.6 t60 -63.43 -49.53 73.35 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.211 178.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 293' ' ' MET . . . . . 0.455 ' HG2' ' O ' ' A' ' 289' ' ' VAL . 85.5 mmm -68.19 -33.03 73.68 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 123.669 0.606 . . . . 0.0 111.057 -175.022 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -65.58 -47.16 76.71 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.373 0.669 . . . . 0.0 110.327 176.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 29.3 m -64.44 -38.23 90.29 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 123.403 0.681 . . . . 0.0 111.104 177.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 78.9 t60 -67.0 -39.24 87.05 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.341 1.056 . . . . 0.0 111.047 -178.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 297' ' ' LEU . . . . . 0.546 HD21 ' SG ' ' A' ' 271' ' ' CYS . 40.8 mt -95.93 -3.63 44.88 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.845 0.858 . . . . 0.0 111.416 -178.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 71.65 14.33 75.14 Favored Glycine 0 N--CA 1.476 1.333 0 C-N-CA 123.075 0.369 . . . . 0.0 113.769 177.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 299' ' ' VAL . . . . . 0.481 HG11 HG11 ' A' ' 334' ' ' VAL . 33.0 m -101.91 173.41 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.042 0.937 . . . . 0.0 110.624 -178.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 300' ' ' SER . . . . . 0.443 ' HB2' ' HG3' ' A' ' 303' ' ' ARG . 16.5 m -79.97 151.59 73.46 Favored Pre-proline 0 CA--C 1.555 1.162 0 C-N-CA 123.141 0.576 . . . . 0.0 110.042 178.511 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -56.08 -29.11 73.07 Favored 'Trans proline' 0 C--N 1.385 2.459 0 C-N-CA 123.193 2.595 . . . . 0.0 113.216 177.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 302' ' ' SER . . . . . 0.436 ' O ' ' HB2' ' A' ' 338' ' ' SER . 33.5 t -69.31 -18.71 63.85 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.633 0.373 . . . . 0.0 111.212 -179.309 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 303' ' ' ARG . . . . . 0.443 ' HG3' ' HB2' ' A' ' 300' ' ' SER . 52.1 mtt-85 -90.17 -12.91 36.79 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.246 0.618 . . . . 0.0 111.811 -174.103 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 304' ' ' ILE . . . . . 0.559 ' HB ' HG13 ' A' ' 290' ' ' VAL . 49.7 mm -86.77 117.59 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 122.944 0.498 . . . . 0.0 110.233 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 40.3 tp -114.02 120.08 39.37 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.665 0.786 . . . . 0.0 109.205 174.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 306' ' ' LEU . . . . . 0.421 HD21 HG22 ' A' ' 290' ' ' VAL . 2.8 mm? -91.36 136.74 32.89 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 177.182 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 307' ' ' LEU . . . . . 0.498 HD23 ' HA ' ' A' ' 312' ' ' GLU . 75.5 mt -134.28 106.96 7.38 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.602 0.761 . . . . 0.0 109.471 -177.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 308' ' ' PHE . . . . . 0.553 ' HB2' HD11 ' A' ' 313' ' ' LEU . 44.8 t80 -85.84 90.28 8.01 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -178.336 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 64.94 -88.89 0.09 OUTLIER Glycine 0 C--N 1.349 1.289 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.818 -178.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -129.9 70.26 1.43 Allowed 'General case' 0 C--O 1.242 0.705 0 C-N-CA 124.191 0.996 . . . . 0.0 109.667 176.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 10.0 t -169.23 150.87 4.45 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.691 0.796 . . . . 0.0 109.533 170.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 312' ' ' GLU . . . . . 0.498 ' HA ' HD23 ' A' ' 307' ' ' LEU . 36.3 tt0 -92.97 134.48 35.07 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 177.469 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.553 HD11 ' HB2' ' A' ' 308' ' ' PHE . 49.7 mt -117.52 149.7 40.18 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.014 0.526 . . . . 0.0 110.551 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 50.9 m -108.24 149.88 39.8 Favored Pre-proline 0 CA--C 1.551 1.016 0 C-N-CA 123.688 0.795 . . . . 0.0 110.472 179.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 315' ' ' PRO . . . . . 0.515 ' HB3' HG21 ' A' ' 290' ' ' VAL . 12.1 Cg_endo -56.14 -39.94 88.03 Favored 'Trans proline' 0 C--N 1.383 2.349 0 C-N-CA 123.325 2.684 . . . . 0.0 112.639 173.013 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 41.7 p -75.5 -18.23 59.88 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.22 0.608 . . . . 0.0 112.182 -177.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -74.27 142.61 45.26 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.102 0.561 . . . . 0.0 109.493 174.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 318' ' ' THR . . . . . 0.558 ' HA ' ' HA ' ' A' ' 285' ' ' PRO . 75.5 p -98.28 146.27 31.25 Favored Pre-proline 0 N--CA 1.473 0.71 0 C-N-CA 122.977 0.511 . . . . 0.0 110.533 -176.523 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 319' ' ' PRO . . . . . 0.73 ' HG3' HD21 ' A' ' 280' ' ' LEU . 31.6 Cg_endo -62.07 -14.33 36.96 Favored 'Trans proline' 0 C--N 1.365 1.418 0 C-N-CA 122.903 2.402 . . . . 0.0 111.962 168.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 43.6 ttt85 -61.55 -58.21 9.03 Favored 'General case' 0 C--N 1.352 0.711 0 C-N-CA 123.505 0.722 . . . . 0.0 110.761 172.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 10.1 t -66.83 -32.36 73.59 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 122.544 0.338 . . . . 0.0 111.461 -178.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 322' ' ' LEU . . . . . . . . . . . . . 47.7 mt -77.95 -20.66 52.31 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.311 0.644 . . . . 0.0 111.21 177.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 20.7 tptm 55.14 63.19 2.19 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.397 1.479 . . . . 0.0 110.914 -174.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 76.4 mt -90.25 170.05 10.6 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.04 178.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 325' ' ' GLY . . . . . 0.468 ' H ' ' HB2' ' A' ' 328' ' ' ASP . . . -162.54 -161.14 11.78 Favored Glycine 0 C--N 1.339 0.729 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.047 -171.135 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 31.5 m -76.89 -19.75 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 123.633 0.773 . . . . 0.0 111.872 -176.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -111.52 -17.34 13.09 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.833 0.853 . . . . 0.0 111.424 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 328' ' ' ASP . . . . . 0.468 ' HB2' ' H ' ' A' ' 325' ' ' GLY . 49.0 m-20 -75.71 101.05 4.88 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 177.181 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 46.1 mt -95.29 134.54 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 123.567 0.747 . . . . 0.0 110.404 -175.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 37.4 pt -121.97 127.23 75.3 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.929 0 C-N-CA 123.568 0.747 . . . . 0.0 110.114 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 331' ' ' ASP . . . . . 0.418 ' O ' ' HA ' ' A' ' 306' ' ' LEU . 5.1 m-20 -74.46 126.99 31.93 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.042 0.937 . . . . 0.0 111.778 -175.067 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 332' ' ' CYS . . . . . 0.475 ' SG ' HD12 ' A' ' 304' ' ' ILE . 52.5 t -93.76 93.41 7.97 Favored 'General case' 0 C--O 1.244 0.794 0 C-N-CA 123.983 0.913 . . . . 0.0 109.74 175.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 71.8 t -100.42 122.47 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 123.53 0.732 . . . . 0.0 109.573 177.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 334' ' ' VAL . . . . . 0.481 HG11 HG11 ' A' ' 299' ' ' VAL . 94.0 t -87.78 112.92 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 122.906 0.482 . . . . 0.0 110.265 177.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 84.0 mt -103.8 159.81 15.32 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.069 0.948 . . . . 0.0 109.093 171.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 336' ' ' THR . . . . . . . . . . . . . 32.4 p -78.2 88.01 4.28 Favored 'General case' 0 CA--C 1.55 0.964 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 176.031 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 22.9 m 74.12 157.78 0.2 Allowed 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 125.65 1.58 . . . . 0.0 111.794 -177.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 338' ' ' SER . . . . . 0.436 ' HB2' ' O ' ' A' ' 302' ' ' SER . 24.7 t . . . . . 0 CA--C 1.549 0.916 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 173.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 . . . . . 0 N--CA 1.472 0.637 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -85.16 57.55 4.97 Favored Glycine 0 C--N 1.353 1.517 0 O-C-N 123.638 0.586 . . . . 0.0 112.446 178.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -85.33 6.29 27.01 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.04 0.936 . . . . 0.0 112.487 -175.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -72.61 81.9 1.11 Allowed 'General case' 0 CA--C 1.55 0.949 0 CA-C-O 121.623 0.725 . . . . 0.0 110.29 -177.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -132.77 70.28 1.47 Allowed 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 179.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -167.67 156.46 9.59 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 114.383 -1.28 . . . . 0.0 108.191 -171.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 28.4 m -81.79 42.3 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.563 1.443 0 C-N-CA 123.797 0.839 . . . . 0.0 111.563 178.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 6.4 p -79.4 91.05 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.074 0 C-N-CA 124.768 1.227 . . . . 0.0 110.237 -176.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 6.5 tt -84.58 83.73 7.91 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.292 -178.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 10.0 p -167.99 129.7 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.162 0 C-N-CA 124.329 1.052 . . . . 0.0 109.203 173.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -146.2 128.92 16.21 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.969 0.907 . . . . 0.0 109.058 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 55.49 63.59 5.15 Favored Glycine 0 CA--C 1.535 1.335 0 O-C-N 124.116 0.885 . . . . 0.0 112.496 -176.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -76.15 72.49 5.32 Favored 'Trans proline' 0 C--N 1.378 2.117 0 C-N-CA 123.082 2.522 . . . . 0.0 110.692 -177.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 17.4 m 68.99 156.21 0.13 Allowed 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 125.122 1.369 . . . . 0.0 109.991 -165.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 89.6 mt -107.94 92.56 9.31 Favored Pre-proline 0 N--CA 1.477 0.891 0 O-C-N 121.657 -0.652 . . . . 0.0 109.515 173.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.5 -17.49 34.19 Favored 'Trans proline' 0 C--N 1.379 2.179 0 C-N-CA 122.547 2.165 . . . . 0.0 111.25 169.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -112.48 104.12 12.23 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 125.282 1.433 . . . . 0.0 108.153 177.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 12.3 p -81.42 145.65 55.82 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 122.867 0.467 . . . . 0.0 110.591 176.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -63.67 117.56 4.53 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 122.439 2.093 . . . . 0.0 110.257 173.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 74.7 mtt180 -56.44 125.75 23.39 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.591 1.156 . . . . 0.0 112.167 -165.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 3.4 mp -103.17 130.71 50.45 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.12 -174.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -106.56 147.6 35.27 Favored Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 123.839 0.856 . . . . 0.0 109.111 176.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -63.84 95.58 0.2 Allowed 'Trans proline' 0 C--N 1.376 1.988 0 C-N-CA 122.478 2.118 . . . . 0.0 111.812 172.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 267' ' ' LEU . . . . . 0.466 HD12 HG13 ' A' ' 269' ' ' ILE . 1.5 tm? -62.89 130.59 45.5 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 173.174 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.549 ' HG2' HG12 ' A' ' 329' ' ' ILE . 3.8 tppp? -94.51 107.39 19.37 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 123.539 0.736 . . . . 0.0 110.244 -177.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 269' ' ' ILE . . . . . 0.466 HG13 HD12 ' A' ' 267' ' ' LEU . 2.1 mp -106.56 131.96 55.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 175.23 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 270' ' ' ARG . . . . . 0.429 ' HB2' ' CG2' ' A' ' 329' ' ' ILE . 26.4 ttm180 -91.63 111.38 22.88 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 171.21 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 271' ' ' CYS . . . . . 0.604 ' SG ' HD21 ' A' ' 297' ' ' LEU . 16.5 t -75.53 -166.69 0.57 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 122.634 0.373 . . . . 0.0 110.222 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 272' ' ' ARG . . . . . 0.437 ' HG2' ' SG ' ' A' ' 271' ' ' CYS . 23.4 ptt180 -53.55 -27.76 27.88 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.354 1.062 . . . . 0.0 112.992 172.304 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -139.3 -63.49 0.52 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.019 0.528 . . . . 0.0 111.502 -177.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -107.48 163.44 13.05 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 123.692 0.797 . . . . 0.0 111.191 -170.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.533 HD13 ' HD2' ' A' ' 268' ' ' LYS . 96.0 mt -78.7 127.18 31.74 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 123.828 0.851 . . . . 0.0 111.898 -179.344 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 85.7 t -99.66 139.31 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 170.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 277' ' ' ARG . . . . . 0.448 ' HD3' ' HE2' ' A' ' 268' ' ' LYS . 62.9 mtm180 -128.19 122.49 31.97 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.794 0.838 . . . . 0.0 108.915 177.512 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 4.2 pp -131.08 139.65 36.19 Favored Pre-proline 0 N--CA 1.485 1.293 0 CA-C-O 119.379 -0.343 . . . . 0.0 110.52 177.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -70.77 107.62 2.09 Favored 'Trans proline' 0 C--N 1.382 2.313 0 C-N-CA 122.622 2.215 . . . . 0.0 110.618 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.706 HD21 ' HG3' ' A' ' 319' ' ' PRO . 0.1 OUTLIER -124.92 151.94 44.73 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.214 1.006 . . . . 0.0 110.274 -175.933 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 281' ' ' ARG . . . . . 0.566 ' HB2' ' HB2' ' A' ' 284' ' ' GLU . 58.5 mtm180 -89.97 153.82 20.31 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.973 0.909 . . . . 0.0 109.688 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 282' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -66.54 -44.55 82.08 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 122.572 0.349 . . . . 0.0 110.591 178.472 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 49.9 m -70.39 -20.3 62.95 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.39 0.676 . . . . 0.0 112.061 178.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 284' ' ' GLU . . . . . 0.566 ' HB2' ' HB2' ' A' ' 281' ' ' ARG . 6.7 tp10 -65.57 126.34 91.39 Favored Pre-proline 0 CA--C 1.542 0.639 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 176.191 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -65.06 168.25 14.32 Favored 'Trans proline' 0 C--N 1.368 1.595 0 C-N-CA 121.98 1.786 . . . . 0.0 111.707 172.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.425 ' O ' HG23 ' A' ' 290' ' ' VAL . 62.6 mt -64.95 -15.43 62.15 Favored 'General case' 0 C--O 1.214 -0.809 0 CA-C-O 118.837 -0.601 . . . . 0.0 111.263 -178.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 287' ' ' GLN . . . . . 0.462 ' HA ' ' HB ' ' A' ' 290' ' ' VAL . 24.0 tp60 -52.25 -23.54 5.86 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 123.71 0.804 . . . . 0.0 112.402 178.454 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 288' ' ' SER . . . . . 0.504 ' HB3' HD12 ' A' ' 280' ' ' LEU . 37.9 t -58.61 -60.95 3.0 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.337 0.655 . . . . 0.0 110.69 168.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 15.2 m -68.98 -29.82 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 122.821 0.448 . . . . 0.0 111.065 -178.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 290' ' ' VAL . . . . . 0.477 HG13 ' HB ' ' A' ' 304' ' ' ILE . 76.4 t -66.46 -51.85 53.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 123.782 0.833 . . . . 0.0 109.974 -178.639 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -70.18 -37.95 75.28 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.815 0.846 . . . . 0.0 111.017 -178.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 13.1 t60 -66.04 -50.65 63.43 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.033 0.533 . . . . 0.0 110.142 -178.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 293' ' ' MET . . . . . 0.413 ' HG3' HG21 ' A' ' 269' ' ' ILE . 94.6 mmm -63.68 -37.3 86.82 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 123.8 0.687 . . . . 0.0 110.784 178.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -61.48 -51.27 69.36 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 123.847 0.717 . . . . 0.0 111.591 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 9.8 m -68.22 -30.84 70.0 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 123.186 0.595 . . . . 0.0 110.838 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -71.45 -35.39 70.88 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.577 0.751 . . . . 0.0 111.26 178.064 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 297' ' ' LEU . . . . . 0.604 HD21 ' SG ' ' A' ' 271' ' ' CYS . 95.9 mt -96.14 -10.62 27.79 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.745 0.818 . . . . 0.0 112.007 -177.407 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 80.29 16.84 75.37 Favored Glycine 0 CA--C 1.534 1.227 0 O-C-N 123.379 0.424 . . . . 0.0 113.485 178.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 299' ' ' VAL . . . . . 0.483 HG11 HG11 ' A' ' 334' ' ' VAL . 28.7 m -109.17 173.92 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 124.08 0.952 . . . . 0.0 111.003 178.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 22.8 m -80.07 147.32 65.2 Favored Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 123.306 0.643 . . . . 0.0 110.724 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.09 -23.49 73.56 Favored 'Trans proline' 0 C--N 1.383 2.394 0 C-N-CA 122.72 2.28 . . . . 0.0 112.334 170.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 48.6 p -69.95 -15.41 63.04 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-O 121.041 0.448 . . . . 0.0 111.574 176.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 303' ' ' ARG . . . . . 0.69 ' HG2' ' HA ' ' A' ' 336' ' ' THR . 94.3 mtt180 -102.98 -15.56 16.08 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.106 0.962 . . . . 0.0 111.824 -175.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 304' ' ' ILE . . . . . 0.58 HD12 ' SG ' ' A' ' 332' ' ' CYS . 36.2 mm -83.84 110.06 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 176.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 37.5 tp -114.08 114.93 26.77 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.614 0.766 . . . . 0.0 109.362 178.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 306' ' ' LEU . . . . . 0.476 ' HG ' HD12 ' A' ' 330' ' ' ILE . 3.2 mm? -86.99 124.14 32.85 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 307' ' ' LEU . . . . . 0.433 HD12 HG21 ' A' ' 333' ' ' VAL . 41.3 mt -133.88 108.86 8.68 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 308' ' ' PHE . . . . . 0.484 ' HB2' HG22 ' A' ' 330' ' ' ILE . 71.0 t80 -75.67 86.82 2.72 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 174.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 68.17 -84.99 0.17 Allowed Glycine 0 C--N 1.349 1.257 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.963 -179.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -133.66 75.24 1.59 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.319 1.048 . . . . 0.0 109.11 177.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 15.2 t -159.1 151.75 21.72 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.318 1.047 . . . . 0.0 108.309 171.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -104.13 114.41 28.63 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 122.856 0.462 . . . . 0.0 109.868 -176.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 30.1 mt -117.88 142.78 46.94 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.199 0.6 . . . . 0.0 109.92 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 60.7 m -109.31 159.49 31.13 Favored Pre-proline 0 CA--C 1.556 1.203 0 C-N-CA 123.808 0.843 . . . . 0.0 110.952 -178.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_exo -56.86 -32.07 90.93 Favored 'Trans proline' 0 C--N 1.39 2.739 0 C-N-CA 123.202 2.601 . . . . 0.0 112.573 172.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 45.7 p -70.65 -29.6 65.99 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 114.922 -1.035 . . . . 0.0 111.715 -179.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -68.02 138.24 55.7 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.628 0.771 . . . . 0.0 110.706 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 318' ' ' THR . . . . . . . . . . . . . 71.2 p -98.49 140.23 21.68 Favored Pre-proline 0 CA--C 1.543 0.702 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 178.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 319' ' ' PRO . . . . . 0.706 ' HG3' HD21 ' A' ' 280' ' ' LEU . 19.8 Cg_endo -55.2 -17.12 14.41 Favored 'Trans proline' 0 C--N 1.367 1.512 0 C-N-CA 123.529 2.819 . . . . 0.0 112.878 171.224 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 50.5 ttt-85 -67.43 -55.85 12.02 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.441 0.696 . . . . 0.0 110.395 172.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 13.7 t -71.32 -22.01 61.99 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.633 0.373 . . . . 0.0 111.427 -177.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 322' ' ' LEU . . . . . 0.469 ' HB2' ' HG ' ' A' ' 324' ' ' LEU . 58.2 mt -90.9 -16.63 27.83 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.412 0.685 . . . . 0.0 110.996 177.365 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 19.7 tptm 65.45 32.31 9.65 Favored 'General case' 0 CA--C 1.562 1.416 0 C-N-CA 124.962 1.305 . . . . 0.0 111.408 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.469 ' HG ' ' HB2' ' A' ' 322' ' ' LEU . 33.8 mt -69.8 172.5 7.54 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 123.605 0.762 . . . . 0.0 111.175 178.204 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 325' ' ' GLY . . . . . 0.445 ' H ' ' HB3' ' A' ' 328' ' ' ASP . . . -167.9 -164.64 23.93 Favored Glycine 0 C--N 1.347 1.152 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.942 -177.167 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 33.1 m -73.6 -28.81 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 124.168 0.987 . . . . 0.0 111.578 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -88.35 -25.86 22.52 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.533 0.733 . . . . 0.0 111.053 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 328' ' ' ASP . . . . . 0.445 ' HB3' ' H ' ' A' ' 325' ' ' GLY . 12.9 t70 -76.87 130.46 37.62 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.077 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 329' ' ' ILE . . . . . 0.549 HG12 ' HG2' ' A' ' 268' ' ' LYS . 5.9 mt -121.87 99.63 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 122.984 0.513 . . . . 0.0 110.605 -171.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 330' ' ' ILE . . . . . 0.484 HG22 ' HB2' ' A' ' 308' ' ' PHE . 25.0 pt -87.54 126.78 41.17 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 C-N-CA 122.679 0.392 . . . . 0.0 111.086 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -79.05 118.33 20.93 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.552 0.741 . . . . 0.0 110.588 -175.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 332' ' ' CYS . . . . . 0.58 ' SG ' HD12 ' A' ' 304' ' ' ILE . 43.2 t -78.04 90.1 4.2 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.439 1.096 . . . . 0.0 110.191 176.535 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 333' ' ' VAL . . . . . 0.433 HG21 HD12 ' A' ' 307' ' ' LEU . 74.0 t -94.75 110.68 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 123.322 0.649 . . . . 0.0 109.355 -177.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 334' ' ' VAL . . . . . 0.483 HG11 HG11 ' A' ' 299' ' ' VAL . 62.0 t -81.42 94.53 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 CA-C-O 121.319 0.58 . . . . 0.0 110.014 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 60.3 mt -98.57 -146.58 0.32 Allowed 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.536 1.134 . . . . 0.0 108.971 170.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 336' ' ' THR . . . . . 0.69 ' HA ' ' HG2' ' A' ' 303' ' ' ARG . 13.3 t -151.42 154.39 36.52 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.377 0.671 . . . . 0.0 109.621 171.262 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 27.4 t -135.4 144.2 46.41 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.038 0.535 . . . . 0.0 110.494 -174.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 48.3 t . . . . . 0 C--O 1.251 1.174 0 C-N-CA 123.88 0.872 . . . . 0.0 108.743 -179.997 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 . . . . . 0 N--CA 1.479 0.978 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -80.12 89.42 1.28 Allowed Glycine 0 C--N 1.346 1.094 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.101 -178.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -65.62 -22.77 66.7 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.174 0.59 . . . . 0.0 110.518 174.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -66.7 113.94 5.22 Favored 'General case' 0 CA--C 1.552 1.044 0 O-C-N 123.683 0.614 . . . . 0.0 109.727 171.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -83.65 -27.27 29.22 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.798 0.839 . . . . 0.0 110.255 177.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -52.34 125.29 15.6 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.463 1.105 . . . . 0.0 112.752 -175.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 51.1 t -70.82 118.46 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 123.068 0.547 . . . . 0.0 109.956 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 251' ' ' VAL . . . . . 0.414 HG12 HG22 ' A' ' 253' ' ' VAL . 15.2 t -101.67 65.63 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 123.956 0.903 . . . . 0.0 108.661 179.312 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 55.3 tp -77.33 87.46 3.73 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.514 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.414 HG22 HG12 ' A' ' 251' ' ' VAL . 4.5 m -140.3 103.29 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 124.454 1.102 . . . . 0.0 108.575 177.056 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -72.52 91.92 1.44 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.602 0.761 . . . . 0.0 109.871 -177.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -174.29 -69.43 0.05 OUTLIER Glycine 0 CA--C 1.529 0.929 0 CA-C-N 115.109 -0.951 . . . . 0.0 111.09 -176.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -77.39 -156.32 0.06 OUTLIER 'Trans proline' 0 C--N 1.376 2.022 0 C-N-CA 123.161 2.574 . . . . 0.0 111.315 173.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 21.1 m -63.05 135.29 57.17 Favored 'General case' 0 C--N 1.358 0.951 0 C-N-CA 122.666 0.387 . . . . 0.0 110.163 176.004 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 86.0 mt -109.53 89.5 7.48 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 123.662 0.785 . . . . 0.0 109.98 178.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -74.2 -26.94 12.12 Favored 'Trans proline' 0 C--N 1.379 2.15 0 C-N-CA 123.115 2.543 . . . . 0.0 113.476 -175.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.56 96.17 2.91 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-O 122.044 0.926 . . . . 0.0 109.47 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 41.2 m -76.09 133.71 71.91 Favored Pre-proline 0 CA--C 1.552 1.05 0 CA-C-N 115.133 -0.939 . . . . 0.0 110.013 -178.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -54.32 147.06 47.8 Favored 'Trans proline' 0 C--N 1.388 2.608 0 C-N-CA 123.003 2.469 . . . . 0.0 112.263 172.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -62.83 108.47 1.19 Allowed 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.287 1.035 . . . . 0.0 112.017 -170.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 2.9 mp -86.22 140.06 30.48 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 174.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 265' ' ' PHE . . . . . 0.476 ' CE1' ' HG2' ' A' ' 282' ' ' MET . 28.0 p90 -109.32 146.15 33.33 Favored Pre-proline 0 CA--C 1.55 0.948 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 176.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -64.19 98.65 0.27 Allowed 'Trans proline' 0 C--N 1.378 2.091 0 C-N-CA 122.573 2.182 . . . . 0.0 111.904 171.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 267' ' ' LEU . . . . . 0.528 HD12 HG13 ' A' ' 269' ' ' ILE . 1.2 tm? -61.8 130.43 45.7 Favored 'General case' 0 C--O 1.244 0.8 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 172.119 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -94.55 104.43 16.38 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 269' ' ' ILE . . . . . 0.528 HG13 HD12 ' A' ' 267' ' ' LEU . 2.9 mp -97.86 133.81 38.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 123.334 0.653 . . . . 0.0 109.257 176.384 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 270' ' ' ARG . . . . . 0.584 ' HB3' ' HA ' ' A' ' 331' ' ' ASP . 5.4 tpm_? -85.16 106.47 16.63 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 170.53 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 271' ' ' CYS . . . . . 0.479 ' SG ' HD21 ' A' ' 297' ' ' LEU . 41.8 t -74.28 176.8 6.33 Favored 'General case' 0 C--O 1.247 0.935 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 170.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -51.1 -36.11 38.63 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.235 1.014 . . . . 0.0 112.756 -178.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -156.62 22.9 0.34 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.179 0.592 . . . . 0.0 111.608 178.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -146.97 179.99 7.21 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 178.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.524 HD23 ' HA ' ' A' ' 270' ' ' ARG . 91.5 mt -121.11 126.3 49.41 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.018 0.927 . . . . 0.0 109.729 174.662 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 97.7 t -100.01 141.7 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 124.121 0.969 . . . . 0.0 108.522 174.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 39.4 mtt180 -128.5 122.74 31.86 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 178.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.468 HD11 HG12 ' A' ' 289' ' ' VAL . 4.2 pp -134.86 143.32 45.78 Favored Pre-proline 0 N--CA 1.491 1.587 0 CA-C-N 118.139 0.427 . . . . 0.0 110.925 176.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.33 120.28 6.86 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 122.498 2.132 . . . . 0.0 110.865 175.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.665 HD21 ' HG3' ' A' ' 319' ' ' PRO . 0.0 OUTLIER -141.96 145.87 34.99 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.828 0.851 . . . . 0.0 109.932 -177.15 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 281' ' ' ARG . . . . . 0.416 ' HB2' ' HB2' ' A' ' 284' ' ' GLU . 48.5 mtt85 -79.35 147.71 32.31 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.835 0.854 . . . . 0.0 108.729 176.455 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 282' ' ' MET . . . . . 0.476 ' HG2' ' CE1' ' A' ' 265' ' ' PHE . 26.8 mtp -66.62 -32.03 73.1 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 118.292 0.497 . . . . 0.0 109.878 174.434 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 38.8 p -72.06 -29.19 63.89 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.716 1.207 . . . . 0.0 112.007 178.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 284' ' ' GLU . . . . . 0.458 ' O ' ' HD2' ' A' ' 319' ' ' PRO . 18.5 tp10 -66.46 129.85 94.15 Favored Pre-proline 0 N--CA 1.474 0.772 0 C-N-CA 124.282 1.033 . . . . 0.0 109.269 177.369 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -65.07 166.5 18.54 Favored 'Trans proline' 0 C--N 1.377 2.037 0 C-N-CA 122.012 1.808 . . . . 0.0 111.567 174.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.431 ' O ' HG23 ' A' ' 290' ' ' VAL . 71.7 mt -65.59 -11.63 45.91 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 118.65 -0.691 . . . . 0.0 112.292 -177.143 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 287' ' ' GLN . . . . . 0.433 ' HA ' ' HB ' ' A' ' 290' ' ' VAL . 7.1 tp-100 -55.62 -22.06 20.66 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.167 0.587 . . . . 0.0 112.013 178.235 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 288' ' ' SER . . . . . 0.476 ' HB3' HD12 ' A' ' 280' ' ' LEU . 33.5 t -60.34 -57.11 14.16 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 123.292 0.637 . . . . 0.0 110.566 170.021 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.468 HG12 HD11 ' A' ' 278' ' ' LEU . 18.1 m -71.83 -28.73 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 122.725 0.41 . . . . 0.0 111.531 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 290' ' ' VAL . . . . . 0.532 HG13 ' HB ' ' A' ' 304' ' ' ILE . 73.3 t -67.03 -51.12 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.809 0.844 . . . . 0.0 110.333 -179.151 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -69.8 -36.58 75.8 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.428 0.691 . . . . 0.0 111.44 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -66.21 -48.65 69.92 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.325 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 293' ' ' MET . . . . . 0.445 ' HG3' HG21 ' A' ' 269' ' ' ILE . 94.0 mmm -67.7 -29.17 68.36 Favored 'General case' 0 N--CA 1.479 0.976 0 O-C-N 123.918 0.761 . . . . 0.0 110.958 178.647 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -61.44 -49.5 76.59 Favored 'General case' 0 C--O 1.219 -0.516 0 O-C-N 123.65 0.594 . . . . 0.0 110.657 174.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 33.0 m -70.68 -31.81 68.83 Favored 'General case' 0 CA--C 1.549 0.909 0 O-C-N 123.512 0.508 . . . . 0.0 111.045 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 80.8 t60 -69.22 -35.49 76.23 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 123.733 0.813 . . . . 0.0 111.034 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 297' ' ' LEU . . . . . 0.479 HD21 ' SG ' ' A' ' 271' ' ' CYS . 67.7 mt -101.38 -4.07 27.61 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 124.052 0.941 . . . . 0.0 111.339 -179.556 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 78.63 12.08 84.6 Favored Glycine 0 C--N 1.351 1.398 0 C-N-CA 123.481 0.563 . . . . 0.0 114.073 173.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 299' ' ' VAL . . . . . 0.473 HG11 HG11 ' A' ' 334' ' ' VAL . 33.9 m -106.1 -176.53 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 124.266 1.026 . . . . 0.0 111.293 -178.002 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 42.7 m -84.29 148.29 52.46 Favored Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 123.749 0.82 . . . . 0.0 110.327 177.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -57.27 -30.58 88.06 Favored 'Trans proline' 0 C--N 1.379 2.166 0 C-N-CA 123.357 2.705 . . . . 0.0 112.144 172.328 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 20.4 m -70.5 -12.02 61.3 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 123.26 0.624 . . . . 0.0 112.006 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 75.8 mtt180 -95.94 -24.17 16.53 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.142 0.977 . . . . 0.0 110.923 176.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 304' ' ' ILE . . . . . 0.549 HD12 ' SG ' ' A' ' 332' ' ' CYS . 34.5 mm -78.45 122.9 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 123.016 0.526 . . . . 0.0 110.499 -178.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 36.8 tp -126.2 116.36 21.19 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.822 0.849 . . . . 0.0 109.033 177.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -85.06 135.06 34.16 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 177.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 74.3 mt -134.17 115.21 13.94 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.299 1.04 . . . . 0.0 109.208 -176.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -83.77 88.08 7.08 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 174.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 74.88 -81.87 0.87 Allowed Glycine 0 C--N 1.35 1.336 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.856 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -118.32 -32.13 4.75 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.07 0.948 . . . . 0.0 110.403 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 6.0 t -74.6 141.68 44.69 Favored 'General case' 0 C--O 1.245 0.859 0 CA-C-O 121.016 0.436 . . . . 0.0 110.249 -170.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -93.45 116.9 29.44 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.73 -175.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.442 HD13 HD13 ' A' ' 322' ' ' LEU . 47.2 mt -95.67 164.87 12.59 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.784 0.434 . . . . 0.0 110.17 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 49.8 m -123.1 147.47 51.82 Favored Pre-proline 0 N--CA 1.479 1.015 0 C-N-CA 123.436 0.694 . . . . 0.0 109.734 -178.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -55.83 -29.02 70.36 Favored 'Trans proline' 0 C--N 1.383 2.36 0 C-N-CA 122.976 2.451 . . . . 0.0 113.036 173.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 29.4 p -76.01 -29.53 58.17 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.621 0.768 . . . . 0.0 111.837 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -65.6 143.5 57.57 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.141 0.576 . . . . 0.0 110.747 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 318' ' ' THR . . . . . . . . . . . . . 78.0 p -100.32 141.21 22.29 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 122.903 0.481 . . . . 0.0 110.408 -178.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 319' ' ' PRO . . . . . 0.665 ' HG3' HD21 ' A' ' 280' ' ' LEU . 19.2 Cg_endo -55.92 -16.89 17.21 Favored 'Trans proline' 0 C--N 1.37 1.708 0 C-N-CA 123.789 2.993 . . . . 0.0 113.48 171.233 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 53.0 ttt180 -67.66 -54.9 15.78 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 122.836 0.454 . . . . 0.0 110.346 175.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 13.7 t -71.09 -21.93 62.16 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 122.844 0.458 . . . . 0.0 111.97 -177.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 322' ' ' LEU . . . . . 0.442 HD13 HD13 ' A' ' 313' ' ' LEU . 53.8 mt -88.87 -18.92 26.59 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.648 0.779 . . . . 0.0 111.161 176.528 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 20.9 tptm 56.63 53.02 8.89 Favored 'General case' 0 CA--C 1.56 1.351 0 C-N-CA 125.044 1.337 . . . . 0.0 110.842 -175.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.425 HD12 ' HB3' ' A' ' 319' ' ' PRO . 61.5 mt -79.71 164.84 23.41 Favored 'General case' 0 C--O 1.246 0.9 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.375 173.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 325' ' ' GLY . . . . . 0.433 ' H ' ' HB3' ' A' ' 328' ' ' ASP . . . -160.08 -175.84 31.5 Favored Glycine 0 C--N 1.34 0.801 0 CA-C-N 116.372 -0.376 . . . . 0.0 113.087 -173.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 35.2 m -70.21 -28.93 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.119 0.968 . . . . 0.0 111.046 176.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -105.74 15.26 27.07 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.595 1.158 . . . . 0.0 110.658 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 328' ' ' ASP . . . . . 0.433 ' HB3' ' H ' ' A' ' 325' ' ' GLY . 10.9 t70 -123.8 124.81 43.52 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 177.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 3.1 mt -113.37 146.38 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 O-C-N 123.708 0.63 . . . . 0.0 110.622 -169.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 24.1 pt -133.72 129.71 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 123.646 0.779 . . . . 0.0 110.944 179.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 331' ' ' ASP . . . . . 0.584 ' HA ' ' HB3' ' A' ' 270' ' ' ARG . 5.4 m-20 -74.56 114.43 12.96 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.75 1.22 . . . . 0.0 112.351 -173.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 332' ' ' CYS . . . . . 0.549 ' SG ' HD12 ' A' ' 304' ' ' ILE . 42.6 t -83.46 97.48 9.01 Favored 'General case' 0 C--O 1.243 0.729 0 C-N-CA 124.246 1.018 . . . . 0.0 110.136 173.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 89.0 t -102.1 122.5 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 123.747 0.819 . . . . 0.0 109.936 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 334' ' ' VAL . . . . . 0.473 HG11 HG11 ' A' ' 299' ' ' VAL . 90.2 t -85.62 102.93 11.99 Favored 'Isoleucine or valine' 0 C--O 1.242 0.683 0 C-N-CA 123.176 0.591 . . . . 0.0 109.514 175.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 81.1 mt -77.79 106.32 9.53 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 123.349 0.659 . . . . 0.0 109.753 171.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 336' ' ' THR . . . . . . . . . . . . . 33.2 p -82.39 81.42 8.24 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.684 178.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 43.5 m 60.01 82.16 0.16 Allowed 'General case' 0 CA--C 1.55 0.942 0 C-N-CA 124.754 1.221 . . . . 0.0 111.208 -177.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 47.0 t . . . . . 0 CA--C 1.554 1.124 0 C-N-CA 123.508 0.723 . . . . 0.0 109.517 179.224 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.488 1.44 0 N-CA-C 110.352 -0.24 . . . . 0.0 110.352 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 83.57 161.86 32.37 Favored Glycine 0 C--N 1.349 1.268 0 O-C-N 123.802 0.689 . . . . 0.0 112.058 -176.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -130.21 108.02 9.73 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.192 0.597 . . . . 0.0 109.883 179.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -124.31 31.71 5.7 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.243 1.017 . . . . 0.0 110.224 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -64.33 -18.58 64.76 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 123.748 0.819 . . . . 0.0 111.95 -173.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -54.78 104.63 0.12 Allowed 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.033 1.333 . . . . 0.0 109.878 177.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 16.0 m -122.63 117.29 51.5 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.999 0 C-N-CA 124.003 0.921 . . . . 0.0 109.791 178.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 35.8 m -77.16 -26.36 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 123.0 0.52 . . . . 0.0 110.147 176.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 89.7 mt -74.76 94.05 2.68 Favored 'General case' 0 C--N 1.347 0.461 0 C-N-CA 123.534 0.734 . . . . 0.0 109.423 173.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 7.3 p -146.65 133.85 14.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 176.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -118.38 175.08 5.88 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.35 0.66 . . . . 0.0 110.735 -176.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 157.39 79.94 0.03 OUTLIER Glycine 0 CA--C 1.524 0.622 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -173.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -69.69 159.98 51.44 Favored 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 122.863 2.376 . . . . 0.0 112.571 -176.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 39.1 m -58.96 139.7 56.42 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 123.582 0.753 . . . . 0.0 110.506 177.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 47.8 mt -109.1 85.39 3.28 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 123.902 0.881 . . . . 0.0 109.022 177.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -74.95 -19.24 18.16 Favored 'Trans proline' 0 C--N 1.383 2.374 0 C-N-CA 122.113 1.875 . . . . 0.0 111.565 176.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -91.34 135.69 33.64 Favored 'General case' 0 C--O 1.244 0.778 0 C-N-CA 124.13 0.972 . . . . 0.0 109.128 173.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 18.4 p -65.81 147.91 98.51 Favored Pre-proline 0 CA--C 1.549 0.925 0 O-C-N 123.728 0.643 . . . . 0.0 110.597 173.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -64.79 171.5 8.43 Favored 'Trans proline' 0 C--N 1.372 1.814 0 C-N-CA 123.041 2.494 . . . . 0.0 113.4 -178.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -76.78 80.99 3.38 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.696 176.219 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.408 HD13 ' HB2' ' A' ' 279' ' ' PRO . 0.4 OUTLIER -113.27 150.68 32.1 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.361 177.57 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 265' ' ' PHE . . . . . 0.527 ' CE1' ' SD ' ' A' ' 282' ' ' MET . 11.0 p90 -130.9 149.15 72.89 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 124.409 1.083 . . . . 0.0 108.942 -172.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 266' ' ' PRO . . . . . 0.524 ' HB2' ' HB3' ' A' ' 277' ' ' ARG . 45.7 Cg_endo -66.03 92.28 0.26 Allowed 'Trans proline' 0 C--N 1.369 1.656 0 C-N-CA 122.42 2.08 . . . . 0.0 112.086 173.133 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 267' ' ' LEU . . . . . 0.462 HD12 HG13 ' A' ' 269' ' ' ILE . 1.6 tm? -61.52 127.51 31.81 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 170.473 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.488 ' HG2' HG12 ' A' ' 329' ' ' ILE . 3.9 ttpt -91.08 111.65 23.21 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-O 121.5 0.666 . . . . 0.0 110.699 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 269' ' ' ILE . . . . . 0.494 HG21 ' HG3' ' A' ' 293' ' ' MET . 1.9 mp -106.81 133.59 50.94 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 C-N-CA 124.198 0.999 . . . . 0.0 108.306 176.467 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 270' ' ' ARG . . . . . 0.6 ' HB2' HG22 ' A' ' 329' ' ' ILE . 28.2 ttp180 -99.97 101.08 12.08 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 123.924 0.889 . . . . 0.0 109.997 178.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 271' ' ' CYS . . . . . 0.753 ' SG ' HD21 ' A' ' 297' ' ' LEU . 49.0 t -70.05 177.43 3.21 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.918 172.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 272' ' ' ARG . . . . . 0.538 ' HG2' ' SG ' ' A' ' 271' ' ' CYS . 38.8 ptt180 -43.14 -40.84 3.43 Favored 'General case' 0 CA--C 1.559 1.299 0 C-N-CA 125.372 1.469 . . . . 0.0 113.147 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -152.03 6.09 0.43 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.588 0.755 . . . . 0.0 111.31 174.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -115.57 158.09 23.15 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.449 1.1 . . . . 0.0 109.848 -174.199 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -119.76 117.87 29.36 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.533 0.733 . . . . 0.0 109.45 175.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 276' ' ' VAL . . . . . 0.418 HG21 ' SD ' ' A' ' 293' ' ' MET . 67.8 t -102.04 137.89 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.168 0.987 . . . . 0.0 108.452 171.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 277' ' ' ARG . . . . . 0.524 ' HB3' ' HB2' ' A' ' 266' ' ' PRO . 83.7 mtm180 -128.37 95.66 4.21 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 173.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.512 HD21 ' HA ' ' A' ' 289' ' ' VAL . 4.2 pp -109.74 142.45 25.82 Favored Pre-proline 0 N--CA 1.487 1.403 0 CA-C-O 119.39 -0.338 . . . . 0.0 110.868 -173.231 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 279' ' ' PRO . . . . . 0.408 ' HB2' HD13 ' A' ' 264' ' ' LEU . 73.4 Cg_endo -70.69 86.74 0.7 Allowed 'Trans proline' 0 C--N 1.383 2.361 0 C-N-CA 122.945 2.43 . . . . 0.0 112.279 -176.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.64 HD21 ' HG3' ' A' ' 319' ' ' PRO . 3.0 tt -95.94 144.43 26.26 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 114.768 -1.105 . . . . 0.0 109.502 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 281' ' ' ARG . . . . . 0.588 ' HB2' ' HB2' ' A' ' 284' ' ' GLU . 32.3 mtm180 -90.0 143.73 26.53 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.943 0.897 . . . . 0.0 110.415 178.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 282' ' ' MET . . . . . 0.527 ' SD ' ' CE1' ' A' ' 265' ' ' PHE . 87.2 mmm -64.18 -33.38 75.67 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 122.803 0.441 . . . . 0.0 111.621 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 35.6 t -86.94 -0.82 57.2 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.469 0.708 . . . . 0.0 111.524 178.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 284' ' ' GLU . . . . . 0.588 ' HB2' ' HB2' ' A' ' 281' ' ' ARG . 6.8 tp10 -91.33 134.82 29.01 Favored Pre-proline 0 CA--C 1.538 0.488 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 174.086 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.07 170.71 8.62 Favored 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 121.897 1.732 . . . . 0.0 111.683 170.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.419 ' O ' HG23 ' A' ' 290' ' ' VAL . 84.1 mt -67.53 -11.42 57.95 Favored 'General case' 0 C--O 1.219 -0.548 0 C-N-CA 123.153 0.581 . . . . 0.0 111.714 -178.14 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 287' ' ' GLN . . . . . 0.564 ' HA ' ' HB ' ' A' ' 290' ' ' VAL . 8.0 tp-100 -55.05 -20.66 10.07 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 123.136 0.574 . . . . 0.0 111.95 175.573 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 288' ' ' SER . . . . . 0.63 ' HB3' HD12 ' A' ' 280' ' ' LEU . 47.4 t -60.7 -54.62 43.04 Favored 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 123.011 0.524 . . . . 0.0 111.19 169.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.512 ' HA ' HD21 ' A' ' 278' ' ' LEU . 34.9 m -69.83 -35.56 65.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 CA-C-N 117.716 0.235 . . . . 0.0 110.974 177.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 290' ' ' VAL . . . . . 0.587 HG13 ' HB ' ' A' ' 304' ' ' ILE . 76.9 t -61.2 -41.9 91.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 123.995 0.918 . . . . 0.0 111.078 -179.364 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -69.88 -47.48 62.44 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.694 0.798 . . . . 0.0 110.837 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 292' ' ' HIS . . . . . 0.459 ' HB3' HD22 ' A' ' 278' ' ' LEU . 9.8 t60 -71.68 -36.64 70.67 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.135 -174.213 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 293' ' ' MET . . . . . 0.494 ' HG3' HG21 ' A' ' 269' ' ' ILE . 95.6 mmm -72.36 -29.88 64.2 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.367 0.667 . . . . 0.0 110.514 177.69 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -63.35 -44.7 94.09 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 123.776 0.673 . . . . 0.0 110.847 175.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 24.2 m -70.85 -31.38 68.06 Favored 'General case' 0 CA--C 1.552 1.026 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.052 176.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -71.66 -30.14 65.4 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.959 0.904 . . . . 0.0 111.709 179.159 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 297' ' ' LEU . . . . . 0.753 HD21 ' SG ' ' A' ' 271' ' ' CYS . 50.1 mt -107.73 -5.68 17.24 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 124.009 0.924 . . . . 0.0 111.892 -176.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 72.86 22.4 79.1 Favored Glycine 0 CA--C 1.531 1.072 0 O-C-N 123.573 0.546 . . . . 0.0 113.198 177.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 299' ' ' VAL . . . . . 0.505 HG11 HG11 ' A' ' 334' ' ' VAL . 22.7 m -114.45 179.92 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 124.513 1.125 . . . . 0.0 110.341 -176.394 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 48.3 t -81.42 145.54 55.58 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 123.554 0.742 . . . . 0.0 110.29 177.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -57.6 -29.91 86.8 Favored 'Trans proline' 0 C--N 1.376 2.004 0 C-N-CA 122.72 2.28 . . . . 0.0 111.815 167.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 38.7 t -67.65 -13.87 62.45 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 123.491 0.716 . . . . 0.0 111.1 179.284 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -106.15 -17.11 14.42 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.216 1.006 . . . . 0.0 112.264 -178.081 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 304' ' ' ILE . . . . . 0.587 ' HB ' HG13 ' A' ' 290' ' ' VAL . 30.1 mm -77.49 112.58 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 CA-C-O 120.775 0.322 . . . . 0.0 110.145 176.459 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 41.6 tp -114.43 127.65 55.94 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.696 0.798 . . . . 0.0 108.992 175.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -95.9 133.65 39.82 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 176.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 307' ' ' LEU . . . . . 0.455 HD23 ' HA ' ' A' ' 312' ' ' GLU . 46.0 mt -140.38 111.54 7.12 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.437 1.095 . . . . 0.0 108.294 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 308' ' ' PHE . . . . . 0.496 ' HB2' HG22 ' A' ' 330' ' ' ILE . 68.9 t80 -81.33 82.55 7.15 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 173.363 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 69.87 -94.36 0.43 Allowed Glycine 0 C--N 1.35 1.317 0 CA-C-N 114.827 -1.079 . . . . 0.0 112.586 -175.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -95.76 -31.36 13.24 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.604 0.762 . . . . 0.0 112.407 -174.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 14.6 t -77.77 151.87 33.83 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.68 0.392 . . . . 0.0 111.151 -172.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 312' ' ' GLU . . . . . 0.455 ' HA ' HD23 ' A' ' 307' ' ' LEU . 33.3 tt0 -98.12 122.21 40.99 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 176.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 29.7 mt -110.08 114.78 28.56 Favored 'General case' 0 C--O 1.243 0.752 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 49.5 m -77.98 139.79 61.76 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 123.755 0.822 . . . . 0.0 110.699 -178.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 315' ' ' PRO . . . . . 0.452 ' HB3' HG21 ' A' ' 290' ' ' VAL . 43.4 Cg_exo -57.52 -28.38 80.6 Favored 'Trans proline' 0 C--N 1.386 2.536 0 C-N-CA 123.317 2.678 . . . . 0.0 112.886 174.406 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 56.3 p -74.71 -25.97 59.5 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.052 0.941 . . . . 0.0 111.828 -178.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -81.38 156.02 25.64 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.431 0.692 . . . . 0.0 111.084 -178.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 318' ' ' THR . . . . . . . . . . . . . 71.6 p -98.54 159.29 30.84 Favored Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 123.691 0.796 . . . . 0.0 110.334 -177.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 319' ' ' PRO . . . . . 0.64 ' HG3' HD21 ' A' ' 280' ' ' LEU . 92.0 Cg_endo -70.28 -18.03 34.83 Favored 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 122.778 2.319 . . . . 0.0 112.042 174.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -65.82 -51.98 54.4 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.685 1.194 . . . . 0.0 109.944 -175.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 9.8 t -69.72 -23.83 63.47 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.559 179.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 322' ' ' LEU . . . . . 0.447 ' HB2' ' HG ' ' A' ' 324' ' ' LEU . 68.5 mt -91.12 -11.73 37.66 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.757 0.823 . . . . 0.0 111.974 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 48.9 tptt 55.31 46.98 22.42 Favored 'General case' 0 CA--C 1.565 1.541 0 C-N-CA 124.429 1.092 . . . . 0.0 111.339 -176.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.447 ' HG ' ' HB2' ' A' ' 322' ' ' LEU . 46.6 mt -81.48 165.42 21.23 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.696 0.799 . . . . 0.0 109.478 175.36 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 325' ' ' GLY . . . . . 0.435 ' H ' ' HB3' ' A' ' 328' ' ' ASP . . . -164.7 -171.7 31.26 Favored Glycine 0 C--N 1.34 0.769 0 CA-C-N 116.423 -0.353 . . . . 0.0 112.417 -176.24 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 28.3 m -69.6 -25.3 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 C-N-CA 123.617 0.767 . . . . 0.0 111.178 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -104.27 13.4 32.25 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.866 0.866 . . . . 0.0 111.344 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 328' ' ' ASP . . . . . 0.435 ' HB3' ' H ' ' A' ' 325' ' ' GLY . 12.3 t70 -109.25 127.66 54.44 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 177.28 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 329' ' ' ILE . . . . . 0.6 HG22 ' HB2' ' A' ' 270' ' ' ARG . 13.2 mt -120.72 99.14 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 O-C-N 123.798 0.686 . . . . 0.0 110.463 -164.403 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 330' ' ' ILE . . . . . 0.496 HG22 ' HB2' ' A' ' 308' ' ' PHE . 39.4 pt -100.31 127.18 53.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 123.371 0.668 . . . . 0.0 111.913 -173.368 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -71.94 116.92 12.91 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.116 0.967 . . . . 0.0 111.875 -173.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 332' ' ' CYS . . . . . 0.547 ' SG ' HD12 ' A' ' 304' ' ' ILE . 48.8 t -86.06 99.41 11.46 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.017 0.927 . . . . 0.0 109.901 174.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 47.0 t -103.9 115.86 46.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 C-N-CA 123.6 0.76 . . . . 0.0 109.004 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 334' ' ' VAL . . . . . 0.505 HG11 HG11 ' A' ' 299' ' ' VAL . 82.5 t -80.28 104.33 8.45 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 CA-C-O 120.942 0.401 . . . . 0.0 109.962 176.676 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 93.9 mt -111.68 116.81 31.38 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.031 0.932 . . . . 0.0 109.092 173.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 336' ' ' THR . . . . . . . . . . . . . 21.1 p -65.14 106.26 1.26 Allowed 'General case' 0 C--O 1.241 0.64 0 C-N-CA 123.541 0.736 . . . . 0.0 110.308 -178.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 14.6 p -74.73 72.71 2.02 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.681 1.192 . . . . 0.0 110.708 -178.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 25.5 m . . . . . 0 CA--C 1.556 1.2 0 C-N-CA 123.77 0.828 . . . . 0.0 109.271 -175.083 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 . . . . . 0 N--CA 1.484 1.259 0 CA-C-O 120.716 0.293 . . . . 0.0 110.753 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -141.21 75.46 0.33 Allowed Glycine 0 C--N 1.341 0.812 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 178.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -86.47 71.72 10.39 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.514 0.725 . . . . 0.0 110.447 -178.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 61.66 40.1 13.63 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.976 0.911 . . . . 0.0 111.158 -178.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -90.89 -0.01 57.61 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 115.387 -0.824 . . . . 0.0 112.176 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 249' ' ' GLU . . . . . 0.61 ' HA ' ' HB2' ' A' ' 259' ' ' PRO . 46.8 mt-10 -55.8 90.1 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.959 0.904 . . . . 0.0 112.821 -173.133 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 250' ' ' VAL . . . . . 0.449 HG23 ' H ' ' A' ' 252' ' ' LEU . 26.3 m -111.54 171.98 3.01 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 C-N-CA 124.31 1.044 . . . . 0.0 109.798 175.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 19.2 m -87.43 27.92 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 C-N-CA 122.985 0.514 . . . . 0.0 111.581 177.185 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 252' ' ' LEU . . . . . 0.449 ' H ' HG23 ' A' ' 250' ' ' VAL . 56.4 tp -127.93 96.6 4.54 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 124.412 1.085 . . . . 0.0 108.298 172.167 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.517 HG12 ' HG2' ' A' ' 259' ' ' PRO . 15.8 m -119.28 178.52 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.559 0.744 . . . . 0.0 110.111 -177.255 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 59.16 78.51 0.26 Allowed 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.343 1.057 . . . . 0.0 111.626 170.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 154.17 -109.39 0.4 Allowed Glycine 0 N--CA 1.471 1.005 0 CA-C-O 118.776 -1.013 . . . . 0.0 112.558 178.104 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.26 -20.07 28.51 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 122.918 2.412 . . . . 0.0 112.588 -175.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 17.1 m -143.4 144.9 32.23 Favored 'General case' 0 C--O 1.244 0.773 0 C-N-CA 124.447 1.099 . . . . 0.0 108.148 -179.007 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 77.7 mt -119.09 77.4 16.25 Favored Pre-proline 0 N--CA 1.478 0.959 0 C-N-CA 123.511 0.724 . . . . 0.0 109.12 171.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 259' ' ' PRO . . . . . 0.61 ' HB2' ' HA ' ' A' ' 249' ' ' GLU . 49.2 Cg_endo -86.49 -7.31 7.73 Favored 'Trans proline' 0 C--N 1.371 1.756 0 C-N-CA 122.746 2.298 . . . . 0.0 112.27 176.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.39 118.05 12.71 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 17.2 m -70.6 124.92 91.76 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 123.138 0.575 . . . . 0.0 109.8 -173.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 262' ' ' PRO . . . . . 0.469 ' O ' HD12 ' A' ' 264' ' ' LEU . 15.4 Cg_endo -55.96 154.8 25.68 Favored 'Trans proline' 0 C--N 1.383 2.344 0 C-N-CA 122.582 2.188 . . . . 0.0 111.779 176.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 87.2 mtt180 -90.06 86.13 6.49 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-O 121.668 0.747 . . . . 0.0 110.367 -175.127 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.469 HD12 ' O ' ' A' ' 262' ' ' PRO . 3.7 mp -92.76 128.61 38.68 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 114.245 -1.343 . . . . 0.0 108.614 173.61 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -101.94 150.24 37.24 Favored Pre-proline 0 CA--C 1.547 0.847 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 174.108 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.9 93.82 0.54 Allowed 'Trans proline' 0 C--N 1.375 1.964 0 C-N-CA 121.881 1.72 . . . . 0.0 111.292 176.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 267' ' ' LEU . . . . . 0.49 HD12 HG13 ' A' ' 269' ' ' ILE . 1.6 tm? -59.97 130.54 47.26 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 114.942 -1.026 . . . . 0.0 108.255 175.087 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.482 ' HG2' HG12 ' A' ' 329' ' ' ILE . 4.0 tppp? -93.0 107.92 19.6 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.172 0.51 . . . . 0.0 110.421 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 269' ' ' ILE . . . . . 0.511 HG21 ' HG3' ' A' ' 293' ' ' MET . 2.4 mp -106.19 132.92 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 175.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 270' ' ' ARG . . . . . 0.528 ' HA ' HD23 ' A' ' 275' ' ' LEU . 18.3 ttm-85 -86.76 104.41 16.11 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 173.273 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 271' ' ' CYS . . . . . 0.62 ' SG ' HD21 ' A' ' 297' ' ' LEU . 49.6 t -68.77 176.22 3.16 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.581 0.752 . . . . 0.0 109.992 175.43 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -58.22 -23.19 54.98 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -174.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -163.62 36.04 0.09 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.467 0.707 . . . . 0.0 111.012 175.308 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -164.44 178.2 7.62 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.26 0.624 . . . . 0.0 110.116 -177.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.528 HD23 ' HA ' ' A' ' 270' ' ' ARG . 92.9 mt -119.89 119.92 34.92 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.115 0.966 . . . . 0.0 110.337 173.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 89.9 t -97.4 137.38 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.518 0.727 . . . . 0.0 109.088 173.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 277' ' ' ARG . . . . . 0.426 ' HE ' ' HE2' ' A' ' 268' ' ' LYS . 73.3 mtt180 -118.96 108.68 15.06 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 173.103 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.504 HD11 HG12 ' A' ' 289' ' ' VAL . 4.6 pp -114.91 144.12 31.39 Favored Pre-proline 0 N--CA 1.488 1.46 0 CA-C-N 118.42 0.555 . . . . 0.0 110.34 177.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 279' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 278' ' ' LEU . 16.8 Cg_exo -67.13 123.55 11.06 Favored 'Trans proline' 0 C--N 1.369 1.655 0 C-N-CA 122.641 2.227 . . . . 0.0 110.784 174.428 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.72 HD21 ' HG3' ' A' ' 319' ' ' PRO . 0.1 OUTLIER -150.33 141.31 22.93 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.561 0.744 . . . . 0.0 109.824 -179.225 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 40.0 mtm180 -82.46 156.87 23.86 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.43 0.692 . . . . 0.0 109.671 174.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 282' ' ' MET . . . . . . . . . . . . . 25.4 mtp -68.94 -31.66 70.71 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 175.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 23.6 p -68.6 -30.3 69.01 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.359 1.063 . . . . 0.0 111.833 176.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -68.85 128.35 92.86 Favored Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 123.601 0.76 . . . . 0.0 109.11 177.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -66.99 170.69 12.46 Favored 'Trans proline' 0 C--N 1.374 1.883 0 C-N-CA 122.33 2.02 . . . . 0.0 112.21 176.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.42 ' O ' HG23 ' A' ' 290' ' ' VAL . 67.9 mt -66.56 -15.09 63.16 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-O 118.776 -0.63 . . . . 0.0 111.52 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 27.4 tp60 -53.19 -23.33 8.2 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 123.169 0.588 . . . . 0.0 112.023 176.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 288' ' ' SER . . . . . 0.508 ' HB3' HD12 ' A' ' 280' ' ' LEU . 23.2 t -65.49 -53.64 39.6 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.225 0.61 . . . . 0.0 111.129 173.321 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.504 HG12 HD11 ' A' ' 278' ' ' LEU . 17.7 m -68.81 -32.62 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-O 120.578 0.227 . . . . 0.0 110.408 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 290' ' ' VAL . . . . . 0.537 ' HA ' HG21 ' A' ' 304' ' ' ILE . 55.0 t -62.7 -51.49 71.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 124.015 0.926 . . . . 0.0 110.675 177.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -62.44 -49.2 76.4 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.226 1.01 . . . . 0.0 110.975 -178.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 21.9 t60 -64.4 -45.12 88.98 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.814 -176.22 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 293' ' ' MET . . . . . 0.511 ' HG3' HG21 ' A' ' 269' ' ' ILE . 97.1 mmm -71.72 -28.41 63.66 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.312 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -67.27 -42.66 83.49 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 122.621 0.368 . . . . 0.0 110.7 175.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 29.2 m -69.8 -36.18 75.45 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.443 178.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -69.98 -48.62 57.49 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.609 0.764 . . . . 0.0 110.963 -179.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 297' ' ' LEU . . . . . 0.62 HD21 ' SG ' ' A' ' 271' ' ' CYS . 96.2 mt -82.98 -16.83 45.68 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.795 0.838 . . . . 0.0 112.086 -175.221 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 76.11 33.55 49.44 Favored Glycine 0 C--N 1.345 1.041 0 O-C-N 123.435 0.459 . . . . 0.0 112.446 -179.22 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 14.9 m -120.34 176.39 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 124.411 1.085 . . . . 0.0 109.47 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 15.4 m -81.51 145.78 55.79 Favored Pre-proline 0 CA--C 1.547 0.848 0 CA-C-O 118.902 -0.571 . . . . 0.0 109.929 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -55.26 -34.01 86.82 Favored 'Trans proline' 0 C--N 1.389 2.688 0 C-N-CA 122.663 2.242 . . . . 0.0 111.767 173.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 70.2 m -63.63 -32.44 73.92 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 120.779 0.323 . . . . 0.0 110.738 -178.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -75.23 -23.75 57.6 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.877 0.871 . . . . 0.0 112.284 -178.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 304' ' ' ILE . . . . . 0.561 HD12 ' SG ' ' A' ' 332' ' ' CYS . 31.3 mm -73.64 101.72 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 305' ' ' LEU . . . . . 0.591 HD11 ' HG3' ' A' ' 312' ' ' GLU . 38.8 tp -103.99 116.94 33.16 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 173.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 306' ' ' LEU . . . . . 0.455 ' HG ' HD12 ' A' ' 330' ' ' ILE . 2.5 mm? -87.89 135.55 33.35 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 177.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 69.3 mt -133.67 107.28 7.85 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -178.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 308' ' ' PHE . . . . . 0.465 ' HB2' HD11 ' A' ' 313' ' ' LEU . 61.1 t80 -79.0 88.41 4.77 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 177.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 67.71 -90.69 0.21 Allowed Glycine 0 C--N 1.346 1.11 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.431 -174.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -132.59 78.71 1.81 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.598 0.759 . . . . 0.0 109.627 -179.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 12.7 t -171.19 149.49 2.84 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.98 0.912 . . . . 0.0 109.287 175.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 312' ' ' GLU . . . . . 0.591 ' HG3' HD11 ' A' ' 305' ' ' LEU . 35.0 tt0 -91.86 119.2 31.43 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.132 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.465 HD11 ' HB2' ' A' ' 308' ' ' PHE . 57.1 mt -107.42 123.68 48.74 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.23 179.112 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 29.5 m -82.6 150.44 62.97 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 123.789 0.836 . . . . 0.0 110.604 179.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 315' ' ' PRO . . . . . 0.533 ' HB3' HG21 ' A' ' 290' ' ' VAL . 22.1 Cg_endo -59.92 -25.46 79.54 Favored 'Trans proline' 0 C--N 1.381 2.255 0 C-N-CA 122.73 2.287 . . . . 0.0 112.875 172.435 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 42.4 p -84.69 -3.69 58.66 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.808 0.843 . . . . 0.0 112.274 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -85.8 148.18 25.96 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 122.901 0.48 . . . . 0.0 109.957 175.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 318' ' ' THR . . . . . . . . . . . . . 28.9 p -103.4 139.74 20.39 Favored Pre-proline 0 N--CA 1.476 0.845 0 C-N-CA 122.754 0.422 . . . . 0.0 110.865 178.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 319' ' ' PRO . . . . . 0.72 ' HG3' HD21 ' A' ' 280' ' ' LEU . 27.0 Cg_endo -57.88 -15.99 24.13 Favored 'Trans proline' 0 C--N 1.374 1.906 0 C-N-CA 123.856 3.038 . . . . 0.0 113.094 171.108 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 37.0 ttt180 -56.99 -62.8 1.49 Allowed 'General case' 0 C--N 1.352 0.702 0 C-N-CA 123.921 0.888 . . . . 0.0 110.446 173.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 15.1 t -71.59 -23.32 61.71 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 122.895 0.478 . . . . 0.0 111.479 -176.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 322' ' ' LEU . . . . . 0.432 HD13 HD13 ' A' ' 313' ' ' LEU . 59.3 mt -82.71 -16.03 49.62 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.328 0.651 . . . . 0.0 111.575 178.012 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp 59.91 44.02 14.13 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.784 1.234 . . . . 0.0 111.749 178.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.427 HD12 ' HB3' ' A' ' 319' ' ' PRO . 63.9 mt -79.28 168.56 19.37 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.194 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 325' ' ' GLY . . . . . 0.465 ' H ' ' HB2' ' A' ' 328' ' ' ASP . . . -167.32 -162.85 20.05 Favored Glycine 0 C--N 1.35 1.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 113.061 -172.26 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 25.0 m -74.89 -30.32 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 123.414 0.686 . . . . 0.0 111.204 -178.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -94.97 -25.93 16.32 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.713 0.805 . . . . 0.0 110.907 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 328' ' ' ASP . . . . . 0.465 ' HB2' ' H ' ' A' ' 325' ' ' GLY . 7.1 m-20 -77.77 106.77 9.82 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 122.932 0.493 . . . . 0.0 109.823 -178.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 329' ' ' ILE . . . . . 0.482 HG12 ' HG2' ' A' ' 268' ' ' LYS . 3.1 mt -97.04 139.13 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 122.83 0.452 . . . . 0.0 110.681 -174.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 330' ' ' ILE . . . . . 0.455 HD12 ' HG ' ' A' ' 306' ' ' LEU . 32.3 pt -119.93 125.01 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 123.061 0.545 . . . . 0.0 109.99 174.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -71.15 114.4 9.17 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.198 0.999 . . . . 0.0 111.274 -175.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 332' ' ' CYS . . . . . 0.561 ' SG ' HD12 ' A' ' 304' ' ' ILE . 45.0 t -81.28 88.89 6.04 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.305 0.642 . . . . 0.0 109.704 174.505 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 85.5 t -98.85 111.98 29.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 123.619 0.767 . . . . 0.0 109.413 -177.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 90.8 t -82.41 106.19 13.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.808 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 97.0 mt -110.82 132.79 53.9 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.605 0.762 . . . . 0.0 109.687 176.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 336' ' ' THR . . . . . . . . . . . . . 70.8 p -71.23 -31.77 67.97 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.101 0.56 . . . . 0.0 110.791 177.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 54.1 m -82.52 59.32 4.59 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.149 0.98 . . . . 0.0 110.363 176.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 68.0 m . . . . . 0 C--O 1.252 1.22 0 C-N-CA 124.139 0.975 . . . . 0.0 109.336 -174.24 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 . . . . . 0 N--CA 1.482 1.159 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 79.77 137.81 1.68 Allowed Glycine 0 C--N 1.354 1.55 0 CA-C-N 116.13 -0.487 . . . . 0.0 112.8 -178.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 26.2 pt20 -94.99 44.27 1.1 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.209 0.604 . . . . 0.0 109.896 175.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -62.72 -51.46 67.1 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.51 1.124 . . . . 0.0 111.535 -172.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -70.29 92.75 0.8 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.57 1.148 . . . . 0.0 110.827 -174.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -120.13 155.8 32.32 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.661 0.784 . . . . 0.0 108.902 175.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 35.7 m -73.62 160.04 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 CA-C-O 120.532 0.206 . . . . 0.0 110.736 176.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 251' ' ' VAL . . . . . 0.416 HG12 HG12 ' A' ' 253' ' ' VAL . 59.7 t -68.0 92.95 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 173.456 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 21.2 tp -96.71 14.36 25.27 Favored 'General case' 0 CA--C 1.551 0.997 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.32 -171.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.606 HG22 ' H ' ' A' ' 255' ' ' GLY . 11.9 p -65.29 128.27 27.76 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.188 0 CA-C-O 121.152 0.501 . . . . 0.0 110.353 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -106.48 12.97 29.01 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.322 1.049 . . . . 0.0 110.372 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 255' ' ' GLY . . . . . 0.606 ' H ' HG22 ' A' ' 253' ' ' VAL . . . -113.82 87.23 0.44 Allowed Glycine 0 CA--C 1.53 1.013 0 CA-C-O 119.355 -0.691 . . . . 0.0 112.211 -178.441 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -86.93 176.53 4.46 Favored 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 123.137 2.558 . . . . 0.0 111.155 174.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 40.6 p -73.12 141.97 47.5 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 122.512 0.325 . . . . 0.0 110.137 176.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 96.5 mt -102.78 97.92 10.22 Favored Pre-proline 0 C--O 1.242 0.689 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 175.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.53 -17.63 57.64 Favored 'Trans proline' 0 C--N 1.375 1.924 0 C-N-CA 122.763 2.308 . . . . 0.0 112.821 174.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 21.1 mp0 -68.4 89.98 0.36 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.818 0.847 . . . . 0.0 109.726 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 21.9 p -76.99 138.5 65.41 Favored Pre-proline 0 C--O 1.242 0.663 0 C-N-CA 123.05 0.54 . . . . 0.0 109.695 174.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 262' ' ' PRO . . . . . 0.528 ' HB2' ' HG2' ' A' ' 281' ' ' ARG . 74.4 Cg_endo -68.2 143.51 59.31 Favored 'Trans proline' 0 C--N 1.369 1.613 0 C-N-CA 122.502 2.135 . . . . 0.0 111.251 -179.448 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 40.8 mtt180 -68.96 87.25 0.37 Allowed 'General case' 0 N--CA 1.477 0.91 0 CA-C-O 121.648 0.737 . . . . 0.0 110.533 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.497 HD12 ' H ' ' A' ' 264' ' ' LEU . 0.1 OUTLIER -86.73 124.94 33.54 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 114.616 -1.174 . . . . 0.0 109.336 174.144 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 265' ' ' PHE . . . . . 0.531 ' CE1' ' SD ' ' A' ' 282' ' ' MET . 28.9 p90 -98.08 150.5 36.81 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 124.776 1.23 . . . . 0.0 108.526 -178.389 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 266' ' ' PRO . . . . . 0.467 ' HB2' ' HB3' ' A' ' 277' ' ' ARG . 56.0 Cg_endo -67.66 92.61 0.36 Allowed 'Trans proline' 0 C--N 1.368 1.554 0 C-N-CA 122.405 2.07 . . . . 0.0 112.443 175.513 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.1 111.99 3.67 Favored 'General case' 0 C--O 1.247 0.933 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 173.086 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.428 ' HE3' HG12 ' A' ' 329' ' ' ILE . 22.3 ttpt -83.81 126.65 33.15 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.65 0.738 . . . . 0.0 111.009 -178.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 5.0 mt -125.91 124.3 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.92 1.288 . . . . 0.0 108.52 -175.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 23.0 ttp180 -89.07 102.36 15.01 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-O 121.287 0.565 . . . . 0.0 109.575 176.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 271' ' ' CYS . . . . . 0.765 ' SG ' HD21 ' A' ' 297' ' ' LEU . 36.5 t -73.11 -174.99 1.68 Allowed 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.064 170.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 35.4 ptt180 -56.41 -28.44 59.39 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 124.477 1.111 . . . . 0.0 113.543 -178.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -166.47 32.07 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.629 0.772 . . . . 0.0 110.322 177.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -151.16 150.88 31.16 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.102 0.561 . . . . 0.0 110.103 -172.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -117.18 101.13 8.2 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.932 0.893 . . . . 0.0 109.858 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 72.8 t -92.7 117.71 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.618 0.767 . . . . 0.0 109.707 176.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 277' ' ' ARG . . . . . 0.467 ' HB3' ' HB2' ' A' ' 266' ' ' PRO . 44.0 mtm-85 -112.48 91.4 3.64 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 175.136 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.576 HD21 ' HA ' ' A' ' 289' ' ' VAL . 4.6 pp -98.3 147.69 33.47 Favored Pre-proline 0 N--CA 1.483 1.195 0 C-N-CA 122.485 0.314 . . . . 0.0 110.319 -174.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -71.5 107.21 2.11 Favored 'Trans proline' 0 C--N 1.373 1.843 0 C-N-CA 122.416 2.077 . . . . 0.0 111.689 177.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.837 HD21 ' HG3' ' A' ' 319' ' ' PRO . 0.5 OUTLIER -129.11 150.34 50.55 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.145 1.378 . . . . 0.0 108.473 178.137 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 281' ' ' ARG . . . . . 0.528 ' HG2' ' HB2' ' A' ' 262' ' ' PRO . 0.1 OUTLIER -99.4 155.64 17.43 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.02 0.528 . . . . 0.0 109.905 179.683 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 282' ' ' MET . . . . . 0.531 ' SD ' ' CE1' ' A' ' 265' ' ' PHE . 76.7 mmm -60.32 -33.86 72.98 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.262 0.625 . . . . 0.0 112.059 -175.535 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 35.0 t -83.77 -19.18 35.55 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.271 0.628 . . . . 0.0 111.896 -178.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -67.74 127.66 93.39 Favored Pre-proline 0 N--CA 1.484 1.233 0 CA-C-O 118.272 -0.87 . . . . 0.0 109.153 175.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -64.95 166.61 17.97 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 122.019 1.813 . . . . 0.0 111.394 173.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.464 ' O ' HG22 ' A' ' 289' ' ' VAL . 82.6 mt -66.74 -10.01 42.62 Favored 'General case' 0 C--O 1.213 -0.834 0 CA-C-O 118.594 -0.717 . . . . 0.0 111.939 -176.215 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 287' ' ' GLN . . . . . 0.429 ' HA ' ' HB ' ' A' ' 290' ' ' VAL . 27.3 tp60 -53.85 -26.2 23.38 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 123.345 0.658 . . . . 0.0 112.541 178.25 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 288' ' ' SER . . . . . 0.642 ' HB3' HD12 ' A' ' 280' ' ' LEU . 34.6 t -60.66 -52.63 64.32 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.936 0.494 . . . . 0.0 110.642 171.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.576 ' HA ' HD21 ' A' ' 278' ' ' LEU . 10.2 m -71.75 -30.72 38.96 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 122.364 0.266 . . . . 0.0 110.85 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 290' ' ' VAL . . . . . 0.558 HG13 ' HB ' ' A' ' 304' ' ' ILE . 66.8 t -65.44 -51.23 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.084 0.954 . . . . 0.0 110.657 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -67.54 -39.61 85.03 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.868 0.867 . . . . 0.0 110.984 -176.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 21.5 t60 -66.27 -52.48 47.11 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.751 179.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 94.7 mmm -65.22 -27.89 68.98 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 123.44 0.462 . . . . 0.0 111.214 -177.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -61.84 -49.97 74.14 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.644 0.777 . . . . 0.0 110.476 172.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 36.8 m -70.9 -28.66 64.7 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.639 0.775 . . . . 0.0 111.195 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -70.3 -36.77 74.54 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.292 1.037 . . . . 0.0 110.87 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 297' ' ' LEU . . . . . 0.765 HD21 ' SG ' ' A' ' 271' ' ' CYS . 78.7 mt -101.87 -5.6 24.57 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.996 0.919 . . . . 0.0 112.095 -178.562 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 79.4 3.38 88.64 Favored Glycine 0 N--CA 1.475 1.243 0 O-C-N 123.417 0.448 . . . . 0.0 113.239 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 299' ' ' VAL . . . . . 0.479 HG11 HG11 ' A' ' 334' ' ' VAL . 30.9 m -91.48 -177.78 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 124.244 1.017 . . . . 0.0 111.083 -178.299 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 39.7 m -89.15 150.19 44.56 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 123.482 0.713 . . . . 0.0 110.922 -178.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.13 -30.37 90.22 Favored 'Trans proline' 0 C--N 1.391 2.775 0 C-N-CA 123.094 2.529 . . . . 0.0 111.594 172.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 16.7 m -64.95 -15.77 62.55 Favored 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 123.18 0.592 . . . . 0.0 111.907 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 303' ' ' ARG . . . . . 0.456 ' HG2' ' HA ' ' A' ' 336' ' ' THR . 55.1 mtt180 -100.51 -15.78 17.75 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.933 0.893 . . . . 0.0 112.782 -175.142 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 304' ' ' ILE . . . . . 0.558 ' HB ' HG13 ' A' ' 290' ' ' VAL . 42.7 mm -82.58 102.48 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 CA-C-N 118.148 0.431 . . . . 0.0 110.682 -176.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 53.6 tp -101.37 114.78 29.08 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.969 0.908 . . . . 0.0 109.363 175.11 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 306' ' ' LEU . . . . . 0.456 ' HG ' HD12 ' A' ' 330' ' ' ILE . 2.5 mm? -86.5 133.04 33.78 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 178.268 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 307' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' A' ' 312' ' ' GLU . 92.7 mt -132.58 103.29 6.07 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.927 0.891 . . . . 0.0 109.009 -176.27 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 308' ' ' PHE . . . . . 0.486 ' HB2' HD11 ' A' ' 313' ' ' LEU . 33.1 t80 -82.89 89.67 6.87 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -174.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 67.35 -84.58 0.13 Allowed Glycine 0 C--N 1.348 1.231 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.238 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -134.27 52.04 2.08 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.953 0.901 . . . . 0.0 110.036 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 11.7 t -153.49 149.29 27.56 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 122.805 0.442 . . . . 0.0 110.689 172.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 312' ' ' GLU . . . . . 0.436 ' HA ' HD23 ' A' ' 307' ' ' LEU . 42.4 tt0 -96.79 121.36 38.57 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.179 0.592 . . . . 0.0 110.058 -178.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.486 HD11 ' HB2' ' A' ' 308' ' ' PHE . 58.5 mt -102.05 175.71 5.44 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 122.961 0.504 . . . . 0.0 111.406 -176.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 50.1 m -130.39 146.63 62.53 Favored Pre-proline 0 CA--C 1.547 0.842 0 C-N-CA 123.545 0.738 . . . . 0.0 110.056 -177.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 315' ' ' PRO . . . . . 0.537 ' HB3' HG21 ' A' ' 290' ' ' VAL . 31.1 Cg_endo -61.45 -26.88 81.72 Favored 'Trans proline' 0 C--N 1.385 2.477 0 C-N-CA 123.036 2.491 . . . . 0.0 112.373 174.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 73.1 p -80.19 -22.99 41.33 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.474 1.11 . . . . 0.0 111.889 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -76.82 147.44 37.18 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.553 0.741 . . . . 0.0 111.519 -176.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 318' ' ' THR . . . . . . . . . . . . . 41.3 p -100.98 141.44 22.63 Favored Pre-proline 0 N--CA 1.475 0.782 0 C-N-CA 124.155 0.982 . . . . 0.0 110.05 -178.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 319' ' ' PRO . . . . . 0.837 ' HG3' HD21 ' A' ' 280' ' ' LEU . 59.0 Cg_endo -62.39 -19.71 68.13 Favored 'Trans proline' 0 C--N 1.37 1.665 0 C-N-CA 123.668 2.912 . . . . 0.0 113.294 -178.118 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 53.3 ttp180 -59.28 -56.51 21.23 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 123.893 0.877 . . . . 0.0 110.697 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 15.3 t -69.63 -25.67 64.05 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.066 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 322' ' ' LEU . . . . . 0.507 ' HB2' ' HG ' ' A' ' 324' ' ' LEU . 46.4 mt -85.71 -4.8 59.26 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.63 0.772 . . . . 0.0 111.842 -178.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp 64.49 29.57 13.25 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.499 1.12 . . . . 0.0 112.063 176.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.507 ' HG ' ' HB2' ' A' ' 322' ' ' LEU . 46.8 mt -78.19 168.74 19.38 Favored 'General case' 0 C--O 1.243 0.755 0 C-N-CA 123.603 0.761 . . . . 0.0 110.774 178.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 325' ' ' GLY . . . . . 0.477 ' H ' ' HB2' ' A' ' 328' ' ' ASP . . . -168.5 -162.48 20.66 Favored Glycine 0 C--O 1.243 0.665 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.89 -173.275 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 35.1 m -73.41 -36.99 50.06 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 C-N-CA 123.737 0.815 . . . . 0.0 111.478 -177.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -100.15 -12.84 19.27 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.428 1.091 . . . . 0.0 111.292 -177.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 328' ' ' ASP . . . . . 0.477 ' HB2' ' H ' ' A' ' 325' ' ' GLY . 31.8 m-20 -76.22 116.57 17.03 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 174.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 329' ' ' ILE . . . . . 0.428 HG12 ' HE3' ' A' ' 268' ' ' LYS . 18.0 mt -105.04 124.86 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 123.242 0.617 . . . . 0.0 110.55 -170.448 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 330' ' ' ILE . . . . . 0.456 HD12 ' HG ' ' A' ' 306' ' ' LEU . 40.2 pt -106.5 126.88 62.24 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 123.103 0.561 . . . . 0.0 110.51 176.545 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 331' ' ' ASP . . . . . 0.404 ' HB2' ' HB2' ' A' ' 307' ' ' LEU . 7.1 m-20 -72.98 106.06 4.71 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.727 0.811 . . . . 0.0 111.328 -179.361 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 332' ' ' CYS . . . . . 0.457 ' SG ' HD12 ' A' ' 304' ' ' ILE . 34.7 t -71.71 102.27 2.76 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 169.345 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 333' ' ' VAL . . . . . 0.423 HG21 HD12 ' A' ' 307' ' ' LEU . 87.1 t -113.78 112.53 40.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 334' ' ' VAL . . . . . 0.479 HG11 HG11 ' A' ' 299' ' ' VAL . 76.7 t -77.86 104.18 5.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.746 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 75.0 mt -116.57 123.53 47.61 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.022 0.929 . . . . 0.0 109.193 172.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 336' ' ' THR . . . . . 0.456 ' HA ' ' HG2' ' A' ' 303' ' ' ARG . 13.4 t -89.03 8.26 30.63 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.272 0.629 . . . . 0.0 111.082 -179.104 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 15.8 m 71.11 157.38 0.17 Allowed 'General case' 0 C--N 1.362 1.12 0 C-N-CA 125.969 1.708 . . . . 0.0 111.274 -175.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 22.3 p . . . . . 0 C--O 1.252 1.189 0 C-N-CA 123.16 0.584 . . . . 0.0 109.454 -176.578 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 . . . . . 0 N--CA 1.48 1.03 0 N-CA-C 110.463 -0.199 . . . . 0.0 110.463 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -93.64 -75.18 1.29 Allowed Glycine 0 C--N 1.346 1.124 0 CA-C-N 116.255 -0.43 . . . . 0.0 112.319 -178.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 58.76 26.06 14.23 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 124.646 1.178 . . . . 0.0 111.726 -179.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.19 72.29 9.25 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.523 1.129 . . . . 0.0 108.362 -178.452 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -169.67 92.45 0.24 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 114.496 -1.229 . . . . 0.0 108.424 -171.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.51 166.84 26.5 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.81 0.844 . . . . 0.0 109.473 176.468 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 27.3 m -67.14 164.26 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 123.379 0.672 . . . . 0.0 111.848 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 28.7 m -82.12 41.71 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.244 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.42 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 45.5 tp -156.39 95.18 1.56 Allowed 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.26 1.024 . . . . 0.0 108.277 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 30.2 m -109.15 145.39 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 123.898 0.879 . . . . 0.0 109.623 176.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 254' ' ' GLU . . . . . 0.519 ' HG3' ' HD3' ' A' ' 256' ' ' PRO . 11.7 tp10 -95.79 140.41 30.61 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.52 0.728 . . . . 0.0 109.798 178.537 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -159.86 78.38 0.17 Allowed Glycine 0 C--N 1.341 0.813 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 178.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 256' ' ' PRO . . . . . 0.519 ' HD3' ' HG3' ' A' ' 254' ' ' GLU . 48.1 Cg_endo -81.47 -152.76 0.04 OUTLIER 'Trans proline' 0 C--N 1.372 1.816 0 C-N-CA 123.518 2.812 . . . . 0.0 112.03 -177.151 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 41.3 m -64.01 99.8 0.28 Allowed 'General case' 0 C--N 1.352 0.704 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 169.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 94.6 mt -110.81 98.07 36.36 Favored Pre-proline 0 N--CA 1.471 0.613 0 C-N-CA 123.104 0.561 . . . . 0.0 109.671 178.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -69.0 -14.15 37.94 Favored 'Trans proline' 0 C--N 1.377 2.074 0 C-N-CA 122.494 2.13 . . . . 0.0 111.353 168.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -65.28 89.68 0.09 Allowed 'General case' 0 C--O 1.244 0.776 0 C-N-CA 124.66 1.184 . . . . 0.0 109.699 173.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 16.3 p -81.78 135.68 48.71 Favored Pre-proline 0 C--O 1.241 0.62 0 C-N-CA 123.052 0.541 . . . . 0.0 110.63 177.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -61.67 118.23 5.1 Favored 'Trans proline' 0 C--N 1.379 2.137 0 C-N-CA 122.566 2.177 . . . . 0.0 109.964 171.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -54.67 105.73 0.17 Allowed 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.484 1.114 . . . . 0.0 112.617 -164.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 4.2 mp -80.79 133.77 35.68 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.714 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 265' ' ' PHE . . . . . 0.499 ' CE1' ' HG2' ' A' ' 282' ' ' MET . 31.3 p90 -112.0 141.16 24.37 Favored Pre-proline 0 CA--C 1.55 0.95 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 175.537 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 266' ' ' PRO . . . . . 0.537 ' HB2' ' HB3' ' A' ' 277' ' ' ARG . 38.0 Cg_endo -65.11 92.64 0.21 Allowed 'Trans proline' 0 C--N 1.375 1.922 0 C-N-CA 122.696 2.264 . . . . 0.0 112.974 176.485 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 267' ' ' LEU . . . . . 0.464 HD12 HG13 ' A' ' 269' ' ' ILE . 0.4 OUTLIER -61.69 122.55 15.61 Favored 'General case' 0 C--N 1.356 0.88 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 173.271 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.451 ' HD2' HD13 ' A' ' 275' ' ' LEU . 20.8 ttpt -88.27 108.38 19.29 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 121.216 0.531 . . . . 0.0 110.614 178.31 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 269' ' ' ILE . . . . . 0.464 HG13 HD12 ' A' ' 267' ' ' LEU . 3.8 mp -105.79 129.22 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 176.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 270' ' ' ARG . . . . . 0.425 ' HA ' HD23 ' A' ' 275' ' ' LEU . 41.1 ttm180 -87.0 119.34 27.11 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 122.847 0.459 . . . . 0.0 110.016 174.021 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 271' ' ' CYS . . . . . 0.712 ' SG ' HD21 ' A' ' 297' ' ' LEU . 10.1 t -88.75 -165.06 1.24 Allowed 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.722 0.809 . . . . 0.0 109.687 173.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -52.96 -39.73 63.18 Favored 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 124.584 1.154 . . . . 0.0 112.85 176.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -162.19 42.82 0.13 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.511 0.725 . . . . 0.0 109.87 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 274' ' ' ASP . . . . . 0.402 ' HB3' ' HB3' ' A' ' 271' ' ' CYS . 38.1 t70 -155.58 162.01 40.73 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.704 -171.162 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.451 HD13 ' HD2' ' A' ' 268' ' ' LYS . 72.3 mt -127.85 106.58 9.21 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.176 0.99 . . . . 0.0 110.032 174.001 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 84.6 t -92.88 108.99 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 123.696 0.798 . . . . 0.0 108.937 174.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 277' ' ' ARG . . . . . 0.537 ' HB3' ' HB2' ' A' ' 266' ' ' PRO . 67.4 mtm180 -98.76 83.46 2.96 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 174.573 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.404 HD11 HG12 ' A' ' 289' ' ' VAL . 4.3 pp -93.38 137.14 23.6 Favored Pre-proline 0 N--CA 1.488 1.447 0 CA-C-O 119.141 -0.457 . . . . 0.0 110.413 -175.418 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -63.91 123.67 12.32 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 122.54 2.16 . . . . 0.0 111.477 175.191 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.655 HD21 ' HG3' ' A' ' 319' ' ' PRO . 0.0 OUTLIER -143.72 151.94 40.66 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.226 1.01 . . . . 0.0 110.066 -176.549 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 281' ' ' ARG . . . . . 0.425 ' H ' ' HD2' ' A' ' 281' ' ' ARG . 1.6 mpt_? -87.85 149.71 23.96 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 177.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 282' ' ' MET . . . . . 0.499 ' HG2' ' CE1' ' A' ' 265' ' ' PHE . 14.9 mtp -68.06 -37.08 80.87 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 117.928 0.331 . . . . 0.0 110.672 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 22.8 t -75.08 -15.34 60.62 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.748 0.819 . . . . 0.0 111.314 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 284' ' ' GLU . . . . . 0.434 ' O ' ' HD2' ' A' ' 319' ' ' PRO . 4.5 tp10 -73.52 134.31 79.45 Favored Pre-proline 0 CA--C 1.543 0.691 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 174.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.89 166.57 26.01 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 122.062 1.842 . . . . 0.0 111.686 175.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 82.6 mt -66.7 -12.62 59.17 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.985 0.514 . . . . 0.0 111.721 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 287' ' ' GLN . . . . . 0.479 ' HA ' ' HB ' ' A' ' 290' ' ' VAL . 25.6 tp60 -56.2 -22.36 28.75 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.342 0.657 . . . . 0.0 111.687 173.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 288' ' ' SER . . . . . 0.465 ' HB3' HD12 ' A' ' 280' ' ' LEU . 22.8 t -61.22 -57.64 11.58 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.462 0.705 . . . . 0.0 110.455 172.095 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.416 HG13 HD13 ' A' ' 280' ' ' LEU . 17.9 m -68.99 -30.36 46.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 122.484 0.313 . . . . 0.0 110.553 -179.302 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 290' ' ' VAL . . . . . 0.6 HG13 ' HB ' ' A' ' 304' ' ' ILE . 43.0 t -63.72 -44.51 98.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.507 1.123 . . . . 0.0 111.15 176.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -59.58 -47.61 84.89 Favored 'General case' 0 N--CA 1.479 0.998 0 O-C-N 124.044 0.84 . . . . 0.0 110.204 178.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 42.7 t60 -64.62 -50.63 66.37 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.406 -178.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 293' ' ' MET . . . . . 0.432 ' HG3' HG21 ' A' ' 269' ' ' ILE . 94.3 mmm -69.37 -30.55 68.58 Favored 'General case' 0 N--CA 1.483 1.177 0 O-C-N 123.666 0.604 . . . . 0.0 111.356 -174.386 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -64.68 -46.44 82.37 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 123.656 0.598 . . . . 0.0 110.277 175.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 26.1 m -73.26 -29.24 62.61 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.309 0.644 . . . . 0.0 111.119 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 67.6 t60 -65.05 -38.74 91.82 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.404 1.082 . . . . 0.0 110.279 176.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 297' ' ' LEU . . . . . 0.712 HD21 ' SG ' ' A' ' 271' ' ' CYS . 58.2 mt -101.05 -5.84 25.21 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.369 1.068 . . . . 0.0 111.876 -177.439 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 74.21 10.37 81.51 Favored Glycine 0 N--CA 1.476 1.303 0 O-C-N 123.267 0.355 . . . . 0.0 113.61 178.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 299' ' ' VAL . . . . . 0.434 HG11 HG11 ' A' ' 334' ' ' VAL . 33.5 m -95.99 176.03 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.208 1.003 . . . . 0.0 110.855 -178.727 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 300' ' ' SER . . . . . 0.412 ' H ' ' HD2' ' A' ' 303' ' ' ARG . 20.2 m -78.95 148.56 72.24 Favored Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 123.298 0.639 . . . . 0.0 110.428 178.125 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -57.86 -28.33 82.06 Favored 'Trans proline' 0 C--N 1.385 2.486 0 C-N-CA 122.97 2.446 . . . . 0.0 112.247 172.123 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 19.5 m -72.58 -7.54 50.69 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.429 0.691 . . . . 0.0 111.958 -178.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 303' ' ' ARG . . . . . 0.412 ' HD2' ' H ' ' A' ' 300' ' ' SER . 95.7 mtt180 -99.25 -21.28 16.16 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.845 0.858 . . . . 0.0 110.943 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 304' ' ' ILE . . . . . 0.6 ' HB ' HG13 ' A' ' 290' ' ' VAL . 39.4 mm -80.73 115.34 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 122.852 0.461 . . . . 0.0 110.506 -176.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 33.5 tp -113.46 137.65 51.24 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 171.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 306' ' ' LEU . . . . . 0.448 ' HG ' HD12 ' A' ' 330' ' ' ILE . 2.0 mm? -104.15 133.8 48.48 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 177.286 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 80.8 mt -131.42 111.43 11.81 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.47 0.708 . . . . 0.0 109.101 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 308' ' ' PHE . . . . . 0.548 ' HB2' HD11 ' A' ' 313' ' ' LEU . 87.1 t80 -82.49 81.79 8.17 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.297 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 77.16 -67.8 2.71 Favored Glycine 0 C--N 1.354 1.53 0 CA-C-N 114.885 -1.052 . . . . 0.0 112.842 -178.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -134.96 -26.8 1.3 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.087 0.955 . . . . 0.0 111.596 -174.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 14.3 t -82.1 147.66 28.97 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 122.658 0.383 . . . . 0.0 110.641 -176.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -93.44 117.39 30.02 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 120.923 0.392 . . . . 0.0 110.01 -178.37 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.548 HD11 ' HB2' ' A' ' 308' ' ' PHE . 48.1 mt -105.9 114.71 29.03 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.841 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 49.5 m -75.15 147.44 83.19 Favored Pre-proline 0 CA--C 1.553 1.059 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.388 177.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 315' ' ' PRO . . . . . 0.573 ' HB3' HG21 ' A' ' 290' ' ' VAL . 33.9 Cg_endo -60.23 -23.6 74.56 Favored 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 123.265 2.643 . . . . 0.0 112.937 177.358 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 4.6 m -72.48 -33.95 67.33 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.785 0.834 . . . . 0.0 111.08 178.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -66.43 146.24 54.78 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.826 0.85 . . . . 0.0 111.425 -177.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 318' ' ' THR . . . . . . . . . . . . . 81.2 p -100.83 138.35 20.03 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 123.027 0.531 . . . . 0.0 109.921 -178.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 319' ' ' PRO . . . . . 0.655 ' HG3' HD21 ' A' ' 280' ' ' LEU . 10.0 Cg_endo -51.03 -20.08 6.73 Favored 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 124.153 3.235 . . . . 0.0 113.531 170.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 40.9 ttt180 -60.92 -58.79 6.94 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.649 0.78 . . . . 0.0 110.912 173.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 13.2 t -71.34 -20.72 62.14 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 122.932 0.493 . . . . 0.0 111.531 -175.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 322' ' ' LEU . . . . . 0.466 HD13 HD13 ' A' ' 313' ' ' LEU . 39.0 mt -88.9 -22.03 23.32 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.646 0.778 . . . . 0.0 111.01 178.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 2.3 tmtp? 56.41 80.83 0.14 Allowed 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.869 1.267 . . . . 0.0 109.204 -167.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 69.5 mt -110.31 143.83 39.94 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 172.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 325' ' ' GLY . . . . . 0.437 ' H ' ' HB2' ' A' ' 328' ' ' ASP . . . -128.22 -167.72 12.29 Favored Glycine 0 C--N 1.337 0.613 0 C-N-CA 123.939 0.78 . . . . 0.0 111.511 -178.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 14.5 m -73.88 -21.98 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 123.314 0.645 . . . . 0.0 111.469 -177.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -99.96 -22.84 15.11 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.193 0.997 . . . . 0.0 111.253 -178.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 328' ' ' ASP . . . . . 0.437 ' HB2' ' H ' ' A' ' 325' ' ' GLY . 3.9 m-20 -70.37 124.96 25.46 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.992 0.517 . . . . 0.0 109.813 178.656 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 329' ' ' ILE . . . . . 0.412 HG12 ' HG2' ' A' ' 268' ' ' LYS . 12.9 mt -104.11 139.57 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.028 0.531 . . . . 0.0 109.933 -178.207 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 330' ' ' ILE . . . . . 0.448 HD12 ' HG ' ' A' ' 306' ' ' LEU . 35.7 pt -123.84 126.58 72.87 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 123.162 0.585 . . . . 0.0 109.837 174.029 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -75.39 106.1 6.75 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.027 0.931 . . . . 0.0 110.963 -176.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 332' ' ' CYS . . . . . 0.554 ' SG ' HD12 ' A' ' 304' ' ' ILE . 38.1 t -74.54 92.06 2.35 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.701 0.801 . . . . 0.0 110.168 172.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 97.4 t -95.87 117.08 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 123.431 0.693 . . . . 0.0 109.679 177.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 334' ' ' VAL . . . . . 0.434 HG11 HG11 ' A' ' 299' ' ' VAL . 62.1 t -83.38 99.76 6.32 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 123.582 0.753 . . . . 0.0 109.713 177.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 84.9 mt -78.48 178.84 7.43 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.883 0.873 . . . . 0.0 110.535 172.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 336' ' ' THR . . . . . . . . . . . . . 94.8 m -68.01 -54.02 21.58 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 170.081 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 66.4 m -157.56 136.12 11.3 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.79 1.236 . . . . 0.0 108.437 176.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 15.0 m . . . . . 0 C--O 1.253 1.286 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -178.579 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 . . . . . 0 N--CA 1.481 1.119 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -160.63 63.48 0.28 Allowed Glycine 0 C--N 1.348 1.196 0 N-CA-C 111.106 -0.797 . . . . 0.0 111.106 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 65.48 41.54 4.15 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.566 1.147 . . . . 0.0 110.465 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -73.22 97.67 2.48 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.186 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -93.59 22.82 5.08 Favored 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 124.444 1.098 . . . . 0.0 109.997 177.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -68.37 157.22 36.18 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.944 0.898 . . . . 0.0 112.405 -175.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 6.4 m -74.89 113.6 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.173 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.235 175.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 58.2 t -89.53 141.91 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.488 0.715 . . . . 0.0 111.369 -169.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 33.1 tp 65.37 35.96 7.16 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 125.375 1.47 . . . . 0.0 110.895 175.072 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 8.0 m -73.64 87.78 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 CA-C-O 122.342 1.068 . . . . 0.0 110.232 174.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -164.47 146.92 8.76 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 114.204 -1.362 . . . . 0.0 108.657 -176.093 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -76.17 105.57 2.0 Favored Glycine 0 C--N 1.346 1.085 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 170.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -80.56 172.92 12.86 Favored 'Trans proline' 0 C--N 1.37 1.67 0 C-N-CA 122.503 2.135 . . . . 0.0 113.046 -170.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 65.3 m -72.61 142.39 48.36 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 169.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 76.3 mt -104.05 94.08 6.19 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 123.699 0.8 . . . . 0.0 109.416 178.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -74.97 -15.41 20.84 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 122.346 2.031 . . . . 0.0 111.682 172.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -96.42 103.93 15.86 Favored 'General case' 0 C--O 1.242 0.7 0 C-N-CA 124.244 1.018 . . . . 0.0 108.85 174.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 55.5 m -85.03 135.03 40.05 Favored Pre-proline 0 C--O 1.243 0.761 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 171.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -63.19 149.4 91.51 Favored 'Trans proline' 0 C--N 1.385 2.453 0 C-N-CA 121.834 1.689 . . . . 0.0 110.327 170.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 21.7 ptt-85 -91.98 110.68 22.05 Favored 'General case' 0 N--CA 1.482 1.175 0 CA-C-O 121.644 0.735 . . . . 0.0 110.006 -177.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 4.2 mp -107.81 151.66 25.43 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.005 0.922 . . . . 0.0 109.383 177.023 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -125.88 141.57 39.77 Favored Pre-proline 0 CA--C 1.549 0.931 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 175.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -64.26 94.13 0.2 Allowed 'Trans proline' 0 C--N 1.379 2.137 0 C-N-CA 122.531 2.154 . . . . 0.0 112.091 176.259 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 267' ' ' LEU . . . . . 0.437 HD12 HG13 ' A' ' 269' ' ' ILE . 1.1 tm? -59.6 131.71 51.75 Favored 'General case' 0 C--N 1.354 0.782 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 173.55 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.43 ' HG2' HG12 ' A' ' 329' ' ' ILE . 3.0 tppp? -94.96 103.53 15.39 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.465 0.65 . . . . 0.0 109.973 -178.52 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 269' ' ' ILE . . . . . 0.437 HG13 HD12 ' A' ' 267' ' ' LEU . 2.4 mp -100.59 154.03 4.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 175.326 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 270' ' ' ARG . . . . . 0.486 ' HB2' HG22 ' A' ' 329' ' ' ILE . 22.5 ttp180 -118.35 103.61 9.96 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.792 0.837 . . . . 0.0 109.017 176.526 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 271' ' ' CYS . . . . . 0.722 ' SG ' HD21 ' A' ' 297' ' ' LEU . 21.0 t -69.09 -178.14 1.21 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.007 0.923 . . . . 0.0 110.598 176.103 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -50.98 -32.84 22.37 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.712 1.205 . . . . 0.0 113.175 -177.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -161.04 42.08 0.16 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.645 0.778 . . . . 0.0 110.03 178.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -161.35 164.84 29.77 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.257 -174.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 69.6 mt -112.53 113.46 25.62 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.252 1.021 . . . . 0.0 110.155 172.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 276' ' ' VAL . . . . . 0.438 HG21 ' SD ' ' A' ' 293' ' ' MET . 65.7 t -95.43 138.89 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 123.684 0.794 . . . . 0.0 109.264 178.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 42.7 mtt180 -125.08 115.64 20.82 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 177.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.523 HD21 ' HA ' ' A' ' 289' ' ' VAL . 4.0 pp -126.49 135.58 27.43 Favored Pre-proline 0 N--CA 1.482 1.13 0 CA-C-O 119.258 -0.401 . . . . 0.0 109.942 175.174 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -64.7 127.91 19.85 Favored 'Trans proline' 0 C--N 1.375 1.97 0 C-N-CA 122.657 2.238 . . . . 0.0 110.149 174.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.827 HD21 ' HG3' ' A' ' 319' ' ' PRO . 0.2 OUTLIER -150.22 150.92 32.24 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.002 0.921 . . . . 0.0 109.943 -173.815 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 281' ' ' ARG . . . . . 0.494 ' HB2' ' HB2' ' A' ' 284' ' ' GLU . 83.5 mtm180 -93.17 155.43 17.46 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.588 0.755 . . . . 0.0 110.815 -178.401 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 282' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -65.72 -38.24 88.62 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.885 0.474 . . . . 0.0 110.213 176.222 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 24.3 t -73.99 -17.93 60.93 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.552 0.741 . . . . 0.0 111.802 178.054 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 284' ' ' GLU . . . . . 0.494 ' HB2' ' HB2' ' A' ' 281' ' ' ARG . 5.9 tp10 -72.93 131.77 83.56 Favored Pre-proline 0 N--CA 1.473 0.72 0 C-N-CA 123.712 0.805 . . . . 0.0 109.121 179.277 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -67.76 168.38 18.67 Favored 'Trans proline' 0 C--N 1.374 1.918 0 C-N-CA 121.903 1.735 . . . . 0.0 111.79 171.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 54.3 mt -70.41 -10.22 58.5 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 118.982 -0.532 . . . . 0.0 110.874 179.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 26.0 tp60 -54.68 -23.08 15.85 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.217 0.607 . . . . 0.0 111.644 175.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 288' ' ' SER . . . . . 0.551 ' HB3' HD12 ' A' ' 280' ' ' LEU . 34.3 t -64.42 -56.48 14.01 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.619 0.768 . . . . 0.0 110.935 171.108 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.523 ' HA ' HD21 ' A' ' 278' ' ' LEU . 18.0 m -66.73 -30.43 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 C-N-CA 122.254 0.222 . . . . 0.0 110.701 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 290' ' ' VAL . . . . . 0.581 HG13 ' HB ' ' A' ' 304' ' ' ILE . 43.9 t -66.88 -50.24 66.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 124.397 1.079 . . . . 0.0 110.565 179.4 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -64.1 -43.54 95.03 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.105 0.962 . . . . 0.0 110.887 -178.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 26.0 t60 -67.2 -49.09 65.87 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.378 -177.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 293' ' ' MET . . . . . 0.438 ' SD ' HG21 ' A' ' 276' ' ' VAL . 90.0 mmm -66.36 -32.52 73.96 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.447 0.699 . . . . 0.0 111.369 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -61.57 -53.63 53.79 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 123.863 0.727 . . . . 0.0 110.352 177.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 28.3 m -66.2 -34.09 77.24 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.658 0.783 . . . . 0.0 111.304 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -67.46 -35.44 79.19 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.682 0.793 . . . . 0.0 111.499 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 297' ' ' LEU . . . . . 0.722 HD21 ' SG ' ' A' ' 271' ' ' CYS . 86.6 mt -97.83 -3.46 38.75 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.874 0.87 . . . . 0.0 111.319 178.399 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 75.15 10.15 84.18 Favored Glycine 0 C--N 1.345 1.049 0 O-C-N 123.625 0.578 . . . . 0.0 113.44 177.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 33.1 m -98.6 -179.04 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.126 0.97 . . . . 0.0 111.252 -178.214 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 21.7 m -85.2 147.78 48.44 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 123.347 0.659 . . . . 0.0 110.686 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -56.79 -29.65 81.7 Favored 'Trans proline' 0 C--N 1.384 2.428 0 C-N-CA 123.044 2.496 . . . . 0.0 112.297 171.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 44.8 m -68.24 -19.56 64.74 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.037 0.535 . . . . 0.0 111.739 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 61.3 mtt85 -89.19 -19.48 25.4 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.924 0.89 . . . . 0.0 111.737 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 304' ' ' ILE . . . . . 0.581 ' HB ' HG13 ' A' ' 290' ' ' VAL . 41.9 mm -80.62 125.39 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 CA-C-N 117.997 0.362 . . . . 0.0 110.748 -178.383 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 305' ' ' LEU . . . . . 0.604 HD22 HD11 ' A' ' 335' ' ' LEU . 46.3 tp -129.76 121.52 27.01 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.809 0.844 . . . . 0.0 108.963 176.564 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 306' ' ' LEU . . . . . 0.409 ' HA ' ' O ' ' A' ' 331' ' ' ASP . 2.6 mm? -88.43 127.86 35.51 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -179.328 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 307' ' ' LEU . . . . . 0.516 HD12 HG21 ' A' ' 333' ' ' VAL . 79.1 mt -136.32 104.76 5.73 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.794 0.837 . . . . 0.0 109.615 -176.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 308' ' ' PHE . . . . . 0.515 ' HB2' HG22 ' A' ' 330' ' ' ILE . 85.3 t80 -81.84 93.65 6.91 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 177.328 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 66.77 -87.72 0.13 Allowed Glycine 0 C--N 1.349 1.274 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.595 -177.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -137.17 77.46 1.64 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.277 1.031 . . . . 0.0 109.339 177.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 14.3 t -166.92 146.26 5.39 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.234 1.014 . . . . 0.0 108.899 173.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 312' ' ' GLU . . . . . 0.425 ' HA ' HD23 ' A' ' 307' ' ' LEU . 44.3 tt0 -97.36 123.38 41.16 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 122.532 0.333 . . . . 0.0 110.345 -176.326 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.474 HD22 HD22 ' A' ' 322' ' ' LEU . 27.7 mt -121.11 131.63 54.38 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.59 0.756 . . . . 0.0 109.099 -179.3 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 52.6 m -98.75 152.69 37.96 Favored Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 123.59 0.756 . . . . 0.0 111.573 -174.075 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -49.23 -37.82 40.29 Favored 'Trans proline' 0 C--N 1.388 2.617 0 C-N-CA 123.695 2.93 . . . . 0.0 113.294 167.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 43.1 p -70.44 -27.61 64.39 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.321 -178.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -73.51 145.71 45.42 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.608 0.763 . . . . 0.0 110.857 -179.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 318' ' ' THR . . . . . . . . . . . . . 76.1 p -99.2 146.79 32.32 Favored Pre-proline 0 N--CA 1.476 0.857 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 177.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 319' ' ' PRO . . . . . 0.827 ' HG3' HD21 ' A' ' 280' ' ' LEU . 34.8 Cg_endo -62.19 -12.18 25.59 Favored 'Trans proline' 0 C--N 1.367 1.518 0 C-N-CA 123.081 2.521 . . . . 0.0 112.56 171.528 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 44.2 ttt-85 -68.25 -56.13 9.74 Favored 'General case' 0 C--N 1.35 0.613 0 C-N-CA 122.999 0.519 . . . . 0.0 110.15 173.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 13.6 t -68.81 -25.42 64.67 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 120.639 0.257 . . . . 0.0 111.265 -178.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 322' ' ' LEU . . . . . 0.474 HD22 HD22 ' A' ' 313' ' ' LEU . 52.2 mt -90.04 -13.75 35.3 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.288 0.635 . . . . 0.0 111.721 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt 61.87 35.15 16.6 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.657 1.183 . . . . 0.0 112.384 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.449 ' HG ' ' HB2' ' A' ' 322' ' ' LEU . 30.8 mt -73.74 166.13 23.85 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.545 0.738 . . . . 0.0 109.836 175.213 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 325' ' ' GLY . . . . . 0.447 ' H ' ' HB3' ' A' ' 328' ' ' ASP . . . -164.03 -171.91 30.86 Favored Glycine 0 C--N 1.337 0.635 0 CA-C-N 116.475 -0.33 . . . . 0.0 112.326 -176.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 35.0 m -68.4 -27.87 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 123.973 0.909 . . . . 0.0 111.402 178.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -99.57 11.63 38.65 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.118 0.967 . . . . 0.0 111.625 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 328' ' ' ASP . . . . . 0.447 ' HB3' ' H ' ' A' ' 325' ' ' GLY . 10.9 t70 -122.8 124.09 42.52 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -175.058 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 329' ' ' ILE . . . . . 0.486 HG22 ' HB2' ' A' ' 270' ' ' ARG . 3.5 mt -116.72 109.83 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 O-C-N 123.411 0.445 . . . . 0.0 111.824 -163.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 330' ' ' ILE . . . . . 0.515 HG22 ' HB2' ' A' ' 308' ' ' PHE . 34.4 pt -102.06 131.94 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 123.679 0.792 . . . . 0.0 111.117 -177.603 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 331' ' ' ASP . . . . . 0.409 ' O ' ' HA ' ' A' ' 306' ' ' LEU . 7.5 m-20 -73.95 126.91 31.52 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 123.293 0.637 . . . . 0.0 111.759 -178.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 332' ' ' CYS . . . . . 0.563 ' SG ' HD12 ' A' ' 304' ' ' ILE . 43.2 t -90.55 91.17 8.31 Favored 'General case' 0 C--O 1.244 0.785 0 C-N-CA 123.89 0.876 . . . . 0.0 109.043 172.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 333' ' ' VAL . . . . . 0.516 HG21 HD12 ' A' ' 307' ' ' LEU . 90.8 t -95.02 115.55 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 123.253 0.621 . . . . 0.0 109.506 -178.108 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 93.1 t -83.69 98.77 5.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 177.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 335' ' ' LEU . . . . . 0.604 HD11 HD22 ' A' ' 305' ' ' LEU . 86.3 mt -67.25 168.9 9.61 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 114.662 -1.153 . . . . 0.0 111.401 172.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 336' ' ' THR . . . . . . . . . . . . . 37.4 p -90.89 26.7 2.01 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.876 0.87 . . . . 0.0 111.374 174.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 18.4 m -57.37 114.45 2.2 Favored 'General case' 0 C--N 1.359 0.99 0 C-N-CA 123.948 0.899 . . . . 0.0 110.609 176.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 29.9 m . . . . . 0 C--O 1.254 1.311 0 C-N-CA 123.11 0.564 . . . . 0.0 110.007 -177.999 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 . . . . . 0 N--CA 1.478 0.967 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -85.81 45.29 3.46 Favored Glycine 0 C--N 1.349 1.289 0 N-CA-C 114.165 0.426 . . . . 0.0 114.165 -171.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -90.06 174.75 7.47 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.757 0.823 . . . . 0.0 110.392 175.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -86.28 79.54 9.02 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.498 0.666 . . . . 0.0 109.231 178.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -147.38 12.74 1.06 Allowed 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.122 178.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.33 119.7 8.44 Favored 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 124.385 1.074 . . . . 0.0 111.568 -172.355 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 17.7 m -137.74 175.23 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 125.069 1.347 . . . . 0.0 109.783 -178.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 5.4 p -71.89 105.71 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 CA-C-O 121.87 0.843 . . . . 0.0 109.123 172.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 43.0 tp -152.08 129.38 11.27 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 -178.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 16.2 m -73.29 79.33 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 CA-C-O 122.81 1.291 . . . . 0.0 111.086 -178.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -135.64 141.72 45.09 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 114.076 -1.42 . . . . 0.0 109.019 179.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -108.84 79.3 0.25 Allowed Glycine 0 CA--C 1.524 0.641 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 165.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -81.25 154.16 18.85 Favored 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 122.771 2.314 . . . . 0.0 111.54 -171.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 31.6 m -65.12 124.09 21.21 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 174.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 87.1 mt -112.48 88.94 11.75 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 123.371 0.668 . . . . 0.0 109.261 178.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -76.75 -22.02 12.21 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 121.909 1.74 . . . . 0.0 110.872 169.266 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -80.01 106.73 12.25 Favored 'General case' 0 C--O 1.242 0.687 0 C-N-CA 124.018 0.927 . . . . 0.0 108.937 176.157 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 27.2 m -75.33 137.2 71.67 Favored Pre-proline 0 CA--C 1.548 0.893 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 172.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 262' ' ' PRO . . . . . 0.455 ' O ' HD12 ' A' ' 264' ' ' LEU . 99.7 Cg_exo -48.28 173.93 0.03 OUTLIER 'Trans proline' 0 C--N 1.383 2.383 0 C-N-CA 123.318 2.679 . . . . 0.0 114.567 175.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 75.6 mtt180 -92.73 89.27 6.58 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-O 121.703 0.763 . . . . 0.0 109.664 -177.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.455 HD12 ' O ' ' A' ' 262' ' ' PRO . 3.0 mp -89.82 162.89 15.27 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 114.187 -1.369 . . . . 0.0 109.017 174.141 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -141.75 145.67 37.92 Favored Pre-proline 0 CA--C 1.546 0.792 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 175.023 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 266' ' ' PRO . . . . . 0.42 ' HB2' ' HB3' ' A' ' 277' ' ' ARG . 58.5 Cg_endo -67.93 89.11 0.37 Allowed 'Trans proline' 0 C--N 1.374 1.909 0 C-N-CA 122.875 2.383 . . . . 0.0 112.626 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 267' ' ' LEU . . . . . 0.497 ' O ' ' HA ' ' A' ' 277' ' ' ARG . 1.4 tm? -58.93 127.83 34.18 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.478 1.111 . . . . 0.0 108.96 176.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.684 ' HG2' HG12 ' A' ' 329' ' ' ILE . 5.6 tppp? -83.6 109.35 17.35 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-O 121.336 0.589 . . . . 0.0 111.19 176.064 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 269' ' ' ILE . . . . . 0.46 HG12 ' HB ' ' A' ' 289' ' ' VAL . 2.4 mp -106.39 145.22 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 171.44 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 30.8 ttp180 -107.47 106.88 17.49 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 173.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 271' ' ' CYS . . . . . 0.583 ' SG ' HD21 ' A' ' 297' ' ' LEU . 17.4 t -69.82 172.65 7.32 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.746 171.334 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 16.3 ptt180 -62.13 -14.1 33.6 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 123.871 0.868 . . . . 0.0 113.187 -174.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -162.52 34.03 0.11 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.694 0.798 . . . . 0.0 111.029 176.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -164.23 162.82 22.8 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 122.826 0.451 . . . . 0.0 111.647 -175.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 51.9 mt -114.2 116.36 28.93 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.244 1.018 . . . . 0.0 109.653 170.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 60.3 t -100.46 142.72 15.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 124.193 0.997 . . . . 0.0 109.114 176.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 277' ' ' ARG . . . . . 0.497 ' HA ' ' O ' ' A' ' 267' ' ' LEU . 57.8 mtm180 -127.72 120.8 28.77 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 167.496 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.547 HD21 ' HA ' ' A' ' 289' ' ' VAL . 4.1 pp -123.9 146.33 50.54 Favored Pre-proline 0 N--CA 1.48 1.04 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 178.428 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -64.67 110.91 1.54 Allowed 'Trans proline' 0 C--N 1.372 1.788 0 C-N-CA 122.805 2.337 . . . . 0.0 110.94 174.266 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.659 HD21 ' HG3' ' A' ' 319' ' ' PRO . 0.1 OUTLIER -130.05 143.67 50.92 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.15 0.98 . . . . 0.0 109.835 178.9 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 70.4 mtp180 -89.44 159.79 17.11 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.001 0.92 . . . . 0.0 110.728 178.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 282' ' ' MET . . . . . . . . . . . . . 1.3 mmt -70.53 -34.02 71.82 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.199 176.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 35.2 m -77.81 -26.64 49.74 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.734 0.814 . . . . 0.0 111.222 177.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -72.56 123.37 89.45 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-O 118.135 -0.936 . . . . 0.0 108.642 176.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -68.25 179.52 2.87 Favored 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 122.759 2.306 . . . . 0.0 112.481 179.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.439 ' O ' HG23 ' A' ' 290' ' ' VAL . 66.6 mt -64.43 -18.37 64.67 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 118.954 -0.545 . . . . 0.0 111.557 177.449 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 26.6 tp60 -53.47 -22.61 8.25 Favored 'General case' 0 CA--C 1.559 1.294 0 C-N-CA 123.543 0.737 . . . . 0.0 112.307 178.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 288' ' ' SER . . . . . 0.494 ' HB3' HD12 ' A' ' 280' ' ' LEU . 32.1 t -63.18 -56.65 14.92 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.847 0.859 . . . . 0.0 111.069 171.46 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.547 ' HA ' HD21 ' A' ' 278' ' ' LEU . 15.4 m -67.33 -33.72 64.41 Favored 'Isoleucine or valine' 0 C--N 1.361 1.085 0 C-N-CA 122.64 0.376 . . . . 0.0 110.498 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 290' ' ' VAL . . . . . 0.576 HG13 ' HB ' ' A' ' 304' ' ' ILE . 73.8 t -61.12 -49.24 85.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 124.426 1.09 . . . . 0.0 111.026 177.287 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -61.27 -50.05 74.59 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 124.31 1.006 . . . . 0.0 110.467 -178.03 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 22.8 t60 -59.32 -49.03 79.41 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 124.526 1.141 . . . . 0.0 111.203 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 293' ' ' MET . . . . . 0.411 ' HG2' ' O ' ' A' ' 289' ' ' VAL . 91.7 mmm -68.33 -31.08 70.24 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 122.779 0.431 . . . . 0.0 111.103 -178.164 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -70.0 -38.16 75.91 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.272 0.629 . . . . 0.0 111.034 176.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 27.7 m -68.96 -43.35 75.16 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.611 0.764 . . . . 0.0 110.275 178.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 83.4 t60 -67.66 -47.98 67.98 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.546 -177.295 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 297' ' ' LEU . . . . . 0.583 HD21 ' SG ' ' A' ' 271' ' ' CYS . 76.6 mt -83.52 -9.0 59.24 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.512 0.725 . . . . 0.0 111.654 -178.099 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 69.66 26.4 74.49 Favored Glycine 0 C--N 1.349 1.28 0 O-C-N 123.697 0.623 . . . . 0.0 112.682 177.295 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 299' ' ' VAL . . . . . 0.488 HG11 HG11 ' A' ' 334' ' ' VAL . 28.0 m -110.36 178.14 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.435 1.094 . . . . 0.0 110.434 -177.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 27.4 m -80.4 143.16 55.23 Favored Pre-proline 0 CA--C 1.55 0.971 0 CA-C-O 119.114 -0.469 . . . . 0.0 110.207 178.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -56.91 -28.19 76.42 Favored 'Trans proline' 0 C--N 1.384 2.398 0 C-N-CA 123.052 2.502 . . . . 0.0 112.45 171.127 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 41.2 t -68.56 -27.31 65.96 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 120.83 0.347 . . . . 0.0 110.978 179.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 66.7 mtt180 -85.55 -11.86 53.05 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.34 1.056 . . . . 0.0 112.047 -176.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 304' ' ' ILE . . . . . 0.576 ' HB ' HG13 ' A' ' 290' ' ' VAL . 35.5 mm -82.67 101.97 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 177.078 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 36.9 tp -102.37 112.05 24.6 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.271 0.628 . . . . 0.0 109.471 176.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 306' ' ' LEU . . . . . 0.447 HD21 HG22 ' A' ' 290' ' ' VAL . 3.1 mm? -81.56 131.22 35.27 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 177.01 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 307' ' ' LEU . . . . . 0.505 HD12 HG21 ' A' ' 333' ' ' VAL . 72.5 mt -131.99 109.94 10.4 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.04 0.936 . . . . 0.0 108.735 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 308' ' ' PHE . . . . . 0.519 ' HB2' HD11 ' A' ' 313' ' ' LEU . 28.7 t80 -77.74 89.64 4.01 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -179.381 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 66.44 -83.43 0.1 Allowed Glycine 0 C--N 1.346 1.112 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.728 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -122.56 3.09 9.62 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.134 0.973 . . . . 0.0 112.207 -176.266 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 5.0 t -115.26 147.01 40.91 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 118.256 0.48 . . . . 0.0 110.225 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -85.05 132.71 34.29 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 123.184 0.594 . . . . 0.0 110.007 177.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.522 HD13 HD13 ' A' ' 322' ' ' LEU . 53.2 mt -112.3 156.74 21.93 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.114 0.566 . . . . 0.0 110.366 177.152 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 314' ' ' SER . . . . . 0.424 ' O ' HD12 ' A' ' 286' ' ' LEU . 22.3 m -99.22 130.4 27.28 Favored Pre-proline 0 CA--C 1.544 0.749 0 CA-C-O 118.644 -0.693 . . . . 0.0 109.44 175.133 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -59.51 -21.92 64.11 Favored 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 123.228 2.618 . . . . 0.0 113.475 175.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 27.3 p -78.26 -29.44 48.06 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.969 0.908 . . . . 0.0 111.858 176.295 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -67.28 157.74 33.17 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.366 0.666 . . . . 0.0 111.475 -177.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 318' ' ' THR . . . . . . . . . . . . . 61.6 p -99.36 144.17 27.77 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 123.158 0.583 . . . . 0.0 109.916 -173.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 319' ' ' PRO . . . . . 0.659 ' HG3' HD21 ' A' ' 280' ' ' LEU . 55.7 Cg_endo -63.22 -16.65 55.81 Favored 'Trans proline' 0 C--N 1.363 1.342 0 C-N-CA 123.43 2.753 . . . . 0.0 112.508 175.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 -73.21 -48.65 33.33 Favored 'General case' 0 C--N 1.355 0.843 0 C-N-CA 122.72 0.408 . . . . 0.0 110.488 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 13.7 t -70.54 -26.37 63.53 Favored 'General case' 0 CA--C 1.549 0.926 0 O-C-N 123.324 0.39 . . . . 0.0 110.637 178.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 322' ' ' LEU . . . . . 0.522 HD13 HD13 ' A' ' 313' ' ' LEU . 68.6 mt -85.7 -12.17 51.87 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.362 0.665 . . . . 0.0 111.41 175.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp 60.02 35.74 21.45 Favored 'General case' 0 CA--C 1.561 1.394 0 C-N-CA 124.712 1.205 . . . . 0.0 111.52 175.224 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 60.5 mt -69.31 169.75 11.65 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.198 0.999 . . . . 0.0 111.26 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 325' ' ' GLY . . . . . 0.45 ' H ' ' HB3' ' A' ' 328' ' ' ASP . . . -154.89 -170.18 20.3 Favored Glycine 0 C--N 1.348 1.212 0 CA-C-N 116.411 -0.358 . . . . 0.0 113.084 -172.61 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 14.9 m -81.56 -28.45 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 123.683 0.793 . . . . 0.0 111.542 -176.378 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -99.33 -23.78 15.04 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.17 0.988 . . . . 0.0 110.041 176.203 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 328' ' ' ASP . . . . . 0.45 ' HB3' ' H ' ' A' ' 325' ' ' GLY . 17.3 t70 -72.19 120.09 17.31 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.889 0.876 . . . . 0.0 110.245 -175.371 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 329' ' ' ILE . . . . . 0.684 HG12 ' HG2' ' A' ' 268' ' ' LYS . 5.2 mt -100.6 134.36 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 123.819 0.848 . . . . 0.0 111.812 -166.559 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 42.8 pt -126.3 126.34 69.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 123.471 0.708 . . . . 0.0 110.345 172.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -73.89 110.44 8.19 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.485 1.114 . . . . 0.0 112.132 -175.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 332' ' ' CYS . . . . . 0.478 ' SG ' HD12 ' A' ' 304' ' ' ILE . 41.6 t -74.57 89.89 2.22 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.563 0.745 . . . . 0.0 109.878 167.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 333' ' ' VAL . . . . . 0.505 HG21 HD12 ' A' ' 307' ' ' LEU . 93.1 t -100.61 111.1 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 123.226 0.61 . . . . 0.0 109.483 -178.03 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 334' ' ' VAL . . . . . 0.488 HG11 HG11 ' A' ' 299' ' ' VAL . 57.9 t -83.41 108.91 16.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 123.033 0.533 . . . . 0.0 109.947 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 88.9 mt -115.17 156.38 25.41 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.881 0.872 . . . . 0.0 110.58 178.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 336' ' ' THR . . . . . . . . . . . . . 7.1 t -80.67 71.13 7.55 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-O 122.524 1.154 . . . . 0.0 110.032 176.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 21.9 p -79.53 112.25 16.6 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 114.685 -1.143 . . . . 0.0 111.434 -173.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 58.0 m . . . . . 0 C--O 1.257 1.467 0 C-N-CA 124.247 1.019 . . . . 0.0 108.499 175.76 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 . . . . . 0 N--CA 1.483 1.209 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 80.78 -72.26 2.73 Favored Glycine 0 C--N 1.348 1.212 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 -169.349 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 246' ' ' GLN . . . . . 0.676 ' HG2' ' H ' ' A' ' 247' ' ' GLU . 53.8 tt0 -90.85 -168.34 2.05 Favored 'General case' 0 CA--C 1.562 1.417 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 161.268 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 247' ' ' GLU . . . . . 0.676 ' H ' ' HG2' ' A' ' 246' ' ' GLN . 38.2 tt0 78.2 -4.84 2.15 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 124.645 1.178 . . . . 0.0 111.256 175.652 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -83.39 103.68 12.95 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 177.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -124.98 112.66 16.84 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 178.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 27.7 m -57.83 110.78 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.051 0 O-C-N 124.167 0.917 . . . . 0.0 111.192 -171.189 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 251' ' ' VAL . . . . . 0.597 HG12 HG22 ' A' ' 253' ' ' VAL . 24.5 t -76.09 86.96 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.561 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 175.204 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 35.7 tp -78.64 75.66 5.15 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.369 -172.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.597 HG22 HG12 ' A' ' 251' ' ' VAL . 16.0 m -146.86 148.59 16.61 Favored 'Isoleucine or valine' 0 C--O 1.247 0.965 0 C-N-CA 125.229 1.411 . . . . 0.0 108.678 175.428 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -170.13 172.96 6.11 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.762 0.825 . . . . 0.0 109.768 175.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 133.96 -69.5 0.53 Allowed Glycine 0 CA--C 1.533 1.174 0 N-CA-C 110.901 -0.879 . . . . 0.0 110.901 -178.342 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.08 169.17 21.22 Favored 'Trans proline' 0 C--N 1.38 2.217 0 C-N-CA 122.95 2.434 . . . . 0.0 112.585 177.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 16.5 p -66.78 99.48 0.62 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.221 0.608 . . . . 0.0 109.696 175.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 94.1 mt -100.23 99.27 9.16 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 123.588 0.755 . . . . 0.0 109.291 177.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -67.51 -19.36 48.85 Favored 'Trans proline' 0 C--N 1.383 2.356 0 C-N-CA 122.767 2.312 . . . . 0.0 112.771 176.184 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -68.69 96.35 0.72 Allowed 'General case' 0 C--N 1.354 0.787 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 174.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 23.1 m -89.87 134.37 32.13 Favored Pre-proline 0 CA--C 1.546 0.809 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.756 -177.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -60.63 152.81 66.2 Favored 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 122.345 2.03 . . . . 0.0 111.59 172.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -71.65 109.14 5.37 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.687 0.795 . . . . 0.0 111.063 -173.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 1.6 mp -91.21 169.24 11.0 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.949 177.064 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 265' ' ' PHE . . . . . 0.495 ' CE1' ' HG2' ' A' ' 282' ' ' MET . 10.1 p90 -150.45 138.94 12.64 Favored Pre-proline 0 CA--C 1.545 0.78 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 170.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -62.54 94.38 0.14 Allowed 'Trans proline' 0 C--N 1.377 2.03 0 C-N-CA 122.616 2.211 . . . . 0.0 111.555 173.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 267' ' ' LEU . . . . . 0.538 HD12 HG13 ' A' ' 269' ' ' ILE . 0.9 OUTLIER -59.69 125.82 25.15 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 174.266 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.579 ' HG2' HG12 ' A' ' 329' ' ' ILE . 4.8 tppp? -88.41 102.64 15.08 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.348 0.659 . . . . 0.0 110.396 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 269' ' ' ILE . . . . . 0.538 HG13 HD12 ' A' ' 267' ' ' LEU . 2.1 mp -103.63 129.8 55.07 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 173.439 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 30.8 ttp180 -90.45 109.37 20.5 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-O 121.303 0.573 . . . . 0.0 110.192 174.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 271' ' ' CYS . . . . . 0.709 ' SG ' HD21 ' A' ' 297' ' ' LEU . 49.2 t -77.87 -179.59 6.11 Favored 'General case' 0 CA--C 1.55 0.95 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.315 172.379 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 272' ' ' ARG . . . . . 0.401 ' N ' ' SG ' ' A' ' 271' ' ' CYS . 15.9 ptt-85 -53.24 -31.67 44.53 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.978 1.311 . . . . 0.0 113.805 -178.486 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -161.68 27.98 0.12 Allowed 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.694 0.798 . . . . 0.0 110.279 177.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 274' ' ' ASP . . . . . 0.462 ' HB3' ' HB3' ' A' ' 271' ' ' CYS . 34.8 t70 -144.76 158.68 43.69 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.447 0.699 . . . . 0.0 109.795 -172.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 66.2 mt -119.92 101.47 7.89 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.652 0.781 . . . . 0.0 109.81 176.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 276' ' ' VAL . . . . . 0.504 HG21 ' SD ' ' A' ' 293' ' ' MET . 65.0 t -83.75 125.57 40.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.924 179.577 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 86.1 mtm180 -118.86 104.83 10.9 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 175.41 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.494 HD21 ' HA ' ' A' ' 289' ' ' VAL . 4.3 pp -116.21 131.99 23.51 Favored Pre-proline 0 N--CA 1.487 1.398 0 CA-C-N 118.182 0.446 . . . . 0.0 110.744 178.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -65.9 115.95 3.71 Favored 'Trans proline' 0 C--N 1.381 2.24 0 C-N-CA 122.627 2.218 . . . . 0.0 110.736 177.225 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.714 HD21 ' HG3' ' A' ' 319' ' ' PRO . 0.4 OUTLIER -136.66 148.29 47.32 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.521 1.128 . . . . 0.0 109.463 -174.688 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -88.18 144.37 26.5 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 178.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 282' ' ' MET . . . . . 0.5 ' HB3' ' HB2' ' A' ' 320' ' ' ARG . 16.2 mtp -66.3 -27.41 67.9 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 118.154 0.434 . . . . 0.0 111.68 -177.105 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 35.1 m -79.16 -12.17 59.98 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.52 0.728 . . . . 0.0 112.01 176.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 25.6 tp10 -85.67 130.17 52.0 Favored Pre-proline 0 N--CA 1.472 0.632 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 178.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -65.01 167.32 16.24 Favored 'Trans proline' 0 C--N 1.381 2.267 0 C-N-CA 122.498 2.132 . . . . 0.0 113.119 178.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.402 ' O ' HG22 ' A' ' 289' ' ' VAL . 91.5 mt -68.48 -9.29 47.92 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.502 -178.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 26.3 tp60 -53.85 -27.98 33.13 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.563 0.745 . . . . 0.0 111.444 174.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 288' ' ' SER . . . . . 0.467 ' HB2' HD12 ' A' ' 280' ' ' LEU . 67.0 m -65.92 -47.08 75.93 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.709 0.804 . . . . 0.0 112.075 175.184 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.494 ' HA ' HD21 ' A' ' 278' ' ' LEU . 17.1 m -71.55 -34.31 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 177.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 290' ' ' VAL . . . . . 0.569 HG13 ' HB ' ' A' ' 304' ' ' ILE . 37.5 t -61.61 -45.07 99.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.667 1.187 . . . . 0.0 110.95 177.483 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -63.74 -48.95 74.94 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.04 0.936 . . . . 0.0 110.79 -178.092 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 49.4 t-80 -64.36 -44.9 89.98 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.18 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 293' ' ' MET . . . . . 0.504 ' SD ' HG21 ' A' ' 276' ' ' VAL . 90.9 mmm -68.34 -32.08 71.94 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 123.724 0.64 . . . . 0.0 111.42 -177.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -63.76 -43.36 96.63 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 123.698 0.624 . . . . 0.0 110.404 176.255 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 29.2 m -73.5 -33.08 64.62 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 123.272 0.629 . . . . 0.0 111.254 176.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 58.4 t60 -66.2 -34.43 78.0 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.183 0.993 . . . . 0.0 110.719 -178.435 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 297' ' ' LEU . . . . . 0.709 HD21 ' SG ' ' A' ' 271' ' ' CYS . 62.2 mt -102.31 -21.35 14.33 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.921 0.888 . . . . 0.0 111.83 -177.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 85.36 24.42 43.62 Favored Glycine 0 N--CA 1.475 1.258 0 O-C-N 123.007 0.192 . . . . 0.0 112.999 -178.123 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 299' ' ' VAL . . . . . 0.495 HG11 HG11 ' A' ' 334' ' ' VAL . 31.4 m -109.87 -179.42 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 124.013 0.925 . . . . 0.0 110.808 177.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 19.2 m -82.82 146.29 52.17 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 123.542 0.737 . . . . 0.0 110.277 178.224 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -58.92 -27.35 84.29 Favored 'Trans proline' 0 C--N 1.386 2.545 0 C-N-CA 123.001 2.468 . . . . 0.0 112.295 173.077 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 40.2 p -67.06 -17.39 64.87 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.847 0.859 . . . . 0.0 112.021 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 89.5 mtt180 -95.68 -25.79 15.98 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.041 0.937 . . . . 0.0 111.926 -176.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 304' ' ' ILE . . . . . 0.569 ' HB ' HG13 ' A' ' 290' ' ' VAL . 32.9 mm -72.51 115.66 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 122.601 0.36 . . . . 0.0 110.363 -177.755 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 27.0 tp -124.17 122.32 37.49 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.241 0.616 . . . . 0.0 109.367 177.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 306' ' ' LEU . . . . . 0.427 ' HG ' HD12 ' A' ' 330' ' ' ILE . 2.2 mm? -89.16 123.31 33.3 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -177.754 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 307' ' ' LEU . . . . . 0.516 HD12 HG21 ' A' ' 333' ' ' VAL . 72.7 mt -129.74 112.89 14.08 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.469 0.708 . . . . 0.0 109.622 -177.173 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -84.7 92.55 8.22 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 173.037 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 70.43 -94.59 0.49 Allowed Glycine 0 C--N 1.346 1.088 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 -174.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -133.69 82.67 2.0 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.577 0.751 . . . . 0.0 109.411 174.009 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 12.1 t -166.0 138.84 4.09 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 174.032 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -90.74 114.03 26.28 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-O 120.697 0.284 . . . . 0.0 110.698 -174.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 46.0 mt -103.74 114.49 28.8 Favored 'General case' 0 C--O 1.245 0.842 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 177.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 12.8 m -72.6 143.9 85.51 Favored Pre-proline 0 CA--C 1.553 1.079 0 C-N-CA 124.215 1.006 . . . . 0.0 111.219 -173.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 315' ' ' PRO . . . . . 0.542 ' HB3' HG21 ' A' ' 290' ' ' VAL . 36.5 Cg_endo -62.63 -28.65 77.1 Favored 'Trans proline' 0 C--N 1.381 2.263 0 C-N-CA 123.015 2.477 . . . . 0.0 112.357 175.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 4.7 m -73.67 -28.72 61.9 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.09 0.956 . . . . 0.0 111.329 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -78.29 154.78 30.62 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.532 0.733 . . . . 0.0 110.756 -178.044 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 318' ' ' THR . . . . . . . . . . . . . 82.8 p -99.46 152.9 37.96 Favored Pre-proline 0 CA--C 1.545 0.764 0 C-N-CA 123.495 0.718 . . . . 0.0 109.901 -178.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 319' ' ' PRO . . . . . 0.714 ' HG3' HD21 ' A' ' 280' ' ' LEU . 60.9 Cg_endo -67.92 -9.69 26.44 Favored 'Trans proline' 0 C--N 1.363 1.339 0 C-N-CA 122.975 2.45 . . . . 0.0 113.324 174.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 320' ' ' ARG . . . . . 0.5 ' HB2' ' HB3' ' A' ' 282' ' ' MET . 44.5 ttm180 -75.11 -48.2 24.95 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 117.786 0.266 . . . . 0.0 110.474 178.264 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 14.6 t -68.74 -22.88 64.29 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 122.659 0.383 . . . . 0.0 110.946 179.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 322' ' ' LEU . . . . . 0.449 ' HB2' ' HG ' ' A' ' 324' ' ' LEU . 53.2 mt -92.05 -16.13 26.86 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.73 0.812 . . . . 0.0 111.511 176.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp 65.06 31.94 10.71 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.753 1.221 . . . . 0.0 112.57 -179.223 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.449 ' HG ' ' HB2' ' A' ' 322' ' ' LEU . 42.0 mt -67.54 165.12 17.51 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.682 0.793 . . . . 0.0 110.839 175.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 325' ' ' GLY . . . . . 0.486 ' H ' ' HB3' ' A' ' 328' ' ' ASP . . . -158.63 -169.48 22.13 Favored Glycine 0 C--N 1.342 0.884 0 CA-C-N 116.046 -0.524 . . . . 0.0 112.699 -173.137 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 21.5 m -77.25 -25.72 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.542 0.737 . . . . 0.0 110.46 178.19 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -94.28 -19.44 20.69 Favored 'General case' 0 C--N 1.353 0.734 0 C-N-CA 124.164 0.985 . . . . 0.0 110.957 179.074 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 328' ' ' ASP . . . . . 0.486 ' HB3' ' H ' ' A' ' 325' ' ' GLY . 13.1 t70 -82.77 128.4 34.36 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 178.086 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 329' ' ' ILE . . . . . 0.579 HG12 ' HG2' ' A' ' 268' ' ' LYS . 9.4 mt -115.21 113.87 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 123.107 0.563 . . . . 0.0 109.852 -170.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 330' ' ' ILE . . . . . 0.427 HD12 ' HG ' ' A' ' 306' ' ' LEU . 38.6 pt -108.43 125.47 65.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-O 121.083 0.468 . . . . 0.0 110.79 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -72.34 116.96 13.4 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.839 0.856 . . . . 0.0 111.387 -175.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 332' ' ' CYS . . . . . 0.536 ' SG ' HD12 ' A' ' 304' ' ' ILE . 37.6 t -74.27 92.1 2.22 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 123.307 0.643 . . . . 0.0 109.415 169.599 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 333' ' ' VAL . . . . . 0.516 HG21 HD12 ' A' ' 307' ' ' LEU . 60.5 t -101.36 109.84 26.74 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -178.25 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 334' ' ' VAL . . . . . 0.495 HG11 HG11 ' A' ' 299' ' ' VAL . 57.6 t -79.31 93.91 1.77 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.451 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.694 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 87.4 mt -91.74 97.36 10.96 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.565 0.698 . . . . 0.0 109.508 172.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 336' ' ' THR . . . . . . . . . . . . . 10.4 t -79.61 -22.81 43.18 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 114.502 -1.226 . . . . 0.0 109.65 176.347 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 42.8 p -71.23 103.09 2.7 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.556 0.742 . . . . 0.0 109.548 173.138 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 C--O 1.251 1.149 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -179.659 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 23.0 mp0 . . . . . 0 N--CA 1.479 1.019 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -107.15 130.29 10.09 Favored Glycine 0 C--N 1.343 0.938 0 CA-C-O 119.449 -0.639 . . . . 0.0 111.557 178.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -78.78 79.42 5.19 Favored 'General case' 0 C--N 1.354 0.797 0 CA-C-O 122.029 0.918 . . . . 0.0 110.168 -178.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -104.0 25.45 9.93 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 114.662 -1.154 . . . . 0.0 109.62 174.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -72.55 84.21 1.13 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.354 1.062 . . . . 0.0 110.241 -178.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -127.52 144.9 51.01 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 114.842 -1.072 . . . . 0.0 108.8 174.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 19.6 m -94.05 59.19 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 CA-C-O 121.791 0.805 . . . . 0.0 110.186 178.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 38.1 t -69.14 95.82 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.578 -177.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 52.7 tp -152.34 95.88 2.1 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 -175.099 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 7.1 m -111.94 94.4 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 CA-C-O 122.034 0.921 . . . . 0.0 109.728 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.69 -169.03 1.51 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.196 0.998 . . . . 0.0 109.959 -178.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 105.76 101.19 2.69 Favored Glycine 0 C--N 1.339 0.734 0 CA-C-O 119.029 -0.873 . . . . 0.0 110.974 -176.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -73.83 171.57 17.6 Favored 'Trans proline' 0 C--N 1.376 1.986 0 C-N-CA 122.647 2.231 . . . . 0.0 112.08 -177.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 13.1 m -69.19 98.05 0.98 Allowed 'General case' 0 C--N 1.347 0.487 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 176.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 86.1 mt -91.37 107.74 23.81 Favored Pre-proline 0 CA--C 1.544 0.713 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 174.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -62.49 -23.12 74.78 Favored 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 122.728 2.285 . . . . 0.0 111.719 169.047 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -81.6 127.61 33.05 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 124.674 1.19 . . . . 0.0 110.15 176.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 67.6 m -68.59 126.12 92.42 Favored Pre-proline 0 CA--C 1.548 0.881 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 168.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.78 143.05 82.3 Favored 'Trans proline' 0 C--N 1.379 2.163 0 C-N-CA 122.584 2.19 . . . . 0.0 111.01 174.535 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 84.7 mtt180 -66.69 81.43 0.1 Allowed 'General case' 0 N--CA 1.483 1.205 0 CA-C-O 122.024 0.916 . . . . 0.0 112.299 -169.13 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.485 HD23 ' HG2' ' A' ' 281' ' ' ARG . 45.9 mt -72.22 125.37 27.15 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 114.736 -1.12 . . . . 0.0 108.536 174.731 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -109.18 142.23 25.15 Favored Pre-proline 0 C--O 1.247 0.924 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 173.031 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -67.09 96.01 0.38 Allowed 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 122.275 1.983 . . . . 0.0 111.363 175.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 267' ' ' LEU . . . . . 0.514 HD12 HG13 ' A' ' 269' ' ' ILE . 1.0 OUTLIER -62.06 129.07 39.12 Favored 'General case' 0 C--O 1.246 0.899 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 174.656 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.495 ' HG2' HG12 ' A' ' 329' ' ' ILE . 2.6 tppp? -94.37 102.32 14.29 Favored 'General case' 0 C--O 1.241 0.653 0 O-C-N 123.751 0.657 . . . . 0.0 109.872 -176.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 269' ' ' ILE . . . . . 0.514 HG13 HD12 ' A' ' 267' ' ' LEU . 1.5 mp -104.48 114.19 43.42 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 176.664 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 33.1 ttp180 -75.54 104.28 6.03 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 175.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 271' ' ' CYS . . . . . 0.601 ' SG ' HD21 ' A' ' 297' ' ' LEU . 38.1 t -72.59 175.98 5.87 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.27 1.028 . . . . 0.0 110.069 174.445 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 25.7 ptt180 -57.13 -28.05 62.37 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.017 0.927 . . . . 0.0 113.142 -178.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -155.45 30.14 0.38 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.376 0.67 . . . . 0.0 111.175 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -160.56 164.0 32.33 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 122.696 0.398 . . . . 0.0 110.907 -173.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -113.54 103.08 10.9 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.258 1.023 . . . . 0.0 108.948 171.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 72.8 t -83.68 130.61 35.54 Favored 'Isoleucine or valine' 0 C--N 1.343 0.301 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 177.286 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 76.4 mtt85 -124.32 99.49 6.23 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -179.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.493 HD21 ' HA ' ' A' ' 289' ' ' VAL . 4.3 pp -111.8 142.36 26.53 Favored Pre-proline 0 N--CA 1.489 1.476 0 CA-C-N 117.917 0.326 . . . . 0.0 110.324 -178.495 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -69.26 115.57 4.09 Favored 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 122.282 1.988 . . . . 0.0 110.502 177.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.733 HD21 ' HG3' ' A' ' 319' ' ' PRO . 0.9 OUTLIER -138.34 149.94 46.11 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.835 0.854 . . . . 0.0 109.992 -176.481 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 281' ' ' ARG . . . . . 0.485 ' HG2' HD23 ' A' ' 264' ' ' LEU . 16.2 mmm180 -94.36 151.1 19.66 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.104 0.962 . . . . 0.0 111.092 178.001 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 282' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -57.1 -41.31 78.67 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.122 0.569 . . . . 0.0 111.118 175.223 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 19.6 m -76.25 -17.83 59.3 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.378 1.071 . . . . 0.0 112.554 -177.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 284' ' ' GLU . . . . . 0.451 ' O ' ' HD2' ' A' ' 319' ' ' PRO . 8.5 tp10 -72.49 130.29 86.03 Favored Pre-proline 0 N--CA 1.476 0.838 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 176.293 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -66.23 166.7 20.37 Favored 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 121.937 1.758 . . . . 0.0 111.807 172.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.482 ' O ' HG23 ' A' ' 290' ' ' VAL . 65.3 mt -66.27 -15.12 62.95 Favored 'General case' 0 C--O 1.215 -0.751 0 CA-C-O 118.932 -0.556 . . . . 0.0 111.779 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 -50.54 -26.2 4.95 Favored 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 123.967 0.907 . . . . 0.0 112.204 178.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 288' ' ' SER . . . . . 0.468 ' HB3' HD12 ' A' ' 280' ' ' LEU . 29.5 t -61.61 -57.2 12.96 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.087 0.955 . . . . 0.0 110.939 171.774 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.493 ' HA ' HD21 ' A' ' 278' ' ' LEU . 13.2 m -68.03 -29.68 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 122.494 0.317 . . . . 0.0 110.908 -179.376 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 290' ' ' VAL . . . . . 0.601 HG13 ' HB ' ' A' ' 304' ' ' ILE . 78.1 t -66.2 -55.37 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 123.951 0.9 . . . . 0.0 110.35 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -64.0 -37.66 88.25 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.276 -179.118 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 62.5 t60 -68.72 -47.63 65.87 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 122.982 0.513 . . . . 0.0 110.978 -177.079 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 293' ' ' MET . . . . . 0.472 ' HG3' HG21 ' A' ' 269' ' ' ILE . 91.0 mmm -65.9 -32.68 74.32 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.276 0.63 . . . . 0.0 110.966 178.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -63.6 -53.08 57.26 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 123.876 0.735 . . . . 0.0 110.964 176.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 55.4 m -64.46 -29.49 70.53 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.814 0.846 . . . . 0.0 111.176 179.305 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 71.1 t60 -71.42 -46.25 60.62 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.614 0.766 . . . . 0.0 110.997 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 297' ' ' LEU . . . . . 0.601 HD21 ' SG ' ' A' ' 271' ' ' CYS . 72.7 mt -91.74 -3.56 56.07 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.733 0.813 . . . . 0.0 111.797 -176.284 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 77.27 22.68 70.14 Favored Glycine 0 C--N 1.349 1.292 0 C-N-CA 123.206 0.432 . . . . 0.0 113.196 175.006 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 299' ' ' VAL . . . . . 0.518 HG11 HG11 ' A' ' 334' ' ' VAL . 25.0 m -112.07 -179.23 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 124.777 1.231 . . . . 0.0 110.832 178.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 51.7 m -87.81 147.61 41.6 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 123.831 0.852 . . . . 0.0 110.769 178.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.36 -25.9 75.06 Favored 'Trans proline' 0 C--N 1.391 2.773 0 C-N-CA 123.215 2.61 . . . . 0.0 111.909 173.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 9.2 m -61.1 -22.47 64.66 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 123.817 0.847 . . . . 0.0 111.995 178.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 46.6 mtt180 -97.83 -19.88 17.87 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.485 0.714 . . . . 0.0 112.385 -174.097 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 304' ' ' ILE . . . . . 0.601 ' HB ' HG13 ' A' ' 290' ' ' VAL . 37.0 mm -77.39 99.31 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 CA-C-O 121.101 0.477 . . . . 0.0 110.28 -177.619 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 305' ' ' LEU . . . . . 0.434 HD22 HD11 ' A' ' 335' ' ' LEU . 29.2 tp -101.55 112.32 24.84 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.843 0.857 . . . . 0.0 109.209 178.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -85.05 120.94 27.13 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 307' ' ' LEU . . . . . 0.487 HD12 HG21 ' A' ' 333' ' ' VAL . 70.8 mt -129.41 116.2 18.66 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.035 0.934 . . . . 0.0 108.868 -177.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -87.56 85.71 7.13 Favored 'General case' 0 C--O 1.244 0.764 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 174.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 67.62 -96.98 0.38 Allowed Glycine 0 C--N 1.342 0.898 0 CA-C-N 115.154 -0.93 . . . . 0.0 112.991 -179.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -110.21 11.68 23.54 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.528 0.731 . . . . 0.0 112.06 -174.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 11.4 t -116.98 152.85 33.71 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 117.863 0.301 . . . . 0.0 110.244 176.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -105.36 129.42 53.69 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.2 0.6 . . . . 0.0 109.818 178.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.425 HD22 HD22 ' A' ' 322' ' ' LEU . 49.8 mt -113.33 135.17 54.14 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.353 0.661 . . . . 0.0 109.921 -179.049 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 20.1 m -80.65 143.36 54.54 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 123.457 0.703 . . . . 0.0 110.717 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -63.26 -29.88 73.47 Favored 'Trans proline' 0 C--N 1.384 2.408 0 C-N-CA 122.866 2.377 . . . . 0.0 112.127 174.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 34.1 p -88.13 -1.36 57.96 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.273 1.029 . . . . 0.0 111.944 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -88.58 153.17 21.35 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.274 0.63 . . . . 0.0 109.981 175.168 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 318' ' ' THR . . . . . . . . . . . . . 82.6 p -99.37 142.79 25.24 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 123.372 0.669 . . . . 0.0 109.979 -178.213 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 319' ' ' PRO . . . . . 0.733 ' HG3' HD21 ' A' ' 280' ' ' LEU . 29.8 Cg_endo -60.76 -13.69 27.81 Favored 'Trans proline' 0 C--N 1.369 1.65 0 C-N-CA 123.441 2.761 . . . . 0.0 113.143 172.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 53.1 ttt180 -67.07 -55.2 15.32 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.167 0.587 . . . . 0.0 110.105 174.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 10.8 t -71.09 -21.06 62.27 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.06 -177.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 322' ' ' LEU . . . . . 0.445 ' HB2' ' HG ' ' A' ' 324' ' ' LEU . 53.5 mt -93.76 -10.19 35.07 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.657 0.783 . . . . 0.0 111.518 176.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 11.3 mptt 62.15 25.65 15.37 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 125.129 1.371 . . . . 0.0 112.592 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.446 HD13 HD13 ' A' ' 330' ' ' ILE . 33.3 mt -66.79 159.09 28.79 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.363 0.665 . . . . 0.0 110.276 177.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 325' ' ' GLY . . . . . 0.43 ' H ' ' HB3' ' A' ' 328' ' ' ASP . . . -157.06 -157.17 8.23 Favored Glycine 0 C--O 1.242 0.598 0 CA-C-N 116.233 -0.439 . . . . 0.0 112.466 -173.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 17.6 m -83.31 -36.67 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 123.258 0.623 . . . . 0.0 110.625 -179.316 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -88.85 -17.64 29.27 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.053 0.941 . . . . 0.0 110.727 178.309 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 328' ' ' ASP . . . . . 0.43 ' HB3' ' H ' ' A' ' 325' ' ' GLY . 3.9 t70 -90.39 115.96 27.97 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.628 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 329' ' ' ILE . . . . . 0.495 HG12 ' HG2' ' A' ' 268' ' ' LYS . 16.0 mt -114.52 120.95 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 123.144 0.578 . . . . 0.0 111.353 -163.612 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 330' ' ' ILE . . . . . 0.446 HD13 HD13 ' A' ' 324' ' ' LEU . 35.8 pt -108.95 137.08 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 123.344 0.657 . . . . 0.0 111.311 -176.775 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -79.9 119.46 22.79 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.724 0.81 . . . . 0.0 111.713 -176.495 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 332' ' ' CYS . . . . . 0.524 ' SG ' HD12 ' A' ' 304' ' ' ILE . 26.9 t -77.79 90.27 4.05 Favored 'General case' 0 C--O 1.243 0.741 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 167.548 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 333' ' ' VAL . . . . . 0.487 HG21 HD12 ' A' ' 307' ' ' LEU . 28.3 t -97.27 109.45 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -178.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 334' ' ' VAL . . . . . 0.518 HG11 HG11 ' A' ' 299' ' ' VAL . 40.0 t -85.08 100.96 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.03 -175.379 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 335' ' ' LEU . . . . . 0.434 HD11 HD22 ' A' ' 305' ' ' LEU . 3.4 pp -142.31 155.35 45.19 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.764 0.426 . . . . 0.0 111.087 -179.103 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 336' ' ' THR . . . . . . . . . . . . . 3.5 t -131.19 94.69 3.62 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 174.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 19.4 m -71.06 80.34 0.67 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.774 0.83 . . . . 0.0 109.697 178.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 42.7 m . . . . . 0 C--O 1.249 1.05 0 C-N-CA 124.518 1.127 . . . . 0.0 108.356 -175.12 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 . . . . . 0 N--CA 1.481 1.102 0 CA-C-O 120.718 0.294 . . . . 0.0 110.412 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -166.55 63.62 0.21 Allowed Glycine 0 C--N 1.343 0.967 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 -178.386 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -114.43 97.61 6.41 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.417 1.087 . . . . 0.0 110.397 -175.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -87.31 66.21 9.07 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 175.234 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -73.42 -32.05 64.19 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.314 175.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -99.3 114.5 27.39 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 166.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 31.8 m -75.63 148.73 7.21 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 122.906 0.482 . . . . 0.0 110.938 -178.126 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 5.7 p -154.55 126.38 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 123.257 0.623 . . . . 0.0 110.214 -175.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 14.6 tp -128.97 29.86 5.14 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 121.768 0.794 . . . . 0.0 109.352 178.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 3.5 p -142.83 123.27 10.43 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 124.425 1.09 . . . . 0.0 108.837 178.172 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 61.28 26.0 15.9 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 124.199 0.999 . . . . 0.0 112.573 178.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -133.12 109.1 0.8 Allowed Glycine 0 C--N 1.349 1.257 0 CA-C-O 119.059 -0.856 . . . . 0.0 111.697 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -87.41 11.07 3.31 Favored 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 123.138 2.559 . . . . 0.0 112.229 177.232 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 31.4 p -69.95 141.43 53.05 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 123.925 0.89 . . . . 0.0 110.691 178.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 85.2 mt -114.67 99.56 51.87 Favored Pre-proline 0 C--O 1.244 0.79 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 175.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -48.71 -35.27 29.71 Favored 'Trans proline' 0 C--N 1.381 2.276 0 C-N-CA 123.304 2.669 . . . . 0.0 111.823 170.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -73.3 92.04 1.76 Allowed 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 114.534 -1.212 . . . . 0.0 108.591 172.057 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 54.5 m -100.63 127.13 33.4 Favored Pre-proline 0 CA--C 1.547 0.859 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.163 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -70.4 111.74 3.02 Favored 'Trans proline' 0 C--N 1.377 2.069 0 C-N-CA 122.207 1.938 . . . . 0.0 110.712 175.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 24.8 ptt-85 -58.69 142.14 50.63 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.258 1.023 . . . . 0.0 112.147 -175.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.456 HD23 HH11 ' A' ' 281' ' ' ARG . 0.9 OUTLIER -126.6 136.12 52.11 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.948 0.899 . . . . 0.0 109.165 -175.298 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -113.41 142.56 27.75 Favored Pre-proline 0 N--CA 1.481 1.092 0 C-N-CA 123.053 0.541 . . . . 0.0 109.841 176.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 266' ' ' PRO . . . . . 0.412 ' O ' ' HA ' ' A' ' 326' ' ' VAL . 23.5 Cg_exo -63.3 100.43 0.26 Allowed 'Trans proline' 0 C--N 1.379 2.162 0 C-N-CA 122.914 2.409 . . . . 0.0 112.362 175.494 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 267' ' ' LEU . . . . . 0.518 HD23 HD22 ' A' ' 280' ' ' LEU . 0.4 OUTLIER -71.23 122.41 20.17 Favored 'General case' 0 CA--C 1.551 0.99 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 173.583 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.611 ' HG2' HG12 ' A' ' 329' ' ' ILE . 13.8 tppt? -85.52 119.97 26.46 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.528 0.731 . . . . 0.0 110.081 179.299 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 16.4 mt -121.18 138.56 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 124.539 1.136 . . . . 0.0 109.032 179.051 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 270' ' ' ARG . . . . . 0.436 ' HB2' HG22 ' A' ' 329' ' ' ILE . 29.7 ttp180 -107.82 103.88 13.24 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 123.715 0.806 . . . . 0.0 109.443 177.229 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 271' ' ' CYS . . . . . 0.77 ' SG ' HD21 ' A' ' 297' ' ' LEU . 49.8 t -77.93 179.53 6.68 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 124.482 1.113 . . . . 0.0 110.616 176.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 272' ' ' ARG . . . . . 0.42 ' N ' ' SG ' ' A' ' 271' ' ' CYS . 26.8 ptt180 -54.22 -31.87 54.31 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 125.414 1.486 . . . . 0.0 113.192 -179.149 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -162.82 33.83 0.1 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.981 0.913 . . . . 0.0 110.362 -178.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -157.97 158.05 34.2 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.353 0.661 . . . . 0.0 110.097 -170.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -117.78 123.21 45.43 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.055 0.942 . . . . 0.0 108.881 173.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 276' ' ' VAL . . . . . 0.533 HG21 ' SD ' ' A' ' 293' ' ' MET . 91.8 t -109.73 121.87 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 124.096 0.958 . . . . 0.0 109.818 178.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 20.7 mtm180 -111.51 122.17 47.13 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 169.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.462 HD11 HG12 ' A' ' 289' ' ' VAL . 4.6 pp -131.43 138.78 33.51 Favored Pre-proline 0 N--CA 1.476 0.85 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 175.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.89 94.22 0.87 Allowed 'Trans proline' 0 C--N 1.367 1.511 0 C-N-CA 122.326 2.017 . . . . 0.0 111.312 -177.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.69 HD21 ' HG3' ' A' ' 319' ' ' PRO . 2.8 tt -103.11 156.95 17.33 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.629 1.172 . . . . 0.0 110.287 -178.25 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 281' ' ' ARG . . . . . 0.456 HH11 HD23 ' A' ' 264' ' ' LEU . 0.1 OUTLIER -99.43 144.79 28.13 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.177 0.991 . . . . 0.0 110.087 -179.55 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 282' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -58.07 -34.18 69.85 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 123.918 0.887 . . . . 0.0 112.372 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 16.1 m -78.57 -22.45 47.12 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.77 0.828 . . . . 0.0 111.78 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 284' ' ' GLU . . . . . 0.427 ' HB2' ' HB2' ' A' ' 281' ' ' ARG . 8.2 tp10 -75.22 130.77 79.54 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 124.084 0.953 . . . . 0.0 109.647 -176.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -68.48 169.83 16.3 Favored 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 122.229 1.953 . . . . 0.0 112.209 174.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.41 ' O ' HG23 ' A' ' 290' ' ' VAL . 87.4 mt -71.01 -6.63 40.43 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.073 0.549 . . . . 0.0 111.688 -179.25 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 26.5 tp60 -57.06 -26.1 59.8 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.617 0.767 . . . . 0.0 110.526 173.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 288' ' ' SER . . . . . 0.409 ' HB3' HD12 ' A' ' 280' ' ' LEU . 40.6 t -61.46 -55.9 26.16 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.591 1.156 . . . . 0.0 111.423 172.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.462 HG12 HD11 ' A' ' 278' ' ' LEU . 21.0 m -67.62 -32.5 57.16 Favored 'Isoleucine or valine' 0 C--N 1.359 1.021 0 CA-C-N 116.695 -0.229 . . . . 0.0 110.429 -179.354 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 290' ' ' VAL . . . . . 0.548 HG13 ' HB ' ' A' ' 304' ' ' ILE . 40.0 t -59.53 -48.02 88.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 124.576 1.15 . . . . 0.0 110.842 176.32 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -59.81 -48.08 83.11 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 124.243 0.964 . . . . 0.0 110.973 -179.071 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 13.9 t60 -65.64 -46.29 79.76 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.99 -178.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 293' ' ' MET . . . . . 0.533 ' SD ' HG21 ' A' ' 276' ' ' VAL . 89.5 mmm -67.56 -34.53 77.25 Favored 'General case' 0 N--CA 1.484 1.242 0 O-C-N 123.652 0.595 . . . . 0.0 111.418 -176.194 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -64.3 -42.25 96.45 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 123.733 0.646 . . . . 0.0 110.178 175.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 37.0 m -74.16 -23.86 59.31 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 123.754 0.822 . . . . 0.0 111.169 178.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 77.3 t60 -82.69 -27.39 31.27 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.267 0.627 . . . . 0.0 111.151 -178.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 297' ' ' LEU . . . . . 0.77 HD21 ' SG ' ' A' ' 271' ' ' CYS . 87.8 mt -110.44 -7.33 14.78 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.59 0.756 . . . . 0.0 111.966 -176.116 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 71.66 30.74 65.94 Favored Glycine 0 C--N 1.342 0.894 0 O-C-N 123.315 0.384 . . . . 0.0 112.763 178.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 299' ' ' VAL . . . . . 0.463 HG11 HG11 ' A' ' 334' ' ' VAL . 33.0 m -115.29 -177.95 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.234 1.014 . . . . 0.0 110.232 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 300' ' ' SER . . . . . 0.519 ' HB2' ' HG3' ' A' ' 303' ' ' ARG . 45.1 m -85.3 146.53 45.09 Favored Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 123.37 0.668 . . . . 0.0 110.969 178.047 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -56.65 -30.59 84.21 Favored 'Trans proline' 0 C--N 1.386 2.506 0 C-N-CA 123.036 2.491 . . . . 0.0 112.227 169.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 32.1 t -74.95 -2.42 27.02 Favored 'General case' 0 CA--C 1.556 1.195 0 C-N-CA 123.323 0.649 . . . . 0.0 111.629 -178.082 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 303' ' ' ARG . . . . . 0.519 ' HG3' ' HB2' ' A' ' 300' ' ' SER . 60.4 mtt-85 -101.47 -27.01 13.37 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.849 0.859 . . . . 0.0 111.645 177.371 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 304' ' ' ILE . . . . . 0.548 ' HB ' HG13 ' A' ' 290' ' ' VAL . 33.5 mm -74.26 112.52 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 C-N-CA 122.938 0.495 . . . . 0.0 110.868 -174.445 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 48.3 tp -114.61 117.04 29.75 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.891 0.876 . . . . 0.0 109.331 176.106 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -86.86 127.81 35.04 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 177.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 72.8 mt -132.31 108.15 9.02 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 177.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 308' ' ' PHE . . . . . 0.502 ' HB2' HG22 ' A' ' 330' ' ' ILE . 39.6 t80 -75.55 92.19 2.89 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -176.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 71.56 -78.39 0.59 Allowed Glycine 0 C--N 1.348 1.239 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.065 -177.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -130.52 -12.08 3.93 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.825 0.85 . . . . 0.0 111.79 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 5.1 t -90.91 147.31 23.22 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 118.353 0.524 . . . . 0.0 110.95 -172.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -87.02 121.07 28.98 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.391 0.676 . . . . 0.0 110.534 -174.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.537 HD22 HD22 ' A' ' 322' ' ' LEU . 24.7 mt -114.5 168.75 9.59 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.073 0.549 . . . . 0.0 109.535 175.702 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 45.6 m -126.89 152.87 75.95 Favored Pre-proline 0 N--CA 1.48 1.066 0 C-N-CA 123.317 0.647 . . . . 0.0 109.879 177.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 315' ' ' PRO . . . . . 0.442 ' HB3' HG21 ' A' ' 290' ' ' VAL . 34.9 Cg_exo -58.24 -33.28 97.43 Favored 'Trans proline' 0 C--N 1.382 2.31 0 C-N-CA 122.916 2.411 . . . . 0.0 111.502 170.45 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 53.9 p -81.63 -0.79 44.1 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 114.643 -1.162 . . . . 0.0 112.369 -177.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -96.99 149.08 22.32 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.655 0.782 . . . . 0.0 110.755 179.331 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 318' ' ' THR . . . . . . . . . . . . . 28.2 p -102.39 139.94 20.68 Favored Pre-proline 0 N--CA 1.48 1.068 0 C-N-CA 123.87 0.868 . . . . 0.0 110.257 -177.427 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 319' ' ' PRO . . . . . 0.69 ' HG3' HD21 ' A' ' 280' ' ' LEU . 72.3 Cg_endo -66.12 -14.68 45.47 Favored 'Trans proline' 0 C--N 1.371 1.731 0 C-N-CA 123.753 2.969 . . . . 0.0 113.363 -173.607 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 22.5 ttt180 -63.37 -56.29 17.54 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.537 0.735 . . . . 0.0 110.592 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 10.0 t -70.83 -27.93 64.23 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.337 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 322' ' ' LEU . . . . . 0.537 HD22 HD22 ' A' ' 313' ' ' LEU . 43.9 mt -80.44 -10.01 59.75 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.531 0.732 . . . . 0.0 111.093 178.468 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp 68.49 24.3 7.13 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 125.31 1.444 . . . . 0.0 112.148 175.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.46 ' HG ' ' HB2' ' A' ' 322' ' ' LEU . 23.7 mt -75.29 156.91 35.13 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.752 0.821 . . . . 0.0 110.681 178.046 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 325' ' ' GLY . . . . . 0.449 ' H ' ' HB2' ' A' ' 328' ' ' ASP . . . -163.04 -151.97 6.62 Favored Glycine 0 C--O 1.243 0.705 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.348 -175.146 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 326' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 266' ' ' PRO . 34.0 m -76.73 -33.05 21.19 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 C-N-CA 123.08 0.552 . . . . 0.0 111.325 -178.481 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -94.77 -20.06 19.82 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.595 0.758 . . . . 0.0 111.629 -176.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 328' ' ' ASP . . . . . 0.449 ' HB2' ' H ' ' A' ' 325' ' ' GLY . 7.7 m-20 -78.02 120.68 23.21 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 122.922 0.489 . . . . 0.0 109.927 -177.177 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 329' ' ' ILE . . . . . 0.611 HG12 ' HG2' ' A' ' 268' ' ' LYS . 8.7 mt -105.19 111.23 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 123.84 0.856 . . . . 0.0 110.623 -169.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 330' ' ' ILE . . . . . 0.502 HG22 ' HB2' ' A' ' 308' ' ' PHE . 45.5 pt -102.56 124.21 56.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 CA-C-O 121.22 0.533 . . . . 0.0 111.135 -179.02 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -73.34 115.89 13.25 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.673 0.789 . . . . 0.0 111.035 -178.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 332' ' ' CYS . . . . . 0.471 ' SG ' HD12 ' A' ' 304' ' ' ILE . 39.5 t -78.11 95.03 4.8 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 170.598 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 59.4 t -102.02 109.91 27.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 123.452 0.701 . . . . 0.0 109.111 -177.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 334' ' ' VAL . . . . . 0.48 HG22 HD13 ' A' ' 304' ' ' ILE . 47.5 t -83.8 99.32 6.2 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 C-N-CA 123.26 0.624 . . . . 0.0 110.052 -178.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 85.8 mt -101.38 -172.38 2.15 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.967 0.907 . . . . 0.0 110.225 175.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 336' ' ' THR . . . . . . . . . . . . . 25.9 m -124.66 59.38 1.2 Allowed 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 174.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 11.9 p -67.83 108.56 3.03 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 114.316 -1.311 . . . . 0.0 110.193 -178.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 15.6 m . . . . . 0 C--O 1.254 1.316 0 C-N-CA 124.221 1.009 . . . . 0.0 109.3 -175.883 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 . . . . . 0 N--CA 1.474 0.726 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -88.81 -26.08 27.94 Favored Glycine 0 C--N 1.349 1.267 0 CA-C-O 119.551 -0.583 . . . . 0.0 113.245 179.246 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 63.95 -79.79 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 125.225 1.41 . . . . 0.0 110.98 -175.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 56.12 35.02 24.92 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.555 1.142 . . . . 0.0 111.093 -176.738 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -133.22 70.63 1.46 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 -179.243 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.82 36.84 4.39 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 114.389 -1.278 . . . . 0.0 110.392 -176.194 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 59.4 t -64.89 140.61 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 CA-C-N 114.717 -1.128 . . . . 0.0 109.638 175.177 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 45.7 t -72.71 81.15 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 CA-C-O 121.9 0.857 . . . . 0.0 109.996 -179.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 27.8 tp -159.95 16.25 0.14 Allowed 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 125.833 1.653 . . . . 0.0 107.313 170.124 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 7.3 p -72.55 133.12 32.39 Favored 'Isoleucine or valine' 0 C--N 1.354 0.773 0 C-N-CA 123.846 0.858 . . . . 0.0 110.618 -171.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -162.32 103.02 1.09 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.936 0.894 . . . . 0.0 108.738 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 135.94 -73.06 0.45 Allowed Glycine 0 CA--C 1.535 1.305 0 CA-C-O 118.987 -0.896 . . . . 0.0 112.998 -178.016 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -59.74 -67.46 0.05 OUTLIER 'Trans proline' 0 C--N 1.382 2.301 0 C-N-CA 123.28 2.653 . . . . 0.0 113.4 -175.173 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 23.8 p -145.37 132.89 20.82 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.233 1.013 . . . . 0.0 109.126 -177.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 87.9 mt -114.97 79.58 6.17 Favored Pre-proline 0 N--CA 1.481 1.103 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 171.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.66 -32.19 24.55 Favored 'Trans proline' 0 C--N 1.383 2.365 0 C-N-CA 122.666 2.244 . . . . 0.0 112.202 -173.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -138.14 107.44 6.1 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.409 1.083 . . . . 0.0 109.648 177.147 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 19.4 p -94.22 167.44 13.47 Favored Pre-proline 0 CA--C 1.556 1.176 0 C-N-CA 124.483 1.113 . . . . 0.0 109.943 172.08 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -45.1 117.42 1.59 Allowed 'Trans proline' 0 C--N 1.392 2.868 0 C-N-CA 123.155 2.57 . . . . 0.0 111.11 170.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 19.2 mtp180 -56.54 124.78 19.41 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 124.587 1.179 . . . . 0.0 111.871 -165.068 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.499 ' HG ' ' HG3' ' A' ' 281' ' ' ARG . 3.3 mp -96.4 149.26 21.92 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.707 -170.256 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 265' ' ' PHE . . . . . 0.468 ' CE1' ' HG2' ' A' ' 282' ' ' MET . 15.2 p90 -125.34 143.83 45.76 Favored Pre-proline 0 CA--C 1.549 0.92 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 172.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -62.93 96.61 0.17 Allowed 'Trans proline' 0 C--N 1.373 1.852 0 C-N-CA 122.564 2.176 . . . . 0.0 112.01 174.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.37 120.14 12.8 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 170.099 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.513 ' HE3' HG12 ' A' ' 329' ' ' ILE . 25.5 ttpt -93.95 111.61 23.34 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 121.464 0.65 . . . . 0.0 110.008 -177.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 4.3 mp -106.75 130.33 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.31 1.044 . . . . 0.0 108.872 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 270' ' ' ARG . . . . . 0.409 ' HB2' ' CG2' ' A' ' 329' ' ' ILE . 23.1 ttm180 -84.5 101.01 11.74 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.196 0.522 . . . . 0.0 109.916 173.725 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 271' ' ' CYS . . . . . 0.586 ' SG ' HD21 ' A' ' 297' ' ' LEU . 52.5 t -69.5 175.56 4.0 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.971 169.687 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 272' ' ' ARG . . . . . 0.457 ' HG2' ' SG ' ' A' ' 271' ' ' CYS . 7.5 ptm180 -53.29 -25.95 16.65 Favored 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 124.862 1.265 . . . . 0.0 113.344 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -163.45 37.24 0.09 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.268 0.627 . . . . 0.0 111.205 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -165.27 162.65 19.94 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 122.838 0.455 . . . . 0.0 111.4 -175.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.447 HD13 ' HD2' ' A' ' 268' ' ' LYS . 86.5 mt -114.55 104.15 11.72 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.437 1.095 . . . . 0.0 109.662 172.197 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 79.5 t -86.47 110.29 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 174.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 20.6 mtm180 -103.95 84.13 2.21 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.519 HD21 ' HA ' ' A' ' 289' ' ' VAL . 4.4 pp -94.68 147.58 33.42 Favored Pre-proline 0 N--CA 1.486 1.367 0 CA-C-O 119.296 -0.383 . . . . 0.0 110.797 -174.386 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.01 120.75 6.5 Favored 'Trans proline' 0 C--N 1.378 2.105 0 C-N-CA 122.35 2.033 . . . . 0.0 111.008 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.718 HD21 ' HG3' ' A' ' 319' ' ' PRO . 1.0 OUTLIER -139.72 151.19 45.66 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.488 1.115 . . . . 0.0 109.265 -175.98 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 281' ' ' ARG . . . . . 0.501 ' H ' ' HD2' ' A' ' 281' ' ' ARG . 0.0 OUTLIER -97.15 149.36 22.08 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.534 -0.914 . . . . 0.0 108.534 -177.386 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 282' ' ' MET . . . . . 0.541 ' HA ' ' HG2' ' A' ' 319' ' ' PRO . 14.4 mtp -70.88 -20.15 62.55 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 118.448 0.567 . . . . 0.0 111.378 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 20.6 t -92.6 5.03 52.43 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 123.696 0.799 . . . . 0.0 111.081 176.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -99.25 133.47 22.03 Favored Pre-proline 0 N--CA 1.478 0.96 0 C-N-CA 124.178 0.991 . . . . 0.0 109.027 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.32 164.38 23.2 Favored 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 122.154 1.903 . . . . 0.0 111.941 171.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 67.9 mt -65.64 -12.03 49.85 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 118.861 -0.59 . . . . 0.0 112.204 -178.086 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 287' ' ' GLN . . . . . 0.414 ' HA ' ' HB ' ' A' ' 290' ' ' VAL . 25.5 tp60 -55.0 -23.42 19.27 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 122.94 0.496 . . . . 0.0 111.945 177.126 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 288' ' ' SER . . . . . 0.634 ' HB3' HD12 ' A' ' 280' ' ' LEU . 43.7 t -59.4 -54.19 49.52 Favored 'General case' 0 CA--C 1.557 1.249 0 C-N-CA 123.464 0.706 . . . . 0.0 111.47 169.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.519 ' HA ' HD21 ' A' ' 278' ' ' LEU . 20.6 m -70.42 -36.15 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 C-N-CA 122.026 0.131 . . . . 0.0 110.862 179.246 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 290' ' ' VAL . . . . . 0.565 HG13 ' HB ' ' A' ' 304' ' ' ILE . 74.3 t -61.82 -45.29 99.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.184 0.994 . . . . 0.0 110.853 -178.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -64.08 -51.26 64.91 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 124.046 0.842 . . . . 0.0 110.975 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 47.8 t60 -63.99 -42.55 97.17 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 123.784 0.678 . . . . 0.0 111.097 -176.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 95.4 mmm -67.32 -35.62 79.8 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.218 0.607 . . . . 0.0 110.766 178.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -65.78 -43.78 87.78 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.148 0.579 . . . . 0.0 110.923 176.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 31.9 m -68.36 -34.51 76.2 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.581 0.753 . . . . 0.0 111.068 178.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 23.3 t60 -69.97 -49.87 47.45 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.677 0.791 . . . . 0.0 110.2 -179.124 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 297' ' ' LEU . . . . . 0.586 HD21 ' SG ' ' A' ' 271' ' ' CYS . 55.9 mt -84.49 -11.66 55.71 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.017 0.927 . . . . 0.0 111.737 -175.159 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 72.04 37.91 59.99 Favored Glycine 0 C--N 1.351 1.362 0 O-C-N 123.273 0.358 . . . . 0.0 112.757 178.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 299' ' ' VAL . . . . . 0.496 HG11 HG11 ' A' ' 334' ' ' VAL . 34.8 m -123.42 177.9 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.326 1.051 . . . . 0.0 110.145 178.292 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 300' ' ' SER . . . . . 0.492 ' HB2' ' HG3' ' A' ' 303' ' ' ARG . 46.9 m -79.03 147.88 70.69 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 123.431 0.692 . . . . 0.0 110.556 175.619 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -57.68 -27.29 76.87 Favored 'Trans proline' 0 C--N 1.385 2.46 0 C-N-CA 123.068 2.512 . . . . 0.0 112.336 172.391 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 57.3 p -68.42 -18.52 64.46 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.768 0.827 . . . . 0.0 111.922 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 303' ' ' ARG . . . . . 0.492 ' HG3' ' HB2' ' A' ' 300' ' ' SER . 97.1 mtt180 -89.21 -28.05 20.23 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.69 0.796 . . . . 0.0 111.707 -178.487 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 304' ' ' ILE . . . . . 0.565 ' HB ' HG13 ' A' ' 290' ' ' VAL . 40.3 mm -72.95 117.72 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 123.06 0.544 . . . . 0.0 109.737 -179.434 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 31.4 tp -125.16 114.73 19.4 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 177.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -83.91 121.67 27.67 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -178.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 307' ' ' LEU . . . . . 0.451 HD12 HG21 ' A' ' 333' ' ' VAL . 76.7 mt -129.54 116.46 18.96 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.298 1.039 . . . . 0.0 109.082 -176.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -91.82 96.66 10.53 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 174.15 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 74.36 -82.98 0.77 Allowed Glycine 0 C--N 1.345 1.045 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.872 177.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -132.05 -6.19 3.49 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.296 0.638 . . . . 0.0 111.458 -179.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 6.2 t -91.98 147.2 23.14 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 122.538 0.335 . . . . 0.0 110.344 -179.15 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -98.84 131.05 45.25 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.066 0.546 . . . . 0.0 109.757 178.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.525 HD22 HD22 ' A' ' 322' ' ' LEU . 44.9 mt -113.53 130.76 56.28 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.3 0.64 . . . . 0.0 109.63 -179.115 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 37.4 m -76.24 142.33 71.61 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 123.153 0.581 . . . . 0.0 111.314 178.359 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 315' ' ' PRO . . . . . 0.504 ' HB3' HG21 ' A' ' 290' ' ' VAL . 35.3 Cg_endo -62.5 -23.26 74.83 Favored 'Trans proline' 0 C--N 1.38 2.217 0 C-N-CA 123.041 2.494 . . . . 0.0 112.436 173.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 52.3 p -80.78 -22.83 39.76 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.035 0.934 . . . . 0.0 111.573 178.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -71.6 154.74 41.21 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.289 0.636 . . . . 0.0 111.477 -178.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 318' ' ' THR . . . . . . . . . . . . . 74.2 p -105.74 149.41 37.91 Favored Pre-proline 0 N--CA 1.477 0.89 0 C-N-CA 123.998 0.919 . . . . 0.0 109.884 -176.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 319' ' ' PRO . . . . . 0.718 ' HG3' HD21 ' A' ' 280' ' ' LEU . 85.6 Cg_endo -68.66 -11.38 31.74 Favored 'Trans proline' 0 C--N 1.372 1.789 0 C-N-CA 123.263 2.642 . . . . 0.0 112.871 -178.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 38.5 ttt180 -69.01 -56.37 7.99 Favored 'General case' 0 C--N 1.347 0.488 0 C-N-CA 123.138 0.575 . . . . 0.0 109.6 177.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 15.1 t -71.01 -24.31 62.35 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.259 -178.287 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 322' ' ' LEU . . . . . 0.525 HD22 HD22 ' A' ' 313' ' ' LEU . 69.8 mt -86.01 -15.75 40.44 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.24 0.616 . . . . 0.0 111.31 175.702 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 44.4 tptt 68.05 27.89 6.87 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 125.251 1.42 . . . . 0.0 111.804 177.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.439 ' HG ' ' HB2' ' A' ' 322' ' ' LEU . 29.0 mt -68.29 159.18 31.83 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.483 0.713 . . . . 0.0 110.59 178.264 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 325' ' ' GLY . . . . . 0.472 ' H ' ' HB3' ' A' ' 328' ' ' ASP . . . -160.8 -178.15 34.53 Favored Glycine 0 C--N 1.341 0.846 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.429 -172.104 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 34.2 m -70.81 -20.06 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 123.943 0.897 . . . . 0.0 111.909 179.473 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -97.51 -15.76 20.41 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.001 0.92 . . . . 0.0 111.274 176.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 328' ' ' ASP . . . . . 0.472 ' HB3' ' H ' ' A' ' 325' ' ' GLY . 15.4 t70 -83.35 143.38 30.38 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.113 0.565 . . . . 0.0 109.671 -177.796 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 329' ' ' ILE . . . . . 0.513 HG12 ' HE3' ' A' ' 268' ' ' LYS . 6.2 mt -130.0 120.6 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 122.72 0.408 . . . . 0.0 110.402 -178.483 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 30.1 pt -113.55 131.87 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 123.42 0.688 . . . . 0.0 110.595 178.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -77.35 118.68 20.05 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.729 0.812 . . . . 0.0 111.792 -172.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 332' ' ' CYS . . . . . 0.552 ' SG ' HD12 ' A' ' 304' ' ' ILE . 40.5 t -80.03 94.58 5.96 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.947 0.899 . . . . 0.0 109.999 171.535 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 333' ' ' VAL . . . . . 0.451 HG21 HD12 ' A' ' 307' ' ' LEU . 90.9 t -97.36 112.54 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 123.213 0.605 . . . . 0.0 109.594 178.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 334' ' ' VAL . . . . . 0.496 HG11 HG11 ' A' ' 299' ' ' VAL . 83.9 t -82.85 125.24 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 175.637 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 1.2 pp -148.34 173.43 13.06 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.261 1.025 . . . . 0.0 110.564 -177.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 336' ' ' THR . . . . . . . . . . . . . 76.0 m -104.54 -60.62 1.57 Allowed 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.142 0.577 . . . . 0.0 110.204 177.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 36.7 m 65.33 -73.08 0.06 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 125.769 1.628 . . . . 0.0 112.213 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 19.9 m . . . . . 0 CA--C 1.558 1.283 0 C-N-CA 125.259 1.423 . . . . 0.0 110.934 179.289 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 24.2 mp0 . . . . . 0 N--CA 1.482 1.138 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 156.48 145.99 4.35 Favored Glycine 0 C--N 1.346 1.113 0 O-C-N 123.562 0.539 . . . . 0.0 112.686 173.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -141.28 89.67 2.25 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 172.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -99.21 18.15 18.24 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 123.654 0.782 . . . . 0.0 109.6 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -75.69 83.19 2.68 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 124.327 1.051 . . . . 0.0 110.082 -178.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -89.5 49.71 1.79 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.469 1.108 . . . . 0.0 110.011 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 31.3 m -87.77 153.28 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.02 0.928 . . . . 0.0 110.879 -176.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 17.8 m -70.54 -14.8 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 C-N-CA 122.431 0.292 . . . . 0.0 111.206 179.218 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 55.2 tp -78.96 90.98 4.78 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.749 0.82 . . . . 0.0 108.973 171.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 4.1 p -88.73 102.14 12.58 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 172.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -103.02 147.02 27.48 Favored 'General case' 0 C--O 1.242 0.658 0 C-N-CA 123.384 0.673 . . . . 0.0 110.236 -176.412 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 127.15 72.41 0.18 Allowed Glycine 0 CA--C 1.528 0.871 0 CA-C-O 119.17 -0.794 . . . . 0.0 111.818 178.053 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -68.64 141.32 49.7 Favored 'Trans proline' 0 C--N 1.383 2.357 0 C-N-CA 123.543 2.829 . . . . 0.0 110.835 178.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 47.8 m 69.75 162.0 0.22 Allowed 'General case' 0 CA--C 1.563 1.449 0 C-N-CA 124.7 1.2 . . . . 0.0 110.609 -175.239 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 61.2 mt -113.74 79.0 4.18 Favored Pre-proline 0 CA--C 1.553 1.074 0 O-C-N 121.481 -0.762 . . . . 0.0 109.293 171.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -72.69 -41.94 1.37 Allowed 'Trans proline' 0 C--N 1.383 2.353 0 C-N-CA 122.398 2.066 . . . . 0.0 110.88 177.216 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -103.11 96.58 6.88 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.901 1.28 . . . . 0.0 108.049 170.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 65.5 m -57.59 135.65 82.36 Favored Pre-proline 0 CA--C 1.554 1.111 0 CA-C-O 117.951 -1.023 . . . . 0.0 109.987 173.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -42.07 115.77 0.51 Allowed 'Trans proline' 0 C--N 1.399 3.192 0 C-N-CA 123.993 3.128 . . . . 0.0 111.402 178.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 64.8 ttt180 -57.65 104.96 0.21 Allowed 'General case' 0 C--N 1.354 0.785 0 O-C-N 124.171 0.919 . . . . 0.0 112.868 -162.189 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.452 HD12 ' H ' ' A' ' 264' ' ' LEU . 3.6 mp -76.89 167.82 21.16 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.49 176.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 265' ' ' PHE . . . . . 0.418 ' CE1' ' HG2' ' A' ' 282' ' ' MET . 34.8 p90 -138.39 144.58 43.36 Favored Pre-proline 0 N--CA 1.478 0.934 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 177.699 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.09 88.34 0.08 OUTLIER 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 123.25 2.633 . . . . 0.0 113.325 175.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -67.48 121.76 16.51 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 171.264 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.45 ' HE3' HG12 ' A' ' 329' ' ' ILE . 23.4 ttpt -97.32 122.76 40.72 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 121.37 0.605 . . . . 0.0 110.769 -178.671 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 269' ' ' ILE . . . . . 0.451 HG21 ' HG3' ' A' ' 293' ' ' MET . 2.1 mp -119.36 130.99 73.26 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 C-N-CA 124.943 1.297 . . . . 0.0 108.163 -178.032 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 25.5 ttp180 -94.92 107.41 19.45 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 122.989 0.516 . . . . 0.0 110.447 177.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 271' ' ' CYS . . . . . 0.787 ' SG ' HD21 ' A' ' 297' ' ' LEU . 37.7 t -70.42 -176.54 1.25 Allowed 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.147 0.979 . . . . 0.0 110.065 168.676 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 21.3 ptt180 -59.78 -30.6 68.99 Favored 'General case' 0 CA--C 1.557 1.23 0 C-N-CA 123.455 0.702 . . . . 0.0 112.077 179.132 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -159.42 35.03 0.2 Allowed 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.409 0.684 . . . . 0.0 111.37 -178.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -156.02 151.73 27.23 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 122.766 0.426 . . . . 0.0 110.519 -176.065 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -116.37 114.76 24.73 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.137 0.975 . . . . 0.0 109.109 174.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 95.6 t -99.85 129.48 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.086 0.955 . . . . 0.0 108.883 173.196 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 90.7 mtm180 -119.47 86.17 2.51 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 176.315 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.401 HD21 HG12 ' A' ' 289' ' ' VAL . 4.3 pp -96.72 141.03 22.49 Favored Pre-proline 0 N--CA 1.478 0.941 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -176.253 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.62 120.49 7.42 Favored 'Trans proline' 0 C--N 1.371 1.718 0 C-N-CA 122.407 2.071 . . . . 0.0 110.841 173.021 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.712 HD21 ' HG3' ' A' ' 319' ' ' PRO . 0.0 OUTLIER -135.39 155.42 50.6 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.31 1.044 . . . . 0.0 110.001 -178.329 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -93.23 143.16 26.53 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.514 1.126 . . . . 0.0 109.641 177.131 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 282' ' ' MET . . . . . 0.477 ' HA ' ' HG2' ' A' ' 319' ' ' PRO . 35.0 mtp -67.99 -25.2 65.29 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 118.354 0.524 . . . . 0.0 110.095 176.736 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 10.3 p -74.64 -34.72 62.81 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.004 1.321 . . . . 0.0 111.592 176.23 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -70.02 125.49 92.01 Favored Pre-proline 0 N--CA 1.473 0.715 0 C-N-CA 124.121 0.969 . . . . 0.0 108.764 173.368 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 285' ' ' PRO . . . . . 0.481 ' HA ' ' HA ' ' A' ' 318' ' ' THR . 44.8 Cg_endo -63.58 176.81 2.0 Favored 'Trans proline' 0 C--N 1.381 2.263 0 C-N-CA 122.598 2.199 . . . . 0.0 112.439 174.66 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.458 ' O ' HG23 ' A' ' 290' ' ' VAL . 86.5 mt -65.26 -17.01 64.16 Favored 'General case' 0 C--O 1.22 -0.483 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.773 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 24.7 tp60 -48.89 -27.63 3.21 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.905 0.882 . . . . 0.0 112.657 178.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 288' ' ' SER . . . . . 0.467 ' HB3' HD12 ' A' ' 280' ' ' LEU . 43.2 t -57.4 -62.13 1.99 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.553 1.141 . . . . 0.0 111.205 170.221 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.403 ' HB ' HG12 ' A' ' 269' ' ' ILE . 15.9 m -69.19 -26.84 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 123.149 0.58 . . . . 0.0 110.784 -176.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 290' ' ' VAL . . . . . 0.556 HG13 ' HB ' ' A' ' 304' ' ' ILE . 77.1 t -62.62 -52.16 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 123.802 0.841 . . . . 0.0 110.223 176.394 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -67.24 -39.6 86.21 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.378 0.671 . . . . 0.0 110.882 -178.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 23.3 t60 -67.5 -45.58 75.41 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 123.443 0.465 . . . . 0.0 110.833 -176.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 293' ' ' MET . . . . . 0.451 ' HG3' HG21 ' A' ' 269' ' ' ILE . 93.3 mmm -70.06 -30.09 67.26 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.064 0.546 . . . . 0.0 110.818 178.529 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -64.91 -42.72 94.5 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.201 0.6 . . . . 0.0 110.64 173.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 41.3 m -68.71 -34.26 75.34 Favored 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 123.781 0.832 . . . . 0.0 110.62 176.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -70.54 -34.39 72.2 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.185 0.994 . . . . 0.0 111.3 -178.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 297' ' ' LEU . . . . . 0.787 HD21 ' SG ' ' A' ' 271' ' ' CYS . 36.8 mt -100.73 -7.19 24.01 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.116 0.966 . . . . 0.0 111.501 -179.124 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 77.2 6.06 85.88 Favored Glycine 0 N--CA 1.474 1.194 0 C-N-CA 123.412 0.53 . . . . 0.0 113.784 178.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 32.3 m -94.88 -176.82 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 124.139 0.975 . . . . 0.0 111.053 -177.128 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 19.8 m -87.28 147.34 42.07 Favored Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 123.238 0.615 . . . . 0.0 110.159 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -55.08 -29.67 66.59 Favored 'Trans proline' 0 C--N 1.387 2.559 0 C-N-CA 122.946 2.431 . . . . 0.0 112.459 170.173 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 20.3 m -62.57 -26.92 68.84 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 122.941 0.496 . . . . 0.0 111.478 178.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 58.3 mtt180 -88.0 -20.13 26.25 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.301 1.04 . . . . 0.0 112.416 -175.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 304' ' ' ILE . . . . . 0.58 HD12 ' SG ' ' A' ' 332' ' ' CYS . 41.7 mm -82.64 125.65 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 122.811 0.444 . . . . 0.0 110.996 -177.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 48.6 tp -127.98 121.69 30.45 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.101 0.96 . . . . 0.0 108.94 176.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 306' ' ' LEU . . . . . 0.445 ' HG ' HD12 ' A' ' 330' ' ' ILE . 3.0 mm? -88.48 134.54 33.82 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.538 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 307' ' ' LEU . . . . . 0.408 HD12 HG21 ' A' ' 333' ' ' VAL . 76.1 mt -136.48 103.97 5.43 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.86 0.864 . . . . 0.0 109.257 -177.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 308' ' ' PHE . . . . . 0.475 ' HB2' HD11 ' A' ' 313' ' ' LEU . 82.5 t80 -77.37 92.44 3.94 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -178.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 70.5 -78.52 0.46 Allowed Glycine 0 C--N 1.349 1.275 0 CA-C-N 116.24 -0.436 . . . . 0.0 112.326 -179.239 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -146.49 54.47 1.13 Allowed 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 123.929 0.892 . . . . 0.0 110.643 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 11.2 t -147.27 150.82 35.56 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 122.815 0.446 . . . . 0.0 110.238 175.223 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -87.98 119.73 28.63 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.807 0.843 . . . . 0.0 110.119 -179.184 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.527 HD22 HD22 ' A' ' 322' ' ' LEU . 45.7 mt -117.55 122.3 43.29 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 178.055 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 18.3 m -79.73 150.81 73.24 Favored Pre-proline 0 CA--C 1.55 0.979 0 C-N-CA 123.413 0.685 . . . . 0.0 110.853 178.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 315' ' ' PRO . . . . . 0.414 ' HB3' HG21 ' A' ' 290' ' ' VAL . 51.2 Cg_exo -56.21 -32.48 87.61 Favored 'Trans proline' 0 C--N 1.382 2.298 0 C-N-CA 122.827 2.351 . . . . 0.0 112.22 170.371 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 77.2 p -75.77 -16.93 60.05 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-N 114.353 -1.294 . . . . 0.0 112.128 -178.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -77.18 144.45 38.33 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.236 0.614 . . . . 0.0 110.334 178.024 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 318' ' ' THR . . . . . 0.481 ' HA ' ' HA ' ' A' ' 285' ' ' PRO . 25.2 p -99.21 138.38 20.55 Favored Pre-proline 0 N--CA 1.474 0.76 0 C-N-CA 123.568 0.747 . . . . 0.0 109.981 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 319' ' ' PRO . . . . . 0.712 ' HG3' HD21 ' A' ' 280' ' ' LEU . 18.5 Cg_endo -55.94 -19.82 27.31 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 123.926 3.084 . . . . 0.0 113.974 179.695 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -66.63 -51.01 61.03 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.146 0.578 . . . . 0.0 111.5 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 15.2 t -72.94 -20.16 61.11 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.502 0.321 . . . . 0.0 110.93 -179.111 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 322' ' ' LEU . . . . . 0.527 HD22 HD22 ' A' ' 313' ' ' LEU . 36.9 mt -85.1 -17.55 37.0 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.362 0.665 . . . . 0.0 110.404 176.63 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 323' ' ' LYS . . . . . 0.526 ' HA ' ' HE2' ' A' ' 323' ' ' LYS . 0.5 OUTLIER 61.56 58.1 2.14 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.233 1.413 . . . . 0.0 110.466 -178.749 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.457 ' HG ' ' HB2' ' A' ' 322' ' ' LEU . 76.3 mt -95.56 171.27 8.79 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.051 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 325' ' ' GLY . . . . . 0.457 ' H ' ' HB2' ' A' ' 328' ' ' ASP . . . -167.87 -171.99 34.42 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.108 -175.189 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 34.1 m -67.82 -28.93 43.28 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 C-N-CA 123.977 0.911 . . . . 0.0 111.452 177.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -93.54 -15.87 25.02 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.144 0.978 . . . . 0.0 111.387 -178.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 328' ' ' ASP . . . . . 0.457 ' HB2' ' H ' ' A' ' 325' ' ' GLY . 5.3 m-20 -89.78 123.94 34.21 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.176 0.591 . . . . 0.0 109.708 -178.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 329' ' ' ILE . . . . . 0.45 HG12 ' HE3' ' A' ' 268' ' ' LYS . 19.6 mt -109.41 127.36 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 123.378 0.671 . . . . 0.0 110.183 -175.811 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 330' ' ' ILE . . . . . 0.445 HD12 ' HG ' ' A' ' 306' ' ' LEU . 30.9 pt -111.56 128.53 68.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 C-N-CA 123.251 0.62 . . . . 0.0 110.346 177.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -76.81 110.43 11.41 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.844 0.858 . . . . 0.0 111.587 -174.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 332' ' ' CYS . . . . . 0.58 ' SG ' HD12 ' A' ' 304' ' ' ILE . 31.8 t -75.69 105.2 6.6 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.788 0.835 . . . . 0.0 110.447 172.622 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 333' ' ' VAL . . . . . 0.408 HG21 HD12 ' A' ' 307' ' ' LEU . 88.4 t -111.47 122.03 65.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 123.668 0.787 . . . . 0.0 110.041 -178.561 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 59.7 t -86.05 98.62 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 123.305 0.642 . . . . 0.0 109.741 178.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 92.8 mt -100.35 137.28 38.98 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 172.107 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 336' ' ' THR . . . . . . . . . . . . . 40.3 p -72.46 81.43 1.06 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.644 0.777 . . . . 0.0 111.055 -176.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 19.3 m -86.1 142.95 28.32 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.997 0.919 . . . . 0.0 111.015 -177.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 29.0 p . . . . . 0 C--O 1.25 1.12 0 C-N-CA 123.517 0.727 . . . . 0.0 109.422 179.998 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 . . . . . 0 N--CA 1.482 1.136 0 CA-C-O 120.709 0.29 . . . . 0.0 111.224 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -174.47 -124.98 0.82 Allowed Glycine 0 C--N 1.35 1.349 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.528 179.114 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -76.99 -6.91 54.48 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.232 1.013 . . . . 0.0 111.499 -176.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -69.71 -12.23 61.47 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 123.34 0.656 . . . . 0.0 111.022 174.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -61.45 93.72 0.04 OUTLIER 'General case' 0 C--N 1.36 1.045 0 C-N-CA 123.852 0.861 . . . . 0.0 110.429 178.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -129.25 -170.93 2.37 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 114.272 -1.331 . . . . 0.0 109.396 178.001 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 35.9 m -59.77 135.04 24.78 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.222 0 C-N-CA 123.497 0.719 . . . . 0.0 111.878 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 44.1 t -80.67 93.97 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -178.485 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 3.3 pp -95.89 4.62 52.62 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.057 0.943 . . . . 0.0 111.925 -176.39 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 11.4 p -148.97 144.56 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 123.715 0.806 . . . . 0.0 109.027 -175.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 254' ' ' GLU . . . . . 0.458 ' HG2' ' HD3' ' A' ' 256' ' ' PRO . 0.5 OUTLIER -118.92 175.19 5.87 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.944 0.897 . . . . 0.0 110.036 175.762 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -129.39 80.45 0.35 Allowed Glycine 0 N--CA 1.468 0.824 0 N-CA-C 111.329 -0.708 . . . . 0.0 111.329 178.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 256' ' ' PRO . . . . . 0.458 ' HD3' ' HG2' ' A' ' 254' ' ' GLU . 58.4 Cg_endo -68.88 102.15 0.86 Allowed 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 122.68 2.253 . . . . 0.0 111.24 177.642 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 29.4 p -75.03 86.89 2.34 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.978 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 85.3 mt -121.51 92.51 48.68 Favored Pre-proline 0 N--CA 1.472 0.63 0 C-N-CA 124.755 1.222 . . . . 0.0 109.074 -178.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -72.33 -25.68 18.22 Favored 'Trans proline' 0 C--N 1.37 1.702 0 C-N-CA 122.254 1.969 . . . . 0.0 111.672 173.249 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -76.36 93.33 3.45 Favored 'General case' 0 C--N 1.352 0.687 0 C-N-CA 124.283 1.033 . . . . 0.0 109.049 177.072 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 20.9 m -73.48 141.15 79.62 Favored Pre-proline 0 CA--C 1.55 0.98 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.67 176.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 262' ' ' PRO . . . . . 0.415 ' O ' HD12 ' A' ' 264' ' ' LEU . 25.3 Cg_endo -58.71 168.77 3.86 Favored 'Trans proline' 0 C--N 1.389 2.708 0 C-N-CA 122.411 2.074 . . . . 0.0 112.256 172.559 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -88.43 92.2 9.09 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-O 121.363 0.601 . . . . 0.0 110.279 -178.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.415 HD12 ' O ' ' A' ' 262' ' ' PRO . 3.7 mp -88.76 152.57 21.7 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 114.668 -1.151 . . . . 0.0 108.699 171.238 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -136.9 150.52 69.99 Favored Pre-proline 0 CA--C 1.549 0.905 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -68.07 90.73 0.38 Allowed 'Trans proline' 0 C--N 1.376 1.983 0 C-N-CA 122.459 2.106 . . . . 0.0 112.029 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.37 113.49 4.68 Favored 'General case' 0 C--N 1.349 0.55 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 169.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.444 ' O ' ' HA ' ' A' ' 329' ' ' ILE . 22.6 ttpt -92.37 111.58 23.21 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.259 0.623 . . . . 0.0 109.883 -176.27 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 4.7 mp -106.72 129.3 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 123.703 0.801 . . . . 0.0 109.271 179.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 270' ' ' ARG . . . . . 0.414 ' HA ' HD13 ' A' ' 275' ' ' LEU . 39.5 ttp180 -84.57 98.78 10.34 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 122.879 0.471 . . . . 0.0 110.002 175.657 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 271' ' ' CYS . . . . . 0.745 ' SG ' HD21 ' A' ' 297' ' ' LEU . 41.9 t -69.56 175.6 4.02 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.1 171.51 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 272' ' ' ARG . . . . . 0.416 ' N ' ' SG ' ' A' ' 271' ' ' CYS . 16.2 ptt180 -54.33 -30.1 50.24 Favored 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 124.299 1.04 . . . . 0.0 112.314 178.433 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -159.76 37.82 0.19 Allowed 'General case' 0 C--N 1.354 0.801 0 C-N-CA 123.794 0.838 . . . . 0.0 110.948 -176.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -166.23 158.79 14.47 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 122.673 0.389 . . . . 0.0 111.128 -175.726 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.414 HD13 ' HA ' ' A' ' 270' ' ' ARG . 4.2 mm? -115.69 97.39 6.1 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.118 0.967 . . . . 0.0 109.07 173.575 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 46.3 t -84.99 98.53 6.29 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.595 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 39.6 mtt85 -96.89 79.86 2.96 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -178.209 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.6 pp -92.15 142.53 26.34 Favored Pre-proline 0 N--CA 1.487 1.386 0 CA-C-O 119.404 -0.331 . . . . 0.0 110.392 -172.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -74.23 109.75 2.95 Favored 'Trans proline' 0 C--N 1.373 1.835 0 C-N-CA 122.223 1.949 . . . . 0.0 110.698 177.277 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.725 HD21 ' HG3' ' A' ' 319' ' ' PRO . 0.0 OUTLIER -123.46 153.06 41.0 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.342 1.057 . . . . 0.0 109.617 179.018 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 281' ' ' ARG . . . . . 0.583 ' HB2' ' HB2' ' A' ' 284' ' ' GLU . 31.9 mtp180 -88.38 147.34 24.78 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.932 0.893 . . . . 0.0 110.318 177.711 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 282' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -62.51 -34.19 76.39 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 122.928 0.491 . . . . 0.0 110.361 173.514 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 23.7 m -67.79 -31.32 71.11 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.203 1.001 . . . . 0.0 111.718 176.2 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 284' ' ' GLU . . . . . 0.583 ' HB2' ' HB2' ' A' ' 281' ' ' ARG . 6.2 tp10 -73.31 132.21 82.15 Favored Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 124.009 0.923 . . . . 0.0 109.108 -178.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -70.39 178.32 5.08 Favored 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 122.163 1.908 . . . . 0.0 112.28 174.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.439 ' O ' HG23 ' A' ' 290' ' ' VAL . 70.7 mt -67.1 -19.04 65.57 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 118.744 -0.646 . . . . 0.0 111.66 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 27.7 tp60 -53.68 -22.39 8.87 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.282 0.633 . . . . 0.0 112.193 178.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 288' ' ' SER . . . . . 0.52 ' HB3' HD12 ' A' ' 280' ' ' LEU . 24.8 t -64.74 -54.32 33.26 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.413 0.685 . . . . 0.0 110.984 172.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.442 HG13 HD13 ' A' ' 280' ' ' LEU . 17.2 m -70.9 -29.21 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 122.532 0.333 . . . . 0.0 110.753 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 290' ' ' VAL . . . . . 0.538 HG13 ' HB ' ' A' ' 304' ' ' ILE . 78.1 t -63.83 -49.22 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 123.702 0.801 . . . . 0.0 110.099 176.418 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -63.89 -46.93 82.64 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.743 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 43.2 t60 -67.15 -41.83 85.4 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.15 -174.278 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 90.9 mmm -68.09 -30.33 69.48 Favored 'General case' 0 N--CA 1.483 1.201 0 O-C-N 123.401 0.438 . . . . 0.0 111.227 177.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -67.47 -43.45 80.99 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.13 0.572 . . . . 0.0 110.615 175.107 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 27.7 m -69.43 -29.59 67.34 Favored 'General case' 0 CA--C 1.557 1.216 0 C-N-CA 124.063 0.945 . . . . 0.0 110.837 176.174 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 77.8 t60 -74.59 -34.63 62.91 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.839 0.856 . . . . 0.0 111.442 -178.426 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 297' ' ' LEU . . . . . 0.745 HD21 ' SG ' ' A' ' 271' ' ' CYS . 75.5 mt -105.74 -8.26 17.93 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.655 0.782 . . . . 0.0 112.283 -175.58 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 72.93 31.67 61.8 Favored Glycine 0 C--N 1.347 1.188 0 O-C-N 123.598 0.561 . . . . 0.0 112.55 178.214 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 299' ' ' VAL . . . . . 0.531 HG11 HG11 ' A' ' 334' ' ' VAL . 33.2 m -117.75 -177.33 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.357 1.063 . . . . 0.0 110.057 179.313 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 300' ' ' SER . . . . . 0.551 ' HB3' ' HG3' ' A' ' 303' ' ' ARG . 32.2 t -82.36 147.02 55.54 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 123.194 0.598 . . . . 0.0 110.18 178.119 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -59.49 -27.97 86.31 Favored 'Trans proline' 0 C--N 1.385 2.453 0 C-N-CA 122.774 2.316 . . . . 0.0 111.124 169.198 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 22.8 t -67.11 -15.73 63.9 Favored 'General case' 0 CA--C 1.559 1.29 0 C-N-CA 123.454 0.702 . . . . 0.0 111.207 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 303' ' ' ARG . . . . . 0.551 ' HG3' ' HB3' ' A' ' 300' ' ' SER . 59.3 mtt180 -94.59 -26.51 16.35 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.006 0.922 . . . . 0.0 111.63 -178.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 304' ' ' ILE . . . . . 0.553 HD12 ' SG ' ' A' ' 332' ' ' CYS . 37.9 mm -77.02 103.58 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 122.861 0.464 . . . . 0.0 110.865 -175.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 34.8 tp -105.68 123.79 48.51 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 174.065 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 306' ' ' LEU . . . . . 0.433 ' HA ' ' O ' ' A' ' 331' ' ' ASP . 3.4 mm? -89.26 128.35 35.84 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 177.573 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 307' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 312' ' ' GLU . 68.4 mt -134.05 114.8 13.58 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.477 1.111 . . . . 0.0 108.608 -177.677 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -79.42 81.26 5.7 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 176.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 66.63 -85.97 0.11 Allowed Glycine 0 C--N 1.357 1.731 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.862 -176.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -127.1 75.68 1.6 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.142 0.977 . . . . 0.0 109.684 177.031 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 14.5 t -173.51 147.37 1.44 Allowed 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.489 1.116 . . . . 0.0 108.831 169.301 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 312' ' ' GLU . . . . . 0.414 ' HA ' HD23 ' A' ' 307' ' ' LEU . 42.2 tt0 -93.52 128.87 39.83 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 -178.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.463 HD13 HD13 ' A' ' 322' ' ' LEU . 45.2 mt -113.33 127.42 56.13 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 123.667 0.604 . . . . 0.0 109.762 177.797 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 314' ' ' SER . . . . . 0.413 ' O ' HD12 ' A' ' 286' ' ' LEU . 39.0 m -77.81 140.61 63.16 Favored Pre-proline 0 CA--C 1.554 1.105 0 C-N-CA 123.529 0.731 . . . . 0.0 110.633 179.248 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 315' ' ' PRO . . . . . 0.424 ' HB3' HG21 ' A' ' 290' ' ' VAL . 40.8 Cg_endo -63.94 -24.34 67.52 Favored 'Trans proline' 0 C--N 1.384 2.402 0 C-N-CA 122.871 2.381 . . . . 0.0 113.042 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 6.5 m -81.75 -18.47 44.13 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 123.788 0.835 . . . . 0.0 111.344 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -70.25 150.72 46.11 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 122.852 0.461 . . . . 0.0 109.967 176.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 318' ' ' THR . . . . . . . . . . . . . 69.5 p -98.57 144.4 28.07 Favored Pre-proline 0 CA--C 1.541 0.598 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 319' ' ' PRO . . . . . 0.725 ' HG3' HD21 ' A' ' 280' ' ' LEU . 20.8 Cg_endo -57.83 -17.31 29.35 Favored 'Trans proline' 0 C--N 1.366 1.486 0 C-N-CA 123.171 2.581 . . . . 0.0 112.578 170.578 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 44.9 ttt180 -71.02 -48.5 52.72 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.525 0.73 . . . . 0.0 110.454 -179.533 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 15.0 t -70.27 -29.08 65.77 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-O 120.809 0.338 . . . . 0.0 110.626 178.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 322' ' ' LEU . . . . . 0.463 HD13 HD13 ' A' ' 313' ' ' LEU . 64.7 mt -81.58 -14.83 56.32 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.82 177.266 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp 59.62 36.32 22.59 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.566 1.146 . . . . 0.0 112.413 -177.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.426 ' HG ' ' HB2' ' A' ' 322' ' ' LEU . 44.7 mt -68.96 145.46 53.6 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.701 0.8 . . . . 0.0 109.809 174.177 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 325' ' ' GLY . . . . . 0.447 ' H ' ' HB3' ' A' ' 328' ' ' ASP . . . -140.31 -169.29 11.64 Favored Glycine 0 C--O 1.24 0.472 0 C-N-CA 123.435 0.541 . . . . 0.0 112.08 -174.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 26.0 m -74.09 -26.86 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.771 0.828 . . . . 0.0 111.915 -175.397 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -101.03 -3.24 29.72 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.713 0.805 . . . . 0.0 111.141 179.128 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 328' ' ' ASP . . . . . 0.447 ' HB3' ' H ' ' A' ' 325' ' ' GLY . 12.2 t70 -83.28 144.78 29.49 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 175.82 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 329' ' ' ILE . . . . . 0.444 ' HA ' ' O ' ' A' ' 268' ' ' LYS . 24.2 mt -131.29 125.33 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 123.232 0.613 . . . . 0.0 109.673 -178.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 28.4 pt -116.82 131.93 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 123.367 0.667 . . . . 0.0 110.365 176.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 331' ' ' ASP . . . . . 0.433 ' O ' ' HA ' ' A' ' 306' ' ' LEU . 7.1 m-20 -68.13 135.67 52.5 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.951 0.9 . . . . 0.0 111.712 -179.193 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 332' ' ' CYS . . . . . 0.553 ' SG ' HD12 ' A' ' 304' ' ' ILE . 26.2 t -103.79 99.51 9.3 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.08 0.952 . . . . 0.0 109.011 171.46 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 47.9 t -104.48 113.46 41.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -178.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 334' ' ' VAL . . . . . 0.531 HG11 HG11 ' A' ' 299' ' ' VAL . 58.3 t -81.71 99.01 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.723 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 80.6 mt -83.57 160.14 21.5 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.655 0.782 . . . . 0.0 110.389 175.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 336' ' ' THR . . . . . . . . . . . . . 11.3 t -96.98 -22.4 16.86 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 171.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 44.4 t -113.11 132.41 55.45 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.115 0.966 . . . . 0.0 109.399 178.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 20.7 m . . . . . 0 C--O 1.257 1.472 0 C-N-CA 124.17 0.988 . . . . 0.0 109.444 176.866 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 . . . . . 0 N--CA 1.48 1.064 0 N-CA-C 111.366 0.136 . . . . 0.0 111.366 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -103.25 72.38 0.28 Allowed Glycine 0 C--N 1.355 1.634 0 N-CA-C 111.991 -0.444 . . . . 0.0 111.991 -177.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 246' ' ' GLN . . . . . 0.53 ' NE2' ' HB3' ' A' ' 248' ' ' ASP . 24.0 tm0? -75.54 107.85 7.96 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.57 0.748 . . . . 0.0 109.213 -178.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -101.71 -9.85 20.5 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.615 0.766 . . . . 0.0 112.524 -173.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 248' ' ' ASP . . . . . 0.53 ' HB3' ' NE2' ' A' ' 246' ' ' GLN . 16.2 t70 -69.34 93.18 0.63 Allowed 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -174.18 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -63.02 92.34 0.05 Allowed 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.653 173.095 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 33.4 m -64.3 124.78 19.76 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.943 -170.362 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 38.7 t 52.75 72.43 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.087 0 C-N-CA 124.861 1.264 . . . . 0.0 111.08 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 33.6 tp -151.39 85.21 1.32 Allowed 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.222 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.686 HG12 HD22 ' A' ' 258' ' ' LEU . 43.9 t -122.76 97.44 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 176.618 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -163.07 148.82 11.89 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.525 0.73 . . . . 0.0 109.42 -172.059 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 122.33 -77.99 0.34 Allowed Glycine 0 N--CA 1.472 1.056 0 N-CA-C 111.715 -0.554 . . . . 0.0 111.715 -178.227 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -75.88 -168.47 0.55 Allowed 'Trans proline' 0 C--N 1.373 1.823 0 C-N-CA 123.184 2.589 . . . . 0.0 112.32 175.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 70.4 m -63.28 128.12 34.39 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 123.544 0.738 . . . . 0.0 110.039 173.008 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.686 HD22 HG12 ' A' ' 253' ' ' VAL . 31.2 mt -105.65 94.0 8.05 Favored Pre-proline 0 CA--C 1.543 0.705 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 176.504 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -69.64 -21.53 33.9 Favored 'Trans proline' 0 C--N 1.377 2.077 0 C-N-CA 122.366 2.044 . . . . 0.0 111.852 176.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -72.12 104.38 3.59 Favored 'General case' 0 C--N 1.349 0.56 0 C-N-CA 124.768 1.227 . . . . 0.0 109.704 -177.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 20.6 p -71.25 146.67 92.51 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 123.103 0.561 . . . . 0.0 110.224 176.459 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -65.73 -179.61 1.36 Allowed 'Trans proline' 0 C--N 1.376 2.017 0 C-N-CA 122.697 2.264 . . . . 0.0 112.732 -179.066 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 78.7 mtt180 -86.36 102.23 13.83 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.316 0.579 . . . . 0.0 110.022 174.466 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.437 HD22 ' HB2' ' A' ' 279' ' ' PRO . 3.8 mp -100.87 171.93 7.35 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.745 172.15 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 265' ' ' PHE . . . . . 0.455 ' CE1' ' SD ' ' A' ' 282' ' ' MET . 46.4 p90 -145.63 147.33 32.64 Favored Pre-proline 0 C--O 1.243 0.725 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 173.855 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -68.12 94.02 0.41 Allowed 'Trans proline' 0 C--N 1.37 1.691 0 C-N-CA 122.061 1.84 . . . . 0.0 110.759 174.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 267' ' ' LEU . . . . . 0.479 HD12 HG13 ' A' ' 269' ' ' ILE . 1.9 tm? -58.55 130.14 45.41 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 173.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.58 ' HD2' HD22 ' A' ' 275' ' ' LEU . 4.7 tppp? -90.04 109.63 20.66 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 123.846 0.716 . . . . 0.0 110.497 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 269' ' ' ILE . . . . . 0.479 HG13 HD12 ' A' ' 267' ' ' LEU . 2.8 mp -110.93 154.95 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 174.401 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 270' ' ' ARG . . . . . 0.514 ' HG2' HD23 ' A' ' 275' ' ' LEU . 30.0 mtp-105 -113.75 131.11 56.32 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 162.812 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 271' ' ' CYS . . . . . 0.62 ' SG ' HD21 ' A' ' 297' ' ' LEU . 30.7 t -74.1 -160.14 0.09 Allowed 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 123.961 0.905 . . . . 0.0 109.399 168.335 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -58.67 -19.07 36.2 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.324 0.65 . . . . 0.0 112.051 173.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -153.86 -56.21 0.11 Allowed 'General case' 0 C--N 1.352 0.706 0 C-N-CA 123.532 0.733 . . . . 0.0 110.631 176.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -68.19 162.38 25.0 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.473 1.109 . . . . 0.0 112.652 -170.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.58 HD22 ' HD2' ' A' ' 268' ' ' LYS . 66.3 mt -88.86 128.09 35.65 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.714 0.806 . . . . 0.0 110.063 170.232 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 94.2 t -115.53 131.74 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 174.294 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 88.8 mtm180 -124.79 127.72 47.63 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.606 0.762 . . . . 0.0 109.189 176.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.545 HD21 ' HA ' ' A' ' 289' ' ' VAL . 3.7 pp -135.43 144.33 49.02 Favored Pre-proline 0 N--CA 1.483 1.187 0 CA-C-O 119.436 -0.316 . . . . 0.0 110.242 177.369 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 279' ' ' PRO . . . . . 0.437 ' HB2' HD22 ' A' ' 264' ' ' LEU . 69.1 Cg_endo -71.57 116.33 4.65 Favored 'Trans proline' 0 C--N 1.372 1.799 0 C-N-CA 122.179 1.919 . . . . 0.0 111.033 177.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.718 HD21 ' HG3' ' A' ' 319' ' ' PRO . 0.5 OUTLIER -135.23 151.6 50.76 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.82 1.248 . . . . 0.0 109.544 -178.051 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -96.48 154.31 17.34 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.248 0.619 . . . . 0.0 109.585 178.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 282' ' ' MET . . . . . 0.455 ' SD ' ' CE1' ' A' ' 265' ' ' PHE . 94.2 mmm -63.44 -29.01 70.37 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 122.851 0.46 . . . . 0.0 111.577 176.415 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 39.7 t -79.91 -28.5 39.81 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.76 0.824 . . . . 0.0 111.363 176.318 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -67.96 123.22 86.62 Favored Pre-proline 0 N--CA 1.481 1.084 0 C-N-CA 123.915 0.886 . . . . 0.0 109.843 -177.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -64.51 167.47 15.01 Favored 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 122.573 2.182 . . . . 0.0 112.118 178.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.426 ' O ' HG23 ' A' ' 290' ' ' VAL . 56.2 mt -63.9 -16.47 61.49 Favored 'General case' 0 C--O 1.216 -0.705 0 CA-C-O 118.596 -0.716 . . . . 0.0 112.028 -177.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 287' ' ' GLN . . . . . 0.406 ' HA ' ' HB ' ' A' ' 290' ' ' VAL . 24.9 tp60 -49.82 -27.33 4.9 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.58 0.752 . . . . 0.0 112.379 177.38 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 288' ' ' SER . . . . . 0.571 ' HB3' HD12 ' A' ' 280' ' ' LEU . 36.2 t -60.83 -55.87 27.91 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 123.925 0.89 . . . . 0.0 111.201 172.696 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.545 ' HA ' HD21 ' A' ' 278' ' ' LEU . 15.6 m -69.56 -31.5 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 122.413 0.285 . . . . 0.0 110.934 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 290' ' ' VAL . . . . . 0.56 HG13 ' HB ' ' A' ' 304' ' ' ILE . 46.1 t -63.21 -55.69 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 124.794 1.237 . . . . 0.0 111.018 -178.532 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -67.99 -36.21 79.63 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.844 -176.348 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 9.7 t60 -61.07 -49.96 75.22 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.475 0.71 . . . . 0.0 110.374 176.559 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 93.9 mmm -69.65 -29.16 66.55 Favored 'General case' 0 C--O 1.217 -0.624 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.97 -179.656 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -69.59 -37.61 76.99 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.327 0.651 . . . . 0.0 110.777 178.269 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 56.1 m -73.26 -37.37 66.34 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.229 0.611 . . . . 0.0 110.161 176.254 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -63.61 -47.25 82.2 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.954 0.901 . . . . 0.0 110.522 179.129 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 297' ' ' LEU . . . . . 0.62 HD21 ' SG ' ' A' ' 271' ' ' CYS . 38.2 mt -89.26 -11.13 44.43 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.258 1.023 . . . . 0.0 112.125 -174.587 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 72.9 19.2 79.37 Favored Glycine 0 C--N 1.352 1.433 0 O-C-N 123.515 0.51 . . . . 0.0 112.932 -178.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 20.5 m -105.33 178.85 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 124.405 1.082 . . . . 0.0 110.305 -177.14 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 21.2 m -82.62 148.01 57.14 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 123.262 0.625 . . . . 0.0 109.898 178.344 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -60.83 -29.15 87.62 Favored 'Trans proline' 0 C--N 1.386 2.511 0 C-N-CA 122.494 2.129 . . . . 0.0 112.334 175.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 36.1 t -72.47 -17.93 61.72 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 122.261 -0.274 . . . . 0.0 110.739 -179.27 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -90.21 -7.37 53.72 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.779 0.832 . . . . 0.0 111.372 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 304' ' ' ILE . . . . . 0.56 ' HB ' HG13 ' A' ' 290' ' ' VAL . 41.6 mm -84.83 109.2 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 CA-C-N 118.373 0.533 . . . . 0.0 110.187 177.422 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 39.5 tp -109.8 112.09 23.93 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.47 0.708 . . . . 0.0 109.095 177.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 306' ' ' LEU . . . . . 0.505 HD21 HG22 ' A' ' 290' ' ' VAL . 2.5 mm? -85.05 133.46 34.24 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.544 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 307' ' ' LEU . . . . . 0.48 HD23 ' HA ' ' A' ' 312' ' ' GLU . 76.7 mt -132.8 103.09 5.92 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.312 0.645 . . . . 0.0 109.987 -177.1 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 308' ' ' PHE . . . . . 0.479 ' HB2' HD11 ' A' ' 313' ' ' LEU . 69.8 t80 -77.56 92.3 4.05 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -178.428 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 72.27 -81.29 0.59 Allowed Glycine 0 C--N 1.343 0.953 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.703 -174.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -131.75 -11.76 3.42 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.584 0.754 . . . . 0.0 112.384 -179.314 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 6.9 t -86.79 148.55 25.35 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 118.115 0.416 . . . . 0.0 111.004 -177.493 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 312' ' ' GLU . . . . . 0.48 ' HA ' HD23 ' A' ' 307' ' ' LEU . 37.2 tt0 -93.79 123.97 37.48 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 122.847 0.459 . . . . 0.0 110.226 -176.397 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.484 HD13 HD13 ' A' ' 322' ' ' LEU . 47.5 mt -111.4 126.98 55.51 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.995 -178.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 42.0 m -71.37 144.46 89.32 Favored Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 123.693 0.797 . . . . 0.0 110.12 173.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -63.11 -18.11 63.48 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 123.027 2.485 . . . . 0.0 112.751 176.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 37.7 p -90.36 -8.42 50.78 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.573 1.149 . . . . 0.0 112.427 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -72.88 152.71 41.35 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.099 0.559 . . . . 0.0 111.036 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 318' ' ' THR . . . . . . . . . . . . . 32.4 p -103.93 142.82 25.4 Favored Pre-proline 0 N--CA 1.478 0.928 0 C-N-CA 122.999 0.52 . . . . 0.0 109.672 177.525 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 319' ' ' PRO . . . . . 0.718 ' HG3' HD21 ' A' ' 280' ' ' LEU . 70.3 Cg_endo -66.0 -14.17 43.24 Favored 'Trans proline' 0 C--N 1.369 1.64 0 C-N-CA 123.649 2.899 . . . . 0.0 113.192 -176.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 70.3 ttt180 -69.21 -53.47 19.78 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.234 0.614 . . . . 0.0 110.557 -177.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 9.8 t -66.8 -29.92 69.99 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.347 0.659 . . . . 0.0 111.364 177.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 322' ' ' LEU . . . . . 0.484 HD13 HD13 ' A' ' 313' ' ' LEU . 43.4 mt -81.89 -19.41 40.91 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.395 0.678 . . . . 0.0 111.0 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 53.69 75.67 0.25 Allowed 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 125.108 1.363 . . . . 0.0 109.623 -170.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 70.6 mt -106.98 164.57 12.03 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.627 176.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 325' ' ' GLY . . . . . 0.467 ' H ' ' HB2' ' A' ' 328' ' ' ASP . . . -169.53 -160.63 18.22 Favored Glycine 0 C--N 1.343 0.95 0 CA-C-N 115.928 -0.578 . . . . 0.0 113.374 -170.683 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 30.6 m -80.5 -24.55 11.26 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 124.481 1.112 . . . . 0.0 111.296 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -101.73 -25.85 13.69 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.054 0.942 . . . . 0.0 110.457 177.635 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 328' ' ' ASP . . . . . 0.467 ' HB2' ' H ' ' A' ' 325' ' ' GLY . 34.1 m-20 -76.02 111.5 11.47 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.433 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 329' ' ' ILE . . . . . 0.516 HG12 ' HG2' ' A' ' 268' ' ' LYS . 4.4 mt -99.13 133.21 42.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.088 0.555 . . . . 0.0 110.942 -173.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 41.2 pt -119.23 128.91 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 123.211 0.605 . . . . 0.0 109.739 174.055 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -85.22 109.65 18.47 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.374 0.67 . . . . 0.0 110.514 -176.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 332' ' ' CYS . . . . . 0.559 ' SG ' HD12 ' A' ' 304' ' ' ILE . 35.9 t -73.12 95.08 2.01 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.385 0.674 . . . . 0.0 109.583 170.1 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 58.2 t -106.86 122.39 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 178.378 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 91.4 t -78.53 102.01 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-O 121.18 0.514 . . . . 0.0 110.517 -176.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.54 138.12 58.07 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 125.077 1.351 . . . . 0.0 109.061 170.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 336' ' ' THR . . . . . . . . . . . . . 19.1 m -69.51 -72.79 0.18 Allowed 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 123.29 0.636 . . . . 0.0 110.75 -178.022 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 49.9 m -144.14 169.46 17.83 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.962 0.905 . . . . 0.0 109.463 -177.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 22.6 t . . . . . 0 CA--C 1.555 1.166 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -179.208 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 244' ' ' GLN . . . . . 0.84 HE21 ' N ' ' A' ' 244' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.87 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 53.89 42.84 70.56 Favored Glycine 0 C--N 1.346 1.12 0 O-C-N 123.837 0.71 . . . . 0.0 114.609 173.537 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -68.14 95.87 0.6 Allowed 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.195 0.522 . . . . 0.0 110.055 177.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -142.9 122.79 13.5 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 175.257 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -155.03 -43.3 0.08 Allowed 'General case' 0 C--O 1.24 0.59 0 C-N-CA 123.474 0.709 . . . . 0.0 110.4 -171.222 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -81.07 72.93 8.12 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.273 -173.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 46.2 t -83.59 131.02 34.82 Favored 'Isoleucine or valine' 0 C--O 1.244 0.795 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.338 176.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 59.2 t -71.47 83.38 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 176.058 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 6.2 tt -178.46 114.98 0.07 Allowed 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 -177.45 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 7.6 p -134.97 135.54 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 122.99 0.516 . . . . 0.0 109.794 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 254' ' ' GLU . . . . . 0.48 ' HG3' ' HD3' ' A' ' 256' ' ' PRO . 10.6 pt-20 -158.98 178.32 10.2 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.428 1.091 . . . . 0.0 109.304 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -125.78 79.72 0.37 Allowed Glycine 0 CA--C 1.528 0.852 0 CA-C-O 119.47 -0.628 . . . . 0.0 111.922 177.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 256' ' ' PRO . . . . . 0.48 ' HD3' ' HG3' ' A' ' 254' ' ' GLU . 83.1 Cg_endo -82.4 157.88 16.98 Favored 'Trans proline' 0 C--N 1.373 1.844 0 C-N-CA 122.658 2.239 . . . . 0.0 111.843 174.304 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 47.6 p -74.72 102.58 4.69 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 175.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 73.7 mt -100.67 96.82 5.82 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 123.601 0.761 . . . . 0.0 108.995 176.208 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -63.3 -35.24 63.67 Favored 'Trans proline' 0 C--N 1.379 2.151 0 C-N-CA 122.241 1.961 . . . . 0.0 111.264 176.537 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -77.53 97.0 4.89 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.504 0.722 . . . . 0.0 109.117 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 91.4 m -71.55 136.63 83.45 Favored Pre-proline 0 CA--C 1.553 1.071 0 C-N-CA 124.147 0.979 . . . . 0.0 110.889 -178.116 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -54.08 130.68 40.72 Favored 'Trans proline' 0 C--N 1.386 2.552 0 C-N-CA 122.738 2.292 . . . . 0.0 111.691 174.073 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 64.5 mtt180 -63.26 113.27 3.09 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 123.878 0.871 . . . . 0.0 111.737 -172.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 3.0 mp -84.59 167.99 15.77 Favored 'General case' 0 C--O 1.243 0.757 0 CA-C-N 114.653 -1.158 . . . . 0.0 108.632 173.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -144.85 146.51 31.71 Favored Pre-proline 0 CA--C 1.543 0.697 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 175.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 266' ' ' PRO . . . . . 0.503 ' HB2' ' HB3' ' A' ' 277' ' ' ARG . 46.2 Cg_endo -66.85 91.36 0.3 Allowed 'Trans proline' 0 C--N 1.374 1.903 0 C-N-CA 122.182 1.921 . . . . 0.0 112.197 176.809 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 267' ' ' LEU . . . . . 0.581 HD23 HD22 ' A' ' 280' ' ' LEU . 0.4 OUTLIER -63.28 115.53 4.64 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 170.747 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.582 ' HD3' HD13 ' A' ' 275' ' ' LEU . 30.7 ttmt -90.96 118.38 30.3 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 123.414 0.446 . . . . 0.0 109.892 -179.378 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 269' ' ' ILE . . . . . 0.571 HG21 ' HG3' ' A' ' 293' ' ' MET . 2.4 mp -113.93 136.37 50.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 C-N-CA 123.6 0.76 . . . . 0.0 108.958 177.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 270' ' ' ARG . . . . . 0.484 ' HA ' HD23 ' A' ' 275' ' ' LEU . 0.7 OUTLIER -85.95 106.67 17.3 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 123.626 0.579 . . . . 0.0 110.469 -177.561 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 271' ' ' CYS . . . . . 0.531 ' SG ' HD21 ' A' ' 297' ' ' LEU . 38.6 t -75.2 179.49 5.06 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.742 0.817 . . . . 0.0 109.789 167.208 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 272' ' ' ARG . . . . . 0.462 ' HG2' ' SG ' ' A' ' 271' ' ' CYS . 17.2 ptm180 -54.18 -36.08 63.03 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.012 0.925 . . . . 0.0 112.789 178.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -159.44 49.39 0.32 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.63 0.772 . . . . 0.0 109.621 178.594 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 274' ' ' ASP . . . . . 0.456 ' HB3' ' HB3' ' A' ' 271' ' ' CYS . 19.9 t70 -166.43 162.52 17.01 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.714 0.805 . . . . 0.0 110.123 -173.4 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.582 HD13 ' HD3' ' A' ' 268' ' ' LYS . 81.0 mt -131.36 104.72 7.18 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.392 1.077 . . . . 0.0 109.615 176.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 276' ' ' VAL . . . . . 0.43 ' O ' HD12 ' A' ' 269' ' ' ILE . 78.3 t -83.44 115.5 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 177.302 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 277' ' ' ARG . . . . . 0.503 ' HB3' ' HB2' ' A' ' 266' ' ' PRO . 61.2 mtm-85 -107.31 80.68 1.44 Allowed 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -179.046 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.406 ' HA ' ' HD3' ' A' ' 279' ' ' PRO . 4.3 pp -93.13 142.89 25.92 Favored Pre-proline 0 N--CA 1.484 1.226 0 CA-C-O 119.579 -0.248 . . . . 0.0 111.054 -173.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 279' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 278' ' ' LEU . 12.7 Cg_exo -68.23 109.14 1.92 Allowed 'Trans proline' 0 C--N 1.375 1.932 0 C-N-CA 122.833 2.355 . . . . 0.0 110.696 177.429 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.581 HD22 HD23 ' A' ' 267' ' ' LEU . 2.9 tt -127.39 139.17 53.02 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.448 1.099 . . . . 0.0 109.466 -178.073 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 68.3 mtm180 -80.45 152.71 28.64 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.898 0.879 . . . . 0.0 110.649 179.154 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 282' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -65.66 -23.85 66.89 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 122.543 0.337 . . . . 0.0 111.581 177.531 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 20.7 t -91.17 -1.36 57.74 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.117 0.967 . . . . 0.0 111.985 179.175 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -85.01 132.89 44.32 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 123.606 0.763 . . . . 0.0 109.537 -178.05 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -66.58 164.46 28.81 Favored 'Trans proline' 0 C--N 1.372 1.797 0 C-N-CA 121.864 1.71 . . . . 0.0 111.203 169.438 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.433 ' O ' HG23 ' A' ' 290' ' ' VAL . 49.3 mt -67.85 -13.7 62.36 Favored 'General case' 0 C--O 1.211 -0.936 0 CA-C-O 119.027 -0.511 . . . . 0.0 111.261 178.813 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 26.6 tp60 -51.1 -27.61 8.73 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.282 1.033 . . . . 0.0 112.013 178.077 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 39.9 t -58.14 -59.84 4.66 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.206 1.002 . . . . 0.0 111.114 170.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.418 ' HB ' HG12 ' A' ' 269' ' ' ILE . 13.0 m -70.15 -25.76 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 122.774 0.43 . . . . 0.0 110.833 -178.391 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 290' ' ' VAL . . . . . 0.476 HG13 ' HB ' ' A' ' 304' ' ' ILE . 55.8 t -65.19 -51.34 66.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 123.92 0.888 . . . . 0.0 109.97 178.597 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -71.29 -38.18 71.82 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.881 -178.332 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 8.5 t60 -66.8 -48.45 68.95 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.234 0.614 . . . . 0.0 110.36 -178.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 293' ' ' MET . . . . . 0.571 ' HG3' HG21 ' A' ' 269' ' ' ILE . 97.5 mmm -67.69 -31.08 70.79 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.783 0.433 . . . . 0.0 110.87 179.254 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -59.71 -45.85 90.88 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 122.844 0.458 . . . . 0.0 110.403 173.133 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 24.9 m -69.98 -30.3 67.6 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 123.191 0.597 . . . . 0.0 110.958 178.081 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 71.7 t60 -73.81 -29.1 61.97 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.781 0.832 . . . . 0.0 111.211 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 297' ' ' LEU . . . . . 0.531 HD21 ' SG ' ' A' ' 271' ' ' CYS . 52.4 mt -109.0 -2.44 18.22 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.946 0.898 . . . . 0.0 111.507 -175.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 77.47 19.09 76.92 Favored Glycine 0 N--CA 1.478 1.471 0 C-N-CA 123.343 0.497 . . . . 0.0 113.869 172.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 299' ' ' VAL . . . . . 0.641 ' HB ' ' HD2' ' A' ' 303' ' ' ARG . 27.3 m -116.29 -176.38 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 124.551 1.14 . . . . 0.0 111.369 -176.205 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 20.3 m -86.3 146.61 42.75 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 123.612 0.765 . . . . 0.0 110.457 178.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -53.46 -35.59 76.49 Favored 'Trans proline' 0 C--N 1.387 2.578 0 C-N-CA 123.14 2.56 . . . . 0.0 112.294 176.296 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 29.7 p -61.14 -24.48 66.31 Favored 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 123.354 0.661 . . . . 0.0 112.29 -174.37 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 303' ' ' ARG . . . . . 0.641 ' HD2' ' HB ' ' A' ' 299' ' ' VAL . 90.1 mtt180 -82.16 -25.58 34.19 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.268 1.027 . . . . 0.0 112.096 -176.653 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 304' ' ' ILE . . . . . 0.585 HD12 ' SG ' ' A' ' 332' ' ' CYS . 38.0 mm -73.77 103.55 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 C-N-CA 123.42 0.688 . . . . 0.0 111.308 -173.676 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 305' ' ' LEU . . . . . 0.416 HD22 HD11 ' A' ' 335' ' ' LEU . 50.9 tp -101.17 114.68 28.86 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.661 0.784 . . . . 0.0 108.913 173.64 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 306' ' ' LEU . . . . . 0.403 ' HG ' HD12 ' A' ' 330' ' ' ILE . 2.6 mm? -86.32 131.34 34.24 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 177.175 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 307' ' ' LEU . . . . . 0.455 HD12 HG21 ' A' ' 333' ' ' VAL . 75.2 mt -130.86 111.06 11.76 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 178.841 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 308' ' ' PHE . . . . . 0.453 ' HB2' HD11 ' A' ' 313' ' ' LEU . 56.4 t80 -78.7 88.57 4.58 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.79 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 72.99 -82.35 0.63 Allowed Glycine 0 C--N 1.345 1.076 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.808 -175.43 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -121.48 -27.56 4.76 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.903 0.881 . . . . 0.0 111.103 -176.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 6.1 t -78.74 145.45 34.44 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 122.649 0.38 . . . . 0.0 110.789 -173.292 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 312' ' ' GLU . . . . . 0.43 ' HA ' HD23 ' A' ' 307' ' ' LEU . 44.1 tt0 -89.28 124.45 34.41 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 122.901 0.481 . . . . 0.0 110.343 -177.611 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.459 HD13 HD13 ' A' ' 322' ' ' LEU . 28.0 mt -106.79 154.56 20.82 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 122.899 0.479 . . . . 0.0 110.067 177.739 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 49.0 m -107.92 151.29 41.17 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 123.412 0.685 . . . . 0.0 110.111 -179.602 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -62.45 -27.03 76.83 Favored 'Trans proline' 0 C--N 1.381 2.266 0 C-N-CA 122.585 2.19 . . . . 0.0 112.352 174.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 38.5 p -78.77 -21.68 47.51 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.626 0.77 . . . . 0.0 112.114 177.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -66.22 144.56 56.55 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.427 0.691 . . . . 0.0 111.798 -175.354 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 318' ' ' THR . . . . . . . . . . . . . 68.3 p -100.11 153.47 37.74 Favored Pre-proline 0 CA--C 1.553 1.074 0 C-N-CA 123.839 0.856 . . . . 0.0 109.754 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 319' ' ' PRO . . . . . 0.565 ' HG3' HD21 ' A' ' 280' ' ' LEU . 60.3 Cg_endo -73.49 -10.6 23.93 Favored 'Trans proline' 0 C--N 1.371 1.725 0 C-N-CA 123.165 2.577 . . . . 0.0 112.179 -177.637 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -69.23 -54.71 13.36 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.91 0.884 . . . . 0.0 110.183 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 10.2 t -67.18 -23.03 65.72 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.384 0.674 . . . . 0.0 111.44 178.277 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 322' ' ' LEU . . . . . 0.531 ' HB2' ' HG ' ' A' ' 324' ' ' LEU . 54.9 mt -96.67 -8.38 31.69 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.438 0.695 . . . . 0.0 111.993 -178.448 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt 59.16 29.24 18.76 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 124.238 1.015 . . . . 0.0 113.008 -178.59 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.531 ' HG ' ' HB2' ' A' ' 322' ' ' LEU . 55.3 mt -72.81 132.54 43.7 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 122.877 0.471 . . . . 0.0 110.476 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 325' ' ' GLY . . . . . 0.422 ' H ' ' HB2' ' A' ' 328' ' ' ASP . . . -138.15 -146.62 5.06 Favored Glycine 0 C--N 1.337 0.629 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 179.05 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 326' ' ' VAL . . . . . 0.418 ' O ' ' HE3' ' A' ' 268' ' ' LYS . 11.3 m -81.19 -26.33 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 123.033 0.533 . . . . 0.0 110.937 -176.697 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -97.53 -12.91 22.03 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.469 0.708 . . . . 0.0 111.665 -177.3 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 328' ' ' ASP . . . . . 0.422 ' HB2' ' H ' ' A' ' 325' ' ' GLY . 24.6 m-20 -87.3 108.37 18.93 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.002 0.43 . . . . 0.0 109.856 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 329' ' ' ILE . . . . . 0.448 HG12 ' HD2' ' A' ' 268' ' ' LYS . 38.0 mt -92.95 128.64 44.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.665 177.482 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 330' ' ' ILE . . . . . 0.457 HG13 HG23 ' A' ' 269' ' ' ILE . 41.0 pt -112.73 122.34 66.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 121.14 0.495 . . . . 0.0 109.711 175.176 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -71.78 113.82 9.21 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.045 0.938 . . . . 0.0 111.181 -173.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 332' ' ' CYS . . . . . 0.585 ' SG ' HD12 ' A' ' 304' ' ' ILE . 42.1 t -81.9 97.59 8.12 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.552 0.741 . . . . 0.0 110.198 177.845 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 333' ' ' VAL . . . . . 0.455 HG21 HD12 ' A' ' 307' ' ' LEU . 47.0 t -99.85 111.99 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 123.437 0.695 . . . . 0.0 109.435 -177.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 334' ' ' VAL . . . . . 0.542 HG11 HG11 ' A' ' 299' ' ' VAL . 60.5 t -80.84 103.93 8.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.662 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 335' ' ' LEU . . . . . 0.416 HD11 HD22 ' A' ' 305' ' ' LEU . 80.3 mt -89.94 -175.07 4.47 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.229 173.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 336' ' ' THR . . . . . . . . . . . . . 68.4 p -86.55 -42.72 13.28 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 168.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 49.6 m 58.2 23.99 10.9 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 125.005 1.322 . . . . 0.0 111.856 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 14.7 m . . . . . 0 C--O 1.254 1.33 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.702 -177.196 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 . . . . . 0 N--CA 1.478 0.932 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -123.92 -140.62 5.62 Favored Glycine 0 C--N 1.346 1.135 0 CA-C-O 118.741 -1.033 . . . . 0.0 111.064 179.31 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 76.1 -37.03 0.29 Allowed 'General case' 0 N--CA 1.499 2.001 0 C-N-CA 125.905 1.682 . . . . 0.0 112.454 -178.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -88.99 46.13 1.36 Allowed 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.404 1.082 . . . . 0.0 110.298 176.241 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -68.03 -35.1 77.72 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.01 0.924 . . . . 0.0 110.004 175.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -63.89 115.76 5.16 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.668 173.498 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 21.8 m -83.79 61.7 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.03 0 CA-C-O 122.32 1.057 . . . . 0.0 111.149 -176.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 2.9 p -74.56 95.4 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 CA-C-N 114.465 -1.243 . . . . 0.0 110.457 -179.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 40.8 tp -95.8 87.9 4.79 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 115.454 -0.794 . . . . 0.0 108.95 -178.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 28.9 t 57.68 76.27 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.064 0 C-N-CA 125.177 1.391 . . . . 0.0 111.589 178.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -129.06 111.08 12.6 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 172.538 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 69.22 71.8 0.93 Allowed Glycine 0 CA--C 1.531 1.055 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 -170.469 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -60.16 88.38 0.08 OUTLIER 'Trans proline' 0 C--N 1.389 2.691 0 C-N-CA 123.781 2.987 . . . . 0.0 112.558 -178.278 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 68.0 m -153.21 146.91 25.14 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 125.758 1.623 . . . . 0.0 106.794 178.208 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 91.4 mt -101.43 97.19 7.12 Favored Pre-proline 0 N--CA 1.479 0.998 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 173.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -70.09 -34.03 14.24 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 122.293 1.995 . . . . 0.0 110.505 174.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -147.21 120.27 8.82 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 124.845 1.258 . . . . 0.0 107.991 171.147 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 89.6 m -73.3 132.84 81.47 Favored Pre-proline 0 CA--C 1.553 1.091 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 170.219 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 262' ' ' PRO . . . . . 0.401 ' O ' HD12 ' A' ' 264' ' ' LEU . 12.7 Cg_endo -54.99 164.23 3.6 Favored 'Trans proline' 0 C--N 1.387 2.568 0 C-N-CA 123.236 2.624 . . . . 0.0 113.537 178.665 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -82.4 95.43 7.65 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.819 178.258 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.401 HD12 ' O ' ' A' ' 262' ' ' PRO . 4.8 mp -95.27 104.36 16.25 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.162 173.22 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -93.08 148.04 34.97 Favored Pre-proline 0 CA--C 1.55 0.955 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.227 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 266' ' ' PRO . . . . . 0.49 ' HB2' ' HB3' ' A' ' 277' ' ' ARG . 74.3 Cg_endo -70.41 92.12 0.58 Allowed 'Trans proline' 0 C--N 1.376 2.007 0 C-N-CA 122.393 2.062 . . . . 0.0 112.239 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 267' ' ' LEU . . . . . 0.474 HD23 HD22 ' A' ' 280' ' ' LEU . 0.3 OUTLIER -64.32 126.21 27.05 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 172.304 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 22.9 ttpt -95.17 114.64 26.45 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-O 121.486 0.66 . . . . 0.0 111.083 -178.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 2.3 mp -113.08 124.99 70.27 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 C-N-CA 124.811 1.245 . . . . 0.0 109.231 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 35.5 ttp180 -93.09 107.21 19.05 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.165 0.507 . . . . 0.0 109.995 175.506 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 271' ' ' CYS . . . . . 0.668 ' SG ' HD21 ' A' ' 297' ' ' LEU . 48.9 t -82.33 -172.76 4.17 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.782 0.833 . . . . 0.0 111.322 179.042 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 272' ' ' ARG . . . . . 0.478 ' N ' ' SG ' ' A' ' 271' ' ' CYS . 35.8 ptt180 -57.37 -34.88 69.3 Favored 'General case' 0 CA--C 1.552 1.058 0 C-N-CA 124.622 1.169 . . . . 0.0 112.772 176.168 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -153.62 27.54 0.49 Allowed 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.165 0.586 . . . . 0.0 110.687 -177.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 274' ' ' ASP . . . . . 0.531 ' HB2' ' HB3' ' A' ' 271' ' ' CYS . 4.7 m-20 -141.29 158.85 43.34 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.589 0.756 . . . . 0.0 109.681 -175.316 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 26.9 tp -132.79 86.46 2.32 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 169.479 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 67.7 t -86.23 144.43 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.6 0.76 . . . . 0.0 109.927 -174.525 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 277' ' ' ARG . . . . . 0.49 ' HB3' ' HB2' ' A' ' 266' ' ' PRO . 52.9 mtp180 -128.5 87.02 2.52 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 172.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.455 HD11 HG12 ' A' ' 289' ' ' VAL . 3.9 pp -95.66 142.93 25.27 Favored Pre-proline 0 N--CA 1.48 1.056 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 -175.546 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -65.55 125.33 14.21 Favored 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 122.919 2.413 . . . . 0.0 111.343 175.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.696 HD21 ' HG3' ' A' ' 319' ' ' PRO . 0.1 OUTLIER -140.72 148.31 40.55 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.954 0.902 . . . . 0.0 110.639 -178.151 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 70.3 mtp180 -87.9 142.94 27.4 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.347 1.059 . . . . 0.0 110.671 179.099 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 282' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -62.04 -35.03 77.36 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.658 0.783 . . . . 0.0 111.829 175.024 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 44.4 p -75.36 -20.38 59.04 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.892 0.877 . . . . 0.0 111.595 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -86.57 130.23 49.96 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 124.207 1.003 . . . . 0.0 108.99 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 285' ' ' PRO . . . . . 0.509 ' HA ' ' HA ' ' A' ' 318' ' ' THR . 40.9 Cg_endo -65.76 178.25 2.38 Favored 'Trans proline' 0 C--N 1.38 2.209 0 C-N-CA 122.608 2.205 . . . . 0.0 112.753 173.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.45 ' O ' HG23 ' A' ' 290' ' ' VAL . 90.7 mt -64.43 -18.22 64.53 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.563 0.745 . . . . 0.0 111.965 -179.122 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 27.7 tp60 -52.48 -23.36 6.07 Favored 'General case' 0 CA--C 1.558 1.264 0 C-N-CA 123.678 0.791 . . . . 0.0 112.271 178.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 288' ' ' SER . . . . . 0.56 ' HB3' HD12 ' A' ' 280' ' ' LEU . 37.3 t -63.24 -57.31 10.87 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.841 0.856 . . . . 0.0 110.856 171.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.47 ' O ' ' HG2' ' A' ' 293' ' ' MET . 27.7 m -65.4 -35.36 75.13 Favored 'Isoleucine or valine' 0 C--N 1.368 1.381 0 O-C-N 123.167 0.292 . . . . 0.0 110.342 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 290' ' ' VAL . . . . . 0.592 HG13 ' HB ' ' A' ' 304' ' ' ILE . 71.6 t -55.73 -53.21 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 124.42 1.088 . . . . 0.0 111.336 178.259 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -63.87 -42.97 97.4 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.066 -177.061 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 13.5 t60 -71.85 -38.09 70.15 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.231 -176.011 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 293' ' ' MET . . . . . 0.47 ' HG2' ' O ' ' A' ' 289' ' ' VAL . 91.0 mmm -68.9 -34.38 75.31 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 123.156 0.582 . . . . 0.0 110.125 177.327 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -66.29 -43.4 86.46 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.571 0.748 . . . . 0.0 111.376 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 26.2 m -70.14 -32.65 70.74 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.381 0.672 . . . . 0.0 110.644 176.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 79.2 t60 -63.36 -35.11 79.32 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.905 0.882 . . . . 0.0 111.812 177.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 297' ' ' LEU . . . . . 0.668 HD21 ' SG ' ' A' ' 271' ' ' CYS . 75.7 mt -99.53 -23.27 15.14 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.244 0.618 . . . . 0.0 111.893 -177.743 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 82.63 25.12 51.57 Favored Glycine 0 CA--C 1.531 1.071 0 O-C-N 123.262 0.351 . . . . 0.0 112.787 -173.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 33.4 m -107.33 177.99 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 124.521 1.128 . . . . 0.0 109.878 176.19 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 47.6 m -83.17 144.36 46.93 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 123.042 0.537 . . . . 0.0 110.6 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -55.75 -31.99 82.48 Favored 'Trans proline' 0 C--N 1.388 2.606 0 C-N-CA 123.263 2.642 . . . . 0.0 112.096 170.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 34.2 t -70.85 -6.02 34.9 Favored 'General case' 0 CA--C 1.56 1.328 0 C-N-CA 122.558 0.343 . . . . 0.0 111.787 -178.419 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 58.1 mtt180 -106.44 -16.25 14.59 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.243 1.017 . . . . 0.0 112.173 178.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 304' ' ' ILE . . . . . 0.592 ' HB ' HG13 ' A' ' 290' ' ' VAL . 38.9 mm -81.16 108.17 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 177.758 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 24.1 tp -110.36 130.25 55.59 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 174.429 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -95.89 131.41 42.26 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 307' ' ' LEU . . . . . 0.469 HD12 HG21 ' A' ' 333' ' ' VAL . 72.9 mt -133.48 105.69 7.05 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.587 0.755 . . . . 0.0 109.602 -175.623 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 308' ' ' PHE . . . . . 0.578 ' HB2' HD11 ' A' ' 313' ' ' LEU . 85.4 t80 -78.23 95.1 4.89 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -176.816 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 73.17 -85.11 0.59 Allowed Glycine 0 C--N 1.344 1.017 0 N-CA-C 111.436 -0.666 . . . . 0.0 111.436 -177.056 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -139.2 13.59 2.61 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.706 0.802 . . . . 0.0 111.566 -179.1 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 6.2 t -104.77 147.49 27.65 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 175.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -92.92 122.97 35.84 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.956 0.502 . . . . 0.0 110.32 -176.288 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.578 HD11 ' HB2' ' A' ' 308' ' ' PHE . 40.2 mt -110.83 130.72 55.5 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.096 0.559 . . . . 0.0 109.802 -179.49 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 16.5 m -73.65 142.18 80.32 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 123.054 0.542 . . . . 0.0 110.198 174.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 315' ' ' PRO . . . . . 0.44 ' HB3' HG21 ' A' ' 290' ' ' VAL . 30.9 Cg_endo -62.62 -25.81 75.49 Favored 'Trans proline' 0 C--N 1.381 2.255 0 C-N-CA 122.821 2.347 . . . . 0.0 111.934 173.152 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 28.6 p -78.63 -18.32 54.67 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.558 1.143 . . . . 0.0 111.853 177.325 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -73.94 149.77 41.21 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.052 0.541 . . . . 0.0 110.257 176.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 318' ' ' THR . . . . . 0.509 ' HA ' ' HA ' ' A' ' 285' ' ' PRO . 60.7 p -99.2 142.6 24.9 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 123.26 0.624 . . . . 0.0 110.361 -176.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 319' ' ' PRO . . . . . 0.696 ' HG3' HD21 ' A' ' 280' ' ' LEU . 37.9 Cg_endo -62.49 -15.96 48.96 Favored 'Trans proline' 0 C--N 1.377 2.046 0 C-N-CA 123.378 2.719 . . . . 0.0 112.521 174.724 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 73.4 ttt-85 -60.78 -57.8 11.14 Favored 'General case' 0 C--N 1.358 0.951 0 C-N-CA 123.826 0.851 . . . . 0.0 111.044 176.298 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 14.7 t -70.73 -25.14 62.79 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.309 -177.086 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 322' ' ' LEU . . . . . 0.519 HD13 HD13 ' A' ' 313' ' ' LEU . 65.5 mt -79.0 -19.7 50.91 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.277 0.631 . . . . 0.0 110.689 177.457 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt 59.06 57.44 3.52 Favored 'General case' 0 CA--C 1.55 0.942 0 C-N-CA 124.787 1.235 . . . . 0.0 109.9 -176.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.426 ' HG ' ' HB2' ' A' ' 322' ' ' LEU . 69.8 mt -93.9 140.24 29.93 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 114.416 -1.266 . . . . 0.0 108.85 177.371 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . -128.82 -157.73 9.38 Favored Glycine 0 C--O 1.239 0.436 0 O-C-N 123.977 0.798 . . . . 0.0 111.156 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 326' ' ' VAL . . . . . 0.427 ' HB ' ' NH2' ' A' ' 277' ' ' ARG . 29.6 m -75.07 -25.58 18.46 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 C-N-CA 123.382 0.673 . . . . 0.0 111.868 -175.343 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -98.31 -16.79 19.23 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.006 0.922 . . . . 0.0 111.915 -177.138 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -73.13 123.67 24.06 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.04 0.536 . . . . 0.0 110.605 -176.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 29.0 mt -106.26 120.32 57.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 C-N-CA 123.975 0.91 . . . . 0.0 110.357 -175.206 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 32.1 pt -113.71 130.4 67.85 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 174.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -77.76 111.08 13.19 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.74 0.816 . . . . 0.0 111.823 -174.114 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 332' ' ' CYS . . . . . 0.591 ' SG ' HD12 ' A' ' 304' ' ' ILE . 29.5 t -72.57 96.62 1.99 Allowed 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.545 0.738 . . . . 0.0 109.783 166.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 333' ' ' VAL . . . . . 0.469 HG21 HD12 ' A' ' 307' ' ' LEU . 75.3 t -105.28 114.34 44.57 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 177.576 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 52.5 t -78.66 90.13 1.27 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.775 0 CA-C-O 121.565 0.698 . . . . 0.0 109.606 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 86.0 mt -89.44 112.97 24.25 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.067 174.402 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 336' ' ' THR . . . . . . . . . . . . . 71.2 p -54.85 -32.97 61.24 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.754 1.222 . . . . 0.0 111.235 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 23.4 m 78.65 -51.73 0.47 Allowed 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 126.097 1.759 . . . . 0.0 111.812 175.263 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 49.5 m . . . . . 0 C--O 1.253 1.271 0 C-N-CA 124.48 1.112 . . . . 0.0 108.773 176.937 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 . . . . . 0 N--CA 1.48 1.056 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -177.3 168.69 40.56 Favored Glycine 0 C--N 1.34 0.761 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.178 179.012 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -70.39 138.06 51.01 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-O 121.077 0.465 . . . . 0.0 110.379 -179.249 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -90.62 24.94 2.47 Favored 'General case' 0 CA--C 1.562 1.41 0 C-N-CA 123.875 0.87 . . . . 0.0 110.67 -174.366 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 25.6 t70 56.19 70.28 0.66 Allowed 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.569 1.147 . . . . 0.0 110.487 -178.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -136.52 50.86 2.02 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.158 -173.052 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 23.0 m -67.89 141.18 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 177.261 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 12.1 m -70.26 87.78 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.088 0 CA-C-O 122.391 1.091 . . . . 0.0 110.491 177.274 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 5.5 tt -106.84 79.32 1.32 Allowed 'General case' 0 C--O 1.241 0.635 0 N-CA-C 106.714 -1.588 . . . . 0.0 106.714 175.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 51.4 t -81.82 104.38 10.3 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-N 114.74 -1.118 . . . . 0.0 109.324 -176.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -151.19 -73.51 0.15 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.835 0.854 . . . . 0.0 109.035 -178.126 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 173.69 66.59 0.05 OUTLIER Glycine 0 CA--C 1.528 0.856 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -177.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -62.83 135.14 50.36 Favored 'Trans proline' 0 C--N 1.38 2.211 0 C-N-CA 123.867 3.044 . . . . 0.0 112.737 -172.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 47.1 m -56.15 144.12 30.69 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.436 1.095 . . . . 0.0 110.783 176.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 90.8 mt -103.48 96.2 8.3 Favored Pre-proline 0 N--CA 1.479 1.009 0 C-N-CA 123.324 0.65 . . . . 0.0 110.943 -178.291 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -84.7 -14.39 6.5 Favored 'Trans proline' 0 C--N 1.373 1.86 0 C-N-CA 122.441 2.094 . . . . 0.0 111.094 163.349 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -74.89 92.99 2.6 Favored 'General case' 0 C--N 1.351 0.662 0 C-N-CA 124.971 1.308 . . . . 0.0 110.408 -174.086 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 18.7 p -71.73 149.06 92.9 Favored Pre-proline 0 CA--C 1.543 0.712 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.049 172.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -71.22 177.32 6.72 Favored 'Trans proline' 0 C--N 1.369 1.621 0 C-N-CA 122.458 2.105 . . . . 0.0 111.78 178.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -88.09 90.28 8.32 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 121.257 0.551 . . . . 0.0 109.711 178.404 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 5.0 mp -79.69 109.95 14.57 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.0 -1.0 . . . . 0.0 108.386 173.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -79.39 141.48 57.16 Favored Pre-proline 0 C--O 1.245 0.854 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -178.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -66.15 101.33 0.5 Allowed 'Trans proline' 0 C--N 1.373 1.829 0 C-N-CA 122.228 1.952 . . . . 0.0 111.153 175.21 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -68.03 127.77 34.07 Favored 'General case' 0 CA--C 1.549 0.937 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 172.498 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.511 ' HG2' HG12 ' A' ' 329' ' ' ILE . 5.2 tppp? -90.62 108.43 19.8 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.313 0.645 . . . . 0.0 110.238 177.248 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 3.6 mp -102.67 126.2 56.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 123.917 0.887 . . . . 0.0 109.177 178.401 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 30.8 ttp180 -96.93 95.13 7.62 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.276 0.631 . . . . 0.0 109.413 173.342 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 271' ' ' CYS . . . . . 0.487 ' SG ' HD21 ' A' ' 297' ' ' LEU . 42.8 t -71.85 -173.65 1.04 Allowed 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 123.819 0.848 . . . . 0.0 110.651 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 272' ' ' ARG . . . . . 0.409 ' HG2' ' SG ' ' A' ' 271' ' ' CYS . 7.5 ptm180 -55.48 -30.97 61.58 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.406 1.082 . . . . 0.0 112.311 174.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -144.89 -38.35 0.27 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.118 0.967 . . . . 0.0 110.366 -178.298 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -79.3 154.09 29.37 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.206 1.002 . . . . 0.0 111.433 -173.022 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 25.4 tp -119.69 85.33 2.36 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 173.092 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 95.0 t -89.94 147.56 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 114.856 -1.065 . . . . 0.0 109.875 -167.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -127.9 127.68 43.79 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 171.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.497 HD11 HG12 ' A' ' 289' ' ' VAL . 4.2 pp -129.41 144.35 52.48 Favored Pre-proline 0 N--CA 1.482 1.161 0 CA-C-N 118.023 0.374 . . . . 0.0 110.411 174.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -68.33 122.45 9.48 Favored 'Trans proline' 0 C--N 1.374 1.906 0 C-N-CA 122.68 2.254 . . . . 0.0 110.714 174.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.807 HD21 ' HG3' ' A' ' 319' ' ' PRO . 0.3 OUTLIER -149.02 150.75 33.34 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.007 0.923 . . . . 0.0 109.993 -177.441 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 58.1 mtm-85 -97.72 155.88 16.81 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.306 0.643 . . . . 0.0 110.486 179.206 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 282' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -61.31 -39.51 90.73 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.335 0.654 . . . . 0.0 111.228 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 12.1 t -78.67 -23.93 45.42 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.348 -178.516 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -70.61 122.36 86.4 Favored Pre-proline 0 C--N 1.352 0.707 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 175.34 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 285' ' ' PRO . . . . . 0.507 ' HA ' ' HA ' ' A' ' 318' ' ' THR . 55.5 Cg_endo -65.59 175.45 4.32 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 122.363 2.042 . . . . 0.0 112.639 -179.279 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.42 ' O ' HG23 ' A' ' 290' ' ' VAL . 78.4 mt -64.87 -16.97 63.87 Favored 'General case' 0 C--O 1.211 -0.967 0 CA-C-O 118.449 -0.786 . . . . 0.0 111.64 178.816 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 23.8 tp60 -52.52 -27.48 16.65 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.218 0.607 . . . . 0.0 112.274 179.297 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 288' ' ' SER . . . . . 0.613 ' HB3' HD12 ' A' ' 280' ' ' LEU . 41.8 t -61.12 -55.7 29.38 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.7 0.8 . . . . 0.0 110.524 171.165 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.497 HG12 HD11 ' A' ' 278' ' ' LEU . 11.4 m -69.33 -28.27 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 122.503 0.321 . . . . 0.0 111.441 179.375 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 290' ' ' VAL . . . . . 0.529 HG13 ' HB ' ' A' ' 304' ' ' ILE . 54.9 t -69.53 -52.39 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 123.731 0.812 . . . . 0.0 109.991 -177.192 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -71.84 -32.99 68.09 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 122.955 0.502 . . . . 0.0 110.869 -178.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -64.3 -51.89 61.23 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.341 0.656 . . . . 0.0 110.008 178.298 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 94.2 mmm -68.99 -29.3 67.48 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.365 0.666 . . . . 0.0 111.065 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -61.7 -53.33 57.53 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.341 0.656 . . . . 0.0 110.682 176.241 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 21.9 m -65.25 -35.61 81.55 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 123.689 0.796 . . . . 0.0 110.846 178.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -67.04 -33.22 75.05 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.324 1.049 . . . . 0.0 111.663 -179.385 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 297' ' ' LEU . . . . . 0.487 HD21 ' SG ' ' A' ' 271' ' ' CYS . 47.6 mt -102.17 -3.68 27.04 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.06 0.944 . . . . 0.0 111.248 178.835 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 76.74 9.37 86.41 Favored Glycine 0 C--N 1.352 1.46 0 C-N-CA 123.548 0.594 . . . . 0.0 113.909 176.298 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 299' ' ' VAL . . . . . 0.484 HG11 HG11 ' A' ' 334' ' ' VAL . 35.4 m -102.48 179.82 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.056 0.942 . . . . 0.0 111.462 -177.173 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 49.4 m -77.65 147.62 75.09 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 123.54 0.736 . . . . 0.0 111.14 178.32 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.68 -27.47 83.28 Favored 'Trans proline' 0 C--N 1.384 2.407 0 C-N-CA 122.634 2.222 . . . . 0.0 111.333 168.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 20.2 m -64.12 -26.16 68.42 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 124.107 0.963 . . . . 0.0 111.549 178.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 78.2 mtt85 -84.35 -33.58 23.83 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.899 0.88 . . . . 0.0 111.64 179.41 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 304' ' ' ILE . . . . . 0.529 ' HB ' HG13 ' A' ' 290' ' ' VAL . 36.5 mm -72.55 105.12 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 122.703 0.401 . . . . 0.0 110.942 -175.84 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 305' ' ' LEU . . . . . 0.527 HD22 HD11 ' A' ' 335' ' ' LEU . 29.7 tp -107.62 129.24 55.02 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 123.618 0.767 . . . . 0.0 109.231 172.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -92.11 138.26 31.68 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 174.396 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 307' ' ' LEU . . . . . 0.463 HD23 ' HA ' ' A' ' 312' ' ' GLU . 92.6 mt -133.3 115.02 14.42 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.99 0.916 . . . . 0.0 109.47 -177.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 308' ' ' PHE . . . . . 0.572 ' HB2' HD11 ' A' ' 313' ' ' LEU . 66.0 t80 -87.25 88.16 7.62 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.06 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 73.74 -78.36 0.89 Allowed Glycine 0 C--N 1.349 1.269 0 CA-C-N 115.209 -0.905 . . . . 0.0 112.331 -177.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -120.62 -33.47 3.81 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.449 0.699 . . . . 0.0 110.644 179.193 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 8.5 t -76.65 148.38 36.91 Favored 'General case' 0 C--N 1.35 0.622 0 C-N-CA 122.757 0.423 . . . . 0.0 111.393 -169.019 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 312' ' ' GLU . . . . . 0.463 ' HA ' HD23 ' A' ' 307' ' ' LEU . 42.7 tt0 -85.24 130.56 34.58 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.687 178.772 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.594 HD22 HD22 ' A' ' 322' ' ' LEU . 46.9 mt -111.85 126.93 55.62 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 176.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 31.9 m -78.89 144.72 64.54 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 123.237 0.615 . . . . 0.0 110.727 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -59.75 -32.51 95.74 Favored 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 123.103 2.535 . . . . 0.0 112.747 178.306 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 7.1 m -79.36 -20.48 47.68 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 123.415 0.686 . . . . 0.0 111.361 -179.323 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -68.72 144.66 54.32 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.17 0.588 . . . . 0.0 110.543 178.644 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 318' ' ' THR . . . . . 0.507 ' HA ' ' HA ' ' A' ' 285' ' ' PRO . 81.8 p -98.8 142.72 25.08 Favored Pre-proline 0 N--CA 1.475 0.808 0 C-N-CA 123.399 0.679 . . . . 0.0 109.98 -175.688 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 319' ' ' PRO . . . . . 0.807 ' HG3' HD21 ' A' ' 280' ' ' LEU . 18.8 Cg_endo -56.88 -19.97 34.03 Favored 'Trans proline' 0 C--N 1.368 1.586 0 C-N-CA 123.143 2.562 . . . . 0.0 112.477 173.015 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 31.2 ttt180 -60.55 -55.33 34.71 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.504 0.722 . . . . 0.0 110.62 170.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 321' ' ' THR . . . . . 0.453 HG22 ' O ' ' A' ' 318' ' ' THR . 12.4 t -72.17 -18.9 61.83 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -176.017 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 322' ' ' LEU . . . . . 0.594 HD22 HD22 ' A' ' 313' ' ' LEU . 47.0 mt -91.68 -18.74 23.52 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.657 0.783 . . . . 0.0 111.332 179.256 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 58.02 78.59 0.24 Allowed 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 124.606 1.162 . . . . 0.0 108.821 -169.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 66.5 mt -116.15 165.17 13.45 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.76 0.824 . . . . 0.0 109.022 174.359 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 325' ' ' GLY . . . . . 0.436 ' H ' ' HB3' ' A' ' 328' ' ' ASP . . . -158.69 -171.62 24.76 Favored Glycine 0 C--N 1.345 1.072 0 O-C-N 122.946 0.154 . . . . 0.0 112.76 -171.168 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 35.1 m -64.58 -32.73 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.325 1.05 . . . . 0.0 112.102 -175.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -112.17 4.84 18.14 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.606 0.762 . . . . 0.0 111.499 -178.522 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 328' ' ' ASP . . . . . 0.436 ' HB3' ' H ' ' A' ' 325' ' ' GLY . 23.7 t0 -95.89 127.47 41.94 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -178.203 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 329' ' ' ILE . . . . . 0.511 HG12 ' HG2' ' A' ' 268' ' ' LYS . 6.0 mt -111.47 143.15 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 C-N-CA 123.414 0.686 . . . . 0.0 111.798 -165.028 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 27.7 pt -137.54 133.9 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 123.612 0.765 . . . . 0.0 111.168 177.258 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 331' ' ' ASP . . . . . 0.404 ' HB2' ' HB2' ' A' ' 307' ' ' LEU . 6.2 m-20 -72.89 111.49 8.06 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.709 1.204 . . . . 0.0 112.523 -175.588 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 332' ' ' CYS . . . . . 0.487 ' HB3' ' HA ' ' A' ' 271' ' ' CYS . 42.0 t -75.61 115.97 15.84 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 165.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 333' ' ' VAL . . . . . 0.442 HG21 HD12 ' A' ' 307' ' ' LEU . 99.3 t -126.12 117.84 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 123.812 0.845 . . . . 0.0 109.402 -177.695 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 334' ' ' VAL . . . . . 0.484 HG11 HG11 ' A' ' 299' ' ' VAL . 62.0 t -84.57 99.69 7.12 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 123.187 0.595 . . . . 0.0 109.664 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 335' ' ' LEU . . . . . 0.527 HD11 HD22 ' A' ' 305' ' ' LEU . 89.1 mt -72.88 160.08 32.7 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.863 0.865 . . . . 0.0 111.165 177.392 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 336' ' ' THR . . . . . . . . . . . . . 9.4 t -86.74 57.58 4.58 Favored 'General case' 0 CA--C 1.555 1.169 0 CA-C-O 121.979 0.895 . . . . 0.0 110.153 178.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 11.0 m -73.19 82.91 1.33 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.106 0.963 . . . . 0.0 110.208 -176.491 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 13.4 p . . . . . 0 CA--C 1.553 1.081 0 C-N-CA 124.642 1.177 . . . . 0.0 108.502 -176.739 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 4.1 mp . . . . . 0 N--CA 1.477 0.884 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' PHE . . . . . 0.467 ' CE1' ' HG2' ' A' ' 282' ' ' MET . 31.4 p90 -147.85 152.5 40.8 Favored Pre-proline 0 CA--C 1.544 0.73 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 174.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -69.27 93.64 0.48 Allowed 'Trans proline' 0 C--N 1.371 1.747 0 C-N-CA 122.383 2.055 . . . . 0.0 111.634 173.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' LEU . . . . . 0.513 HD12 HG13 ' A' ' 269' ' ' ILE . 1.3 tm? -60.28 127.55 32.34 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 173.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . 0.44 ' HG2' HG12 ' A' ' 329' ' ' ILE . 4.1 tppp? -91.7 103.96 16.48 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 123.763 0.665 . . . . 0.0 110.438 -179.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . 0.513 HG13 HD12 ' A' ' 267' ' ' LEU . 1.4 mp -101.82 146.14 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 174.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 27.8 ttp180 -106.7 118.89 37.86 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 172.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 271' ' ' CYS . . . . . 0.559 ' SG ' HD21 ' A' ' 297' ' ' LEU . 13.7 t -73.92 -158.33 0.06 Allowed 'General case' 0 CA--C 1.562 1.407 0 C-N-CA 124.473 1.109 . . . . 0.0 109.638 172.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 -64.94 -31.04 72.09 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 122.828 0.451 . . . . 0.0 111.791 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -160.27 22.91 0.16 Allowed 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -175.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -152.93 162.11 41.72 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 122.752 0.421 . . . . 0.0 110.596 -172.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.419 HD13 ' HD2' ' A' ' 268' ' ' LYS . 76.3 mt -107.19 129.06 54.91 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.627 0.771 . . . . 0.0 110.948 176.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 46.5 t -115.79 138.61 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.467 1.107 . . . . 0.0 108.668 174.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . 0.409 ' HA ' ' O ' ' A' ' 267' ' ' LEU . 74.5 mtm180 -116.65 130.42 56.72 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.654 0.781 . . . . 0.0 109.598 173.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.488 HD21 ' HA ' ' A' ' 289' ' ' VAL . 4.6 pp -128.63 144.99 54.33 Favored Pre-proline 0 N--CA 1.488 1.436 0 CA-C-O 119.245 -0.407 . . . . 0.0 110.229 172.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -71.95 117.87 5.35 Favored 'Trans proline' 0 C--N 1.379 2.142 0 C-N-CA 122.467 2.111 . . . . 0.0 110.677 178.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.768 HD21 ' HG3' ' A' ' 319' ' ' PRO . 0.2 OUTLIER -144.87 148.41 33.92 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.877 0.871 . . . . 0.0 110.103 -174.45 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . 0.402 ' HB2' ' HB2' ' A' ' 284' ' ' GLU . 87.7 mtm180 -86.4 152.28 22.84 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.99 0.916 . . . . 0.0 109.781 176.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 282' ' ' MET . . . . . 0.467 ' HG2' ' CE1' ' A' ' 265' ' ' PHE . 11.2 mtp -66.72 -31.77 72.64 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.127 0.489 . . . . 0.0 109.926 176.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 39.0 p -77.04 -18.96 57.75 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.855 1.262 . . . . 0.0 111.93 177.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 284' ' ' GLU . . . . . 0.402 ' HB2' ' HB2' ' A' ' 281' ' ' ARG . 7.6 tp10 -70.45 128.39 91.24 Favored Pre-proline 0 N--CA 1.475 0.813 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 176.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -65.65 161.55 38.23 Favored 'Trans proline' 0 C--N 1.377 2.033 0 C-N-CA 122.116 1.877 . . . . 0.0 111.554 174.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.409 ' O ' HG23 ' A' ' 290' ' ' VAL . 58.5 mt -64.63 -10.76 28.83 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 118.83 -0.605 . . . . 0.0 112.272 -178.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 -52.45 -27.49 16.31 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.614 0.765 . . . . 0.0 111.864 176.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 288' ' ' SER . . . . . 0.418 ' HB3' HD12 ' A' ' 280' ' ' LEU . 46.8 t -60.69 -57.06 14.3 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.831 0.852 . . . . 0.0 111.084 172.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.488 ' HA ' HD21 ' A' ' 278' ' ' LEU . 15.8 m -69.18 -30.21 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 122.494 0.317 . . . . 0.0 110.749 -178.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . 0.57 HG13 ' HB ' ' A' ' 304' ' ' ILE . 45.1 t -64.1 -52.37 57.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 124.323 1.049 . . . . 0.0 110.705 179.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -61.74 -43.72 98.3 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.293 1.037 . . . . 0.0 110.694 -179.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 54.5 t60 -68.09 -45.26 74.23 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.045 -176.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 293' ' ' MET . . . . . 0.474 ' HB3' ' SG ' ' A' ' 332' ' ' CYS . 92.9 mmm -68.77 -32.21 71.8 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 123.543 0.527 . . . . 0.0 110.908 178.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -64.42 -43.94 92.78 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.335 0.654 . . . . 0.0 110.557 177.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 52.5 m -68.45 -31.72 71.22 Favored 'General case' 0 CA--C 1.554 1.106 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.562 177.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -73.33 -39.01 65.57 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.304 1.041 . . . . 0.0 111.723 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 297' ' ' LEU . . . . . 0.559 HD21 ' SG ' ' A' ' 271' ' ' CYS . 71.4 mt -94.16 -8.6 38.95 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.852 0.861 . . . . 0.0 111.467 -176.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 76.15 20.89 76.9 Favored Glycine 0 C--N 1.349 1.258 0 O-C-N 123.505 0.503 . . . . 0.0 113.496 178.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 30.1 m -111.75 176.97 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 124.229 1.012 . . . . 0.0 110.865 -177.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 48.9 m -80.08 143.65 57.42 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 123.361 0.664 . . . . 0.0 110.005 175.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -54.16 -28.72 52.74 Favored 'Trans proline' 0 C--N 1.39 2.726 0 C-N-CA 123.228 2.619 . . . . 0.0 112.691 173.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 39.5 t -64.46 -27.55 69.07 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 122.925 0.49 . . . . 0.0 111.62 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 61.3 mtt180 -82.59 -20.08 37.16 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.562 0.745 . . . . 0.0 111.684 -176.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 304' ' ' ILE . . . . . 0.639 HD12 ' SG ' ' A' ' 332' ' ' CYS . 42.6 mm -76.68 125.56 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 123.152 0.581 . . . . 0.0 110.763 -176.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 37.9 tp -126.52 120.76 30.47 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.934 0.894 . . . . 0.0 108.664 174.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . 0.411 ' HG ' HD12 ' A' ' 330' ' ' ILE . 2.6 mm? -85.64 134.67 33.98 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 177.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . 0.447 HD23 ' HA ' ' A' ' 312' ' ' GLU . 94.2 mt -136.94 106.7 6.21 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.636 0.774 . . . . 0.0 109.975 -175.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -87.51 95.44 10.03 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 175.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 74.72 -80.74 0.9 Allowed Glycine 0 C--N 1.339 0.73 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.438 178.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -135.6 -5.65 2.24 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.966 0.906 . . . . 0.0 111.856 -177.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 11.6 t -89.37 148.91 23.25 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 117.987 0.358 . . . . 0.0 110.48 -177.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . 0.447 ' HA ' HD23 ' A' ' 307' ' ' LEU . 38.8 tt0 -98.64 110.74 23.29 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.363 0.665 . . . . 0.0 109.628 -178.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . 0.411 HD22 HD22 ' A' ' 322' ' ' LEU . 44.7 mt -95.42 167.75 11.13 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.742 0.417 . . . . 0.0 110.012 177.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 53.2 m -134.4 154.94 80.11 Favored Pre-proline 0 N--CA 1.48 1.06 0 C-N-CA 123.187 0.595 . . . . 0.0 109.963 -177.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . 0.502 ' HB3' HG21 ' A' ' 290' ' ' VAL . 26.9 Cg_endo -58.43 -26.94 80.0 Favored 'Trans proline' 0 C--N 1.385 2.465 0 C-N-CA 123.31 2.674 . . . . 0.0 113.309 177.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 20.8 m -78.5 -29.03 46.41 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 123.668 0.787 . . . . 0.0 111.406 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -66.48 143.42 57.1 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.75 0.82 . . . . 0.0 111.126 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 318' ' ' THR . . . . . . . . . . . . . 36.1 p -108.26 135.82 19.9 Favored Pre-proline 0 N--CA 1.475 0.788 0 C-N-CA 123.318 0.647 . . . . 0.0 111.072 -177.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 319' ' ' PRO . . . . . 0.768 ' HG3' HD21 ' A' ' 280' ' ' LEU . 6.4 Cg_endo -47.35 -23.04 2.91 Favored 'Trans proline' 0 C--N 1.375 1.96 0 C-N-CA 124.824 3.683 . . . . 0.0 115.088 172.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 30.3 ttt180 -60.54 -62.25 2.0 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.156 0.582 . . . . 0.0 110.834 175.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 8.9 t -68.49 -30.35 69.17 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 122.66 0.384 . . . . 0.0 111.151 -178.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 322' ' ' LEU . . . . . 0.445 ' HB2' ' HG ' ' A' ' 324' ' ' LEU . 86.4 mt -78.55 -17.91 55.44 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.288 0.635 . . . . 0.0 111.868 -178.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 83.7 tttt 64.01 38.81 8.36 Favored 'General case' 0 CA--C 1.562 1.432 0 C-N-CA 124.158 0.983 . . . . 0.0 110.882 -177.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.445 ' HG ' ' HB2' ' A' ' 322' ' ' LEU . 31.7 mt -78.52 162.6 26.21 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 122.921 0.488 . . . . 0.0 110.141 175.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . -166.49 -160.79 14.24 Favored Glycine 0 C--N 1.341 0.808 0 CA-C-N 116.325 -0.398 . . . . 0.0 112.887 -173.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 24.7 m -77.97 -31.68 16.98 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 C-N-CA 124.046 0.938 . . . . 0.0 111.062 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -98.65 -19.01 17.77 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.959 0.903 . . . . 0.0 110.701 178.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -87.2 108.25 18.84 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 -177.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . 0.44 HG12 ' HG2' ' A' ' 268' ' ' LYS . 7.7 mt -104.53 134.5 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 123.463 0.705 . . . . 0.0 111.254 -165.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 330' ' ' ILE . . . . . 0.411 HD12 ' HG ' ' A' ' 306' ' ' LEU . 34.6 pt -120.05 127.08 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 123.225 0.61 . . . . 0.0 111.225 -179.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -76.66 116.43 17.34 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.849 0.859 . . . . 0.0 111.251 -177.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 332' ' ' CYS . . . . . 0.639 ' SG ' HD12 ' A' ' 304' ' ' ILE . 36.2 t -82.77 98.42 9.1 Favored 'General case' 0 C--O 1.243 0.752 0 C-N-CA 123.587 0.755 . . . . 0.0 109.851 172.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 59.2 t -108.84 125.57 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 123.449 0.699 . . . . 0.0 109.792 -176.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 61.3 t -86.23 111.09 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.23 0.612 . . . . 0.0 109.401 177.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 60.7 mt . . . . . 0 N--CA 1.474 0.737 0 C-N-CA 123.57 0.748 . . . . 0.0 111.263 177.614 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 1.5 mp . . . . . 0 CA--C 1.541 0.612 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' PHE . . . . . 0.407 ' CE1' ' HG2' ' A' ' 282' ' ' MET . 27.6 p90 -113.46 149.04 40.94 Favored Pre-proline 0 N--CA 1.475 0.791 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 172.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' PRO . . . . . 0.508 ' HB2' ' HB3' ' A' ' 277' ' ' ARG . 56.8 Cg_endo -69.06 97.41 0.57 Allowed 'Trans proline' 0 C--N 1.372 1.765 0 C-N-CA 122.275 1.984 . . . . 0.0 111.892 175.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.01 119.25 13.01 Favored 'General case' 0 C--N 1.35 0.603 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 171.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 24.6 ttpt -95.73 109.09 21.44 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 121.652 0.739 . . . . 0.0 111.133 -178.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 2.8 mp -100.51 143.86 13.42 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 C-N-CA 125.083 1.353 . . . . 0.0 108.118 176.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 37.2 ttp180 -106.15 95.88 6.08 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 123.315 0.646 . . . . 0.0 109.94 178.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 271' ' ' CYS . . . . . 0.546 ' SG ' HD21 ' A' ' 297' ' ' LEU . 44.6 t -71.92 178.82 3.5 Favored 'General case' 0 C--O 1.245 0.827 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.827 170.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -59.5 -31.35 69.28 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.523 0.729 . . . . 0.0 111.995 177.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -147.38 14.71 1.12 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 122.843 0.457 . . . . 0.0 112.187 -177.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -137.31 129.58 29.52 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 122.806 0.443 . . . . 0.0 110.556 -174.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 24.1 mt -95.5 90.86 5.91 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 164.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 58.6 t -82.48 122.7 37.49 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.861 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.163 -175.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . 0.508 ' HB3' ' HB2' ' A' ' 266' ' ' PRO . 77.0 mtm180 -116.13 75.54 0.96 Allowed 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.532 HD11 HG12 ' A' ' 289' ' ' VAL . 4.6 pp -85.58 147.66 47.11 Favored Pre-proline 0 N--CA 1.483 1.204 0 CA-C-O 119.527 -0.273 . . . . 0.0 110.826 -172.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -69.17 118.48 5.7 Favored 'Trans proline' 0 C--N 1.374 1.92 0 C-N-CA 122.112 1.875 . . . . 0.0 110.719 175.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.73 HD21 ' HG3' ' A' ' 319' ' ' PRO . 0.8 OUTLIER -143.24 147.89 35.55 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.861 0.864 . . . . 0.0 110.242 -178.537 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 25.5 mmm180 -96.97 143.57 27.71 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.236 1.015 . . . . 0.0 109.045 174.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 282' ' ' MET . . . . . 0.431 ' HA ' ' HG2' ' A' ' 319' ' ' PRO . 44.1 mtp -61.06 -39.57 90.37 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 122.839 0.456 . . . . 0.0 111.813 -177.078 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 53.7 m -67.44 -25.37 65.88 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.6 0.76 . . . . 0.0 111.584 178.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -77.67 126.08 84.91 Favored Pre-proline 0 CA--C 1.546 0.797 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 173.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 285' ' ' PRO . . . . . 0.558 ' HA ' ' HA ' ' A' ' 318' ' ' THR . 60.2 Cg_endo -66.51 174.81 5.83 Favored 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 122.421 2.081 . . . . 0.0 113.682 -176.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.461 ' O ' HG22 ' A' ' 289' ' ' VAL . 90.8 mt -65.74 -13.2 58.87 Favored 'General case' 0 C--O 1.21 -1.007 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.643 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 26.5 tp60 -55.24 -24.08 25.88 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.198 0.599 . . . . 0.0 111.589 177.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 288' ' ' SER . . . . . 0.543 ' HB2' HD12 ' A' ' 280' ' ' LEU . 22.3 m -68.67 -47.68 65.89 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.941 0.897 . . . . 0.0 111.221 174.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.532 HG12 HD11 ' A' ' 278' ' ' LEU . 13.8 m -69.92 -34.91 62.15 Favored 'Isoleucine or valine' 0 C--N 1.365 1.253 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 177.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . 0.559 HG13 ' HB ' ' A' ' 304' ' ' ILE . 54.0 t -63.77 -43.62 98.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 124.594 1.157 . . . . 0.0 110.733 179.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -63.27 -45.7 90.29 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 124.088 0.868 . . . . 0.0 110.065 -179.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 24.6 t60 -63.43 -49.53 73.35 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.211 178.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 293' ' ' MET . . . . . 0.455 ' HG2' ' O ' ' A' ' 289' ' ' VAL . 85.5 mmm -68.19 -33.03 73.68 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 123.669 0.606 . . . . 0.0 111.057 -175.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -65.58 -47.16 76.71 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.373 0.669 . . . . 0.0 110.327 176.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 29.3 m -64.44 -38.23 90.29 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 123.403 0.681 . . . . 0.0 111.104 177.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 78.9 t60 -67.0 -39.24 87.05 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.341 1.056 . . . . 0.0 111.047 -178.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 297' ' ' LEU . . . . . 0.546 HD21 ' SG ' ' A' ' 271' ' ' CYS . 40.8 mt -95.93 -3.63 44.88 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.845 0.858 . . . . 0.0 111.416 -178.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 71.65 14.33 75.14 Favored Glycine 0 N--CA 1.476 1.333 0 C-N-CA 123.075 0.369 . . . . 0.0 113.769 177.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 299' ' ' VAL . . . . . 0.481 HG11 HG11 ' A' ' 334' ' ' VAL . 33.0 m -101.91 173.41 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.042 0.937 . . . . 0.0 110.624 -178.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . 0.443 ' HB2' ' HG3' ' A' ' 303' ' ' ARG . 16.5 m -79.97 151.59 73.46 Favored Pre-proline 0 CA--C 1.555 1.162 0 C-N-CA 123.141 0.576 . . . . 0.0 110.042 178.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -56.08 -29.11 73.07 Favored 'Trans proline' 0 C--N 1.385 2.459 0 C-N-CA 123.193 2.595 . . . . 0.0 113.216 177.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 33.5 t -69.31 -18.71 63.85 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.633 0.373 . . . . 0.0 111.212 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 303' ' ' ARG . . . . . 0.443 ' HG3' ' HB2' ' A' ' 300' ' ' SER . 52.1 mtt-85 -90.17 -12.91 36.79 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.246 0.618 . . . . 0.0 111.811 -174.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 304' ' ' ILE . . . . . 0.559 ' HB ' HG13 ' A' ' 290' ' ' VAL . 49.7 mm -86.77 117.59 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 122.944 0.498 . . . . 0.0 110.233 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 40.3 tp -114.02 120.08 39.37 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.665 0.786 . . . . 0.0 109.205 174.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . 0.421 HD21 HG22 ' A' ' 290' ' ' VAL . 2.8 mm? -91.36 136.74 32.89 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 177.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . 0.498 HD23 ' HA ' ' A' ' 312' ' ' GLU . 75.5 mt -134.28 106.96 7.38 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.602 0.761 . . . . 0.0 109.471 -177.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . 0.553 ' HB2' HD11 ' A' ' 313' ' ' LEU . 44.8 t80 -85.84 90.28 8.01 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -178.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 64.94 -88.89 0.09 OUTLIER Glycine 0 C--N 1.349 1.289 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.818 -178.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -129.9 70.26 1.43 Allowed 'General case' 0 C--O 1.242 0.705 0 C-N-CA 124.191 0.996 . . . . 0.0 109.667 176.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 10.0 t -169.23 150.87 4.45 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.691 0.796 . . . . 0.0 109.533 170.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . 0.498 ' HA ' HD23 ' A' ' 307' ' ' LEU . 36.3 tt0 -92.97 134.48 35.07 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 177.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . 0.553 HD11 ' HB2' ' A' ' 308' ' ' PHE . 49.7 mt -117.52 149.7 40.18 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.014 0.526 . . . . 0.0 110.551 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 50.9 m -108.24 149.88 39.8 Favored Pre-proline 0 CA--C 1.551 1.016 0 C-N-CA 123.688 0.795 . . . . 0.0 110.472 179.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . 0.515 ' HB3' HG21 ' A' ' 290' ' ' VAL . 12.1 Cg_endo -56.14 -39.94 88.03 Favored 'Trans proline' 0 C--N 1.383 2.349 0 C-N-CA 123.325 2.684 . . . . 0.0 112.639 173.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 41.7 p -75.5 -18.23 59.88 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.22 0.608 . . . . 0.0 112.182 -177.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -74.27 142.61 45.26 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.102 0.561 . . . . 0.0 109.493 174.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 318' ' ' THR . . . . . 0.558 ' HA ' ' HA ' ' A' ' 285' ' ' PRO . 75.5 p -98.28 146.27 31.25 Favored Pre-proline 0 N--CA 1.473 0.71 0 C-N-CA 122.977 0.511 . . . . 0.0 110.533 -176.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 319' ' ' PRO . . . . . 0.73 ' HG3' HD21 ' A' ' 280' ' ' LEU . 31.6 Cg_endo -62.07 -14.33 36.96 Favored 'Trans proline' 0 C--N 1.365 1.418 0 C-N-CA 122.903 2.402 . . . . 0.0 111.962 168.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 43.6 ttt85 -61.55 -58.21 9.03 Favored 'General case' 0 C--N 1.352 0.711 0 C-N-CA 123.505 0.722 . . . . 0.0 110.761 172.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 10.1 t -66.83 -32.36 73.59 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 122.544 0.338 . . . . 0.0 111.461 -178.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 322' ' ' LEU . . . . . . . . . . . . . 47.7 mt -77.95 -20.66 52.31 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.311 0.644 . . . . 0.0 111.21 177.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 20.7 tptm 55.14 63.19 2.19 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.397 1.479 . . . . 0.0 110.914 -174.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 76.4 mt -90.25 170.05 10.6 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.04 178.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 325' ' ' GLY . . . . . 0.468 ' H ' ' HB2' ' A' ' 328' ' ' ASP . . . -162.54 -161.14 11.78 Favored Glycine 0 C--N 1.339 0.729 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.047 -171.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 31.5 m -76.89 -19.75 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 123.633 0.773 . . . . 0.0 111.872 -176.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -111.52 -17.34 13.09 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.833 0.853 . . . . 0.0 111.424 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 328' ' ' ASP . . . . . 0.468 ' HB2' ' H ' ' A' ' 325' ' ' GLY . 49.0 m-20 -75.71 101.05 4.88 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 177.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 46.1 mt -95.29 134.54 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 123.567 0.747 . . . . 0.0 110.404 -175.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 37.4 pt -121.97 127.23 75.3 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.929 0 C-N-CA 123.568 0.747 . . . . 0.0 110.114 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 331' ' ' ASP . . . . . 0.418 ' O ' ' HA ' ' A' ' 306' ' ' LEU . 5.1 m-20 -74.46 126.99 31.93 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.042 0.937 . . . . 0.0 111.778 -175.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 332' ' ' CYS . . . . . 0.475 ' SG ' HD12 ' A' ' 304' ' ' ILE . 52.5 t -93.76 93.41 7.97 Favored 'General case' 0 C--O 1.244 0.794 0 C-N-CA 123.983 0.913 . . . . 0.0 109.74 175.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 71.8 t -100.42 122.47 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 123.53 0.732 . . . . 0.0 109.573 177.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 334' ' ' VAL . . . . . 0.481 HG11 HG11 ' A' ' 299' ' ' VAL . 94.0 t -87.78 112.92 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 122.906 0.482 . . . . 0.0 110.265 177.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 84.0 mt . . . . . 0 N--CA 1.47 0.559 0 C-N-CA 124.069 0.948 . . . . 0.0 109.093 171.532 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 3.4 mp . . . . . 0 C--O 1.24 0.583 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -106.56 147.6 35.27 Favored Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 123.839 0.856 . . . . 0.0 109.111 176.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -63.84 95.58 0.2 Allowed 'Trans proline' 0 C--N 1.376 1.988 0 C-N-CA 122.478 2.118 . . . . 0.0 111.812 172.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' LEU . . . . . 0.466 HD12 HG13 ' A' ' 269' ' ' ILE . 1.5 tm? -62.89 130.59 45.5 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 173.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . 0.549 ' HG2' HG12 ' A' ' 329' ' ' ILE . 3.8 tppp? -94.51 107.39 19.37 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 123.539 0.736 . . . . 0.0 110.244 -177.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . 0.466 HG13 HD12 ' A' ' 267' ' ' LEU . 2.1 mp -106.56 131.96 55.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 175.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 270' ' ' ARG . . . . . 0.429 ' HB2' ' CG2' ' A' ' 329' ' ' ILE . 26.4 ttm180 -91.63 111.38 22.88 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 171.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 271' ' ' CYS . . . . . 0.604 ' SG ' HD21 ' A' ' 297' ' ' LEU . 16.5 t -75.53 -166.69 0.57 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 122.634 0.373 . . . . 0.0 110.222 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 272' ' ' ARG . . . . . 0.437 ' HG2' ' SG ' ' A' ' 271' ' ' CYS . 23.4 ptt180 -53.55 -27.76 27.88 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.354 1.062 . . . . 0.0 112.992 172.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -139.3 -63.49 0.52 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.019 0.528 . . . . 0.0 111.502 -177.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -107.48 163.44 13.05 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 123.692 0.797 . . . . 0.0 111.191 -170.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.533 HD13 ' HD2' ' A' ' 268' ' ' LYS . 96.0 mt -78.7 127.18 31.74 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 123.828 0.851 . . . . 0.0 111.898 -179.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 85.7 t -99.66 139.31 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 170.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . 0.448 ' HD3' ' HE2' ' A' ' 268' ' ' LYS . 62.9 mtm180 -128.19 122.49 31.97 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.794 0.838 . . . . 0.0 108.915 177.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 4.2 pp -131.08 139.65 36.19 Favored Pre-proline 0 N--CA 1.485 1.293 0 CA-C-O 119.379 -0.343 . . . . 0.0 110.52 177.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -70.77 107.62 2.09 Favored 'Trans proline' 0 C--N 1.382 2.313 0 C-N-CA 122.622 2.215 . . . . 0.0 110.618 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.706 HD21 ' HG3' ' A' ' 319' ' ' PRO . 0.1 OUTLIER -124.92 151.94 44.73 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.214 1.006 . . . . 0.0 110.274 -175.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . 0.566 ' HB2' ' HB2' ' A' ' 284' ' ' GLU . 58.5 mtm180 -89.97 153.82 20.31 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.973 0.909 . . . . 0.0 109.688 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 282' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -66.54 -44.55 82.08 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 122.572 0.349 . . . . 0.0 110.591 178.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 49.9 m -70.39 -20.3 62.95 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.39 0.676 . . . . 0.0 112.061 178.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 284' ' ' GLU . . . . . 0.566 ' HB2' ' HB2' ' A' ' 281' ' ' ARG . 6.7 tp10 -65.57 126.34 91.39 Favored Pre-proline 0 CA--C 1.542 0.639 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 176.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -65.06 168.25 14.32 Favored 'Trans proline' 0 C--N 1.368 1.595 0 C-N-CA 121.98 1.786 . . . . 0.0 111.707 172.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.425 ' O ' HG23 ' A' ' 290' ' ' VAL . 62.6 mt -64.95 -15.43 62.15 Favored 'General case' 0 C--O 1.214 -0.809 0 CA-C-O 118.837 -0.601 . . . . 0.0 111.263 -178.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 287' ' ' GLN . . . . . 0.462 ' HA ' ' HB ' ' A' ' 290' ' ' VAL . 24.0 tp60 -52.25 -23.54 5.86 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 123.71 0.804 . . . . 0.0 112.402 178.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 288' ' ' SER . . . . . 0.504 ' HB3' HD12 ' A' ' 280' ' ' LEU . 37.9 t -58.61 -60.95 3.0 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.337 0.655 . . . . 0.0 110.69 168.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 15.2 m -68.98 -29.82 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 122.821 0.448 . . . . 0.0 111.065 -178.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . 0.477 HG13 ' HB ' ' A' ' 304' ' ' ILE . 76.4 t -66.46 -51.85 53.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 123.782 0.833 . . . . 0.0 109.974 -178.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -70.18 -37.95 75.28 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.815 0.846 . . . . 0.0 111.017 -178.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 13.1 t60 -66.04 -50.65 63.43 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.033 0.533 . . . . 0.0 110.142 -178.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 293' ' ' MET . . . . . 0.413 ' HG3' HG21 ' A' ' 269' ' ' ILE . 94.6 mmm -63.68 -37.3 86.82 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 123.8 0.687 . . . . 0.0 110.784 178.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -61.48 -51.27 69.36 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 123.847 0.717 . . . . 0.0 111.591 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 9.8 m -68.22 -30.84 70.0 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 123.186 0.595 . . . . 0.0 110.838 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -71.45 -35.39 70.88 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.577 0.751 . . . . 0.0 111.26 178.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 297' ' ' LEU . . . . . 0.604 HD21 ' SG ' ' A' ' 271' ' ' CYS . 95.9 mt -96.14 -10.62 27.79 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.745 0.818 . . . . 0.0 112.007 -177.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 80.29 16.84 75.37 Favored Glycine 0 CA--C 1.534 1.227 0 O-C-N 123.379 0.424 . . . . 0.0 113.485 178.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 299' ' ' VAL . . . . . 0.483 HG11 HG11 ' A' ' 334' ' ' VAL . 28.7 m -109.17 173.92 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 124.08 0.952 . . . . 0.0 111.003 178.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 22.8 m -80.07 147.32 65.2 Favored Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 123.306 0.643 . . . . 0.0 110.724 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.09 -23.49 73.56 Favored 'Trans proline' 0 C--N 1.383 2.394 0 C-N-CA 122.72 2.28 . . . . 0.0 112.334 170.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 48.6 p -69.95 -15.41 63.04 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-O 121.041 0.448 . . . . 0.0 111.574 176.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -102.98 -15.56 16.08 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.106 0.962 . . . . 0.0 111.824 -175.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 304' ' ' ILE . . . . . 0.58 HD12 ' SG ' ' A' ' 332' ' ' CYS . 36.2 mm -83.84 110.06 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 176.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 37.5 tp -114.08 114.93 26.77 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.614 0.766 . . . . 0.0 109.362 178.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . 0.476 ' HG ' HD12 ' A' ' 330' ' ' ILE . 3.2 mm? -86.99 124.14 32.85 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . 0.433 HD12 HG21 ' A' ' 333' ' ' VAL . 41.3 mt -133.88 108.86 8.68 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . 0.484 ' HB2' HG22 ' A' ' 330' ' ' ILE . 71.0 t80 -75.67 86.82 2.72 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 174.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 68.17 -84.99 0.17 Allowed Glycine 0 C--N 1.349 1.257 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.963 -179.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -133.66 75.24 1.59 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.319 1.048 . . . . 0.0 109.11 177.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 15.2 t -159.1 151.75 21.72 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.318 1.047 . . . . 0.0 108.309 171.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -104.13 114.41 28.63 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 122.856 0.462 . . . . 0.0 109.868 -176.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 30.1 mt -117.88 142.78 46.94 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.199 0.6 . . . . 0.0 109.92 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 60.7 m -109.31 159.49 31.13 Favored Pre-proline 0 CA--C 1.556 1.203 0 C-N-CA 123.808 0.843 . . . . 0.0 110.952 -178.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_exo -56.86 -32.07 90.93 Favored 'Trans proline' 0 C--N 1.39 2.739 0 C-N-CA 123.202 2.601 . . . . 0.0 112.573 172.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 45.7 p -70.65 -29.6 65.99 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 114.922 -1.035 . . . . 0.0 111.715 -179.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -68.02 138.24 55.7 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.628 0.771 . . . . 0.0 110.706 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 318' ' ' THR . . . . . . . . . . . . . 71.2 p -98.49 140.23 21.68 Favored Pre-proline 0 CA--C 1.543 0.702 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 178.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 319' ' ' PRO . . . . . 0.706 ' HG3' HD21 ' A' ' 280' ' ' LEU . 19.8 Cg_endo -55.2 -17.12 14.41 Favored 'Trans proline' 0 C--N 1.367 1.512 0 C-N-CA 123.529 2.819 . . . . 0.0 112.878 171.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 50.5 ttt-85 -67.43 -55.85 12.02 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.441 0.696 . . . . 0.0 110.395 172.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 13.7 t -71.32 -22.01 61.99 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.633 0.373 . . . . 0.0 111.427 -177.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 322' ' ' LEU . . . . . 0.469 ' HB2' ' HG ' ' A' ' 324' ' ' LEU . 58.2 mt -90.9 -16.63 27.83 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.412 0.685 . . . . 0.0 110.996 177.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 19.7 tptm 65.45 32.31 9.65 Favored 'General case' 0 CA--C 1.562 1.416 0 C-N-CA 124.962 1.305 . . . . 0.0 111.408 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.469 ' HG ' ' HB2' ' A' ' 322' ' ' LEU . 33.8 mt -69.8 172.5 7.54 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 123.605 0.762 . . . . 0.0 111.175 178.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 325' ' ' GLY . . . . . 0.445 ' H ' ' HB3' ' A' ' 328' ' ' ASP . . . -167.9 -164.64 23.93 Favored Glycine 0 C--N 1.347 1.152 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.942 -177.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 33.1 m -73.6 -28.81 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 124.168 0.987 . . . . 0.0 111.578 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -88.35 -25.86 22.52 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.533 0.733 . . . . 0.0 111.053 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 328' ' ' ASP . . . . . 0.445 ' HB3' ' H ' ' A' ' 325' ' ' GLY . 12.9 t70 -76.87 130.46 37.62 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.077 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . 0.549 HG12 ' HG2' ' A' ' 268' ' ' LYS . 5.9 mt -121.87 99.63 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 122.984 0.513 . . . . 0.0 110.605 -171.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 330' ' ' ILE . . . . . 0.484 HG22 ' HB2' ' A' ' 308' ' ' PHE . 25.0 pt -87.54 126.78 41.17 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 C-N-CA 122.679 0.392 . . . . 0.0 111.086 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -79.05 118.33 20.93 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.552 0.741 . . . . 0.0 110.588 -175.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 332' ' ' CYS . . . . . 0.58 ' SG ' HD12 ' A' ' 304' ' ' ILE . 43.2 t -78.04 90.1 4.2 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.439 1.096 . . . . 0.0 110.191 176.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . 0.433 HG21 HD12 ' A' ' 307' ' ' LEU . 74.0 t -94.75 110.68 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 123.322 0.649 . . . . 0.0 109.355 -177.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 334' ' ' VAL . . . . . 0.483 HG11 HG11 ' A' ' 299' ' ' VAL . 62.0 t -81.42 94.53 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 CA-C-O 121.319 0.58 . . . . 0.0 110.014 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 60.3 mt . . . . . 0 CA--C 1.546 0.799 0 C-N-CA 124.536 1.134 . . . . 0.0 108.971 170.745 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 2.9 mp . . . . . 0 N--CA 1.483 1.175 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' PHE . . . . . 0.476 ' CE1' ' HG2' ' A' ' 282' ' ' MET . 28.0 p90 -109.32 146.15 33.33 Favored Pre-proline 0 CA--C 1.55 0.948 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 176.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -64.19 98.65 0.27 Allowed 'Trans proline' 0 C--N 1.378 2.091 0 C-N-CA 122.573 2.182 . . . . 0.0 111.904 171.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' LEU . . . . . 0.528 HD12 HG13 ' A' ' 269' ' ' ILE . 1.2 tm? -61.8 130.43 45.7 Favored 'General case' 0 C--O 1.244 0.8 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 172.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -94.55 104.43 16.38 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . 0.528 HG13 HD12 ' A' ' 267' ' ' LEU . 2.9 mp -97.86 133.81 38.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 123.334 0.653 . . . . 0.0 109.257 176.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 270' ' ' ARG . . . . . 0.584 ' HB3' ' HA ' ' A' ' 331' ' ' ASP . 5.4 tpm_? -85.16 106.47 16.63 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 170.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 271' ' ' CYS . . . . . 0.479 ' SG ' HD21 ' A' ' 297' ' ' LEU . 41.8 t -74.28 176.8 6.33 Favored 'General case' 0 C--O 1.247 0.935 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 170.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -51.1 -36.11 38.63 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.235 1.014 . . . . 0.0 112.756 -178.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -156.62 22.9 0.34 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.179 0.592 . . . . 0.0 111.608 178.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -146.97 179.99 7.21 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 178.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.524 HD23 ' HA ' ' A' ' 270' ' ' ARG . 91.5 mt -121.11 126.3 49.41 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.018 0.927 . . . . 0.0 109.729 174.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 97.7 t -100.01 141.7 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 124.121 0.969 . . . . 0.0 108.522 174.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 39.4 mtt180 -128.5 122.74 31.86 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 178.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.468 HD11 HG12 ' A' ' 289' ' ' VAL . 4.2 pp -134.86 143.32 45.78 Favored Pre-proline 0 N--CA 1.491 1.587 0 CA-C-N 118.139 0.427 . . . . 0.0 110.925 176.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.33 120.28 6.86 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 122.498 2.132 . . . . 0.0 110.865 175.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.665 HD21 ' HG3' ' A' ' 319' ' ' PRO . 0.0 OUTLIER -141.96 145.87 34.99 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.828 0.851 . . . . 0.0 109.932 -177.15 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . 0.416 ' HB2' ' HB2' ' A' ' 284' ' ' GLU . 48.5 mtt85 -79.35 147.71 32.31 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.835 0.854 . . . . 0.0 108.729 176.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 282' ' ' MET . . . . . 0.476 ' HG2' ' CE1' ' A' ' 265' ' ' PHE . 26.8 mtp -66.62 -32.03 73.1 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 118.292 0.497 . . . . 0.0 109.878 174.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 38.8 p -72.06 -29.19 63.89 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.716 1.207 . . . . 0.0 112.007 178.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 284' ' ' GLU . . . . . 0.458 ' O ' ' HD2' ' A' ' 319' ' ' PRO . 18.5 tp10 -66.46 129.85 94.15 Favored Pre-proline 0 N--CA 1.474 0.772 0 C-N-CA 124.282 1.033 . . . . 0.0 109.269 177.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -65.07 166.5 18.54 Favored 'Trans proline' 0 C--N 1.377 2.037 0 C-N-CA 122.012 1.808 . . . . 0.0 111.567 174.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.431 ' O ' HG23 ' A' ' 290' ' ' VAL . 71.7 mt -65.59 -11.63 45.91 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 118.65 -0.691 . . . . 0.0 112.292 -177.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 287' ' ' GLN . . . . . 0.433 ' HA ' ' HB ' ' A' ' 290' ' ' VAL . 22.9 tp60 -55.62 -22.06 20.66 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.167 0.587 . . . . 0.0 112.013 178.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 288' ' ' SER . . . . . 0.476 ' HB3' HD12 ' A' ' 280' ' ' LEU . 33.5 t -60.34 -57.11 14.16 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 123.292 0.637 . . . . 0.0 110.566 170.021 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.468 HG12 HD11 ' A' ' 278' ' ' LEU . 18.1 m -71.83 -28.73 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 122.725 0.41 . . . . 0.0 111.531 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . 0.532 HG13 ' HB ' ' A' ' 304' ' ' ILE . 73.3 t -67.03 -51.12 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.809 0.844 . . . . 0.0 110.333 -179.151 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -69.8 -36.58 75.8 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.428 0.691 . . . . 0.0 111.44 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -66.21 -48.65 69.92 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.325 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 293' ' ' MET . . . . . 0.445 ' HG3' HG21 ' A' ' 269' ' ' ILE . 94.0 mmm -67.7 -29.17 68.36 Favored 'General case' 0 N--CA 1.479 0.976 0 O-C-N 123.918 0.761 . . . . 0.0 110.958 178.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -61.44 -49.5 76.59 Favored 'General case' 0 C--O 1.219 -0.516 0 O-C-N 123.65 0.594 . . . . 0.0 110.657 174.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 33.0 m -70.68 -31.81 68.83 Favored 'General case' 0 CA--C 1.549 0.909 0 O-C-N 123.512 0.508 . . . . 0.0 111.045 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 80.8 t60 -69.22 -35.49 76.23 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 123.733 0.813 . . . . 0.0 111.034 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 297' ' ' LEU . . . . . 0.479 HD21 ' SG ' ' A' ' 271' ' ' CYS . 67.7 mt -101.38 -4.07 27.61 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 124.052 0.941 . . . . 0.0 111.339 -179.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 78.63 12.08 84.6 Favored Glycine 0 C--N 1.351 1.398 0 C-N-CA 123.481 0.563 . . . . 0.0 114.073 173.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 299' ' ' VAL . . . . . 0.473 HG11 HG11 ' A' ' 334' ' ' VAL . 33.9 m -106.1 -176.53 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 124.266 1.026 . . . . 0.0 111.293 -178.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 42.7 m -84.29 148.29 52.46 Favored Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 123.749 0.82 . . . . 0.0 110.327 177.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -57.27 -30.58 88.06 Favored 'Trans proline' 0 C--N 1.379 2.166 0 C-N-CA 123.357 2.705 . . . . 0.0 112.144 172.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 20.4 m -70.5 -12.02 61.3 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 123.26 0.624 . . . . 0.0 112.006 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 75.8 mtt180 -95.94 -24.17 16.53 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.142 0.977 . . . . 0.0 110.923 176.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 304' ' ' ILE . . . . . 0.549 HD12 ' SG ' ' A' ' 332' ' ' CYS . 34.5 mm -78.45 122.9 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 123.016 0.526 . . . . 0.0 110.499 -178.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 36.8 tp -126.2 116.36 21.19 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.822 0.849 . . . . 0.0 109.033 177.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -85.06 135.06 34.16 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 177.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 74.3 mt -134.17 115.21 13.94 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.299 1.04 . . . . 0.0 109.208 -176.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -83.77 88.08 7.08 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 174.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 74.88 -81.87 0.87 Allowed Glycine 0 C--N 1.35 1.336 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.856 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -118.32 -32.13 4.75 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.07 0.948 . . . . 0.0 110.403 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 6.0 t -74.6 141.68 44.69 Favored 'General case' 0 C--O 1.245 0.859 0 CA-C-O 121.016 0.436 . . . . 0.0 110.249 -170.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -93.45 116.9 29.44 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.73 -175.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . 0.442 HD13 HD13 ' A' ' 322' ' ' LEU . 47.2 mt -95.67 164.87 12.59 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.784 0.434 . . . . 0.0 110.17 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 49.8 m -123.1 147.47 51.82 Favored Pre-proline 0 N--CA 1.479 1.015 0 C-N-CA 123.436 0.694 . . . . 0.0 109.734 -178.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -55.83 -29.02 70.36 Favored 'Trans proline' 0 C--N 1.383 2.36 0 C-N-CA 122.976 2.451 . . . . 0.0 113.036 173.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 29.4 p -76.01 -29.53 58.17 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.621 0.768 . . . . 0.0 111.837 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -65.6 143.5 57.57 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.141 0.576 . . . . 0.0 110.747 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 318' ' ' THR . . . . . . . . . . . . . 78.0 p -100.32 141.21 22.29 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 122.903 0.481 . . . . 0.0 110.408 -178.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 319' ' ' PRO . . . . . 0.665 ' HG3' HD21 ' A' ' 280' ' ' LEU . 19.2 Cg_endo -55.92 -16.89 17.21 Favored 'Trans proline' 0 C--N 1.37 1.708 0 C-N-CA 123.789 2.993 . . . . 0.0 113.48 171.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 53.0 ttt180 -67.66 -54.9 15.78 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 122.836 0.454 . . . . 0.0 110.346 175.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 13.7 t -71.09 -21.93 62.16 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 122.844 0.458 . . . . 0.0 111.97 -177.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 322' ' ' LEU . . . . . 0.442 HD13 HD13 ' A' ' 313' ' ' LEU . 53.8 mt -88.87 -18.92 26.59 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.648 0.779 . . . . 0.0 111.161 176.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 20.9 tptm 56.63 53.02 8.89 Favored 'General case' 0 CA--C 1.56 1.351 0 C-N-CA 125.044 1.337 . . . . 0.0 110.842 -175.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.425 HD12 ' HB3' ' A' ' 319' ' ' PRO . 61.5 mt -79.71 164.84 23.41 Favored 'General case' 0 C--O 1.246 0.9 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.375 173.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 325' ' ' GLY . . . . . 0.433 ' H ' ' HB3' ' A' ' 328' ' ' ASP . . . -160.08 -175.84 31.5 Favored Glycine 0 C--N 1.34 0.801 0 CA-C-N 116.372 -0.376 . . . . 0.0 113.087 -173.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 35.2 m -70.21 -28.93 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.119 0.968 . . . . 0.0 111.046 176.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -105.74 15.26 27.07 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.595 1.158 . . . . 0.0 110.658 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 328' ' ' ASP . . . . . 0.433 ' HB3' ' H ' ' A' ' 325' ' ' GLY . 10.9 t70 -123.8 124.81 43.52 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 177.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 3.1 mt -113.37 146.38 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 O-C-N 123.708 0.63 . . . . 0.0 110.622 -169.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 24.1 pt -133.72 129.71 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 123.646 0.779 . . . . 0.0 110.944 179.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 331' ' ' ASP . . . . . 0.584 ' HA ' ' HB3' ' A' ' 270' ' ' ARG . 5.4 m-20 -74.56 114.43 12.96 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.75 1.22 . . . . 0.0 112.351 -173.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 332' ' ' CYS . . . . . 0.549 ' SG ' HD12 ' A' ' 304' ' ' ILE . 42.6 t -83.46 97.48 9.01 Favored 'General case' 0 C--O 1.243 0.729 0 C-N-CA 124.246 1.018 . . . . 0.0 110.136 173.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 89.0 t -102.1 122.5 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 123.747 0.819 . . . . 0.0 109.936 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 334' ' ' VAL . . . . . 0.473 HG11 HG11 ' A' ' 299' ' ' VAL . 90.2 t -85.62 102.93 11.99 Favored 'Isoleucine or valine' 0 C--O 1.242 0.683 0 C-N-CA 123.176 0.591 . . . . 0.0 109.514 175.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 81.1 mt . . . . . 0 C--O 1.242 0.693 0 C-N-CA 123.349 0.659 . . . . 0.0 109.753 171.708 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 0.408 HD13 ' HB2' ' A' ' 279' ' ' PRO . 0.4 OUTLIER . . . . . 0 N--CA 1.474 0.772 0 CA-C-O 121.357 0.599 . . . . 0.0 110.361 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' PHE . . . . . 0.527 ' CE1' ' SD ' ' A' ' 282' ' ' MET . 11.0 p90 -130.9 149.15 72.89 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 124.409 1.083 . . . . 0.0 108.942 -172.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 266' ' ' PRO . . . . . 0.524 ' HB2' ' HB3' ' A' ' 277' ' ' ARG . 45.7 Cg_endo -66.03 92.28 0.26 Allowed 'Trans proline' 0 C--N 1.369 1.656 0 C-N-CA 122.42 2.08 . . . . 0.0 112.086 173.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 267' ' ' LEU . . . . . 0.462 HD12 HG13 ' A' ' 269' ' ' ILE . 1.6 tm? -61.52 127.51 31.81 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 170.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . 0.488 ' HG2' HG12 ' A' ' 329' ' ' ILE . 3.9 ttpt -91.08 111.65 23.21 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-O 121.5 0.666 . . . . 0.0 110.699 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . 0.494 HG21 ' HG3' ' A' ' 293' ' ' MET . 1.9 mp -106.81 133.59 50.94 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 C-N-CA 124.198 0.999 . . . . 0.0 108.306 176.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 270' ' ' ARG . . . . . 0.6 ' HB2' HG22 ' A' ' 329' ' ' ILE . 28.2 ttp180 -99.97 101.08 12.08 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 123.924 0.889 . . . . 0.0 109.997 178.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 271' ' ' CYS . . . . . 0.753 ' SG ' HD21 ' A' ' 297' ' ' LEU . 49.0 t -70.05 177.43 3.21 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.918 172.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 272' ' ' ARG . . . . . 0.538 ' HG2' ' SG ' ' A' ' 271' ' ' CYS . 38.8 ptt180 -43.14 -40.84 3.43 Favored 'General case' 0 CA--C 1.559 1.299 0 C-N-CA 125.372 1.469 . . . . 0.0 113.147 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -152.03 6.09 0.43 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.588 0.755 . . . . 0.0 111.31 174.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -115.57 158.09 23.15 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.449 1.1 . . . . 0.0 109.848 -174.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -119.76 117.87 29.36 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.533 0.733 . . . . 0.0 109.45 175.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 276' ' ' VAL . . . . . 0.418 HG21 ' SD ' ' A' ' 293' ' ' MET . 67.8 t -102.04 137.89 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.168 0.987 . . . . 0.0 108.452 171.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . 0.524 ' HB3' ' HB2' ' A' ' 266' ' ' PRO . 83.7 mtm180 -128.37 95.66 4.21 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 173.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.512 HD21 ' HA ' ' A' ' 289' ' ' VAL . 4.2 pp -109.74 142.45 25.82 Favored Pre-proline 0 N--CA 1.487 1.403 0 CA-C-O 119.39 -0.338 . . . . 0.0 110.868 -173.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 279' ' ' PRO . . . . . 0.408 ' HB2' HD13 ' A' ' 264' ' ' LEU . 73.4 Cg_endo -70.69 86.74 0.7 Allowed 'Trans proline' 0 C--N 1.383 2.361 0 C-N-CA 122.945 2.43 . . . . 0.0 112.279 -176.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.64 HD21 ' HG3' ' A' ' 319' ' ' PRO . 3.0 tt -95.94 144.43 26.26 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 114.768 -1.105 . . . . 0.0 109.502 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . 0.588 ' HB2' ' HB2' ' A' ' 284' ' ' GLU . 32.3 mtm180 -90.0 143.73 26.53 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.943 0.897 . . . . 0.0 110.415 178.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 282' ' ' MET . . . . . 0.527 ' SD ' ' CE1' ' A' ' 265' ' ' PHE . 87.2 mmm -64.18 -33.38 75.67 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 122.803 0.441 . . . . 0.0 111.621 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 35.6 t -86.94 -0.82 57.2 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.469 0.708 . . . . 0.0 111.524 178.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 284' ' ' GLU . . . . . 0.588 ' HB2' ' HB2' ' A' ' 281' ' ' ARG . 6.8 tp10 -91.33 134.82 29.01 Favored Pre-proline 0 CA--C 1.538 0.488 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 174.086 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.07 170.71 8.62 Favored 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 121.897 1.732 . . . . 0.0 111.683 170.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.419 ' O ' HG23 ' A' ' 290' ' ' VAL . 84.1 mt -67.53 -11.42 57.95 Favored 'General case' 0 C--O 1.219 -0.548 0 C-N-CA 123.153 0.581 . . . . 0.0 111.714 -178.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 287' ' ' GLN . . . . . 0.564 ' HA ' ' HB ' ' A' ' 290' ' ' VAL . 26.4 tp60 -55.05 -20.66 10.07 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 123.136 0.574 . . . . 0.0 111.95 175.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 288' ' ' SER . . . . . 0.63 ' HB3' HD12 ' A' ' 280' ' ' LEU . 47.4 t -60.7 -54.62 43.04 Favored 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 123.011 0.524 . . . . 0.0 111.19 169.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.512 ' HA ' HD21 ' A' ' 278' ' ' LEU . 34.9 m -69.83 -35.56 65.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 CA-C-N 117.716 0.235 . . . . 0.0 110.974 177.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . 0.587 HG13 ' HB ' ' A' ' 304' ' ' ILE . 76.9 t -61.2 -41.9 91.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 123.995 0.918 . . . . 0.0 111.078 -179.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -69.88 -47.48 62.44 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.694 0.798 . . . . 0.0 110.837 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 292' ' ' HIS . . . . . 0.459 ' HB3' HD22 ' A' ' 278' ' ' LEU . 9.8 t60 -71.68 -36.64 70.67 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.135 -174.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 293' ' ' MET . . . . . 0.494 ' HG3' HG21 ' A' ' 269' ' ' ILE . 95.6 mmm -72.36 -29.88 64.2 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.367 0.667 . . . . 0.0 110.514 177.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -63.35 -44.7 94.09 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 123.776 0.673 . . . . 0.0 110.847 175.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 24.2 m -70.85 -31.38 68.06 Favored 'General case' 0 CA--C 1.552 1.026 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.052 176.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -71.66 -30.14 65.4 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.959 0.904 . . . . 0.0 111.709 179.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 297' ' ' LEU . . . . . 0.753 HD21 ' SG ' ' A' ' 271' ' ' CYS . 50.1 mt -107.73 -5.68 17.24 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 124.009 0.924 . . . . 0.0 111.892 -176.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 72.86 22.4 79.1 Favored Glycine 0 CA--C 1.531 1.072 0 O-C-N 123.573 0.546 . . . . 0.0 113.198 177.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 299' ' ' VAL . . . . . 0.505 HG11 HG11 ' A' ' 334' ' ' VAL . 22.7 m -114.45 179.92 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 124.513 1.125 . . . . 0.0 110.341 -176.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 48.3 t -81.42 145.54 55.58 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 123.554 0.742 . . . . 0.0 110.29 177.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 301' ' ' PRO . . . . . 0.479 ' HB3' HE22 ' A' ' 287' ' ' GLN . 33.1 Cg_exo -57.6 -29.91 86.8 Favored 'Trans proline' 0 C--N 1.376 2.004 0 C-N-CA 122.72 2.28 . . . . 0.0 111.815 167.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 38.7 t -67.65 -13.87 62.45 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 123.491 0.716 . . . . 0.0 111.1 179.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -106.15 -17.11 14.42 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.216 1.006 . . . . 0.0 112.264 -178.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 304' ' ' ILE . . . . . 0.587 ' HB ' HG13 ' A' ' 290' ' ' VAL . 30.1 mm -77.49 112.58 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 CA-C-O 120.775 0.322 . . . . 0.0 110.145 176.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 41.6 tp -114.43 127.65 55.94 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.696 0.798 . . . . 0.0 108.992 175.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -95.9 133.65 39.82 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 176.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . 0.455 HD23 ' HA ' ' A' ' 312' ' ' GLU . 46.0 mt -140.38 111.54 7.12 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.437 1.095 . . . . 0.0 108.294 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . 0.496 ' HB2' HG22 ' A' ' 330' ' ' ILE . 68.9 t80 -81.33 82.55 7.15 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 173.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 69.87 -94.36 0.43 Allowed Glycine 0 C--N 1.35 1.317 0 CA-C-N 114.827 -1.079 . . . . 0.0 112.586 -175.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -95.76 -31.36 13.24 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.604 0.762 . . . . 0.0 112.407 -174.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 14.6 t -77.77 151.87 33.83 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.68 0.392 . . . . 0.0 111.151 -172.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . 0.455 ' HA ' HD23 ' A' ' 307' ' ' LEU . 33.3 tt0 -98.12 122.21 40.99 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 176.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 29.7 mt -110.08 114.78 28.56 Favored 'General case' 0 C--O 1.243 0.752 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 49.5 m -77.98 139.79 61.76 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 123.755 0.822 . . . . 0.0 110.699 -178.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . 0.452 ' HB3' HG21 ' A' ' 290' ' ' VAL . 43.4 Cg_exo -57.52 -28.38 80.6 Favored 'Trans proline' 0 C--N 1.386 2.536 0 C-N-CA 123.317 2.678 . . . . 0.0 112.886 174.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 56.3 p -74.71 -25.97 59.5 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.052 0.941 . . . . 0.0 111.828 -178.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -81.38 156.02 25.64 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.431 0.692 . . . . 0.0 111.084 -178.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 318' ' ' THR . . . . . . . . . . . . . 71.6 p -98.54 159.29 30.84 Favored Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 123.691 0.796 . . . . 0.0 110.334 -177.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 319' ' ' PRO . . . . . 0.64 ' HG3' HD21 ' A' ' 280' ' ' LEU . 92.0 Cg_endo -70.28 -18.03 34.83 Favored 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 122.778 2.319 . . . . 0.0 112.042 174.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -65.82 -51.98 54.4 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.685 1.194 . . . . 0.0 109.944 -175.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 9.8 t -69.72 -23.83 63.47 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.559 179.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 322' ' ' LEU . . . . . 0.447 ' HB2' ' HG ' ' A' ' 324' ' ' LEU . 68.5 mt -91.12 -11.73 37.66 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.757 0.823 . . . . 0.0 111.974 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 48.9 tptt 55.31 46.98 22.42 Favored 'General case' 0 CA--C 1.565 1.541 0 C-N-CA 124.429 1.092 . . . . 0.0 111.339 -176.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.447 ' HG ' ' HB2' ' A' ' 322' ' ' LEU . 46.6 mt -81.48 165.42 21.23 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.696 0.799 . . . . 0.0 109.478 175.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 325' ' ' GLY . . . . . 0.435 ' H ' ' HB3' ' A' ' 328' ' ' ASP . . . -164.7 -171.7 31.26 Favored Glycine 0 C--N 1.34 0.769 0 CA-C-N 116.423 -0.353 . . . . 0.0 112.417 -176.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 28.3 m -69.6 -25.3 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 C-N-CA 123.617 0.767 . . . . 0.0 111.178 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -104.27 13.4 32.25 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.866 0.866 . . . . 0.0 111.344 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 328' ' ' ASP . . . . . 0.435 ' HB3' ' H ' ' A' ' 325' ' ' GLY . 12.3 t70 -109.25 127.66 54.44 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 177.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . 0.6 HG22 ' HB2' ' A' ' 270' ' ' ARG . 13.2 mt -120.72 99.14 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 O-C-N 123.798 0.686 . . . . 0.0 110.463 -164.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 330' ' ' ILE . . . . . 0.496 HG22 ' HB2' ' A' ' 308' ' ' PHE . 39.4 pt -100.31 127.18 53.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 123.371 0.668 . . . . 0.0 111.913 -173.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -71.94 116.92 12.91 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.116 0.967 . . . . 0.0 111.875 -173.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 332' ' ' CYS . . . . . 0.547 ' SG ' HD12 ' A' ' 304' ' ' ILE . 48.8 t -86.06 99.41 11.46 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.017 0.927 . . . . 0.0 109.901 174.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 47.0 t -103.9 115.86 46.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 C-N-CA 123.6 0.76 . . . . 0.0 109.004 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 334' ' ' VAL . . . . . 0.505 HG11 HG11 ' A' ' 299' ' ' VAL . 82.5 t -80.28 104.33 8.45 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 CA-C-O 120.942 0.401 . . . . 0.0 109.962 176.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 93.9 mt . . . . . 0 N--CA 1.468 0.464 0 C-N-CA 124.031 0.932 . . . . 0.0 109.092 173.529 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 3.7 mp . . . . . 0 C--O 1.238 0.473 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -101.94 150.24 37.24 Favored Pre-proline 0 CA--C 1.547 0.847 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 174.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.9 93.82 0.54 Allowed 'Trans proline' 0 C--N 1.375 1.964 0 C-N-CA 121.881 1.72 . . . . 0.0 111.292 176.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 267' ' ' LEU . . . . . 0.49 HD12 HG13 ' A' ' 269' ' ' ILE . 1.6 tm? -59.97 130.54 47.26 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 114.942 -1.026 . . . . 0.0 108.255 175.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . 0.482 ' HG2' HG12 ' A' ' 329' ' ' ILE . 4.0 tppp? -93.0 107.92 19.6 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.172 0.51 . . . . 0.0 110.421 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . 0.511 HG21 ' HG3' ' A' ' 293' ' ' MET . 2.4 mp -106.19 132.92 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 175.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 270' ' ' ARG . . . . . 0.528 ' HA ' HD23 ' A' ' 275' ' ' LEU . 18.3 ttm-85 -86.76 104.41 16.11 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 173.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 271' ' ' CYS . . . . . 0.62 ' SG ' HD21 ' A' ' 297' ' ' LEU . 49.6 t -68.77 176.22 3.16 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.581 0.752 . . . . 0.0 109.992 175.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -58.22 -23.19 54.98 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -174.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -163.62 36.04 0.09 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.467 0.707 . . . . 0.0 111.012 175.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -164.44 178.2 7.62 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.26 0.624 . . . . 0.0 110.116 -177.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.528 HD23 ' HA ' ' A' ' 270' ' ' ARG . 92.9 mt -119.89 119.92 34.92 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.115 0.966 . . . . 0.0 110.337 173.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 89.9 t -97.4 137.38 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.518 0.727 . . . . 0.0 109.088 173.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . 0.426 ' HE ' ' HE2' ' A' ' 268' ' ' LYS . 73.3 mtt180 -118.96 108.68 15.06 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 173.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.504 HD11 HG12 ' A' ' 289' ' ' VAL . 4.6 pp -114.91 144.12 31.39 Favored Pre-proline 0 N--CA 1.488 1.46 0 CA-C-N 118.42 0.555 . . . . 0.0 110.34 177.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 279' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 278' ' ' LEU . 16.8 Cg_exo -67.13 123.55 11.06 Favored 'Trans proline' 0 C--N 1.369 1.655 0 C-N-CA 122.641 2.227 . . . . 0.0 110.784 174.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.72 HD21 ' HG3' ' A' ' 319' ' ' PRO . 0.1 OUTLIER -150.33 141.31 22.93 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.561 0.744 . . . . 0.0 109.824 -179.225 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 40.0 mtm180 -82.46 156.87 23.86 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.43 0.692 . . . . 0.0 109.671 174.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 282' ' ' MET . . . . . . . . . . . . . 25.4 mtp -68.94 -31.66 70.71 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 175.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 23.6 p -68.6 -30.3 69.01 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.359 1.063 . . . . 0.0 111.833 176.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -68.85 128.35 92.86 Favored Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 123.601 0.76 . . . . 0.0 109.11 177.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -66.99 170.69 12.46 Favored 'Trans proline' 0 C--N 1.374 1.883 0 C-N-CA 122.33 2.02 . . . . 0.0 112.21 176.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.42 ' O ' HG23 ' A' ' 290' ' ' VAL . 67.9 mt -66.56 -15.09 63.16 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-O 118.776 -0.63 . . . . 0.0 111.52 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 27.4 tp60 -53.19 -23.33 8.2 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 123.169 0.588 . . . . 0.0 112.023 176.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 288' ' ' SER . . . . . 0.508 ' HB3' HD12 ' A' ' 280' ' ' LEU . 23.2 t -65.49 -53.64 39.6 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.225 0.61 . . . . 0.0 111.129 173.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.504 HG12 HD11 ' A' ' 278' ' ' LEU . 17.7 m -68.81 -32.62 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-O 120.578 0.227 . . . . 0.0 110.408 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . 0.537 ' HA ' HG21 ' A' ' 304' ' ' ILE . 55.0 t -62.7 -51.49 71.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 124.015 0.926 . . . . 0.0 110.675 177.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -62.44 -49.2 76.4 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.226 1.01 . . . . 0.0 110.975 -178.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 21.9 t60 -64.4 -45.12 88.98 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.814 -176.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 293' ' ' MET . . . . . 0.511 ' HG3' HG21 ' A' ' 269' ' ' ILE . 97.1 mmm -71.72 -28.41 63.66 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.312 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -67.27 -42.66 83.49 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 122.621 0.368 . . . . 0.0 110.7 175.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 29.2 m -69.8 -36.18 75.45 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.443 178.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -69.98 -48.62 57.49 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.609 0.764 . . . . 0.0 110.963 -179.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 297' ' ' LEU . . . . . 0.62 HD21 ' SG ' ' A' ' 271' ' ' CYS . 96.2 mt -82.98 -16.83 45.68 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.795 0.838 . . . . 0.0 112.086 -175.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 76.11 33.55 49.44 Favored Glycine 0 C--N 1.345 1.041 0 O-C-N 123.435 0.459 . . . . 0.0 112.446 -179.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 14.9 m -120.34 176.39 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 124.411 1.085 . . . . 0.0 109.47 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 15.4 m -81.51 145.78 55.79 Favored Pre-proline 0 CA--C 1.547 0.848 0 CA-C-O 118.902 -0.571 . . . . 0.0 109.929 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -55.26 -34.01 86.82 Favored 'Trans proline' 0 C--N 1.389 2.688 0 C-N-CA 122.663 2.242 . . . . 0.0 111.767 173.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 70.2 m -63.63 -32.44 73.92 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 120.779 0.323 . . . . 0.0 110.738 -178.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -75.23 -23.75 57.6 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.877 0.871 . . . . 0.0 112.284 -178.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 304' ' ' ILE . . . . . 0.561 HD12 ' SG ' ' A' ' 332' ' ' CYS . 31.3 mm -73.64 101.72 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . 0.591 HD11 ' HG3' ' A' ' 312' ' ' GLU . 38.8 tp -103.99 116.94 33.16 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 173.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . 0.455 ' HG ' HD12 ' A' ' 330' ' ' ILE . 2.5 mm? -87.89 135.55 33.35 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 177.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 69.3 mt -133.67 107.28 7.85 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -178.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . 0.465 ' HB2' HD11 ' A' ' 313' ' ' LEU . 61.1 t80 -79.0 88.41 4.77 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 177.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 67.71 -90.69 0.21 Allowed Glycine 0 C--N 1.346 1.11 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.431 -174.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -132.59 78.71 1.81 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.598 0.759 . . . . 0.0 109.627 -179.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 12.7 t -171.19 149.49 2.84 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.98 0.912 . . . . 0.0 109.287 175.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . 0.591 ' HG3' HD11 ' A' ' 305' ' ' LEU . 35.0 tt0 -91.86 119.2 31.43 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . 0.465 HD11 ' HB2' ' A' ' 308' ' ' PHE . 57.1 mt -107.42 123.68 48.74 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.23 179.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 29.5 m -82.6 150.44 62.97 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 123.789 0.836 . . . . 0.0 110.604 179.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . 0.533 ' HB3' HG21 ' A' ' 290' ' ' VAL . 22.1 Cg_endo -59.92 -25.46 79.54 Favored 'Trans proline' 0 C--N 1.381 2.255 0 C-N-CA 122.73 2.287 . . . . 0.0 112.875 172.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 42.4 p -84.69 -3.69 58.66 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.808 0.843 . . . . 0.0 112.274 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -85.8 148.18 25.96 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 122.901 0.48 . . . . 0.0 109.957 175.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 318' ' ' THR . . . . . . . . . . . . . 28.9 p -103.4 139.74 20.39 Favored Pre-proline 0 N--CA 1.476 0.845 0 C-N-CA 122.754 0.422 . . . . 0.0 110.865 178.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 319' ' ' PRO . . . . . 0.72 ' HG3' HD21 ' A' ' 280' ' ' LEU . 27.0 Cg_endo -57.88 -15.99 24.13 Favored 'Trans proline' 0 C--N 1.374 1.906 0 C-N-CA 123.856 3.038 . . . . 0.0 113.094 171.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 37.0 ttt180 -56.99 -62.8 1.49 Allowed 'General case' 0 C--N 1.352 0.702 0 C-N-CA 123.921 0.888 . . . . 0.0 110.446 173.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 15.1 t -71.59 -23.32 61.71 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 122.895 0.478 . . . . 0.0 111.479 -176.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 322' ' ' LEU . . . . . 0.432 HD13 HD13 ' A' ' 313' ' ' LEU . 59.3 mt -82.71 -16.03 49.62 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.328 0.651 . . . . 0.0 111.575 178.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp 59.91 44.02 14.13 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.784 1.234 . . . . 0.0 111.749 178.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.427 HD12 ' HB3' ' A' ' 319' ' ' PRO . 63.9 mt -79.28 168.56 19.37 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.194 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 325' ' ' GLY . . . . . 0.465 ' H ' ' HB2' ' A' ' 328' ' ' ASP . . . -167.32 -162.85 20.05 Favored Glycine 0 C--N 1.35 1.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 113.061 -172.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 25.0 m -74.89 -30.32 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 123.414 0.686 . . . . 0.0 111.204 -178.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -94.97 -25.93 16.32 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.713 0.805 . . . . 0.0 110.907 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 328' ' ' ASP . . . . . 0.465 ' HB2' ' H ' ' A' ' 325' ' ' GLY . 7.1 m-20 -77.77 106.77 9.82 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 122.932 0.493 . . . . 0.0 109.823 -178.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . 0.482 HG12 ' HG2' ' A' ' 268' ' ' LYS . 3.1 mt -97.04 139.13 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 122.83 0.452 . . . . 0.0 110.681 -174.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 330' ' ' ILE . . . . . 0.455 HD12 ' HG ' ' A' ' 306' ' ' LEU . 32.3 pt -119.93 125.01 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 123.061 0.545 . . . . 0.0 109.99 174.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -71.15 114.4 9.17 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.198 0.999 . . . . 0.0 111.274 -175.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 332' ' ' CYS . . . . . 0.561 ' SG ' HD12 ' A' ' 304' ' ' ILE . 45.0 t -81.28 88.89 6.04 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.305 0.642 . . . . 0.0 109.704 174.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 85.5 t -98.85 111.98 29.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 123.619 0.767 . . . . 0.0 109.413 -177.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 90.8 t -82.41 106.19 13.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.808 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 97.0 mt . . . . . 0 N--CA 1.475 0.812 0 C-N-CA 123.605 0.762 . . . . 0.0 109.687 176.386 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.469 0.487 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 265' ' ' PHE . . . . . 0.531 ' CE1' ' SD ' ' A' ' 282' ' ' MET . 28.9 p90 -98.08 150.5 36.81 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 124.776 1.23 . . . . 0.0 108.526 -178.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 266' ' ' PRO . . . . . 0.467 ' HB2' ' HB3' ' A' ' 277' ' ' ARG . 56.0 Cg_endo -67.66 92.61 0.36 Allowed 'Trans proline' 0 C--N 1.368 1.554 0 C-N-CA 122.405 2.07 . . . . 0.0 112.443 175.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.1 111.99 3.67 Favored 'General case' 0 C--O 1.247 0.933 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 173.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . 0.428 ' HE3' HG12 ' A' ' 329' ' ' ILE . 22.3 ttpt -83.81 126.65 33.15 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.65 0.738 . . . . 0.0 111.009 -178.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 5.0 mt -125.91 124.3 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.92 1.288 . . . . 0.0 108.52 -175.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 23.0 ttp180 -89.07 102.36 15.01 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-O 121.287 0.565 . . . . 0.0 109.575 176.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 271' ' ' CYS . . . . . 0.765 ' SG ' HD21 ' A' ' 297' ' ' LEU . 36.5 t -73.11 -174.99 1.68 Allowed 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.064 170.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 35.4 ptt180 -56.41 -28.44 59.39 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 124.477 1.111 . . . . 0.0 113.543 -178.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -166.47 32.07 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.629 0.772 . . . . 0.0 110.322 177.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -151.16 150.88 31.16 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.102 0.561 . . . . 0.0 110.103 -172.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -117.18 101.13 8.2 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.932 0.893 . . . . 0.0 109.858 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 72.8 t -92.7 117.71 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.618 0.767 . . . . 0.0 109.707 176.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . 0.467 ' HB3' ' HB2' ' A' ' 266' ' ' PRO . 44.0 mtm-85 -112.48 91.4 3.64 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 175.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.576 HD21 ' HA ' ' A' ' 289' ' ' VAL . 4.6 pp -98.3 147.69 33.47 Favored Pre-proline 0 N--CA 1.483 1.195 0 C-N-CA 122.485 0.314 . . . . 0.0 110.319 -174.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -71.5 107.21 2.11 Favored 'Trans proline' 0 C--N 1.373 1.843 0 C-N-CA 122.416 2.077 . . . . 0.0 111.689 177.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.837 HD21 ' HG3' ' A' ' 319' ' ' PRO . 0.5 OUTLIER -129.11 150.34 50.55 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.145 1.378 . . . . 0.0 108.473 178.137 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.4 155.64 17.43 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.02 0.528 . . . . 0.0 109.905 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 282' ' ' MET . . . . . 0.531 ' SD ' ' CE1' ' A' ' 265' ' ' PHE . 76.7 mmm -60.32 -33.86 72.98 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.262 0.625 . . . . 0.0 112.059 -175.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 35.0 t -83.77 -19.18 35.55 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.271 0.628 . . . . 0.0 111.896 -178.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -67.74 127.66 93.39 Favored Pre-proline 0 N--CA 1.484 1.233 0 CA-C-O 118.272 -0.87 . . . . 0.0 109.153 175.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -64.95 166.61 17.97 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 122.019 1.813 . . . . 0.0 111.394 173.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.464 ' O ' HG22 ' A' ' 289' ' ' VAL . 82.6 mt -66.74 -10.01 42.62 Favored 'General case' 0 C--O 1.213 -0.834 0 CA-C-O 118.594 -0.717 . . . . 0.0 111.939 -176.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 287' ' ' GLN . . . . . 0.429 ' HA ' ' HB ' ' A' ' 290' ' ' VAL . 27.3 tp60 -53.85 -26.2 23.38 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 123.345 0.658 . . . . 0.0 112.541 178.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 288' ' ' SER . . . . . 0.642 ' HB3' HD12 ' A' ' 280' ' ' LEU . 34.6 t -60.66 -52.63 64.32 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.936 0.494 . . . . 0.0 110.642 171.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.576 ' HA ' HD21 ' A' ' 278' ' ' LEU . 10.2 m -71.75 -30.72 38.96 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 122.364 0.266 . . . . 0.0 110.85 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . 0.558 HG13 ' HB ' ' A' ' 304' ' ' ILE . 66.8 t -65.44 -51.23 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.084 0.954 . . . . 0.0 110.657 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -67.54 -39.61 85.03 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.868 0.867 . . . . 0.0 110.984 -176.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 21.5 t60 -66.27 -52.48 47.11 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.751 179.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 94.7 mmm -65.22 -27.89 68.98 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 123.44 0.462 . . . . 0.0 111.214 -177.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -61.84 -49.97 74.14 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.644 0.777 . . . . 0.0 110.476 172.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 36.8 m -70.9 -28.66 64.7 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.639 0.775 . . . . 0.0 111.195 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -70.3 -36.77 74.54 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.292 1.037 . . . . 0.0 110.87 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 297' ' ' LEU . . . . . 0.765 HD21 ' SG ' ' A' ' 271' ' ' CYS . 78.7 mt -101.87 -5.6 24.57 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.996 0.919 . . . . 0.0 112.095 -178.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 79.4 3.38 88.64 Favored Glycine 0 N--CA 1.475 1.243 0 O-C-N 123.417 0.448 . . . . 0.0 113.239 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 299' ' ' VAL . . . . . 0.479 HG11 HG11 ' A' ' 334' ' ' VAL . 30.9 m -91.48 -177.78 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 124.244 1.017 . . . . 0.0 111.083 -178.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 39.7 m -89.15 150.19 44.56 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 123.482 0.713 . . . . 0.0 110.922 -178.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.13 -30.37 90.22 Favored 'Trans proline' 0 C--N 1.391 2.775 0 C-N-CA 123.094 2.529 . . . . 0.0 111.594 172.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 16.7 m -64.95 -15.77 62.55 Favored 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 123.18 0.592 . . . . 0.0 111.907 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 55.1 mtt180 -100.51 -15.78 17.75 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.933 0.893 . . . . 0.0 112.782 -175.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 304' ' ' ILE . . . . . 0.558 ' HB ' HG13 ' A' ' 290' ' ' VAL . 42.7 mm -82.58 102.48 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 CA-C-N 118.148 0.431 . . . . 0.0 110.682 -176.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 53.6 tp -101.37 114.78 29.08 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.969 0.908 . . . . 0.0 109.363 175.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . 0.456 ' HG ' HD12 ' A' ' 330' ' ' ILE . 2.5 mm? -86.5 133.04 33.78 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 178.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' A' ' 312' ' ' GLU . 92.7 mt -132.58 103.29 6.07 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.927 0.891 . . . . 0.0 109.009 -176.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . 0.486 ' HB2' HD11 ' A' ' 313' ' ' LEU . 33.1 t80 -82.89 89.67 6.87 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -174.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 67.35 -84.58 0.13 Allowed Glycine 0 C--N 1.348 1.231 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.238 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -134.27 52.04 2.08 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.953 0.901 . . . . 0.0 110.036 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 11.7 t -153.49 149.29 27.56 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 122.805 0.442 . . . . 0.0 110.689 172.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . 0.436 ' HA ' HD23 ' A' ' 307' ' ' LEU . 42.4 tt0 -96.79 121.36 38.57 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.179 0.592 . . . . 0.0 110.058 -178.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . 0.486 HD11 ' HB2' ' A' ' 308' ' ' PHE . 58.5 mt -102.05 175.71 5.44 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 122.961 0.504 . . . . 0.0 111.406 -176.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 50.1 m -130.39 146.63 62.53 Favored Pre-proline 0 CA--C 1.547 0.842 0 C-N-CA 123.545 0.738 . . . . 0.0 110.056 -177.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . 0.537 ' HB3' HG21 ' A' ' 290' ' ' VAL . 31.1 Cg_endo -61.45 -26.88 81.72 Favored 'Trans proline' 0 C--N 1.385 2.477 0 C-N-CA 123.036 2.491 . . . . 0.0 112.373 174.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 73.1 p -80.19 -22.99 41.33 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.474 1.11 . . . . 0.0 111.889 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -76.82 147.44 37.18 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.553 0.741 . . . . 0.0 111.519 -176.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 318' ' ' THR . . . . . . . . . . . . . 41.3 p -100.98 141.44 22.63 Favored Pre-proline 0 N--CA 1.475 0.782 0 C-N-CA 124.155 0.982 . . . . 0.0 110.05 -178.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 319' ' ' PRO . . . . . 0.837 ' HG3' HD21 ' A' ' 280' ' ' LEU . 59.0 Cg_endo -62.39 -19.71 68.13 Favored 'Trans proline' 0 C--N 1.37 1.665 0 C-N-CA 123.668 2.912 . . . . 0.0 113.294 -178.118 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 53.3 ttp180 -59.28 -56.51 21.23 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 123.893 0.877 . . . . 0.0 110.697 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 15.3 t -69.63 -25.67 64.05 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.066 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 322' ' ' LEU . . . . . 0.507 ' HB2' ' HG ' ' A' ' 324' ' ' LEU . 46.4 mt -85.71 -4.8 59.26 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.63 0.772 . . . . 0.0 111.842 -178.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp 64.49 29.57 13.25 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.499 1.12 . . . . 0.0 112.063 176.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.507 ' HG ' ' HB2' ' A' ' 322' ' ' LEU . 46.8 mt -78.19 168.74 19.38 Favored 'General case' 0 C--O 1.243 0.755 0 C-N-CA 123.603 0.761 . . . . 0.0 110.774 178.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 325' ' ' GLY . . . . . 0.477 ' H ' ' HB2' ' A' ' 328' ' ' ASP . . . -168.5 -162.48 20.66 Favored Glycine 0 C--O 1.243 0.665 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.89 -173.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 35.1 m -73.41 -36.99 50.06 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 C-N-CA 123.737 0.815 . . . . 0.0 111.478 -177.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -100.15 -12.84 19.27 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.428 1.091 . . . . 0.0 111.292 -177.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 328' ' ' ASP . . . . . 0.477 ' HB2' ' H ' ' A' ' 325' ' ' GLY . 31.8 m-20 -76.22 116.57 17.03 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 174.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . 0.428 HG12 ' HE3' ' A' ' 268' ' ' LYS . 18.0 mt -105.04 124.86 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 123.242 0.617 . . . . 0.0 110.55 -170.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 330' ' ' ILE . . . . . 0.456 HD12 ' HG ' ' A' ' 306' ' ' LEU . 40.2 pt -106.5 126.88 62.24 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 123.103 0.561 . . . . 0.0 110.51 176.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 331' ' ' ASP . . . . . 0.404 ' HB2' ' HB2' ' A' ' 307' ' ' LEU . 7.1 m-20 -72.98 106.06 4.71 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.727 0.811 . . . . 0.0 111.328 -179.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 332' ' ' CYS . . . . . 0.457 ' SG ' HD12 ' A' ' 304' ' ' ILE . 34.7 t -71.71 102.27 2.76 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 169.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . 0.423 HG21 HD12 ' A' ' 307' ' ' LEU . 87.1 t -113.78 112.53 40.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 334' ' ' VAL . . . . . 0.479 HG11 HG11 ' A' ' 299' ' ' VAL . 76.7 t -77.86 104.18 5.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.746 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 75.0 mt . . . . . 0 N--CA 1.468 0.426 0 C-N-CA 124.022 0.929 . . . . 0.0 109.193 172.243 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 4.2 mp . . . . . 0 C--O 1.238 0.474 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 265' ' ' PHE . . . . . 0.499 ' CE1' ' HG2' ' A' ' 282' ' ' MET . 31.3 p90 -112.0 141.16 24.37 Favored Pre-proline 0 CA--C 1.55 0.95 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 175.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 266' ' ' PRO . . . . . 0.537 ' HB2' ' HB3' ' A' ' 277' ' ' ARG . 38.0 Cg_endo -65.11 92.64 0.21 Allowed 'Trans proline' 0 C--N 1.375 1.922 0 C-N-CA 122.696 2.264 . . . . 0.0 112.974 176.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 267' ' ' LEU . . . . . 0.464 HD12 HG13 ' A' ' 269' ' ' ILE . 0.4 OUTLIER -61.69 122.55 15.61 Favored 'General case' 0 C--N 1.356 0.88 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 173.271 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . 0.451 ' HD2' HD13 ' A' ' 275' ' ' LEU . 20.8 ttpt -88.27 108.38 19.29 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 121.216 0.531 . . . . 0.0 110.614 178.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . 0.464 HG13 HD12 ' A' ' 267' ' ' LEU . 3.8 mp -105.79 129.22 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 176.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 270' ' ' ARG . . . . . 0.425 ' HA ' HD23 ' A' ' 275' ' ' LEU . 41.1 ttm180 -87.0 119.34 27.11 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 122.847 0.459 . . . . 0.0 110.016 174.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 271' ' ' CYS . . . . . 0.712 ' SG ' HD21 ' A' ' 297' ' ' LEU . 10.1 t -88.75 -165.06 1.24 Allowed 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.722 0.809 . . . . 0.0 109.687 173.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -52.96 -39.73 63.18 Favored 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 124.584 1.154 . . . . 0.0 112.85 176.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -162.19 42.82 0.13 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.511 0.725 . . . . 0.0 109.87 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 274' ' ' ASP . . . . . 0.402 ' HB3' ' HB3' ' A' ' 271' ' ' CYS . 38.1 t70 -155.58 162.01 40.73 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.704 -171.162 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.451 HD13 ' HD2' ' A' ' 268' ' ' LYS . 72.3 mt -127.85 106.58 9.21 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.176 0.99 . . . . 0.0 110.032 174.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 84.6 t -92.88 108.99 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 123.696 0.798 . . . . 0.0 108.937 174.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . 0.537 ' HB3' ' HB2' ' A' ' 266' ' ' PRO . 67.4 mtm180 -98.76 83.46 2.96 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 174.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.404 HD11 HG12 ' A' ' 289' ' ' VAL . 4.3 pp -93.38 137.14 23.6 Favored Pre-proline 0 N--CA 1.488 1.447 0 CA-C-O 119.141 -0.457 . . . . 0.0 110.413 -175.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -63.91 123.67 12.32 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 122.54 2.16 . . . . 0.0 111.477 175.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.655 HD21 ' HG3' ' A' ' 319' ' ' PRO . 0.0 OUTLIER -143.72 151.94 40.66 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.226 1.01 . . . . 0.0 110.066 -176.549 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . 0.425 ' HD2' ' H ' ' A' ' 281' ' ' ARG . 1.6 mpt_? -87.85 149.71 23.96 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 177.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 282' ' ' MET . . . . . 0.499 ' HG2' ' CE1' ' A' ' 265' ' ' PHE . 14.9 mtp -68.06 -37.08 80.87 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 117.928 0.331 . . . . 0.0 110.672 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 22.8 t -75.08 -15.34 60.62 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.748 0.819 . . . . 0.0 111.314 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 284' ' ' GLU . . . . . 0.434 ' O ' ' HD2' ' A' ' 319' ' ' PRO . 4.5 tp10 -73.52 134.31 79.45 Favored Pre-proline 0 CA--C 1.543 0.691 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 174.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.89 166.57 26.01 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 122.062 1.842 . . . . 0.0 111.686 175.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 82.6 mt -66.7 -12.62 59.17 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.985 0.514 . . . . 0.0 111.721 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 287' ' ' GLN . . . . . 0.479 ' HA ' ' HB ' ' A' ' 290' ' ' VAL . 25.6 tp60 -56.2 -22.36 28.75 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.342 0.657 . . . . 0.0 111.687 173.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 288' ' ' SER . . . . . 0.465 ' HB3' HD12 ' A' ' 280' ' ' LEU . 22.8 t -61.22 -57.64 11.58 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.462 0.705 . . . . 0.0 110.455 172.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.416 HG13 HD13 ' A' ' 280' ' ' LEU . 17.9 m -68.99 -30.36 46.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 122.484 0.313 . . . . 0.0 110.553 -179.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . 0.6 HG13 ' HB ' ' A' ' 304' ' ' ILE . 43.0 t -63.72 -44.51 98.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.507 1.123 . . . . 0.0 111.15 176.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -59.58 -47.61 84.89 Favored 'General case' 0 N--CA 1.479 0.998 0 O-C-N 124.044 0.84 . . . . 0.0 110.204 178.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 42.7 t60 -64.62 -50.63 66.37 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.406 -178.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 293' ' ' MET . . . . . 0.432 ' HG3' HG21 ' A' ' 269' ' ' ILE . 94.3 mmm -69.37 -30.55 68.58 Favored 'General case' 0 N--CA 1.483 1.177 0 O-C-N 123.666 0.604 . . . . 0.0 111.356 -174.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -64.68 -46.44 82.37 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 123.656 0.598 . . . . 0.0 110.277 175.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 26.1 m -73.26 -29.24 62.61 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.309 0.644 . . . . 0.0 111.119 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 67.6 t60 -65.05 -38.74 91.82 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.404 1.082 . . . . 0.0 110.279 176.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 297' ' ' LEU . . . . . 0.712 HD21 ' SG ' ' A' ' 271' ' ' CYS . 58.2 mt -101.05 -5.84 25.21 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.369 1.068 . . . . 0.0 111.876 -177.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 74.21 10.37 81.51 Favored Glycine 0 N--CA 1.476 1.303 0 O-C-N 123.267 0.355 . . . . 0.0 113.61 178.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 299' ' ' VAL . . . . . 0.434 HG11 HG11 ' A' ' 334' ' ' VAL . 33.5 m -95.99 176.03 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.208 1.003 . . . . 0.0 110.855 -178.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . 0.412 ' H ' ' HD2' ' A' ' 303' ' ' ARG . 20.2 m -78.95 148.56 72.24 Favored Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 123.298 0.639 . . . . 0.0 110.428 178.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -57.86 -28.33 82.06 Favored 'Trans proline' 0 C--N 1.385 2.486 0 C-N-CA 122.97 2.446 . . . . 0.0 112.247 172.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 19.5 m -72.58 -7.54 50.69 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.429 0.691 . . . . 0.0 111.958 -178.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 303' ' ' ARG . . . . . 0.412 ' HD2' ' H ' ' A' ' 300' ' ' SER . 95.7 mtt180 -99.25 -21.28 16.16 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.845 0.858 . . . . 0.0 110.943 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 304' ' ' ILE . . . . . 0.6 ' HB ' HG13 ' A' ' 290' ' ' VAL . 39.4 mm -80.73 115.34 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 122.852 0.461 . . . . 0.0 110.506 -176.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 33.5 tp -113.46 137.65 51.24 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 171.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . 0.448 ' HG ' HD12 ' A' ' 330' ' ' ILE . 2.0 mm? -104.15 133.8 48.48 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 177.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 80.8 mt -131.42 111.43 11.81 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.47 0.708 . . . . 0.0 109.101 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . 0.548 ' HB2' HD11 ' A' ' 313' ' ' LEU . 87.1 t80 -82.49 81.79 8.17 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 77.16 -67.8 2.71 Favored Glycine 0 C--N 1.354 1.53 0 CA-C-N 114.885 -1.052 . . . . 0.0 112.842 -178.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -134.96 -26.8 1.3 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.087 0.955 . . . . 0.0 111.596 -174.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 14.3 t -82.1 147.66 28.97 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 122.658 0.383 . . . . 0.0 110.641 -176.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -93.44 117.39 30.02 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 120.923 0.392 . . . . 0.0 110.01 -178.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . 0.548 HD11 ' HB2' ' A' ' 308' ' ' PHE . 48.1 mt -105.9 114.71 29.03 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.841 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 49.5 m -75.15 147.44 83.19 Favored Pre-proline 0 CA--C 1.553 1.059 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.388 177.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . 0.573 ' HB3' HG21 ' A' ' 290' ' ' VAL . 33.9 Cg_endo -60.23 -23.6 74.56 Favored 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 123.265 2.643 . . . . 0.0 112.937 177.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 4.6 m -72.48 -33.95 67.33 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.785 0.834 . . . . 0.0 111.08 178.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -66.43 146.24 54.78 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.826 0.85 . . . . 0.0 111.425 -177.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 318' ' ' THR . . . . . . . . . . . . . 81.2 p -100.83 138.35 20.03 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 123.027 0.531 . . . . 0.0 109.921 -178.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 319' ' ' PRO . . . . . 0.655 ' HG3' HD21 ' A' ' 280' ' ' LEU . 10.0 Cg_endo -51.03 -20.08 6.73 Favored 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 124.153 3.235 . . . . 0.0 113.531 170.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 40.9 ttt180 -60.92 -58.79 6.94 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.649 0.78 . . . . 0.0 110.912 173.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 13.2 t -71.34 -20.72 62.14 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 122.932 0.493 . . . . 0.0 111.531 -175.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 322' ' ' LEU . . . . . 0.466 HD13 HD13 ' A' ' 313' ' ' LEU . 39.0 mt -88.9 -22.03 23.32 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.646 0.778 . . . . 0.0 111.01 178.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 2.3 tmtp? 56.41 80.83 0.14 Allowed 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.869 1.267 . . . . 0.0 109.204 -167.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 69.5 mt -110.31 143.83 39.94 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 172.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 325' ' ' GLY . . . . . 0.437 ' H ' ' HB2' ' A' ' 328' ' ' ASP . . . -128.22 -167.72 12.29 Favored Glycine 0 C--N 1.337 0.613 0 C-N-CA 123.939 0.78 . . . . 0.0 111.511 -178.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 14.5 m -73.88 -21.98 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 123.314 0.645 . . . . 0.0 111.469 -177.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -99.96 -22.84 15.11 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.193 0.997 . . . . 0.0 111.253 -178.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 328' ' ' ASP . . . . . 0.437 ' HB2' ' H ' ' A' ' 325' ' ' GLY . 3.9 m-20 -70.37 124.96 25.46 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.992 0.517 . . . . 0.0 109.813 178.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . 0.412 HG12 ' HG2' ' A' ' 268' ' ' LYS . 12.9 mt -104.11 139.57 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.028 0.531 . . . . 0.0 109.933 -178.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 330' ' ' ILE . . . . . 0.448 HD12 ' HG ' ' A' ' 306' ' ' LEU . 35.7 pt -123.84 126.58 72.87 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 123.162 0.585 . . . . 0.0 109.837 174.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -75.39 106.1 6.75 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.027 0.931 . . . . 0.0 110.963 -176.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 332' ' ' CYS . . . . . 0.554 ' SG ' HD12 ' A' ' 304' ' ' ILE . 38.1 t -74.54 92.06 2.35 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.701 0.801 . . . . 0.0 110.168 172.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 97.4 t -95.87 117.08 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 123.431 0.693 . . . . 0.0 109.679 177.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 334' ' ' VAL . . . . . 0.434 HG11 HG11 ' A' ' 299' ' ' VAL . 62.1 t -83.38 99.76 6.32 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 123.582 0.753 . . . . 0.0 109.713 177.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 84.9 mt . . . . . 0 CA--C 1.542 0.64 0 C-N-CA 123.883 0.873 . . . . 0.0 110.535 172.663 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 4.2 mp . . . . . 0 N--CA 1.477 0.879 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -125.88 141.57 39.77 Favored Pre-proline 0 CA--C 1.549 0.931 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 175.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -64.26 94.13 0.2 Allowed 'Trans proline' 0 C--N 1.379 2.137 0 C-N-CA 122.531 2.154 . . . . 0.0 112.091 176.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 267' ' ' LEU . . . . . 0.437 HD12 HG13 ' A' ' 269' ' ' ILE . 1.1 tm? -59.6 131.71 51.75 Favored 'General case' 0 C--N 1.354 0.782 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 173.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . 0.43 ' HG2' HG12 ' A' ' 329' ' ' ILE . 3.0 tppp? -94.96 103.53 15.39 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.465 0.65 . . . . 0.0 109.973 -178.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . 0.437 HG13 HD12 ' A' ' 267' ' ' LEU . 2.4 mp -100.59 154.03 4.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 175.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 270' ' ' ARG . . . . . 0.486 ' HB2' HG22 ' A' ' 329' ' ' ILE . 22.5 ttp180 -118.35 103.61 9.96 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.792 0.837 . . . . 0.0 109.017 176.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 271' ' ' CYS . . . . . 0.722 ' SG ' HD21 ' A' ' 297' ' ' LEU . 21.0 t -69.09 -178.14 1.21 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.007 0.923 . . . . 0.0 110.598 176.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -50.98 -32.84 22.37 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.712 1.205 . . . . 0.0 113.175 -177.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -161.04 42.08 0.16 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.645 0.778 . . . . 0.0 110.03 178.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -161.35 164.84 29.77 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.257 -174.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 69.6 mt -112.53 113.46 25.62 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.252 1.021 . . . . 0.0 110.155 172.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 276' ' ' VAL . . . . . 0.438 HG21 ' SD ' ' A' ' 293' ' ' MET . 65.7 t -95.43 138.89 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 123.684 0.794 . . . . 0.0 109.264 178.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 42.7 mtt180 -125.08 115.64 20.82 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 177.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.523 HD21 ' HA ' ' A' ' 289' ' ' VAL . 4.0 pp -126.49 135.58 27.43 Favored Pre-proline 0 N--CA 1.482 1.13 0 CA-C-O 119.258 -0.401 . . . . 0.0 109.942 175.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -64.7 127.91 19.85 Favored 'Trans proline' 0 C--N 1.375 1.97 0 C-N-CA 122.657 2.238 . . . . 0.0 110.149 174.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.827 HD21 ' HG3' ' A' ' 319' ' ' PRO . 0.2 OUTLIER -150.22 150.92 32.24 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.002 0.921 . . . . 0.0 109.943 -173.815 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . 0.494 ' HB2' ' HB2' ' A' ' 284' ' ' GLU . 83.5 mtm180 -93.17 155.43 17.46 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.588 0.755 . . . . 0.0 110.815 -178.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 282' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -65.72 -38.24 88.62 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.885 0.474 . . . . 0.0 110.213 176.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 24.3 t -73.99 -17.93 60.93 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.552 0.741 . . . . 0.0 111.802 178.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 284' ' ' GLU . . . . . 0.494 ' HB2' ' HB2' ' A' ' 281' ' ' ARG . 5.9 tp10 -72.93 131.77 83.56 Favored Pre-proline 0 N--CA 1.473 0.72 0 C-N-CA 123.712 0.805 . . . . 0.0 109.121 179.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -67.76 168.38 18.67 Favored 'Trans proline' 0 C--N 1.374 1.918 0 C-N-CA 121.903 1.735 . . . . 0.0 111.79 171.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 54.3 mt -70.41 -10.22 58.5 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 118.982 -0.532 . . . . 0.0 110.874 179.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 26.0 tp60 -54.68 -23.08 15.85 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.217 0.607 . . . . 0.0 111.644 175.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 288' ' ' SER . . . . . 0.551 ' HB3' HD12 ' A' ' 280' ' ' LEU . 34.3 t -64.42 -56.48 14.01 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.619 0.768 . . . . 0.0 110.935 171.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.523 ' HA ' HD21 ' A' ' 278' ' ' LEU . 18.0 m -66.73 -30.43 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 C-N-CA 122.254 0.222 . . . . 0.0 110.701 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . 0.581 HG13 ' HB ' ' A' ' 304' ' ' ILE . 43.9 t -66.88 -50.24 66.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 124.397 1.079 . . . . 0.0 110.565 179.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -64.1 -43.54 95.03 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.105 0.962 . . . . 0.0 110.887 -178.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 26.0 t60 -67.2 -49.09 65.87 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.378 -177.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 293' ' ' MET . . . . . 0.438 ' SD ' HG21 ' A' ' 276' ' ' VAL . 90.0 mmm -66.36 -32.52 73.96 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.447 0.699 . . . . 0.0 111.369 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -61.57 -53.63 53.79 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 123.863 0.727 . . . . 0.0 110.352 177.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 28.3 m -66.2 -34.09 77.24 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.658 0.783 . . . . 0.0 111.304 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -67.46 -35.44 79.19 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.682 0.793 . . . . 0.0 111.499 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 297' ' ' LEU . . . . . 0.722 HD21 ' SG ' ' A' ' 271' ' ' CYS . 86.6 mt -97.83 -3.46 38.75 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.874 0.87 . . . . 0.0 111.319 178.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 75.15 10.15 84.18 Favored Glycine 0 C--N 1.345 1.049 0 O-C-N 123.625 0.578 . . . . 0.0 113.44 177.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 33.1 m -98.6 -179.04 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.126 0.97 . . . . 0.0 111.252 -178.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 21.7 m -85.2 147.78 48.44 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 123.347 0.659 . . . . 0.0 110.686 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -56.79 -29.65 81.7 Favored 'Trans proline' 0 C--N 1.384 2.428 0 C-N-CA 123.044 2.496 . . . . 0.0 112.297 171.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 44.8 m -68.24 -19.56 64.74 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.037 0.535 . . . . 0.0 111.739 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 61.3 mtt85 -89.19 -19.48 25.4 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.924 0.89 . . . . 0.0 111.737 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 304' ' ' ILE . . . . . 0.581 ' HB ' HG13 ' A' ' 290' ' ' VAL . 41.9 mm -80.62 125.39 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 CA-C-N 117.997 0.362 . . . . 0.0 110.748 -178.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . 0.604 HD22 HD11 ' A' ' 335' ' ' LEU . 46.3 tp -129.76 121.52 27.01 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.809 0.844 . . . . 0.0 108.963 176.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . 0.409 ' HA ' ' O ' ' A' ' 331' ' ' ASP . 2.6 mm? -88.43 127.86 35.51 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -179.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . 0.516 HD12 HG21 ' A' ' 333' ' ' VAL . 79.1 mt -136.32 104.76 5.73 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.794 0.837 . . . . 0.0 109.615 -176.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . 0.515 ' HB2' HG22 ' A' ' 330' ' ' ILE . 85.3 t80 -81.84 93.65 6.91 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 177.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 66.77 -87.72 0.13 Allowed Glycine 0 C--N 1.349 1.274 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.595 -177.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -137.17 77.46 1.64 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.277 1.031 . . . . 0.0 109.339 177.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 14.3 t -166.92 146.26 5.39 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.234 1.014 . . . . 0.0 108.899 173.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . 0.425 ' HA ' HD23 ' A' ' 307' ' ' LEU . 44.3 tt0 -97.36 123.38 41.16 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 122.532 0.333 . . . . 0.0 110.345 -176.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . 0.474 HD22 HD22 ' A' ' 322' ' ' LEU . 27.7 mt -121.11 131.63 54.38 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.59 0.756 . . . . 0.0 109.099 -179.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 52.6 m -98.75 152.69 37.96 Favored Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 123.59 0.756 . . . . 0.0 111.573 -174.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -49.23 -37.82 40.29 Favored 'Trans proline' 0 C--N 1.388 2.617 0 C-N-CA 123.695 2.93 . . . . 0.0 113.294 167.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 43.1 p -70.44 -27.61 64.39 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.321 -178.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -73.51 145.71 45.42 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.608 0.763 . . . . 0.0 110.857 -179.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 318' ' ' THR . . . . . . . . . . . . . 76.1 p -99.2 146.79 32.32 Favored Pre-proline 0 N--CA 1.476 0.857 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 177.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 319' ' ' PRO . . . . . 0.827 ' HG3' HD21 ' A' ' 280' ' ' LEU . 34.8 Cg_endo -62.19 -12.18 25.59 Favored 'Trans proline' 0 C--N 1.367 1.518 0 C-N-CA 123.081 2.521 . . . . 0.0 112.56 171.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 44.2 ttt-85 -68.25 -56.13 9.74 Favored 'General case' 0 C--N 1.35 0.613 0 C-N-CA 122.999 0.519 . . . . 0.0 110.15 173.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 13.6 t -68.81 -25.42 64.67 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 120.639 0.257 . . . . 0.0 111.265 -178.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 322' ' ' LEU . . . . . 0.474 HD22 HD22 ' A' ' 313' ' ' LEU . 52.2 mt -90.04 -13.75 35.3 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.288 0.635 . . . . 0.0 111.721 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt 61.87 35.15 16.6 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.657 1.183 . . . . 0.0 112.384 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.449 ' HG ' ' HB2' ' A' ' 322' ' ' LEU . 30.8 mt -73.74 166.13 23.85 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.545 0.738 . . . . 0.0 109.836 175.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 325' ' ' GLY . . . . . 0.447 ' H ' ' HB3' ' A' ' 328' ' ' ASP . . . -164.03 -171.91 30.86 Favored Glycine 0 C--N 1.337 0.635 0 CA-C-N 116.475 -0.33 . . . . 0.0 112.326 -176.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 35.0 m -68.4 -27.87 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 123.973 0.909 . . . . 0.0 111.402 178.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -99.57 11.63 38.65 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.118 0.967 . . . . 0.0 111.625 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 328' ' ' ASP . . . . . 0.447 ' HB3' ' H ' ' A' ' 325' ' ' GLY . 10.9 t70 -122.8 124.09 42.52 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -175.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . 0.486 HG22 ' HB2' ' A' ' 270' ' ' ARG . 3.5 mt -116.72 109.83 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 O-C-N 123.411 0.445 . . . . 0.0 111.824 -163.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 330' ' ' ILE . . . . . 0.515 HG22 ' HB2' ' A' ' 308' ' ' PHE . 34.4 pt -102.06 131.94 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 123.679 0.792 . . . . 0.0 111.117 -177.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 331' ' ' ASP . . . . . 0.409 ' O ' ' HA ' ' A' ' 306' ' ' LEU . 7.5 m-20 -73.95 126.91 31.52 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 123.293 0.637 . . . . 0.0 111.759 -178.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 332' ' ' CYS . . . . . 0.563 ' SG ' HD12 ' A' ' 304' ' ' ILE . 43.2 t -90.55 91.17 8.31 Favored 'General case' 0 C--O 1.244 0.785 0 C-N-CA 123.89 0.876 . . . . 0.0 109.043 172.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . 0.516 HG21 HD12 ' A' ' 307' ' ' LEU . 90.8 t -95.02 115.55 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 123.253 0.621 . . . . 0.0 109.506 -178.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 93.1 t -83.69 98.77 5.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 177.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 335' ' ' LEU . . . . . 0.604 HD11 HD22 ' A' ' 305' ' ' LEU . 86.3 mt . . . . . 0 N--CA 1.47 0.529 0 CA-C-N 114.662 -1.153 . . . . 0.0 111.401 172.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 3.0 mp . . . . . 0 N--CA 1.472 0.668 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -141.75 145.67 37.92 Favored Pre-proline 0 CA--C 1.546 0.792 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 175.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 266' ' ' PRO . . . . . 0.42 ' HB2' ' HB3' ' A' ' 277' ' ' ARG . 58.5 Cg_endo -67.93 89.11 0.37 Allowed 'Trans proline' 0 C--N 1.374 1.909 0 C-N-CA 122.875 2.383 . . . . 0.0 112.626 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 267' ' ' LEU . . . . . 0.497 ' O ' ' HA ' ' A' ' 277' ' ' ARG . 1.4 tm? -58.93 127.83 34.18 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.478 1.111 . . . . 0.0 108.96 176.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . 0.684 ' HG2' HG12 ' A' ' 329' ' ' ILE . 5.6 tppp? -83.6 109.35 17.35 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-O 121.336 0.589 . . . . 0.0 111.19 176.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . 0.46 HG12 ' HB ' ' A' ' 289' ' ' VAL . 2.4 mp -106.39 145.22 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 171.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 30.8 ttp180 -107.47 106.88 17.49 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 173.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 271' ' ' CYS . . . . . 0.583 ' SG ' HD21 ' A' ' 297' ' ' LEU . 17.4 t -69.82 172.65 7.32 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.746 171.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 16.3 ptt180 -62.13 -14.1 33.6 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 123.871 0.868 . . . . 0.0 113.187 -174.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -162.52 34.03 0.11 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.694 0.798 . . . . 0.0 111.029 176.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -164.23 162.82 22.8 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 122.826 0.451 . . . . 0.0 111.647 -175.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 51.9 mt -114.2 116.36 28.93 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.244 1.018 . . . . 0.0 109.653 170.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 60.3 t -100.46 142.72 15.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 124.193 0.997 . . . . 0.0 109.114 176.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . 0.497 ' HA ' ' O ' ' A' ' 267' ' ' LEU . 57.8 mtm180 -127.72 120.8 28.77 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 167.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.547 HD21 ' HA ' ' A' ' 289' ' ' VAL . 4.1 pp -123.9 146.33 50.54 Favored Pre-proline 0 N--CA 1.48 1.04 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 178.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -64.67 110.91 1.54 Allowed 'Trans proline' 0 C--N 1.372 1.788 0 C-N-CA 122.805 2.337 . . . . 0.0 110.94 174.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.659 HD21 ' HG3' ' A' ' 319' ' ' PRO . 0.1 OUTLIER -130.05 143.67 50.92 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.15 0.98 . . . . 0.0 109.835 178.9 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 70.4 mtp180 -89.44 159.79 17.11 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.001 0.92 . . . . 0.0 110.728 178.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 282' ' ' MET . . . . . . . . . . . . . 1.3 mmt -70.53 -34.02 71.82 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.199 176.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 35.2 m -77.81 -26.64 49.74 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.734 0.814 . . . . 0.0 111.222 177.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -72.56 123.37 89.45 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-O 118.135 -0.936 . . . . 0.0 108.642 176.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -68.25 179.52 2.87 Favored 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 122.759 2.306 . . . . 0.0 112.481 179.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.439 ' O ' HG23 ' A' ' 290' ' ' VAL . 66.6 mt -64.43 -18.37 64.67 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 118.954 -0.545 . . . . 0.0 111.557 177.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 26.6 tp60 -53.47 -22.61 8.25 Favored 'General case' 0 CA--C 1.559 1.294 0 C-N-CA 123.543 0.737 . . . . 0.0 112.307 178.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 288' ' ' SER . . . . . 0.494 ' HB3' HD12 ' A' ' 280' ' ' LEU . 32.1 t -63.18 -56.65 14.92 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.847 0.859 . . . . 0.0 111.069 171.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.547 ' HA ' HD21 ' A' ' 278' ' ' LEU . 15.4 m -67.33 -33.72 64.41 Favored 'Isoleucine or valine' 0 C--N 1.361 1.085 0 C-N-CA 122.64 0.376 . . . . 0.0 110.498 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . 0.576 HG13 ' HB ' ' A' ' 304' ' ' ILE . 73.8 t -61.12 -49.24 85.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 124.426 1.09 . . . . 0.0 111.026 177.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -61.27 -50.05 74.59 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 124.31 1.006 . . . . 0.0 110.467 -178.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 22.8 t60 -59.32 -49.03 79.41 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 124.526 1.141 . . . . 0.0 111.203 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 293' ' ' MET . . . . . 0.411 ' HG2' ' O ' ' A' ' 289' ' ' VAL . 91.7 mmm -68.33 -31.08 70.24 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 122.779 0.431 . . . . 0.0 111.103 -178.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -70.0 -38.16 75.91 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.272 0.629 . . . . 0.0 111.034 176.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 27.7 m -68.96 -43.35 75.16 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.611 0.764 . . . . 0.0 110.275 178.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 83.4 t60 -67.66 -47.98 67.98 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.546 -177.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 297' ' ' LEU . . . . . 0.583 HD21 ' SG ' ' A' ' 271' ' ' CYS . 76.6 mt -83.52 -9.0 59.24 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.512 0.725 . . . . 0.0 111.654 -178.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 69.66 26.4 74.49 Favored Glycine 0 C--N 1.349 1.28 0 O-C-N 123.697 0.623 . . . . 0.0 112.682 177.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 299' ' ' VAL . . . . . 0.488 HG11 HG11 ' A' ' 334' ' ' VAL . 28.0 m -110.36 178.14 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.435 1.094 . . . . 0.0 110.434 -177.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 27.4 m -80.4 143.16 55.23 Favored Pre-proline 0 CA--C 1.55 0.971 0 CA-C-O 119.114 -0.469 . . . . 0.0 110.207 178.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -56.91 -28.19 76.42 Favored 'Trans proline' 0 C--N 1.384 2.398 0 C-N-CA 123.052 2.502 . . . . 0.0 112.45 171.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 41.2 t -68.56 -27.31 65.96 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 120.83 0.347 . . . . 0.0 110.978 179.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 66.7 mtt180 -85.55 -11.86 53.05 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.34 1.056 . . . . 0.0 112.047 -176.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 304' ' ' ILE . . . . . 0.576 ' HB ' HG13 ' A' ' 290' ' ' VAL . 35.5 mm -82.67 101.97 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 177.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 36.9 tp -102.37 112.05 24.6 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.271 0.628 . . . . 0.0 109.471 176.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . 0.447 HD21 HG22 ' A' ' 290' ' ' VAL . 3.1 mm? -81.56 131.22 35.27 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 177.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . 0.505 HD12 HG21 ' A' ' 333' ' ' VAL . 72.5 mt -131.99 109.94 10.4 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.04 0.936 . . . . 0.0 108.735 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . 0.519 ' HB2' HD11 ' A' ' 313' ' ' LEU . 28.7 t80 -77.74 89.64 4.01 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -179.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 66.44 -83.43 0.1 Allowed Glycine 0 C--N 1.346 1.112 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.728 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -122.56 3.09 9.62 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.134 0.973 . . . . 0.0 112.207 -176.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 5.0 t -115.26 147.01 40.91 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 118.256 0.48 . . . . 0.0 110.225 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -85.05 132.71 34.29 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 123.184 0.594 . . . . 0.0 110.007 177.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . 0.522 HD13 HD13 ' A' ' 322' ' ' LEU . 53.2 mt -112.3 156.74 21.93 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.114 0.566 . . . . 0.0 110.366 177.152 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 314' ' ' SER . . . . . 0.424 ' O ' HD12 ' A' ' 286' ' ' LEU . 22.3 m -99.22 130.4 27.28 Favored Pre-proline 0 CA--C 1.544 0.749 0 CA-C-O 118.644 -0.693 . . . . 0.0 109.44 175.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -59.51 -21.92 64.11 Favored 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 123.228 2.618 . . . . 0.0 113.475 175.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 27.3 p -78.26 -29.44 48.06 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.969 0.908 . . . . 0.0 111.858 176.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -67.28 157.74 33.17 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.366 0.666 . . . . 0.0 111.475 -177.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 318' ' ' THR . . . . . . . . . . . . . 61.6 p -99.36 144.17 27.77 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 123.158 0.583 . . . . 0.0 109.916 -173.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 319' ' ' PRO . . . . . 0.659 ' HG3' HD21 ' A' ' 280' ' ' LEU . 55.7 Cg_endo -63.22 -16.65 55.81 Favored 'Trans proline' 0 C--N 1.363 1.342 0 C-N-CA 123.43 2.753 . . . . 0.0 112.508 175.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 -73.21 -48.65 33.33 Favored 'General case' 0 C--N 1.355 0.843 0 C-N-CA 122.72 0.408 . . . . 0.0 110.488 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 13.7 t -70.54 -26.37 63.53 Favored 'General case' 0 CA--C 1.549 0.926 0 O-C-N 123.324 0.39 . . . . 0.0 110.637 178.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 322' ' ' LEU . . . . . 0.522 HD13 HD13 ' A' ' 313' ' ' LEU . 68.6 mt -85.7 -12.17 51.87 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.362 0.665 . . . . 0.0 111.41 175.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp 60.02 35.74 21.45 Favored 'General case' 0 CA--C 1.561 1.394 0 C-N-CA 124.712 1.205 . . . . 0.0 111.52 175.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 60.5 mt -69.31 169.75 11.65 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.198 0.999 . . . . 0.0 111.26 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 325' ' ' GLY . . . . . 0.45 ' H ' ' HB3' ' A' ' 328' ' ' ASP . . . -154.89 -170.18 20.3 Favored Glycine 0 C--N 1.348 1.212 0 CA-C-N 116.411 -0.358 . . . . 0.0 113.084 -172.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 14.9 m -81.56 -28.45 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 123.683 0.793 . . . . 0.0 111.542 -176.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -99.33 -23.78 15.04 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.17 0.988 . . . . 0.0 110.041 176.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 328' ' ' ASP . . . . . 0.45 ' HB3' ' H ' ' A' ' 325' ' ' GLY . 17.3 t70 -72.19 120.09 17.31 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.889 0.876 . . . . 0.0 110.245 -175.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . 0.684 HG12 ' HG2' ' A' ' 268' ' ' LYS . 5.2 mt -100.6 134.36 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 123.819 0.848 . . . . 0.0 111.812 -166.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 42.8 pt -126.3 126.34 69.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 123.471 0.708 . . . . 0.0 110.345 172.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -73.89 110.44 8.19 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.485 1.114 . . . . 0.0 112.132 -175.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 332' ' ' CYS . . . . . 0.478 ' SG ' HD12 ' A' ' 304' ' ' ILE . 41.6 t -74.57 89.89 2.22 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.563 0.745 . . . . 0.0 109.878 167.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . 0.505 HG21 HD12 ' A' ' 307' ' ' LEU . 93.1 t -100.61 111.1 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 123.226 0.61 . . . . 0.0 109.483 -178.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 334' ' ' VAL . . . . . 0.488 HG11 HG11 ' A' ' 299' ' ' VAL . 57.9 t -83.41 108.91 16.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 123.033 0.533 . . . . 0.0 109.947 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 88.9 mt . . . . . 0 N--CA 1.48 1.053 0 C-N-CA 123.881 0.872 . . . . 0.0 110.58 178.898 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 1.6 mp . . . . . 0 N--CA 1.475 0.803 0 CA-C-O 121.107 0.48 . . . . 0.0 109.949 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 265' ' ' PHE . . . . . 0.495 ' CE1' ' HG2' ' A' ' 282' ' ' MET . 10.1 p90 -150.45 138.94 12.64 Favored Pre-proline 0 CA--C 1.545 0.78 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 170.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -62.54 94.38 0.14 Allowed 'Trans proline' 0 C--N 1.377 2.03 0 C-N-CA 122.616 2.211 . . . . 0.0 111.555 173.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 267' ' ' LEU . . . . . 0.538 HD12 HG13 ' A' ' 269' ' ' ILE . 0.9 OUTLIER -59.69 125.82 25.15 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 174.266 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . 0.579 ' HG2' HG12 ' A' ' 329' ' ' ILE . 4.8 tppp? -88.41 102.64 15.08 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.348 0.659 . . . . 0.0 110.396 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . 0.538 HG13 HD12 ' A' ' 267' ' ' LEU . 2.1 mp -103.63 129.8 55.07 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 173.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 30.8 ttp180 -90.45 109.37 20.5 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-O 121.303 0.573 . . . . 0.0 110.192 174.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 271' ' ' CYS . . . . . 0.709 ' SG ' HD21 ' A' ' 297' ' ' LEU . 49.2 t -77.87 -179.59 6.11 Favored 'General case' 0 CA--C 1.55 0.95 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.315 172.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 272' ' ' ARG . . . . . 0.401 ' N ' ' SG ' ' A' ' 271' ' ' CYS . 15.9 ptt-85 -53.24 -31.67 44.53 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.978 1.311 . . . . 0.0 113.805 -178.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -161.68 27.98 0.12 Allowed 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.694 0.798 . . . . 0.0 110.279 177.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 274' ' ' ASP . . . . . 0.462 ' HB3' ' HB3' ' A' ' 271' ' ' CYS . 34.8 t70 -144.76 158.68 43.69 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.447 0.699 . . . . 0.0 109.795 -172.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 66.2 mt -119.92 101.47 7.89 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.652 0.781 . . . . 0.0 109.81 176.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 276' ' ' VAL . . . . . 0.504 HG21 ' SD ' ' A' ' 293' ' ' MET . 65.0 t -83.75 125.57 40.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.924 179.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 86.1 mtm180 -118.86 104.83 10.9 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 175.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.494 HD21 ' HA ' ' A' ' 289' ' ' VAL . 4.3 pp -116.21 131.99 23.51 Favored Pre-proline 0 N--CA 1.487 1.398 0 CA-C-N 118.182 0.446 . . . . 0.0 110.744 178.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -65.9 115.95 3.71 Favored 'Trans proline' 0 C--N 1.381 2.24 0 C-N-CA 122.627 2.218 . . . . 0.0 110.736 177.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.714 HD21 ' HG3' ' A' ' 319' ' ' PRO . 0.4 OUTLIER -136.66 148.29 47.32 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.521 1.128 . . . . 0.0 109.463 -174.688 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -88.18 144.37 26.5 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 178.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 282' ' ' MET . . . . . 0.5 ' HB3' ' HB2' ' A' ' 320' ' ' ARG . 16.2 mtp -66.3 -27.41 67.9 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 118.154 0.434 . . . . 0.0 111.68 -177.105 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 35.1 m -79.16 -12.17 59.98 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.52 0.728 . . . . 0.0 112.01 176.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 25.6 tp10 -85.67 130.17 52.0 Favored Pre-proline 0 N--CA 1.472 0.632 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 178.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -65.01 167.32 16.24 Favored 'Trans proline' 0 C--N 1.381 2.267 0 C-N-CA 122.498 2.132 . . . . 0.0 113.119 178.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.402 ' O ' HG22 ' A' ' 289' ' ' VAL . 91.5 mt -68.48 -9.29 47.92 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.502 -178.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 26.3 tp60 -53.85 -27.98 33.13 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.563 0.745 . . . . 0.0 111.444 174.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 288' ' ' SER . . . . . 0.467 ' HB2' HD12 ' A' ' 280' ' ' LEU . 67.0 m -65.92 -47.08 75.93 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.709 0.804 . . . . 0.0 112.075 175.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.494 ' HA ' HD21 ' A' ' 278' ' ' LEU . 17.1 m -71.55 -34.31 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 177.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . 0.569 HG13 ' HB ' ' A' ' 304' ' ' ILE . 37.5 t -61.61 -45.07 99.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.667 1.187 . . . . 0.0 110.95 177.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -63.74 -48.95 74.94 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.04 0.936 . . . . 0.0 110.79 -178.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 74.7 t60 -64.36 -44.9 89.98 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.18 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 293' ' ' MET . . . . . 0.504 ' SD ' HG21 ' A' ' 276' ' ' VAL . 90.9 mmm -68.34 -32.08 71.94 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 123.724 0.64 . . . . 0.0 111.42 -177.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -63.76 -43.36 96.63 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 123.698 0.624 . . . . 0.0 110.404 176.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 29.2 m -73.5 -33.08 64.62 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 123.272 0.629 . . . . 0.0 111.254 176.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 58.4 t60 -66.2 -34.43 78.0 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.183 0.993 . . . . 0.0 110.719 -178.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 297' ' ' LEU . . . . . 0.709 HD21 ' SG ' ' A' ' 271' ' ' CYS . 62.2 mt -102.31 -21.35 14.33 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.921 0.888 . . . . 0.0 111.83 -177.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 85.36 24.42 43.62 Favored Glycine 0 N--CA 1.475 1.258 0 O-C-N 123.007 0.192 . . . . 0.0 112.999 -178.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 299' ' ' VAL . . . . . 0.495 HG11 HG11 ' A' ' 334' ' ' VAL . 31.4 m -109.87 -179.42 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 124.013 0.925 . . . . 0.0 110.808 177.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 19.2 m -82.82 146.29 52.17 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 123.542 0.737 . . . . 0.0 110.277 178.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -58.92 -27.35 84.29 Favored 'Trans proline' 0 C--N 1.386 2.545 0 C-N-CA 123.001 2.468 . . . . 0.0 112.295 173.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 40.2 p -67.06 -17.39 64.87 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.847 0.859 . . . . 0.0 112.021 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 89.5 mtt180 -95.68 -25.79 15.98 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.041 0.937 . . . . 0.0 111.926 -176.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 304' ' ' ILE . . . . . 0.569 ' HB ' HG13 ' A' ' 290' ' ' VAL . 32.9 mm -72.51 115.66 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 122.601 0.36 . . . . 0.0 110.363 -177.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 27.0 tp -124.17 122.32 37.49 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.241 0.616 . . . . 0.0 109.367 177.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . 0.427 ' HG ' HD12 ' A' ' 330' ' ' ILE . 2.2 mm? -89.16 123.31 33.3 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -177.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . 0.516 HD12 HG21 ' A' ' 333' ' ' VAL . 72.7 mt -129.74 112.89 14.08 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.469 0.708 . . . . 0.0 109.622 -177.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -84.7 92.55 8.22 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 173.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 70.43 -94.59 0.49 Allowed Glycine 0 C--N 1.346 1.088 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 -174.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -133.69 82.67 2.0 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.577 0.751 . . . . 0.0 109.411 174.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 12.1 t -166.0 138.84 4.09 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 174.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -90.74 114.03 26.28 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-O 120.697 0.284 . . . . 0.0 110.698 -174.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 46.0 mt -103.74 114.49 28.8 Favored 'General case' 0 C--O 1.245 0.842 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 177.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 12.8 m -72.6 143.9 85.51 Favored Pre-proline 0 CA--C 1.553 1.079 0 C-N-CA 124.215 1.006 . . . . 0.0 111.219 -173.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . 0.542 ' HB3' HG21 ' A' ' 290' ' ' VAL . 36.5 Cg_endo -62.63 -28.65 77.1 Favored 'Trans proline' 0 C--N 1.381 2.263 0 C-N-CA 123.015 2.477 . . . . 0.0 112.357 175.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 4.7 m -73.67 -28.72 61.9 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.09 0.956 . . . . 0.0 111.329 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -78.29 154.78 30.62 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.532 0.733 . . . . 0.0 110.756 -178.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 318' ' ' THR . . . . . . . . . . . . . 82.8 p -99.46 152.9 37.96 Favored Pre-proline 0 CA--C 1.545 0.764 0 C-N-CA 123.495 0.718 . . . . 0.0 109.901 -178.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 319' ' ' PRO . . . . . 0.714 ' HG3' HD21 ' A' ' 280' ' ' LEU . 60.9 Cg_endo -67.92 -9.69 26.44 Favored 'Trans proline' 0 C--N 1.363 1.339 0 C-N-CA 122.975 2.45 . . . . 0.0 113.324 174.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . 0.5 ' HB2' ' HB3' ' A' ' 282' ' ' MET . 44.5 ttm180 -75.11 -48.2 24.95 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 117.786 0.266 . . . . 0.0 110.474 178.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 14.6 t -68.74 -22.88 64.29 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 122.659 0.383 . . . . 0.0 110.946 179.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 322' ' ' LEU . . . . . 0.449 ' HB2' ' HG ' ' A' ' 324' ' ' LEU . 53.2 mt -92.05 -16.13 26.86 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.73 0.812 . . . . 0.0 111.511 176.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp 65.06 31.94 10.71 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.753 1.221 . . . . 0.0 112.57 -179.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.449 ' HG ' ' HB2' ' A' ' 322' ' ' LEU . 42.0 mt -67.54 165.12 17.51 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.682 0.793 . . . . 0.0 110.839 175.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 325' ' ' GLY . . . . . 0.486 ' H ' ' HB3' ' A' ' 328' ' ' ASP . . . -158.63 -169.48 22.13 Favored Glycine 0 C--N 1.342 0.884 0 CA-C-N 116.046 -0.524 . . . . 0.0 112.699 -173.137 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 21.5 m -77.25 -25.72 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.542 0.737 . . . . 0.0 110.46 178.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -94.28 -19.44 20.69 Favored 'General case' 0 C--N 1.353 0.734 0 C-N-CA 124.164 0.985 . . . . 0.0 110.957 179.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 328' ' ' ASP . . . . . 0.486 ' HB3' ' H ' ' A' ' 325' ' ' GLY . 13.1 t70 -82.77 128.4 34.36 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 178.086 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . 0.579 HG12 ' HG2' ' A' ' 268' ' ' LYS . 9.4 mt -115.21 113.87 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 123.107 0.563 . . . . 0.0 109.852 -170.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 330' ' ' ILE . . . . . 0.427 HD12 ' HG ' ' A' ' 306' ' ' LEU . 38.6 pt -108.43 125.47 65.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-O 121.083 0.468 . . . . 0.0 110.79 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -72.34 116.96 13.4 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.839 0.856 . . . . 0.0 111.387 -175.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 332' ' ' CYS . . . . . 0.536 ' SG ' HD12 ' A' ' 304' ' ' ILE . 37.6 t -74.27 92.1 2.22 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 123.307 0.643 . . . . 0.0 109.415 169.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . 0.516 HG21 HD12 ' A' ' 307' ' ' LEU . 60.5 t -101.36 109.84 26.74 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -178.25 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 334' ' ' VAL . . . . . 0.495 HG11 HG11 ' A' ' 299' ' ' VAL . 57.6 t -79.31 93.91 1.77 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.451 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.694 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 87.4 mt . . . . . 0 C--O 1.239 0.506 0 CA-C-O 121.565 0.698 . . . . 0.0 109.508 172.72 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 0.485 HD23 ' HG2' ' A' ' 281' ' ' ARG . 45.9 mt . . . . . 0 C--O 1.24 0.569 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -109.18 142.23 25.15 Favored Pre-proline 0 C--O 1.247 0.924 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 173.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -67.09 96.01 0.38 Allowed 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 122.275 1.983 . . . . 0.0 111.363 175.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 267' ' ' LEU . . . . . 0.514 HD12 HG13 ' A' ' 269' ' ' ILE . 1.0 OUTLIER -62.06 129.07 39.12 Favored 'General case' 0 C--O 1.246 0.899 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 174.656 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . 0.495 ' HG2' HG12 ' A' ' 329' ' ' ILE . 2.6 tppp? -94.37 102.32 14.29 Favored 'General case' 0 C--O 1.241 0.653 0 O-C-N 123.751 0.657 . . . . 0.0 109.872 -176.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . 0.514 HG13 HD12 ' A' ' 267' ' ' LEU . 1.5 mp -104.48 114.19 43.42 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 176.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 33.1 ttp180 -75.54 104.28 6.03 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 175.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 271' ' ' CYS . . . . . 0.601 ' SG ' HD21 ' A' ' 297' ' ' LEU . 38.1 t -72.59 175.98 5.87 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.27 1.028 . . . . 0.0 110.069 174.445 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 25.7 ptt180 -57.13 -28.05 62.37 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.017 0.927 . . . . 0.0 113.142 -178.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -155.45 30.14 0.38 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.376 0.67 . . . . 0.0 111.175 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -160.56 164.0 32.33 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 122.696 0.398 . . . . 0.0 110.907 -173.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -113.54 103.08 10.9 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.258 1.023 . . . . 0.0 108.948 171.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 72.8 t -83.68 130.61 35.54 Favored 'Isoleucine or valine' 0 C--N 1.343 0.301 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 177.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 76.4 mtt85 -124.32 99.49 6.23 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -179.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.493 HD21 ' HA ' ' A' ' 289' ' ' VAL . 4.3 pp -111.8 142.36 26.53 Favored Pre-proline 0 N--CA 1.489 1.476 0 CA-C-N 117.917 0.326 . . . . 0.0 110.324 -178.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -69.26 115.57 4.09 Favored 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 122.282 1.988 . . . . 0.0 110.502 177.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.733 HD21 ' HG3' ' A' ' 319' ' ' PRO . 0.9 OUTLIER -138.34 149.94 46.11 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.835 0.854 . . . . 0.0 109.992 -176.481 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . 0.485 ' HG2' HD23 ' A' ' 264' ' ' LEU . 16.2 mmm180 -94.36 151.1 19.66 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.104 0.962 . . . . 0.0 111.092 178.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 282' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -57.1 -41.31 78.67 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.122 0.569 . . . . 0.0 111.118 175.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 19.6 m -76.25 -17.83 59.3 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.378 1.071 . . . . 0.0 112.554 -177.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 284' ' ' GLU . . . . . 0.451 ' O ' ' HD2' ' A' ' 319' ' ' PRO . 8.5 tp10 -72.49 130.29 86.03 Favored Pre-proline 0 N--CA 1.476 0.838 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 176.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -66.23 166.7 20.37 Favored 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 121.937 1.758 . . . . 0.0 111.807 172.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.482 ' O ' HG23 ' A' ' 290' ' ' VAL . 65.3 mt -66.27 -15.12 62.95 Favored 'General case' 0 C--O 1.215 -0.751 0 CA-C-O 118.932 -0.556 . . . . 0.0 111.779 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 -50.54 -26.2 4.95 Favored 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 123.967 0.907 . . . . 0.0 112.204 178.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 288' ' ' SER . . . . . 0.468 ' HB3' HD12 ' A' ' 280' ' ' LEU . 29.5 t -61.61 -57.2 12.96 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.087 0.955 . . . . 0.0 110.939 171.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.493 ' HA ' HD21 ' A' ' 278' ' ' LEU . 13.2 m -68.03 -29.68 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 122.494 0.317 . . . . 0.0 110.908 -179.376 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . 0.601 HG13 ' HB ' ' A' ' 304' ' ' ILE . 78.1 t -66.2 -55.37 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 123.951 0.9 . . . . 0.0 110.35 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -64.0 -37.66 88.25 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.276 -179.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 62.5 t60 -68.72 -47.63 65.87 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 122.982 0.513 . . . . 0.0 110.978 -177.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 293' ' ' MET . . . . . 0.472 ' HG3' HG21 ' A' ' 269' ' ' ILE . 91.0 mmm -65.9 -32.68 74.32 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.276 0.63 . . . . 0.0 110.966 178.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -63.6 -53.08 57.26 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 123.876 0.735 . . . . 0.0 110.964 176.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 55.4 m -64.46 -29.49 70.53 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.814 0.846 . . . . 0.0 111.176 179.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 71.1 t60 -71.42 -46.25 60.62 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.614 0.766 . . . . 0.0 110.997 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 297' ' ' LEU . . . . . 0.601 HD21 ' SG ' ' A' ' 271' ' ' CYS . 72.7 mt -91.74 -3.56 56.07 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.733 0.813 . . . . 0.0 111.797 -176.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 77.27 22.68 70.14 Favored Glycine 0 C--N 1.349 1.292 0 C-N-CA 123.206 0.432 . . . . 0.0 113.196 175.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 299' ' ' VAL . . . . . 0.518 HG11 HG11 ' A' ' 334' ' ' VAL . 25.0 m -112.07 -179.23 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 124.777 1.231 . . . . 0.0 110.832 178.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 51.7 m -87.81 147.61 41.6 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 123.831 0.852 . . . . 0.0 110.769 178.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.36 -25.9 75.06 Favored 'Trans proline' 0 C--N 1.391 2.773 0 C-N-CA 123.215 2.61 . . . . 0.0 111.909 173.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 9.2 m -61.1 -22.47 64.66 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 123.817 0.847 . . . . 0.0 111.995 178.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 46.6 mtt180 -97.83 -19.88 17.87 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.485 0.714 . . . . 0.0 112.385 -174.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 304' ' ' ILE . . . . . 0.601 ' HB ' HG13 ' A' ' 290' ' ' VAL . 37.0 mm -77.39 99.31 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 CA-C-O 121.101 0.477 . . . . 0.0 110.28 -177.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . 0.434 HD22 HD11 ' A' ' 335' ' ' LEU . 29.2 tp -101.55 112.32 24.84 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.843 0.857 . . . . 0.0 109.209 178.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -85.05 120.94 27.13 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . 0.487 HD12 HG21 ' A' ' 333' ' ' VAL . 70.8 mt -129.41 116.2 18.66 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.035 0.934 . . . . 0.0 108.868 -177.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -87.56 85.71 7.13 Favored 'General case' 0 C--O 1.244 0.764 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 174.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 67.62 -96.98 0.38 Allowed Glycine 0 C--N 1.342 0.898 0 CA-C-N 115.154 -0.93 . . . . 0.0 112.991 -179.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -110.21 11.68 23.54 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.528 0.731 . . . . 0.0 112.06 -174.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 11.4 t -116.98 152.85 33.71 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 117.863 0.301 . . . . 0.0 110.244 176.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -105.36 129.42 53.69 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.2 0.6 . . . . 0.0 109.818 178.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . 0.425 HD22 HD22 ' A' ' 322' ' ' LEU . 49.8 mt -113.33 135.17 54.14 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.353 0.661 . . . . 0.0 109.921 -179.049 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 20.1 m -80.65 143.36 54.54 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 123.457 0.703 . . . . 0.0 110.717 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -63.26 -29.88 73.47 Favored 'Trans proline' 0 C--N 1.384 2.408 0 C-N-CA 122.866 2.377 . . . . 0.0 112.127 174.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 34.1 p -88.13 -1.36 57.96 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.273 1.029 . . . . 0.0 111.944 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -88.58 153.17 21.35 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.274 0.63 . . . . 0.0 109.981 175.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 318' ' ' THR . . . . . . . . . . . . . 82.6 p -99.37 142.79 25.24 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 123.372 0.669 . . . . 0.0 109.979 -178.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 319' ' ' PRO . . . . . 0.733 ' HG3' HD21 ' A' ' 280' ' ' LEU . 29.8 Cg_endo -60.76 -13.69 27.81 Favored 'Trans proline' 0 C--N 1.369 1.65 0 C-N-CA 123.441 2.761 . . . . 0.0 113.143 172.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 53.1 ttt180 -67.07 -55.2 15.32 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.167 0.587 . . . . 0.0 110.105 174.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 10.8 t -71.09 -21.06 62.27 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.06 -177.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 322' ' ' LEU . . . . . 0.445 ' HB2' ' HG ' ' A' ' 324' ' ' LEU . 53.5 mt -93.76 -10.19 35.07 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.657 0.783 . . . . 0.0 111.518 176.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 11.3 mptt 62.15 25.65 15.37 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 125.129 1.371 . . . . 0.0 112.592 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.446 HD13 HD13 ' A' ' 330' ' ' ILE . 33.3 mt -66.79 159.09 28.79 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.363 0.665 . . . . 0.0 110.276 177.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 325' ' ' GLY . . . . . 0.43 ' H ' ' HB3' ' A' ' 328' ' ' ASP . . . -157.06 -157.17 8.23 Favored Glycine 0 C--O 1.242 0.598 0 CA-C-N 116.233 -0.439 . . . . 0.0 112.466 -173.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 17.6 m -83.31 -36.67 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 123.258 0.623 . . . . 0.0 110.625 -179.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -88.85 -17.64 29.27 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.053 0.941 . . . . 0.0 110.727 178.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 328' ' ' ASP . . . . . 0.43 ' HB3' ' H ' ' A' ' 325' ' ' GLY . 3.9 t70 -90.39 115.96 27.97 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . 0.495 HG12 ' HG2' ' A' ' 268' ' ' LYS . 16.0 mt -114.52 120.95 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 123.144 0.578 . . . . 0.0 111.353 -163.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 330' ' ' ILE . . . . . 0.446 HD13 HD13 ' A' ' 324' ' ' LEU . 35.8 pt -108.95 137.08 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 123.344 0.657 . . . . 0.0 111.311 -176.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -79.9 119.46 22.79 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.724 0.81 . . . . 0.0 111.713 -176.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 332' ' ' CYS . . . . . 0.524 ' SG ' HD12 ' A' ' 304' ' ' ILE . 26.9 t -77.79 90.27 4.05 Favored 'General case' 0 C--O 1.243 0.741 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 167.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . 0.487 HG21 HD12 ' A' ' 307' ' ' LEU . 28.3 t -97.27 109.45 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -178.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 334' ' ' VAL . . . . . 0.518 HG11 HG11 ' A' ' 299' ' ' VAL . 40.0 t -85.08 100.96 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.03 -175.379 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 335' ' ' LEU . . . . . 0.434 HD11 HD22 ' A' ' 305' ' ' LEU . 3.4 pp . . . . . 0 N--CA 1.472 0.638 0 C-N-CA 122.764 0.426 . . . . 0.0 111.087 -179.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 0.456 HD23 HH11 ' A' ' 281' ' ' ARG . 0.9 OUTLIER . . . . . 0 N--CA 1.476 0.838 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -113.41 142.56 27.75 Favored Pre-proline 0 N--CA 1.481 1.092 0 C-N-CA 123.053 0.541 . . . . 0.0 109.841 176.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 266' ' ' PRO . . . . . 0.412 ' O ' ' HA ' ' A' ' 326' ' ' VAL . 23.5 Cg_exo -63.3 100.43 0.26 Allowed 'Trans proline' 0 C--N 1.379 2.162 0 C-N-CA 122.914 2.409 . . . . 0.0 112.362 175.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 267' ' ' LEU . . . . . 0.518 HD23 HD22 ' A' ' 280' ' ' LEU . 0.4 OUTLIER -71.23 122.41 20.17 Favored 'General case' 0 CA--C 1.551 0.99 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 173.583 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . 0.611 ' HG2' HG12 ' A' ' 329' ' ' ILE . 13.8 tppt? -85.52 119.97 26.46 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.528 0.731 . . . . 0.0 110.081 179.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 16.4 mt -121.18 138.56 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 124.539 1.136 . . . . 0.0 109.032 179.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 270' ' ' ARG . . . . . 0.436 ' HB2' HG22 ' A' ' 329' ' ' ILE . 29.7 ttp180 -107.82 103.88 13.24 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 123.715 0.806 . . . . 0.0 109.443 177.229 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 271' ' ' CYS . . . . . 0.77 ' SG ' HD21 ' A' ' 297' ' ' LEU . 49.8 t -77.93 179.53 6.68 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 124.482 1.113 . . . . 0.0 110.616 176.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 272' ' ' ARG . . . . . 0.42 ' N ' ' SG ' ' A' ' 271' ' ' CYS . 26.8 ptt180 -54.22 -31.87 54.31 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 125.414 1.486 . . . . 0.0 113.192 -179.149 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -162.82 33.83 0.1 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.981 0.913 . . . . 0.0 110.362 -178.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -157.97 158.05 34.2 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.353 0.661 . . . . 0.0 110.097 -170.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -117.78 123.21 45.43 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.055 0.942 . . . . 0.0 108.881 173.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 276' ' ' VAL . . . . . 0.533 HG21 ' SD ' ' A' ' 293' ' ' MET . 91.8 t -109.73 121.87 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 124.096 0.958 . . . . 0.0 109.818 178.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 20.7 mtm180 -111.51 122.17 47.13 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 169.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.462 HD11 HG12 ' A' ' 289' ' ' VAL . 4.6 pp -131.43 138.78 33.51 Favored Pre-proline 0 N--CA 1.476 0.85 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 175.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.89 94.22 0.87 Allowed 'Trans proline' 0 C--N 1.367 1.511 0 C-N-CA 122.326 2.017 . . . . 0.0 111.312 -177.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.69 HD21 ' HG3' ' A' ' 319' ' ' PRO . 2.8 tt -103.11 156.95 17.33 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.629 1.172 . . . . 0.0 110.287 -178.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . 0.456 HH11 HD23 ' A' ' 264' ' ' LEU . 0.1 OUTLIER -99.43 144.79 28.13 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.177 0.991 . . . . 0.0 110.087 -179.55 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 282' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -58.07 -34.18 69.85 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 123.918 0.887 . . . . 0.0 112.372 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 16.1 m -78.57 -22.45 47.12 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.77 0.828 . . . . 0.0 111.78 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 284' ' ' GLU . . . . . 0.427 ' HB2' ' HB2' ' A' ' 281' ' ' ARG . 8.2 tp10 -75.22 130.77 79.54 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 124.084 0.953 . . . . 0.0 109.647 -176.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -68.48 169.83 16.3 Favored 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 122.229 1.953 . . . . 0.0 112.209 174.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.41 ' O ' HG23 ' A' ' 290' ' ' VAL . 87.4 mt -71.01 -6.63 40.43 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.073 0.549 . . . . 0.0 111.688 -179.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 26.5 tp60 -57.06 -26.1 59.8 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.617 0.767 . . . . 0.0 110.526 173.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 288' ' ' SER . . . . . 0.409 ' HB3' HD12 ' A' ' 280' ' ' LEU . 40.6 t -61.46 -55.9 26.16 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.591 1.156 . . . . 0.0 111.423 172.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.462 HG12 HD11 ' A' ' 278' ' ' LEU . 21.0 m -67.62 -32.5 57.16 Favored 'Isoleucine or valine' 0 C--N 1.359 1.021 0 CA-C-N 116.695 -0.229 . . . . 0.0 110.429 -179.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . 0.548 HG13 ' HB ' ' A' ' 304' ' ' ILE . 40.0 t -59.53 -48.02 88.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 124.576 1.15 . . . . 0.0 110.842 176.32 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -59.81 -48.08 83.11 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 124.243 0.964 . . . . 0.0 110.973 -179.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 13.9 t60 -65.64 -46.29 79.76 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.99 -178.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 293' ' ' MET . . . . . 0.533 ' SD ' HG21 ' A' ' 276' ' ' VAL . 89.5 mmm -67.56 -34.53 77.25 Favored 'General case' 0 N--CA 1.484 1.242 0 O-C-N 123.652 0.595 . . . . 0.0 111.418 -176.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -64.3 -42.25 96.45 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 123.733 0.646 . . . . 0.0 110.178 175.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 37.0 m -74.16 -23.86 59.31 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 123.754 0.822 . . . . 0.0 111.169 178.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 77.3 t60 -82.69 -27.39 31.27 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.267 0.627 . . . . 0.0 111.151 -178.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 297' ' ' LEU . . . . . 0.77 HD21 ' SG ' ' A' ' 271' ' ' CYS . 87.8 mt -110.44 -7.33 14.78 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.59 0.756 . . . . 0.0 111.966 -176.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 71.66 30.74 65.94 Favored Glycine 0 C--N 1.342 0.894 0 O-C-N 123.315 0.384 . . . . 0.0 112.763 178.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 299' ' ' VAL . . . . . 0.463 HG11 HG11 ' A' ' 334' ' ' VAL . 33.0 m -115.29 -177.95 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.234 1.014 . . . . 0.0 110.232 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . 0.519 ' HB2' ' HG3' ' A' ' 303' ' ' ARG . 45.1 m -85.3 146.53 45.09 Favored Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 123.37 0.668 . . . . 0.0 110.969 178.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -56.65 -30.59 84.21 Favored 'Trans proline' 0 C--N 1.386 2.506 0 C-N-CA 123.036 2.491 . . . . 0.0 112.227 169.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 32.1 t -74.95 -2.42 27.02 Favored 'General case' 0 CA--C 1.556 1.195 0 C-N-CA 123.323 0.649 . . . . 0.0 111.629 -178.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 303' ' ' ARG . . . . . 0.519 ' HG3' ' HB2' ' A' ' 300' ' ' SER . 60.4 mtt-85 -101.47 -27.01 13.37 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.849 0.859 . . . . 0.0 111.645 177.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 304' ' ' ILE . . . . . 0.548 ' HB ' HG13 ' A' ' 290' ' ' VAL . 33.5 mm -74.26 112.52 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 C-N-CA 122.938 0.495 . . . . 0.0 110.868 -174.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 48.3 tp -114.61 117.04 29.75 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.891 0.876 . . . . 0.0 109.331 176.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -86.86 127.81 35.04 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 177.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 72.8 mt -132.31 108.15 9.02 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 177.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . 0.502 ' HB2' HG22 ' A' ' 330' ' ' ILE . 39.6 t80 -75.55 92.19 2.89 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -176.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 71.56 -78.39 0.59 Allowed Glycine 0 C--N 1.348 1.239 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.065 -177.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -130.52 -12.08 3.93 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.825 0.85 . . . . 0.0 111.79 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 5.1 t -90.91 147.31 23.22 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 118.353 0.524 . . . . 0.0 110.95 -172.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -87.02 121.07 28.98 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.391 0.676 . . . . 0.0 110.534 -174.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . 0.537 HD22 HD22 ' A' ' 322' ' ' LEU . 24.7 mt -114.5 168.75 9.59 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.073 0.549 . . . . 0.0 109.535 175.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 45.6 m -126.89 152.87 75.95 Favored Pre-proline 0 N--CA 1.48 1.066 0 C-N-CA 123.317 0.647 . . . . 0.0 109.879 177.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . 0.442 ' HB3' HG21 ' A' ' 290' ' ' VAL . 34.9 Cg_exo -58.24 -33.28 97.43 Favored 'Trans proline' 0 C--N 1.382 2.31 0 C-N-CA 122.916 2.411 . . . . 0.0 111.502 170.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 53.9 p -81.63 -0.79 44.1 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 114.643 -1.162 . . . . 0.0 112.369 -177.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -96.99 149.08 22.32 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.655 0.782 . . . . 0.0 110.755 179.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 318' ' ' THR . . . . . . . . . . . . . 28.2 p -102.39 139.94 20.68 Favored Pre-proline 0 N--CA 1.48 1.068 0 C-N-CA 123.87 0.868 . . . . 0.0 110.257 -177.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 319' ' ' PRO . . . . . 0.69 ' HG3' HD21 ' A' ' 280' ' ' LEU . 72.3 Cg_endo -66.12 -14.68 45.47 Favored 'Trans proline' 0 C--N 1.371 1.731 0 C-N-CA 123.753 2.969 . . . . 0.0 113.363 -173.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 22.5 ttt180 -63.37 -56.29 17.54 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.537 0.735 . . . . 0.0 110.592 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 10.0 t -70.83 -27.93 64.23 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.337 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 322' ' ' LEU . . . . . 0.537 HD22 HD22 ' A' ' 313' ' ' LEU . 43.9 mt -80.44 -10.01 59.75 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.531 0.732 . . . . 0.0 111.093 178.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp 68.49 24.3 7.13 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 125.31 1.444 . . . . 0.0 112.148 175.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.46 ' HG ' ' HB2' ' A' ' 322' ' ' LEU . 23.7 mt -75.29 156.91 35.13 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.752 0.821 . . . . 0.0 110.681 178.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 325' ' ' GLY . . . . . 0.449 ' H ' ' HB2' ' A' ' 328' ' ' ASP . . . -163.04 -151.97 6.62 Favored Glycine 0 C--O 1.243 0.705 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.348 -175.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 266' ' ' PRO . 34.0 m -76.73 -33.05 21.19 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 C-N-CA 123.08 0.552 . . . . 0.0 111.325 -178.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -94.77 -20.06 19.82 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.595 0.758 . . . . 0.0 111.629 -176.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 328' ' ' ASP . . . . . 0.449 ' HB2' ' H ' ' A' ' 325' ' ' GLY . 7.7 m-20 -78.02 120.68 23.21 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 122.922 0.489 . . . . 0.0 109.927 -177.177 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . 0.611 HG12 ' HG2' ' A' ' 268' ' ' LYS . 8.7 mt -105.19 111.23 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 123.84 0.856 . . . . 0.0 110.623 -169.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 330' ' ' ILE . . . . . 0.502 HG22 ' HB2' ' A' ' 308' ' ' PHE . 45.5 pt -102.56 124.21 56.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 CA-C-O 121.22 0.533 . . . . 0.0 111.135 -179.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -73.34 115.89 13.25 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.673 0.789 . . . . 0.0 111.035 -178.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 332' ' ' CYS . . . . . 0.471 ' SG ' HD12 ' A' ' 304' ' ' ILE . 39.5 t -78.11 95.03 4.8 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 170.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 59.4 t -102.02 109.91 27.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 123.452 0.701 . . . . 0.0 109.111 -177.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 334' ' ' VAL . . . . . 0.48 HG22 HD13 ' A' ' 304' ' ' ILE . 47.5 t -83.8 99.32 6.2 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 C-N-CA 123.26 0.624 . . . . 0.0 110.052 -178.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 85.8 mt . . . . . 0 N--CA 1.479 1.007 0 C-N-CA 123.967 0.907 . . . . 0.0 110.225 175.65 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 0.499 ' HG ' ' HG3' ' A' ' 281' ' ' ARG . 3.3 mp . . . . . 0 C--O 1.239 0.522 0 CA-C-O 120.828 0.347 . . . . 0.0 110.707 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 265' ' ' PHE . . . . . 0.468 ' CE1' ' HG2' ' A' ' 282' ' ' MET . 15.2 p90 -125.34 143.83 45.76 Favored Pre-proline 0 CA--C 1.549 0.92 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 172.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -62.93 96.61 0.17 Allowed 'Trans proline' 0 C--N 1.373 1.852 0 C-N-CA 122.564 2.176 . . . . 0.0 112.01 174.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.37 120.14 12.8 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 170.099 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . 0.513 ' HE3' HG12 ' A' ' 329' ' ' ILE . 25.5 ttpt -93.95 111.61 23.34 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 121.464 0.65 . . . . 0.0 110.008 -177.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 4.3 mp -106.75 130.33 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.31 1.044 . . . . 0.0 108.872 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 270' ' ' ARG . . . . . 0.409 ' HB2' ' CG2' ' A' ' 329' ' ' ILE . 23.1 ttm180 -84.5 101.01 11.74 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.196 0.522 . . . . 0.0 109.916 173.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 271' ' ' CYS . . . . . 0.586 ' SG ' HD21 ' A' ' 297' ' ' LEU . 52.5 t -69.5 175.56 4.0 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.971 169.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 272' ' ' ARG . . . . . 0.457 ' HG2' ' SG ' ' A' ' 271' ' ' CYS . 7.5 ptm180 -53.29 -25.95 16.65 Favored 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 124.862 1.265 . . . . 0.0 113.344 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -163.45 37.24 0.09 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.268 0.627 . . . . 0.0 111.205 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -165.27 162.65 19.94 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 122.838 0.455 . . . . 0.0 111.4 -175.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.447 HD13 ' HD2' ' A' ' 268' ' ' LYS . 86.5 mt -114.55 104.15 11.72 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.437 1.095 . . . . 0.0 109.662 172.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 79.5 t -86.47 110.29 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 174.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 20.6 mtm180 -103.95 84.13 2.21 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.519 HD21 ' HA ' ' A' ' 289' ' ' VAL . 4.4 pp -94.68 147.58 33.42 Favored Pre-proline 0 N--CA 1.486 1.367 0 CA-C-O 119.296 -0.383 . . . . 0.0 110.797 -174.386 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.01 120.75 6.5 Favored 'Trans proline' 0 C--N 1.378 2.105 0 C-N-CA 122.35 2.033 . . . . 0.0 111.008 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.718 HD21 ' HG3' ' A' ' 319' ' ' PRO . 1.0 OUTLIER -139.72 151.19 45.66 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.488 1.115 . . . . 0.0 109.265 -175.98 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . 0.501 ' HD2' ' H ' ' A' ' 281' ' ' ARG . 0.0 OUTLIER -97.15 149.36 22.08 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.534 -0.914 . . . . 0.0 108.534 -177.386 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 282' ' ' MET . . . . . 0.541 ' HA ' ' HG2' ' A' ' 319' ' ' PRO . 14.4 mtp -70.88 -20.15 62.55 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 118.448 0.567 . . . . 0.0 111.378 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 20.6 t -92.6 5.03 52.43 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 123.696 0.799 . . . . 0.0 111.081 176.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -99.25 133.47 22.03 Favored Pre-proline 0 N--CA 1.478 0.96 0 C-N-CA 124.178 0.991 . . . . 0.0 109.027 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.32 164.38 23.2 Favored 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 122.154 1.903 . . . . 0.0 111.941 171.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 67.9 mt -65.64 -12.03 49.85 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 118.861 -0.59 . . . . 0.0 112.204 -178.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 287' ' ' GLN . . . . . 0.414 ' HA ' ' HB ' ' A' ' 290' ' ' VAL . 25.5 tp60 -55.0 -23.42 19.27 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 122.94 0.496 . . . . 0.0 111.945 177.126 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 288' ' ' SER . . . . . 0.634 ' HB3' HD12 ' A' ' 280' ' ' LEU . 43.7 t -59.4 -54.19 49.52 Favored 'General case' 0 CA--C 1.557 1.249 0 C-N-CA 123.464 0.706 . . . . 0.0 111.47 169.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.519 ' HA ' HD21 ' A' ' 278' ' ' LEU . 20.6 m -70.42 -36.15 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 C-N-CA 122.026 0.131 . . . . 0.0 110.862 179.246 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . 0.565 HG13 ' HB ' ' A' ' 304' ' ' ILE . 74.3 t -61.82 -45.29 99.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.184 0.994 . . . . 0.0 110.853 -178.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -64.08 -51.26 64.91 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 124.046 0.842 . . . . 0.0 110.975 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 47.8 t60 -63.99 -42.55 97.17 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 123.784 0.678 . . . . 0.0 111.097 -176.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 95.4 mmm -67.32 -35.62 79.8 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.218 0.607 . . . . 0.0 110.766 178.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -65.78 -43.78 87.78 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.148 0.579 . . . . 0.0 110.923 176.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 31.9 m -68.36 -34.51 76.2 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.581 0.753 . . . . 0.0 111.068 178.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 23.3 t60 -69.97 -49.87 47.45 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.677 0.791 . . . . 0.0 110.2 -179.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 297' ' ' LEU . . . . . 0.586 HD21 ' SG ' ' A' ' 271' ' ' CYS . 55.9 mt -84.49 -11.66 55.71 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.017 0.927 . . . . 0.0 111.737 -175.159 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 72.04 37.91 59.99 Favored Glycine 0 C--N 1.351 1.362 0 O-C-N 123.273 0.358 . . . . 0.0 112.757 178.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 299' ' ' VAL . . . . . 0.496 HG11 HG11 ' A' ' 334' ' ' VAL . 34.8 m -123.42 177.9 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.326 1.051 . . . . 0.0 110.145 178.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . 0.492 ' HB2' ' HG3' ' A' ' 303' ' ' ARG . 46.9 m -79.03 147.88 70.69 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 123.431 0.692 . . . . 0.0 110.556 175.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -57.68 -27.29 76.87 Favored 'Trans proline' 0 C--N 1.385 2.46 0 C-N-CA 123.068 2.512 . . . . 0.0 112.336 172.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 57.3 p -68.42 -18.52 64.46 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.768 0.827 . . . . 0.0 111.922 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 303' ' ' ARG . . . . . 0.492 ' HG3' ' HB2' ' A' ' 300' ' ' SER . 97.1 mtt180 -89.21 -28.05 20.23 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.69 0.796 . . . . 0.0 111.707 -178.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 304' ' ' ILE . . . . . 0.565 ' HB ' HG13 ' A' ' 290' ' ' VAL . 40.3 mm -72.95 117.72 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 123.06 0.544 . . . . 0.0 109.737 -179.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 31.4 tp -125.16 114.73 19.4 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 177.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -83.91 121.67 27.67 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -178.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . 0.451 HD12 HG21 ' A' ' 333' ' ' VAL . 76.7 mt -129.54 116.46 18.96 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.298 1.039 . . . . 0.0 109.082 -176.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -91.82 96.66 10.53 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 174.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 74.36 -82.98 0.77 Allowed Glycine 0 C--N 1.345 1.045 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.872 177.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -132.05 -6.19 3.49 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.296 0.638 . . . . 0.0 111.458 -179.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 6.2 t -91.98 147.2 23.14 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 122.538 0.335 . . . . 0.0 110.344 -179.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -98.84 131.05 45.25 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.066 0.546 . . . . 0.0 109.757 178.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . 0.525 HD22 HD22 ' A' ' 322' ' ' LEU . 44.9 mt -113.53 130.76 56.28 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.3 0.64 . . . . 0.0 109.63 -179.115 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 37.4 m -76.24 142.33 71.61 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 123.153 0.581 . . . . 0.0 111.314 178.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . 0.504 ' HB3' HG21 ' A' ' 290' ' ' VAL . 35.3 Cg_endo -62.5 -23.26 74.83 Favored 'Trans proline' 0 C--N 1.38 2.217 0 C-N-CA 123.041 2.494 . . . . 0.0 112.436 173.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 52.3 p -80.78 -22.83 39.76 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.035 0.934 . . . . 0.0 111.573 178.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -71.6 154.74 41.21 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.289 0.636 . . . . 0.0 111.477 -178.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 318' ' ' THR . . . . . . . . . . . . . 74.2 p -105.74 149.41 37.91 Favored Pre-proline 0 N--CA 1.477 0.89 0 C-N-CA 123.998 0.919 . . . . 0.0 109.884 -176.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 319' ' ' PRO . . . . . 0.718 ' HG3' HD21 ' A' ' 280' ' ' LEU . 85.6 Cg_endo -68.66 -11.38 31.74 Favored 'Trans proline' 0 C--N 1.372 1.789 0 C-N-CA 123.263 2.642 . . . . 0.0 112.871 -178.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 38.5 ttt180 -69.01 -56.37 7.99 Favored 'General case' 0 C--N 1.347 0.488 0 C-N-CA 123.138 0.575 . . . . 0.0 109.6 177.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 15.1 t -71.01 -24.31 62.35 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.259 -178.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 322' ' ' LEU . . . . . 0.525 HD22 HD22 ' A' ' 313' ' ' LEU . 69.8 mt -86.01 -15.75 40.44 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.24 0.616 . . . . 0.0 111.31 175.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 44.4 tptt 68.05 27.89 6.87 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 125.251 1.42 . . . . 0.0 111.804 177.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.439 ' HG ' ' HB2' ' A' ' 322' ' ' LEU . 29.0 mt -68.29 159.18 31.83 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.483 0.713 . . . . 0.0 110.59 178.264 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 325' ' ' GLY . . . . . 0.472 ' H ' ' HB3' ' A' ' 328' ' ' ASP . . . -160.8 -178.15 34.53 Favored Glycine 0 C--N 1.341 0.846 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.429 -172.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 34.2 m -70.81 -20.06 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 123.943 0.897 . . . . 0.0 111.909 179.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -97.51 -15.76 20.41 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.001 0.92 . . . . 0.0 111.274 176.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 328' ' ' ASP . . . . . 0.472 ' HB3' ' H ' ' A' ' 325' ' ' GLY . 15.4 t70 -83.35 143.38 30.38 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.113 0.565 . . . . 0.0 109.671 -177.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . 0.513 HG12 ' HE3' ' A' ' 268' ' ' LYS . 6.2 mt -130.0 120.6 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 122.72 0.408 . . . . 0.0 110.402 -178.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 30.1 pt -113.55 131.87 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 123.42 0.688 . . . . 0.0 110.595 178.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -77.35 118.68 20.05 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.729 0.812 . . . . 0.0 111.792 -172.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 332' ' ' CYS . . . . . 0.552 ' SG ' HD12 ' A' ' 304' ' ' ILE . 40.5 t -80.03 94.58 5.96 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.947 0.899 . . . . 0.0 109.999 171.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . 0.451 HG21 HD12 ' A' ' 307' ' ' LEU . 90.9 t -97.36 112.54 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 123.213 0.605 . . . . 0.0 109.594 178.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 334' ' ' VAL . . . . . 0.496 HG11 HG11 ' A' ' 299' ' ' VAL . 83.9 t -82.85 125.24 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 175.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 1.2 pp . . . . . 0 N--CA 1.48 1.038 0 C-N-CA 124.261 1.025 . . . . 0.0 110.564 -177.907 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 3.6 mp . . . . . 0 CA--C 1.547 0.865 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 265' ' ' PHE . . . . . 0.418 ' CE1' ' HG2' ' A' ' 282' ' ' MET . 34.8 p90 -138.39 144.58 43.36 Favored Pre-proline 0 N--CA 1.478 0.934 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 177.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.09 88.34 0.08 OUTLIER 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 123.25 2.633 . . . . 0.0 113.325 175.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -67.48 121.76 16.51 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 171.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . 0.45 ' HE3' HG12 ' A' ' 329' ' ' ILE . 23.4 ttpt -97.32 122.76 40.72 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 121.37 0.605 . . . . 0.0 110.769 -178.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . 0.451 HG21 ' HG3' ' A' ' 293' ' ' MET . 2.1 mp -119.36 130.99 73.26 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 C-N-CA 124.943 1.297 . . . . 0.0 108.163 -178.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 25.5 ttp180 -94.92 107.41 19.45 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 122.989 0.516 . . . . 0.0 110.447 177.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 271' ' ' CYS . . . . . 0.787 ' SG ' HD21 ' A' ' 297' ' ' LEU . 37.7 t -70.42 -176.54 1.25 Allowed 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.147 0.979 . . . . 0.0 110.065 168.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 21.3 ptt180 -59.78 -30.6 68.99 Favored 'General case' 0 CA--C 1.557 1.23 0 C-N-CA 123.455 0.702 . . . . 0.0 112.077 179.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -159.42 35.03 0.2 Allowed 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.409 0.684 . . . . 0.0 111.37 -178.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -156.02 151.73 27.23 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 122.766 0.426 . . . . 0.0 110.519 -176.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -116.37 114.76 24.73 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.137 0.975 . . . . 0.0 109.109 174.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 95.6 t -99.85 129.48 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.086 0.955 . . . . 0.0 108.883 173.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 90.7 mtm180 -119.47 86.17 2.51 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 176.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.401 HD21 HG12 ' A' ' 289' ' ' VAL . 4.3 pp -96.72 141.03 22.49 Favored Pre-proline 0 N--CA 1.478 0.941 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -176.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.62 120.49 7.42 Favored 'Trans proline' 0 C--N 1.371 1.718 0 C-N-CA 122.407 2.071 . . . . 0.0 110.841 173.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.712 HD21 ' HG3' ' A' ' 319' ' ' PRO . 0.0 OUTLIER -135.39 155.42 50.6 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.31 1.044 . . . . 0.0 110.001 -178.329 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -93.23 143.16 26.53 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.514 1.126 . . . . 0.0 109.641 177.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 282' ' ' MET . . . . . 0.477 ' HA ' ' HG2' ' A' ' 319' ' ' PRO . 35.0 mtp -67.99 -25.2 65.29 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 118.354 0.524 . . . . 0.0 110.095 176.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 10.3 p -74.64 -34.72 62.81 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.004 1.321 . . . . 0.0 111.592 176.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -70.02 125.49 92.01 Favored Pre-proline 0 N--CA 1.473 0.715 0 C-N-CA 124.121 0.969 . . . . 0.0 108.764 173.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 285' ' ' PRO . . . . . 0.481 ' HA ' ' HA ' ' A' ' 318' ' ' THR . 44.8 Cg_endo -63.58 176.81 2.0 Favored 'Trans proline' 0 C--N 1.381 2.263 0 C-N-CA 122.598 2.199 . . . . 0.0 112.439 174.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.458 ' O ' HG23 ' A' ' 290' ' ' VAL . 86.5 mt -65.26 -17.01 64.16 Favored 'General case' 0 C--O 1.22 -0.483 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.773 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 24.7 tp60 -48.89 -27.63 3.21 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.905 0.882 . . . . 0.0 112.657 178.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 288' ' ' SER . . . . . 0.467 ' HB3' HD12 ' A' ' 280' ' ' LEU . 43.2 t -57.4 -62.13 1.99 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.553 1.141 . . . . 0.0 111.205 170.221 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.403 ' HB ' HG12 ' A' ' 269' ' ' ILE . 15.9 m -69.19 -26.84 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 123.149 0.58 . . . . 0.0 110.784 -176.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . 0.556 HG13 ' HB ' ' A' ' 304' ' ' ILE . 77.1 t -62.62 -52.16 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 123.802 0.841 . . . . 0.0 110.223 176.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -67.24 -39.6 86.21 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.378 0.671 . . . . 0.0 110.882 -178.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 23.3 t60 -67.5 -45.58 75.41 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 123.443 0.465 . . . . 0.0 110.833 -176.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 293' ' ' MET . . . . . 0.451 ' HG3' HG21 ' A' ' 269' ' ' ILE . 93.3 mmm -70.06 -30.09 67.26 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.064 0.546 . . . . 0.0 110.818 178.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -64.91 -42.72 94.5 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.201 0.6 . . . . 0.0 110.64 173.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 41.3 m -68.71 -34.26 75.34 Favored 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 123.781 0.832 . . . . 0.0 110.62 176.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -70.54 -34.39 72.2 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.185 0.994 . . . . 0.0 111.3 -178.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 297' ' ' LEU . . . . . 0.787 HD21 ' SG ' ' A' ' 271' ' ' CYS . 36.8 mt -100.73 -7.19 24.01 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.116 0.966 . . . . 0.0 111.501 -179.124 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 77.2 6.06 85.88 Favored Glycine 0 N--CA 1.474 1.194 0 C-N-CA 123.412 0.53 . . . . 0.0 113.784 178.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 32.3 m -94.88 -176.82 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 124.139 0.975 . . . . 0.0 111.053 -177.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 19.8 m -87.28 147.34 42.07 Favored Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 123.238 0.615 . . . . 0.0 110.159 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -55.08 -29.67 66.59 Favored 'Trans proline' 0 C--N 1.387 2.559 0 C-N-CA 122.946 2.431 . . . . 0.0 112.459 170.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 20.3 m -62.57 -26.92 68.84 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 122.941 0.496 . . . . 0.0 111.478 178.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 58.3 mtt180 -88.0 -20.13 26.25 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.301 1.04 . . . . 0.0 112.416 -175.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 304' ' ' ILE . . . . . 0.58 HD12 ' SG ' ' A' ' 332' ' ' CYS . 41.7 mm -82.64 125.65 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 122.811 0.444 . . . . 0.0 110.996 -177.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 48.6 tp -127.98 121.69 30.45 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.101 0.96 . . . . 0.0 108.94 176.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . 0.445 ' HG ' HD12 ' A' ' 330' ' ' ILE . 3.0 mm? -88.48 134.54 33.82 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . 0.408 HD12 HG21 ' A' ' 333' ' ' VAL . 76.1 mt -136.48 103.97 5.43 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.86 0.864 . . . . 0.0 109.257 -177.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . 0.475 ' HB2' HD11 ' A' ' 313' ' ' LEU . 82.5 t80 -77.37 92.44 3.94 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -178.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 70.5 -78.52 0.46 Allowed Glycine 0 C--N 1.349 1.275 0 CA-C-N 116.24 -0.436 . . . . 0.0 112.326 -179.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -146.49 54.47 1.13 Allowed 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 123.929 0.892 . . . . 0.0 110.643 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 11.2 t -147.27 150.82 35.56 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 122.815 0.446 . . . . 0.0 110.238 175.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -87.98 119.73 28.63 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.807 0.843 . . . . 0.0 110.119 -179.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . 0.527 HD22 HD22 ' A' ' 322' ' ' LEU . 45.7 mt -117.55 122.3 43.29 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 178.055 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 18.3 m -79.73 150.81 73.24 Favored Pre-proline 0 CA--C 1.55 0.979 0 C-N-CA 123.413 0.685 . . . . 0.0 110.853 178.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . 0.414 ' HB3' HG21 ' A' ' 290' ' ' VAL . 51.2 Cg_exo -56.21 -32.48 87.61 Favored 'Trans proline' 0 C--N 1.382 2.298 0 C-N-CA 122.827 2.351 . . . . 0.0 112.22 170.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 77.2 p -75.77 -16.93 60.05 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-N 114.353 -1.294 . . . . 0.0 112.128 -178.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -77.18 144.45 38.33 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.236 0.614 . . . . 0.0 110.334 178.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 318' ' ' THR . . . . . 0.481 ' HA ' ' HA ' ' A' ' 285' ' ' PRO . 25.2 p -99.21 138.38 20.55 Favored Pre-proline 0 N--CA 1.474 0.76 0 C-N-CA 123.568 0.747 . . . . 0.0 109.981 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 319' ' ' PRO . . . . . 0.712 ' HG3' HD21 ' A' ' 280' ' ' LEU . 18.5 Cg_endo -55.94 -19.82 27.31 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 123.926 3.084 . . . . 0.0 113.974 179.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -66.63 -51.01 61.03 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.146 0.578 . . . . 0.0 111.5 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 15.2 t -72.94 -20.16 61.11 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.502 0.321 . . . . 0.0 110.93 -179.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 322' ' ' LEU . . . . . 0.527 HD22 HD22 ' A' ' 313' ' ' LEU . 36.9 mt -85.1 -17.55 37.0 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.362 0.665 . . . . 0.0 110.404 176.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 323' ' ' LYS . . . . . 0.526 ' HE2' ' HA ' ' A' ' 323' ' ' LYS . 0.5 OUTLIER 61.56 58.1 2.14 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.233 1.413 . . . . 0.0 110.466 -178.749 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.457 ' HG ' ' HB2' ' A' ' 322' ' ' LEU . 76.3 mt -95.56 171.27 8.79 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.051 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 325' ' ' GLY . . . . . 0.457 ' H ' ' HB2' ' A' ' 328' ' ' ASP . . . -167.87 -171.99 34.42 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.108 -175.189 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 34.1 m -67.82 -28.93 43.28 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 C-N-CA 123.977 0.911 . . . . 0.0 111.452 177.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -93.54 -15.87 25.02 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.144 0.978 . . . . 0.0 111.387 -178.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 328' ' ' ASP . . . . . 0.457 ' HB2' ' H ' ' A' ' 325' ' ' GLY . 5.3 m-20 -89.78 123.94 34.21 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.176 0.591 . . . . 0.0 109.708 -178.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . 0.45 HG12 ' HE3' ' A' ' 268' ' ' LYS . 19.6 mt -109.41 127.36 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 123.378 0.671 . . . . 0.0 110.183 -175.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 330' ' ' ILE . . . . . 0.445 HD12 ' HG ' ' A' ' 306' ' ' LEU . 30.9 pt -111.56 128.53 68.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 C-N-CA 123.251 0.62 . . . . 0.0 110.346 177.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -76.81 110.43 11.41 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.844 0.858 . . . . 0.0 111.587 -174.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 332' ' ' CYS . . . . . 0.58 ' SG ' HD12 ' A' ' 304' ' ' ILE . 31.8 t -75.69 105.2 6.6 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.788 0.835 . . . . 0.0 110.447 172.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . 0.408 HG21 HD12 ' A' ' 307' ' ' LEU . 88.4 t -111.47 122.03 65.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 123.668 0.787 . . . . 0.0 110.041 -178.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 59.7 t -86.05 98.62 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 123.305 0.642 . . . . 0.0 109.741 178.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 92.8 mt . . . . . 0 N--CA 1.471 0.603 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 172.107 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 3.7 mp . . . . . 0 N--CA 1.469 0.513 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -136.9 150.52 69.99 Favored Pre-proline 0 CA--C 1.549 0.905 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -68.07 90.73 0.38 Allowed 'Trans proline' 0 C--N 1.376 1.983 0 C-N-CA 122.459 2.106 . . . . 0.0 112.029 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.37 113.49 4.68 Favored 'General case' 0 C--N 1.349 0.55 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 169.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . 0.444 ' O ' ' HA ' ' A' ' 329' ' ' ILE . 22.6 ttpt -92.37 111.58 23.21 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.259 0.623 . . . . 0.0 109.883 -176.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 4.7 mp -106.72 129.3 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 123.703 0.801 . . . . 0.0 109.271 179.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 270' ' ' ARG . . . . . 0.414 ' HA ' HD13 ' A' ' 275' ' ' LEU . 39.5 ttp180 -84.57 98.78 10.34 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 122.879 0.471 . . . . 0.0 110.002 175.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 271' ' ' CYS . . . . . 0.745 ' SG ' HD21 ' A' ' 297' ' ' LEU . 41.9 t -69.56 175.6 4.02 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.1 171.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 272' ' ' ARG . . . . . 0.416 ' N ' ' SG ' ' A' ' 271' ' ' CYS . 16.2 ptt180 -54.33 -30.1 50.24 Favored 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 124.299 1.04 . . . . 0.0 112.314 178.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -159.76 37.82 0.19 Allowed 'General case' 0 C--N 1.354 0.801 0 C-N-CA 123.794 0.838 . . . . 0.0 110.948 -176.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -166.23 158.79 14.47 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 122.673 0.389 . . . . 0.0 111.128 -175.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.414 HD13 ' HA ' ' A' ' 270' ' ' ARG . 4.2 mm? -115.69 97.39 6.1 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.118 0.967 . . . . 0.0 109.07 173.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 46.3 t -84.99 98.53 6.29 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.595 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 39.6 mtt85 -96.89 79.86 2.96 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -178.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.6 pp -92.15 142.53 26.34 Favored Pre-proline 0 N--CA 1.487 1.386 0 CA-C-O 119.404 -0.331 . . . . 0.0 110.392 -172.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -74.23 109.75 2.95 Favored 'Trans proline' 0 C--N 1.373 1.835 0 C-N-CA 122.223 1.949 . . . . 0.0 110.698 177.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.725 HD21 ' HG3' ' A' ' 319' ' ' PRO . 0.0 OUTLIER -123.46 153.06 41.0 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.342 1.057 . . . . 0.0 109.617 179.018 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . 0.583 ' HB2' ' HB2' ' A' ' 284' ' ' GLU . 31.9 mtp180 -88.38 147.34 24.78 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.932 0.893 . . . . 0.0 110.318 177.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 282' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -62.51 -34.19 76.39 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 122.928 0.491 . . . . 0.0 110.361 173.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 23.7 m -67.79 -31.32 71.11 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.203 1.001 . . . . 0.0 111.718 176.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 284' ' ' GLU . . . . . 0.583 ' HB2' ' HB2' ' A' ' 281' ' ' ARG . 6.2 tp10 -73.31 132.21 82.15 Favored Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 124.009 0.923 . . . . 0.0 109.108 -178.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -70.39 178.32 5.08 Favored 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 122.163 1.908 . . . . 0.0 112.28 174.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.439 ' O ' HG23 ' A' ' 290' ' ' VAL . 70.7 mt -67.1 -19.04 65.57 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 118.744 -0.646 . . . . 0.0 111.66 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 27.7 tp60 -53.68 -22.39 8.87 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.282 0.633 . . . . 0.0 112.193 178.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 288' ' ' SER . . . . . 0.52 ' HB3' HD12 ' A' ' 280' ' ' LEU . 24.8 t -64.74 -54.32 33.26 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.413 0.685 . . . . 0.0 110.984 172.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.442 HG13 HD13 ' A' ' 280' ' ' LEU . 17.2 m -70.9 -29.21 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 122.532 0.333 . . . . 0.0 110.753 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . 0.538 HG13 ' HB ' ' A' ' 304' ' ' ILE . 78.1 t -63.83 -49.22 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 123.702 0.801 . . . . 0.0 110.099 176.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -63.89 -46.93 82.64 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.743 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 43.2 t60 -67.15 -41.83 85.4 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.15 -174.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 90.9 mmm -68.09 -30.33 69.48 Favored 'General case' 0 N--CA 1.483 1.201 0 O-C-N 123.401 0.438 . . . . 0.0 111.227 177.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -67.47 -43.45 80.99 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.13 0.572 . . . . 0.0 110.615 175.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 27.7 m -69.43 -29.59 67.34 Favored 'General case' 0 CA--C 1.557 1.216 0 C-N-CA 124.063 0.945 . . . . 0.0 110.837 176.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 77.8 t60 -74.59 -34.63 62.91 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.839 0.856 . . . . 0.0 111.442 -178.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 297' ' ' LEU . . . . . 0.745 HD21 ' SG ' ' A' ' 271' ' ' CYS . 75.5 mt -105.74 -8.26 17.93 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.655 0.782 . . . . 0.0 112.283 -175.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 72.93 31.67 61.8 Favored Glycine 0 C--N 1.347 1.188 0 O-C-N 123.598 0.561 . . . . 0.0 112.55 178.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 299' ' ' VAL . . . . . 0.531 HG11 HG11 ' A' ' 334' ' ' VAL . 33.2 m -117.75 -177.33 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.357 1.063 . . . . 0.0 110.057 179.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . 0.551 ' HB3' ' HG3' ' A' ' 303' ' ' ARG . 32.2 t -82.36 147.02 55.54 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 123.194 0.598 . . . . 0.0 110.18 178.119 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -59.49 -27.97 86.31 Favored 'Trans proline' 0 C--N 1.385 2.453 0 C-N-CA 122.774 2.316 . . . . 0.0 111.124 169.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 22.8 t -67.11 -15.73 63.9 Favored 'General case' 0 CA--C 1.559 1.29 0 C-N-CA 123.454 0.702 . . . . 0.0 111.207 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 303' ' ' ARG . . . . . 0.551 ' HG3' ' HB3' ' A' ' 300' ' ' SER . 59.3 mtt180 -94.59 -26.51 16.35 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.006 0.922 . . . . 0.0 111.63 -178.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 304' ' ' ILE . . . . . 0.553 HD12 ' SG ' ' A' ' 332' ' ' CYS . 37.9 mm -77.02 103.58 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 122.861 0.464 . . . . 0.0 110.865 -175.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 34.8 tp -105.68 123.79 48.51 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 174.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . 0.433 ' HA ' ' O ' ' A' ' 331' ' ' ASP . 3.4 mm? -89.26 128.35 35.84 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 177.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 312' ' ' GLU . 68.4 mt -134.05 114.8 13.58 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.477 1.111 . . . . 0.0 108.608 -177.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -79.42 81.26 5.7 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 176.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 66.63 -85.97 0.11 Allowed Glycine 0 C--N 1.357 1.731 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.862 -176.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -127.1 75.68 1.6 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.142 0.977 . . . . 0.0 109.684 177.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 14.5 t -173.51 147.37 1.44 Allowed 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.489 1.116 . . . . 0.0 108.831 169.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . 0.414 ' HA ' HD23 ' A' ' 307' ' ' LEU . 42.2 tt0 -93.52 128.87 39.83 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 -178.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . 0.463 HD13 HD13 ' A' ' 322' ' ' LEU . 45.2 mt -113.33 127.42 56.13 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 123.667 0.604 . . . . 0.0 109.762 177.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 314' ' ' SER . . . . . 0.413 ' O ' HD12 ' A' ' 286' ' ' LEU . 39.0 m -77.81 140.61 63.16 Favored Pre-proline 0 CA--C 1.554 1.105 0 C-N-CA 123.529 0.731 . . . . 0.0 110.633 179.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . 0.424 ' HB3' HG21 ' A' ' 290' ' ' VAL . 40.8 Cg_endo -63.94 -24.34 67.52 Favored 'Trans proline' 0 C--N 1.384 2.402 0 C-N-CA 122.871 2.381 . . . . 0.0 113.042 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 6.5 m -81.75 -18.47 44.13 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 123.788 0.835 . . . . 0.0 111.344 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -70.25 150.72 46.11 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 122.852 0.461 . . . . 0.0 109.967 176.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 318' ' ' THR . . . . . . . . . . . . . 69.5 p -98.57 144.4 28.07 Favored Pre-proline 0 CA--C 1.541 0.598 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 319' ' ' PRO . . . . . 0.725 ' HG3' HD21 ' A' ' 280' ' ' LEU . 20.8 Cg_endo -57.83 -17.31 29.35 Favored 'Trans proline' 0 C--N 1.366 1.486 0 C-N-CA 123.171 2.581 . . . . 0.0 112.578 170.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 44.9 ttt180 -71.02 -48.5 52.72 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.525 0.73 . . . . 0.0 110.454 -179.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 15.0 t -70.27 -29.08 65.77 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-O 120.809 0.338 . . . . 0.0 110.626 178.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 322' ' ' LEU . . . . . 0.463 HD13 HD13 ' A' ' 313' ' ' LEU . 64.7 mt -81.58 -14.83 56.32 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.82 177.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp 59.62 36.32 22.59 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.566 1.146 . . . . 0.0 112.413 -177.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.426 ' HG ' ' HB2' ' A' ' 322' ' ' LEU . 44.7 mt -68.96 145.46 53.6 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.701 0.8 . . . . 0.0 109.809 174.177 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 325' ' ' GLY . . . . . 0.447 ' H ' ' HB3' ' A' ' 328' ' ' ASP . . . -140.31 -169.29 11.64 Favored Glycine 0 C--O 1.24 0.472 0 C-N-CA 123.435 0.541 . . . . 0.0 112.08 -174.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 26.0 m -74.09 -26.86 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.771 0.828 . . . . 0.0 111.915 -175.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -101.03 -3.24 29.72 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.713 0.805 . . . . 0.0 111.141 179.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 328' ' ' ASP . . . . . 0.447 ' HB3' ' H ' ' A' ' 325' ' ' GLY . 12.2 t70 -83.28 144.78 29.49 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 175.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . 0.444 ' HA ' ' O ' ' A' ' 268' ' ' LYS . 24.2 mt -131.29 125.33 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 123.232 0.613 . . . . 0.0 109.673 -178.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 28.4 pt -116.82 131.93 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 123.367 0.667 . . . . 0.0 110.365 176.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 331' ' ' ASP . . . . . 0.433 ' O ' ' HA ' ' A' ' 306' ' ' LEU . 7.1 m-20 -68.13 135.67 52.5 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.951 0.9 . . . . 0.0 111.712 -179.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 332' ' ' CYS . . . . . 0.553 ' SG ' HD12 ' A' ' 304' ' ' ILE . 26.2 t -103.79 99.51 9.3 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.08 0.952 . . . . 0.0 109.011 171.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 47.9 t -104.48 113.46 41.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -178.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 334' ' ' VAL . . . . . 0.531 HG11 HG11 ' A' ' 299' ' ' VAL . 58.3 t -81.71 99.01 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.723 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 80.6 mt . . . . . 0 N--CA 1.47 0.551 0 C-N-CA 123.655 0.782 . . . . 0.0 110.389 175.941 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 0.437 HD22 ' HB2' ' A' ' 279' ' ' PRO . 3.8 mp . . . . . 0 C--O 1.24 0.591 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 265' ' ' PHE . . . . . 0.455 ' CE1' ' SD ' ' A' ' 282' ' ' MET . 46.4 p90 -145.63 147.33 32.64 Favored Pre-proline 0 C--O 1.243 0.725 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 173.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -68.12 94.02 0.41 Allowed 'Trans proline' 0 C--N 1.37 1.691 0 C-N-CA 122.061 1.84 . . . . 0.0 110.759 174.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 267' ' ' LEU . . . . . 0.479 HD12 HG13 ' A' ' 269' ' ' ILE . 1.9 tm? -58.55 130.14 45.41 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 173.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . 0.58 ' HD2' HD22 ' A' ' 275' ' ' LEU . 4.7 tppp? -90.04 109.63 20.66 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 123.846 0.716 . . . . 0.0 110.497 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . 0.479 HG13 HD12 ' A' ' 267' ' ' LEU . 2.8 mp -110.93 154.95 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 174.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 270' ' ' ARG . . . . . 0.514 ' HG2' HD23 ' A' ' 275' ' ' LEU . 30.0 mtp-105 -113.75 131.11 56.32 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 162.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 271' ' ' CYS . . . . . 0.62 ' SG ' HD21 ' A' ' 297' ' ' LEU . 30.7 t -74.1 -160.14 0.09 Allowed 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 123.961 0.905 . . . . 0.0 109.399 168.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -58.67 -19.07 36.2 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.324 0.65 . . . . 0.0 112.051 173.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -153.86 -56.21 0.11 Allowed 'General case' 0 C--N 1.352 0.706 0 C-N-CA 123.532 0.733 . . . . 0.0 110.631 176.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -68.19 162.38 25.0 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.473 1.109 . . . . 0.0 112.652 -170.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.58 HD22 ' HD2' ' A' ' 268' ' ' LYS . 66.3 mt -88.86 128.09 35.65 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.714 0.806 . . . . 0.0 110.063 170.232 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 94.2 t -115.53 131.74 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 174.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 88.8 mtm180 -124.79 127.72 47.63 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.606 0.762 . . . . 0.0 109.189 176.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.545 HD21 ' HA ' ' A' ' 289' ' ' VAL . 3.7 pp -135.43 144.33 49.02 Favored Pre-proline 0 N--CA 1.483 1.187 0 CA-C-O 119.436 -0.316 . . . . 0.0 110.242 177.369 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 279' ' ' PRO . . . . . 0.437 ' HB2' HD22 ' A' ' 264' ' ' LEU . 69.1 Cg_endo -71.57 116.33 4.65 Favored 'Trans proline' 0 C--N 1.372 1.799 0 C-N-CA 122.179 1.919 . . . . 0.0 111.033 177.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.718 HD21 ' HG3' ' A' ' 319' ' ' PRO . 0.5 OUTLIER -135.23 151.6 50.76 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.82 1.248 . . . . 0.0 109.544 -178.051 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -96.48 154.31 17.34 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.248 0.619 . . . . 0.0 109.585 178.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 282' ' ' MET . . . . . 0.455 ' SD ' ' CE1' ' A' ' 265' ' ' PHE . 94.2 mmm -63.44 -29.01 70.37 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 122.851 0.46 . . . . 0.0 111.577 176.415 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 39.7 t -79.91 -28.5 39.81 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.76 0.824 . . . . 0.0 111.363 176.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -67.96 123.22 86.62 Favored Pre-proline 0 N--CA 1.481 1.084 0 C-N-CA 123.915 0.886 . . . . 0.0 109.843 -177.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -64.51 167.47 15.01 Favored 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 122.573 2.182 . . . . 0.0 112.118 178.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.426 ' O ' HG23 ' A' ' 290' ' ' VAL . 56.2 mt -63.9 -16.47 61.49 Favored 'General case' 0 C--O 1.216 -0.705 0 CA-C-O 118.596 -0.716 . . . . 0.0 112.028 -177.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 287' ' ' GLN . . . . . 0.406 ' HA ' ' HB ' ' A' ' 290' ' ' VAL . 24.9 tp60 -49.82 -27.33 4.9 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.58 0.752 . . . . 0.0 112.379 177.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 288' ' ' SER . . . . . 0.571 ' HB3' HD12 ' A' ' 280' ' ' LEU . 36.2 t -60.83 -55.87 27.91 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 123.925 0.89 . . . . 0.0 111.201 172.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.545 ' HA ' HD21 ' A' ' 278' ' ' LEU . 15.6 m -69.56 -31.5 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 122.413 0.285 . . . . 0.0 110.934 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . 0.56 HG13 ' HB ' ' A' ' 304' ' ' ILE . 46.1 t -63.21 -55.69 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 124.794 1.237 . . . . 0.0 111.018 -178.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -67.99 -36.21 79.63 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.844 -176.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 9.7 t60 -61.07 -49.96 75.22 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.475 0.71 . . . . 0.0 110.374 176.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 93.9 mmm -69.65 -29.16 66.55 Favored 'General case' 0 C--O 1.217 -0.624 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.97 -179.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -69.59 -37.61 76.99 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.327 0.651 . . . . 0.0 110.777 178.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 56.1 m -73.26 -37.37 66.34 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.229 0.611 . . . . 0.0 110.161 176.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -63.61 -47.25 82.2 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.954 0.901 . . . . 0.0 110.522 179.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 297' ' ' LEU . . . . . 0.62 HD21 ' SG ' ' A' ' 271' ' ' CYS . 38.2 mt -89.26 -11.13 44.43 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.258 1.023 . . . . 0.0 112.125 -174.587 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 72.9 19.2 79.37 Favored Glycine 0 C--N 1.352 1.433 0 O-C-N 123.515 0.51 . . . . 0.0 112.932 -178.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 20.5 m -105.33 178.85 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 124.405 1.082 . . . . 0.0 110.305 -177.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 21.2 m -82.62 148.01 57.14 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 123.262 0.625 . . . . 0.0 109.898 178.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -60.83 -29.15 87.62 Favored 'Trans proline' 0 C--N 1.386 2.511 0 C-N-CA 122.494 2.129 . . . . 0.0 112.334 175.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 36.1 t -72.47 -17.93 61.72 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 122.261 -0.274 . . . . 0.0 110.739 -179.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -90.21 -7.37 53.72 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.779 0.832 . . . . 0.0 111.372 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 304' ' ' ILE . . . . . 0.56 ' HB ' HG13 ' A' ' 290' ' ' VAL . 41.6 mm -84.83 109.2 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 CA-C-N 118.373 0.533 . . . . 0.0 110.187 177.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 39.5 tp -109.8 112.09 23.93 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.47 0.708 . . . . 0.0 109.095 177.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . 0.505 HD21 HG22 ' A' ' 290' ' ' VAL . 2.5 mm? -85.05 133.46 34.24 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . 0.48 HD23 ' HA ' ' A' ' 312' ' ' GLU . 76.7 mt -132.8 103.09 5.92 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.312 0.645 . . . . 0.0 109.987 -177.1 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . 0.479 ' HB2' HD11 ' A' ' 313' ' ' LEU . 69.8 t80 -77.56 92.3 4.05 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -178.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 72.27 -81.29 0.59 Allowed Glycine 0 C--N 1.343 0.953 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.703 -174.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -131.75 -11.76 3.42 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.584 0.754 . . . . 0.0 112.384 -179.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 6.9 t -86.79 148.55 25.35 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 118.115 0.416 . . . . 0.0 111.004 -177.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . 0.48 ' HA ' HD23 ' A' ' 307' ' ' LEU . 37.2 tt0 -93.79 123.97 37.48 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 122.847 0.459 . . . . 0.0 110.226 -176.397 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . 0.484 HD13 HD13 ' A' ' 322' ' ' LEU . 47.5 mt -111.4 126.98 55.51 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.995 -178.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 42.0 m -71.37 144.46 89.32 Favored Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 123.693 0.797 . . . . 0.0 110.12 173.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -63.11 -18.11 63.48 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 123.027 2.485 . . . . 0.0 112.751 176.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 37.7 p -90.36 -8.42 50.78 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.573 1.149 . . . . 0.0 112.427 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -72.88 152.71 41.35 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.099 0.559 . . . . 0.0 111.036 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 318' ' ' THR . . . . . . . . . . . . . 32.4 p -103.93 142.82 25.4 Favored Pre-proline 0 N--CA 1.478 0.928 0 C-N-CA 122.999 0.52 . . . . 0.0 109.672 177.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 319' ' ' PRO . . . . . 0.718 ' HG3' HD21 ' A' ' 280' ' ' LEU . 70.3 Cg_endo -66.0 -14.17 43.24 Favored 'Trans proline' 0 C--N 1.369 1.64 0 C-N-CA 123.649 2.899 . . . . 0.0 113.192 -176.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 70.3 ttt180 -69.21 -53.47 19.78 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.234 0.614 . . . . 0.0 110.557 -177.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 9.8 t -66.8 -29.92 69.99 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.347 0.659 . . . . 0.0 111.364 177.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 322' ' ' LEU . . . . . 0.484 HD13 HD13 ' A' ' 313' ' ' LEU . 43.4 mt -81.89 -19.41 40.91 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.395 0.678 . . . . 0.0 111.0 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 53.69 75.67 0.25 Allowed 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 125.108 1.363 . . . . 0.0 109.623 -170.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 70.6 mt -106.98 164.57 12.03 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.627 176.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 325' ' ' GLY . . . . . 0.467 ' H ' ' HB2' ' A' ' 328' ' ' ASP . . . -169.53 -160.63 18.22 Favored Glycine 0 C--N 1.343 0.95 0 CA-C-N 115.928 -0.578 . . . . 0.0 113.374 -170.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 30.6 m -80.5 -24.55 11.26 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 124.481 1.112 . . . . 0.0 111.296 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -101.73 -25.85 13.69 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.054 0.942 . . . . 0.0 110.457 177.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 328' ' ' ASP . . . . . 0.467 ' HB2' ' H ' ' A' ' 325' ' ' GLY . 34.1 m-20 -76.02 111.5 11.47 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . 0.516 HG12 ' HG2' ' A' ' 268' ' ' LYS . 4.4 mt -99.13 133.21 42.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.088 0.555 . . . . 0.0 110.942 -173.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 41.2 pt -119.23 128.91 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 123.211 0.605 . . . . 0.0 109.739 174.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -85.22 109.65 18.47 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.374 0.67 . . . . 0.0 110.514 -176.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 332' ' ' CYS . . . . . 0.559 ' SG ' HD12 ' A' ' 304' ' ' ILE . 35.9 t -73.12 95.08 2.01 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.385 0.674 . . . . 0.0 109.583 170.1 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 58.2 t -106.86 122.39 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 178.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 91.4 t -78.53 102.01 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-O 121.18 0.514 . . . . 0.0 110.517 -176.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.554 1.114 0 C-N-CA 125.077 1.351 . . . . 0.0 109.061 170.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 3.0 mp . . . . . 0 C--O 1.243 0.757 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -144.85 146.51 31.71 Favored Pre-proline 0 CA--C 1.543 0.697 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 175.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 266' ' ' PRO . . . . . 0.503 ' HB2' ' HB3' ' A' ' 277' ' ' ARG . 46.2 Cg_endo -66.85 91.36 0.3 Allowed 'Trans proline' 0 C--N 1.374 1.903 0 C-N-CA 122.182 1.921 . . . . 0.0 112.197 176.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 267' ' ' LEU . . . . . 0.581 HD23 HD22 ' A' ' 280' ' ' LEU . 0.4 OUTLIER -63.28 115.53 4.64 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 170.747 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . 0.582 ' HD3' HD13 ' A' ' 275' ' ' LEU . 30.7 ttmt -90.96 118.38 30.3 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 123.414 0.446 . . . . 0.0 109.892 -179.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . 0.571 HG21 ' HG3' ' A' ' 293' ' ' MET . 2.4 mp -113.93 136.37 50.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 C-N-CA 123.6 0.76 . . . . 0.0 108.958 177.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 270' ' ' ARG . . . . . 0.484 ' HA ' HD23 ' A' ' 275' ' ' LEU . 0.7 OUTLIER -85.95 106.67 17.3 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 123.626 0.579 . . . . 0.0 110.469 -177.561 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 271' ' ' CYS . . . . . 0.531 ' SG ' HD21 ' A' ' 297' ' ' LEU . 38.6 t -75.2 179.49 5.06 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.742 0.817 . . . . 0.0 109.789 167.208 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 272' ' ' ARG . . . . . 0.462 ' HG2' ' SG ' ' A' ' 271' ' ' CYS . 17.2 ptm180 -54.18 -36.08 63.03 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.012 0.925 . . . . 0.0 112.789 178.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -159.44 49.39 0.32 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.63 0.772 . . . . 0.0 109.621 178.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 274' ' ' ASP . . . . . 0.456 ' HB3' ' HB3' ' A' ' 271' ' ' CYS . 19.9 t70 -166.43 162.52 17.01 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.714 0.805 . . . . 0.0 110.123 -173.4 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.582 HD13 ' HD3' ' A' ' 268' ' ' LYS . 81.0 mt -131.36 104.72 7.18 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.392 1.077 . . . . 0.0 109.615 176.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 276' ' ' VAL . . . . . 0.43 ' O ' HD12 ' A' ' 269' ' ' ILE . 78.3 t -83.44 115.5 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 177.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . 0.503 ' HB3' ' HB2' ' A' ' 266' ' ' PRO . 61.2 mtm-85 -107.31 80.68 1.44 Allowed 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -179.046 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.406 ' HA ' ' HD3' ' A' ' 279' ' ' PRO . 4.3 pp -93.13 142.89 25.92 Favored Pre-proline 0 N--CA 1.484 1.226 0 CA-C-O 119.579 -0.248 . . . . 0.0 111.054 -173.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 279' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 278' ' ' LEU . 12.7 Cg_exo -68.23 109.14 1.92 Allowed 'Trans proline' 0 C--N 1.375 1.932 0 C-N-CA 122.833 2.355 . . . . 0.0 110.696 177.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.581 HD22 HD23 ' A' ' 267' ' ' LEU . 2.9 tt -127.39 139.17 53.02 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.448 1.099 . . . . 0.0 109.466 -178.073 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 68.3 mtm180 -80.45 152.71 28.64 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.898 0.879 . . . . 0.0 110.649 179.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 282' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -65.66 -23.85 66.89 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 122.543 0.337 . . . . 0.0 111.581 177.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 20.7 t -91.17 -1.36 57.74 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.117 0.967 . . . . 0.0 111.985 179.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -85.01 132.89 44.32 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 123.606 0.763 . . . . 0.0 109.537 -178.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -66.58 164.46 28.81 Favored 'Trans proline' 0 C--N 1.372 1.797 0 C-N-CA 121.864 1.71 . . . . 0.0 111.203 169.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.433 ' O ' HG23 ' A' ' 290' ' ' VAL . 49.3 mt -67.85 -13.7 62.36 Favored 'General case' 0 C--O 1.211 -0.936 0 CA-C-O 119.027 -0.511 . . . . 0.0 111.261 178.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 26.6 tp60 -51.1 -27.61 8.73 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.282 1.033 . . . . 0.0 112.013 178.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 39.9 t -58.14 -59.84 4.66 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.206 1.002 . . . . 0.0 111.114 170.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.418 ' HB ' HG12 ' A' ' 269' ' ' ILE . 13.0 m -70.15 -25.76 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 122.774 0.43 . . . . 0.0 110.833 -178.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . 0.476 HG13 ' HB ' ' A' ' 304' ' ' ILE . 55.8 t -65.19 -51.34 66.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 123.92 0.888 . . . . 0.0 109.97 178.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -71.29 -38.18 71.82 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.881 -178.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 8.5 t60 -66.8 -48.45 68.95 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.234 0.614 . . . . 0.0 110.36 -178.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 293' ' ' MET . . . . . 0.571 ' HG3' HG21 ' A' ' 269' ' ' ILE . 97.5 mmm -67.69 -31.08 70.79 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.783 0.433 . . . . 0.0 110.87 179.254 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -59.71 -45.85 90.88 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 122.844 0.458 . . . . 0.0 110.403 173.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 24.9 m -69.98 -30.3 67.6 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 123.191 0.597 . . . . 0.0 110.958 178.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 71.7 t60 -73.81 -29.1 61.97 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.781 0.832 . . . . 0.0 111.211 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 297' ' ' LEU . . . . . 0.531 HD21 ' SG ' ' A' ' 271' ' ' CYS . 52.4 mt -109.0 -2.44 18.22 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.946 0.898 . . . . 0.0 111.507 -175.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 77.47 19.09 76.92 Favored Glycine 0 N--CA 1.478 1.471 0 C-N-CA 123.343 0.497 . . . . 0.0 113.869 172.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 299' ' ' VAL . . . . . 0.641 ' HB ' ' HD2' ' A' ' 303' ' ' ARG . 27.3 m -116.29 -176.38 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 124.551 1.14 . . . . 0.0 111.369 -176.205 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 20.3 m -86.3 146.61 42.75 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 123.612 0.765 . . . . 0.0 110.457 178.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -53.46 -35.59 76.49 Favored 'Trans proline' 0 C--N 1.387 2.578 0 C-N-CA 123.14 2.56 . . . . 0.0 112.294 176.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 29.7 p -61.14 -24.48 66.31 Favored 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 123.354 0.661 . . . . 0.0 112.29 -174.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 303' ' ' ARG . . . . . 0.641 ' HD2' ' HB ' ' A' ' 299' ' ' VAL . 90.1 mtt180 -82.16 -25.58 34.19 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.268 1.027 . . . . 0.0 112.096 -176.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 304' ' ' ILE . . . . . 0.585 HD12 ' SG ' ' A' ' 332' ' ' CYS . 38.0 mm -73.77 103.55 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 C-N-CA 123.42 0.688 . . . . 0.0 111.308 -173.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . 0.416 HD22 HD11 ' A' ' 335' ' ' LEU . 50.9 tp -101.17 114.68 28.86 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.661 0.784 . . . . 0.0 108.913 173.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . 0.403 ' HG ' HD12 ' A' ' 330' ' ' ILE . 2.6 mm? -86.32 131.34 34.24 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 177.175 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . 0.455 HD12 HG21 ' A' ' 333' ' ' VAL . 75.2 mt -130.86 111.06 11.76 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 178.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . 0.453 ' HB2' HD11 ' A' ' 313' ' ' LEU . 56.4 t80 -78.7 88.57 4.58 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 72.99 -82.35 0.63 Allowed Glycine 0 C--N 1.345 1.076 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.808 -175.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -121.48 -27.56 4.76 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.903 0.881 . . . . 0.0 111.103 -176.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 6.1 t -78.74 145.45 34.44 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 122.649 0.38 . . . . 0.0 110.789 -173.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . 0.43 ' HA ' HD23 ' A' ' 307' ' ' LEU . 44.1 tt0 -89.28 124.45 34.41 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 122.901 0.481 . . . . 0.0 110.343 -177.611 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . 0.459 HD13 HD13 ' A' ' 322' ' ' LEU . 28.0 mt -106.79 154.56 20.82 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 122.899 0.479 . . . . 0.0 110.067 177.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 49.0 m -107.92 151.29 41.17 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 123.412 0.685 . . . . 0.0 110.111 -179.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -62.45 -27.03 76.83 Favored 'Trans proline' 0 C--N 1.381 2.266 0 C-N-CA 122.585 2.19 . . . . 0.0 112.352 174.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 38.5 p -78.77 -21.68 47.51 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.626 0.77 . . . . 0.0 112.114 177.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -66.22 144.56 56.55 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.427 0.691 . . . . 0.0 111.798 -175.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 318' ' ' THR . . . . . . . . . . . . . 68.3 p -100.11 153.47 37.74 Favored Pre-proline 0 CA--C 1.553 1.074 0 C-N-CA 123.839 0.856 . . . . 0.0 109.754 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 319' ' ' PRO . . . . . 0.565 ' HG3' HD21 ' A' ' 280' ' ' LEU . 60.3 Cg_endo -73.49 -10.6 23.93 Favored 'Trans proline' 0 C--N 1.371 1.725 0 C-N-CA 123.165 2.577 . . . . 0.0 112.179 -177.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -69.23 -54.71 13.36 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.91 0.884 . . . . 0.0 110.183 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 10.2 t -67.18 -23.03 65.72 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.384 0.674 . . . . 0.0 111.44 178.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 322' ' ' LEU . . . . . 0.531 ' HB2' ' HG ' ' A' ' 324' ' ' LEU . 54.9 mt -96.67 -8.38 31.69 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.438 0.695 . . . . 0.0 111.993 -178.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt 59.16 29.24 18.76 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 124.238 1.015 . . . . 0.0 113.008 -178.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.531 ' HG ' ' HB2' ' A' ' 322' ' ' LEU . 55.3 mt -72.81 132.54 43.7 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 122.877 0.471 . . . . 0.0 110.476 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 325' ' ' GLY . . . . . 0.422 ' H ' ' HB2' ' A' ' 328' ' ' ASP . . . -138.15 -146.62 5.06 Favored Glycine 0 C--N 1.337 0.629 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 179.05 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . 0.418 ' O ' ' HE3' ' A' ' 268' ' ' LYS . 11.3 m -81.19 -26.33 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 123.033 0.533 . . . . 0.0 110.937 -176.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -97.53 -12.91 22.03 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.469 0.708 . . . . 0.0 111.665 -177.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 328' ' ' ASP . . . . . 0.422 ' HB2' ' H ' ' A' ' 325' ' ' GLY . 24.6 m-20 -87.3 108.37 18.93 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.002 0.43 . . . . 0.0 109.856 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . 0.448 HG12 ' HD2' ' A' ' 268' ' ' LYS . 38.0 mt -92.95 128.64 44.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.665 177.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 330' ' ' ILE . . . . . 0.457 HG13 HG23 ' A' ' 269' ' ' ILE . 41.0 pt -112.73 122.34 66.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 121.14 0.495 . . . . 0.0 109.711 175.176 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -71.78 113.82 9.21 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.045 0.938 . . . . 0.0 111.181 -173.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 332' ' ' CYS . . . . . 0.585 ' SG ' HD12 ' A' ' 304' ' ' ILE . 42.1 t -81.9 97.59 8.12 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.552 0.741 . . . . 0.0 110.198 177.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . 0.455 HG21 HD12 ' A' ' 307' ' ' LEU . 47.0 t -99.85 111.99 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 123.437 0.695 . . . . 0.0 109.435 -177.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 334' ' ' VAL . . . . . 0.542 HG11 HG11 ' A' ' 299' ' ' VAL . 60.5 t -80.84 103.93 8.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 335' ' ' LEU . . . . . 0.416 HD11 HD22 ' A' ' 305' ' ' LEU . 80.3 mt . . . . . 0 C--O 1.24 0.574 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.229 173.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 4.8 mp . . . . . 0 CA--C 1.54 0.566 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -93.08 148.04 34.97 Favored Pre-proline 0 CA--C 1.55 0.955 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 266' ' ' PRO . . . . . 0.49 ' HB2' ' HB3' ' A' ' 277' ' ' ARG . 74.3 Cg_endo -70.41 92.12 0.58 Allowed 'Trans proline' 0 C--N 1.376 2.007 0 C-N-CA 122.393 2.062 . . . . 0.0 112.239 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 267' ' ' LEU . . . . . 0.474 HD23 HD22 ' A' ' 280' ' ' LEU . 0.3 OUTLIER -64.32 126.21 27.05 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 172.304 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 22.9 ttpt -95.17 114.64 26.45 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-O 121.486 0.66 . . . . 0.0 111.083 -178.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 2.3 mp -113.08 124.99 70.27 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 C-N-CA 124.811 1.245 . . . . 0.0 109.231 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 35.5 ttp180 -93.09 107.21 19.05 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.165 0.507 . . . . 0.0 109.995 175.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 271' ' ' CYS . . . . . 0.668 ' SG ' HD21 ' A' ' 297' ' ' LEU . 48.9 t -82.33 -172.76 4.17 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.782 0.833 . . . . 0.0 111.322 179.042 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 272' ' ' ARG . . . . . 0.478 ' N ' ' SG ' ' A' ' 271' ' ' CYS . 35.8 ptt180 -57.37 -34.88 69.3 Favored 'General case' 0 CA--C 1.552 1.058 0 C-N-CA 124.622 1.169 . . . . 0.0 112.772 176.168 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -153.62 27.54 0.49 Allowed 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.165 0.586 . . . . 0.0 110.687 -177.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 274' ' ' ASP . . . . . 0.531 ' HB2' ' HB3' ' A' ' 271' ' ' CYS . 4.7 m-20 -141.29 158.85 43.34 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.589 0.756 . . . . 0.0 109.681 -175.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 26.9 tp -132.79 86.46 2.32 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 169.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 67.7 t -86.23 144.43 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.6 0.76 . . . . 0.0 109.927 -174.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . 0.49 ' HB3' ' HB2' ' A' ' 266' ' ' PRO . 52.9 mtp180 -128.5 87.02 2.52 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 172.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.455 HD11 HG12 ' A' ' 289' ' ' VAL . 3.9 pp -95.66 142.93 25.27 Favored Pre-proline 0 N--CA 1.48 1.056 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 -175.546 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -65.55 125.33 14.21 Favored 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 122.919 2.413 . . . . 0.0 111.343 175.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.696 HD21 ' HG3' ' A' ' 319' ' ' PRO . 0.1 OUTLIER -140.72 148.31 40.55 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.954 0.902 . . . . 0.0 110.639 -178.151 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 70.3 mtp180 -87.9 142.94 27.4 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.347 1.059 . . . . 0.0 110.671 179.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 282' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -62.04 -35.03 77.36 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.658 0.783 . . . . 0.0 111.829 175.024 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 44.4 p -75.36 -20.38 59.04 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.892 0.877 . . . . 0.0 111.595 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -86.57 130.23 49.96 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 124.207 1.003 . . . . 0.0 108.99 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 285' ' ' PRO . . . . . 0.509 ' HA ' ' HA ' ' A' ' 318' ' ' THR . 40.9 Cg_endo -65.76 178.25 2.38 Favored 'Trans proline' 0 C--N 1.38 2.209 0 C-N-CA 122.608 2.205 . . . . 0.0 112.753 173.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.45 ' O ' HG23 ' A' ' 290' ' ' VAL . 90.7 mt -64.43 -18.22 64.53 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.563 0.745 . . . . 0.0 111.965 -179.122 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 27.7 tp60 -52.48 -23.36 6.07 Favored 'General case' 0 CA--C 1.558 1.264 0 C-N-CA 123.678 0.791 . . . . 0.0 112.271 178.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 288' ' ' SER . . . . . 0.56 ' HB3' HD12 ' A' ' 280' ' ' LEU . 37.3 t -63.24 -57.31 10.87 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.841 0.856 . . . . 0.0 110.856 171.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.47 ' O ' ' HG2' ' A' ' 293' ' ' MET . 27.7 m -65.4 -35.36 75.13 Favored 'Isoleucine or valine' 0 C--N 1.368 1.381 0 O-C-N 123.167 0.292 . . . . 0.0 110.342 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . 0.592 HG13 ' HB ' ' A' ' 304' ' ' ILE . 71.6 t -55.73 -53.21 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 124.42 1.088 . . . . 0.0 111.336 178.259 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -63.87 -42.97 97.4 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.066 -177.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 13.5 t60 -71.85 -38.09 70.15 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.231 -176.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 293' ' ' MET . . . . . 0.47 ' HG2' ' O ' ' A' ' 289' ' ' VAL . 91.0 mmm -68.9 -34.38 75.31 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 123.156 0.582 . . . . 0.0 110.125 177.327 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -66.29 -43.4 86.46 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.571 0.748 . . . . 0.0 111.376 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 26.2 m -70.14 -32.65 70.74 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.381 0.672 . . . . 0.0 110.644 176.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 79.2 t60 -63.36 -35.11 79.32 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.905 0.882 . . . . 0.0 111.812 177.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 297' ' ' LEU . . . . . 0.668 HD21 ' SG ' ' A' ' 271' ' ' CYS . 75.7 mt -99.53 -23.27 15.14 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.244 0.618 . . . . 0.0 111.893 -177.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 82.63 25.12 51.57 Favored Glycine 0 CA--C 1.531 1.071 0 O-C-N 123.262 0.351 . . . . 0.0 112.787 -173.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 33.4 m -107.33 177.99 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 124.521 1.128 . . . . 0.0 109.878 176.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 47.6 m -83.17 144.36 46.93 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 123.042 0.537 . . . . 0.0 110.6 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -55.75 -31.99 82.48 Favored 'Trans proline' 0 C--N 1.388 2.606 0 C-N-CA 123.263 2.642 . . . . 0.0 112.096 170.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 34.2 t -70.85 -6.02 34.9 Favored 'General case' 0 CA--C 1.56 1.328 0 C-N-CA 122.558 0.343 . . . . 0.0 111.787 -178.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 58.1 mtt180 -106.44 -16.25 14.59 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.243 1.017 . . . . 0.0 112.173 178.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 304' ' ' ILE . . . . . 0.592 ' HB ' HG13 ' A' ' 290' ' ' VAL . 38.9 mm -81.16 108.17 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 177.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 24.1 tp -110.36 130.25 55.59 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 174.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -95.89 131.41 42.26 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . 0.469 HD12 HG21 ' A' ' 333' ' ' VAL . 72.9 mt -133.48 105.69 7.05 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.587 0.755 . . . . 0.0 109.602 -175.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . 0.578 ' HB2' HD11 ' A' ' 313' ' ' LEU . 85.4 t80 -78.23 95.1 4.89 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -176.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 73.17 -85.11 0.59 Allowed Glycine 0 C--N 1.344 1.017 0 N-CA-C 111.436 -0.666 . . . . 0.0 111.436 -177.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -139.2 13.59 2.61 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.706 0.802 . . . . 0.0 111.566 -179.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 6.2 t -104.77 147.49 27.65 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 175.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -92.92 122.97 35.84 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.956 0.502 . . . . 0.0 110.32 -176.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . 0.578 HD11 ' HB2' ' A' ' 308' ' ' PHE . 40.2 mt -110.83 130.72 55.5 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.096 0.559 . . . . 0.0 109.802 -179.49 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 16.5 m -73.65 142.18 80.32 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 123.054 0.542 . . . . 0.0 110.198 174.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . 0.44 ' HB3' HG21 ' A' ' 290' ' ' VAL . 30.9 Cg_endo -62.62 -25.81 75.49 Favored 'Trans proline' 0 C--N 1.381 2.255 0 C-N-CA 122.821 2.347 . . . . 0.0 111.934 173.152 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 28.6 p -78.63 -18.32 54.67 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.558 1.143 . . . . 0.0 111.853 177.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -73.94 149.77 41.21 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.052 0.541 . . . . 0.0 110.257 176.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 318' ' ' THR . . . . . 0.509 ' HA ' ' HA ' ' A' ' 285' ' ' PRO . 60.7 p -99.2 142.6 24.9 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 123.26 0.624 . . . . 0.0 110.361 -176.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 319' ' ' PRO . . . . . 0.696 ' HG3' HD21 ' A' ' 280' ' ' LEU . 37.9 Cg_endo -62.49 -15.96 48.96 Favored 'Trans proline' 0 C--N 1.377 2.046 0 C-N-CA 123.378 2.719 . . . . 0.0 112.521 174.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 73.4 ttt-85 -60.78 -57.8 11.14 Favored 'General case' 0 C--N 1.358 0.951 0 C-N-CA 123.826 0.851 . . . . 0.0 111.044 176.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 14.7 t -70.73 -25.14 62.79 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.309 -177.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 322' ' ' LEU . . . . . 0.519 HD13 HD13 ' A' ' 313' ' ' LEU . 65.5 mt -79.0 -19.7 50.91 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.277 0.631 . . . . 0.0 110.689 177.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt 59.06 57.44 3.52 Favored 'General case' 0 CA--C 1.55 0.942 0 C-N-CA 124.787 1.235 . . . . 0.0 109.9 -176.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.426 ' HG ' ' HB2' ' A' ' 322' ' ' LEU . 69.8 mt -93.9 140.24 29.93 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 114.416 -1.266 . . . . 0.0 108.85 177.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . -128.82 -157.73 9.38 Favored Glycine 0 C--O 1.239 0.436 0 O-C-N 123.977 0.798 . . . . 0.0 111.156 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . 0.427 ' HB ' ' NH2' ' A' ' 277' ' ' ARG . 29.6 m -75.07 -25.58 18.46 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 C-N-CA 123.382 0.673 . . . . 0.0 111.868 -175.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -98.31 -16.79 19.23 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.006 0.922 . . . . 0.0 111.915 -177.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -73.13 123.67 24.06 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.04 0.536 . . . . 0.0 110.605 -176.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 29.0 mt -106.26 120.32 57.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 C-N-CA 123.975 0.91 . . . . 0.0 110.357 -175.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 32.1 pt -113.71 130.4 67.85 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 174.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -77.76 111.08 13.19 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.74 0.816 . . . . 0.0 111.823 -174.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 332' ' ' CYS . . . . . 0.591 ' SG ' HD12 ' A' ' 304' ' ' ILE . 29.5 t -72.57 96.62 1.99 Allowed 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.545 0.738 . . . . 0.0 109.783 166.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . 0.469 HG21 HD12 ' A' ' 307' ' ' LEU . 75.3 t -105.28 114.34 44.57 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 177.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 52.5 t -78.66 90.13 1.27 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.775 0 CA-C-O 121.565 0.698 . . . . 0.0 109.606 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 86.0 mt . . . . . 0 C--O 1.235 0.296 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.067 174.402 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 5.0 mp . . . . . 0 C--O 1.234 0.262 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -79.39 141.48 57.16 Favored Pre-proline 0 C--O 1.245 0.854 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -178.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -66.15 101.33 0.5 Allowed 'Trans proline' 0 C--N 1.373 1.829 0 C-N-CA 122.228 1.952 . . . . 0.0 111.153 175.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -68.03 127.77 34.07 Favored 'General case' 0 CA--C 1.549 0.937 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 172.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . 0.511 ' HG2' HG12 ' A' ' 329' ' ' ILE . 5.2 tppp? -90.62 108.43 19.8 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.313 0.645 . . . . 0.0 110.238 177.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 3.6 mp -102.67 126.2 56.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 123.917 0.887 . . . . 0.0 109.177 178.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 30.8 ttp180 -96.93 95.13 7.62 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.276 0.631 . . . . 0.0 109.413 173.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 271' ' ' CYS . . . . . 0.487 ' HA ' ' HB3' ' A' ' 332' ' ' CYS . 42.8 t -71.85 -173.65 1.04 Allowed 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 123.819 0.848 . . . . 0.0 110.651 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 272' ' ' ARG . . . . . 0.409 ' HG2' ' SG ' ' A' ' 271' ' ' CYS . 7.5 ptm180 -55.48 -30.97 61.58 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.406 1.082 . . . . 0.0 112.311 174.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -144.89 -38.35 0.27 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.118 0.967 . . . . 0.0 110.366 -178.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -79.3 154.09 29.37 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.206 1.002 . . . . 0.0 111.433 -173.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 25.4 tp -119.69 85.33 2.36 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 173.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 95.0 t -89.94 147.56 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 114.856 -1.065 . . . . 0.0 109.875 -167.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -127.9 127.68 43.79 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 171.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.497 HD11 HG12 ' A' ' 289' ' ' VAL . 4.2 pp -129.41 144.35 52.48 Favored Pre-proline 0 N--CA 1.482 1.161 0 CA-C-N 118.023 0.374 . . . . 0.0 110.411 174.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -68.33 122.45 9.48 Favored 'Trans proline' 0 C--N 1.374 1.906 0 C-N-CA 122.68 2.254 . . . . 0.0 110.714 174.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.807 HD21 ' HG3' ' A' ' 319' ' ' PRO . 0.3 OUTLIER -149.02 150.75 33.34 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.007 0.923 . . . . 0.0 109.993 -177.441 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 58.1 mtm-85 -97.72 155.88 16.81 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.306 0.643 . . . . 0.0 110.486 179.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 282' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -61.31 -39.51 90.73 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.335 0.654 . . . . 0.0 111.228 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 12.1 t -78.67 -23.93 45.42 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.348 -178.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -70.61 122.36 86.4 Favored Pre-proline 0 C--N 1.352 0.707 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 175.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 285' ' ' PRO . . . . . 0.507 ' HA ' ' HA ' ' A' ' 318' ' ' THR . 55.5 Cg_endo -65.59 175.45 4.32 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 122.363 2.042 . . . . 0.0 112.639 -179.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.42 ' O ' HG23 ' A' ' 290' ' ' VAL . 78.4 mt -64.87 -16.97 63.87 Favored 'General case' 0 C--O 1.211 -0.967 0 CA-C-O 118.449 -0.786 . . . . 0.0 111.64 178.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 23.8 tp60 -52.52 -27.48 16.65 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.218 0.607 . . . . 0.0 112.274 179.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 288' ' ' SER . . . . . 0.613 ' HB3' HD12 ' A' ' 280' ' ' LEU . 41.8 t -61.12 -55.7 29.38 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.7 0.8 . . . . 0.0 110.524 171.165 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.497 HG12 HD11 ' A' ' 278' ' ' LEU . 11.4 m -69.33 -28.27 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 122.503 0.321 . . . . 0.0 111.441 179.375 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . 0.529 HG13 ' HB ' ' A' ' 304' ' ' ILE . 54.9 t -69.53 -52.39 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 123.731 0.812 . . . . 0.0 109.991 -177.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -71.84 -32.99 68.09 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 122.955 0.502 . . . . 0.0 110.869 -178.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -64.3 -51.89 61.23 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.341 0.656 . . . . 0.0 110.008 178.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 94.2 mmm -68.99 -29.3 67.48 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.365 0.666 . . . . 0.0 111.065 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -61.7 -53.33 57.53 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.341 0.656 . . . . 0.0 110.682 176.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 21.9 m -65.25 -35.61 81.55 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 123.689 0.796 . . . . 0.0 110.846 178.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -67.04 -33.22 75.05 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.324 1.049 . . . . 0.0 111.663 -179.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 297' ' ' LEU . . . . . 0.487 HD21 ' SG ' ' A' ' 271' ' ' CYS . 47.6 mt -102.17 -3.68 27.04 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.06 0.944 . . . . 0.0 111.248 178.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 76.74 9.37 86.41 Favored Glycine 0 C--N 1.352 1.46 0 C-N-CA 123.548 0.594 . . . . 0.0 113.909 176.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 299' ' ' VAL . . . . . 0.484 HG11 HG11 ' A' ' 334' ' ' VAL . 35.4 m -102.48 179.82 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.056 0.942 . . . . 0.0 111.462 -177.173 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 49.4 m -77.65 147.62 75.09 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 123.54 0.736 . . . . 0.0 111.14 178.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.68 -27.47 83.28 Favored 'Trans proline' 0 C--N 1.384 2.407 0 C-N-CA 122.634 2.222 . . . . 0.0 111.333 168.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 20.2 m -64.12 -26.16 68.42 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 124.107 0.963 . . . . 0.0 111.549 178.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 78.2 mtt85 -84.35 -33.58 23.83 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.899 0.88 . . . . 0.0 111.64 179.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 304' ' ' ILE . . . . . 0.529 ' HB ' HG13 ' A' ' 290' ' ' VAL . 36.5 mm -72.55 105.12 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 122.703 0.401 . . . . 0.0 110.942 -175.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . 0.527 HD22 HD11 ' A' ' 335' ' ' LEU . 29.7 tp -107.62 129.24 55.02 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 123.618 0.767 . . . . 0.0 109.231 172.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -92.11 138.26 31.68 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 174.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . 0.463 HD23 ' HA ' ' A' ' 312' ' ' GLU . 92.6 mt -133.3 115.02 14.42 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.99 0.916 . . . . 0.0 109.47 -177.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . 0.572 ' HB2' HD11 ' A' ' 313' ' ' LEU . 66.0 t80 -87.25 88.16 7.62 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.06 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 73.74 -78.36 0.89 Allowed Glycine 0 C--N 1.349 1.269 0 CA-C-N 115.209 -0.905 . . . . 0.0 112.331 -177.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -120.62 -33.47 3.81 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.449 0.699 . . . . 0.0 110.644 179.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 8.5 t -76.65 148.38 36.91 Favored 'General case' 0 C--N 1.35 0.622 0 C-N-CA 122.757 0.423 . . . . 0.0 111.393 -169.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . 0.463 ' HA ' HD23 ' A' ' 307' ' ' LEU . 42.7 tt0 -85.24 130.56 34.58 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.687 178.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . 0.594 HD22 HD22 ' A' ' 322' ' ' LEU . 46.9 mt -111.85 126.93 55.62 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 176.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 31.9 m -78.89 144.72 64.54 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 123.237 0.615 . . . . 0.0 110.727 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -59.75 -32.51 95.74 Favored 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 123.103 2.535 . . . . 0.0 112.747 178.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 7.1 m -79.36 -20.48 47.68 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 123.415 0.686 . . . . 0.0 111.361 -179.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -68.72 144.66 54.32 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.17 0.588 . . . . 0.0 110.543 178.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 318' ' ' THR . . . . . 0.507 ' HA ' ' HA ' ' A' ' 285' ' ' PRO . 81.8 p -98.8 142.72 25.08 Favored Pre-proline 0 N--CA 1.475 0.808 0 C-N-CA 123.399 0.679 . . . . 0.0 109.98 -175.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 319' ' ' PRO . . . . . 0.807 ' HG3' HD21 ' A' ' 280' ' ' LEU . 18.8 Cg_endo -56.88 -19.97 34.03 Favored 'Trans proline' 0 C--N 1.368 1.586 0 C-N-CA 123.143 2.562 . . . . 0.0 112.477 173.015 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 31.2 ttt180 -60.55 -55.33 34.71 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.504 0.722 . . . . 0.0 110.62 170.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . 0.453 HG22 ' O ' ' A' ' 318' ' ' THR . 12.4 t -72.17 -18.9 61.83 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -176.017 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 322' ' ' LEU . . . . . 0.594 HD22 HD22 ' A' ' 313' ' ' LEU . 47.0 mt -91.68 -18.74 23.52 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.657 0.783 . . . . 0.0 111.332 179.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 58.02 78.59 0.24 Allowed 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 124.606 1.162 . . . . 0.0 108.821 -169.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 66.5 mt -116.15 165.17 13.45 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.76 0.824 . . . . 0.0 109.022 174.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 325' ' ' GLY . . . . . 0.436 ' H ' ' HB3' ' A' ' 328' ' ' ASP . . . -158.69 -171.62 24.76 Favored Glycine 0 C--N 1.345 1.072 0 O-C-N 122.946 0.154 . . . . 0.0 112.76 -171.168 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 35.1 m -64.58 -32.73 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.325 1.05 . . . . 0.0 112.102 -175.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -112.17 4.84 18.14 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.606 0.762 . . . . 0.0 111.499 -178.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 328' ' ' ASP . . . . . 0.436 ' HB3' ' H ' ' A' ' 325' ' ' GLY . 23.7 t0 -95.89 127.47 41.94 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -178.203 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . 0.511 HG12 ' HG2' ' A' ' 268' ' ' LYS . 6.0 mt -111.47 143.15 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 C-N-CA 123.414 0.686 . . . . 0.0 111.798 -165.028 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 27.7 pt -137.54 133.9 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 123.612 0.765 . . . . 0.0 111.168 177.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 331' ' ' ASP . . . . . 0.404 ' HB2' ' HB2' ' A' ' 307' ' ' LEU . 6.2 m-20 -72.89 111.49 8.06 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.709 1.204 . . . . 0.0 112.523 -175.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 332' ' ' CYS . . . . . 0.487 ' HB3' ' HA ' ' A' ' 271' ' ' CYS . 42.0 t -75.61 115.97 15.84 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 165.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . 0.442 HG21 HD12 ' A' ' 307' ' ' LEU . 99.3 t -126.12 117.84 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 123.812 0.845 . . . . 0.0 109.402 -177.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 334' ' ' VAL . . . . . 0.484 HG11 HG11 ' A' ' 299' ' ' VAL . 62.0 t -84.57 99.69 7.12 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 123.187 0.595 . . . . 0.0 109.664 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 335' ' ' LEU . . . . . 0.527 HD11 HD22 ' A' ' 305' ' ' LEU . 89.1 mt . . . . . 0 N--CA 1.472 0.657 0 C-N-CA 123.863 0.865 . . . . 0.0 111.165 177.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 . . . . . 0 N--CA 1.476 0.871 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 156.98 67.93 0.01 OUTLIER Glycine 0 C--N 1.349 1.269 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.612 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 12.3 mp0 -82.63 81.67 8.32 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.835 0.854 . . . . 0.0 108.763 177.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -99.27 96.21 7.59 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.921 -175.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -172.09 163.1 5.94 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.859 0.863 . . . . 0.0 109.617 175.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -137.51 118.02 13.85 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.989 0.916 . . . . 0.0 108.598 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 15.9 m -76.65 81.18 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 CA-C-O 121.981 0.896 . . . . 0.0 111.068 -177.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 17.7 t -88.46 64.2 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-O 122.192 0.996 . . . . 0.0 108.785 177.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 35.4 tp -172.29 146.75 1.89 Allowed 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 113.864 -1.516 . . . . 0.0 107.966 -178.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 62.0 t 60.98 87.99 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 124.299 1.04 . . . . 0.0 109.401 -176.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 72.68 140.08 0.06 Allowed 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 125.442 1.497 . . . . 0.0 110.628 -171.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -118.34 85.28 0.39 Allowed Glycine 0 N--CA 1.471 0.997 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 174.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -76.86 173.39 14.55 Favored 'Trans proline' 0 C--N 1.375 1.939 0 C-N-CA 123.104 2.536 . . . . 0.0 112.796 -176.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 20.3 p -74.03 106.3 5.66 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 173.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 74.9 mt -102.66 97.01 8.31 Favored Pre-proline 0 CA--C 1.546 0.826 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 176.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -66.52 -27.41 46.31 Favored 'Trans proline' 0 C--N 1.38 2.23 0 C-N-CA 122.668 2.246 . . . . 0.0 111.737 177.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -69.65 105.5 2.72 Favored 'General case' 0 C--O 1.245 0.825 0 O-C-N 123.788 0.68 . . . . 0.0 109.279 172.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 25.0 p -72.14 158.04 88.3 Favored Pre-proline 0 CA--C 1.549 0.907 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.306 172.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . 0.499 ' O ' HD12 ' A' ' 264' ' ' LEU . 34.9 Cg_endo -60.51 168.03 7.25 Favored 'Trans proline' 0 C--N 1.375 1.932 0 C-N-CA 122.768 2.312 . . . . 0.0 111.731 171.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 87.9 mtt180 -84.33 90.7 7.61 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 121.37 0.605 . . . . 0.0 109.425 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.499 HD12 ' O ' ' A' ' 262' ' ' PRO . 4.1 mp -81.46 172.36 13.61 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 114.741 -1.118 . . . . 0.0 109.397 173.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' PHE . . . . . 0.467 ' CE1' ' HG2' ' A' ' 282' ' ' MET . 31.4 p90 -147.85 152.5 40.8 Favored Pre-proline 0 CA--C 1.544 0.73 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 174.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -69.27 93.64 0.48 Allowed 'Trans proline' 0 C--N 1.371 1.747 0 C-N-CA 122.383 2.055 . . . . 0.0 111.634 173.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' LEU . . . . . 0.513 HD12 HG13 ' A' ' 269' ' ' ILE . 1.3 tm? -60.28 127.55 32.34 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 173.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.44 ' HG2' HG12 ' A' ' 329' ' ' ILE . 4.1 tppp? -91.7 103.96 16.48 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 123.763 0.665 . . . . 0.0 110.438 -179.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . 0.513 HG13 HD12 ' A' ' 267' ' ' LEU . 1.4 mp -101.82 146.14 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 174.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 27.8 ttp180 -106.7 118.89 37.86 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 172.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' CYS . . . . . 0.559 ' SG ' HD21 ' A' ' 297' ' ' LEU . 13.7 t -73.92 -158.33 0.06 Allowed 'General case' 0 CA--C 1.562 1.407 0 C-N-CA 124.473 1.109 . . . . 0.0 109.638 172.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 -64.94 -31.04 72.09 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 122.828 0.451 . . . . 0.0 111.791 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -160.27 22.91 0.16 Allowed 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -175.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -152.93 162.11 41.72 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 122.752 0.421 . . . . 0.0 110.596 -172.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.419 HD13 ' HD2' ' A' ' 268' ' ' LYS . 76.3 mt -107.19 129.06 54.91 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.627 0.771 . . . . 0.0 110.948 176.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 46.5 t -115.79 138.61 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.467 1.107 . . . . 0.0 108.668 174.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . 0.409 ' HA ' ' O ' ' A' ' 267' ' ' LEU . 74.5 mtm180 -116.65 130.42 56.72 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.654 0.781 . . . . 0.0 109.598 173.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.488 HD21 ' HA ' ' A' ' 289' ' ' VAL . 4.6 pp -128.63 144.99 54.33 Favored Pre-proline 0 N--CA 1.488 1.436 0 CA-C-O 119.245 -0.407 . . . . 0.0 110.229 172.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -71.95 117.87 5.35 Favored 'Trans proline' 0 C--N 1.379 2.142 0 C-N-CA 122.467 2.111 . . . . 0.0 110.677 178.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.768 HD21 ' HG3' ' A' ' 319' ' ' PRO . 0.2 OUTLIER -144.87 148.41 33.92 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.877 0.871 . . . . 0.0 110.103 -174.45 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . 0.402 ' HB2' ' HB2' ' A' ' 284' ' ' GLU . 87.7 mtm180 -86.4 152.28 22.84 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.99 0.916 . . . . 0.0 109.781 176.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' MET . . . . . 0.467 ' HG2' ' CE1' ' A' ' 265' ' ' PHE . 11.2 mtp -66.72 -31.77 72.64 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.127 0.489 . . . . 0.0 109.926 176.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 39.0 p -77.04 -18.96 57.75 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.855 1.262 . . . . 0.0 111.93 177.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' GLU . . . . . 0.402 ' HB2' ' HB2' ' A' ' 281' ' ' ARG . 7.6 tp10 -70.45 128.39 91.24 Favored Pre-proline 0 N--CA 1.475 0.813 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 176.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -65.65 161.55 38.23 Favored 'Trans proline' 0 C--N 1.377 2.033 0 C-N-CA 122.116 1.877 . . . . 0.0 111.554 174.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.409 ' O ' HG23 ' A' ' 290' ' ' VAL . 58.5 mt -64.63 -10.76 28.83 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 118.83 -0.605 . . . . 0.0 112.272 -178.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 -52.45 -27.49 16.31 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.614 0.765 . . . . 0.0 111.864 176.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . 0.418 ' HB3' HD12 ' A' ' 280' ' ' LEU . 46.8 t -60.69 -57.06 14.3 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.831 0.852 . . . . 0.0 111.084 172.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.488 ' HA ' HD21 ' A' ' 278' ' ' LEU . 15.8 m -69.18 -30.21 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 122.494 0.317 . . . . 0.0 110.749 -178.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . 0.57 HG13 ' HB ' ' A' ' 304' ' ' ILE . 45.1 t -64.1 -52.37 57.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 124.323 1.049 . . . . 0.0 110.705 179.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -61.74 -43.72 98.3 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.293 1.037 . . . . 0.0 110.694 -179.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 54.5 t60 -68.09 -45.26 74.23 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.045 -176.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' MET . . . . . 0.474 ' HB3' ' SG ' ' A' ' 332' ' ' CYS . 92.9 mmm -68.77 -32.21 71.8 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 123.543 0.527 . . . . 0.0 110.908 178.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -64.42 -43.94 92.78 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.335 0.654 . . . . 0.0 110.557 177.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 52.5 m -68.45 -31.72 71.22 Favored 'General case' 0 CA--C 1.554 1.106 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.562 177.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -73.33 -39.01 65.57 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.304 1.041 . . . . 0.0 111.723 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' LEU . . . . . 0.559 HD21 ' SG ' ' A' ' 271' ' ' CYS . 71.4 mt -94.16 -8.6 38.95 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.852 0.861 . . . . 0.0 111.467 -176.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 76.15 20.89 76.9 Favored Glycine 0 C--N 1.349 1.258 0 O-C-N 123.505 0.503 . . . . 0.0 113.496 178.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 30.1 m -111.75 176.97 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 124.229 1.012 . . . . 0.0 110.865 -177.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 48.9 m -80.08 143.65 57.42 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 123.361 0.664 . . . . 0.0 110.005 175.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -54.16 -28.72 52.74 Favored 'Trans proline' 0 C--N 1.39 2.726 0 C-N-CA 123.228 2.619 . . . . 0.0 112.691 173.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 39.5 t -64.46 -27.55 69.07 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 122.925 0.49 . . . . 0.0 111.62 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 61.3 mtt180 -82.59 -20.08 37.16 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.562 0.745 . . . . 0.0 111.684 -176.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' ILE . . . . . 0.639 HD12 ' SG ' ' A' ' 332' ' ' CYS . 42.6 mm -76.68 125.56 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 123.152 0.581 . . . . 0.0 110.763 -176.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 37.9 tp -126.52 120.76 30.47 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.934 0.894 . . . . 0.0 108.664 174.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . 0.411 ' HG ' HD12 ' A' ' 330' ' ' ILE . 2.6 mm? -85.64 134.67 33.98 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 177.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . 0.447 HD23 ' HA ' ' A' ' 312' ' ' GLU . 94.2 mt -136.94 106.7 6.21 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.636 0.774 . . . . 0.0 109.975 -175.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -87.51 95.44 10.03 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 175.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 74.72 -80.74 0.9 Allowed Glycine 0 C--N 1.339 0.73 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.438 178.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -135.6 -5.65 2.24 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.966 0.906 . . . . 0.0 111.856 -177.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 11.6 t -89.37 148.91 23.25 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 117.987 0.358 . . . . 0.0 110.48 -177.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . 0.447 ' HA ' HD23 ' A' ' 307' ' ' LEU . 38.8 tt0 -98.64 110.74 23.29 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.363 0.665 . . . . 0.0 109.628 -178.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.411 HD22 HD22 ' A' ' 322' ' ' LEU . 44.7 mt -95.42 167.75 11.13 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.742 0.417 . . . . 0.0 110.012 177.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 53.2 m -134.4 154.94 80.11 Favored Pre-proline 0 N--CA 1.48 1.06 0 C-N-CA 123.187 0.595 . . . . 0.0 109.963 -177.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . 0.502 ' HB3' HG21 ' A' ' 290' ' ' VAL . 26.9 Cg_endo -58.43 -26.94 80.0 Favored 'Trans proline' 0 C--N 1.385 2.465 0 C-N-CA 123.31 2.674 . . . . 0.0 113.309 177.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 20.8 m -78.5 -29.03 46.41 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 123.668 0.787 . . . . 0.0 111.406 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -66.48 143.42 57.1 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.75 0.82 . . . . 0.0 111.126 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' THR . . . . . . . . . . . . . 36.1 p -108.26 135.82 19.9 Favored Pre-proline 0 N--CA 1.475 0.788 0 C-N-CA 123.318 0.647 . . . . 0.0 111.072 -177.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . 0.768 ' HG3' HD21 ' A' ' 280' ' ' LEU . 6.4 Cg_endo -47.35 -23.04 2.91 Favored 'Trans proline' 0 C--N 1.375 1.96 0 C-N-CA 124.824 3.683 . . . . 0.0 115.088 172.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 30.3 ttt180 -60.54 -62.25 2.0 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.156 0.582 . . . . 0.0 110.834 175.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 8.9 t -68.49 -30.35 69.17 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 122.66 0.384 . . . . 0.0 111.151 -178.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 322' ' ' LEU . . . . . 0.445 ' HB2' ' HG ' ' A' ' 324' ' ' LEU . 86.4 mt -78.55 -17.91 55.44 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.288 0.635 . . . . 0.0 111.868 -178.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 83.7 tttt 64.01 38.81 8.36 Favored 'General case' 0 CA--C 1.562 1.432 0 C-N-CA 124.158 0.983 . . . . 0.0 110.882 -177.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.445 ' HG ' ' HB2' ' A' ' 322' ' ' LEU . 31.7 mt -78.52 162.6 26.21 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 122.921 0.488 . . . . 0.0 110.141 175.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . -166.49 -160.79 14.24 Favored Glycine 0 C--N 1.341 0.808 0 CA-C-N 116.325 -0.398 . . . . 0.0 112.887 -173.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 24.7 m -77.97 -31.68 16.98 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 C-N-CA 124.046 0.938 . . . . 0.0 111.062 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -98.65 -19.01 17.77 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.959 0.903 . . . . 0.0 110.701 178.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -87.2 108.25 18.84 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 -177.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . 0.44 HG12 ' HG2' ' A' ' 268' ' ' LYS . 7.7 mt -104.53 134.5 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 123.463 0.705 . . . . 0.0 111.254 -165.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 330' ' ' ILE . . . . . 0.411 HD12 ' HG ' ' A' ' 306' ' ' LEU . 34.6 pt -120.05 127.08 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 123.225 0.61 . . . . 0.0 111.225 -179.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -76.66 116.43 17.34 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.849 0.859 . . . . 0.0 111.251 -177.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 332' ' ' CYS . . . . . 0.639 ' SG ' HD12 ' A' ' 304' ' ' ILE . 36.2 t -82.77 98.42 9.1 Favored 'General case' 0 C--O 1.243 0.752 0 C-N-CA 123.587 0.755 . . . . 0.0 109.851 172.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 59.2 t -108.84 125.57 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 123.449 0.699 . . . . 0.0 109.792 -176.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 61.3 t -86.23 111.09 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.23 0.612 . . . . 0.0 109.401 177.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 60.7 mt -102.88 168.95 8.89 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.57 0.748 . . . . 0.0 111.263 177.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 336' ' ' THR . . . . . . . . . . . . . 37.9 p -83.76 73.28 10.3 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.799 172.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 50.7 p -73.92 93.72 2.23 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.418 -177.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 56.5 m . . . . . 0 C--O 1.252 1.204 0 C-N-CA 124.382 1.073 . . . . 0.0 109.636 -177.312 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 . . . . . 0 N--CA 1.475 0.791 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 75.21 69.5 1.38 Allowed Glycine 0 C--N 1.348 1.206 0 O-C-N 123.656 0.597 . . . . 0.0 111.641 -175.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -61.48 -30.86 70.87 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.697 0.799 . . . . 0.0 111.508 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -112.26 78.97 1.17 Allowed 'General case' 0 C--O 1.244 0.779 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 174.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -107.49 95.62 5.83 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.156 177.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -85.06 136.09 33.72 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.349 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 23.8 m -73.02 103.53 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.994 0 CA-C-O 122.123 0.963 . . . . 0.0 111.41 -174.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 5.7 p -131.18 124.81 56.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 124.154 0.981 . . . . 0.0 108.904 177.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -162.43 77.61 0.48 Allowed 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 177.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 61.6 t -112.84 114.97 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 67.8 129.03 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 125.066 1.347 . . . . 0.0 112.832 176.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 135.7 98.03 0.54 Allowed Glycine 0 C--N 1.343 0.921 0 CA-C-O 118.875 -0.958 . . . . 0.0 112.007 177.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -66.5 145.67 77.48 Favored 'Trans proline' 0 C--N 1.38 2.231 0 C-N-CA 122.661 2.24 . . . . 0.0 110.838 175.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 17.4 m 73.98 145.38 0.08 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 125.256 1.422 . . . . 0.0 111.025 -173.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 70.2 mt -98.01 97.94 4.94 Favored Pre-proline 0 CA--C 1.55 0.972 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 172.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -64.08 -10.87 24.85 Favored 'Trans proline' 0 C--N 1.386 2.505 0 C-N-CA 123.474 2.783 . . . . 0.0 113.156 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -65.8 128.03 34.38 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.979 0.911 . . . . 0.0 110.225 174.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 90.9 m -66.73 121.55 78.04 Favored Pre-proline 0 CA--C 1.551 0.997 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 170.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -59.64 110.35 0.72 Allowed 'Trans proline' 0 C--N 1.383 2.348 0 C-N-CA 122.36 2.04 . . . . 0.0 109.336 175.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 59.7 ttt180 -71.19 92.51 1.01 Allowed 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.173 0.589 . . . . 0.0 110.382 -168.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 1.5 mp -77.02 154.5 33.39 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.569 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' PHE . . . . . 0.407 ' CE1' ' HG2' ' A' ' 282' ' ' MET . 27.6 p90 -113.46 149.04 40.94 Favored Pre-proline 0 N--CA 1.475 0.791 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 172.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' PRO . . . . . 0.508 ' HB2' ' HB3' ' A' ' 277' ' ' ARG . 56.8 Cg_endo -69.06 97.41 0.57 Allowed 'Trans proline' 0 C--N 1.372 1.765 0 C-N-CA 122.275 1.984 . . . . 0.0 111.892 175.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.01 119.25 13.01 Favored 'General case' 0 C--N 1.35 0.603 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 171.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 24.6 ttpt -95.73 109.09 21.44 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 121.652 0.739 . . . . 0.0 111.133 -178.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 2.8 mp -100.51 143.86 13.42 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 C-N-CA 125.083 1.353 . . . . 0.0 108.118 176.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 37.2 ttp180 -106.15 95.88 6.08 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 123.315 0.646 . . . . 0.0 109.94 178.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' CYS . . . . . 0.546 ' SG ' HD21 ' A' ' 297' ' ' LEU . 44.6 t -71.92 178.82 3.5 Favored 'General case' 0 C--O 1.245 0.827 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.827 170.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -59.5 -31.35 69.28 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.523 0.729 . . . . 0.0 111.995 177.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -147.38 14.71 1.12 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 122.843 0.457 . . . . 0.0 112.187 -177.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -137.31 129.58 29.52 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 122.806 0.443 . . . . 0.0 110.556 -174.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 24.1 mt -95.5 90.86 5.91 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 164.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 58.6 t -82.48 122.7 37.49 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.861 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.163 -175.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . 0.508 ' HB3' ' HB2' ' A' ' 266' ' ' PRO . 77.0 mtm180 -116.13 75.54 0.96 Allowed 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.532 HD11 HG12 ' A' ' 289' ' ' VAL . 4.6 pp -85.58 147.66 47.11 Favored Pre-proline 0 N--CA 1.483 1.204 0 CA-C-O 119.527 -0.273 . . . . 0.0 110.826 -172.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -69.17 118.48 5.7 Favored 'Trans proline' 0 C--N 1.374 1.92 0 C-N-CA 122.112 1.875 . . . . 0.0 110.719 175.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.73 HD21 ' HG3' ' A' ' 319' ' ' PRO . 0.8 OUTLIER -143.24 147.89 35.55 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.861 0.864 . . . . 0.0 110.242 -178.537 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 25.5 mmm180 -96.97 143.57 27.71 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.236 1.015 . . . . 0.0 109.045 174.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' MET . . . . . 0.431 ' HA ' ' HG2' ' A' ' 319' ' ' PRO . 44.1 mtp -61.06 -39.57 90.37 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 122.839 0.456 . . . . 0.0 111.813 -177.078 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 53.7 m -67.44 -25.37 65.88 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.6 0.76 . . . . 0.0 111.584 178.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -77.67 126.08 84.91 Favored Pre-proline 0 CA--C 1.546 0.797 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 173.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . 0.558 ' HA ' ' HA ' ' A' ' 318' ' ' THR . 60.2 Cg_endo -66.51 174.81 5.83 Favored 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 122.421 2.081 . . . . 0.0 113.682 -176.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.461 ' O ' HG22 ' A' ' 289' ' ' VAL . 90.8 mt -65.74 -13.2 58.87 Favored 'General case' 0 C--O 1.21 -1.007 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.643 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 26.5 tp60 -55.24 -24.08 25.88 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.198 0.599 . . . . 0.0 111.589 177.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . 0.543 ' HB2' HD12 ' A' ' 280' ' ' LEU . 22.3 m -68.67 -47.68 65.89 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.941 0.897 . . . . 0.0 111.221 174.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.532 HG12 HD11 ' A' ' 278' ' ' LEU . 13.8 m -69.92 -34.91 62.15 Favored 'Isoleucine or valine' 0 C--N 1.365 1.253 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 177.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . 0.559 HG13 ' HB ' ' A' ' 304' ' ' ILE . 54.0 t -63.77 -43.62 98.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 124.594 1.157 . . . . 0.0 110.733 179.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -63.27 -45.7 90.29 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 124.088 0.868 . . . . 0.0 110.065 -179.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 24.6 t60 -63.43 -49.53 73.35 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.211 178.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' MET . . . . . 0.455 ' HG2' ' O ' ' A' ' 289' ' ' VAL . 85.5 mmm -68.19 -33.03 73.68 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 123.669 0.606 . . . . 0.0 111.057 -175.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -65.58 -47.16 76.71 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.373 0.669 . . . . 0.0 110.327 176.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 29.3 m -64.44 -38.23 90.29 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 123.403 0.681 . . . . 0.0 111.104 177.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 78.9 t60 -67.0 -39.24 87.05 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.341 1.056 . . . . 0.0 111.047 -178.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' LEU . . . . . 0.546 HD21 ' SG ' ' A' ' 271' ' ' CYS . 40.8 mt -95.93 -3.63 44.88 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.845 0.858 . . . . 0.0 111.416 -178.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 71.65 14.33 75.14 Favored Glycine 0 N--CA 1.476 1.333 0 C-N-CA 123.075 0.369 . . . . 0.0 113.769 177.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 299' ' ' VAL . . . . . 0.481 HG11 HG11 ' A' ' 334' ' ' VAL . 33.0 m -101.91 173.41 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.042 0.937 . . . . 0.0 110.624 -178.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . 0.443 ' HB2' ' HG3' ' A' ' 303' ' ' ARG . 16.5 m -79.97 151.59 73.46 Favored Pre-proline 0 CA--C 1.555 1.162 0 C-N-CA 123.141 0.576 . . . . 0.0 110.042 178.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -56.08 -29.11 73.07 Favored 'Trans proline' 0 C--N 1.385 2.459 0 C-N-CA 123.193 2.595 . . . . 0.0 113.216 177.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . 0.436 ' O ' ' HB2' ' A' ' 338' ' ' SER . 33.5 t -69.31 -18.71 63.85 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.633 0.373 . . . . 0.0 111.212 -179.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 303' ' ' ARG . . . . . 0.443 ' HG3' ' HB2' ' A' ' 300' ' ' SER . 52.1 mtt-85 -90.17 -12.91 36.79 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.246 0.618 . . . . 0.0 111.811 -174.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 304' ' ' ILE . . . . . 0.559 ' HB ' HG13 ' A' ' 290' ' ' VAL . 49.7 mm -86.77 117.59 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 122.944 0.498 . . . . 0.0 110.233 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 40.3 tp -114.02 120.08 39.37 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.665 0.786 . . . . 0.0 109.205 174.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . 0.421 HD21 HG22 ' A' ' 290' ' ' VAL . 2.8 mm? -91.36 136.74 32.89 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 177.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . 0.498 HD23 ' HA ' ' A' ' 312' ' ' GLU . 75.5 mt -134.28 106.96 7.38 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.602 0.761 . . . . 0.0 109.471 -177.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . 0.553 ' HB2' HD11 ' A' ' 313' ' ' LEU . 44.8 t80 -85.84 90.28 8.01 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -178.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 64.94 -88.89 0.09 OUTLIER Glycine 0 C--N 1.349 1.289 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.818 -178.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -129.9 70.26 1.43 Allowed 'General case' 0 C--O 1.242 0.705 0 C-N-CA 124.191 0.996 . . . . 0.0 109.667 176.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 10.0 t -169.23 150.87 4.45 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.691 0.796 . . . . 0.0 109.533 170.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . 0.498 ' HA ' HD23 ' A' ' 307' ' ' LEU . 36.3 tt0 -92.97 134.48 35.07 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 177.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.553 HD11 ' HB2' ' A' ' 308' ' ' PHE . 49.7 mt -117.52 149.7 40.18 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.014 0.526 . . . . 0.0 110.551 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 50.9 m -108.24 149.88 39.8 Favored Pre-proline 0 CA--C 1.551 1.016 0 C-N-CA 123.688 0.795 . . . . 0.0 110.472 179.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . 0.515 ' HB3' HG21 ' A' ' 290' ' ' VAL . 12.1 Cg_endo -56.14 -39.94 88.03 Favored 'Trans proline' 0 C--N 1.383 2.349 0 C-N-CA 123.325 2.684 . . . . 0.0 112.639 173.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 41.7 p -75.5 -18.23 59.88 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.22 0.608 . . . . 0.0 112.182 -177.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -74.27 142.61 45.26 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.102 0.561 . . . . 0.0 109.493 174.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 318' ' ' THR . . . . . 0.558 ' HA ' ' HA ' ' A' ' 285' ' ' PRO . 75.5 p -98.28 146.27 31.25 Favored Pre-proline 0 N--CA 1.473 0.71 0 C-N-CA 122.977 0.511 . . . . 0.0 110.533 -176.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . 0.73 ' HG3' HD21 ' A' ' 280' ' ' LEU . 31.6 Cg_endo -62.07 -14.33 36.96 Favored 'Trans proline' 0 C--N 1.365 1.418 0 C-N-CA 122.903 2.402 . . . . 0.0 111.962 168.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 43.6 ttt85 -61.55 -58.21 9.03 Favored 'General case' 0 C--N 1.352 0.711 0 C-N-CA 123.505 0.722 . . . . 0.0 110.761 172.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 10.1 t -66.83 -32.36 73.59 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 122.544 0.338 . . . . 0.0 111.461 -178.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 322' ' ' LEU . . . . . . . . . . . . . 47.7 mt -77.95 -20.66 52.31 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.311 0.644 . . . . 0.0 111.21 177.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 20.7 tptm 55.14 63.19 2.19 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.397 1.479 . . . . 0.0 110.914 -174.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 76.4 mt -90.25 170.05 10.6 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.04 178.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 325' ' ' GLY . . . . . 0.468 ' H ' ' HB2' ' A' ' 328' ' ' ASP . . . -162.54 -161.14 11.78 Favored Glycine 0 C--N 1.339 0.729 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.047 -171.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 31.5 m -76.89 -19.75 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 123.633 0.773 . . . . 0.0 111.872 -176.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -111.52 -17.34 13.09 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.833 0.853 . . . . 0.0 111.424 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 328' ' ' ASP . . . . . 0.468 ' HB2' ' H ' ' A' ' 325' ' ' GLY . 49.0 m-20 -75.71 101.05 4.88 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 177.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 46.1 mt -95.29 134.54 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 123.567 0.747 . . . . 0.0 110.404 -175.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 37.4 pt -121.97 127.23 75.3 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.929 0 C-N-CA 123.568 0.747 . . . . 0.0 110.114 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 331' ' ' ASP . . . . . 0.418 ' O ' ' HA ' ' A' ' 306' ' ' LEU . 5.1 m-20 -74.46 126.99 31.93 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.042 0.937 . . . . 0.0 111.778 -175.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 332' ' ' CYS . . . . . 0.475 ' SG ' HD12 ' A' ' 304' ' ' ILE . 52.5 t -93.76 93.41 7.97 Favored 'General case' 0 C--O 1.244 0.794 0 C-N-CA 123.983 0.913 . . . . 0.0 109.74 175.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 71.8 t -100.42 122.47 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 123.53 0.732 . . . . 0.0 109.573 177.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 334' ' ' VAL . . . . . 0.481 HG11 HG11 ' A' ' 299' ' ' VAL . 94.0 t -87.78 112.92 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 122.906 0.482 . . . . 0.0 110.265 177.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 84.0 mt -103.8 159.81 15.32 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.069 0.948 . . . . 0.0 109.093 171.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 336' ' ' THR . . . . . . . . . . . . . 32.4 p -78.2 88.01 4.28 Favored 'General case' 0 CA--C 1.55 0.964 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 176.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 22.9 m 74.12 157.78 0.2 Allowed 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 125.65 1.58 . . . . 0.0 111.794 -177.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 338' ' ' SER . . . . . 0.436 ' HB2' ' O ' ' A' ' 302' ' ' SER . 24.7 t . . . . . 0 CA--C 1.549 0.916 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 173.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 . . . . . 0 N--CA 1.472 0.637 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -85.16 57.55 4.97 Favored Glycine 0 C--N 1.353 1.517 0 O-C-N 123.638 0.586 . . . . 0.0 112.446 178.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -85.33 6.29 27.01 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.04 0.936 . . . . 0.0 112.487 -175.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -72.61 81.9 1.11 Allowed 'General case' 0 CA--C 1.55 0.949 0 CA-C-O 121.623 0.725 . . . . 0.0 110.29 -177.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -132.77 70.28 1.47 Allowed 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 179.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -167.67 156.46 9.59 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 114.383 -1.28 . . . . 0.0 108.191 -171.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 28.4 m -81.79 42.3 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.563 1.443 0 C-N-CA 123.797 0.839 . . . . 0.0 111.563 178.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 6.4 p -79.4 91.05 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.074 0 C-N-CA 124.768 1.227 . . . . 0.0 110.237 -176.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 6.5 tt -84.58 83.73 7.91 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.292 -178.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 10.0 p -167.99 129.7 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.162 0 C-N-CA 124.329 1.052 . . . . 0.0 109.203 173.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -146.2 128.92 16.21 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.969 0.907 . . . . 0.0 109.058 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 55.49 63.59 5.15 Favored Glycine 0 CA--C 1.535 1.335 0 O-C-N 124.116 0.885 . . . . 0.0 112.496 -176.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -76.15 72.49 5.32 Favored 'Trans proline' 0 C--N 1.378 2.117 0 C-N-CA 123.082 2.522 . . . . 0.0 110.692 -177.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 17.4 m 68.99 156.21 0.13 Allowed 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 125.122 1.369 . . . . 0.0 109.991 -165.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 89.6 mt -107.94 92.56 9.31 Favored Pre-proline 0 N--CA 1.477 0.891 0 O-C-N 121.657 -0.652 . . . . 0.0 109.515 173.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.5 -17.49 34.19 Favored 'Trans proline' 0 C--N 1.379 2.179 0 C-N-CA 122.547 2.165 . . . . 0.0 111.25 169.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -112.48 104.12 12.23 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 125.282 1.433 . . . . 0.0 108.153 177.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 12.3 p -81.42 145.65 55.82 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 122.867 0.467 . . . . 0.0 110.591 176.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -63.67 117.56 4.53 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 122.439 2.093 . . . . 0.0 110.257 173.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 74.7 mtt180 -56.44 125.75 23.39 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.591 1.156 . . . . 0.0 112.167 -165.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 3.4 mp -103.17 130.71 50.45 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.12 -174.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -106.56 147.6 35.27 Favored Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 123.839 0.856 . . . . 0.0 109.111 176.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -63.84 95.58 0.2 Allowed 'Trans proline' 0 C--N 1.376 1.988 0 C-N-CA 122.478 2.118 . . . . 0.0 111.812 172.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' LEU . . . . . 0.466 HD12 HG13 ' A' ' 269' ' ' ILE . 1.5 tm? -62.89 130.59 45.5 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 173.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.549 ' HG2' HG12 ' A' ' 329' ' ' ILE . 3.8 tppp? -94.51 107.39 19.37 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 123.539 0.736 . . . . 0.0 110.244 -177.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . 0.466 HG13 HD12 ' A' ' 267' ' ' LEU . 2.1 mp -106.56 131.96 55.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 175.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' ARG . . . . . 0.429 ' HB2' ' CG2' ' A' ' 329' ' ' ILE . 26.4 ttm180 -91.63 111.38 22.88 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 171.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' CYS . . . . . 0.604 ' SG ' HD21 ' A' ' 297' ' ' LEU . 16.5 t -75.53 -166.69 0.57 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 122.634 0.373 . . . . 0.0 110.222 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' ARG . . . . . 0.437 ' HG2' ' SG ' ' A' ' 271' ' ' CYS . 23.4 ptt180 -53.55 -27.76 27.88 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.354 1.062 . . . . 0.0 112.992 172.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -139.3 -63.49 0.52 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.019 0.528 . . . . 0.0 111.502 -177.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -107.48 163.44 13.05 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 123.692 0.797 . . . . 0.0 111.191 -170.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.533 HD13 ' HD2' ' A' ' 268' ' ' LYS . 96.0 mt -78.7 127.18 31.74 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 123.828 0.851 . . . . 0.0 111.898 -179.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 85.7 t -99.66 139.31 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 170.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . 0.448 ' HD3' ' HE2' ' A' ' 268' ' ' LYS . 62.9 mtm180 -128.19 122.49 31.97 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.794 0.838 . . . . 0.0 108.915 177.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 4.2 pp -131.08 139.65 36.19 Favored Pre-proline 0 N--CA 1.485 1.293 0 CA-C-O 119.379 -0.343 . . . . 0.0 110.52 177.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -70.77 107.62 2.09 Favored 'Trans proline' 0 C--N 1.382 2.313 0 C-N-CA 122.622 2.215 . . . . 0.0 110.618 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.706 HD21 ' HG3' ' A' ' 319' ' ' PRO . 0.1 OUTLIER -124.92 151.94 44.73 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.214 1.006 . . . . 0.0 110.274 -175.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . 0.566 ' HB2' ' HB2' ' A' ' 284' ' ' GLU . 58.5 mtm180 -89.97 153.82 20.31 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.973 0.909 . . . . 0.0 109.688 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -66.54 -44.55 82.08 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 122.572 0.349 . . . . 0.0 110.591 178.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 49.9 m -70.39 -20.3 62.95 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.39 0.676 . . . . 0.0 112.061 178.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' GLU . . . . . 0.566 ' HB2' ' HB2' ' A' ' 281' ' ' ARG . 6.7 tp10 -65.57 126.34 91.39 Favored Pre-proline 0 CA--C 1.542 0.639 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 176.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -65.06 168.25 14.32 Favored 'Trans proline' 0 C--N 1.368 1.595 0 C-N-CA 121.98 1.786 . . . . 0.0 111.707 172.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.425 ' O ' HG23 ' A' ' 290' ' ' VAL . 62.6 mt -64.95 -15.43 62.15 Favored 'General case' 0 C--O 1.214 -0.809 0 CA-C-O 118.837 -0.601 . . . . 0.0 111.263 -178.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' GLN . . . . . 0.462 ' HA ' ' HB ' ' A' ' 290' ' ' VAL . 24.0 tp60 -52.25 -23.54 5.86 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 123.71 0.804 . . . . 0.0 112.402 178.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . 0.504 ' HB3' HD12 ' A' ' 280' ' ' LEU . 37.9 t -58.61 -60.95 3.0 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.337 0.655 . . . . 0.0 110.69 168.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 15.2 m -68.98 -29.82 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 122.821 0.448 . . . . 0.0 111.065 -178.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . 0.477 HG13 ' HB ' ' A' ' 304' ' ' ILE . 76.4 t -66.46 -51.85 53.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 123.782 0.833 . . . . 0.0 109.974 -178.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -70.18 -37.95 75.28 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.815 0.846 . . . . 0.0 111.017 -178.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 13.1 t60 -66.04 -50.65 63.43 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.033 0.533 . . . . 0.0 110.142 -178.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' MET . . . . . 0.413 ' HG3' HG21 ' A' ' 269' ' ' ILE . 94.6 mmm -63.68 -37.3 86.82 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 123.8 0.687 . . . . 0.0 110.784 178.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -61.48 -51.27 69.36 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 123.847 0.717 . . . . 0.0 111.591 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 9.8 m -68.22 -30.84 70.0 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 123.186 0.595 . . . . 0.0 110.838 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -71.45 -35.39 70.88 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.577 0.751 . . . . 0.0 111.26 178.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' LEU . . . . . 0.604 HD21 ' SG ' ' A' ' 271' ' ' CYS . 95.9 mt -96.14 -10.62 27.79 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.745 0.818 . . . . 0.0 112.007 -177.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 80.29 16.84 75.37 Favored Glycine 0 CA--C 1.534 1.227 0 O-C-N 123.379 0.424 . . . . 0.0 113.485 178.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 299' ' ' VAL . . . . . 0.483 HG11 HG11 ' A' ' 334' ' ' VAL . 28.7 m -109.17 173.92 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 124.08 0.952 . . . . 0.0 111.003 178.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 22.8 m -80.07 147.32 65.2 Favored Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 123.306 0.643 . . . . 0.0 110.724 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.09 -23.49 73.56 Favored 'Trans proline' 0 C--N 1.383 2.394 0 C-N-CA 122.72 2.28 . . . . 0.0 112.334 170.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 48.6 p -69.95 -15.41 63.04 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-O 121.041 0.448 . . . . 0.0 111.574 176.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 303' ' ' ARG . . . . . 0.69 ' HG2' ' HA ' ' A' ' 336' ' ' THR . 94.3 mtt180 -102.98 -15.56 16.08 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.106 0.962 . . . . 0.0 111.824 -175.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 304' ' ' ILE . . . . . 0.58 HD12 ' SG ' ' A' ' 332' ' ' CYS . 36.2 mm -83.84 110.06 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 176.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 37.5 tp -114.08 114.93 26.77 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.614 0.766 . . . . 0.0 109.362 178.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . 0.476 ' HG ' HD12 ' A' ' 330' ' ' ILE . 3.2 mm? -86.99 124.14 32.85 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . 0.433 HD12 HG21 ' A' ' 333' ' ' VAL . 41.3 mt -133.88 108.86 8.68 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . 0.484 ' HB2' HG22 ' A' ' 330' ' ' ILE . 71.0 t80 -75.67 86.82 2.72 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 174.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 68.17 -84.99 0.17 Allowed Glycine 0 C--N 1.349 1.257 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.963 -179.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -133.66 75.24 1.59 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.319 1.048 . . . . 0.0 109.11 177.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 15.2 t -159.1 151.75 21.72 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.318 1.047 . . . . 0.0 108.309 171.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -104.13 114.41 28.63 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 122.856 0.462 . . . . 0.0 109.868 -176.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 30.1 mt -117.88 142.78 46.94 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.199 0.6 . . . . 0.0 109.92 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 60.7 m -109.31 159.49 31.13 Favored Pre-proline 0 CA--C 1.556 1.203 0 C-N-CA 123.808 0.843 . . . . 0.0 110.952 -178.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_exo -56.86 -32.07 90.93 Favored 'Trans proline' 0 C--N 1.39 2.739 0 C-N-CA 123.202 2.601 . . . . 0.0 112.573 172.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 45.7 p -70.65 -29.6 65.99 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 114.922 -1.035 . . . . 0.0 111.715 -179.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -68.02 138.24 55.7 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.628 0.771 . . . . 0.0 110.706 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 318' ' ' THR . . . . . . . . . . . . . 71.2 p -98.49 140.23 21.68 Favored Pre-proline 0 CA--C 1.543 0.702 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 178.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . 0.706 ' HG3' HD21 ' A' ' 280' ' ' LEU . 19.8 Cg_endo -55.2 -17.12 14.41 Favored 'Trans proline' 0 C--N 1.367 1.512 0 C-N-CA 123.529 2.819 . . . . 0.0 112.878 171.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 50.5 ttt-85 -67.43 -55.85 12.02 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.441 0.696 . . . . 0.0 110.395 172.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 13.7 t -71.32 -22.01 61.99 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.633 0.373 . . . . 0.0 111.427 -177.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 322' ' ' LEU . . . . . 0.469 ' HB2' ' HG ' ' A' ' 324' ' ' LEU . 58.2 mt -90.9 -16.63 27.83 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.412 0.685 . . . . 0.0 110.996 177.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 19.7 tptm 65.45 32.31 9.65 Favored 'General case' 0 CA--C 1.562 1.416 0 C-N-CA 124.962 1.305 . . . . 0.0 111.408 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.469 ' HG ' ' HB2' ' A' ' 322' ' ' LEU . 33.8 mt -69.8 172.5 7.54 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 123.605 0.762 . . . . 0.0 111.175 178.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 325' ' ' GLY . . . . . 0.445 ' H ' ' HB3' ' A' ' 328' ' ' ASP . . . -167.9 -164.64 23.93 Favored Glycine 0 C--N 1.347 1.152 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.942 -177.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 33.1 m -73.6 -28.81 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 124.168 0.987 . . . . 0.0 111.578 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -88.35 -25.86 22.52 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.533 0.733 . . . . 0.0 111.053 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 328' ' ' ASP . . . . . 0.445 ' HB3' ' H ' ' A' ' 325' ' ' GLY . 12.9 t70 -76.87 130.46 37.62 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.077 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . 0.549 HG12 ' HG2' ' A' ' 268' ' ' LYS . 5.9 mt -121.87 99.63 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 122.984 0.513 . . . . 0.0 110.605 -171.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 330' ' ' ILE . . . . . 0.484 HG22 ' HB2' ' A' ' 308' ' ' PHE . 25.0 pt -87.54 126.78 41.17 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 C-N-CA 122.679 0.392 . . . . 0.0 111.086 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -79.05 118.33 20.93 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.552 0.741 . . . . 0.0 110.588 -175.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 332' ' ' CYS . . . . . 0.58 ' SG ' HD12 ' A' ' 304' ' ' ILE . 43.2 t -78.04 90.1 4.2 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.439 1.096 . . . . 0.0 110.191 176.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . 0.433 HG21 HD12 ' A' ' 307' ' ' LEU . 74.0 t -94.75 110.68 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 123.322 0.649 . . . . 0.0 109.355 -177.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 334' ' ' VAL . . . . . 0.483 HG11 HG11 ' A' ' 299' ' ' VAL . 62.0 t -81.42 94.53 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 CA-C-O 121.319 0.58 . . . . 0.0 110.014 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 60.3 mt -98.57 -146.58 0.32 Allowed 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.536 1.134 . . . . 0.0 108.971 170.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 336' ' ' THR . . . . . 0.69 ' HA ' ' HG2' ' A' ' 303' ' ' ARG . 13.3 t -151.42 154.39 36.52 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.377 0.671 . . . . 0.0 109.621 171.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 27.4 t -135.4 144.2 46.41 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.038 0.535 . . . . 0.0 110.494 -174.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 48.3 t . . . . . 0 C--O 1.251 1.174 0 C-N-CA 123.88 0.872 . . . . 0.0 108.743 -179.997 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 . . . . . 0 N--CA 1.479 0.978 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -80.12 89.42 1.28 Allowed Glycine 0 C--N 1.346 1.094 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.101 -178.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -65.62 -22.77 66.7 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.174 0.59 . . . . 0.0 110.518 174.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -66.7 113.94 5.22 Favored 'General case' 0 CA--C 1.552 1.044 0 O-C-N 123.683 0.614 . . . . 0.0 109.727 171.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -83.65 -27.27 29.22 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.798 0.839 . . . . 0.0 110.255 177.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -52.34 125.29 15.6 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.463 1.105 . . . . 0.0 112.752 -175.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 51.1 t -70.82 118.46 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 123.068 0.547 . . . . 0.0 109.956 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' VAL . . . . . 0.414 HG12 HG22 ' A' ' 253' ' ' VAL . 15.2 t -101.67 65.63 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 123.956 0.903 . . . . 0.0 108.661 179.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 55.3 tp -77.33 87.46 3.73 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.514 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.414 HG22 HG12 ' A' ' 251' ' ' VAL . 4.5 m -140.3 103.29 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 124.454 1.102 . . . . 0.0 108.575 177.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -72.52 91.92 1.44 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.602 0.761 . . . . 0.0 109.871 -177.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -174.29 -69.43 0.05 OUTLIER Glycine 0 CA--C 1.529 0.929 0 CA-C-N 115.109 -0.951 . . . . 0.0 111.09 -176.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -77.39 -156.32 0.06 OUTLIER 'Trans proline' 0 C--N 1.376 2.022 0 C-N-CA 123.161 2.574 . . . . 0.0 111.315 173.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 21.1 m -63.05 135.29 57.17 Favored 'General case' 0 C--N 1.358 0.951 0 C-N-CA 122.666 0.387 . . . . 0.0 110.163 176.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 86.0 mt -109.53 89.5 7.48 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 123.662 0.785 . . . . 0.0 109.98 178.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -74.2 -26.94 12.12 Favored 'Trans proline' 0 C--N 1.379 2.15 0 C-N-CA 123.115 2.543 . . . . 0.0 113.476 -175.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.56 96.17 2.91 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-O 122.044 0.926 . . . . 0.0 109.47 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 41.2 m -76.09 133.71 71.91 Favored Pre-proline 0 CA--C 1.552 1.05 0 CA-C-N 115.133 -0.939 . . . . 0.0 110.013 -178.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -54.32 147.06 47.8 Favored 'Trans proline' 0 C--N 1.388 2.608 0 C-N-CA 123.003 2.469 . . . . 0.0 112.263 172.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -62.83 108.47 1.19 Allowed 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.287 1.035 . . . . 0.0 112.017 -170.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 2.9 mp -86.22 140.06 30.48 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 174.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' PHE . . . . . 0.476 ' CE1' ' HG2' ' A' ' 282' ' ' MET . 28.0 p90 -109.32 146.15 33.33 Favored Pre-proline 0 CA--C 1.55 0.948 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 176.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -64.19 98.65 0.27 Allowed 'Trans proline' 0 C--N 1.378 2.091 0 C-N-CA 122.573 2.182 . . . . 0.0 111.904 171.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' LEU . . . . . 0.528 HD12 HG13 ' A' ' 269' ' ' ILE . 1.2 tm? -61.8 130.43 45.7 Favored 'General case' 0 C--O 1.244 0.8 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 172.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -94.55 104.43 16.38 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . 0.528 HG13 HD12 ' A' ' 267' ' ' LEU . 2.9 mp -97.86 133.81 38.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 123.334 0.653 . . . . 0.0 109.257 176.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' ARG . . . . . 0.584 ' HB3' ' HA ' ' A' ' 331' ' ' ASP . 5.4 tpm_? -85.16 106.47 16.63 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 170.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' CYS . . . . . 0.479 ' SG ' HD21 ' A' ' 297' ' ' LEU . 41.8 t -74.28 176.8 6.33 Favored 'General case' 0 C--O 1.247 0.935 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 170.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -51.1 -36.11 38.63 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.235 1.014 . . . . 0.0 112.756 -178.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -156.62 22.9 0.34 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.179 0.592 . . . . 0.0 111.608 178.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -146.97 179.99 7.21 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 178.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.524 HD23 ' HA ' ' A' ' 270' ' ' ARG . 91.5 mt -121.11 126.3 49.41 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.018 0.927 . . . . 0.0 109.729 174.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 97.7 t -100.01 141.7 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 124.121 0.969 . . . . 0.0 108.522 174.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 39.4 mtt180 -128.5 122.74 31.86 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 178.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.468 HD11 HG12 ' A' ' 289' ' ' VAL . 4.2 pp -134.86 143.32 45.78 Favored Pre-proline 0 N--CA 1.491 1.587 0 CA-C-N 118.139 0.427 . . . . 0.0 110.925 176.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.33 120.28 6.86 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 122.498 2.132 . . . . 0.0 110.865 175.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.665 HD21 ' HG3' ' A' ' 319' ' ' PRO . 0.0 OUTLIER -141.96 145.87 34.99 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.828 0.851 . . . . 0.0 109.932 -177.15 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . 0.416 ' HB2' ' HB2' ' A' ' 284' ' ' GLU . 48.5 mtt85 -79.35 147.71 32.31 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.835 0.854 . . . . 0.0 108.729 176.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' MET . . . . . 0.476 ' HG2' ' CE1' ' A' ' 265' ' ' PHE . 26.8 mtp -66.62 -32.03 73.1 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 118.292 0.497 . . . . 0.0 109.878 174.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 38.8 p -72.06 -29.19 63.89 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.716 1.207 . . . . 0.0 112.007 178.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' GLU . . . . . 0.458 ' O ' ' HD2' ' A' ' 319' ' ' PRO . 18.5 tp10 -66.46 129.85 94.15 Favored Pre-proline 0 N--CA 1.474 0.772 0 C-N-CA 124.282 1.033 . . . . 0.0 109.269 177.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -65.07 166.5 18.54 Favored 'Trans proline' 0 C--N 1.377 2.037 0 C-N-CA 122.012 1.808 . . . . 0.0 111.567 174.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.431 ' O ' HG23 ' A' ' 290' ' ' VAL . 71.7 mt -65.59 -11.63 45.91 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 118.65 -0.691 . . . . 0.0 112.292 -177.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' GLN . . . . . 0.433 ' HA ' ' HB ' ' A' ' 290' ' ' VAL . 22.9 tp60 -55.62 -22.06 20.66 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.167 0.587 . . . . 0.0 112.013 178.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . 0.476 ' HB3' HD12 ' A' ' 280' ' ' LEU . 33.5 t -60.34 -57.11 14.16 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 123.292 0.637 . . . . 0.0 110.566 170.021 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.468 HG12 HD11 ' A' ' 278' ' ' LEU . 18.1 m -71.83 -28.73 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 122.725 0.41 . . . . 0.0 111.531 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . 0.532 HG13 ' HB ' ' A' ' 304' ' ' ILE . 73.3 t -67.03 -51.12 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.809 0.844 . . . . 0.0 110.333 -179.151 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -69.8 -36.58 75.8 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.428 0.691 . . . . 0.0 111.44 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -66.21 -48.65 69.92 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.325 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' MET . . . . . 0.445 ' HG3' HG21 ' A' ' 269' ' ' ILE . 94.0 mmm -67.7 -29.17 68.36 Favored 'General case' 0 N--CA 1.479 0.976 0 O-C-N 123.918 0.761 . . . . 0.0 110.958 178.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -61.44 -49.5 76.59 Favored 'General case' 0 C--O 1.219 -0.516 0 O-C-N 123.65 0.594 . . . . 0.0 110.657 174.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 33.0 m -70.68 -31.81 68.83 Favored 'General case' 0 CA--C 1.549 0.909 0 O-C-N 123.512 0.508 . . . . 0.0 111.045 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 80.8 t60 -69.22 -35.49 76.23 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 123.733 0.813 . . . . 0.0 111.034 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' LEU . . . . . 0.479 HD21 ' SG ' ' A' ' 271' ' ' CYS . 67.7 mt -101.38 -4.07 27.61 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 124.052 0.941 . . . . 0.0 111.339 -179.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 78.63 12.08 84.6 Favored Glycine 0 C--N 1.351 1.398 0 C-N-CA 123.481 0.563 . . . . 0.0 114.073 173.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 299' ' ' VAL . . . . . 0.473 HG11 HG11 ' A' ' 334' ' ' VAL . 33.9 m -106.1 -176.53 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 124.266 1.026 . . . . 0.0 111.293 -178.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 42.7 m -84.29 148.29 52.46 Favored Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 123.749 0.82 . . . . 0.0 110.327 177.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -57.27 -30.58 88.06 Favored 'Trans proline' 0 C--N 1.379 2.166 0 C-N-CA 123.357 2.705 . . . . 0.0 112.144 172.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 20.4 m -70.5 -12.02 61.3 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 123.26 0.624 . . . . 0.0 112.006 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 75.8 mtt180 -95.94 -24.17 16.53 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.142 0.977 . . . . 0.0 110.923 176.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 304' ' ' ILE . . . . . 0.549 HD12 ' SG ' ' A' ' 332' ' ' CYS . 34.5 mm -78.45 122.9 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 123.016 0.526 . . . . 0.0 110.499 -178.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 36.8 tp -126.2 116.36 21.19 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.822 0.849 . . . . 0.0 109.033 177.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -85.06 135.06 34.16 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 177.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 74.3 mt -134.17 115.21 13.94 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.299 1.04 . . . . 0.0 109.208 -176.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -83.77 88.08 7.08 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 174.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 74.88 -81.87 0.87 Allowed Glycine 0 C--N 1.35 1.336 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.856 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -118.32 -32.13 4.75 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.07 0.948 . . . . 0.0 110.403 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 6.0 t -74.6 141.68 44.69 Favored 'General case' 0 C--O 1.245 0.859 0 CA-C-O 121.016 0.436 . . . . 0.0 110.249 -170.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -93.45 116.9 29.44 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.73 -175.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.442 HD13 HD13 ' A' ' 322' ' ' LEU . 47.2 mt -95.67 164.87 12.59 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.784 0.434 . . . . 0.0 110.17 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 49.8 m -123.1 147.47 51.82 Favored Pre-proline 0 N--CA 1.479 1.015 0 C-N-CA 123.436 0.694 . . . . 0.0 109.734 -178.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -55.83 -29.02 70.36 Favored 'Trans proline' 0 C--N 1.383 2.36 0 C-N-CA 122.976 2.451 . . . . 0.0 113.036 173.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 29.4 p -76.01 -29.53 58.17 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.621 0.768 . . . . 0.0 111.837 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -65.6 143.5 57.57 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.141 0.576 . . . . 0.0 110.747 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 318' ' ' THR . . . . . . . . . . . . . 78.0 p -100.32 141.21 22.29 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 122.903 0.481 . . . . 0.0 110.408 -178.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . 0.665 ' HG3' HD21 ' A' ' 280' ' ' LEU . 19.2 Cg_endo -55.92 -16.89 17.21 Favored 'Trans proline' 0 C--N 1.37 1.708 0 C-N-CA 123.789 2.993 . . . . 0.0 113.48 171.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 53.0 ttt180 -67.66 -54.9 15.78 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 122.836 0.454 . . . . 0.0 110.346 175.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 13.7 t -71.09 -21.93 62.16 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 122.844 0.458 . . . . 0.0 111.97 -177.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 322' ' ' LEU . . . . . 0.442 HD13 HD13 ' A' ' 313' ' ' LEU . 53.8 mt -88.87 -18.92 26.59 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.648 0.779 . . . . 0.0 111.161 176.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 20.9 tptm 56.63 53.02 8.89 Favored 'General case' 0 CA--C 1.56 1.351 0 C-N-CA 125.044 1.337 . . . . 0.0 110.842 -175.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.425 HD12 ' HB3' ' A' ' 319' ' ' PRO . 61.5 mt -79.71 164.84 23.41 Favored 'General case' 0 C--O 1.246 0.9 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.375 173.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 325' ' ' GLY . . . . . 0.433 ' H ' ' HB3' ' A' ' 328' ' ' ASP . . . -160.08 -175.84 31.5 Favored Glycine 0 C--N 1.34 0.801 0 CA-C-N 116.372 -0.376 . . . . 0.0 113.087 -173.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 35.2 m -70.21 -28.93 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.119 0.968 . . . . 0.0 111.046 176.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -105.74 15.26 27.07 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.595 1.158 . . . . 0.0 110.658 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 328' ' ' ASP . . . . . 0.433 ' HB3' ' H ' ' A' ' 325' ' ' GLY . 10.9 t70 -123.8 124.81 43.52 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 177.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 3.1 mt -113.37 146.38 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 O-C-N 123.708 0.63 . . . . 0.0 110.622 -169.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 24.1 pt -133.72 129.71 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 123.646 0.779 . . . . 0.0 110.944 179.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 331' ' ' ASP . . . . . 0.584 ' HA ' ' HB3' ' A' ' 270' ' ' ARG . 5.4 m-20 -74.56 114.43 12.96 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.75 1.22 . . . . 0.0 112.351 -173.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 332' ' ' CYS . . . . . 0.549 ' SG ' HD12 ' A' ' 304' ' ' ILE . 42.6 t -83.46 97.48 9.01 Favored 'General case' 0 C--O 1.243 0.729 0 C-N-CA 124.246 1.018 . . . . 0.0 110.136 173.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 89.0 t -102.1 122.5 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 123.747 0.819 . . . . 0.0 109.936 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 334' ' ' VAL . . . . . 0.473 HG11 HG11 ' A' ' 299' ' ' VAL . 90.2 t -85.62 102.93 11.99 Favored 'Isoleucine or valine' 0 C--O 1.242 0.683 0 C-N-CA 123.176 0.591 . . . . 0.0 109.514 175.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 81.1 mt -77.79 106.32 9.53 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 123.349 0.659 . . . . 0.0 109.753 171.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 336' ' ' THR . . . . . . . . . . . . . 33.2 p -82.39 81.42 8.24 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.684 178.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 43.5 m 60.01 82.16 0.16 Allowed 'General case' 0 CA--C 1.55 0.942 0 C-N-CA 124.754 1.221 . . . . 0.0 111.208 -177.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 47.0 t . . . . . 0 CA--C 1.554 1.124 0 C-N-CA 123.508 0.723 . . . . 0.0 109.517 179.224 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.488 1.44 0 N-CA-C 110.352 -0.24 . . . . 0.0 110.352 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 83.57 161.86 32.37 Favored Glycine 0 C--N 1.349 1.268 0 O-C-N 123.802 0.689 . . . . 0.0 112.058 -176.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -130.21 108.02 9.73 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.192 0.597 . . . . 0.0 109.883 179.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -124.31 31.71 5.7 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.243 1.017 . . . . 0.0 110.224 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -64.33 -18.58 64.76 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 123.748 0.819 . . . . 0.0 111.95 -173.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -54.78 104.63 0.12 Allowed 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.033 1.333 . . . . 0.0 109.878 177.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 16.0 m -122.63 117.29 51.5 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.999 0 C-N-CA 124.003 0.921 . . . . 0.0 109.791 178.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 35.8 m -77.16 -26.36 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 123.0 0.52 . . . . 0.0 110.147 176.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 89.7 mt -74.76 94.05 2.68 Favored 'General case' 0 C--N 1.347 0.461 0 C-N-CA 123.534 0.734 . . . . 0.0 109.423 173.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 7.3 p -146.65 133.85 14.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 176.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -118.38 175.08 5.88 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.35 0.66 . . . . 0.0 110.735 -176.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 157.39 79.94 0.03 OUTLIER Glycine 0 CA--C 1.524 0.622 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -173.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -69.69 159.98 51.44 Favored 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 122.863 2.376 . . . . 0.0 112.571 -176.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 39.1 m -58.96 139.7 56.42 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 123.582 0.753 . . . . 0.0 110.506 177.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 47.8 mt -109.1 85.39 3.28 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 123.902 0.881 . . . . 0.0 109.022 177.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -74.95 -19.24 18.16 Favored 'Trans proline' 0 C--N 1.383 2.374 0 C-N-CA 122.113 1.875 . . . . 0.0 111.565 176.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -91.34 135.69 33.64 Favored 'General case' 0 C--O 1.244 0.778 0 C-N-CA 124.13 0.972 . . . . 0.0 109.128 173.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 18.4 p -65.81 147.91 98.51 Favored Pre-proline 0 CA--C 1.549 0.925 0 O-C-N 123.728 0.643 . . . . 0.0 110.597 173.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -64.79 171.5 8.43 Favored 'Trans proline' 0 C--N 1.372 1.814 0 C-N-CA 123.041 2.494 . . . . 0.0 113.4 -178.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -76.78 80.99 3.38 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.696 176.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.408 HD13 ' HB2' ' A' ' 279' ' ' PRO . 0.4 OUTLIER -113.27 150.68 32.1 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.361 177.57 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' PHE . . . . . 0.527 ' CE1' ' SD ' ' A' ' 282' ' ' MET . 11.0 p90 -130.9 149.15 72.89 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 124.409 1.083 . . . . 0.0 108.942 -172.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' PRO . . . . . 0.524 ' HB2' ' HB3' ' A' ' 277' ' ' ARG . 45.7 Cg_endo -66.03 92.28 0.26 Allowed 'Trans proline' 0 C--N 1.369 1.656 0 C-N-CA 122.42 2.08 . . . . 0.0 112.086 173.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' LEU . . . . . 0.462 HD12 HG13 ' A' ' 269' ' ' ILE . 1.6 tm? -61.52 127.51 31.81 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 170.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.488 ' HG2' HG12 ' A' ' 329' ' ' ILE . 3.9 ttpt -91.08 111.65 23.21 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-O 121.5 0.666 . . . . 0.0 110.699 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . 0.494 HG21 ' HG3' ' A' ' 293' ' ' MET . 1.9 mp -106.81 133.59 50.94 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 C-N-CA 124.198 0.999 . . . . 0.0 108.306 176.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' ARG . . . . . 0.6 ' HB2' HG22 ' A' ' 329' ' ' ILE . 28.2 ttp180 -99.97 101.08 12.08 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 123.924 0.889 . . . . 0.0 109.997 178.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' CYS . . . . . 0.753 ' SG ' HD21 ' A' ' 297' ' ' LEU . 49.0 t -70.05 177.43 3.21 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.918 172.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' ARG . . . . . 0.538 ' HG2' ' SG ' ' A' ' 271' ' ' CYS . 38.8 ptt180 -43.14 -40.84 3.43 Favored 'General case' 0 CA--C 1.559 1.299 0 C-N-CA 125.372 1.469 . . . . 0.0 113.147 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -152.03 6.09 0.43 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.588 0.755 . . . . 0.0 111.31 174.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -115.57 158.09 23.15 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.449 1.1 . . . . 0.0 109.848 -174.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -119.76 117.87 29.36 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.533 0.733 . . . . 0.0 109.45 175.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' VAL . . . . . 0.418 HG21 ' SD ' ' A' ' 293' ' ' MET . 67.8 t -102.04 137.89 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.168 0.987 . . . . 0.0 108.452 171.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . 0.524 ' HB3' ' HB2' ' A' ' 266' ' ' PRO . 83.7 mtm180 -128.37 95.66 4.21 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 173.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.512 HD21 ' HA ' ' A' ' 289' ' ' VAL . 4.2 pp -109.74 142.45 25.82 Favored Pre-proline 0 N--CA 1.487 1.403 0 CA-C-O 119.39 -0.338 . . . . 0.0 110.868 -173.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' PRO . . . . . 0.408 ' HB2' HD13 ' A' ' 264' ' ' LEU . 73.4 Cg_endo -70.69 86.74 0.7 Allowed 'Trans proline' 0 C--N 1.383 2.361 0 C-N-CA 122.945 2.43 . . . . 0.0 112.279 -176.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.64 HD21 ' HG3' ' A' ' 319' ' ' PRO . 3.0 tt -95.94 144.43 26.26 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 114.768 -1.105 . . . . 0.0 109.502 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . 0.588 ' HB2' ' HB2' ' A' ' 284' ' ' GLU . 32.3 mtm180 -90.0 143.73 26.53 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.943 0.897 . . . . 0.0 110.415 178.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' MET . . . . . 0.527 ' SD ' ' CE1' ' A' ' 265' ' ' PHE . 87.2 mmm -64.18 -33.38 75.67 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 122.803 0.441 . . . . 0.0 111.621 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 35.6 t -86.94 -0.82 57.2 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.469 0.708 . . . . 0.0 111.524 178.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' GLU . . . . . 0.588 ' HB2' ' HB2' ' A' ' 281' ' ' ARG . 6.8 tp10 -91.33 134.82 29.01 Favored Pre-proline 0 CA--C 1.538 0.488 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 174.086 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.07 170.71 8.62 Favored 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 121.897 1.732 . . . . 0.0 111.683 170.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.419 ' O ' HG23 ' A' ' 290' ' ' VAL . 84.1 mt -67.53 -11.42 57.95 Favored 'General case' 0 C--O 1.219 -0.548 0 C-N-CA 123.153 0.581 . . . . 0.0 111.714 -178.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' GLN . . . . . 0.564 ' HA ' ' HB ' ' A' ' 290' ' ' VAL . 26.4 tp60 -55.05 -20.66 10.07 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 123.136 0.574 . . . . 0.0 111.95 175.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . 0.63 ' HB3' HD12 ' A' ' 280' ' ' LEU . 47.4 t -60.7 -54.62 43.04 Favored 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 123.011 0.524 . . . . 0.0 111.19 169.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.512 ' HA ' HD21 ' A' ' 278' ' ' LEU . 34.9 m -69.83 -35.56 65.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 CA-C-N 117.716 0.235 . . . . 0.0 110.974 177.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . 0.587 HG13 ' HB ' ' A' ' 304' ' ' ILE . 76.9 t -61.2 -41.9 91.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 123.995 0.918 . . . . 0.0 111.078 -179.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -69.88 -47.48 62.44 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.694 0.798 . . . . 0.0 110.837 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' HIS . . . . . 0.459 ' HB3' HD22 ' A' ' 278' ' ' LEU . 9.8 t60 -71.68 -36.64 70.67 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.135 -174.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' MET . . . . . 0.494 ' HG3' HG21 ' A' ' 269' ' ' ILE . 95.6 mmm -72.36 -29.88 64.2 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.367 0.667 . . . . 0.0 110.514 177.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -63.35 -44.7 94.09 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 123.776 0.673 . . . . 0.0 110.847 175.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 24.2 m -70.85 -31.38 68.06 Favored 'General case' 0 CA--C 1.552 1.026 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.052 176.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -71.66 -30.14 65.4 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.959 0.904 . . . . 0.0 111.709 179.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' LEU . . . . . 0.753 HD21 ' SG ' ' A' ' 271' ' ' CYS . 50.1 mt -107.73 -5.68 17.24 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 124.009 0.924 . . . . 0.0 111.892 -176.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 72.86 22.4 79.1 Favored Glycine 0 CA--C 1.531 1.072 0 O-C-N 123.573 0.546 . . . . 0.0 113.198 177.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 299' ' ' VAL . . . . . 0.505 HG11 HG11 ' A' ' 334' ' ' VAL . 22.7 m -114.45 179.92 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 124.513 1.125 . . . . 0.0 110.341 -176.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 48.3 t -81.42 145.54 55.58 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 123.554 0.742 . . . . 0.0 110.29 177.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' PRO . . . . . 0.479 ' HB3' HE22 ' A' ' 287' ' ' GLN . 33.1 Cg_exo -57.6 -29.91 86.8 Favored 'Trans proline' 0 C--N 1.376 2.004 0 C-N-CA 122.72 2.28 . . . . 0.0 111.815 167.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 38.7 t -67.65 -13.87 62.45 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 123.491 0.716 . . . . 0.0 111.1 179.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -106.15 -17.11 14.42 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.216 1.006 . . . . 0.0 112.264 -178.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 304' ' ' ILE . . . . . 0.587 ' HB ' HG13 ' A' ' 290' ' ' VAL . 30.1 mm -77.49 112.58 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 CA-C-O 120.775 0.322 . . . . 0.0 110.145 176.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 41.6 tp -114.43 127.65 55.94 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.696 0.798 . . . . 0.0 108.992 175.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -95.9 133.65 39.82 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 176.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . 0.455 HD23 ' HA ' ' A' ' 312' ' ' GLU . 46.0 mt -140.38 111.54 7.12 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.437 1.095 . . . . 0.0 108.294 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . 0.496 ' HB2' HG22 ' A' ' 330' ' ' ILE . 68.9 t80 -81.33 82.55 7.15 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 173.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 69.87 -94.36 0.43 Allowed Glycine 0 C--N 1.35 1.317 0 CA-C-N 114.827 -1.079 . . . . 0.0 112.586 -175.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -95.76 -31.36 13.24 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.604 0.762 . . . . 0.0 112.407 -174.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 14.6 t -77.77 151.87 33.83 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.68 0.392 . . . . 0.0 111.151 -172.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . 0.455 ' HA ' HD23 ' A' ' 307' ' ' LEU . 33.3 tt0 -98.12 122.21 40.99 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 176.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 29.7 mt -110.08 114.78 28.56 Favored 'General case' 0 C--O 1.243 0.752 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 49.5 m -77.98 139.79 61.76 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 123.755 0.822 . . . . 0.0 110.699 -178.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . 0.452 ' HB3' HG21 ' A' ' 290' ' ' VAL . 43.4 Cg_exo -57.52 -28.38 80.6 Favored 'Trans proline' 0 C--N 1.386 2.536 0 C-N-CA 123.317 2.678 . . . . 0.0 112.886 174.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 56.3 p -74.71 -25.97 59.5 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.052 0.941 . . . . 0.0 111.828 -178.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -81.38 156.02 25.64 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.431 0.692 . . . . 0.0 111.084 -178.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 318' ' ' THR . . . . . . . . . . . . . 71.6 p -98.54 159.29 30.84 Favored Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 123.691 0.796 . . . . 0.0 110.334 -177.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . 0.64 ' HG3' HD21 ' A' ' 280' ' ' LEU . 92.0 Cg_endo -70.28 -18.03 34.83 Favored 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 122.778 2.319 . . . . 0.0 112.042 174.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -65.82 -51.98 54.4 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.685 1.194 . . . . 0.0 109.944 -175.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 9.8 t -69.72 -23.83 63.47 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.559 179.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 322' ' ' LEU . . . . . 0.447 ' HB2' ' HG ' ' A' ' 324' ' ' LEU . 68.5 mt -91.12 -11.73 37.66 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.757 0.823 . . . . 0.0 111.974 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 48.9 tptt 55.31 46.98 22.42 Favored 'General case' 0 CA--C 1.565 1.541 0 C-N-CA 124.429 1.092 . . . . 0.0 111.339 -176.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.447 ' HG ' ' HB2' ' A' ' 322' ' ' LEU . 46.6 mt -81.48 165.42 21.23 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.696 0.799 . . . . 0.0 109.478 175.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 325' ' ' GLY . . . . . 0.435 ' H ' ' HB3' ' A' ' 328' ' ' ASP . . . -164.7 -171.7 31.26 Favored Glycine 0 C--N 1.34 0.769 0 CA-C-N 116.423 -0.353 . . . . 0.0 112.417 -176.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 28.3 m -69.6 -25.3 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 C-N-CA 123.617 0.767 . . . . 0.0 111.178 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -104.27 13.4 32.25 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.866 0.866 . . . . 0.0 111.344 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 328' ' ' ASP . . . . . 0.435 ' HB3' ' H ' ' A' ' 325' ' ' GLY . 12.3 t70 -109.25 127.66 54.44 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 177.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . 0.6 HG22 ' HB2' ' A' ' 270' ' ' ARG . 13.2 mt -120.72 99.14 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 O-C-N 123.798 0.686 . . . . 0.0 110.463 -164.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 330' ' ' ILE . . . . . 0.496 HG22 ' HB2' ' A' ' 308' ' ' PHE . 39.4 pt -100.31 127.18 53.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 123.371 0.668 . . . . 0.0 111.913 -173.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -71.94 116.92 12.91 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.116 0.967 . . . . 0.0 111.875 -173.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 332' ' ' CYS . . . . . 0.547 ' SG ' HD12 ' A' ' 304' ' ' ILE . 48.8 t -86.06 99.41 11.46 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.017 0.927 . . . . 0.0 109.901 174.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 47.0 t -103.9 115.86 46.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 C-N-CA 123.6 0.76 . . . . 0.0 109.004 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 334' ' ' VAL . . . . . 0.505 HG11 HG11 ' A' ' 299' ' ' VAL . 82.5 t -80.28 104.33 8.45 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 CA-C-O 120.942 0.401 . . . . 0.0 109.962 176.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 93.9 mt -111.68 116.81 31.38 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.031 0.932 . . . . 0.0 109.092 173.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 336' ' ' THR . . . . . . . . . . . . . 21.1 p -65.14 106.26 1.26 Allowed 'General case' 0 C--O 1.241 0.64 0 C-N-CA 123.541 0.736 . . . . 0.0 110.308 -178.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 14.6 p -74.73 72.71 2.02 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.681 1.192 . . . . 0.0 110.708 -178.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 25.5 m . . . . . 0 CA--C 1.556 1.2 0 C-N-CA 123.77 0.828 . . . . 0.0 109.271 -175.083 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 . . . . . 0 N--CA 1.484 1.259 0 CA-C-O 120.716 0.293 . . . . 0.0 110.753 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -141.21 75.46 0.33 Allowed Glycine 0 C--N 1.341 0.812 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 178.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -86.47 71.72 10.39 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.514 0.725 . . . . 0.0 110.447 -178.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 61.66 40.1 13.63 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.976 0.911 . . . . 0.0 111.158 -178.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -90.89 -0.01 57.61 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 115.387 -0.824 . . . . 0.0 112.176 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . 0.61 ' HA ' ' HB2' ' A' ' 259' ' ' PRO . 46.8 mt-10 -55.8 90.1 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.959 0.904 . . . . 0.0 112.821 -173.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . 0.449 HG23 ' H ' ' A' ' 252' ' ' LEU . 26.3 m -111.54 171.98 3.01 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 C-N-CA 124.31 1.044 . . . . 0.0 109.798 175.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 19.2 m -87.43 27.92 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 C-N-CA 122.985 0.514 . . . . 0.0 111.581 177.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . 0.449 ' H ' HG23 ' A' ' 250' ' ' VAL . 56.4 tp -127.93 96.6 4.54 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 124.412 1.085 . . . . 0.0 108.298 172.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.517 HG12 ' HG2' ' A' ' 259' ' ' PRO . 15.8 m -119.28 178.52 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.559 0.744 . . . . 0.0 110.111 -177.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 59.16 78.51 0.26 Allowed 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.343 1.057 . . . . 0.0 111.626 170.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 154.17 -109.39 0.4 Allowed Glycine 0 N--CA 1.471 1.005 0 CA-C-O 118.776 -1.013 . . . . 0.0 112.558 178.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.26 -20.07 28.51 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 122.918 2.412 . . . . 0.0 112.588 -175.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 17.1 m -143.4 144.9 32.23 Favored 'General case' 0 C--O 1.244 0.773 0 C-N-CA 124.447 1.099 . . . . 0.0 108.148 -179.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 77.7 mt -119.09 77.4 16.25 Favored Pre-proline 0 N--CA 1.478 0.959 0 C-N-CA 123.511 0.724 . . . . 0.0 109.12 171.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' PRO . . . . . 0.61 ' HB2' ' HA ' ' A' ' 249' ' ' GLU . 49.2 Cg_endo -86.49 -7.31 7.73 Favored 'Trans proline' 0 C--N 1.371 1.756 0 C-N-CA 122.746 2.298 . . . . 0.0 112.27 176.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.39 118.05 12.71 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 17.2 m -70.6 124.92 91.76 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 123.138 0.575 . . . . 0.0 109.8 -173.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . 0.469 ' O ' HD12 ' A' ' 264' ' ' LEU . 15.4 Cg_endo -55.96 154.8 25.68 Favored 'Trans proline' 0 C--N 1.383 2.344 0 C-N-CA 122.582 2.188 . . . . 0.0 111.779 176.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 87.2 mtt180 -90.06 86.13 6.49 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-O 121.668 0.747 . . . . 0.0 110.367 -175.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.469 HD12 ' O ' ' A' ' 262' ' ' PRO . 3.7 mp -92.76 128.61 38.68 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 114.245 -1.343 . . . . 0.0 108.614 173.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -101.94 150.24 37.24 Favored Pre-proline 0 CA--C 1.547 0.847 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 174.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.9 93.82 0.54 Allowed 'Trans proline' 0 C--N 1.375 1.964 0 C-N-CA 121.881 1.72 . . . . 0.0 111.292 176.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' LEU . . . . . 0.49 HD12 HG13 ' A' ' 269' ' ' ILE . 1.6 tm? -59.97 130.54 47.26 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 114.942 -1.026 . . . . 0.0 108.255 175.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.482 ' HG2' HG12 ' A' ' 329' ' ' ILE . 4.0 tppp? -93.0 107.92 19.6 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.172 0.51 . . . . 0.0 110.421 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . 0.511 HG21 ' HG3' ' A' ' 293' ' ' MET . 2.4 mp -106.19 132.92 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 175.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' ARG . . . . . 0.528 ' HA ' HD23 ' A' ' 275' ' ' LEU . 18.3 ttm-85 -86.76 104.41 16.11 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 173.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' CYS . . . . . 0.62 ' SG ' HD21 ' A' ' 297' ' ' LEU . 49.6 t -68.77 176.22 3.16 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.581 0.752 . . . . 0.0 109.992 175.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -58.22 -23.19 54.98 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -174.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -163.62 36.04 0.09 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.467 0.707 . . . . 0.0 111.012 175.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -164.44 178.2 7.62 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.26 0.624 . . . . 0.0 110.116 -177.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.528 HD23 ' HA ' ' A' ' 270' ' ' ARG . 92.9 mt -119.89 119.92 34.92 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.115 0.966 . . . . 0.0 110.337 173.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 89.9 t -97.4 137.38 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.518 0.727 . . . . 0.0 109.088 173.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . 0.426 ' HE ' ' HE2' ' A' ' 268' ' ' LYS . 73.3 mtt180 -118.96 108.68 15.06 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 173.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.504 HD11 HG12 ' A' ' 289' ' ' VAL . 4.6 pp -114.91 144.12 31.39 Favored Pre-proline 0 N--CA 1.488 1.46 0 CA-C-N 118.42 0.555 . . . . 0.0 110.34 177.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 278' ' ' LEU . 16.8 Cg_exo -67.13 123.55 11.06 Favored 'Trans proline' 0 C--N 1.369 1.655 0 C-N-CA 122.641 2.227 . . . . 0.0 110.784 174.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.72 HD21 ' HG3' ' A' ' 319' ' ' PRO . 0.1 OUTLIER -150.33 141.31 22.93 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.561 0.744 . . . . 0.0 109.824 -179.225 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 40.0 mtm180 -82.46 156.87 23.86 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.43 0.692 . . . . 0.0 109.671 174.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' MET . . . . . . . . . . . . . 25.4 mtp -68.94 -31.66 70.71 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 175.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 23.6 p -68.6 -30.3 69.01 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.359 1.063 . . . . 0.0 111.833 176.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -68.85 128.35 92.86 Favored Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 123.601 0.76 . . . . 0.0 109.11 177.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -66.99 170.69 12.46 Favored 'Trans proline' 0 C--N 1.374 1.883 0 C-N-CA 122.33 2.02 . . . . 0.0 112.21 176.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.42 ' O ' HG23 ' A' ' 290' ' ' VAL . 67.9 mt -66.56 -15.09 63.16 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-O 118.776 -0.63 . . . . 0.0 111.52 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 27.4 tp60 -53.19 -23.33 8.2 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 123.169 0.588 . . . . 0.0 112.023 176.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . 0.508 ' HB3' HD12 ' A' ' 280' ' ' LEU . 23.2 t -65.49 -53.64 39.6 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.225 0.61 . . . . 0.0 111.129 173.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.504 HG12 HD11 ' A' ' 278' ' ' LEU . 17.7 m -68.81 -32.62 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-O 120.578 0.227 . . . . 0.0 110.408 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . 0.537 ' HA ' HG21 ' A' ' 304' ' ' ILE . 55.0 t -62.7 -51.49 71.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 124.015 0.926 . . . . 0.0 110.675 177.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -62.44 -49.2 76.4 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.226 1.01 . . . . 0.0 110.975 -178.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 21.9 t60 -64.4 -45.12 88.98 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.814 -176.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 293' ' ' MET . . . . . 0.511 ' HG3' HG21 ' A' ' 269' ' ' ILE . 97.1 mmm -71.72 -28.41 63.66 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.312 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -67.27 -42.66 83.49 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 122.621 0.368 . . . . 0.0 110.7 175.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 29.2 m -69.8 -36.18 75.45 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.443 178.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -69.98 -48.62 57.49 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.609 0.764 . . . . 0.0 110.963 -179.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 297' ' ' LEU . . . . . 0.62 HD21 ' SG ' ' A' ' 271' ' ' CYS . 96.2 mt -82.98 -16.83 45.68 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.795 0.838 . . . . 0.0 112.086 -175.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 76.11 33.55 49.44 Favored Glycine 0 C--N 1.345 1.041 0 O-C-N 123.435 0.459 . . . . 0.0 112.446 -179.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 14.9 m -120.34 176.39 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 124.411 1.085 . . . . 0.0 109.47 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 15.4 m -81.51 145.78 55.79 Favored Pre-proline 0 CA--C 1.547 0.848 0 CA-C-O 118.902 -0.571 . . . . 0.0 109.929 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -55.26 -34.01 86.82 Favored 'Trans proline' 0 C--N 1.389 2.688 0 C-N-CA 122.663 2.242 . . . . 0.0 111.767 173.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 70.2 m -63.63 -32.44 73.92 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 120.779 0.323 . . . . 0.0 110.738 -178.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -75.23 -23.75 57.6 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.877 0.871 . . . . 0.0 112.284 -178.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 304' ' ' ILE . . . . . 0.561 HD12 ' SG ' ' A' ' 332' ' ' CYS . 31.3 mm -73.64 101.72 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . 0.591 HD11 ' HG3' ' A' ' 312' ' ' GLU . 38.8 tp -103.99 116.94 33.16 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 173.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . 0.455 ' HG ' HD12 ' A' ' 330' ' ' ILE . 2.5 mm? -87.89 135.55 33.35 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 177.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 69.3 mt -133.67 107.28 7.85 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -178.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . 0.465 ' HB2' HD11 ' A' ' 313' ' ' LEU . 61.1 t80 -79.0 88.41 4.77 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 177.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 67.71 -90.69 0.21 Allowed Glycine 0 C--N 1.346 1.11 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.431 -174.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -132.59 78.71 1.81 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.598 0.759 . . . . 0.0 109.627 -179.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 12.7 t -171.19 149.49 2.84 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.98 0.912 . . . . 0.0 109.287 175.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . 0.591 ' HG3' HD11 ' A' ' 305' ' ' LEU . 35.0 tt0 -91.86 119.2 31.43 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.465 HD11 ' HB2' ' A' ' 308' ' ' PHE . 57.1 mt -107.42 123.68 48.74 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.23 179.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 29.5 m -82.6 150.44 62.97 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 123.789 0.836 . . . . 0.0 110.604 179.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . 0.533 ' HB3' HG21 ' A' ' 290' ' ' VAL . 22.1 Cg_endo -59.92 -25.46 79.54 Favored 'Trans proline' 0 C--N 1.381 2.255 0 C-N-CA 122.73 2.287 . . . . 0.0 112.875 172.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 42.4 p -84.69 -3.69 58.66 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.808 0.843 . . . . 0.0 112.274 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -85.8 148.18 25.96 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 122.901 0.48 . . . . 0.0 109.957 175.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 318' ' ' THR . . . . . . . . . . . . . 28.9 p -103.4 139.74 20.39 Favored Pre-proline 0 N--CA 1.476 0.845 0 C-N-CA 122.754 0.422 . . . . 0.0 110.865 178.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . 0.72 ' HG3' HD21 ' A' ' 280' ' ' LEU . 27.0 Cg_endo -57.88 -15.99 24.13 Favored 'Trans proline' 0 C--N 1.374 1.906 0 C-N-CA 123.856 3.038 . . . . 0.0 113.094 171.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 37.0 ttt180 -56.99 -62.8 1.49 Allowed 'General case' 0 C--N 1.352 0.702 0 C-N-CA 123.921 0.888 . . . . 0.0 110.446 173.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 15.1 t -71.59 -23.32 61.71 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 122.895 0.478 . . . . 0.0 111.479 -176.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 322' ' ' LEU . . . . . 0.432 HD13 HD13 ' A' ' 313' ' ' LEU . 59.3 mt -82.71 -16.03 49.62 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.328 0.651 . . . . 0.0 111.575 178.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp 59.91 44.02 14.13 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.784 1.234 . . . . 0.0 111.749 178.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.427 HD12 ' HB3' ' A' ' 319' ' ' PRO . 63.9 mt -79.28 168.56 19.37 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.194 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 325' ' ' GLY . . . . . 0.465 ' H ' ' HB2' ' A' ' 328' ' ' ASP . . . -167.32 -162.85 20.05 Favored Glycine 0 C--N 1.35 1.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 113.061 -172.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 25.0 m -74.89 -30.32 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 123.414 0.686 . . . . 0.0 111.204 -178.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -94.97 -25.93 16.32 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.713 0.805 . . . . 0.0 110.907 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 328' ' ' ASP . . . . . 0.465 ' HB2' ' H ' ' A' ' 325' ' ' GLY . 7.1 m-20 -77.77 106.77 9.82 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 122.932 0.493 . . . . 0.0 109.823 -178.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . 0.482 HG12 ' HG2' ' A' ' 268' ' ' LYS . 3.1 mt -97.04 139.13 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 122.83 0.452 . . . . 0.0 110.681 -174.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 330' ' ' ILE . . . . . 0.455 HD12 ' HG ' ' A' ' 306' ' ' LEU . 32.3 pt -119.93 125.01 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 123.061 0.545 . . . . 0.0 109.99 174.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -71.15 114.4 9.17 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.198 0.999 . . . . 0.0 111.274 -175.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 332' ' ' CYS . . . . . 0.561 ' SG ' HD12 ' A' ' 304' ' ' ILE . 45.0 t -81.28 88.89 6.04 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.305 0.642 . . . . 0.0 109.704 174.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 85.5 t -98.85 111.98 29.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 123.619 0.767 . . . . 0.0 109.413 -177.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 90.8 t -82.41 106.19 13.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.808 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 97.0 mt -110.82 132.79 53.9 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.605 0.762 . . . . 0.0 109.687 176.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 336' ' ' THR . . . . . . . . . . . . . 70.8 p -71.23 -31.77 67.97 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.101 0.56 . . . . 0.0 110.791 177.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 54.1 m -82.52 59.32 4.59 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.149 0.98 . . . . 0.0 110.363 176.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 68.0 m . . . . . 0 C--O 1.252 1.22 0 C-N-CA 124.139 0.975 . . . . 0.0 109.336 -174.24 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 . . . . . 0 N--CA 1.482 1.159 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 79.77 137.81 1.68 Allowed Glycine 0 C--N 1.354 1.55 0 CA-C-N 116.13 -0.487 . . . . 0.0 112.8 -178.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 26.2 pt20 -94.99 44.27 1.1 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.209 0.604 . . . . 0.0 109.896 175.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -62.72 -51.46 67.1 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.51 1.124 . . . . 0.0 111.535 -172.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -70.29 92.75 0.8 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.57 1.148 . . . . 0.0 110.827 -174.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -120.13 155.8 32.32 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.661 0.784 . . . . 0.0 108.902 175.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 35.7 m -73.62 160.04 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 CA-C-O 120.532 0.206 . . . . 0.0 110.736 176.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' VAL . . . . . 0.416 HG12 HG12 ' A' ' 253' ' ' VAL . 59.7 t -68.0 92.95 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 173.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 21.2 tp -96.71 14.36 25.27 Favored 'General case' 0 CA--C 1.551 0.997 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.32 -171.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.606 HG22 ' H ' ' A' ' 255' ' ' GLY . 11.9 p -65.29 128.27 27.76 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.188 0 CA-C-O 121.152 0.501 . . . . 0.0 110.353 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -106.48 12.97 29.01 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.322 1.049 . . . . 0.0 110.372 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' GLY . . . . . 0.606 ' H ' HG22 ' A' ' 253' ' ' VAL . . . -113.82 87.23 0.44 Allowed Glycine 0 CA--C 1.53 1.013 0 CA-C-O 119.355 -0.691 . . . . 0.0 112.211 -178.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -86.93 176.53 4.46 Favored 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 123.137 2.558 . . . . 0.0 111.155 174.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 40.6 p -73.12 141.97 47.5 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 122.512 0.325 . . . . 0.0 110.137 176.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 96.5 mt -102.78 97.92 10.22 Favored Pre-proline 0 C--O 1.242 0.689 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 175.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.53 -17.63 57.64 Favored 'Trans proline' 0 C--N 1.375 1.924 0 C-N-CA 122.763 2.308 . . . . 0.0 112.821 174.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 21.1 mp0 -68.4 89.98 0.36 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.818 0.847 . . . . 0.0 109.726 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 21.9 p -76.99 138.5 65.41 Favored Pre-proline 0 C--O 1.242 0.663 0 C-N-CA 123.05 0.54 . . . . 0.0 109.695 174.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . 0.528 ' HB2' ' HG2' ' A' ' 281' ' ' ARG . 74.4 Cg_endo -68.2 143.51 59.31 Favored 'Trans proline' 0 C--N 1.369 1.613 0 C-N-CA 122.502 2.135 . . . . 0.0 111.251 -179.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 40.8 mtt180 -68.96 87.25 0.37 Allowed 'General case' 0 N--CA 1.477 0.91 0 CA-C-O 121.648 0.737 . . . . 0.0 110.533 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.497 ' H ' HD12 ' A' ' 264' ' ' LEU . 0.1 OUTLIER -86.73 124.94 33.54 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 114.616 -1.174 . . . . 0.0 109.336 174.144 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' PHE . . . . . 0.531 ' CE1' ' SD ' ' A' ' 282' ' ' MET . 28.9 p90 -98.08 150.5 36.81 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 124.776 1.23 . . . . 0.0 108.526 -178.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' PRO . . . . . 0.467 ' HB2' ' HB3' ' A' ' 277' ' ' ARG . 56.0 Cg_endo -67.66 92.61 0.36 Allowed 'Trans proline' 0 C--N 1.368 1.554 0 C-N-CA 122.405 2.07 . . . . 0.0 112.443 175.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.1 111.99 3.67 Favored 'General case' 0 C--O 1.247 0.933 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 173.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.428 ' HE3' HG12 ' A' ' 329' ' ' ILE . 22.3 ttpt -83.81 126.65 33.15 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.65 0.738 . . . . 0.0 111.009 -178.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 5.0 mt -125.91 124.3 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.92 1.288 . . . . 0.0 108.52 -175.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 23.0 ttp180 -89.07 102.36 15.01 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-O 121.287 0.565 . . . . 0.0 109.575 176.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' CYS . . . . . 0.765 ' SG ' HD21 ' A' ' 297' ' ' LEU . 36.5 t -73.11 -174.99 1.68 Allowed 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.064 170.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 35.4 ptt180 -56.41 -28.44 59.39 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 124.477 1.111 . . . . 0.0 113.543 -178.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -166.47 32.07 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.629 0.772 . . . . 0.0 110.322 177.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -151.16 150.88 31.16 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.102 0.561 . . . . 0.0 110.103 -172.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -117.18 101.13 8.2 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.932 0.893 . . . . 0.0 109.858 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 72.8 t -92.7 117.71 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.618 0.767 . . . . 0.0 109.707 176.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . 0.467 ' HB3' ' HB2' ' A' ' 266' ' ' PRO . 44.0 mtm-85 -112.48 91.4 3.64 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 175.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.576 HD21 ' HA ' ' A' ' 289' ' ' VAL . 4.6 pp -98.3 147.69 33.47 Favored Pre-proline 0 N--CA 1.483 1.195 0 C-N-CA 122.485 0.314 . . . . 0.0 110.319 -174.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -71.5 107.21 2.11 Favored 'Trans proline' 0 C--N 1.373 1.843 0 C-N-CA 122.416 2.077 . . . . 0.0 111.689 177.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.837 HD21 ' HG3' ' A' ' 319' ' ' PRO . 0.5 OUTLIER -129.11 150.34 50.55 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.145 1.378 . . . . 0.0 108.473 178.137 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . 0.528 ' HG2' ' HB2' ' A' ' 262' ' ' PRO . 0.1 OUTLIER -99.4 155.64 17.43 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.02 0.528 . . . . 0.0 109.905 179.683 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' MET . . . . . 0.531 ' SD ' ' CE1' ' A' ' 265' ' ' PHE . 76.7 mmm -60.32 -33.86 72.98 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.262 0.625 . . . . 0.0 112.059 -175.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 35.0 t -83.77 -19.18 35.55 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.271 0.628 . . . . 0.0 111.896 -178.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -67.74 127.66 93.39 Favored Pre-proline 0 N--CA 1.484 1.233 0 CA-C-O 118.272 -0.87 . . . . 0.0 109.153 175.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -64.95 166.61 17.97 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 122.019 1.813 . . . . 0.0 111.394 173.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.464 ' O ' HG22 ' A' ' 289' ' ' VAL . 82.6 mt -66.74 -10.01 42.62 Favored 'General case' 0 C--O 1.213 -0.834 0 CA-C-O 118.594 -0.717 . . . . 0.0 111.939 -176.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' GLN . . . . . 0.429 ' HA ' ' HB ' ' A' ' 290' ' ' VAL . 27.3 tp60 -53.85 -26.2 23.38 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 123.345 0.658 . . . . 0.0 112.541 178.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . 0.642 ' HB3' HD12 ' A' ' 280' ' ' LEU . 34.6 t -60.66 -52.63 64.32 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.936 0.494 . . . . 0.0 110.642 171.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.576 ' HA ' HD21 ' A' ' 278' ' ' LEU . 10.2 m -71.75 -30.72 38.96 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 122.364 0.266 . . . . 0.0 110.85 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . 0.558 HG13 ' HB ' ' A' ' 304' ' ' ILE . 66.8 t -65.44 -51.23 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.084 0.954 . . . . 0.0 110.657 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -67.54 -39.61 85.03 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.868 0.867 . . . . 0.0 110.984 -176.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 21.5 t60 -66.27 -52.48 47.11 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.751 179.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 94.7 mmm -65.22 -27.89 68.98 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 123.44 0.462 . . . . 0.0 111.214 -177.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -61.84 -49.97 74.14 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.644 0.777 . . . . 0.0 110.476 172.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 36.8 m -70.9 -28.66 64.7 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.639 0.775 . . . . 0.0 111.195 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -70.3 -36.77 74.54 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.292 1.037 . . . . 0.0 110.87 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 297' ' ' LEU . . . . . 0.765 HD21 ' SG ' ' A' ' 271' ' ' CYS . 78.7 mt -101.87 -5.6 24.57 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.996 0.919 . . . . 0.0 112.095 -178.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 79.4 3.38 88.64 Favored Glycine 0 N--CA 1.475 1.243 0 O-C-N 123.417 0.448 . . . . 0.0 113.239 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 299' ' ' VAL . . . . . 0.479 HG11 HG11 ' A' ' 334' ' ' VAL . 30.9 m -91.48 -177.78 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 124.244 1.017 . . . . 0.0 111.083 -178.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 39.7 m -89.15 150.19 44.56 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 123.482 0.713 . . . . 0.0 110.922 -178.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.13 -30.37 90.22 Favored 'Trans proline' 0 C--N 1.391 2.775 0 C-N-CA 123.094 2.529 . . . . 0.0 111.594 172.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 16.7 m -64.95 -15.77 62.55 Favored 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 123.18 0.592 . . . . 0.0 111.907 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 303' ' ' ARG . . . . . 0.456 ' HG2' ' HA ' ' A' ' 336' ' ' THR . 55.1 mtt180 -100.51 -15.78 17.75 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.933 0.893 . . . . 0.0 112.782 -175.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 304' ' ' ILE . . . . . 0.558 ' HB ' HG13 ' A' ' 290' ' ' VAL . 42.7 mm -82.58 102.48 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 CA-C-N 118.148 0.431 . . . . 0.0 110.682 -176.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 53.6 tp -101.37 114.78 29.08 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.969 0.908 . . . . 0.0 109.363 175.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . 0.456 ' HG ' HD12 ' A' ' 330' ' ' ILE . 2.5 mm? -86.5 133.04 33.78 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 178.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' A' ' 312' ' ' GLU . 92.7 mt -132.58 103.29 6.07 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.927 0.891 . . . . 0.0 109.009 -176.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . 0.486 ' HB2' HD11 ' A' ' 313' ' ' LEU . 33.1 t80 -82.89 89.67 6.87 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -174.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 67.35 -84.58 0.13 Allowed Glycine 0 C--N 1.348 1.231 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.238 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -134.27 52.04 2.08 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.953 0.901 . . . . 0.0 110.036 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 11.7 t -153.49 149.29 27.56 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 122.805 0.442 . . . . 0.0 110.689 172.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . 0.436 ' HA ' HD23 ' A' ' 307' ' ' LEU . 42.4 tt0 -96.79 121.36 38.57 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.179 0.592 . . . . 0.0 110.058 -178.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.486 HD11 ' HB2' ' A' ' 308' ' ' PHE . 58.5 mt -102.05 175.71 5.44 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 122.961 0.504 . . . . 0.0 111.406 -176.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 50.1 m -130.39 146.63 62.53 Favored Pre-proline 0 CA--C 1.547 0.842 0 C-N-CA 123.545 0.738 . . . . 0.0 110.056 -177.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . 0.537 ' HB3' HG21 ' A' ' 290' ' ' VAL . 31.1 Cg_endo -61.45 -26.88 81.72 Favored 'Trans proline' 0 C--N 1.385 2.477 0 C-N-CA 123.036 2.491 . . . . 0.0 112.373 174.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 73.1 p -80.19 -22.99 41.33 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.474 1.11 . . . . 0.0 111.889 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -76.82 147.44 37.18 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.553 0.741 . . . . 0.0 111.519 -176.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 318' ' ' THR . . . . . . . . . . . . . 41.3 p -100.98 141.44 22.63 Favored Pre-proline 0 N--CA 1.475 0.782 0 C-N-CA 124.155 0.982 . . . . 0.0 110.05 -178.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . 0.837 ' HG3' HD21 ' A' ' 280' ' ' LEU . 59.0 Cg_endo -62.39 -19.71 68.13 Favored 'Trans proline' 0 C--N 1.37 1.665 0 C-N-CA 123.668 2.912 . . . . 0.0 113.294 -178.118 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 53.3 ttp180 -59.28 -56.51 21.23 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 123.893 0.877 . . . . 0.0 110.697 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 15.3 t -69.63 -25.67 64.05 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.066 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 322' ' ' LEU . . . . . 0.507 ' HB2' ' HG ' ' A' ' 324' ' ' LEU . 46.4 mt -85.71 -4.8 59.26 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.63 0.772 . . . . 0.0 111.842 -178.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp 64.49 29.57 13.25 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.499 1.12 . . . . 0.0 112.063 176.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.507 ' HG ' ' HB2' ' A' ' 322' ' ' LEU . 46.8 mt -78.19 168.74 19.38 Favored 'General case' 0 C--O 1.243 0.755 0 C-N-CA 123.603 0.761 . . . . 0.0 110.774 178.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 325' ' ' GLY . . . . . 0.477 ' H ' ' HB2' ' A' ' 328' ' ' ASP . . . -168.5 -162.48 20.66 Favored Glycine 0 C--O 1.243 0.665 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.89 -173.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 35.1 m -73.41 -36.99 50.06 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 C-N-CA 123.737 0.815 . . . . 0.0 111.478 -177.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -100.15 -12.84 19.27 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.428 1.091 . . . . 0.0 111.292 -177.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 328' ' ' ASP . . . . . 0.477 ' HB2' ' H ' ' A' ' 325' ' ' GLY . 31.8 m-20 -76.22 116.57 17.03 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 174.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . 0.428 HG12 ' HE3' ' A' ' 268' ' ' LYS . 18.0 mt -105.04 124.86 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 123.242 0.617 . . . . 0.0 110.55 -170.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 330' ' ' ILE . . . . . 0.456 HD12 ' HG ' ' A' ' 306' ' ' LEU . 40.2 pt -106.5 126.88 62.24 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 123.103 0.561 . . . . 0.0 110.51 176.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 331' ' ' ASP . . . . . 0.404 ' HB2' ' HB2' ' A' ' 307' ' ' LEU . 7.1 m-20 -72.98 106.06 4.71 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.727 0.811 . . . . 0.0 111.328 -179.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 332' ' ' CYS . . . . . 0.457 ' SG ' HD12 ' A' ' 304' ' ' ILE . 34.7 t -71.71 102.27 2.76 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 169.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . 0.423 HG21 HD12 ' A' ' 307' ' ' LEU . 87.1 t -113.78 112.53 40.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 334' ' ' VAL . . . . . 0.479 HG11 HG11 ' A' ' 299' ' ' VAL . 76.7 t -77.86 104.18 5.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.746 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 75.0 mt -116.57 123.53 47.61 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.022 0.929 . . . . 0.0 109.193 172.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 336' ' ' THR . . . . . 0.456 ' HA ' ' HG2' ' A' ' 303' ' ' ARG . 13.4 t -89.03 8.26 30.63 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.272 0.629 . . . . 0.0 111.082 -179.104 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 15.8 m 71.11 157.38 0.17 Allowed 'General case' 0 C--N 1.362 1.12 0 C-N-CA 125.969 1.708 . . . . 0.0 111.274 -175.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 22.3 p . . . . . 0 C--O 1.252 1.189 0 C-N-CA 123.16 0.584 . . . . 0.0 109.454 -176.578 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 . . . . . 0 N--CA 1.48 1.03 0 N-CA-C 110.463 -0.199 . . . . 0.0 110.463 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -93.64 -75.18 1.29 Allowed Glycine 0 C--N 1.346 1.124 0 CA-C-N 116.255 -0.43 . . . . 0.0 112.319 -178.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 58.76 26.06 14.23 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 124.646 1.178 . . . . 0.0 111.726 -179.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.19 72.29 9.25 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.523 1.129 . . . . 0.0 108.362 -178.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -169.67 92.45 0.24 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 114.496 -1.229 . . . . 0.0 108.424 -171.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.51 166.84 26.5 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.81 0.844 . . . . 0.0 109.473 176.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 27.3 m -67.14 164.26 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 123.379 0.672 . . . . 0.0 111.848 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 28.7 m -82.12 41.71 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.244 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.42 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 45.5 tp -156.39 95.18 1.56 Allowed 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.26 1.024 . . . . 0.0 108.277 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 30.2 m -109.15 145.39 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 123.898 0.879 . . . . 0.0 109.623 176.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . 0.519 ' HG3' ' HD3' ' A' ' 256' ' ' PRO . 11.7 tp10 -95.79 140.41 30.61 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.52 0.728 . . . . 0.0 109.798 178.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -159.86 78.38 0.17 Allowed Glycine 0 C--N 1.341 0.813 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 178.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . 0.519 ' HD3' ' HG3' ' A' ' 254' ' ' GLU . 48.1 Cg_endo -81.47 -152.76 0.04 OUTLIER 'Trans proline' 0 C--N 1.372 1.816 0 C-N-CA 123.518 2.812 . . . . 0.0 112.03 -177.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 41.3 m -64.01 99.8 0.28 Allowed 'General case' 0 C--N 1.352 0.704 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 169.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 94.6 mt -110.81 98.07 36.36 Favored Pre-proline 0 N--CA 1.471 0.613 0 C-N-CA 123.104 0.561 . . . . 0.0 109.671 178.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -69.0 -14.15 37.94 Favored 'Trans proline' 0 C--N 1.377 2.074 0 C-N-CA 122.494 2.13 . . . . 0.0 111.353 168.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -65.28 89.68 0.09 Allowed 'General case' 0 C--O 1.244 0.776 0 C-N-CA 124.66 1.184 . . . . 0.0 109.699 173.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 16.3 p -81.78 135.68 48.71 Favored Pre-proline 0 C--O 1.241 0.62 0 C-N-CA 123.052 0.541 . . . . 0.0 110.63 177.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -61.67 118.23 5.1 Favored 'Trans proline' 0 C--N 1.379 2.137 0 C-N-CA 122.566 2.177 . . . . 0.0 109.964 171.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -54.67 105.73 0.17 Allowed 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.484 1.114 . . . . 0.0 112.617 -164.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 4.2 mp -80.79 133.77 35.68 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.714 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' PHE . . . . . 0.499 ' CE1' ' HG2' ' A' ' 282' ' ' MET . 31.3 p90 -112.0 141.16 24.37 Favored Pre-proline 0 CA--C 1.55 0.95 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 175.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' PRO . . . . . 0.537 ' HB2' ' HB3' ' A' ' 277' ' ' ARG . 38.0 Cg_endo -65.11 92.64 0.21 Allowed 'Trans proline' 0 C--N 1.375 1.922 0 C-N-CA 122.696 2.264 . . . . 0.0 112.974 176.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' LEU . . . . . 0.464 HD12 HG13 ' A' ' 269' ' ' ILE . 0.4 OUTLIER -61.69 122.55 15.61 Favored 'General case' 0 C--N 1.356 0.88 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 173.271 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.451 ' HD2' HD13 ' A' ' 275' ' ' LEU . 20.8 ttpt -88.27 108.38 19.29 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 121.216 0.531 . . . . 0.0 110.614 178.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . 0.464 HG13 HD12 ' A' ' 267' ' ' LEU . 3.8 mp -105.79 129.22 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 176.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' ARG . . . . . 0.425 ' HA ' HD23 ' A' ' 275' ' ' LEU . 41.1 ttm180 -87.0 119.34 27.11 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 122.847 0.459 . . . . 0.0 110.016 174.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' CYS . . . . . 0.712 ' SG ' HD21 ' A' ' 297' ' ' LEU . 10.1 t -88.75 -165.06 1.24 Allowed 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.722 0.809 . . . . 0.0 109.687 173.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -52.96 -39.73 63.18 Favored 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 124.584 1.154 . . . . 0.0 112.85 176.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -162.19 42.82 0.13 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.511 0.725 . . . . 0.0 109.87 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' ASP . . . . . 0.402 ' HB3' ' HB3' ' A' ' 271' ' ' CYS . 38.1 t70 -155.58 162.01 40.73 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.704 -171.162 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.451 HD13 ' HD2' ' A' ' 268' ' ' LYS . 72.3 mt -127.85 106.58 9.21 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.176 0.99 . . . . 0.0 110.032 174.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 84.6 t -92.88 108.99 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 123.696 0.798 . . . . 0.0 108.937 174.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . 0.537 ' HB3' ' HB2' ' A' ' 266' ' ' PRO . 67.4 mtm180 -98.76 83.46 2.96 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 174.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.404 HD11 HG12 ' A' ' 289' ' ' VAL . 4.3 pp -93.38 137.14 23.6 Favored Pre-proline 0 N--CA 1.488 1.447 0 CA-C-O 119.141 -0.457 . . . . 0.0 110.413 -175.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -63.91 123.67 12.32 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 122.54 2.16 . . . . 0.0 111.477 175.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.655 HD21 ' HG3' ' A' ' 319' ' ' PRO . 0.0 OUTLIER -143.72 151.94 40.66 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.226 1.01 . . . . 0.0 110.066 -176.549 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . 0.425 ' HD2' ' H ' ' A' ' 281' ' ' ARG . 1.6 mpt_? -87.85 149.71 23.96 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 177.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' MET . . . . . 0.499 ' HG2' ' CE1' ' A' ' 265' ' ' PHE . 14.9 mtp -68.06 -37.08 80.87 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 117.928 0.331 . . . . 0.0 110.672 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 22.8 t -75.08 -15.34 60.62 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.748 0.819 . . . . 0.0 111.314 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' GLU . . . . . 0.434 ' O ' ' HD2' ' A' ' 319' ' ' PRO . 4.5 tp10 -73.52 134.31 79.45 Favored Pre-proline 0 CA--C 1.543 0.691 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 174.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.89 166.57 26.01 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 122.062 1.842 . . . . 0.0 111.686 175.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 82.6 mt -66.7 -12.62 59.17 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.985 0.514 . . . . 0.0 111.721 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' GLN . . . . . 0.479 ' HA ' ' HB ' ' A' ' 290' ' ' VAL . 25.6 tp60 -56.2 -22.36 28.75 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.342 0.657 . . . . 0.0 111.687 173.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . 0.465 ' HB3' HD12 ' A' ' 280' ' ' LEU . 22.8 t -61.22 -57.64 11.58 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.462 0.705 . . . . 0.0 110.455 172.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.416 HG13 HD13 ' A' ' 280' ' ' LEU . 17.9 m -68.99 -30.36 46.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 122.484 0.313 . . . . 0.0 110.553 -179.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . 0.6 HG13 ' HB ' ' A' ' 304' ' ' ILE . 43.0 t -63.72 -44.51 98.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.507 1.123 . . . . 0.0 111.15 176.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -59.58 -47.61 84.89 Favored 'General case' 0 N--CA 1.479 0.998 0 O-C-N 124.044 0.84 . . . . 0.0 110.204 178.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 42.7 t60 -64.62 -50.63 66.37 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.406 -178.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 293' ' ' MET . . . . . 0.432 ' HG3' HG21 ' A' ' 269' ' ' ILE . 94.3 mmm -69.37 -30.55 68.58 Favored 'General case' 0 N--CA 1.483 1.177 0 O-C-N 123.666 0.604 . . . . 0.0 111.356 -174.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -64.68 -46.44 82.37 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 123.656 0.598 . . . . 0.0 110.277 175.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 26.1 m -73.26 -29.24 62.61 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.309 0.644 . . . . 0.0 111.119 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 67.6 t60 -65.05 -38.74 91.82 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.404 1.082 . . . . 0.0 110.279 176.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 297' ' ' LEU . . . . . 0.712 HD21 ' SG ' ' A' ' 271' ' ' CYS . 58.2 mt -101.05 -5.84 25.21 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.369 1.068 . . . . 0.0 111.876 -177.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 74.21 10.37 81.51 Favored Glycine 0 N--CA 1.476 1.303 0 O-C-N 123.267 0.355 . . . . 0.0 113.61 178.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 299' ' ' VAL . . . . . 0.434 HG11 HG11 ' A' ' 334' ' ' VAL . 33.5 m -95.99 176.03 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.208 1.003 . . . . 0.0 110.855 -178.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . 0.412 ' H ' ' HD2' ' A' ' 303' ' ' ARG . 20.2 m -78.95 148.56 72.24 Favored Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 123.298 0.639 . . . . 0.0 110.428 178.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -57.86 -28.33 82.06 Favored 'Trans proline' 0 C--N 1.385 2.486 0 C-N-CA 122.97 2.446 . . . . 0.0 112.247 172.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 19.5 m -72.58 -7.54 50.69 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.429 0.691 . . . . 0.0 111.958 -178.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 303' ' ' ARG . . . . . 0.412 ' HD2' ' H ' ' A' ' 300' ' ' SER . 95.7 mtt180 -99.25 -21.28 16.16 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.845 0.858 . . . . 0.0 110.943 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 304' ' ' ILE . . . . . 0.6 ' HB ' HG13 ' A' ' 290' ' ' VAL . 39.4 mm -80.73 115.34 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 122.852 0.461 . . . . 0.0 110.506 -176.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 33.5 tp -113.46 137.65 51.24 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 171.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . 0.448 ' HG ' HD12 ' A' ' 330' ' ' ILE . 2.0 mm? -104.15 133.8 48.48 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 177.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 80.8 mt -131.42 111.43 11.81 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.47 0.708 . . . . 0.0 109.101 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . 0.548 ' HB2' HD11 ' A' ' 313' ' ' LEU . 87.1 t80 -82.49 81.79 8.17 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 77.16 -67.8 2.71 Favored Glycine 0 C--N 1.354 1.53 0 CA-C-N 114.885 -1.052 . . . . 0.0 112.842 -178.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -134.96 -26.8 1.3 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.087 0.955 . . . . 0.0 111.596 -174.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 14.3 t -82.1 147.66 28.97 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 122.658 0.383 . . . . 0.0 110.641 -176.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -93.44 117.39 30.02 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 120.923 0.392 . . . . 0.0 110.01 -178.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.548 HD11 ' HB2' ' A' ' 308' ' ' PHE . 48.1 mt -105.9 114.71 29.03 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.841 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 49.5 m -75.15 147.44 83.19 Favored Pre-proline 0 CA--C 1.553 1.059 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.388 177.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . 0.573 ' HB3' HG21 ' A' ' 290' ' ' VAL . 33.9 Cg_endo -60.23 -23.6 74.56 Favored 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 123.265 2.643 . . . . 0.0 112.937 177.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 4.6 m -72.48 -33.95 67.33 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.785 0.834 . . . . 0.0 111.08 178.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -66.43 146.24 54.78 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.826 0.85 . . . . 0.0 111.425 -177.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 318' ' ' THR . . . . . . . . . . . . . 81.2 p -100.83 138.35 20.03 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 123.027 0.531 . . . . 0.0 109.921 -178.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . 0.655 ' HG3' HD21 ' A' ' 280' ' ' LEU . 10.0 Cg_endo -51.03 -20.08 6.73 Favored 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 124.153 3.235 . . . . 0.0 113.531 170.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 40.9 ttt180 -60.92 -58.79 6.94 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.649 0.78 . . . . 0.0 110.912 173.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 13.2 t -71.34 -20.72 62.14 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 122.932 0.493 . . . . 0.0 111.531 -175.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 322' ' ' LEU . . . . . 0.466 HD13 HD13 ' A' ' 313' ' ' LEU . 39.0 mt -88.9 -22.03 23.32 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.646 0.778 . . . . 0.0 111.01 178.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 2.3 tmtp? 56.41 80.83 0.14 Allowed 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.869 1.267 . . . . 0.0 109.204 -167.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 69.5 mt -110.31 143.83 39.94 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 172.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 325' ' ' GLY . . . . . 0.437 ' H ' ' HB2' ' A' ' 328' ' ' ASP . . . -128.22 -167.72 12.29 Favored Glycine 0 C--N 1.337 0.613 0 C-N-CA 123.939 0.78 . . . . 0.0 111.511 -178.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 14.5 m -73.88 -21.98 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 123.314 0.645 . . . . 0.0 111.469 -177.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -99.96 -22.84 15.11 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.193 0.997 . . . . 0.0 111.253 -178.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 328' ' ' ASP . . . . . 0.437 ' HB2' ' H ' ' A' ' 325' ' ' GLY . 3.9 m-20 -70.37 124.96 25.46 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.992 0.517 . . . . 0.0 109.813 178.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . 0.412 HG12 ' HG2' ' A' ' 268' ' ' LYS . 12.9 mt -104.11 139.57 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.028 0.531 . . . . 0.0 109.933 -178.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 330' ' ' ILE . . . . . 0.448 HD12 ' HG ' ' A' ' 306' ' ' LEU . 35.7 pt -123.84 126.58 72.87 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 123.162 0.585 . . . . 0.0 109.837 174.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -75.39 106.1 6.75 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.027 0.931 . . . . 0.0 110.963 -176.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 332' ' ' CYS . . . . . 0.554 ' SG ' HD12 ' A' ' 304' ' ' ILE . 38.1 t -74.54 92.06 2.35 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.701 0.801 . . . . 0.0 110.168 172.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 97.4 t -95.87 117.08 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 123.431 0.693 . . . . 0.0 109.679 177.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 334' ' ' VAL . . . . . 0.434 HG11 HG11 ' A' ' 299' ' ' VAL . 62.1 t -83.38 99.76 6.32 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 123.582 0.753 . . . . 0.0 109.713 177.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 84.9 mt -78.48 178.84 7.43 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.883 0.873 . . . . 0.0 110.535 172.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 336' ' ' THR . . . . . . . . . . . . . 94.8 m -68.01 -54.02 21.58 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 170.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 66.4 m -157.56 136.12 11.3 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.79 1.236 . . . . 0.0 108.437 176.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 15.0 m . . . . . 0 C--O 1.253 1.286 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -178.579 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 . . . . . 0 N--CA 1.481 1.119 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -160.63 63.48 0.28 Allowed Glycine 0 C--N 1.348 1.196 0 N-CA-C 111.106 -0.797 . . . . 0.0 111.106 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 65.48 41.54 4.15 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.566 1.147 . . . . 0.0 110.465 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -73.22 97.67 2.48 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.186 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -93.59 22.82 5.08 Favored 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 124.444 1.098 . . . . 0.0 109.997 177.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -68.37 157.22 36.18 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.944 0.898 . . . . 0.0 112.405 -175.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 6.4 m -74.89 113.6 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.173 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.235 175.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 58.2 t -89.53 141.91 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.488 0.715 . . . . 0.0 111.369 -169.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 33.1 tp 65.37 35.96 7.16 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 125.375 1.47 . . . . 0.0 110.895 175.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 8.0 m -73.64 87.78 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 CA-C-O 122.342 1.068 . . . . 0.0 110.232 174.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -164.47 146.92 8.76 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 114.204 -1.362 . . . . 0.0 108.657 -176.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -76.17 105.57 2.0 Favored Glycine 0 C--N 1.346 1.085 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 170.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -80.56 172.92 12.86 Favored 'Trans proline' 0 C--N 1.37 1.67 0 C-N-CA 122.503 2.135 . . . . 0.0 113.046 -170.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 65.3 m -72.61 142.39 48.36 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 169.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 76.3 mt -104.05 94.08 6.19 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 123.699 0.8 . . . . 0.0 109.416 178.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -74.97 -15.41 20.84 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 122.346 2.031 . . . . 0.0 111.682 172.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -96.42 103.93 15.86 Favored 'General case' 0 C--O 1.242 0.7 0 C-N-CA 124.244 1.018 . . . . 0.0 108.85 174.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 55.5 m -85.03 135.03 40.05 Favored Pre-proline 0 C--O 1.243 0.761 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 171.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -63.19 149.4 91.51 Favored 'Trans proline' 0 C--N 1.385 2.453 0 C-N-CA 121.834 1.689 . . . . 0.0 110.327 170.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 21.7 ptt-85 -91.98 110.68 22.05 Favored 'General case' 0 N--CA 1.482 1.175 0 CA-C-O 121.644 0.735 . . . . 0.0 110.006 -177.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 4.2 mp -107.81 151.66 25.43 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.005 0.922 . . . . 0.0 109.383 177.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -125.88 141.57 39.77 Favored Pre-proline 0 CA--C 1.549 0.931 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 175.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -64.26 94.13 0.2 Allowed 'Trans proline' 0 C--N 1.379 2.137 0 C-N-CA 122.531 2.154 . . . . 0.0 112.091 176.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' LEU . . . . . 0.437 HD12 HG13 ' A' ' 269' ' ' ILE . 1.1 tm? -59.6 131.71 51.75 Favored 'General case' 0 C--N 1.354 0.782 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 173.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.43 ' HG2' HG12 ' A' ' 329' ' ' ILE . 3.0 tppp? -94.96 103.53 15.39 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.465 0.65 . . . . 0.0 109.973 -178.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . 0.437 HG13 HD12 ' A' ' 267' ' ' LEU . 2.4 mp -100.59 154.03 4.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 175.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' ARG . . . . . 0.486 ' HB2' HG22 ' A' ' 329' ' ' ILE . 22.5 ttp180 -118.35 103.61 9.96 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.792 0.837 . . . . 0.0 109.017 176.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' CYS . . . . . 0.722 ' SG ' HD21 ' A' ' 297' ' ' LEU . 21.0 t -69.09 -178.14 1.21 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.007 0.923 . . . . 0.0 110.598 176.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -50.98 -32.84 22.37 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.712 1.205 . . . . 0.0 113.175 -177.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -161.04 42.08 0.16 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.645 0.778 . . . . 0.0 110.03 178.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -161.35 164.84 29.77 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.257 -174.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 69.6 mt -112.53 113.46 25.62 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.252 1.021 . . . . 0.0 110.155 172.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' VAL . . . . . 0.438 HG21 ' SD ' ' A' ' 293' ' ' MET . 65.7 t -95.43 138.89 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 123.684 0.794 . . . . 0.0 109.264 178.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 42.7 mtt180 -125.08 115.64 20.82 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 177.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.523 HD21 ' HA ' ' A' ' 289' ' ' VAL . 4.0 pp -126.49 135.58 27.43 Favored Pre-proline 0 N--CA 1.482 1.13 0 CA-C-O 119.258 -0.401 . . . . 0.0 109.942 175.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -64.7 127.91 19.85 Favored 'Trans proline' 0 C--N 1.375 1.97 0 C-N-CA 122.657 2.238 . . . . 0.0 110.149 174.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.827 HD21 ' HG3' ' A' ' 319' ' ' PRO . 0.2 OUTLIER -150.22 150.92 32.24 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.002 0.921 . . . . 0.0 109.943 -173.815 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . 0.494 ' HB2' ' HB2' ' A' ' 284' ' ' GLU . 83.5 mtm180 -93.17 155.43 17.46 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.588 0.755 . . . . 0.0 110.815 -178.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -65.72 -38.24 88.62 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.885 0.474 . . . . 0.0 110.213 176.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 24.3 t -73.99 -17.93 60.93 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.552 0.741 . . . . 0.0 111.802 178.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' GLU . . . . . 0.494 ' HB2' ' HB2' ' A' ' 281' ' ' ARG . 5.9 tp10 -72.93 131.77 83.56 Favored Pre-proline 0 N--CA 1.473 0.72 0 C-N-CA 123.712 0.805 . . . . 0.0 109.121 179.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -67.76 168.38 18.67 Favored 'Trans proline' 0 C--N 1.374 1.918 0 C-N-CA 121.903 1.735 . . . . 0.0 111.79 171.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 54.3 mt -70.41 -10.22 58.5 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 118.982 -0.532 . . . . 0.0 110.874 179.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 26.0 tp60 -54.68 -23.08 15.85 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.217 0.607 . . . . 0.0 111.644 175.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . 0.551 ' HB3' HD12 ' A' ' 280' ' ' LEU . 34.3 t -64.42 -56.48 14.01 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.619 0.768 . . . . 0.0 110.935 171.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.523 ' HA ' HD21 ' A' ' 278' ' ' LEU . 18.0 m -66.73 -30.43 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 C-N-CA 122.254 0.222 . . . . 0.0 110.701 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . 0.581 HG13 ' HB ' ' A' ' 304' ' ' ILE . 43.9 t -66.88 -50.24 66.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 124.397 1.079 . . . . 0.0 110.565 179.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -64.1 -43.54 95.03 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.105 0.962 . . . . 0.0 110.887 -178.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 26.0 t60 -67.2 -49.09 65.87 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.378 -177.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 293' ' ' MET . . . . . 0.438 ' SD ' HG21 ' A' ' 276' ' ' VAL . 90.0 mmm -66.36 -32.52 73.96 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.447 0.699 . . . . 0.0 111.369 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -61.57 -53.63 53.79 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 123.863 0.727 . . . . 0.0 110.352 177.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 28.3 m -66.2 -34.09 77.24 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.658 0.783 . . . . 0.0 111.304 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -67.46 -35.44 79.19 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.682 0.793 . . . . 0.0 111.499 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 297' ' ' LEU . . . . . 0.722 HD21 ' SG ' ' A' ' 271' ' ' CYS . 86.6 mt -97.83 -3.46 38.75 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.874 0.87 . . . . 0.0 111.319 178.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 75.15 10.15 84.18 Favored Glycine 0 C--N 1.345 1.049 0 O-C-N 123.625 0.578 . . . . 0.0 113.44 177.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 33.1 m -98.6 -179.04 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.126 0.97 . . . . 0.0 111.252 -178.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 21.7 m -85.2 147.78 48.44 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 123.347 0.659 . . . . 0.0 110.686 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -56.79 -29.65 81.7 Favored 'Trans proline' 0 C--N 1.384 2.428 0 C-N-CA 123.044 2.496 . . . . 0.0 112.297 171.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 44.8 m -68.24 -19.56 64.74 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.037 0.535 . . . . 0.0 111.739 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 61.3 mtt85 -89.19 -19.48 25.4 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.924 0.89 . . . . 0.0 111.737 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 304' ' ' ILE . . . . . 0.581 ' HB ' HG13 ' A' ' 290' ' ' VAL . 41.9 mm -80.62 125.39 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 CA-C-N 117.997 0.362 . . . . 0.0 110.748 -178.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . 0.604 HD22 HD11 ' A' ' 335' ' ' LEU . 46.3 tp -129.76 121.52 27.01 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.809 0.844 . . . . 0.0 108.963 176.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . 0.409 ' HA ' ' O ' ' A' ' 331' ' ' ASP . 2.6 mm? -88.43 127.86 35.51 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -179.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . 0.516 HD12 HG21 ' A' ' 333' ' ' VAL . 79.1 mt -136.32 104.76 5.73 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.794 0.837 . . . . 0.0 109.615 -176.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . 0.515 ' HB2' HG22 ' A' ' 330' ' ' ILE . 85.3 t80 -81.84 93.65 6.91 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 177.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 66.77 -87.72 0.13 Allowed Glycine 0 C--N 1.349 1.274 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.595 -177.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -137.17 77.46 1.64 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.277 1.031 . . . . 0.0 109.339 177.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 14.3 t -166.92 146.26 5.39 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.234 1.014 . . . . 0.0 108.899 173.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . 0.425 ' HA ' HD23 ' A' ' 307' ' ' LEU . 44.3 tt0 -97.36 123.38 41.16 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 122.532 0.333 . . . . 0.0 110.345 -176.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.474 HD22 HD22 ' A' ' 322' ' ' LEU . 27.7 mt -121.11 131.63 54.38 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.59 0.756 . . . . 0.0 109.099 -179.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 52.6 m -98.75 152.69 37.96 Favored Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 123.59 0.756 . . . . 0.0 111.573 -174.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -49.23 -37.82 40.29 Favored 'Trans proline' 0 C--N 1.388 2.617 0 C-N-CA 123.695 2.93 . . . . 0.0 113.294 167.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 43.1 p -70.44 -27.61 64.39 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.321 -178.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -73.51 145.71 45.42 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.608 0.763 . . . . 0.0 110.857 -179.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 318' ' ' THR . . . . . . . . . . . . . 76.1 p -99.2 146.79 32.32 Favored Pre-proline 0 N--CA 1.476 0.857 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 177.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . 0.827 ' HG3' HD21 ' A' ' 280' ' ' LEU . 34.8 Cg_endo -62.19 -12.18 25.59 Favored 'Trans proline' 0 C--N 1.367 1.518 0 C-N-CA 123.081 2.521 . . . . 0.0 112.56 171.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 44.2 ttt-85 -68.25 -56.13 9.74 Favored 'General case' 0 C--N 1.35 0.613 0 C-N-CA 122.999 0.519 . . . . 0.0 110.15 173.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 13.6 t -68.81 -25.42 64.67 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 120.639 0.257 . . . . 0.0 111.265 -178.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 322' ' ' LEU . . . . . 0.474 HD22 HD22 ' A' ' 313' ' ' LEU . 52.2 mt -90.04 -13.75 35.3 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.288 0.635 . . . . 0.0 111.721 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt 61.87 35.15 16.6 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.657 1.183 . . . . 0.0 112.384 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.449 ' HG ' ' HB2' ' A' ' 322' ' ' LEU . 30.8 mt -73.74 166.13 23.85 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.545 0.738 . . . . 0.0 109.836 175.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 325' ' ' GLY . . . . . 0.447 ' H ' ' HB3' ' A' ' 328' ' ' ASP . . . -164.03 -171.91 30.86 Favored Glycine 0 C--N 1.337 0.635 0 CA-C-N 116.475 -0.33 . . . . 0.0 112.326 -176.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 35.0 m -68.4 -27.87 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 123.973 0.909 . . . . 0.0 111.402 178.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -99.57 11.63 38.65 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.118 0.967 . . . . 0.0 111.625 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 328' ' ' ASP . . . . . 0.447 ' HB3' ' H ' ' A' ' 325' ' ' GLY . 10.9 t70 -122.8 124.09 42.52 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -175.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . 0.486 HG22 ' HB2' ' A' ' 270' ' ' ARG . 3.5 mt -116.72 109.83 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 O-C-N 123.411 0.445 . . . . 0.0 111.824 -163.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 330' ' ' ILE . . . . . 0.515 HG22 ' HB2' ' A' ' 308' ' ' PHE . 34.4 pt -102.06 131.94 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 123.679 0.792 . . . . 0.0 111.117 -177.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 331' ' ' ASP . . . . . 0.409 ' O ' ' HA ' ' A' ' 306' ' ' LEU . 7.5 m-20 -73.95 126.91 31.52 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 123.293 0.637 . . . . 0.0 111.759 -178.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 332' ' ' CYS . . . . . 0.563 ' SG ' HD12 ' A' ' 304' ' ' ILE . 43.2 t -90.55 91.17 8.31 Favored 'General case' 0 C--O 1.244 0.785 0 C-N-CA 123.89 0.876 . . . . 0.0 109.043 172.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . 0.516 HG21 HD12 ' A' ' 307' ' ' LEU . 90.8 t -95.02 115.55 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 123.253 0.621 . . . . 0.0 109.506 -178.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 93.1 t -83.69 98.77 5.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 177.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 335' ' ' LEU . . . . . 0.604 HD11 HD22 ' A' ' 305' ' ' LEU . 86.3 mt -67.25 168.9 9.61 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 114.662 -1.153 . . . . 0.0 111.401 172.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 336' ' ' THR . . . . . . . . . . . . . 37.4 p -90.89 26.7 2.01 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.876 0.87 . . . . 0.0 111.374 174.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 18.4 m -57.37 114.45 2.2 Favored 'General case' 0 C--N 1.359 0.99 0 C-N-CA 123.948 0.899 . . . . 0.0 110.609 176.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 29.9 m . . . . . 0 C--O 1.254 1.311 0 C-N-CA 123.11 0.564 . . . . 0.0 110.007 -177.999 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 . . . . . 0 N--CA 1.478 0.967 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -85.81 45.29 3.46 Favored Glycine 0 C--N 1.349 1.289 0 N-CA-C 114.165 0.426 . . . . 0.0 114.165 -171.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -90.06 174.75 7.47 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.757 0.823 . . . . 0.0 110.392 175.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -86.28 79.54 9.02 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.498 0.666 . . . . 0.0 109.231 178.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -147.38 12.74 1.06 Allowed 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.122 178.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.33 119.7 8.44 Favored 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 124.385 1.074 . . . . 0.0 111.568 -172.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 17.7 m -137.74 175.23 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 125.069 1.347 . . . . 0.0 109.783 -178.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 5.4 p -71.89 105.71 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 CA-C-O 121.87 0.843 . . . . 0.0 109.123 172.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 43.0 tp -152.08 129.38 11.27 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 -178.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 16.2 m -73.29 79.33 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 CA-C-O 122.81 1.291 . . . . 0.0 111.086 -178.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -135.64 141.72 45.09 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 114.076 -1.42 . . . . 0.0 109.019 179.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -108.84 79.3 0.25 Allowed Glycine 0 CA--C 1.524 0.641 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 165.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -81.25 154.16 18.85 Favored 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 122.771 2.314 . . . . 0.0 111.54 -171.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 31.6 m -65.12 124.09 21.21 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 174.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 87.1 mt -112.48 88.94 11.75 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 123.371 0.668 . . . . 0.0 109.261 178.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -76.75 -22.02 12.21 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 121.909 1.74 . . . . 0.0 110.872 169.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -80.01 106.73 12.25 Favored 'General case' 0 C--O 1.242 0.687 0 C-N-CA 124.018 0.927 . . . . 0.0 108.937 176.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 27.2 m -75.33 137.2 71.67 Favored Pre-proline 0 CA--C 1.548 0.893 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 172.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . 0.455 ' O ' HD12 ' A' ' 264' ' ' LEU . 99.7 Cg_exo -48.28 173.93 0.03 OUTLIER 'Trans proline' 0 C--N 1.383 2.383 0 C-N-CA 123.318 2.679 . . . . 0.0 114.567 175.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 75.6 mtt180 -92.73 89.27 6.58 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-O 121.703 0.763 . . . . 0.0 109.664 -177.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.455 HD12 ' O ' ' A' ' 262' ' ' PRO . 3.0 mp -89.82 162.89 15.27 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 114.187 -1.369 . . . . 0.0 109.017 174.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -141.75 145.67 37.92 Favored Pre-proline 0 CA--C 1.546 0.792 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 175.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' PRO . . . . . 0.42 ' HB2' ' HB3' ' A' ' 277' ' ' ARG . 58.5 Cg_endo -67.93 89.11 0.37 Allowed 'Trans proline' 0 C--N 1.374 1.909 0 C-N-CA 122.875 2.383 . . . . 0.0 112.626 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' LEU . . . . . 0.497 ' O ' ' HA ' ' A' ' 277' ' ' ARG . 1.4 tm? -58.93 127.83 34.18 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.478 1.111 . . . . 0.0 108.96 176.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.684 ' HG2' HG12 ' A' ' 329' ' ' ILE . 5.6 tppp? -83.6 109.35 17.35 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-O 121.336 0.589 . . . . 0.0 111.19 176.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . 0.46 HG12 ' HB ' ' A' ' 289' ' ' VAL . 2.4 mp -106.39 145.22 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 171.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 30.8 ttp180 -107.47 106.88 17.49 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 173.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' CYS . . . . . 0.583 ' SG ' HD21 ' A' ' 297' ' ' LEU . 17.4 t -69.82 172.65 7.32 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.746 171.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 16.3 ptt180 -62.13 -14.1 33.6 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 123.871 0.868 . . . . 0.0 113.187 -174.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -162.52 34.03 0.11 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.694 0.798 . . . . 0.0 111.029 176.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -164.23 162.82 22.8 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 122.826 0.451 . . . . 0.0 111.647 -175.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 51.9 mt -114.2 116.36 28.93 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.244 1.018 . . . . 0.0 109.653 170.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 60.3 t -100.46 142.72 15.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 124.193 0.997 . . . . 0.0 109.114 176.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . 0.497 ' HA ' ' O ' ' A' ' 267' ' ' LEU . 57.8 mtm180 -127.72 120.8 28.77 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 167.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.547 HD21 ' HA ' ' A' ' 289' ' ' VAL . 4.1 pp -123.9 146.33 50.54 Favored Pre-proline 0 N--CA 1.48 1.04 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 178.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -64.67 110.91 1.54 Allowed 'Trans proline' 0 C--N 1.372 1.788 0 C-N-CA 122.805 2.337 . . . . 0.0 110.94 174.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.659 HD21 ' HG3' ' A' ' 319' ' ' PRO . 0.1 OUTLIER -130.05 143.67 50.92 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.15 0.98 . . . . 0.0 109.835 178.9 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 70.4 mtp180 -89.44 159.79 17.11 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.001 0.92 . . . . 0.0 110.728 178.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' MET . . . . . . . . . . . . . 1.3 mmt -70.53 -34.02 71.82 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.199 176.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 35.2 m -77.81 -26.64 49.74 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.734 0.814 . . . . 0.0 111.222 177.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -72.56 123.37 89.45 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-O 118.135 -0.936 . . . . 0.0 108.642 176.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -68.25 179.52 2.87 Favored 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 122.759 2.306 . . . . 0.0 112.481 179.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.439 ' O ' HG23 ' A' ' 290' ' ' VAL . 66.6 mt -64.43 -18.37 64.67 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 118.954 -0.545 . . . . 0.0 111.557 177.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 26.6 tp60 -53.47 -22.61 8.25 Favored 'General case' 0 CA--C 1.559 1.294 0 C-N-CA 123.543 0.737 . . . . 0.0 112.307 178.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . 0.494 ' HB3' HD12 ' A' ' 280' ' ' LEU . 32.1 t -63.18 -56.65 14.92 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.847 0.859 . . . . 0.0 111.069 171.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.547 ' HA ' HD21 ' A' ' 278' ' ' LEU . 15.4 m -67.33 -33.72 64.41 Favored 'Isoleucine or valine' 0 C--N 1.361 1.085 0 C-N-CA 122.64 0.376 . . . . 0.0 110.498 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . 0.576 HG13 ' HB ' ' A' ' 304' ' ' ILE . 73.8 t -61.12 -49.24 85.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 124.426 1.09 . . . . 0.0 111.026 177.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -61.27 -50.05 74.59 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 124.31 1.006 . . . . 0.0 110.467 -178.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 22.8 t60 -59.32 -49.03 79.41 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 124.526 1.141 . . . . 0.0 111.203 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 293' ' ' MET . . . . . 0.411 ' HG2' ' O ' ' A' ' 289' ' ' VAL . 91.7 mmm -68.33 -31.08 70.24 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 122.779 0.431 . . . . 0.0 111.103 -178.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -70.0 -38.16 75.91 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.272 0.629 . . . . 0.0 111.034 176.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 27.7 m -68.96 -43.35 75.16 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.611 0.764 . . . . 0.0 110.275 178.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 83.4 t60 -67.66 -47.98 67.98 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.546 -177.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 297' ' ' LEU . . . . . 0.583 HD21 ' SG ' ' A' ' 271' ' ' CYS . 76.6 mt -83.52 -9.0 59.24 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.512 0.725 . . . . 0.0 111.654 -178.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 69.66 26.4 74.49 Favored Glycine 0 C--N 1.349 1.28 0 O-C-N 123.697 0.623 . . . . 0.0 112.682 177.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 299' ' ' VAL . . . . . 0.488 HG11 HG11 ' A' ' 334' ' ' VAL . 28.0 m -110.36 178.14 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.435 1.094 . . . . 0.0 110.434 -177.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 27.4 m -80.4 143.16 55.23 Favored Pre-proline 0 CA--C 1.55 0.971 0 CA-C-O 119.114 -0.469 . . . . 0.0 110.207 178.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -56.91 -28.19 76.42 Favored 'Trans proline' 0 C--N 1.384 2.398 0 C-N-CA 123.052 2.502 . . . . 0.0 112.45 171.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 41.2 t -68.56 -27.31 65.96 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 120.83 0.347 . . . . 0.0 110.978 179.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 66.7 mtt180 -85.55 -11.86 53.05 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.34 1.056 . . . . 0.0 112.047 -176.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 304' ' ' ILE . . . . . 0.576 ' HB ' HG13 ' A' ' 290' ' ' VAL . 35.5 mm -82.67 101.97 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 177.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 36.9 tp -102.37 112.05 24.6 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.271 0.628 . . . . 0.0 109.471 176.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . 0.447 HD21 HG22 ' A' ' 290' ' ' VAL . 3.1 mm? -81.56 131.22 35.27 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 177.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . 0.505 HD12 HG21 ' A' ' 333' ' ' VAL . 72.5 mt -131.99 109.94 10.4 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.04 0.936 . . . . 0.0 108.735 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . 0.519 ' HB2' HD11 ' A' ' 313' ' ' LEU . 28.7 t80 -77.74 89.64 4.01 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -179.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 66.44 -83.43 0.1 Allowed Glycine 0 C--N 1.346 1.112 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.728 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -122.56 3.09 9.62 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.134 0.973 . . . . 0.0 112.207 -176.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 5.0 t -115.26 147.01 40.91 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 118.256 0.48 . . . . 0.0 110.225 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -85.05 132.71 34.29 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 123.184 0.594 . . . . 0.0 110.007 177.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.522 HD13 HD13 ' A' ' 322' ' ' LEU . 53.2 mt -112.3 156.74 21.93 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.114 0.566 . . . . 0.0 110.366 177.152 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 314' ' ' SER . . . . . 0.424 ' O ' HD12 ' A' ' 286' ' ' LEU . 22.3 m -99.22 130.4 27.28 Favored Pre-proline 0 CA--C 1.544 0.749 0 CA-C-O 118.644 -0.693 . . . . 0.0 109.44 175.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -59.51 -21.92 64.11 Favored 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 123.228 2.618 . . . . 0.0 113.475 175.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 27.3 p -78.26 -29.44 48.06 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.969 0.908 . . . . 0.0 111.858 176.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -67.28 157.74 33.17 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.366 0.666 . . . . 0.0 111.475 -177.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 318' ' ' THR . . . . . . . . . . . . . 61.6 p -99.36 144.17 27.77 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 123.158 0.583 . . . . 0.0 109.916 -173.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . 0.659 ' HG3' HD21 ' A' ' 280' ' ' LEU . 55.7 Cg_endo -63.22 -16.65 55.81 Favored 'Trans proline' 0 C--N 1.363 1.342 0 C-N-CA 123.43 2.753 . . . . 0.0 112.508 175.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 -73.21 -48.65 33.33 Favored 'General case' 0 C--N 1.355 0.843 0 C-N-CA 122.72 0.408 . . . . 0.0 110.488 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 13.7 t -70.54 -26.37 63.53 Favored 'General case' 0 CA--C 1.549 0.926 0 O-C-N 123.324 0.39 . . . . 0.0 110.637 178.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 322' ' ' LEU . . . . . 0.522 HD13 HD13 ' A' ' 313' ' ' LEU . 68.6 mt -85.7 -12.17 51.87 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.362 0.665 . . . . 0.0 111.41 175.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp 60.02 35.74 21.45 Favored 'General case' 0 CA--C 1.561 1.394 0 C-N-CA 124.712 1.205 . . . . 0.0 111.52 175.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 60.5 mt -69.31 169.75 11.65 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.198 0.999 . . . . 0.0 111.26 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 325' ' ' GLY . . . . . 0.45 ' H ' ' HB3' ' A' ' 328' ' ' ASP . . . -154.89 -170.18 20.3 Favored Glycine 0 C--N 1.348 1.212 0 CA-C-N 116.411 -0.358 . . . . 0.0 113.084 -172.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 14.9 m -81.56 -28.45 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 123.683 0.793 . . . . 0.0 111.542 -176.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -99.33 -23.78 15.04 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.17 0.988 . . . . 0.0 110.041 176.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 328' ' ' ASP . . . . . 0.45 ' HB3' ' H ' ' A' ' 325' ' ' GLY . 17.3 t70 -72.19 120.09 17.31 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.889 0.876 . . . . 0.0 110.245 -175.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . 0.684 HG12 ' HG2' ' A' ' 268' ' ' LYS . 5.2 mt -100.6 134.36 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 123.819 0.848 . . . . 0.0 111.812 -166.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 42.8 pt -126.3 126.34 69.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 123.471 0.708 . . . . 0.0 110.345 172.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -73.89 110.44 8.19 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.485 1.114 . . . . 0.0 112.132 -175.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 332' ' ' CYS . . . . . 0.478 ' SG ' HD12 ' A' ' 304' ' ' ILE . 41.6 t -74.57 89.89 2.22 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.563 0.745 . . . . 0.0 109.878 167.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . 0.505 HG21 HD12 ' A' ' 307' ' ' LEU . 93.1 t -100.61 111.1 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 123.226 0.61 . . . . 0.0 109.483 -178.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 334' ' ' VAL . . . . . 0.488 HG11 HG11 ' A' ' 299' ' ' VAL . 57.9 t -83.41 108.91 16.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 123.033 0.533 . . . . 0.0 109.947 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 88.9 mt -115.17 156.38 25.41 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.881 0.872 . . . . 0.0 110.58 178.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 336' ' ' THR . . . . . . . . . . . . . 7.1 t -80.67 71.13 7.55 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-O 122.524 1.154 . . . . 0.0 110.032 176.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 21.9 p -79.53 112.25 16.6 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 114.685 -1.143 . . . . 0.0 111.434 -173.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 58.0 m . . . . . 0 C--O 1.257 1.467 0 C-N-CA 124.247 1.019 . . . . 0.0 108.499 175.76 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 . . . . . 0 N--CA 1.483 1.209 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 80.78 -72.26 2.73 Favored Glycine 0 C--N 1.348 1.212 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 -169.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' GLN . . . . . 0.676 ' HG2' ' H ' ' A' ' 247' ' ' GLU . 53.8 tt0 -90.85 -168.34 2.05 Favored 'General case' 0 CA--C 1.562 1.417 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 161.268 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . 0.676 ' H ' ' HG2' ' A' ' 246' ' ' GLN . 38.2 tt0 78.2 -4.84 2.15 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 124.645 1.178 . . . . 0.0 111.256 175.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -83.39 103.68 12.95 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 177.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -124.98 112.66 16.84 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 178.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 27.7 m -57.83 110.78 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.051 0 O-C-N 124.167 0.917 . . . . 0.0 111.192 -171.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' VAL . . . . . 0.597 HG12 HG22 ' A' ' 253' ' ' VAL . 24.5 t -76.09 86.96 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.561 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 175.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 35.7 tp -78.64 75.66 5.15 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.369 -172.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.597 HG22 HG12 ' A' ' 251' ' ' VAL . 16.0 m -146.86 148.59 16.61 Favored 'Isoleucine or valine' 0 C--O 1.247 0.965 0 C-N-CA 125.229 1.411 . . . . 0.0 108.678 175.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -170.13 172.96 6.11 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.762 0.825 . . . . 0.0 109.768 175.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 133.96 -69.5 0.53 Allowed Glycine 0 CA--C 1.533 1.174 0 N-CA-C 110.901 -0.879 . . . . 0.0 110.901 -178.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.08 169.17 21.22 Favored 'Trans proline' 0 C--N 1.38 2.217 0 C-N-CA 122.95 2.434 . . . . 0.0 112.585 177.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 16.5 p -66.78 99.48 0.62 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.221 0.608 . . . . 0.0 109.696 175.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 94.1 mt -100.23 99.27 9.16 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 123.588 0.755 . . . . 0.0 109.291 177.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -67.51 -19.36 48.85 Favored 'Trans proline' 0 C--N 1.383 2.356 0 C-N-CA 122.767 2.312 . . . . 0.0 112.771 176.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -68.69 96.35 0.72 Allowed 'General case' 0 C--N 1.354 0.787 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 174.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 23.1 m -89.87 134.37 32.13 Favored Pre-proline 0 CA--C 1.546 0.809 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.756 -177.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -60.63 152.81 66.2 Favored 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 122.345 2.03 . . . . 0.0 111.59 172.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -71.65 109.14 5.37 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.687 0.795 . . . . 0.0 111.063 -173.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 1.6 mp -91.21 169.24 11.0 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.949 177.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 265' ' ' PHE . . . . . 0.495 ' CE1' ' HG2' ' A' ' 282' ' ' MET . 10.1 p90 -150.45 138.94 12.64 Favored Pre-proline 0 CA--C 1.545 0.78 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 170.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -62.54 94.38 0.14 Allowed 'Trans proline' 0 C--N 1.377 2.03 0 C-N-CA 122.616 2.211 . . . . 0.0 111.555 173.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 267' ' ' LEU . . . . . 0.538 HD12 HG13 ' A' ' 269' ' ' ILE . 0.9 OUTLIER -59.69 125.82 25.15 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 174.266 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.579 ' HG2' HG12 ' A' ' 329' ' ' ILE . 4.8 tppp? -88.41 102.64 15.08 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.348 0.659 . . . . 0.0 110.396 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . 0.538 HG13 HD12 ' A' ' 267' ' ' LEU . 2.1 mp -103.63 129.8 55.07 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 173.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 30.8 ttp180 -90.45 109.37 20.5 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-O 121.303 0.573 . . . . 0.0 110.192 174.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 271' ' ' CYS . . . . . 0.709 ' SG ' HD21 ' A' ' 297' ' ' LEU . 49.2 t -77.87 -179.59 6.11 Favored 'General case' 0 CA--C 1.55 0.95 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.315 172.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 272' ' ' ARG . . . . . 0.401 ' N ' ' SG ' ' A' ' 271' ' ' CYS . 15.9 ptt-85 -53.24 -31.67 44.53 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.978 1.311 . . . . 0.0 113.805 -178.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -161.68 27.98 0.12 Allowed 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.694 0.798 . . . . 0.0 110.279 177.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 274' ' ' ASP . . . . . 0.462 ' HB3' ' HB3' ' A' ' 271' ' ' CYS . 34.8 t70 -144.76 158.68 43.69 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.447 0.699 . . . . 0.0 109.795 -172.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 66.2 mt -119.92 101.47 7.89 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.652 0.781 . . . . 0.0 109.81 176.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 276' ' ' VAL . . . . . 0.504 HG21 ' SD ' ' A' ' 293' ' ' MET . 65.0 t -83.75 125.57 40.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.924 179.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 86.1 mtm180 -118.86 104.83 10.9 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 175.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.494 HD21 ' HA ' ' A' ' 289' ' ' VAL . 4.3 pp -116.21 131.99 23.51 Favored Pre-proline 0 N--CA 1.487 1.398 0 CA-C-N 118.182 0.446 . . . . 0.0 110.744 178.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -65.9 115.95 3.71 Favored 'Trans proline' 0 C--N 1.381 2.24 0 C-N-CA 122.627 2.218 . . . . 0.0 110.736 177.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.714 HD21 ' HG3' ' A' ' 319' ' ' PRO . 0.4 OUTLIER -136.66 148.29 47.32 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.521 1.128 . . . . 0.0 109.463 -174.688 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -88.18 144.37 26.5 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 178.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 282' ' ' MET . . . . . 0.5 ' HB3' ' HB2' ' A' ' 320' ' ' ARG . 16.2 mtp -66.3 -27.41 67.9 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 118.154 0.434 . . . . 0.0 111.68 -177.105 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 35.1 m -79.16 -12.17 59.98 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.52 0.728 . . . . 0.0 112.01 176.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 25.6 tp10 -85.67 130.17 52.0 Favored Pre-proline 0 N--CA 1.472 0.632 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 178.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -65.01 167.32 16.24 Favored 'Trans proline' 0 C--N 1.381 2.267 0 C-N-CA 122.498 2.132 . . . . 0.0 113.119 178.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.402 ' O ' HG22 ' A' ' 289' ' ' VAL . 91.5 mt -68.48 -9.29 47.92 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.502 -178.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 26.3 tp60 -53.85 -27.98 33.13 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.563 0.745 . . . . 0.0 111.444 174.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . 0.467 ' HB2' HD12 ' A' ' 280' ' ' LEU . 67.0 m -65.92 -47.08 75.93 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.709 0.804 . . . . 0.0 112.075 175.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.494 ' HA ' HD21 ' A' ' 278' ' ' LEU . 17.1 m -71.55 -34.31 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 177.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . 0.569 HG13 ' HB ' ' A' ' 304' ' ' ILE . 37.5 t -61.61 -45.07 99.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.667 1.187 . . . . 0.0 110.95 177.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -63.74 -48.95 74.94 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.04 0.936 . . . . 0.0 110.79 -178.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 74.7 t60 -64.36 -44.9 89.98 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.18 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 293' ' ' MET . . . . . 0.504 ' SD ' HG21 ' A' ' 276' ' ' VAL . 90.9 mmm -68.34 -32.08 71.94 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 123.724 0.64 . . . . 0.0 111.42 -177.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -63.76 -43.36 96.63 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 123.698 0.624 . . . . 0.0 110.404 176.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 29.2 m -73.5 -33.08 64.62 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 123.272 0.629 . . . . 0.0 111.254 176.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 58.4 t60 -66.2 -34.43 78.0 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.183 0.993 . . . . 0.0 110.719 -178.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 297' ' ' LEU . . . . . 0.709 HD21 ' SG ' ' A' ' 271' ' ' CYS . 62.2 mt -102.31 -21.35 14.33 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.921 0.888 . . . . 0.0 111.83 -177.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 85.36 24.42 43.62 Favored Glycine 0 N--CA 1.475 1.258 0 O-C-N 123.007 0.192 . . . . 0.0 112.999 -178.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 299' ' ' VAL . . . . . 0.495 HG11 HG11 ' A' ' 334' ' ' VAL . 31.4 m -109.87 -179.42 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 124.013 0.925 . . . . 0.0 110.808 177.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 19.2 m -82.82 146.29 52.17 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 123.542 0.737 . . . . 0.0 110.277 178.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -58.92 -27.35 84.29 Favored 'Trans proline' 0 C--N 1.386 2.545 0 C-N-CA 123.001 2.468 . . . . 0.0 112.295 173.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 40.2 p -67.06 -17.39 64.87 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.847 0.859 . . . . 0.0 112.021 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 89.5 mtt180 -95.68 -25.79 15.98 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.041 0.937 . . . . 0.0 111.926 -176.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 304' ' ' ILE . . . . . 0.569 ' HB ' HG13 ' A' ' 290' ' ' VAL . 32.9 mm -72.51 115.66 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 122.601 0.36 . . . . 0.0 110.363 -177.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 27.0 tp -124.17 122.32 37.49 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.241 0.616 . . . . 0.0 109.367 177.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . 0.427 ' HG ' HD12 ' A' ' 330' ' ' ILE . 2.2 mm? -89.16 123.31 33.3 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -177.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . 0.516 HD12 HG21 ' A' ' 333' ' ' VAL . 72.7 mt -129.74 112.89 14.08 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.469 0.708 . . . . 0.0 109.622 -177.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -84.7 92.55 8.22 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 173.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 70.43 -94.59 0.49 Allowed Glycine 0 C--N 1.346 1.088 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 -174.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -133.69 82.67 2.0 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.577 0.751 . . . . 0.0 109.411 174.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 12.1 t -166.0 138.84 4.09 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 174.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -90.74 114.03 26.28 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-O 120.697 0.284 . . . . 0.0 110.698 -174.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 46.0 mt -103.74 114.49 28.8 Favored 'General case' 0 C--O 1.245 0.842 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 177.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 12.8 m -72.6 143.9 85.51 Favored Pre-proline 0 CA--C 1.553 1.079 0 C-N-CA 124.215 1.006 . . . . 0.0 111.219 -173.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . 0.542 ' HB3' HG21 ' A' ' 290' ' ' VAL . 36.5 Cg_endo -62.63 -28.65 77.1 Favored 'Trans proline' 0 C--N 1.381 2.263 0 C-N-CA 123.015 2.477 . . . . 0.0 112.357 175.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 4.7 m -73.67 -28.72 61.9 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.09 0.956 . . . . 0.0 111.329 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -78.29 154.78 30.62 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.532 0.733 . . . . 0.0 110.756 -178.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 318' ' ' THR . . . . . . . . . . . . . 82.8 p -99.46 152.9 37.96 Favored Pre-proline 0 CA--C 1.545 0.764 0 C-N-CA 123.495 0.718 . . . . 0.0 109.901 -178.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . 0.714 ' HG3' HD21 ' A' ' 280' ' ' LEU . 60.9 Cg_endo -67.92 -9.69 26.44 Favored 'Trans proline' 0 C--N 1.363 1.339 0 C-N-CA 122.975 2.45 . . . . 0.0 113.324 174.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . 0.5 ' HB2' ' HB3' ' A' ' 282' ' ' MET . 44.5 ttm180 -75.11 -48.2 24.95 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 117.786 0.266 . . . . 0.0 110.474 178.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 14.6 t -68.74 -22.88 64.29 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 122.659 0.383 . . . . 0.0 110.946 179.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 322' ' ' LEU . . . . . 0.449 ' HB2' ' HG ' ' A' ' 324' ' ' LEU . 53.2 mt -92.05 -16.13 26.86 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.73 0.812 . . . . 0.0 111.511 176.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp 65.06 31.94 10.71 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.753 1.221 . . . . 0.0 112.57 -179.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.449 ' HG ' ' HB2' ' A' ' 322' ' ' LEU . 42.0 mt -67.54 165.12 17.51 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.682 0.793 . . . . 0.0 110.839 175.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 325' ' ' GLY . . . . . 0.486 ' H ' ' HB3' ' A' ' 328' ' ' ASP . . . -158.63 -169.48 22.13 Favored Glycine 0 C--N 1.342 0.884 0 CA-C-N 116.046 -0.524 . . . . 0.0 112.699 -173.137 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 21.5 m -77.25 -25.72 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.542 0.737 . . . . 0.0 110.46 178.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -94.28 -19.44 20.69 Favored 'General case' 0 C--N 1.353 0.734 0 C-N-CA 124.164 0.985 . . . . 0.0 110.957 179.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 328' ' ' ASP . . . . . 0.486 ' HB3' ' H ' ' A' ' 325' ' ' GLY . 13.1 t70 -82.77 128.4 34.36 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 178.086 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . 0.579 HG12 ' HG2' ' A' ' 268' ' ' LYS . 9.4 mt -115.21 113.87 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 123.107 0.563 . . . . 0.0 109.852 -170.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 330' ' ' ILE . . . . . 0.427 HD12 ' HG ' ' A' ' 306' ' ' LEU . 38.6 pt -108.43 125.47 65.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-O 121.083 0.468 . . . . 0.0 110.79 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -72.34 116.96 13.4 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.839 0.856 . . . . 0.0 111.387 -175.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 332' ' ' CYS . . . . . 0.536 ' SG ' HD12 ' A' ' 304' ' ' ILE . 37.6 t -74.27 92.1 2.22 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 123.307 0.643 . . . . 0.0 109.415 169.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . 0.516 HG21 HD12 ' A' ' 307' ' ' LEU . 60.5 t -101.36 109.84 26.74 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -178.25 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 334' ' ' VAL . . . . . 0.495 HG11 HG11 ' A' ' 299' ' ' VAL . 57.6 t -79.31 93.91 1.77 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.451 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.694 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 87.4 mt -91.74 97.36 10.96 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.565 0.698 . . . . 0.0 109.508 172.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 336' ' ' THR . . . . . . . . . . . . . 10.4 t -79.61 -22.81 43.18 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 114.502 -1.226 . . . . 0.0 109.65 176.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 42.8 p -71.23 103.09 2.7 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.556 0.742 . . . . 0.0 109.548 173.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 C--O 1.251 1.149 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -179.659 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 23.0 mp0 . . . . . 0 N--CA 1.479 1.019 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -107.15 130.29 10.09 Favored Glycine 0 C--N 1.343 0.938 0 CA-C-O 119.449 -0.639 . . . . 0.0 111.557 178.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -78.78 79.42 5.19 Favored 'General case' 0 C--N 1.354 0.797 0 CA-C-O 122.029 0.918 . . . . 0.0 110.168 -178.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -104.0 25.45 9.93 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 114.662 -1.154 . . . . 0.0 109.62 174.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -72.55 84.21 1.13 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.354 1.062 . . . . 0.0 110.241 -178.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -127.52 144.9 51.01 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 114.842 -1.072 . . . . 0.0 108.8 174.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 19.6 m -94.05 59.19 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 CA-C-O 121.791 0.805 . . . . 0.0 110.186 178.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 38.1 t -69.14 95.82 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.578 -177.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 52.7 tp -152.34 95.88 2.1 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 -175.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 7.1 m -111.94 94.4 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 CA-C-O 122.034 0.921 . . . . 0.0 109.728 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.69 -169.03 1.51 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.196 0.998 . . . . 0.0 109.959 -178.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 105.76 101.19 2.69 Favored Glycine 0 C--N 1.339 0.734 0 CA-C-O 119.029 -0.873 . . . . 0.0 110.974 -176.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -73.83 171.57 17.6 Favored 'Trans proline' 0 C--N 1.376 1.986 0 C-N-CA 122.647 2.231 . . . . 0.0 112.08 -177.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 13.1 m -69.19 98.05 0.98 Allowed 'General case' 0 C--N 1.347 0.487 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 176.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 86.1 mt -91.37 107.74 23.81 Favored Pre-proline 0 CA--C 1.544 0.713 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 174.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -62.49 -23.12 74.78 Favored 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 122.728 2.285 . . . . 0.0 111.719 169.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -81.6 127.61 33.05 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 124.674 1.19 . . . . 0.0 110.15 176.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 67.6 m -68.59 126.12 92.42 Favored Pre-proline 0 CA--C 1.548 0.881 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 168.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.78 143.05 82.3 Favored 'Trans proline' 0 C--N 1.379 2.163 0 C-N-CA 122.584 2.19 . . . . 0.0 111.01 174.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 84.7 mtt180 -66.69 81.43 0.1 Allowed 'General case' 0 N--CA 1.483 1.205 0 CA-C-O 122.024 0.916 . . . . 0.0 112.299 -169.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.485 HD23 ' HG2' ' A' ' 281' ' ' ARG . 45.9 mt -72.22 125.37 27.15 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 114.736 -1.12 . . . . 0.0 108.536 174.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -109.18 142.23 25.15 Favored Pre-proline 0 C--O 1.247 0.924 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 173.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -67.09 96.01 0.38 Allowed 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 122.275 1.983 . . . . 0.0 111.363 175.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 267' ' ' LEU . . . . . 0.514 HD12 HG13 ' A' ' 269' ' ' ILE . 1.0 OUTLIER -62.06 129.07 39.12 Favored 'General case' 0 C--O 1.246 0.899 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 174.656 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.495 ' HG2' HG12 ' A' ' 329' ' ' ILE . 2.6 tppp? -94.37 102.32 14.29 Favored 'General case' 0 C--O 1.241 0.653 0 O-C-N 123.751 0.657 . . . . 0.0 109.872 -176.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . 0.514 HG13 HD12 ' A' ' 267' ' ' LEU . 1.5 mp -104.48 114.19 43.42 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 176.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 33.1 ttp180 -75.54 104.28 6.03 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 175.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 271' ' ' CYS . . . . . 0.601 ' SG ' HD21 ' A' ' 297' ' ' LEU . 38.1 t -72.59 175.98 5.87 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.27 1.028 . . . . 0.0 110.069 174.445 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 25.7 ptt180 -57.13 -28.05 62.37 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.017 0.927 . . . . 0.0 113.142 -178.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -155.45 30.14 0.38 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.376 0.67 . . . . 0.0 111.175 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -160.56 164.0 32.33 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 122.696 0.398 . . . . 0.0 110.907 -173.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -113.54 103.08 10.9 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.258 1.023 . . . . 0.0 108.948 171.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 72.8 t -83.68 130.61 35.54 Favored 'Isoleucine or valine' 0 C--N 1.343 0.301 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 177.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 76.4 mtt85 -124.32 99.49 6.23 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -179.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.493 HD21 ' HA ' ' A' ' 289' ' ' VAL . 4.3 pp -111.8 142.36 26.53 Favored Pre-proline 0 N--CA 1.489 1.476 0 CA-C-N 117.917 0.326 . . . . 0.0 110.324 -178.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -69.26 115.57 4.09 Favored 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 122.282 1.988 . . . . 0.0 110.502 177.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.733 HD21 ' HG3' ' A' ' 319' ' ' PRO . 0.9 OUTLIER -138.34 149.94 46.11 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.835 0.854 . . . . 0.0 109.992 -176.481 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . 0.485 ' HG2' HD23 ' A' ' 264' ' ' LEU . 16.2 mmm180 -94.36 151.1 19.66 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.104 0.962 . . . . 0.0 111.092 178.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 282' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -57.1 -41.31 78.67 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.122 0.569 . . . . 0.0 111.118 175.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 19.6 m -76.25 -17.83 59.3 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.378 1.071 . . . . 0.0 112.554 -177.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 284' ' ' GLU . . . . . 0.451 ' O ' ' HD2' ' A' ' 319' ' ' PRO . 8.5 tp10 -72.49 130.29 86.03 Favored Pre-proline 0 N--CA 1.476 0.838 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 176.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -66.23 166.7 20.37 Favored 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 121.937 1.758 . . . . 0.0 111.807 172.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.482 ' O ' HG23 ' A' ' 290' ' ' VAL . 65.3 mt -66.27 -15.12 62.95 Favored 'General case' 0 C--O 1.215 -0.751 0 CA-C-O 118.932 -0.556 . . . . 0.0 111.779 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 -50.54 -26.2 4.95 Favored 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 123.967 0.907 . . . . 0.0 112.204 178.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . 0.468 ' HB3' HD12 ' A' ' 280' ' ' LEU . 29.5 t -61.61 -57.2 12.96 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.087 0.955 . . . . 0.0 110.939 171.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.493 ' HA ' HD21 ' A' ' 278' ' ' LEU . 13.2 m -68.03 -29.68 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 122.494 0.317 . . . . 0.0 110.908 -179.376 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . 0.601 HG13 ' HB ' ' A' ' 304' ' ' ILE . 78.1 t -66.2 -55.37 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 123.951 0.9 . . . . 0.0 110.35 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -64.0 -37.66 88.25 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.276 -179.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 62.5 t60 -68.72 -47.63 65.87 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 122.982 0.513 . . . . 0.0 110.978 -177.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 293' ' ' MET . . . . . 0.472 ' HG3' HG21 ' A' ' 269' ' ' ILE . 91.0 mmm -65.9 -32.68 74.32 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.276 0.63 . . . . 0.0 110.966 178.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -63.6 -53.08 57.26 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 123.876 0.735 . . . . 0.0 110.964 176.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 55.4 m -64.46 -29.49 70.53 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.814 0.846 . . . . 0.0 111.176 179.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 71.1 t60 -71.42 -46.25 60.62 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.614 0.766 . . . . 0.0 110.997 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 297' ' ' LEU . . . . . 0.601 HD21 ' SG ' ' A' ' 271' ' ' CYS . 72.7 mt -91.74 -3.56 56.07 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.733 0.813 . . . . 0.0 111.797 -176.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 77.27 22.68 70.14 Favored Glycine 0 C--N 1.349 1.292 0 C-N-CA 123.206 0.432 . . . . 0.0 113.196 175.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 299' ' ' VAL . . . . . 0.518 HG11 HG11 ' A' ' 334' ' ' VAL . 25.0 m -112.07 -179.23 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 124.777 1.231 . . . . 0.0 110.832 178.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 51.7 m -87.81 147.61 41.6 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 123.831 0.852 . . . . 0.0 110.769 178.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.36 -25.9 75.06 Favored 'Trans proline' 0 C--N 1.391 2.773 0 C-N-CA 123.215 2.61 . . . . 0.0 111.909 173.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 9.2 m -61.1 -22.47 64.66 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 123.817 0.847 . . . . 0.0 111.995 178.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 46.6 mtt180 -97.83 -19.88 17.87 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.485 0.714 . . . . 0.0 112.385 -174.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 304' ' ' ILE . . . . . 0.601 ' HB ' HG13 ' A' ' 290' ' ' VAL . 37.0 mm -77.39 99.31 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 CA-C-O 121.101 0.477 . . . . 0.0 110.28 -177.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . 0.434 HD22 HD11 ' A' ' 335' ' ' LEU . 29.2 tp -101.55 112.32 24.84 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.843 0.857 . . . . 0.0 109.209 178.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -85.05 120.94 27.13 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . 0.487 HD12 HG21 ' A' ' 333' ' ' VAL . 70.8 mt -129.41 116.2 18.66 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.035 0.934 . . . . 0.0 108.868 -177.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -87.56 85.71 7.13 Favored 'General case' 0 C--O 1.244 0.764 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 174.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 67.62 -96.98 0.38 Allowed Glycine 0 C--N 1.342 0.898 0 CA-C-N 115.154 -0.93 . . . . 0.0 112.991 -179.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -110.21 11.68 23.54 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.528 0.731 . . . . 0.0 112.06 -174.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 11.4 t -116.98 152.85 33.71 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 117.863 0.301 . . . . 0.0 110.244 176.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -105.36 129.42 53.69 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.2 0.6 . . . . 0.0 109.818 178.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.425 HD22 HD22 ' A' ' 322' ' ' LEU . 49.8 mt -113.33 135.17 54.14 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.353 0.661 . . . . 0.0 109.921 -179.049 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 20.1 m -80.65 143.36 54.54 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 123.457 0.703 . . . . 0.0 110.717 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -63.26 -29.88 73.47 Favored 'Trans proline' 0 C--N 1.384 2.408 0 C-N-CA 122.866 2.377 . . . . 0.0 112.127 174.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 34.1 p -88.13 -1.36 57.96 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.273 1.029 . . . . 0.0 111.944 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -88.58 153.17 21.35 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.274 0.63 . . . . 0.0 109.981 175.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 318' ' ' THR . . . . . . . . . . . . . 82.6 p -99.37 142.79 25.24 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 123.372 0.669 . . . . 0.0 109.979 -178.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . 0.733 ' HG3' HD21 ' A' ' 280' ' ' LEU . 29.8 Cg_endo -60.76 -13.69 27.81 Favored 'Trans proline' 0 C--N 1.369 1.65 0 C-N-CA 123.441 2.761 . . . . 0.0 113.143 172.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 53.1 ttt180 -67.07 -55.2 15.32 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.167 0.587 . . . . 0.0 110.105 174.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 10.8 t -71.09 -21.06 62.27 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.06 -177.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 322' ' ' LEU . . . . . 0.445 ' HB2' ' HG ' ' A' ' 324' ' ' LEU . 53.5 mt -93.76 -10.19 35.07 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.657 0.783 . . . . 0.0 111.518 176.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 11.3 mptt 62.15 25.65 15.37 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 125.129 1.371 . . . . 0.0 112.592 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.446 HD13 HD13 ' A' ' 330' ' ' ILE . 33.3 mt -66.79 159.09 28.79 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.363 0.665 . . . . 0.0 110.276 177.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 325' ' ' GLY . . . . . 0.43 ' H ' ' HB3' ' A' ' 328' ' ' ASP . . . -157.06 -157.17 8.23 Favored Glycine 0 C--O 1.242 0.598 0 CA-C-N 116.233 -0.439 . . . . 0.0 112.466 -173.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 17.6 m -83.31 -36.67 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 123.258 0.623 . . . . 0.0 110.625 -179.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -88.85 -17.64 29.27 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.053 0.941 . . . . 0.0 110.727 178.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 328' ' ' ASP . . . . . 0.43 ' HB3' ' H ' ' A' ' 325' ' ' GLY . 3.9 t70 -90.39 115.96 27.97 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . 0.495 HG12 ' HG2' ' A' ' 268' ' ' LYS . 16.0 mt -114.52 120.95 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 123.144 0.578 . . . . 0.0 111.353 -163.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 330' ' ' ILE . . . . . 0.446 HD13 HD13 ' A' ' 324' ' ' LEU . 35.8 pt -108.95 137.08 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 123.344 0.657 . . . . 0.0 111.311 -176.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -79.9 119.46 22.79 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.724 0.81 . . . . 0.0 111.713 -176.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 332' ' ' CYS . . . . . 0.524 ' SG ' HD12 ' A' ' 304' ' ' ILE . 26.9 t -77.79 90.27 4.05 Favored 'General case' 0 C--O 1.243 0.741 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 167.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . 0.487 HG21 HD12 ' A' ' 307' ' ' LEU . 28.3 t -97.27 109.45 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -178.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 334' ' ' VAL . . . . . 0.518 HG11 HG11 ' A' ' 299' ' ' VAL . 40.0 t -85.08 100.96 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.03 -175.379 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 335' ' ' LEU . . . . . 0.434 HD11 HD22 ' A' ' 305' ' ' LEU . 3.4 pp -142.31 155.35 45.19 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.764 0.426 . . . . 0.0 111.087 -179.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 336' ' ' THR . . . . . . . . . . . . . 3.5 t -131.19 94.69 3.62 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 174.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 19.4 m -71.06 80.34 0.67 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.774 0.83 . . . . 0.0 109.697 178.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 42.7 m . . . . . 0 C--O 1.249 1.05 0 C-N-CA 124.518 1.127 . . . . 0.0 108.356 -175.12 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 . . . . . 0 N--CA 1.481 1.102 0 CA-C-O 120.718 0.294 . . . . 0.0 110.412 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -166.55 63.62 0.21 Allowed Glycine 0 C--N 1.343 0.967 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 -178.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -114.43 97.61 6.41 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.417 1.087 . . . . 0.0 110.397 -175.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -87.31 66.21 9.07 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 175.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -73.42 -32.05 64.19 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.314 175.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -99.3 114.5 27.39 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 166.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 31.8 m -75.63 148.73 7.21 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 122.906 0.482 . . . . 0.0 110.938 -178.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 5.7 p -154.55 126.38 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 123.257 0.623 . . . . 0.0 110.214 -175.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 14.6 tp -128.97 29.86 5.14 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 121.768 0.794 . . . . 0.0 109.352 178.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 3.5 p -142.83 123.27 10.43 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 124.425 1.09 . . . . 0.0 108.837 178.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 61.28 26.0 15.9 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 124.199 0.999 . . . . 0.0 112.573 178.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -133.12 109.1 0.8 Allowed Glycine 0 C--N 1.349 1.257 0 CA-C-O 119.059 -0.856 . . . . 0.0 111.697 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -87.41 11.07 3.31 Favored 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 123.138 2.559 . . . . 0.0 112.229 177.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 31.4 p -69.95 141.43 53.05 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 123.925 0.89 . . . . 0.0 110.691 178.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 85.2 mt -114.67 99.56 51.87 Favored Pre-proline 0 C--O 1.244 0.79 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 175.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -48.71 -35.27 29.71 Favored 'Trans proline' 0 C--N 1.381 2.276 0 C-N-CA 123.304 2.669 . . . . 0.0 111.823 170.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -73.3 92.04 1.76 Allowed 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 114.534 -1.212 . . . . 0.0 108.591 172.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 54.5 m -100.63 127.13 33.4 Favored Pre-proline 0 CA--C 1.547 0.859 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -70.4 111.74 3.02 Favored 'Trans proline' 0 C--N 1.377 2.069 0 C-N-CA 122.207 1.938 . . . . 0.0 110.712 175.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 24.8 ptt-85 -58.69 142.14 50.63 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.258 1.023 . . . . 0.0 112.147 -175.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.456 HD23 HH11 ' A' ' 281' ' ' ARG . 0.9 OUTLIER -126.6 136.12 52.11 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.948 0.899 . . . . 0.0 109.165 -175.298 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -113.41 142.56 27.75 Favored Pre-proline 0 N--CA 1.481 1.092 0 C-N-CA 123.053 0.541 . . . . 0.0 109.841 176.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 266' ' ' PRO . . . . . 0.412 ' O ' ' HA ' ' A' ' 326' ' ' VAL . 23.5 Cg_exo -63.3 100.43 0.26 Allowed 'Trans proline' 0 C--N 1.379 2.162 0 C-N-CA 122.914 2.409 . . . . 0.0 112.362 175.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 267' ' ' LEU . . . . . 0.518 HD23 HD22 ' A' ' 280' ' ' LEU . 0.4 OUTLIER -71.23 122.41 20.17 Favored 'General case' 0 CA--C 1.551 0.99 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 173.583 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.611 ' HG2' HG12 ' A' ' 329' ' ' ILE . 13.8 tppt? -85.52 119.97 26.46 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.528 0.731 . . . . 0.0 110.081 179.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 16.4 mt -121.18 138.56 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 124.539 1.136 . . . . 0.0 109.032 179.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 270' ' ' ARG . . . . . 0.436 ' HB2' HG22 ' A' ' 329' ' ' ILE . 29.7 ttp180 -107.82 103.88 13.24 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 123.715 0.806 . . . . 0.0 109.443 177.229 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 271' ' ' CYS . . . . . 0.77 ' SG ' HD21 ' A' ' 297' ' ' LEU . 49.8 t -77.93 179.53 6.68 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 124.482 1.113 . . . . 0.0 110.616 176.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 272' ' ' ARG . . . . . 0.42 ' N ' ' SG ' ' A' ' 271' ' ' CYS . 26.8 ptt180 -54.22 -31.87 54.31 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 125.414 1.486 . . . . 0.0 113.192 -179.149 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -162.82 33.83 0.1 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.981 0.913 . . . . 0.0 110.362 -178.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -157.97 158.05 34.2 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.353 0.661 . . . . 0.0 110.097 -170.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -117.78 123.21 45.43 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.055 0.942 . . . . 0.0 108.881 173.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 276' ' ' VAL . . . . . 0.533 HG21 ' SD ' ' A' ' 293' ' ' MET . 91.8 t -109.73 121.87 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 124.096 0.958 . . . . 0.0 109.818 178.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 20.7 mtm180 -111.51 122.17 47.13 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 169.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.462 HD11 HG12 ' A' ' 289' ' ' VAL . 4.6 pp -131.43 138.78 33.51 Favored Pre-proline 0 N--CA 1.476 0.85 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 175.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.89 94.22 0.87 Allowed 'Trans proline' 0 C--N 1.367 1.511 0 C-N-CA 122.326 2.017 . . . . 0.0 111.312 -177.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.69 HD21 ' HG3' ' A' ' 319' ' ' PRO . 2.8 tt -103.11 156.95 17.33 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.629 1.172 . . . . 0.0 110.287 -178.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . 0.456 HH11 HD23 ' A' ' 264' ' ' LEU . 0.1 OUTLIER -99.43 144.79 28.13 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.177 0.991 . . . . 0.0 110.087 -179.55 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 282' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -58.07 -34.18 69.85 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 123.918 0.887 . . . . 0.0 112.372 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 16.1 m -78.57 -22.45 47.12 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.77 0.828 . . . . 0.0 111.78 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 284' ' ' GLU . . . . . 0.427 ' HB2' ' HB2' ' A' ' 281' ' ' ARG . 8.2 tp10 -75.22 130.77 79.54 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 124.084 0.953 . . . . 0.0 109.647 -176.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -68.48 169.83 16.3 Favored 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 122.229 1.953 . . . . 0.0 112.209 174.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.41 ' O ' HG23 ' A' ' 290' ' ' VAL . 87.4 mt -71.01 -6.63 40.43 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.073 0.549 . . . . 0.0 111.688 -179.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 26.5 tp60 -57.06 -26.1 59.8 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.617 0.767 . . . . 0.0 110.526 173.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . 0.409 ' HB3' HD12 ' A' ' 280' ' ' LEU . 40.6 t -61.46 -55.9 26.16 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.591 1.156 . . . . 0.0 111.423 172.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.462 HG12 HD11 ' A' ' 278' ' ' LEU . 21.0 m -67.62 -32.5 57.16 Favored 'Isoleucine or valine' 0 C--N 1.359 1.021 0 CA-C-N 116.695 -0.229 . . . . 0.0 110.429 -179.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . 0.548 HG13 ' HB ' ' A' ' 304' ' ' ILE . 40.0 t -59.53 -48.02 88.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 124.576 1.15 . . . . 0.0 110.842 176.32 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -59.81 -48.08 83.11 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 124.243 0.964 . . . . 0.0 110.973 -179.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 13.9 t60 -65.64 -46.29 79.76 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.99 -178.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 293' ' ' MET . . . . . 0.533 ' SD ' HG21 ' A' ' 276' ' ' VAL . 89.5 mmm -67.56 -34.53 77.25 Favored 'General case' 0 N--CA 1.484 1.242 0 O-C-N 123.652 0.595 . . . . 0.0 111.418 -176.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -64.3 -42.25 96.45 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 123.733 0.646 . . . . 0.0 110.178 175.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 37.0 m -74.16 -23.86 59.31 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 123.754 0.822 . . . . 0.0 111.169 178.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 77.3 t60 -82.69 -27.39 31.27 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.267 0.627 . . . . 0.0 111.151 -178.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 297' ' ' LEU . . . . . 0.77 HD21 ' SG ' ' A' ' 271' ' ' CYS . 87.8 mt -110.44 -7.33 14.78 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.59 0.756 . . . . 0.0 111.966 -176.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 71.66 30.74 65.94 Favored Glycine 0 C--N 1.342 0.894 0 O-C-N 123.315 0.384 . . . . 0.0 112.763 178.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 299' ' ' VAL . . . . . 0.463 HG11 HG11 ' A' ' 334' ' ' VAL . 33.0 m -115.29 -177.95 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.234 1.014 . . . . 0.0 110.232 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . 0.519 ' HB2' ' HG3' ' A' ' 303' ' ' ARG . 45.1 m -85.3 146.53 45.09 Favored Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 123.37 0.668 . . . . 0.0 110.969 178.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -56.65 -30.59 84.21 Favored 'Trans proline' 0 C--N 1.386 2.506 0 C-N-CA 123.036 2.491 . . . . 0.0 112.227 169.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 32.1 t -74.95 -2.42 27.02 Favored 'General case' 0 CA--C 1.556 1.195 0 C-N-CA 123.323 0.649 . . . . 0.0 111.629 -178.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 303' ' ' ARG . . . . . 0.519 ' HG3' ' HB2' ' A' ' 300' ' ' SER . 60.4 mtt-85 -101.47 -27.01 13.37 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.849 0.859 . . . . 0.0 111.645 177.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 304' ' ' ILE . . . . . 0.548 ' HB ' HG13 ' A' ' 290' ' ' VAL . 33.5 mm -74.26 112.52 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 C-N-CA 122.938 0.495 . . . . 0.0 110.868 -174.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 48.3 tp -114.61 117.04 29.75 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.891 0.876 . . . . 0.0 109.331 176.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -86.86 127.81 35.04 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 177.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 72.8 mt -132.31 108.15 9.02 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 177.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . 0.502 ' HB2' HG22 ' A' ' 330' ' ' ILE . 39.6 t80 -75.55 92.19 2.89 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -176.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 71.56 -78.39 0.59 Allowed Glycine 0 C--N 1.348 1.239 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.065 -177.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -130.52 -12.08 3.93 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.825 0.85 . . . . 0.0 111.79 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 5.1 t -90.91 147.31 23.22 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 118.353 0.524 . . . . 0.0 110.95 -172.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -87.02 121.07 28.98 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.391 0.676 . . . . 0.0 110.534 -174.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.537 HD22 HD22 ' A' ' 322' ' ' LEU . 24.7 mt -114.5 168.75 9.59 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.073 0.549 . . . . 0.0 109.535 175.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 45.6 m -126.89 152.87 75.95 Favored Pre-proline 0 N--CA 1.48 1.066 0 C-N-CA 123.317 0.647 . . . . 0.0 109.879 177.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . 0.442 ' HB3' HG21 ' A' ' 290' ' ' VAL . 34.9 Cg_exo -58.24 -33.28 97.43 Favored 'Trans proline' 0 C--N 1.382 2.31 0 C-N-CA 122.916 2.411 . . . . 0.0 111.502 170.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 53.9 p -81.63 -0.79 44.1 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 114.643 -1.162 . . . . 0.0 112.369 -177.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -96.99 149.08 22.32 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.655 0.782 . . . . 0.0 110.755 179.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 318' ' ' THR . . . . . . . . . . . . . 28.2 p -102.39 139.94 20.68 Favored Pre-proline 0 N--CA 1.48 1.068 0 C-N-CA 123.87 0.868 . . . . 0.0 110.257 -177.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . 0.69 ' HG3' HD21 ' A' ' 280' ' ' LEU . 72.3 Cg_endo -66.12 -14.68 45.47 Favored 'Trans proline' 0 C--N 1.371 1.731 0 C-N-CA 123.753 2.969 . . . . 0.0 113.363 -173.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 22.5 ttt180 -63.37 -56.29 17.54 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.537 0.735 . . . . 0.0 110.592 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 10.0 t -70.83 -27.93 64.23 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.337 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 322' ' ' LEU . . . . . 0.537 HD22 HD22 ' A' ' 313' ' ' LEU . 43.9 mt -80.44 -10.01 59.75 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.531 0.732 . . . . 0.0 111.093 178.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp 68.49 24.3 7.13 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 125.31 1.444 . . . . 0.0 112.148 175.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.46 ' HG ' ' HB2' ' A' ' 322' ' ' LEU . 23.7 mt -75.29 156.91 35.13 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.752 0.821 . . . . 0.0 110.681 178.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 325' ' ' GLY . . . . . 0.449 ' H ' ' HB2' ' A' ' 328' ' ' ASP . . . -163.04 -151.97 6.62 Favored Glycine 0 C--O 1.243 0.705 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.348 -175.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 266' ' ' PRO . 34.0 m -76.73 -33.05 21.19 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 C-N-CA 123.08 0.552 . . . . 0.0 111.325 -178.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -94.77 -20.06 19.82 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.595 0.758 . . . . 0.0 111.629 -176.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 328' ' ' ASP . . . . . 0.449 ' HB2' ' H ' ' A' ' 325' ' ' GLY . 7.7 m-20 -78.02 120.68 23.21 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 122.922 0.489 . . . . 0.0 109.927 -177.177 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . 0.611 HG12 ' HG2' ' A' ' 268' ' ' LYS . 8.7 mt -105.19 111.23 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 123.84 0.856 . . . . 0.0 110.623 -169.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 330' ' ' ILE . . . . . 0.502 HG22 ' HB2' ' A' ' 308' ' ' PHE . 45.5 pt -102.56 124.21 56.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 CA-C-O 121.22 0.533 . . . . 0.0 111.135 -179.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -73.34 115.89 13.25 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.673 0.789 . . . . 0.0 111.035 -178.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 332' ' ' CYS . . . . . 0.471 ' SG ' HD12 ' A' ' 304' ' ' ILE . 39.5 t -78.11 95.03 4.8 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 170.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 59.4 t -102.02 109.91 27.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 123.452 0.701 . . . . 0.0 109.111 -177.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 334' ' ' VAL . . . . . 0.48 HG22 HD13 ' A' ' 304' ' ' ILE . 47.5 t -83.8 99.32 6.2 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 C-N-CA 123.26 0.624 . . . . 0.0 110.052 -178.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 85.8 mt -101.38 -172.38 2.15 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.967 0.907 . . . . 0.0 110.225 175.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 336' ' ' THR . . . . . . . . . . . . . 25.9 m -124.66 59.38 1.2 Allowed 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 174.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 11.9 p -67.83 108.56 3.03 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 114.316 -1.311 . . . . 0.0 110.193 -178.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 15.6 m . . . . . 0 C--O 1.254 1.316 0 C-N-CA 124.221 1.009 . . . . 0.0 109.3 -175.883 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 . . . . . 0 N--CA 1.474 0.726 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -88.81 -26.08 27.94 Favored Glycine 0 C--N 1.349 1.267 0 CA-C-O 119.551 -0.583 . . . . 0.0 113.245 179.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 63.95 -79.79 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 125.225 1.41 . . . . 0.0 110.98 -175.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 56.12 35.02 24.92 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.555 1.142 . . . . 0.0 111.093 -176.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -133.22 70.63 1.46 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 -179.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.82 36.84 4.39 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 114.389 -1.278 . . . . 0.0 110.392 -176.194 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 59.4 t -64.89 140.61 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 CA-C-N 114.717 -1.128 . . . . 0.0 109.638 175.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 45.7 t -72.71 81.15 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 CA-C-O 121.9 0.857 . . . . 0.0 109.996 -179.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 27.8 tp -159.95 16.25 0.14 Allowed 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 125.833 1.653 . . . . 0.0 107.313 170.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 7.3 p -72.55 133.12 32.39 Favored 'Isoleucine or valine' 0 C--N 1.354 0.773 0 C-N-CA 123.846 0.858 . . . . 0.0 110.618 -171.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -162.32 103.02 1.09 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.936 0.894 . . . . 0.0 108.738 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 135.94 -73.06 0.45 Allowed Glycine 0 CA--C 1.535 1.305 0 CA-C-O 118.987 -0.896 . . . . 0.0 112.998 -178.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -59.74 -67.46 0.05 OUTLIER 'Trans proline' 0 C--N 1.382 2.301 0 C-N-CA 123.28 2.653 . . . . 0.0 113.4 -175.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 23.8 p -145.37 132.89 20.82 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.233 1.013 . . . . 0.0 109.126 -177.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 87.9 mt -114.97 79.58 6.17 Favored Pre-proline 0 N--CA 1.481 1.103 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 171.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.66 -32.19 24.55 Favored 'Trans proline' 0 C--N 1.383 2.365 0 C-N-CA 122.666 2.244 . . . . 0.0 112.202 -173.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -138.14 107.44 6.1 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.409 1.083 . . . . 0.0 109.648 177.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 19.4 p -94.22 167.44 13.47 Favored Pre-proline 0 CA--C 1.556 1.176 0 C-N-CA 124.483 1.113 . . . . 0.0 109.943 172.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -45.1 117.42 1.59 Allowed 'Trans proline' 0 C--N 1.392 2.868 0 C-N-CA 123.155 2.57 . . . . 0.0 111.11 170.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 19.2 mtp180 -56.54 124.78 19.41 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 124.587 1.179 . . . . 0.0 111.871 -165.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.499 ' HG ' ' HG3' ' A' ' 281' ' ' ARG . 3.3 mp -96.4 149.26 21.92 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.707 -170.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 265' ' ' PHE . . . . . 0.468 ' CE1' ' HG2' ' A' ' 282' ' ' MET . 15.2 p90 -125.34 143.83 45.76 Favored Pre-proline 0 CA--C 1.549 0.92 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 172.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -62.93 96.61 0.17 Allowed 'Trans proline' 0 C--N 1.373 1.852 0 C-N-CA 122.564 2.176 . . . . 0.0 112.01 174.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.37 120.14 12.8 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 170.099 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.513 ' HE3' HG12 ' A' ' 329' ' ' ILE . 25.5 ttpt -93.95 111.61 23.34 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 121.464 0.65 . . . . 0.0 110.008 -177.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 4.3 mp -106.75 130.33 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.31 1.044 . . . . 0.0 108.872 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 270' ' ' ARG . . . . . 0.409 ' HB2' ' CG2' ' A' ' 329' ' ' ILE . 23.1 ttm180 -84.5 101.01 11.74 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.196 0.522 . . . . 0.0 109.916 173.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 271' ' ' CYS . . . . . 0.586 ' SG ' HD21 ' A' ' 297' ' ' LEU . 52.5 t -69.5 175.56 4.0 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.971 169.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 272' ' ' ARG . . . . . 0.457 ' HG2' ' SG ' ' A' ' 271' ' ' CYS . 7.5 ptm180 -53.29 -25.95 16.65 Favored 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 124.862 1.265 . . . . 0.0 113.344 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -163.45 37.24 0.09 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.268 0.627 . . . . 0.0 111.205 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -165.27 162.65 19.94 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 122.838 0.455 . . . . 0.0 111.4 -175.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.447 HD13 ' HD2' ' A' ' 268' ' ' LYS . 86.5 mt -114.55 104.15 11.72 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.437 1.095 . . . . 0.0 109.662 172.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 79.5 t -86.47 110.29 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 174.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 20.6 mtm180 -103.95 84.13 2.21 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.519 HD21 ' HA ' ' A' ' 289' ' ' VAL . 4.4 pp -94.68 147.58 33.42 Favored Pre-proline 0 N--CA 1.486 1.367 0 CA-C-O 119.296 -0.383 . . . . 0.0 110.797 -174.386 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.01 120.75 6.5 Favored 'Trans proline' 0 C--N 1.378 2.105 0 C-N-CA 122.35 2.033 . . . . 0.0 111.008 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.718 HD21 ' HG3' ' A' ' 319' ' ' PRO . 1.0 OUTLIER -139.72 151.19 45.66 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.488 1.115 . . . . 0.0 109.265 -175.98 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . 0.501 ' HD2' ' H ' ' A' ' 281' ' ' ARG . 0.0 OUTLIER -97.15 149.36 22.08 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.534 -0.914 . . . . 0.0 108.534 -177.386 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 282' ' ' MET . . . . . 0.541 ' HA ' ' HG2' ' A' ' 319' ' ' PRO . 14.4 mtp -70.88 -20.15 62.55 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 118.448 0.567 . . . . 0.0 111.378 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 20.6 t -92.6 5.03 52.43 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 123.696 0.799 . . . . 0.0 111.081 176.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -99.25 133.47 22.03 Favored Pre-proline 0 N--CA 1.478 0.96 0 C-N-CA 124.178 0.991 . . . . 0.0 109.027 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.32 164.38 23.2 Favored 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 122.154 1.903 . . . . 0.0 111.941 171.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 67.9 mt -65.64 -12.03 49.85 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 118.861 -0.59 . . . . 0.0 112.204 -178.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 287' ' ' GLN . . . . . 0.414 ' HA ' ' HB ' ' A' ' 290' ' ' VAL . 25.5 tp60 -55.0 -23.42 19.27 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 122.94 0.496 . . . . 0.0 111.945 177.126 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . 0.634 ' HB3' HD12 ' A' ' 280' ' ' LEU . 43.7 t -59.4 -54.19 49.52 Favored 'General case' 0 CA--C 1.557 1.249 0 C-N-CA 123.464 0.706 . . . . 0.0 111.47 169.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.519 ' HA ' HD21 ' A' ' 278' ' ' LEU . 20.6 m -70.42 -36.15 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 C-N-CA 122.026 0.131 . . . . 0.0 110.862 179.246 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . 0.565 HG13 ' HB ' ' A' ' 304' ' ' ILE . 74.3 t -61.82 -45.29 99.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.184 0.994 . . . . 0.0 110.853 -178.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -64.08 -51.26 64.91 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 124.046 0.842 . . . . 0.0 110.975 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 47.8 t60 -63.99 -42.55 97.17 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 123.784 0.678 . . . . 0.0 111.097 -176.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 95.4 mmm -67.32 -35.62 79.8 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.218 0.607 . . . . 0.0 110.766 178.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -65.78 -43.78 87.78 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.148 0.579 . . . . 0.0 110.923 176.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 31.9 m -68.36 -34.51 76.2 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.581 0.753 . . . . 0.0 111.068 178.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 23.3 t60 -69.97 -49.87 47.45 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.677 0.791 . . . . 0.0 110.2 -179.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 297' ' ' LEU . . . . . 0.586 HD21 ' SG ' ' A' ' 271' ' ' CYS . 55.9 mt -84.49 -11.66 55.71 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.017 0.927 . . . . 0.0 111.737 -175.159 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 72.04 37.91 59.99 Favored Glycine 0 C--N 1.351 1.362 0 O-C-N 123.273 0.358 . . . . 0.0 112.757 178.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 299' ' ' VAL . . . . . 0.496 HG11 HG11 ' A' ' 334' ' ' VAL . 34.8 m -123.42 177.9 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.326 1.051 . . . . 0.0 110.145 178.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . 0.492 ' HB2' ' HG3' ' A' ' 303' ' ' ARG . 46.9 m -79.03 147.88 70.69 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 123.431 0.692 . . . . 0.0 110.556 175.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -57.68 -27.29 76.87 Favored 'Trans proline' 0 C--N 1.385 2.46 0 C-N-CA 123.068 2.512 . . . . 0.0 112.336 172.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 57.3 p -68.42 -18.52 64.46 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.768 0.827 . . . . 0.0 111.922 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 303' ' ' ARG . . . . . 0.492 ' HG3' ' HB2' ' A' ' 300' ' ' SER . 97.1 mtt180 -89.21 -28.05 20.23 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.69 0.796 . . . . 0.0 111.707 -178.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 304' ' ' ILE . . . . . 0.565 ' HB ' HG13 ' A' ' 290' ' ' VAL . 40.3 mm -72.95 117.72 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 123.06 0.544 . . . . 0.0 109.737 -179.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 31.4 tp -125.16 114.73 19.4 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 177.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -83.91 121.67 27.67 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -178.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . 0.451 HD12 HG21 ' A' ' 333' ' ' VAL . 76.7 mt -129.54 116.46 18.96 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.298 1.039 . . . . 0.0 109.082 -176.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -91.82 96.66 10.53 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 174.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 74.36 -82.98 0.77 Allowed Glycine 0 C--N 1.345 1.045 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.872 177.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -132.05 -6.19 3.49 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.296 0.638 . . . . 0.0 111.458 -179.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 6.2 t -91.98 147.2 23.14 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 122.538 0.335 . . . . 0.0 110.344 -179.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -98.84 131.05 45.25 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.066 0.546 . . . . 0.0 109.757 178.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.525 HD22 HD22 ' A' ' 322' ' ' LEU . 44.9 mt -113.53 130.76 56.28 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.3 0.64 . . . . 0.0 109.63 -179.115 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 37.4 m -76.24 142.33 71.61 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 123.153 0.581 . . . . 0.0 111.314 178.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . 0.504 ' HB3' HG21 ' A' ' 290' ' ' VAL . 35.3 Cg_endo -62.5 -23.26 74.83 Favored 'Trans proline' 0 C--N 1.38 2.217 0 C-N-CA 123.041 2.494 . . . . 0.0 112.436 173.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 52.3 p -80.78 -22.83 39.76 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.035 0.934 . . . . 0.0 111.573 178.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -71.6 154.74 41.21 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.289 0.636 . . . . 0.0 111.477 -178.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 318' ' ' THR . . . . . . . . . . . . . 74.2 p -105.74 149.41 37.91 Favored Pre-proline 0 N--CA 1.477 0.89 0 C-N-CA 123.998 0.919 . . . . 0.0 109.884 -176.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . 0.718 ' HG3' HD21 ' A' ' 280' ' ' LEU . 85.6 Cg_endo -68.66 -11.38 31.74 Favored 'Trans proline' 0 C--N 1.372 1.789 0 C-N-CA 123.263 2.642 . . . . 0.0 112.871 -178.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 38.5 ttt180 -69.01 -56.37 7.99 Favored 'General case' 0 C--N 1.347 0.488 0 C-N-CA 123.138 0.575 . . . . 0.0 109.6 177.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 15.1 t -71.01 -24.31 62.35 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.259 -178.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 322' ' ' LEU . . . . . 0.525 HD22 HD22 ' A' ' 313' ' ' LEU . 69.8 mt -86.01 -15.75 40.44 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.24 0.616 . . . . 0.0 111.31 175.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 44.4 tptt 68.05 27.89 6.87 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 125.251 1.42 . . . . 0.0 111.804 177.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.439 ' HG ' ' HB2' ' A' ' 322' ' ' LEU . 29.0 mt -68.29 159.18 31.83 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.483 0.713 . . . . 0.0 110.59 178.264 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 325' ' ' GLY . . . . . 0.472 ' H ' ' HB3' ' A' ' 328' ' ' ASP . . . -160.8 -178.15 34.53 Favored Glycine 0 C--N 1.341 0.846 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.429 -172.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 34.2 m -70.81 -20.06 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 123.943 0.897 . . . . 0.0 111.909 179.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -97.51 -15.76 20.41 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.001 0.92 . . . . 0.0 111.274 176.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 328' ' ' ASP . . . . . 0.472 ' HB3' ' H ' ' A' ' 325' ' ' GLY . 15.4 t70 -83.35 143.38 30.38 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.113 0.565 . . . . 0.0 109.671 -177.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . 0.513 HG12 ' HE3' ' A' ' 268' ' ' LYS . 6.2 mt -130.0 120.6 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 122.72 0.408 . . . . 0.0 110.402 -178.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 30.1 pt -113.55 131.87 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 123.42 0.688 . . . . 0.0 110.595 178.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -77.35 118.68 20.05 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.729 0.812 . . . . 0.0 111.792 -172.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 332' ' ' CYS . . . . . 0.552 ' SG ' HD12 ' A' ' 304' ' ' ILE . 40.5 t -80.03 94.58 5.96 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.947 0.899 . . . . 0.0 109.999 171.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . 0.451 HG21 HD12 ' A' ' 307' ' ' LEU . 90.9 t -97.36 112.54 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 123.213 0.605 . . . . 0.0 109.594 178.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 334' ' ' VAL . . . . . 0.496 HG11 HG11 ' A' ' 299' ' ' VAL . 83.9 t -82.85 125.24 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 175.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 1.2 pp -148.34 173.43 13.06 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.261 1.025 . . . . 0.0 110.564 -177.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 336' ' ' THR . . . . . . . . . . . . . 76.0 m -104.54 -60.62 1.57 Allowed 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.142 0.577 . . . . 0.0 110.204 177.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 36.7 m 65.33 -73.08 0.06 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 125.769 1.628 . . . . 0.0 112.213 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 19.9 m . . . . . 0 CA--C 1.558 1.283 0 C-N-CA 125.259 1.423 . . . . 0.0 110.934 179.289 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 24.2 mp0 . . . . . 0 N--CA 1.482 1.138 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 156.48 145.99 4.35 Favored Glycine 0 C--N 1.346 1.113 0 O-C-N 123.562 0.539 . . . . 0.0 112.686 173.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -141.28 89.67 2.25 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 172.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -99.21 18.15 18.24 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 123.654 0.782 . . . . 0.0 109.6 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -75.69 83.19 2.68 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 124.327 1.051 . . . . 0.0 110.082 -178.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -89.5 49.71 1.79 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.469 1.108 . . . . 0.0 110.011 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 31.3 m -87.77 153.28 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.02 0.928 . . . . 0.0 110.879 -176.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 17.8 m -70.54 -14.8 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 C-N-CA 122.431 0.292 . . . . 0.0 111.206 179.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 55.2 tp -78.96 90.98 4.78 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.749 0.82 . . . . 0.0 108.973 171.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 4.1 p -88.73 102.14 12.58 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 172.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -103.02 147.02 27.48 Favored 'General case' 0 C--O 1.242 0.658 0 C-N-CA 123.384 0.673 . . . . 0.0 110.236 -176.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 127.15 72.41 0.18 Allowed Glycine 0 CA--C 1.528 0.871 0 CA-C-O 119.17 -0.794 . . . . 0.0 111.818 178.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -68.64 141.32 49.7 Favored 'Trans proline' 0 C--N 1.383 2.357 0 C-N-CA 123.543 2.829 . . . . 0.0 110.835 178.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 47.8 m 69.75 162.0 0.22 Allowed 'General case' 0 CA--C 1.563 1.449 0 C-N-CA 124.7 1.2 . . . . 0.0 110.609 -175.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 61.2 mt -113.74 79.0 4.18 Favored Pre-proline 0 CA--C 1.553 1.074 0 O-C-N 121.481 -0.762 . . . . 0.0 109.293 171.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -72.69 -41.94 1.37 Allowed 'Trans proline' 0 C--N 1.383 2.353 0 C-N-CA 122.398 2.066 . . . . 0.0 110.88 177.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -103.11 96.58 6.88 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.901 1.28 . . . . 0.0 108.049 170.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 65.5 m -57.59 135.65 82.36 Favored Pre-proline 0 CA--C 1.554 1.111 0 CA-C-O 117.951 -1.023 . . . . 0.0 109.987 173.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -42.07 115.77 0.51 Allowed 'Trans proline' 0 C--N 1.399 3.192 0 C-N-CA 123.993 3.128 . . . . 0.0 111.402 178.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 64.8 ttt180 -57.65 104.96 0.21 Allowed 'General case' 0 C--N 1.354 0.785 0 O-C-N 124.171 0.919 . . . . 0.0 112.868 -162.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.452 ' H ' HD12 ' A' ' 264' ' ' LEU . 3.6 mp -76.89 167.82 21.16 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.49 176.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 265' ' ' PHE . . . . . 0.418 ' CE1' ' HG2' ' A' ' 282' ' ' MET . 34.8 p90 -138.39 144.58 43.36 Favored Pre-proline 0 N--CA 1.478 0.934 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 177.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.09 88.34 0.08 OUTLIER 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 123.25 2.633 . . . . 0.0 113.325 175.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -67.48 121.76 16.51 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 171.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.45 ' HE3' HG12 ' A' ' 329' ' ' ILE . 23.4 ttpt -97.32 122.76 40.72 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 121.37 0.605 . . . . 0.0 110.769 -178.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . 0.451 HG21 ' HG3' ' A' ' 293' ' ' MET . 2.1 mp -119.36 130.99 73.26 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 C-N-CA 124.943 1.297 . . . . 0.0 108.163 -178.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 25.5 ttp180 -94.92 107.41 19.45 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 122.989 0.516 . . . . 0.0 110.447 177.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 271' ' ' CYS . . . . . 0.787 ' SG ' HD21 ' A' ' 297' ' ' LEU . 37.7 t -70.42 -176.54 1.25 Allowed 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.147 0.979 . . . . 0.0 110.065 168.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 21.3 ptt180 -59.78 -30.6 68.99 Favored 'General case' 0 CA--C 1.557 1.23 0 C-N-CA 123.455 0.702 . . . . 0.0 112.077 179.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -159.42 35.03 0.2 Allowed 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.409 0.684 . . . . 0.0 111.37 -178.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -156.02 151.73 27.23 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 122.766 0.426 . . . . 0.0 110.519 -176.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -116.37 114.76 24.73 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.137 0.975 . . . . 0.0 109.109 174.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 95.6 t -99.85 129.48 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.086 0.955 . . . . 0.0 108.883 173.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 90.7 mtm180 -119.47 86.17 2.51 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 176.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.401 HD21 HG12 ' A' ' 289' ' ' VAL . 4.3 pp -96.72 141.03 22.49 Favored Pre-proline 0 N--CA 1.478 0.941 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -176.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.62 120.49 7.42 Favored 'Trans proline' 0 C--N 1.371 1.718 0 C-N-CA 122.407 2.071 . . . . 0.0 110.841 173.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.712 HD21 ' HG3' ' A' ' 319' ' ' PRO . 0.0 OUTLIER -135.39 155.42 50.6 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.31 1.044 . . . . 0.0 110.001 -178.329 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -93.23 143.16 26.53 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.514 1.126 . . . . 0.0 109.641 177.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 282' ' ' MET . . . . . 0.477 ' HA ' ' HG2' ' A' ' 319' ' ' PRO . 35.0 mtp -67.99 -25.2 65.29 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 118.354 0.524 . . . . 0.0 110.095 176.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 10.3 p -74.64 -34.72 62.81 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.004 1.321 . . . . 0.0 111.592 176.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -70.02 125.49 92.01 Favored Pre-proline 0 N--CA 1.473 0.715 0 C-N-CA 124.121 0.969 . . . . 0.0 108.764 173.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . 0.481 ' HA ' ' HA ' ' A' ' 318' ' ' THR . 44.8 Cg_endo -63.58 176.81 2.0 Favored 'Trans proline' 0 C--N 1.381 2.263 0 C-N-CA 122.598 2.199 . . . . 0.0 112.439 174.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.458 ' O ' HG23 ' A' ' 290' ' ' VAL . 86.5 mt -65.26 -17.01 64.16 Favored 'General case' 0 C--O 1.22 -0.483 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.773 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 24.7 tp60 -48.89 -27.63 3.21 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.905 0.882 . . . . 0.0 112.657 178.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . 0.467 ' HB3' HD12 ' A' ' 280' ' ' LEU . 43.2 t -57.4 -62.13 1.99 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.553 1.141 . . . . 0.0 111.205 170.221 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.403 ' HB ' HG12 ' A' ' 269' ' ' ILE . 15.9 m -69.19 -26.84 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 123.149 0.58 . . . . 0.0 110.784 -176.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . 0.556 HG13 ' HB ' ' A' ' 304' ' ' ILE . 77.1 t -62.62 -52.16 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 123.802 0.841 . . . . 0.0 110.223 176.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -67.24 -39.6 86.21 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.378 0.671 . . . . 0.0 110.882 -178.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 23.3 t60 -67.5 -45.58 75.41 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 123.443 0.465 . . . . 0.0 110.833 -176.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 293' ' ' MET . . . . . 0.451 ' HG3' HG21 ' A' ' 269' ' ' ILE . 93.3 mmm -70.06 -30.09 67.26 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.064 0.546 . . . . 0.0 110.818 178.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -64.91 -42.72 94.5 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.201 0.6 . . . . 0.0 110.64 173.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 41.3 m -68.71 -34.26 75.34 Favored 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 123.781 0.832 . . . . 0.0 110.62 176.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -70.54 -34.39 72.2 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.185 0.994 . . . . 0.0 111.3 -178.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 297' ' ' LEU . . . . . 0.787 HD21 ' SG ' ' A' ' 271' ' ' CYS . 36.8 mt -100.73 -7.19 24.01 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.116 0.966 . . . . 0.0 111.501 -179.124 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 77.2 6.06 85.88 Favored Glycine 0 N--CA 1.474 1.194 0 C-N-CA 123.412 0.53 . . . . 0.0 113.784 178.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 32.3 m -94.88 -176.82 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 124.139 0.975 . . . . 0.0 111.053 -177.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 19.8 m -87.28 147.34 42.07 Favored Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 123.238 0.615 . . . . 0.0 110.159 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -55.08 -29.67 66.59 Favored 'Trans proline' 0 C--N 1.387 2.559 0 C-N-CA 122.946 2.431 . . . . 0.0 112.459 170.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 20.3 m -62.57 -26.92 68.84 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 122.941 0.496 . . . . 0.0 111.478 178.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 58.3 mtt180 -88.0 -20.13 26.25 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.301 1.04 . . . . 0.0 112.416 -175.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 304' ' ' ILE . . . . . 0.58 HD12 ' SG ' ' A' ' 332' ' ' CYS . 41.7 mm -82.64 125.65 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 122.811 0.444 . . . . 0.0 110.996 -177.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 48.6 tp -127.98 121.69 30.45 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.101 0.96 . . . . 0.0 108.94 176.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . 0.445 ' HG ' HD12 ' A' ' 330' ' ' ILE . 3.0 mm? -88.48 134.54 33.82 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . 0.408 HD12 HG21 ' A' ' 333' ' ' VAL . 76.1 mt -136.48 103.97 5.43 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.86 0.864 . . . . 0.0 109.257 -177.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . 0.475 ' HB2' HD11 ' A' ' 313' ' ' LEU . 82.5 t80 -77.37 92.44 3.94 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -178.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 70.5 -78.52 0.46 Allowed Glycine 0 C--N 1.349 1.275 0 CA-C-N 116.24 -0.436 . . . . 0.0 112.326 -179.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -146.49 54.47 1.13 Allowed 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 123.929 0.892 . . . . 0.0 110.643 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 11.2 t -147.27 150.82 35.56 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 122.815 0.446 . . . . 0.0 110.238 175.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -87.98 119.73 28.63 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.807 0.843 . . . . 0.0 110.119 -179.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.527 HD22 HD22 ' A' ' 322' ' ' LEU . 45.7 mt -117.55 122.3 43.29 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 178.055 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 18.3 m -79.73 150.81 73.24 Favored Pre-proline 0 CA--C 1.55 0.979 0 C-N-CA 123.413 0.685 . . . . 0.0 110.853 178.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . 0.414 ' HB3' HG21 ' A' ' 290' ' ' VAL . 51.2 Cg_exo -56.21 -32.48 87.61 Favored 'Trans proline' 0 C--N 1.382 2.298 0 C-N-CA 122.827 2.351 . . . . 0.0 112.22 170.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 77.2 p -75.77 -16.93 60.05 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-N 114.353 -1.294 . . . . 0.0 112.128 -178.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -77.18 144.45 38.33 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.236 0.614 . . . . 0.0 110.334 178.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 318' ' ' THR . . . . . 0.481 ' HA ' ' HA ' ' A' ' 285' ' ' PRO . 25.2 p -99.21 138.38 20.55 Favored Pre-proline 0 N--CA 1.474 0.76 0 C-N-CA 123.568 0.747 . . . . 0.0 109.981 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . 0.712 ' HG3' HD21 ' A' ' 280' ' ' LEU . 18.5 Cg_endo -55.94 -19.82 27.31 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 123.926 3.084 . . . . 0.0 113.974 179.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -66.63 -51.01 61.03 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.146 0.578 . . . . 0.0 111.5 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 15.2 t -72.94 -20.16 61.11 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.502 0.321 . . . . 0.0 110.93 -179.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 322' ' ' LEU . . . . . 0.527 HD22 HD22 ' A' ' 313' ' ' LEU . 36.9 mt -85.1 -17.55 37.0 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.362 0.665 . . . . 0.0 110.404 176.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 323' ' ' LYS . . . . . 0.526 ' HE2' ' HA ' ' A' ' 323' ' ' LYS . 0.5 OUTLIER 61.56 58.1 2.14 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.233 1.413 . . . . 0.0 110.466 -178.749 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.457 ' HG ' ' HB2' ' A' ' 322' ' ' LEU . 76.3 mt -95.56 171.27 8.79 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.051 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 325' ' ' GLY . . . . . 0.457 ' H ' ' HB2' ' A' ' 328' ' ' ASP . . . -167.87 -171.99 34.42 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.108 -175.189 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 34.1 m -67.82 -28.93 43.28 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 C-N-CA 123.977 0.911 . . . . 0.0 111.452 177.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -93.54 -15.87 25.02 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.144 0.978 . . . . 0.0 111.387 -178.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 328' ' ' ASP . . . . . 0.457 ' HB2' ' H ' ' A' ' 325' ' ' GLY . 5.3 m-20 -89.78 123.94 34.21 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.176 0.591 . . . . 0.0 109.708 -178.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . 0.45 HG12 ' HE3' ' A' ' 268' ' ' LYS . 19.6 mt -109.41 127.36 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 123.378 0.671 . . . . 0.0 110.183 -175.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 330' ' ' ILE . . . . . 0.445 HD12 ' HG ' ' A' ' 306' ' ' LEU . 30.9 pt -111.56 128.53 68.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 C-N-CA 123.251 0.62 . . . . 0.0 110.346 177.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -76.81 110.43 11.41 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.844 0.858 . . . . 0.0 111.587 -174.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 332' ' ' CYS . . . . . 0.58 ' SG ' HD12 ' A' ' 304' ' ' ILE . 31.8 t -75.69 105.2 6.6 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.788 0.835 . . . . 0.0 110.447 172.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . 0.408 HG21 HD12 ' A' ' 307' ' ' LEU . 88.4 t -111.47 122.03 65.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 123.668 0.787 . . . . 0.0 110.041 -178.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 59.7 t -86.05 98.62 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 123.305 0.642 . . . . 0.0 109.741 178.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 92.8 mt -100.35 137.28 38.98 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 172.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 336' ' ' THR . . . . . . . . . . . . . 40.3 p -72.46 81.43 1.06 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.644 0.777 . . . . 0.0 111.055 -176.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 19.3 m -86.1 142.95 28.32 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.997 0.919 . . . . 0.0 111.015 -177.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 29.0 p . . . . . 0 C--O 1.25 1.12 0 C-N-CA 123.517 0.727 . . . . 0.0 109.422 179.998 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 . . . . . 0 N--CA 1.482 1.136 0 CA-C-O 120.709 0.29 . . . . 0.0 111.224 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -174.47 -124.98 0.82 Allowed Glycine 0 C--N 1.35 1.349 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.528 179.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -76.99 -6.91 54.48 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.232 1.013 . . . . 0.0 111.499 -176.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -69.71 -12.23 61.47 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 123.34 0.656 . . . . 0.0 111.022 174.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -61.45 93.72 0.04 OUTLIER 'General case' 0 C--N 1.36 1.045 0 C-N-CA 123.852 0.861 . . . . 0.0 110.429 178.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -129.25 -170.93 2.37 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 114.272 -1.331 . . . . 0.0 109.396 178.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 35.9 m -59.77 135.04 24.78 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.222 0 C-N-CA 123.497 0.719 . . . . 0.0 111.878 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 44.1 t -80.67 93.97 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -178.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 3.3 pp -95.89 4.62 52.62 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.057 0.943 . . . . 0.0 111.925 -176.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 11.4 p -148.97 144.56 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 123.715 0.806 . . . . 0.0 109.027 -175.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . 0.458 ' HG2' ' HD3' ' A' ' 256' ' ' PRO . 0.5 OUTLIER -118.92 175.19 5.87 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.944 0.897 . . . . 0.0 110.036 175.762 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -129.39 80.45 0.35 Allowed Glycine 0 N--CA 1.468 0.824 0 N-CA-C 111.329 -0.708 . . . . 0.0 111.329 178.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . 0.458 ' HD3' ' HG2' ' A' ' 254' ' ' GLU . 58.4 Cg_endo -68.88 102.15 0.86 Allowed 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 122.68 2.253 . . . . 0.0 111.24 177.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 29.4 p -75.03 86.89 2.34 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.978 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 85.3 mt -121.51 92.51 48.68 Favored Pre-proline 0 N--CA 1.472 0.63 0 C-N-CA 124.755 1.222 . . . . 0.0 109.074 -178.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -72.33 -25.68 18.22 Favored 'Trans proline' 0 C--N 1.37 1.702 0 C-N-CA 122.254 1.969 . . . . 0.0 111.672 173.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -76.36 93.33 3.45 Favored 'General case' 0 C--N 1.352 0.687 0 C-N-CA 124.283 1.033 . . . . 0.0 109.049 177.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 20.9 m -73.48 141.15 79.62 Favored Pre-proline 0 CA--C 1.55 0.98 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.67 176.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . 0.415 ' O ' HD12 ' A' ' 264' ' ' LEU . 25.3 Cg_endo -58.71 168.77 3.86 Favored 'Trans proline' 0 C--N 1.389 2.708 0 C-N-CA 122.411 2.074 . . . . 0.0 112.256 172.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -88.43 92.2 9.09 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-O 121.363 0.601 . . . . 0.0 110.279 -178.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.415 HD12 ' O ' ' A' ' 262' ' ' PRO . 3.7 mp -88.76 152.57 21.7 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 114.668 -1.151 . . . . 0.0 108.699 171.238 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -136.9 150.52 69.99 Favored Pre-proline 0 CA--C 1.549 0.905 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -68.07 90.73 0.38 Allowed 'Trans proline' 0 C--N 1.376 1.983 0 C-N-CA 122.459 2.106 . . . . 0.0 112.029 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.37 113.49 4.68 Favored 'General case' 0 C--N 1.349 0.55 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 169.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.444 ' O ' ' HA ' ' A' ' 329' ' ' ILE . 22.6 ttpt -92.37 111.58 23.21 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.259 0.623 . . . . 0.0 109.883 -176.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 4.7 mp -106.72 129.3 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 123.703 0.801 . . . . 0.0 109.271 179.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 270' ' ' ARG . . . . . 0.414 ' HA ' HD13 ' A' ' 275' ' ' LEU . 39.5 ttp180 -84.57 98.78 10.34 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 122.879 0.471 . . . . 0.0 110.002 175.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 271' ' ' CYS . . . . . 0.745 ' SG ' HD21 ' A' ' 297' ' ' LEU . 41.9 t -69.56 175.6 4.02 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.1 171.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 272' ' ' ARG . . . . . 0.416 ' N ' ' SG ' ' A' ' 271' ' ' CYS . 16.2 ptt180 -54.33 -30.1 50.24 Favored 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 124.299 1.04 . . . . 0.0 112.314 178.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -159.76 37.82 0.19 Allowed 'General case' 0 C--N 1.354 0.801 0 C-N-CA 123.794 0.838 . . . . 0.0 110.948 -176.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -166.23 158.79 14.47 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 122.673 0.389 . . . . 0.0 111.128 -175.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.414 HD13 ' HA ' ' A' ' 270' ' ' ARG . 4.2 mm? -115.69 97.39 6.1 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.118 0.967 . . . . 0.0 109.07 173.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 46.3 t -84.99 98.53 6.29 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.595 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 39.6 mtt85 -96.89 79.86 2.96 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -178.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.6 pp -92.15 142.53 26.34 Favored Pre-proline 0 N--CA 1.487 1.386 0 CA-C-O 119.404 -0.331 . . . . 0.0 110.392 -172.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -74.23 109.75 2.95 Favored 'Trans proline' 0 C--N 1.373 1.835 0 C-N-CA 122.223 1.949 . . . . 0.0 110.698 177.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.725 HD21 ' HG3' ' A' ' 319' ' ' PRO . 0.0 OUTLIER -123.46 153.06 41.0 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.342 1.057 . . . . 0.0 109.617 179.018 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . 0.583 ' HB2' ' HB2' ' A' ' 284' ' ' GLU . 31.9 mtp180 -88.38 147.34 24.78 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.932 0.893 . . . . 0.0 110.318 177.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 282' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -62.51 -34.19 76.39 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 122.928 0.491 . . . . 0.0 110.361 173.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 23.7 m -67.79 -31.32 71.11 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.203 1.001 . . . . 0.0 111.718 176.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 284' ' ' GLU . . . . . 0.583 ' HB2' ' HB2' ' A' ' 281' ' ' ARG . 6.2 tp10 -73.31 132.21 82.15 Favored Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 124.009 0.923 . . . . 0.0 109.108 -178.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -70.39 178.32 5.08 Favored 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 122.163 1.908 . . . . 0.0 112.28 174.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.439 ' O ' HG23 ' A' ' 290' ' ' VAL . 70.7 mt -67.1 -19.04 65.57 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 118.744 -0.646 . . . . 0.0 111.66 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 27.7 tp60 -53.68 -22.39 8.87 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.282 0.633 . . . . 0.0 112.193 178.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . 0.52 ' HB3' HD12 ' A' ' 280' ' ' LEU . 24.8 t -64.74 -54.32 33.26 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.413 0.685 . . . . 0.0 110.984 172.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.442 HG13 HD13 ' A' ' 280' ' ' LEU . 17.2 m -70.9 -29.21 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 122.532 0.333 . . . . 0.0 110.753 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . 0.538 HG13 ' HB ' ' A' ' 304' ' ' ILE . 78.1 t -63.83 -49.22 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 123.702 0.801 . . . . 0.0 110.099 176.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -63.89 -46.93 82.64 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.743 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 43.2 t60 -67.15 -41.83 85.4 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.15 -174.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 90.9 mmm -68.09 -30.33 69.48 Favored 'General case' 0 N--CA 1.483 1.201 0 O-C-N 123.401 0.438 . . . . 0.0 111.227 177.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -67.47 -43.45 80.99 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.13 0.572 . . . . 0.0 110.615 175.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 27.7 m -69.43 -29.59 67.34 Favored 'General case' 0 CA--C 1.557 1.216 0 C-N-CA 124.063 0.945 . . . . 0.0 110.837 176.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 77.8 t60 -74.59 -34.63 62.91 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.839 0.856 . . . . 0.0 111.442 -178.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 297' ' ' LEU . . . . . 0.745 HD21 ' SG ' ' A' ' 271' ' ' CYS . 75.5 mt -105.74 -8.26 17.93 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.655 0.782 . . . . 0.0 112.283 -175.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 72.93 31.67 61.8 Favored Glycine 0 C--N 1.347 1.188 0 O-C-N 123.598 0.561 . . . . 0.0 112.55 178.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 299' ' ' VAL . . . . . 0.531 HG11 HG11 ' A' ' 334' ' ' VAL . 33.2 m -117.75 -177.33 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.357 1.063 . . . . 0.0 110.057 179.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . 0.551 ' HB3' ' HG3' ' A' ' 303' ' ' ARG . 32.2 t -82.36 147.02 55.54 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 123.194 0.598 . . . . 0.0 110.18 178.119 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -59.49 -27.97 86.31 Favored 'Trans proline' 0 C--N 1.385 2.453 0 C-N-CA 122.774 2.316 . . . . 0.0 111.124 169.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 22.8 t -67.11 -15.73 63.9 Favored 'General case' 0 CA--C 1.559 1.29 0 C-N-CA 123.454 0.702 . . . . 0.0 111.207 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 303' ' ' ARG . . . . . 0.551 ' HG3' ' HB3' ' A' ' 300' ' ' SER . 59.3 mtt180 -94.59 -26.51 16.35 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.006 0.922 . . . . 0.0 111.63 -178.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 304' ' ' ILE . . . . . 0.553 HD12 ' SG ' ' A' ' 332' ' ' CYS . 37.9 mm -77.02 103.58 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 122.861 0.464 . . . . 0.0 110.865 -175.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 34.8 tp -105.68 123.79 48.51 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 174.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . 0.433 ' HA ' ' O ' ' A' ' 331' ' ' ASP . 3.4 mm? -89.26 128.35 35.84 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 177.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 312' ' ' GLU . 68.4 mt -134.05 114.8 13.58 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.477 1.111 . . . . 0.0 108.608 -177.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -79.42 81.26 5.7 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 176.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 66.63 -85.97 0.11 Allowed Glycine 0 C--N 1.357 1.731 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.862 -176.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -127.1 75.68 1.6 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.142 0.977 . . . . 0.0 109.684 177.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 14.5 t -173.51 147.37 1.44 Allowed 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.489 1.116 . . . . 0.0 108.831 169.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . 0.414 ' HA ' HD23 ' A' ' 307' ' ' LEU . 42.2 tt0 -93.52 128.87 39.83 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 -178.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.463 HD13 HD13 ' A' ' 322' ' ' LEU . 45.2 mt -113.33 127.42 56.13 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 123.667 0.604 . . . . 0.0 109.762 177.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 314' ' ' SER . . . . . 0.413 ' O ' HD12 ' A' ' 286' ' ' LEU . 39.0 m -77.81 140.61 63.16 Favored Pre-proline 0 CA--C 1.554 1.105 0 C-N-CA 123.529 0.731 . . . . 0.0 110.633 179.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . 0.424 ' HB3' HG21 ' A' ' 290' ' ' VAL . 40.8 Cg_endo -63.94 -24.34 67.52 Favored 'Trans proline' 0 C--N 1.384 2.402 0 C-N-CA 122.871 2.381 . . . . 0.0 113.042 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 6.5 m -81.75 -18.47 44.13 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 123.788 0.835 . . . . 0.0 111.344 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -70.25 150.72 46.11 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 122.852 0.461 . . . . 0.0 109.967 176.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 318' ' ' THR . . . . . . . . . . . . . 69.5 p -98.57 144.4 28.07 Favored Pre-proline 0 CA--C 1.541 0.598 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . 0.725 ' HG3' HD21 ' A' ' 280' ' ' LEU . 20.8 Cg_endo -57.83 -17.31 29.35 Favored 'Trans proline' 0 C--N 1.366 1.486 0 C-N-CA 123.171 2.581 . . . . 0.0 112.578 170.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 44.9 ttt180 -71.02 -48.5 52.72 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.525 0.73 . . . . 0.0 110.454 -179.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 15.0 t -70.27 -29.08 65.77 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-O 120.809 0.338 . . . . 0.0 110.626 178.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 322' ' ' LEU . . . . . 0.463 HD13 HD13 ' A' ' 313' ' ' LEU . 64.7 mt -81.58 -14.83 56.32 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.82 177.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp 59.62 36.32 22.59 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.566 1.146 . . . . 0.0 112.413 -177.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.426 ' HG ' ' HB2' ' A' ' 322' ' ' LEU . 44.7 mt -68.96 145.46 53.6 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.701 0.8 . . . . 0.0 109.809 174.177 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 325' ' ' GLY . . . . . 0.447 ' H ' ' HB3' ' A' ' 328' ' ' ASP . . . -140.31 -169.29 11.64 Favored Glycine 0 C--O 1.24 0.472 0 C-N-CA 123.435 0.541 . . . . 0.0 112.08 -174.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 26.0 m -74.09 -26.86 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.771 0.828 . . . . 0.0 111.915 -175.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -101.03 -3.24 29.72 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.713 0.805 . . . . 0.0 111.141 179.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 328' ' ' ASP . . . . . 0.447 ' HB3' ' H ' ' A' ' 325' ' ' GLY . 12.2 t70 -83.28 144.78 29.49 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 175.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . 0.444 ' HA ' ' O ' ' A' ' 268' ' ' LYS . 24.2 mt -131.29 125.33 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 123.232 0.613 . . . . 0.0 109.673 -178.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 28.4 pt -116.82 131.93 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 123.367 0.667 . . . . 0.0 110.365 176.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 331' ' ' ASP . . . . . 0.433 ' O ' ' HA ' ' A' ' 306' ' ' LEU . 7.1 m-20 -68.13 135.67 52.5 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.951 0.9 . . . . 0.0 111.712 -179.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 332' ' ' CYS . . . . . 0.553 ' SG ' HD12 ' A' ' 304' ' ' ILE . 26.2 t -103.79 99.51 9.3 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.08 0.952 . . . . 0.0 109.011 171.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 47.9 t -104.48 113.46 41.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -178.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 334' ' ' VAL . . . . . 0.531 HG11 HG11 ' A' ' 299' ' ' VAL . 58.3 t -81.71 99.01 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.723 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 80.6 mt -83.57 160.14 21.5 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.655 0.782 . . . . 0.0 110.389 175.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 336' ' ' THR . . . . . . . . . . . . . 11.3 t -96.98 -22.4 16.86 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 171.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 44.4 t -113.11 132.41 55.45 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.115 0.966 . . . . 0.0 109.399 178.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 20.7 m . . . . . 0 C--O 1.257 1.472 0 C-N-CA 124.17 0.988 . . . . 0.0 109.444 176.866 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 . . . . . 0 N--CA 1.48 1.064 0 N-CA-C 111.366 0.136 . . . . 0.0 111.366 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -103.25 72.38 0.28 Allowed Glycine 0 C--N 1.355 1.634 0 N-CA-C 111.991 -0.444 . . . . 0.0 111.991 -177.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' GLN . . . . . 0.53 ' NE2' ' HB3' ' A' ' 248' ' ' ASP . 24.0 tm0? -75.54 107.85 7.96 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.57 0.748 . . . . 0.0 109.213 -178.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -101.71 -9.85 20.5 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.615 0.766 . . . . 0.0 112.524 -173.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . 0.53 ' HB3' ' NE2' ' A' ' 246' ' ' GLN . 16.2 t70 -69.34 93.18 0.63 Allowed 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -174.18 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -63.02 92.34 0.05 Allowed 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.653 173.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 33.4 m -64.3 124.78 19.76 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.943 -170.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 38.7 t 52.75 72.43 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.087 0 C-N-CA 124.861 1.264 . . . . 0.0 111.08 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 33.6 tp -151.39 85.21 1.32 Allowed 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.222 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.686 HG12 HD22 ' A' ' 258' ' ' LEU . 43.9 t -122.76 97.44 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 176.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -163.07 148.82 11.89 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.525 0.73 . . . . 0.0 109.42 -172.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 122.33 -77.99 0.34 Allowed Glycine 0 N--CA 1.472 1.056 0 N-CA-C 111.715 -0.554 . . . . 0.0 111.715 -178.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -75.88 -168.47 0.55 Allowed 'Trans proline' 0 C--N 1.373 1.823 0 C-N-CA 123.184 2.589 . . . . 0.0 112.32 175.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 70.4 m -63.28 128.12 34.39 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 123.544 0.738 . . . . 0.0 110.039 173.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.686 HD22 HG12 ' A' ' 253' ' ' VAL . 31.2 mt -105.65 94.0 8.05 Favored Pre-proline 0 CA--C 1.543 0.705 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 176.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -69.64 -21.53 33.9 Favored 'Trans proline' 0 C--N 1.377 2.077 0 C-N-CA 122.366 2.044 . . . . 0.0 111.852 176.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -72.12 104.38 3.59 Favored 'General case' 0 C--N 1.349 0.56 0 C-N-CA 124.768 1.227 . . . . 0.0 109.704 -177.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 20.6 p -71.25 146.67 92.51 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 123.103 0.561 . . . . 0.0 110.224 176.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -65.73 -179.61 1.36 Allowed 'Trans proline' 0 C--N 1.376 2.017 0 C-N-CA 122.697 2.264 . . . . 0.0 112.732 -179.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 78.7 mtt180 -86.36 102.23 13.83 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.316 0.579 . . . . 0.0 110.022 174.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.437 HD22 ' HB2' ' A' ' 279' ' ' PRO . 3.8 mp -100.87 171.93 7.35 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.745 172.15 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 265' ' ' PHE . . . . . 0.455 ' CE1' ' SD ' ' A' ' 282' ' ' MET . 46.4 p90 -145.63 147.33 32.64 Favored Pre-proline 0 C--O 1.243 0.725 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 173.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -68.12 94.02 0.41 Allowed 'Trans proline' 0 C--N 1.37 1.691 0 C-N-CA 122.061 1.84 . . . . 0.0 110.759 174.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 267' ' ' LEU . . . . . 0.479 HD12 HG13 ' A' ' 269' ' ' ILE . 1.9 tm? -58.55 130.14 45.41 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 173.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.58 ' HD2' HD22 ' A' ' 275' ' ' LEU . 4.7 tppp? -90.04 109.63 20.66 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 123.846 0.716 . . . . 0.0 110.497 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . 0.479 HG13 HD12 ' A' ' 267' ' ' LEU . 2.8 mp -110.93 154.95 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 174.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 270' ' ' ARG . . . . . 0.514 ' HG2' HD23 ' A' ' 275' ' ' LEU . 30.0 mtp-105 -113.75 131.11 56.32 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 162.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 271' ' ' CYS . . . . . 0.62 ' SG ' HD21 ' A' ' 297' ' ' LEU . 30.7 t -74.1 -160.14 0.09 Allowed 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 123.961 0.905 . . . . 0.0 109.399 168.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -58.67 -19.07 36.2 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.324 0.65 . . . . 0.0 112.051 173.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -153.86 -56.21 0.11 Allowed 'General case' 0 C--N 1.352 0.706 0 C-N-CA 123.532 0.733 . . . . 0.0 110.631 176.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -68.19 162.38 25.0 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.473 1.109 . . . . 0.0 112.652 -170.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.58 HD22 ' HD2' ' A' ' 268' ' ' LYS . 66.3 mt -88.86 128.09 35.65 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.714 0.806 . . . . 0.0 110.063 170.232 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 94.2 t -115.53 131.74 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 174.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 88.8 mtm180 -124.79 127.72 47.63 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.606 0.762 . . . . 0.0 109.189 176.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.545 HD21 ' HA ' ' A' ' 289' ' ' VAL . 3.7 pp -135.43 144.33 49.02 Favored Pre-proline 0 N--CA 1.483 1.187 0 CA-C-O 119.436 -0.316 . . . . 0.0 110.242 177.369 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 279' ' ' PRO . . . . . 0.437 ' HB2' HD22 ' A' ' 264' ' ' LEU . 69.1 Cg_endo -71.57 116.33 4.65 Favored 'Trans proline' 0 C--N 1.372 1.799 0 C-N-CA 122.179 1.919 . . . . 0.0 111.033 177.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.718 HD21 ' HG3' ' A' ' 319' ' ' PRO . 0.5 OUTLIER -135.23 151.6 50.76 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.82 1.248 . . . . 0.0 109.544 -178.051 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -96.48 154.31 17.34 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.248 0.619 . . . . 0.0 109.585 178.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 282' ' ' MET . . . . . 0.455 ' SD ' ' CE1' ' A' ' 265' ' ' PHE . 94.2 mmm -63.44 -29.01 70.37 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 122.851 0.46 . . . . 0.0 111.577 176.415 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 39.7 t -79.91 -28.5 39.81 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.76 0.824 . . . . 0.0 111.363 176.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -67.96 123.22 86.62 Favored Pre-proline 0 N--CA 1.481 1.084 0 C-N-CA 123.915 0.886 . . . . 0.0 109.843 -177.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -64.51 167.47 15.01 Favored 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 122.573 2.182 . . . . 0.0 112.118 178.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.426 ' O ' HG23 ' A' ' 290' ' ' VAL . 56.2 mt -63.9 -16.47 61.49 Favored 'General case' 0 C--O 1.216 -0.705 0 CA-C-O 118.596 -0.716 . . . . 0.0 112.028 -177.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 287' ' ' GLN . . . . . 0.406 ' HA ' ' HB ' ' A' ' 290' ' ' VAL . 24.9 tp60 -49.82 -27.33 4.9 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.58 0.752 . . . . 0.0 112.379 177.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . 0.571 ' HB3' HD12 ' A' ' 280' ' ' LEU . 36.2 t -60.83 -55.87 27.91 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 123.925 0.89 . . . . 0.0 111.201 172.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.545 ' HA ' HD21 ' A' ' 278' ' ' LEU . 15.6 m -69.56 -31.5 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 122.413 0.285 . . . . 0.0 110.934 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . 0.56 HG13 ' HB ' ' A' ' 304' ' ' ILE . 46.1 t -63.21 -55.69 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 124.794 1.237 . . . . 0.0 111.018 -178.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -67.99 -36.21 79.63 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.844 -176.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 9.7 t60 -61.07 -49.96 75.22 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.475 0.71 . . . . 0.0 110.374 176.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 93.9 mmm -69.65 -29.16 66.55 Favored 'General case' 0 C--O 1.217 -0.624 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.97 -179.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -69.59 -37.61 76.99 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.327 0.651 . . . . 0.0 110.777 178.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 56.1 m -73.26 -37.37 66.34 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.229 0.611 . . . . 0.0 110.161 176.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -63.61 -47.25 82.2 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.954 0.901 . . . . 0.0 110.522 179.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 297' ' ' LEU . . . . . 0.62 HD21 ' SG ' ' A' ' 271' ' ' CYS . 38.2 mt -89.26 -11.13 44.43 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.258 1.023 . . . . 0.0 112.125 -174.587 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 72.9 19.2 79.37 Favored Glycine 0 C--N 1.352 1.433 0 O-C-N 123.515 0.51 . . . . 0.0 112.932 -178.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 20.5 m -105.33 178.85 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 124.405 1.082 . . . . 0.0 110.305 -177.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 21.2 m -82.62 148.01 57.14 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 123.262 0.625 . . . . 0.0 109.898 178.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -60.83 -29.15 87.62 Favored 'Trans proline' 0 C--N 1.386 2.511 0 C-N-CA 122.494 2.129 . . . . 0.0 112.334 175.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 36.1 t -72.47 -17.93 61.72 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 122.261 -0.274 . . . . 0.0 110.739 -179.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -90.21 -7.37 53.72 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.779 0.832 . . . . 0.0 111.372 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 304' ' ' ILE . . . . . 0.56 ' HB ' HG13 ' A' ' 290' ' ' VAL . 41.6 mm -84.83 109.2 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 CA-C-N 118.373 0.533 . . . . 0.0 110.187 177.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 39.5 tp -109.8 112.09 23.93 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.47 0.708 . . . . 0.0 109.095 177.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . 0.505 HD21 HG22 ' A' ' 290' ' ' VAL . 2.5 mm? -85.05 133.46 34.24 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . 0.48 HD23 ' HA ' ' A' ' 312' ' ' GLU . 76.7 mt -132.8 103.09 5.92 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.312 0.645 . . . . 0.0 109.987 -177.1 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . 0.479 ' HB2' HD11 ' A' ' 313' ' ' LEU . 69.8 t80 -77.56 92.3 4.05 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -178.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 72.27 -81.29 0.59 Allowed Glycine 0 C--N 1.343 0.953 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.703 -174.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -131.75 -11.76 3.42 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.584 0.754 . . . . 0.0 112.384 -179.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 6.9 t -86.79 148.55 25.35 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 118.115 0.416 . . . . 0.0 111.004 -177.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . 0.48 ' HA ' HD23 ' A' ' 307' ' ' LEU . 37.2 tt0 -93.79 123.97 37.48 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 122.847 0.459 . . . . 0.0 110.226 -176.397 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.484 HD13 HD13 ' A' ' 322' ' ' LEU . 47.5 mt -111.4 126.98 55.51 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.995 -178.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 42.0 m -71.37 144.46 89.32 Favored Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 123.693 0.797 . . . . 0.0 110.12 173.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -63.11 -18.11 63.48 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 123.027 2.485 . . . . 0.0 112.751 176.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 37.7 p -90.36 -8.42 50.78 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.573 1.149 . . . . 0.0 112.427 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -72.88 152.71 41.35 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.099 0.559 . . . . 0.0 111.036 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 318' ' ' THR . . . . . . . . . . . . . 32.4 p -103.93 142.82 25.4 Favored Pre-proline 0 N--CA 1.478 0.928 0 C-N-CA 122.999 0.52 . . . . 0.0 109.672 177.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . 0.718 ' HG3' HD21 ' A' ' 280' ' ' LEU . 70.3 Cg_endo -66.0 -14.17 43.24 Favored 'Trans proline' 0 C--N 1.369 1.64 0 C-N-CA 123.649 2.899 . . . . 0.0 113.192 -176.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 70.3 ttt180 -69.21 -53.47 19.78 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.234 0.614 . . . . 0.0 110.557 -177.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 9.8 t -66.8 -29.92 69.99 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.347 0.659 . . . . 0.0 111.364 177.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 322' ' ' LEU . . . . . 0.484 HD13 HD13 ' A' ' 313' ' ' LEU . 43.4 mt -81.89 -19.41 40.91 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.395 0.678 . . . . 0.0 111.0 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 53.69 75.67 0.25 Allowed 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 125.108 1.363 . . . . 0.0 109.623 -170.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 70.6 mt -106.98 164.57 12.03 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.627 176.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 325' ' ' GLY . . . . . 0.467 ' H ' ' HB2' ' A' ' 328' ' ' ASP . . . -169.53 -160.63 18.22 Favored Glycine 0 C--N 1.343 0.95 0 CA-C-N 115.928 -0.578 . . . . 0.0 113.374 -170.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 30.6 m -80.5 -24.55 11.26 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 124.481 1.112 . . . . 0.0 111.296 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -101.73 -25.85 13.69 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.054 0.942 . . . . 0.0 110.457 177.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 328' ' ' ASP . . . . . 0.467 ' HB2' ' H ' ' A' ' 325' ' ' GLY . 34.1 m-20 -76.02 111.5 11.47 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . 0.516 HG12 ' HG2' ' A' ' 268' ' ' LYS . 4.4 mt -99.13 133.21 42.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.088 0.555 . . . . 0.0 110.942 -173.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 41.2 pt -119.23 128.91 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 123.211 0.605 . . . . 0.0 109.739 174.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -85.22 109.65 18.47 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.374 0.67 . . . . 0.0 110.514 -176.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 332' ' ' CYS . . . . . 0.559 ' SG ' HD12 ' A' ' 304' ' ' ILE . 35.9 t -73.12 95.08 2.01 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.385 0.674 . . . . 0.0 109.583 170.1 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 58.2 t -106.86 122.39 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 178.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 91.4 t -78.53 102.01 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-O 121.18 0.514 . . . . 0.0 110.517 -176.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.54 138.12 58.07 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 125.077 1.351 . . . . 0.0 109.061 170.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 336' ' ' THR . . . . . . . . . . . . . 19.1 m -69.51 -72.79 0.18 Allowed 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 123.29 0.636 . . . . 0.0 110.75 -178.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 49.9 m -144.14 169.46 17.83 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.962 0.905 . . . . 0.0 109.463 -177.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 22.6 t . . . . . 0 CA--C 1.555 1.166 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -179.208 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 7.5 pm0 . . . . . 0 N--CA 1.476 0.87 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 53.89 42.84 70.56 Favored Glycine 0 C--N 1.346 1.12 0 O-C-N 123.837 0.71 . . . . 0.0 114.609 173.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -68.14 95.87 0.6 Allowed 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.195 0.522 . . . . 0.0 110.055 177.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -142.9 122.79 13.5 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 175.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -155.03 -43.3 0.08 Allowed 'General case' 0 C--O 1.24 0.59 0 C-N-CA 123.474 0.709 . . . . 0.0 110.4 -171.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -81.07 72.93 8.12 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.273 -173.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 46.2 t -83.59 131.02 34.82 Favored 'Isoleucine or valine' 0 C--O 1.244 0.795 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.338 176.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 59.2 t -71.47 83.38 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 176.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 6.2 tt -178.46 114.98 0.07 Allowed 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 -177.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 7.6 p -134.97 135.54 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 122.99 0.516 . . . . 0.0 109.794 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . 0.48 ' HG3' ' HD3' ' A' ' 256' ' ' PRO . 10.6 pt-20 -158.98 178.32 10.2 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.428 1.091 . . . . 0.0 109.304 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -125.78 79.72 0.37 Allowed Glycine 0 CA--C 1.528 0.852 0 CA-C-O 119.47 -0.628 . . . . 0.0 111.922 177.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . 0.48 ' HD3' ' HG3' ' A' ' 254' ' ' GLU . 83.1 Cg_endo -82.4 157.88 16.98 Favored 'Trans proline' 0 C--N 1.373 1.844 0 C-N-CA 122.658 2.239 . . . . 0.0 111.843 174.304 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 47.6 p -74.72 102.58 4.69 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 175.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 73.7 mt -100.67 96.82 5.82 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 123.601 0.761 . . . . 0.0 108.995 176.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -63.3 -35.24 63.67 Favored 'Trans proline' 0 C--N 1.379 2.151 0 C-N-CA 122.241 1.961 . . . . 0.0 111.264 176.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -77.53 97.0 4.89 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.504 0.722 . . . . 0.0 109.117 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 91.4 m -71.55 136.63 83.45 Favored Pre-proline 0 CA--C 1.553 1.071 0 C-N-CA 124.147 0.979 . . . . 0.0 110.889 -178.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -54.08 130.68 40.72 Favored 'Trans proline' 0 C--N 1.386 2.552 0 C-N-CA 122.738 2.292 . . . . 0.0 111.691 174.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 64.5 mtt180 -63.26 113.27 3.09 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 123.878 0.871 . . . . 0.0 111.737 -172.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 3.0 mp -84.59 167.99 15.77 Favored 'General case' 0 C--O 1.243 0.757 0 CA-C-N 114.653 -1.158 . . . . 0.0 108.632 173.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -144.85 146.51 31.71 Favored Pre-proline 0 CA--C 1.543 0.697 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 175.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 266' ' ' PRO . . . . . 0.503 ' HB2' ' HB3' ' A' ' 277' ' ' ARG . 46.2 Cg_endo -66.85 91.36 0.3 Allowed 'Trans proline' 0 C--N 1.374 1.903 0 C-N-CA 122.182 1.921 . . . . 0.0 112.197 176.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 267' ' ' LEU . . . . . 0.581 HD23 HD22 ' A' ' 280' ' ' LEU . 0.4 OUTLIER -63.28 115.53 4.64 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 170.747 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.582 ' HD3' HD13 ' A' ' 275' ' ' LEU . 30.7 ttmt -90.96 118.38 30.3 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 123.414 0.446 . . . . 0.0 109.892 -179.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . 0.571 HG21 ' HG3' ' A' ' 293' ' ' MET . 2.4 mp -113.93 136.37 50.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 C-N-CA 123.6 0.76 . . . . 0.0 108.958 177.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 270' ' ' ARG . . . . . 0.484 ' HA ' HD23 ' A' ' 275' ' ' LEU . 0.7 OUTLIER -85.95 106.67 17.3 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 123.626 0.579 . . . . 0.0 110.469 -177.561 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 271' ' ' CYS . . . . . 0.531 ' SG ' HD21 ' A' ' 297' ' ' LEU . 38.6 t -75.2 179.49 5.06 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.742 0.817 . . . . 0.0 109.789 167.208 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 272' ' ' ARG . . . . . 0.462 ' HG2' ' SG ' ' A' ' 271' ' ' CYS . 17.2 ptm180 -54.18 -36.08 63.03 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.012 0.925 . . . . 0.0 112.789 178.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -159.44 49.39 0.32 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.63 0.772 . . . . 0.0 109.621 178.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 274' ' ' ASP . . . . . 0.456 ' HB3' ' HB3' ' A' ' 271' ' ' CYS . 19.9 t70 -166.43 162.52 17.01 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.714 0.805 . . . . 0.0 110.123 -173.4 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.582 HD13 ' HD3' ' A' ' 268' ' ' LYS . 81.0 mt -131.36 104.72 7.18 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.392 1.077 . . . . 0.0 109.615 176.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 276' ' ' VAL . . . . . 0.43 ' O ' HD12 ' A' ' 269' ' ' ILE . 78.3 t -83.44 115.5 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 177.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . 0.503 ' HB3' ' HB2' ' A' ' 266' ' ' PRO . 61.2 mtm-85 -107.31 80.68 1.44 Allowed 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -179.046 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.406 ' HA ' ' HD3' ' A' ' 279' ' ' PRO . 4.3 pp -93.13 142.89 25.92 Favored Pre-proline 0 N--CA 1.484 1.226 0 CA-C-O 119.579 -0.248 . . . . 0.0 111.054 -173.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 279' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 278' ' ' LEU . 12.7 Cg_exo -68.23 109.14 1.92 Allowed 'Trans proline' 0 C--N 1.375 1.932 0 C-N-CA 122.833 2.355 . . . . 0.0 110.696 177.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.581 HD22 HD23 ' A' ' 267' ' ' LEU . 2.9 tt -127.39 139.17 53.02 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.448 1.099 . . . . 0.0 109.466 -178.073 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 68.3 mtm180 -80.45 152.71 28.64 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.898 0.879 . . . . 0.0 110.649 179.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 282' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -65.66 -23.85 66.89 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 122.543 0.337 . . . . 0.0 111.581 177.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 20.7 t -91.17 -1.36 57.74 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.117 0.967 . . . . 0.0 111.985 179.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -85.01 132.89 44.32 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 123.606 0.763 . . . . 0.0 109.537 -178.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -66.58 164.46 28.81 Favored 'Trans proline' 0 C--N 1.372 1.797 0 C-N-CA 121.864 1.71 . . . . 0.0 111.203 169.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.433 ' O ' HG23 ' A' ' 290' ' ' VAL . 49.3 mt -67.85 -13.7 62.36 Favored 'General case' 0 C--O 1.211 -0.936 0 CA-C-O 119.027 -0.511 . . . . 0.0 111.261 178.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 26.6 tp60 -51.1 -27.61 8.73 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.282 1.033 . . . . 0.0 112.013 178.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 39.9 t -58.14 -59.84 4.66 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.206 1.002 . . . . 0.0 111.114 170.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.418 ' HB ' HG12 ' A' ' 269' ' ' ILE . 13.0 m -70.15 -25.76 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 122.774 0.43 . . . . 0.0 110.833 -178.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . 0.476 HG13 ' HB ' ' A' ' 304' ' ' ILE . 55.8 t -65.19 -51.34 66.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 123.92 0.888 . . . . 0.0 109.97 178.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -71.29 -38.18 71.82 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.881 -178.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 8.5 t60 -66.8 -48.45 68.95 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.234 0.614 . . . . 0.0 110.36 -178.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 293' ' ' MET . . . . . 0.571 ' HG3' HG21 ' A' ' 269' ' ' ILE . 97.5 mmm -67.69 -31.08 70.79 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.783 0.433 . . . . 0.0 110.87 179.254 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -59.71 -45.85 90.88 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 122.844 0.458 . . . . 0.0 110.403 173.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 24.9 m -69.98 -30.3 67.6 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 123.191 0.597 . . . . 0.0 110.958 178.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 71.7 t60 -73.81 -29.1 61.97 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.781 0.832 . . . . 0.0 111.211 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 297' ' ' LEU . . . . . 0.531 HD21 ' SG ' ' A' ' 271' ' ' CYS . 52.4 mt -109.0 -2.44 18.22 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.946 0.898 . . . . 0.0 111.507 -175.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 77.47 19.09 76.92 Favored Glycine 0 N--CA 1.478 1.471 0 C-N-CA 123.343 0.497 . . . . 0.0 113.869 172.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 299' ' ' VAL . . . . . 0.641 ' HB ' ' HD2' ' A' ' 303' ' ' ARG . 27.3 m -116.29 -176.38 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 124.551 1.14 . . . . 0.0 111.369 -176.205 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 20.3 m -86.3 146.61 42.75 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 123.612 0.765 . . . . 0.0 110.457 178.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -53.46 -35.59 76.49 Favored 'Trans proline' 0 C--N 1.387 2.578 0 C-N-CA 123.14 2.56 . . . . 0.0 112.294 176.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 29.7 p -61.14 -24.48 66.31 Favored 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 123.354 0.661 . . . . 0.0 112.29 -174.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 303' ' ' ARG . . . . . 0.641 ' HD2' ' HB ' ' A' ' 299' ' ' VAL . 90.1 mtt180 -82.16 -25.58 34.19 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.268 1.027 . . . . 0.0 112.096 -176.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 304' ' ' ILE . . . . . 0.585 HD12 ' SG ' ' A' ' 332' ' ' CYS . 38.0 mm -73.77 103.55 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 C-N-CA 123.42 0.688 . . . . 0.0 111.308 -173.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . 0.416 HD22 HD11 ' A' ' 335' ' ' LEU . 50.9 tp -101.17 114.68 28.86 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.661 0.784 . . . . 0.0 108.913 173.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . 0.403 ' HG ' HD12 ' A' ' 330' ' ' ILE . 2.6 mm? -86.32 131.34 34.24 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 177.175 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . 0.455 HD12 HG21 ' A' ' 333' ' ' VAL . 75.2 mt -130.86 111.06 11.76 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 178.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . 0.453 ' HB2' HD11 ' A' ' 313' ' ' LEU . 56.4 t80 -78.7 88.57 4.58 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 72.99 -82.35 0.63 Allowed Glycine 0 C--N 1.345 1.076 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.808 -175.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -121.48 -27.56 4.76 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.903 0.881 . . . . 0.0 111.103 -176.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 6.1 t -78.74 145.45 34.44 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 122.649 0.38 . . . . 0.0 110.789 -173.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . 0.43 ' HA ' HD23 ' A' ' 307' ' ' LEU . 44.1 tt0 -89.28 124.45 34.41 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 122.901 0.481 . . . . 0.0 110.343 -177.611 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.459 HD13 HD13 ' A' ' 322' ' ' LEU . 28.0 mt -106.79 154.56 20.82 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 122.899 0.479 . . . . 0.0 110.067 177.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 49.0 m -107.92 151.29 41.17 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 123.412 0.685 . . . . 0.0 110.111 -179.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -62.45 -27.03 76.83 Favored 'Trans proline' 0 C--N 1.381 2.266 0 C-N-CA 122.585 2.19 . . . . 0.0 112.352 174.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 38.5 p -78.77 -21.68 47.51 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.626 0.77 . . . . 0.0 112.114 177.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -66.22 144.56 56.55 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.427 0.691 . . . . 0.0 111.798 -175.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 318' ' ' THR . . . . . . . . . . . . . 68.3 p -100.11 153.47 37.74 Favored Pre-proline 0 CA--C 1.553 1.074 0 C-N-CA 123.839 0.856 . . . . 0.0 109.754 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . 0.565 ' HG3' HD21 ' A' ' 280' ' ' LEU . 60.3 Cg_endo -73.49 -10.6 23.93 Favored 'Trans proline' 0 C--N 1.371 1.725 0 C-N-CA 123.165 2.577 . . . . 0.0 112.179 -177.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -69.23 -54.71 13.36 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.91 0.884 . . . . 0.0 110.183 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 10.2 t -67.18 -23.03 65.72 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.384 0.674 . . . . 0.0 111.44 178.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 322' ' ' LEU . . . . . 0.531 ' HB2' ' HG ' ' A' ' 324' ' ' LEU . 54.9 mt -96.67 -8.38 31.69 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.438 0.695 . . . . 0.0 111.993 -178.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt 59.16 29.24 18.76 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 124.238 1.015 . . . . 0.0 113.008 -178.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.531 ' HG ' ' HB2' ' A' ' 322' ' ' LEU . 55.3 mt -72.81 132.54 43.7 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 122.877 0.471 . . . . 0.0 110.476 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 325' ' ' GLY . . . . . 0.422 ' H ' ' HB2' ' A' ' 328' ' ' ASP . . . -138.15 -146.62 5.06 Favored Glycine 0 C--N 1.337 0.629 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 179.05 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . 0.418 ' O ' ' HE3' ' A' ' 268' ' ' LYS . 11.3 m -81.19 -26.33 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 123.033 0.533 . . . . 0.0 110.937 -176.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -97.53 -12.91 22.03 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.469 0.708 . . . . 0.0 111.665 -177.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 328' ' ' ASP . . . . . 0.422 ' HB2' ' H ' ' A' ' 325' ' ' GLY . 24.6 m-20 -87.3 108.37 18.93 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.002 0.43 . . . . 0.0 109.856 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . 0.448 HG12 ' HD2' ' A' ' 268' ' ' LYS . 38.0 mt -92.95 128.64 44.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.665 177.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 330' ' ' ILE . . . . . 0.457 HG13 HG23 ' A' ' 269' ' ' ILE . 41.0 pt -112.73 122.34 66.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 121.14 0.495 . . . . 0.0 109.711 175.176 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -71.78 113.82 9.21 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.045 0.938 . . . . 0.0 111.181 -173.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 332' ' ' CYS . . . . . 0.585 ' SG ' HD12 ' A' ' 304' ' ' ILE . 42.1 t -81.9 97.59 8.12 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.552 0.741 . . . . 0.0 110.198 177.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . 0.455 HG21 HD12 ' A' ' 307' ' ' LEU . 47.0 t -99.85 111.99 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 123.437 0.695 . . . . 0.0 109.435 -177.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 334' ' ' VAL . . . . . 0.542 HG11 HG11 ' A' ' 299' ' ' VAL . 60.5 t -80.84 103.93 8.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 335' ' ' LEU . . . . . 0.416 HD11 HD22 ' A' ' 305' ' ' LEU . 80.3 mt -89.94 -175.07 4.47 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.229 173.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 336' ' ' THR . . . . . . . . . . . . . 68.4 p -86.55 -42.72 13.28 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 168.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 49.6 m 58.2 23.99 10.9 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 125.005 1.322 . . . . 0.0 111.856 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 14.7 m . . . . . 0 C--O 1.254 1.33 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.702 -177.196 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 . . . . . 0 N--CA 1.478 0.932 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -123.92 -140.62 5.62 Favored Glycine 0 C--N 1.346 1.135 0 CA-C-O 118.741 -1.033 . . . . 0.0 111.064 179.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 76.1 -37.03 0.29 Allowed 'General case' 0 N--CA 1.499 2.001 0 C-N-CA 125.905 1.682 . . . . 0.0 112.454 -178.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -88.99 46.13 1.36 Allowed 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.404 1.082 . . . . 0.0 110.298 176.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -68.03 -35.1 77.72 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.01 0.924 . . . . 0.0 110.004 175.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -63.89 115.76 5.16 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.668 173.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 21.8 m -83.79 61.7 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.03 0 CA-C-O 122.32 1.057 . . . . 0.0 111.149 -176.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 2.9 p -74.56 95.4 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 CA-C-N 114.465 -1.243 . . . . 0.0 110.457 -179.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 40.8 tp -95.8 87.9 4.79 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 115.454 -0.794 . . . . 0.0 108.95 -178.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 28.9 t 57.68 76.27 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.064 0 C-N-CA 125.177 1.391 . . . . 0.0 111.589 178.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -129.06 111.08 12.6 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 172.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 69.22 71.8 0.93 Allowed Glycine 0 CA--C 1.531 1.055 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 -170.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -60.16 88.38 0.08 OUTLIER 'Trans proline' 0 C--N 1.389 2.691 0 C-N-CA 123.781 2.987 . . . . 0.0 112.558 -178.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 68.0 m -153.21 146.91 25.14 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 125.758 1.623 . . . . 0.0 106.794 178.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 91.4 mt -101.43 97.19 7.12 Favored Pre-proline 0 N--CA 1.479 0.998 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 173.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -70.09 -34.03 14.24 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 122.293 1.995 . . . . 0.0 110.505 174.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -147.21 120.27 8.82 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 124.845 1.258 . . . . 0.0 107.991 171.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 89.6 m -73.3 132.84 81.47 Favored Pre-proline 0 CA--C 1.553 1.091 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 170.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . 0.401 ' O ' HD12 ' A' ' 264' ' ' LEU . 12.7 Cg_endo -54.99 164.23 3.6 Favored 'Trans proline' 0 C--N 1.387 2.568 0 C-N-CA 123.236 2.624 . . . . 0.0 113.537 178.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -82.4 95.43 7.65 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.819 178.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.401 HD12 ' O ' ' A' ' 262' ' ' PRO . 4.8 mp -95.27 104.36 16.25 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.162 173.22 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -93.08 148.04 34.97 Favored Pre-proline 0 CA--C 1.55 0.955 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 266' ' ' PRO . . . . . 0.49 ' HB2' ' HB3' ' A' ' 277' ' ' ARG . 74.3 Cg_endo -70.41 92.12 0.58 Allowed 'Trans proline' 0 C--N 1.376 2.007 0 C-N-CA 122.393 2.062 . . . . 0.0 112.239 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 267' ' ' LEU . . . . . 0.474 HD23 HD22 ' A' ' 280' ' ' LEU . 0.3 OUTLIER -64.32 126.21 27.05 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 172.304 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 22.9 ttpt -95.17 114.64 26.45 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-O 121.486 0.66 . . . . 0.0 111.083 -178.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 2.3 mp -113.08 124.99 70.27 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 C-N-CA 124.811 1.245 . . . . 0.0 109.231 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 35.5 ttp180 -93.09 107.21 19.05 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.165 0.507 . . . . 0.0 109.995 175.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 271' ' ' CYS . . . . . 0.668 ' SG ' HD21 ' A' ' 297' ' ' LEU . 48.9 t -82.33 -172.76 4.17 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.782 0.833 . . . . 0.0 111.322 179.042 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 272' ' ' ARG . . . . . 0.478 ' N ' ' SG ' ' A' ' 271' ' ' CYS . 35.8 ptt180 -57.37 -34.88 69.3 Favored 'General case' 0 CA--C 1.552 1.058 0 C-N-CA 124.622 1.169 . . . . 0.0 112.772 176.168 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -153.62 27.54 0.49 Allowed 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.165 0.586 . . . . 0.0 110.687 -177.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 274' ' ' ASP . . . . . 0.531 ' HB2' ' HB3' ' A' ' 271' ' ' CYS . 4.7 m-20 -141.29 158.85 43.34 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.589 0.756 . . . . 0.0 109.681 -175.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 26.9 tp -132.79 86.46 2.32 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 169.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 67.7 t -86.23 144.43 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.6 0.76 . . . . 0.0 109.927 -174.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . 0.49 ' HB3' ' HB2' ' A' ' 266' ' ' PRO . 52.9 mtp180 -128.5 87.02 2.52 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 172.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.455 HD11 HG12 ' A' ' 289' ' ' VAL . 3.9 pp -95.66 142.93 25.27 Favored Pre-proline 0 N--CA 1.48 1.056 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 -175.546 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -65.55 125.33 14.21 Favored 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 122.919 2.413 . . . . 0.0 111.343 175.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.696 HD21 ' HG3' ' A' ' 319' ' ' PRO . 0.1 OUTLIER -140.72 148.31 40.55 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.954 0.902 . . . . 0.0 110.639 -178.151 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 70.3 mtp180 -87.9 142.94 27.4 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.347 1.059 . . . . 0.0 110.671 179.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 282' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -62.04 -35.03 77.36 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.658 0.783 . . . . 0.0 111.829 175.024 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 44.4 p -75.36 -20.38 59.04 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.892 0.877 . . . . 0.0 111.595 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -86.57 130.23 49.96 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 124.207 1.003 . . . . 0.0 108.99 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . 0.509 ' HA ' ' HA ' ' A' ' 318' ' ' THR . 40.9 Cg_endo -65.76 178.25 2.38 Favored 'Trans proline' 0 C--N 1.38 2.209 0 C-N-CA 122.608 2.205 . . . . 0.0 112.753 173.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.45 ' O ' HG23 ' A' ' 290' ' ' VAL . 90.7 mt -64.43 -18.22 64.53 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.563 0.745 . . . . 0.0 111.965 -179.122 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 27.7 tp60 -52.48 -23.36 6.07 Favored 'General case' 0 CA--C 1.558 1.264 0 C-N-CA 123.678 0.791 . . . . 0.0 112.271 178.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . 0.56 ' HB3' HD12 ' A' ' 280' ' ' LEU . 37.3 t -63.24 -57.31 10.87 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.841 0.856 . . . . 0.0 110.856 171.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.47 ' O ' ' HG2' ' A' ' 293' ' ' MET . 27.7 m -65.4 -35.36 75.13 Favored 'Isoleucine or valine' 0 C--N 1.368 1.381 0 O-C-N 123.167 0.292 . . . . 0.0 110.342 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . 0.592 HG13 ' HB ' ' A' ' 304' ' ' ILE . 71.6 t -55.73 -53.21 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 124.42 1.088 . . . . 0.0 111.336 178.259 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -63.87 -42.97 97.4 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.066 -177.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 13.5 t60 -71.85 -38.09 70.15 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.231 -176.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 293' ' ' MET . . . . . 0.47 ' HG2' ' O ' ' A' ' 289' ' ' VAL . 91.0 mmm -68.9 -34.38 75.31 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 123.156 0.582 . . . . 0.0 110.125 177.327 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -66.29 -43.4 86.46 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.571 0.748 . . . . 0.0 111.376 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 26.2 m -70.14 -32.65 70.74 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.381 0.672 . . . . 0.0 110.644 176.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 79.2 t60 -63.36 -35.11 79.32 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.905 0.882 . . . . 0.0 111.812 177.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 297' ' ' LEU . . . . . 0.668 HD21 ' SG ' ' A' ' 271' ' ' CYS . 75.7 mt -99.53 -23.27 15.14 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.244 0.618 . . . . 0.0 111.893 -177.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 82.63 25.12 51.57 Favored Glycine 0 CA--C 1.531 1.071 0 O-C-N 123.262 0.351 . . . . 0.0 112.787 -173.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 33.4 m -107.33 177.99 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 124.521 1.128 . . . . 0.0 109.878 176.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 47.6 m -83.17 144.36 46.93 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 123.042 0.537 . . . . 0.0 110.6 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -55.75 -31.99 82.48 Favored 'Trans proline' 0 C--N 1.388 2.606 0 C-N-CA 123.263 2.642 . . . . 0.0 112.096 170.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 34.2 t -70.85 -6.02 34.9 Favored 'General case' 0 CA--C 1.56 1.328 0 C-N-CA 122.558 0.343 . . . . 0.0 111.787 -178.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 58.1 mtt180 -106.44 -16.25 14.59 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.243 1.017 . . . . 0.0 112.173 178.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 304' ' ' ILE . . . . . 0.592 ' HB ' HG13 ' A' ' 290' ' ' VAL . 38.9 mm -81.16 108.17 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 177.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 24.1 tp -110.36 130.25 55.59 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 174.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -95.89 131.41 42.26 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . 0.469 HD12 HG21 ' A' ' 333' ' ' VAL . 72.9 mt -133.48 105.69 7.05 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.587 0.755 . . . . 0.0 109.602 -175.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . 0.578 ' HB2' HD11 ' A' ' 313' ' ' LEU . 85.4 t80 -78.23 95.1 4.89 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -176.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 73.17 -85.11 0.59 Allowed Glycine 0 C--N 1.344 1.017 0 N-CA-C 111.436 -0.666 . . . . 0.0 111.436 -177.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -139.2 13.59 2.61 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.706 0.802 . . . . 0.0 111.566 -179.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 6.2 t -104.77 147.49 27.65 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 175.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -92.92 122.97 35.84 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.956 0.502 . . . . 0.0 110.32 -176.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.578 HD11 ' HB2' ' A' ' 308' ' ' PHE . 40.2 mt -110.83 130.72 55.5 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.096 0.559 . . . . 0.0 109.802 -179.49 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 16.5 m -73.65 142.18 80.32 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 123.054 0.542 . . . . 0.0 110.198 174.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . 0.44 ' HB3' HG21 ' A' ' 290' ' ' VAL . 30.9 Cg_endo -62.62 -25.81 75.49 Favored 'Trans proline' 0 C--N 1.381 2.255 0 C-N-CA 122.821 2.347 . . . . 0.0 111.934 173.152 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 28.6 p -78.63 -18.32 54.67 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.558 1.143 . . . . 0.0 111.853 177.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -73.94 149.77 41.21 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.052 0.541 . . . . 0.0 110.257 176.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 318' ' ' THR . . . . . 0.509 ' HA ' ' HA ' ' A' ' 285' ' ' PRO . 60.7 p -99.2 142.6 24.9 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 123.26 0.624 . . . . 0.0 110.361 -176.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . 0.696 ' HG3' HD21 ' A' ' 280' ' ' LEU . 37.9 Cg_endo -62.49 -15.96 48.96 Favored 'Trans proline' 0 C--N 1.377 2.046 0 C-N-CA 123.378 2.719 . . . . 0.0 112.521 174.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 73.4 ttt-85 -60.78 -57.8 11.14 Favored 'General case' 0 C--N 1.358 0.951 0 C-N-CA 123.826 0.851 . . . . 0.0 111.044 176.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 14.7 t -70.73 -25.14 62.79 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.309 -177.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 322' ' ' LEU . . . . . 0.519 HD13 HD13 ' A' ' 313' ' ' LEU . 65.5 mt -79.0 -19.7 50.91 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.277 0.631 . . . . 0.0 110.689 177.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt 59.06 57.44 3.52 Favored 'General case' 0 CA--C 1.55 0.942 0 C-N-CA 124.787 1.235 . . . . 0.0 109.9 -176.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.426 ' HG ' ' HB2' ' A' ' 322' ' ' LEU . 69.8 mt -93.9 140.24 29.93 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 114.416 -1.266 . . . . 0.0 108.85 177.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . -128.82 -157.73 9.38 Favored Glycine 0 C--O 1.239 0.436 0 O-C-N 123.977 0.798 . . . . 0.0 111.156 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . 0.427 ' HB ' ' NH2' ' A' ' 277' ' ' ARG . 29.6 m -75.07 -25.58 18.46 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 C-N-CA 123.382 0.673 . . . . 0.0 111.868 -175.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -98.31 -16.79 19.23 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.006 0.922 . . . . 0.0 111.915 -177.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -73.13 123.67 24.06 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.04 0.536 . . . . 0.0 110.605 -176.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 29.0 mt -106.26 120.32 57.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 C-N-CA 123.975 0.91 . . . . 0.0 110.357 -175.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 32.1 pt -113.71 130.4 67.85 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 174.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -77.76 111.08 13.19 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.74 0.816 . . . . 0.0 111.823 -174.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 332' ' ' CYS . . . . . 0.591 ' SG ' HD12 ' A' ' 304' ' ' ILE . 29.5 t -72.57 96.62 1.99 Allowed 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.545 0.738 . . . . 0.0 109.783 166.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . 0.469 HG21 HD12 ' A' ' 307' ' ' LEU . 75.3 t -105.28 114.34 44.57 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 177.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 52.5 t -78.66 90.13 1.27 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.775 0 CA-C-O 121.565 0.698 . . . . 0.0 109.606 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 86.0 mt -89.44 112.97 24.25 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.067 174.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 336' ' ' THR . . . . . . . . . . . . . 71.2 p -54.85 -32.97 61.24 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.754 1.222 . . . . 0.0 111.235 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 23.4 m 78.65 -51.73 0.47 Allowed 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 126.097 1.759 . . . . 0.0 111.812 175.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 49.5 m . . . . . 0 C--O 1.253 1.271 0 C-N-CA 124.48 1.112 . . . . 0.0 108.773 176.937 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 . . . . . 0 N--CA 1.48 1.056 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -177.3 168.69 40.56 Favored Glycine 0 C--N 1.34 0.761 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.178 179.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -70.39 138.06 51.01 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-O 121.077 0.465 . . . . 0.0 110.379 -179.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -90.62 24.94 2.47 Favored 'General case' 0 CA--C 1.562 1.41 0 C-N-CA 123.875 0.87 . . . . 0.0 110.67 -174.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 25.6 t70 56.19 70.28 0.66 Allowed 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.569 1.147 . . . . 0.0 110.487 -178.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -136.52 50.86 2.02 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.158 -173.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 23.0 m -67.89 141.18 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 177.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 12.1 m -70.26 87.78 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.088 0 CA-C-O 122.391 1.091 . . . . 0.0 110.491 177.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 5.5 tt -106.84 79.32 1.32 Allowed 'General case' 0 C--O 1.241 0.635 0 N-CA-C 106.714 -1.588 . . . . 0.0 106.714 175.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 51.4 t -81.82 104.38 10.3 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-N 114.74 -1.118 . . . . 0.0 109.324 -176.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -151.19 -73.51 0.15 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.835 0.854 . . . . 0.0 109.035 -178.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 173.69 66.59 0.05 OUTLIER Glycine 0 CA--C 1.528 0.856 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -177.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -62.83 135.14 50.36 Favored 'Trans proline' 0 C--N 1.38 2.211 0 C-N-CA 123.867 3.044 . . . . 0.0 112.737 -172.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 47.1 m -56.15 144.12 30.69 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.436 1.095 . . . . 0.0 110.783 176.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 90.8 mt -103.48 96.2 8.3 Favored Pre-proline 0 N--CA 1.479 1.009 0 C-N-CA 123.324 0.65 . . . . 0.0 110.943 -178.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -84.7 -14.39 6.5 Favored 'Trans proline' 0 C--N 1.373 1.86 0 C-N-CA 122.441 2.094 . . . . 0.0 111.094 163.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -74.89 92.99 2.6 Favored 'General case' 0 C--N 1.351 0.662 0 C-N-CA 124.971 1.308 . . . . 0.0 110.408 -174.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 18.7 p -71.73 149.06 92.9 Favored Pre-proline 0 CA--C 1.543 0.712 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.049 172.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -71.22 177.32 6.72 Favored 'Trans proline' 0 C--N 1.369 1.621 0 C-N-CA 122.458 2.105 . . . . 0.0 111.78 178.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -88.09 90.28 8.32 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 121.257 0.551 . . . . 0.0 109.711 178.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 5.0 mp -79.69 109.95 14.57 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.0 -1.0 . . . . 0.0 108.386 173.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 265' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -79.39 141.48 57.16 Favored Pre-proline 0 C--O 1.245 0.854 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -178.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -66.15 101.33 0.5 Allowed 'Trans proline' 0 C--N 1.373 1.829 0 C-N-CA 122.228 1.952 . . . . 0.0 111.153 175.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -68.03 127.77 34.07 Favored 'General case' 0 CA--C 1.549 0.937 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 172.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.511 ' HG2' HG12 ' A' ' 329' ' ' ILE . 5.2 tppp? -90.62 108.43 19.8 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.313 0.645 . . . . 0.0 110.238 177.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 3.6 mp -102.67 126.2 56.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 123.917 0.887 . . . . 0.0 109.177 178.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 30.8 ttp180 -96.93 95.13 7.62 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.276 0.631 . . . . 0.0 109.413 173.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 271' ' ' CYS . . . . . 0.487 ' HA ' ' HB3' ' A' ' 332' ' ' CYS . 42.8 t -71.85 -173.65 1.04 Allowed 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 123.819 0.848 . . . . 0.0 110.651 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 272' ' ' ARG . . . . . 0.409 ' HG2' ' SG ' ' A' ' 271' ' ' CYS . 7.5 ptm180 -55.48 -30.97 61.58 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.406 1.082 . . . . 0.0 112.311 174.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -144.89 -38.35 0.27 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.118 0.967 . . . . 0.0 110.366 -178.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -79.3 154.09 29.37 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.206 1.002 . . . . 0.0 111.433 -173.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 25.4 tp -119.69 85.33 2.36 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 173.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 95.0 t -89.94 147.56 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 114.856 -1.065 . . . . 0.0 109.875 -167.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -127.9 127.68 43.79 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 171.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.497 HD11 HG12 ' A' ' 289' ' ' VAL . 4.2 pp -129.41 144.35 52.48 Favored Pre-proline 0 N--CA 1.482 1.161 0 CA-C-N 118.023 0.374 . . . . 0.0 110.411 174.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -68.33 122.45 9.48 Favored 'Trans proline' 0 C--N 1.374 1.906 0 C-N-CA 122.68 2.254 . . . . 0.0 110.714 174.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.807 HD21 ' HG3' ' A' ' 319' ' ' PRO . 0.3 OUTLIER -149.02 150.75 33.34 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.007 0.923 . . . . 0.0 109.993 -177.441 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 58.1 mtm-85 -97.72 155.88 16.81 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.306 0.643 . . . . 0.0 110.486 179.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 282' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -61.31 -39.51 90.73 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.335 0.654 . . . . 0.0 111.228 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 12.1 t -78.67 -23.93 45.42 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.348 -178.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -70.61 122.36 86.4 Favored Pre-proline 0 C--N 1.352 0.707 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 175.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . 0.507 ' HA ' ' HA ' ' A' ' 318' ' ' THR . 55.5 Cg_endo -65.59 175.45 4.32 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 122.363 2.042 . . . . 0.0 112.639 -179.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.42 ' O ' HG23 ' A' ' 290' ' ' VAL . 78.4 mt -64.87 -16.97 63.87 Favored 'General case' 0 C--O 1.211 -0.967 0 CA-C-O 118.449 -0.786 . . . . 0.0 111.64 178.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 23.8 tp60 -52.52 -27.48 16.65 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.218 0.607 . . . . 0.0 112.274 179.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . 0.613 ' HB3' HD12 ' A' ' 280' ' ' LEU . 41.8 t -61.12 -55.7 29.38 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.7 0.8 . . . . 0.0 110.524 171.165 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.497 HG12 HD11 ' A' ' 278' ' ' LEU . 11.4 m -69.33 -28.27 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 122.503 0.321 . . . . 0.0 111.441 179.375 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . 0.529 HG13 ' HB ' ' A' ' 304' ' ' ILE . 54.9 t -69.53 -52.39 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 123.731 0.812 . . . . 0.0 109.991 -177.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -71.84 -32.99 68.09 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 122.955 0.502 . . . . 0.0 110.869 -178.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -64.3 -51.89 61.23 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.341 0.656 . . . . 0.0 110.008 178.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 94.2 mmm -68.99 -29.3 67.48 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.365 0.666 . . . . 0.0 111.065 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -61.7 -53.33 57.53 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.341 0.656 . . . . 0.0 110.682 176.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 21.9 m -65.25 -35.61 81.55 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 123.689 0.796 . . . . 0.0 110.846 178.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -67.04 -33.22 75.05 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.324 1.049 . . . . 0.0 111.663 -179.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 297' ' ' LEU . . . . . 0.487 HD21 ' SG ' ' A' ' 271' ' ' CYS . 47.6 mt -102.17 -3.68 27.04 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.06 0.944 . . . . 0.0 111.248 178.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 76.74 9.37 86.41 Favored Glycine 0 C--N 1.352 1.46 0 C-N-CA 123.548 0.594 . . . . 0.0 113.909 176.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 299' ' ' VAL . . . . . 0.484 HG11 HG11 ' A' ' 334' ' ' VAL . 35.4 m -102.48 179.82 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.056 0.942 . . . . 0.0 111.462 -177.173 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 49.4 m -77.65 147.62 75.09 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 123.54 0.736 . . . . 0.0 111.14 178.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.68 -27.47 83.28 Favored 'Trans proline' 0 C--N 1.384 2.407 0 C-N-CA 122.634 2.222 . . . . 0.0 111.333 168.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 20.2 m -64.12 -26.16 68.42 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 124.107 0.963 . . . . 0.0 111.549 178.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 78.2 mtt85 -84.35 -33.58 23.83 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.899 0.88 . . . . 0.0 111.64 179.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 304' ' ' ILE . . . . . 0.529 ' HB ' HG13 ' A' ' 290' ' ' VAL . 36.5 mm -72.55 105.12 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 122.703 0.401 . . . . 0.0 110.942 -175.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . 0.527 HD22 HD11 ' A' ' 335' ' ' LEU . 29.7 tp -107.62 129.24 55.02 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 123.618 0.767 . . . . 0.0 109.231 172.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -92.11 138.26 31.68 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 174.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . 0.463 HD23 ' HA ' ' A' ' 312' ' ' GLU . 92.6 mt -133.3 115.02 14.42 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.99 0.916 . . . . 0.0 109.47 -177.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . 0.572 ' HB2' HD11 ' A' ' 313' ' ' LEU . 66.0 t80 -87.25 88.16 7.62 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.06 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 73.74 -78.36 0.89 Allowed Glycine 0 C--N 1.349 1.269 0 CA-C-N 115.209 -0.905 . . . . 0.0 112.331 -177.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -120.62 -33.47 3.81 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.449 0.699 . . . . 0.0 110.644 179.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 8.5 t -76.65 148.38 36.91 Favored 'General case' 0 C--N 1.35 0.622 0 C-N-CA 122.757 0.423 . . . . 0.0 111.393 -169.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . 0.463 ' HA ' HD23 ' A' ' 307' ' ' LEU . 42.7 tt0 -85.24 130.56 34.58 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.687 178.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.594 HD22 HD22 ' A' ' 322' ' ' LEU . 46.9 mt -111.85 126.93 55.62 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 176.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 31.9 m -78.89 144.72 64.54 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 123.237 0.615 . . . . 0.0 110.727 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -59.75 -32.51 95.74 Favored 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 123.103 2.535 . . . . 0.0 112.747 178.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 7.1 m -79.36 -20.48 47.68 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 123.415 0.686 . . . . 0.0 111.361 -179.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -68.72 144.66 54.32 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.17 0.588 . . . . 0.0 110.543 178.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 318' ' ' THR . . . . . 0.507 ' HA ' ' HA ' ' A' ' 285' ' ' PRO . 81.8 p -98.8 142.72 25.08 Favored Pre-proline 0 N--CA 1.475 0.808 0 C-N-CA 123.399 0.679 . . . . 0.0 109.98 -175.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . 0.807 ' HG3' HD21 ' A' ' 280' ' ' LEU . 18.8 Cg_endo -56.88 -19.97 34.03 Favored 'Trans proline' 0 C--N 1.368 1.586 0 C-N-CA 123.143 2.562 . . . . 0.0 112.477 173.015 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 31.2 ttt180 -60.55 -55.33 34.71 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.504 0.722 . . . . 0.0 110.62 170.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . 0.453 HG22 ' O ' ' A' ' 318' ' ' THR . 12.4 t -72.17 -18.9 61.83 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -176.017 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 322' ' ' LEU . . . . . 0.594 HD22 HD22 ' A' ' 313' ' ' LEU . 47.0 mt -91.68 -18.74 23.52 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.657 0.783 . . . . 0.0 111.332 179.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 58.02 78.59 0.24 Allowed 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 124.606 1.162 . . . . 0.0 108.821 -169.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 66.5 mt -116.15 165.17 13.45 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.76 0.824 . . . . 0.0 109.022 174.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 325' ' ' GLY . . . . . 0.436 ' H ' ' HB3' ' A' ' 328' ' ' ASP . . . -158.69 -171.62 24.76 Favored Glycine 0 C--N 1.345 1.072 0 O-C-N 122.946 0.154 . . . . 0.0 112.76 -171.168 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 35.1 m -64.58 -32.73 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.325 1.05 . . . . 0.0 112.102 -175.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -112.17 4.84 18.14 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.606 0.762 . . . . 0.0 111.499 -178.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 328' ' ' ASP . . . . . 0.436 ' HB3' ' H ' ' A' ' 325' ' ' GLY . 23.7 t0 -95.89 127.47 41.94 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -178.203 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . 0.511 HG12 ' HG2' ' A' ' 268' ' ' LYS . 6.0 mt -111.47 143.15 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 C-N-CA 123.414 0.686 . . . . 0.0 111.798 -165.028 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 27.7 pt -137.54 133.9 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 123.612 0.765 . . . . 0.0 111.168 177.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 331' ' ' ASP . . . . . 0.404 ' HB2' ' HB2' ' A' ' 307' ' ' LEU . 6.2 m-20 -72.89 111.49 8.06 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.709 1.204 . . . . 0.0 112.523 -175.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 332' ' ' CYS . . . . . 0.487 ' HB3' ' HA ' ' A' ' 271' ' ' CYS . 42.0 t -75.61 115.97 15.84 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 165.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . 0.442 HG21 HD12 ' A' ' 307' ' ' LEU . 99.3 t -126.12 117.84 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 123.812 0.845 . . . . 0.0 109.402 -177.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 334' ' ' VAL . . . . . 0.484 HG11 HG11 ' A' ' 299' ' ' VAL . 62.0 t -84.57 99.69 7.12 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 123.187 0.595 . . . . 0.0 109.664 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 335' ' ' LEU . . . . . 0.527 HD11 HD22 ' A' ' 305' ' ' LEU . 89.1 mt -72.88 160.08 32.7 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.863 0.865 . . . . 0.0 111.165 177.392 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 336' ' ' THR . . . . . . . . . . . . . 9.4 t -86.74 57.58 4.58 Favored 'General case' 0 CA--C 1.555 1.169 0 CA-C-O 121.979 0.895 . . . . 0.0 110.153 178.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 11.0 m -73.19 82.91 1.33 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.106 0.963 . . . . 0.0 110.208 -176.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 13.4 p . . . . . 0 CA--C 1.553 1.081 0 C-N-CA 124.642 1.177 . . . . 0.0 108.502 -176.739 . . . . . . . . 0 0 . 1 stop_ save_